Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6310540914990664,2.6679542869350548,0.0,0.0,0.0,81/224,11.89%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;CHRM3;GABRA2;GRM1;GLRA1;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;GRIN2B;HCRTR1;SNCA;APBA2;SLC18A3;CAMK4;GABRB2;SLC1A1;GLRA3;GRIK2;SLC12A6;KCNN1;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1
prerank,chemical synaptic transmission (GO:0007268),0.6018059921159324,2.6090495736564576,0.0,0.0,0.0,98/284,11.92%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;PTPRN2;CDH8;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;RIMS1;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;SHISA6;CHRM3;GABRA2;ERC2;GRM1;GLRA1;GRID1;GRID2;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;LIN7A;GRIN2B;HCRTR1;SNCA;APBA2;SLC17A6;SLC18A3;CAMK4;GABRB2;SLC1A1;GRIN2D;GLRA3;GRIK2;GRIK5;DLGAP2;UNC13A;SLC12A6;KCNN1;HSPA8;PPFIA3;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SNPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1;DVL1
prerank,cytoplasmic translation (GO:0002181),0.6617982405866404,2.511628551192895,0.0,0.0,0.0,56/91,19.67%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPL22L1;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;EIF3I;EIF2B3;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29;RWDD1;RPS9;RPL31;RPL19;RPL3;RPS10;EIF4A1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6611680484744527,2.476478884041049,0.0,0.0,0.0,47/91,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;ARL6IP1;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;RPS25;RPS29
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6698672199897123,2.4763751581061313,0.0,0.0,0.0,45/87,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29
prerank,protein targeting to ER (GO:0045047),0.616395005578532,2.348433048992896,0.0,0.0,0.0,48/99,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;SGTB;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;SEC61G;RPS25;RPS29
prerank,glutamate receptor signaling pathway (GO:0007215),0.7201374955461448,2.326089656269894,0.0,0.0,0.0,17/37,10.21%,GRIA2;GRM5;GRIN1;GRIA4;GRM7;GRM1;GRID2;GRIN2A;GRM8;GRIK1;GRIN2B;GRIK2;PLCB1;GRIA3;HOMER1;GRIN3A;HOMER2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6617680349242706,2.2976204131296787,0.0,0.0,0.0,24/57,11.89%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;DLGAP1;LRRC7;NLGN1;SHISA6;MAPK8IP2;NETO1;GRIN2A;GRIA1;GRIN2B;DLGAP2;CACNG2;SHISA8;SHISA7;GRIA3;CACNG3;RELN;OPRM1;CACNG8;NPTX1
prerank,cellular response to copper ion (GO:0071280),0.8693055875586457,2.2697290773761267,0.0,0.0,0.0,10/16,5.23%,MT2A;SNCA;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B
prerank,response to copper ion (GO:0046688),0.8241417224021517,2.2692563048968846,0.0,0.0,0.0,11/20,7.23%,MT2A;SNCA;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;ATP5F1D
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5724430577306077,2.2018932951301915,0.0,7.159650335833139e-05,0.001,50/110,14.45%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28
prerank,regulation of NMDA receptor activity (GO:2000310),0.7016441989552546,2.2011971948836657,0.0,6.563012807847044e-05,0.001,15/32,9.59%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;NLGN1;MAPK8IP2;GRIN2A;GRIA1;GRIN2B;GRIA3;CCL2;RELN;OPRM1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6976120319672594,2.1881479108849096,0.0,0.00012116331337563774,0.002,15/34,8.57%,MPP2;GABRA5;GRIN1;MAPK8IP2;GABRA2;GLRA1;GRID2;GRIN2A;GABRG3;GABRA3;GABRA4;GRIN2B;GRIN2D;AKT1;GABRG2
prerank,extracellular structure organization (GO:0043062),-0.5085518469193888,-2.172298288482736,0.0,0.0023886189333177216,0.002,72/204,12.78%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,neurotransmitter secretion (GO:0007269),0.6465564666674948,2.150174528888598,0.0,0.0006187983504541498,0.011,19/44,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;RIMS2;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,peptide biosynthetic process (GO:0043043),0.5256288158684391,2.1452778497161686,0.0,0.0006825533320160926,0.013,70/153,19.34%,RPS6;RPS19;RPS20;RPL38;RPL29;PCSK1;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;CARNS1;MRPL13;RPL13;MRPS18A;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;GGT7;RPL5;FARSB;RPS4X;RPL21;GGT1;RPS7;RPL23A;EEF1A2;RPL8;MRPL36;MRPL23;RPS14;RPS3;RPS2;RPS5;EEF1A1;RPL18A;RPS28;RPS25;RPS29;HBS1L;TNIP1;MRPS5;RPS9;RPL31;MRPL18;RPL19;RPL3;RPS10
prerank,collagen fibril organization (GO:0030199),-0.5685739647528256,-2.1419395720466534,0.0,0.0035829283999765822,0.006,31/88,11.17%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;COL8A1;COL5A1;COL4A6;COL1A1;COL12A1;COL22A1;COL4A3;LOXL1;COL6A3;COL4A4;COL23A1;COL25A1;COL6A1;COL8A2;COL26A1;PLOD2;COL6A2;COL15A1;CYP1B1;COL13A1;COL18A1;LAMA3;COL5A3;COL27A1;P4HA2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5568838882011671,2.12865003402905,0.0,0.0008367841330004982,0.017,32/107,7.67%,CAMK2A;NRG3;GRM5;CACNA1A;DLGAP1;LRP8;LRRC4C;SYT1;CACNA1B;RIMS1;GRM7;DGKI;TMEM108;NLGN1;MAPK8IP2;GRM1;RIMS2;GRID1;GRID2;GRM8;MCTP1;CDH2;GRIK1;RIMS3;GRIK2;GRIK5;DLGAP2;UNC13A;KCNMB4;KCTD13;HOMER1;CLSTN3
prerank,response to zinc ion (GO:0010043),0.7257073981902353,2.1214570390754215,0.0,0.0008338886861735068,0.018,14/25,11.74%,MT2A;GLRA1;KHK;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SLC30A3;GLRA2;SLC30A5
prerank,external encapsulating structure organization (GO:0045229),-0.4969342260279083,-2.117904461213096,0.0,0.0031848252444236285,0.007,71/205,12.78%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,synapse assembly (GO:0007416),0.5924494844700096,2.107950021469412,0.0,0.0010500820492555269,0.024,23/67,9.15%,SPOCK2;DNM3;DSCAM;KIRREL3;GABRB3;ADGRL3;NRXN1;LRRTM3;NLGN1;GPM6A;GABRA2;GRID2;DNER;SHANK3;CDH2;FGF13;GABRB2;NRXN2;NRCAM;LGI2;PCDHB6;GABRG2;SHANK2
prerank,signal release from synapse (GO:0099643),0.6349834760565913,2.1061873278131067,0.0,0.0010362651801863756,0.025,18/43,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,chloride transmembrane transport (GO:1902476),0.6227441567230387,2.1003347248062836,0.0,0.0011813423054124678,0.03,20/48,10.99%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2;CLCN1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.8551045287791516,-2.097589396035124,0.0,0.004180083133306012,0.013,8/13,7.78%,AKAP13;ROCK2;ASAP3;ROCK1;ALMS1;SLC9A1;FHOD1;CDC42
prerank,cellular response to zinc ion (GO:0071294),0.8184917717213425,2.0936428791471986,0.0,0.0013876084222305177,0.036,11/15,9.42%,MT2A;GLRA1;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;GLRA2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6647719269087335,2.0926295678873696,0.0,0.0013245353121291307,0.036,11/35,9.35%,CDH12;CDH8;NLGN1;CDH7;CDH19;CDH20;PCDHGB4;CDH18;CDH10;PCDHB6;DCHS1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5778038510485887,2.0866808966216284,0.0,0.0013696722381593832,0.039,26/72,10.81%,MPP2;SLC24A2;NRXN1;SYT1;RIMS1;ADCY8;NLGN1;RIMS2;GRIN2A;SHANK3;RIMS3;GRIN2B;GRIN2D;GRIK2;CACNG2;NPTN;KCTD13;SHISA7;CLSTN3;CACNG3;ADRA1A;CCL2;RELN;SHANK2;CACNG8;HAP1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5124064972506495,2.0722410749460543,0.0,0.0017063833300402318,0.048,54/159,12.48%,CLDN5;DSCAM;BSG;KIRREL3;ADGRL3;HMCN1;CDH12;CDH8;PTPRD;LRRC4C;CADM1;IGSF11;MAG;LRFN5;IL1RAPL1;NLGN1;TENM2;PLXNB3;CDH7;CDH19;CDH20;GRID2;TENM1;PCDHGB4;PTPRT;CDH18;MPZ;CDH2;ROBO4;CNTN6;TENM4;CDH10;TGFB2;DSCAML1;CLDN14;UNC5D;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;LRRC4B;ROBO2;NTNG1;DCHS1;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;CRB1;NECTIN1;CNTN2;ITGAM
prerank,regulation of cation channel activity (GO:2001257),0.540514288491817,2.0382270943073184,0.0,0.004315837222440216,0.119,32/89,11.22%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;FGF12;NLGN1;SHISA6;MAPK8IP2;FGF14;NETO1;GRIN2A;ANK3;GRIA1;FGF13;GRIN2B;CACNG2;SHISA8;SHISA7;CACNB2;GRIA3;HOMER1;EPO;KCNAB1;CACNG3;RELN;OPRM1;CACNG8;CACNB4;CALM1;JPH3
prerank,bone development (GO:0060348),-0.6234226240698191,-2.0332570357513355,0.0,0.016003746853228733,0.058,13/39,12.28%,AKAP13;RANBP3L;SULF1;LRP6;SH3PXD2B;CYP26B1;SULF2;SKI;FGFR2;SLC10A7;GJA1;MBTPS2;GNAS
prerank,regulation of glucose import (GO:0046324),-0.6670863182462167,-2.0197249566738833,0.0,0.015326971488788711,0.066,11/30,4.55%,PRKAG2;IGF1;PID1;RHOQ;SORBS1;APPL2;GRB10;ENPP1;OSBPL8;IRS1;CREBL2
prerank,cellular zinc ion homeostasis (GO:0006882),0.6850199010736799,2.0155668521858736,0.002070393374741201,0.006573109750628347,0.183,13/26,11.74%,SLC39A10;MT2A;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SLC30A1;SLC39A8;SLC30A5
prerank,extracellular matrix organization (GO:0030198),-0.455175644368916,-2.009834328270144,0.0,0.017402795085600543,0.089,82/276,12.78%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;GSN;COL12A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;FLRT2;ADAMTSL5;ITGAV;LOXL1;SH3PXD2B;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL25A1;COL6A1;ITGA10;COL8A2;FBLN5;COL26A1;PLOD2;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;CYP1B1;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;P4HA2;ADAM19;ADAMTS15;MMP2;LUM;SCUBE1;FN1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6010139254600477,1.9963055162229615,0.0,0.008167304827542987,0.228,19/46,10.73%,GRM5;NRXN1;SYT1;GRM7;DGKI;NLGN1;MAPK8IP2;GRM1;GRM8;SHANK3;CDH2;GRIK1;CACNG2;UNC13A;HOMER1;CACNG3;CCL2;RELN;CACNG8
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.7460063948982535,1.9958153475759723,0.0,0.0079599969626602,0.231,9/18,4.96%,GRIA2;CDH8;GRID1;GRID2;GRIK1;SLC17A6;GRIK2;GRIK5;UNC13A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.685441201444551,-1.982650763407499,0.001893939393939394,0.024632632749839,0.138,9/24,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.6619583131766021,-1.9810566404994845,0.0,0.023222684073922292,0.144,13/27,10.71%,EGFR;DDX5;BMP4;TNRC6B;PUM2;WTIP;DDX6;EIF4ENIF1;STAT3;DHX9;PUM1;MAP2K1;LIMD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8441279110517163,1.9746787596042936,0.0,0.010238299980241389,0.29,7/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,eye development (GO:0001654),-0.5684433758933749,-1.9671704588417172,0.0,0.027946841519817342,0.185,15/54,6.59%,PBX1;CACNA1C;FBN1;SMOC1;COL5A2;EFEMP1;COL5A1;FOXC1;SH3PXD2B;LAMA1;SHROOM2;RBP4;PBX3;SKI;RAB3GAP1
prerank,positive regulation of synapse assembly (GO:0051965),0.6629173070230892,1.9629011459868242,0.0,0.012075943566438561,0.342,10/27,8.03%,NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;SEMA4A;SEMA4D;CLSTN3;LRRC4B
prerank,actin filament bundle assembly (GO:0051017),-0.6362737961294395,-1.9615325580972112,0.0,0.027469117733153792,0.196,7/33,3.48%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,eye morphogenesis (GO:0048592),-0.7222249591396888,-1.9603712092337142,0.0,0.025578127744277267,0.199,12/19,15.74%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;RARG;MFAP5;SKI;STAT3;NIPBL;VEGFA;FBN2
prerank,inorganic anion transmembrane transport (GO:0098661),0.5493611157801799,1.9520640008570769,0.0,0.01366800344756791,0.384,22/63,9.42%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;SLC37A4;ANO5;GABRD;SLC37A1;SLC25A14;GABRG2;ANO4;SLC12A3;GLRA2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.6654068705510042,-1.947109892050258,0.0,0.028939037076733936,0.241,9/26,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,dendrite self-avoidance (GO:0070593),0.7404711542122638,1.9438772303661278,0.0,0.015062114394008966,0.424,10/16,12.10%,DSCAM;BSG;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ROBO3;CNTN4;CNTN2
prerank,neuromuscular process controlling balance (GO:0050885),0.7818667197912311,1.9386681045905476,0.0021141649048625794,0.016037616752266233,0.453,2/12,0.54%,PCDH15;NRXN1
prerank,cell junction assembly (GO:0034329),0.5105920243734936,1.9385731432870796,0.0,0.01556592214190546,0.453,28/100,9.35%,SPOCK2;CLDN5;DNM3;DSCAM;KIRREL3;ADGRL3;NRXN1;CDH12;CDH8;ACTB;CTNND2;NLGN1;GPM6A;CDH7;CDH19;CDH20;ITGA6;DNER;CDH18;SHANK3;CDH2;CDH10;NRXN2;NRCAM;PCDHB6;VMP1;SHANK2;DCHS1
prerank,odontogenesis (GO:0042476),-0.6087330444997205,-1.9355689531614777,0.0,0.03173450868550687,0.274,11/35,6.61%,COL1A2;LRP6;ANKRD11;GLI2;FOXC1;BMP4;BCOR;EDA;OSR1;WNT6;FGFR2
prerank,embryonic limb morphogenesis (GO:0030326),-0.6179219803748023,-1.9345892134773903,0.0,0.030574322346466835,0.284,17/34,17.03%,CACNA1C;GLI3;LRP6;AFF3;OSR1;CYP26B1;WDPCP;RARG;SKI;CREBBP;ECE1;MAP3K20;NIPBL;HDAC1;PTCH1;SALL1;TBX2
prerank,chloride transport (GO:0006821),0.5284152425778852,1.9340478394526297,0.0,0.015976248320816233,0.473,21/74,9.42%,GABRB3;GABRA5;SLC4A1;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;CLIC5;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2
prerank,synaptic vesicle exocytosis (GO:0016079),0.5907124420018303,1.9338036583684732,0.0,0.015663723901394946,0.474,14/40,11.21%,SYT1;RIMS1;PCLO;SYT7;RIMS2;SNAP25;RIMS3;SNCA;UNC13A;STX3;SNPH;SYT10;CPLX1;SYT2
prerank,actin filament bundle organization (GO:0061572),-0.6219773648706863,-1.9286565487783824,0.002,0.031350623499795095,0.306,7/33,3.48%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6928474652113634,-1.9285207525439494,0.002028397565922921,0.02957672267431649,0.307,8/21,10.61%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4;CCN3;SMAD4
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6205565177438171,1.919212425664178,0.0,0.01888019143965512,0.537,11/33,4.69%,NRG3;CACNA1A;LRP8;LRRC4C;CACNA1B;NLGN1;GRID1;GRID2;GRIK1;GRIK2;GRIK5
prerank,endodermal cell differentiation (GO:0035987),-0.6212741080231678,-1.918786623452334,0.0,0.03284351033311867,0.351,17/31,19.85%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;CTR9;SETD2;LAMA3;MMP14;RTF1;MMP2;FN1;ITGA5;ITGA4;INHBA;CDC73
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.782835785793095,-1.9144443676669078,0.0,0.032372072385753334,0.36,6/13,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4
prerank,regulation of regulated secretory pathway (GO:1903305),0.6081367941971799,1.9119605753332285,0.0,0.020538775871293963,0.581,10/34,3.46%,SYT1;RIMS1;SYT6;SYT7;RIMS2;DOC2A;SYT12;SYT11;PREPL;RIMS3
prerank,zinc ion homeostasis (GO:0055069),0.6347474563767922,1.9076213627858543,0.0020833333333333333,0.021405518696362667,0.601,13/28,11.74%,SLC39A10;MT2A;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SLC30A1;SLC39A8;SLC30A5
prerank,mRNA destabilization (GO:0061157),-0.5907333602178922,-1.9016279112248884,0.0,0.03779989461975294,0.421,12/38,9.94%,ROCK2;CELF1;FTO;DIS3L2;ROCK1;YTHDF3;MOV10;RC3H1;PUM1;TUT4;DHX36;UPF1
prerank,translation (GO:0006412),0.4471257962081608,1.8921613585182429,0.0,0.026166732064886167,0.69,86/208,20.34%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;VARS1;GARS1;RPL10A;RPS24;EEF1B2;RPL27A;RARS1;RPS17;RPL22L1;RPS6KB2;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TUFM;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;RPS7;RPL23A;EEF1A2;RPL8;AIMP2;MRPL36;MRPL23;RPS14;GATB;RPS3;RPS2;IARS1;RPS5;EEF1A1;RPL18A;GATC;RPS28;RPS25;RPS29;RWDD1;HBS1L;TNIP1;MRPS5;NDUFA7;EEF2;RPS9;RPL31;MRPS28;MRPL18;RPL19;RPL3;RPS10;EEF1E1;MRPL37;MRPL2;ASMT
prerank,regulation of muscle contraction (GO:0006937),-0.6471093937885171,-1.8856424915279686,0.0,0.04805673806317797,0.519,5/26,2.75%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6
prerank,neuron cell-cell adhesion (GO:0007158),0.7527234792228853,1.8813532722692583,0.002053388090349076,0.029908129585808338,0.739,9/14,12.13%,NCAM2;NRXN3;NRXN1;NLGN1;ASTN1;NRXN2;ASTN2;CNTN4;RET
prerank,muscle organ development (GO:0007517),-0.5454675467661316,-1.8801657204970015,0.0,0.050486718363306385,0.549,19/54,15.23%,LAMA2;IGF1;LARGE1;FHL1;COL6A3;MEF2A;SPEG;ITGA11;MRAS;VAMP5;SMTN;CHD2;EVC;MEF2C;SRI;FKTN;SOX6;MKX;EMD
prerank,calcium-ion regulated exocytosis (GO:0017156),0.6348771351481927,1.879726099849011,0.0,0.029777326682460303,0.745,9/27,7.62%,SYT1;RIMS1;SYT6;SYT7;RIMS2;SYT12;SYT11;RIMS3;SYT10
prerank,regulation of stress fiber assembly (GO:0051492),-0.5125515453343804,-1.8755876670917468,0.0,0.05228998404023795,0.572,24/74,7.95%,PHLDB2;ROCK2;LPAR1;ARHGAP6;TGFBR1;CGNL1;ASAP3;TPM1;ARHGAP28;CCN2;ROCK1;ABL1;ARHGEF10L;PPM1E;ARAP1;ALMS1;SLC9A1;WASF2;PAK2;NRP1;FHOD1;CDC42;RAPGEF3;S100A10
prerank,skeletal system development (GO:0001501),-0.46160138982406745,-1.8745955107087702,0.0,0.05075815233300158,0.576,40/148,13.92%,BMP6;AKAP13;COL1A2;SULF1;FBN1;IGF1;TGFBR1;SOX5;CREB3L2;COL1A1;PKD1;ANKRD11;GLI2;BMP5;WWOX;BMP7;SH3PXD2B;NPR3;PCSK5;CDH11;RBP4;EXT1;SULF2;ZBTB16;FGFR2;EIF2AK3;SLC10A7;IGF2;GJA1;TNFRSF11B;COL13A1;ITGB8;PRELP;MMP14;EVC;GNAS;SUFU;SOX6;CHD7;TRPS1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.544496521795442,-1.8669241574148188,0.0,0.0545082840583104,0.619,32/50,28.54%,ZIC1;GLI3;FBXL17;SMO;BTRC;DCDC2;TTC23;GPC3;IFT81;CREBBP;FGFR2;GAS1;TULP3;EVC;GLIS2;HERC4;RORA;SUFU;ARMC9;GLI1;PTCH1;WDR11;VCP;MEGF8;PDCL;DLG5;KIF7;MGRN1;GAS8;PTCH2;IFT122;KCTD6
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6765456794960553,-1.8648215085022897,0.0,0.05420327579451753,0.635,8/20,6.42%,IGF1;LRP1;BMPR1A;IGFBP5;PDGFRB;VTN;IGFBP3;NRP1
prerank,response to ethanol (GO:0045471),0.736940429619945,1.864173444287518,0.002207505518763797,0.036099623007255416,0.811,6/14,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;GLRA2;GRIN3A
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.7331567487553228,-1.8574988269911392,0.0,0.05847693018233385,0.673,8/15,11.61%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7372602914811593,1.8564408574336024,0.0021413276231263384,0.03909169083364894,0.833,6/13,17.04%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5208344054611529,-1.8487549240903198,0.0,0.06427944165196083,0.716,26/65,16.37%,FBN1;SMAD3;TGFBR1;LDLRAD4;LTBP1;SMAD6;SMURF2;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;FBN2;VASN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6709490153709929,1.8479098773151101,0.0020920502092050207,0.04307086538696421,0.871,7/20,8.00%,MRAP2;BICD1;STMN1;YWHAB;SNCA;GRK2;RNF157
prerank,regulation of establishment of cell polarity (GO:2000114),-0.7089990511250039,-1.8469676652992293,0.0018726591760299626,0.06354550024326283,0.723,7/16,6.51%,ROCK2;GSN;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.4969145374500584,-1.844712235620496,0.0,0.06369650488847257,0.733,36/82,18.76%,BMP6;RANBP3L;IGF1;SMOC1;CRIM1;BMPR1A;WNT4;SMAD6;DDX5;BMP7;IL6ST;TMEM64;BMP4;YAP1;SKI;FGFR2;REST;NBR1;LIMD1;MEF2C;SUFU;IL6R;TRPM4;ATRAID;CCN1;ACVR1;PTCH1;RUNX2;FBN2;SUCO;TWIST2;CCN4;PRKACA;PRKD1;NPNT;BMP2
prerank,digestive tract development (GO:0048565),-0.5877501090961695,-1.844492895917757,0.0018181818181818182,0.06179588337163911,0.734,18/33,21.34%,GLI3;PKD1;GLI2;CLMP;RARB;SMO;PCSK5;KIT;FGFR2;CHD8;NIPBL;GLI1;CCDC39;SALL1;MEGF8;PKDCC;ZIC3;GATA6
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6371642571192379,1.8421166973263954,0.0,0.04531903018009859,0.891,9/25,7.97%,MPP2;GRIN1;MAPK8IP2;GLRA1;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6960248074229209,-1.8419926523483798,0.0018796992481203006,0.062253380949593116,0.746,12/17,16.73%,PBX1;RBPJ;KAT2B;EP300;CREBBP;NOTCH3;MAML2;WWC1;MAML1;STAT1;PLXND1;HEYL
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5281419427922013,1.8393789629174317,0.0,0.04608072822530903,0.902,25/59,12.10%,DSCAM;BSG;KIRREL3;HMCN1;CADM1;IGSF11;PLXNB3;PTPRT;CDH2;ROBO4;CNTN6;DSCAML1;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;ROBO2;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;NECTIN1;CNTN2
prerank,positive regulation of cell junction assembly (GO:1901890),0.5284040174731065,1.8389573393904621,0.00228310502283105,0.04538323356626232,0.903,15/56,8.03%,CLDN5;CNTNAP2;TEK;NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;PPM1F;KDR;THY1;PTPRJ;CLSTN3;LRRC4B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5420128160850368,-1.8246344935655394,0.0,0.07697867380555748,0.826,20/46,15.51%,ZIC1;TCF7L2;SMAD3;XPO4;GSK3B;FLNA;KHDRBS1;UBR5;CDH1;DHX9;RAPGEF3;JUP;BAG3;PRKCD;MAVS;TPR;YWHAE;EMD;EFCAB7;ANP32B
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.752863430700545,-1.8220686291448325,0.0017921146953405018,0.07741935483870968,0.835,7/12,19.20%,ROCK2;ROCK1;FLOT2;APOE;RANBP9;PICALM;ABCA7
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7434518234966156,-1.819723631596276,0.001937984496124031,0.077425376567113,0.845,4/13,2.90%,UST;DSE;DCN;BGN
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.65747014126914,-1.8153048199283526,0.0,0.08061588899947308,0.862,11/20,19.25%,CELF1;TNRC6B;WTIP;TNRC6A;MOV10;LIMD1;CNOT8;HELZ;TNRC6C;CNOT1;AJUBA
prerank,regulation of ion transport (GO:0043269),0.48945747587160576,1.813906173718707,0.0,0.06200841652083404,0.956,22/76,12.77%,NKAIN2;SYT1;KCNJ3;SYT6;SPTBN4;NKAIN1;SYT7;NKAIN3;KCNJ6;SYT12;SYT11;ANK3;SNCA;KCNJ11;CA2;KCNJ10;SYT10;ATP1A1;SYT2;P2RX7;KCNA2;KCNJ8
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5785698241682591,1.8132915239011596,0.0,0.0613195412662765,0.958,8/32,16.08%,PGLYRP1;RPS19;S100A9;RPL30;CXCL14;HMGN2;DEFA6;RNASE3
prerank,synaptic vesicle cycle (GO:0099504),0.5908031399495637,1.8100583403292312,0.002150537634408602,0.06226368856762185,0.962,10/30,12.16%,RIMS1;PCLO;NLGN1;SYT7;SNAP25;SNCA;SLC17A6;SYT10;CPLX1;PLD2
prerank,potassium ion transport (GO:0006813),0.46406040988401237,1.8097771845832837,0.0,0.06124805491138488,0.962,31/120,8.42%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNMB2;KCNMB3;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1
prerank,embryonic eye morphogenesis (GO:0048048),-0.7782419173878281,-1.8096363066775012,0.0,0.08553838072016165,0.886,7/11,17.03%,FBN1;EFEMP1;LRP6;RARG;MFAP5;FBN2;TBX2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5928663366946152,-1.8091722820785043,0.00196078431372549,0.08357023346962923,0.888,15/35,10.58%,RBFOX2;ZMIZ1;DDX5;NR3C2;YAP1;DDX17;PPARGC1B;NR3C1;UBR5;TRIP4;AR;MED1;PMEPA1;TADA3;CALCOCO1
prerank,cell projection organization (GO:0030030),-0.5838953890571954,-1.8075341752378404,0.0019157088122605363,0.08305044291227769,0.897,9/30,13.83%,PARVA;RHOQ;GSN;RHOJ;PACSIN2;ITGB1;CDC42;NCKAP1;P2RY12
prerank,cell-matrix adhesion (GO:0007160),-0.48262137363652646,-1.8051050627304897,0.0,0.08419881739944968,0.904,32/95,16.00%,ITGBL1;COL3A1;SORBS1;ADAMTS12;VCL;PKD1;ITGAV;ECM2;VTN;ITGA10;FBLN5;BCR;ITGB1;NID2;ITGA11;MKLN1;ITGB5;PTPRK;ACTN2;ADAMTS9;COL13A1;ITGB8;ADAM9;ZYX;FN1;CTTN;EMILIN1;MSLN;TMEM8B;WHAMM;DDR1;ITGA4
prerank,regulation of AMPA receptor activity (GO:2000311),0.6190095918366907,1.8048768983704748,0.006109979633401222,0.06392622135703695,0.968,10/25,10.73%,NLGN1;SHISA6;MAPK8IP2;SHANK3;CACNG2;SHISA8;SHISA7;CACNG3;RELN;CACNG8
prerank,Golgi organization (GO:0007030),-0.45676158365473524,-1.8028020090765715,0.0,0.08499987862708672,0.911,49/112,24.09%,VTI1A;GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;ATL3;UBXN2B;HUWE1;ATP8B1;BCAS3;GOLGB1;SEC23IP;VTI1B;STX16;ARFGEF1;ARHGAP21;OBSL1;SEC22B;CDC42;USP6NL;VCPIP1;ATP8B2;ATL2;TBC1D20;COG3;COG7;STX5;SURF4;PRMT5;GOSR2;TJAP1;TMED3;PRKD1;VAMP4;SEC16B;CSNK1D;TMED5;TMED4;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;PI4K2B;PLK5;LMAN1;BAG5
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7629516396005069,1.8015964407369345,0.002188183807439825,0.06528010072871859,0.975,6/11,17.04%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.6084803652723622,-1.8015959799607526,0.0019305019305019305,0.08465379243436734,0.919,10/26,13.63%,ROCK2;ASAP3;ROCK1;PRKN;ALMS1;SLC9A1;FHOD1;CDC42;SYNPO2;SYNPO
prerank,regulation of dendrite extension (GO:1903859),0.661025182246577,1.7995104852896713,0.0,0.06541056546817156,0.977,7/18,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,transcription by RNA polymerase II (GO:0006366),-0.4115974478701091,-1.7980659966085775,0.0,0.08654577437462815,0.926,132/305,28.24%,NOTCH2;MLLT3;MAF;SOX5;TEAD1;PRRX1;NFKB1;RBPJ;THRB;DDX5;GLIS3;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;CCNT2;NR3C2;PABPN1;TBL1X;CCNH;TBL1XR1;NR6A1;NFIX;RREB1;CCNT1;INTS4;YAP1;PCF11;WDR33;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;SCAF8;MED26;CPSF3;AR;CTR9;PHAX;TAF4;PPARGC1A;TBP;SSU72;ZBTB1;CDK13;MED1;CCNK;TEAD3;RPRD2;SETD2;SLBP;MNAT1;NR1H3;NOTCH3;MAML2;AFF4;RTF1;PARP1;RORA;ERCC3;TFCP2;TEAD2;IRF9;NABP2;COPS2;MAML1;NELFB;HDAC1;TAF5L;SNAPC3;TAF8;RXRA;TAF13;MNT;GTF2B;ICE1;PIR;PMF1;NR4A1;RNGTT;MED27;NR4A2;CSTF3;NFIC;INTS6;POLR2H;SNRPF;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;INTS14;RPAP1;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;GTF2H1;EAF2;NR2F1;TBPL1;SNAPC1;CTDP1;POLR2E;CPSF1;PPARA;NCBP2;NR2C1;TAF7;LSM11;ZBTB7B;HDAC3;TAF1C;SNAPC5;GTF2H4;GTF2E2;THRA;POLR2D;NELFA;CDK9;ESR1;NELFE
prerank,negative regulation of axonogenesis (GO:0050771),0.6036067943615239,1.7965884254875657,0.0021231422505307855,0.0664926954760732,0.979,13/27,14.97%,DCC;MAG;MCF2;MAP2;FGF13;THY1;EFNB3;OMG;LINGO1;RTN4R;DIP2B;RTN4;GDI1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5230732348065862,1.7952941418998314,0.0,0.06630715466285887,0.981,17/54,7.96%,DPP10;KCNJ3;KCNIP4;KCNJ6;KCNN2;AKAP6;BIN1;KCNIP1;KCNMB2;KCNMB3;KCNN1;DPP6;KCNMB4;KCNJ10;KCNN3;GNG2;KCNAB1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7490189799074,-1.7941994374610188,0.0019120458891013384,0.08878605148729848,0.934,4/12,2.90%,UST;DSE;DCN;BGN
prerank,mesenchymal cell differentiation (GO:0048762),-0.5151751760143768,-1.7940078480980304,0.005545286506469501,0.08689264875202465,0.934,16/51,6.61%,ROCK2;RANBP3L;TGFBR3;TGFBR1;LRP6;WNT4;RBPJ;FBXL17;LIMS1;DDX5;FOXC1;BMP7;ROCK1;GSK3B;DDX17;FGFR2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6068613985956848,1.7931553035805397,0.0,0.0669834665816058,0.982,8/29,6.73%,CAMK2A;SHISA6;NETO1;MCTP1;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,inhibitory synapse assembly (GO:1904862),0.7394935830678814,1.7918238542794693,0.004273504273504274,0.06690268513816146,0.984,6/11,8.57%,GABRB3;GABRA2;FGF13;GABRB2;LGI2;GABRG2
prerank,cellular response to purine-containing compound (GO:0071415),0.760813762170746,1.7903801143297275,0.011086474501108648,0.06690335256319277,0.984,5/10,6.95%,RYR2;RYR3;SLC8A1;TRPM2;P2RY1
prerank,Rho protein signal transduction (GO:0007266),-0.5235505906398938,-1.790071374043625,0.0,0.08957320999941455,0.942,17/53,17.63%,COL1A2;ROCK2;ARHGAP29;ARHGAP6;ROCK1;PDPN;RHOJ;CTNNAL1;CDC42;CDC42EP5;RHOA;AGTR1;ARHGDIB;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1
prerank,positive regulation of DNA replication (GO:0045740),-0.6782565553479167,-1.7899132189755156,0.0,0.0877690403795682,0.942,10/16,26.05%,EGFR;GLI2;DHX9;BRPF3;GLI1;CTC1;PCNA;STN1;ATAD5;EGF
prerank,neurotransmitter transport (GO:0006836),0.488130589415259,1.7897843762155714,0.00398406374501992,0.06623263417230559,0.985,29/73,15.59%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;GABRA2;SNAP25;LIN7A;SLC17A6;SLC18A3;SLC1A1;UNC13A;HSPA8;PPFIA3;SLC1A2;NRXN2;SNPH;SLC6A2;GAD1;CPLX1;PPFIA2;DVL1;PPFIA4;CHAT;TSPOAP1;PDZD11;GLS2;GLS;SYN1
prerank,gene silencing by miRNA (GO:0035195),-0.5786937948706953,-1.7896931218046657,0.0,0.08613957028277032,0.942,16/32,23.34%,DICER1;TNRC6B;PUM2;ZC3H7A;WTIP;TNRC6A;MOV10;PUM1;LIMD1;CNOT8;TNRC6C;CNOT1;AJUBA;RBM4;XPO5;AGO1
prerank,positive regulation of actin nucleation (GO:0051127),-0.7535256160406607,-1.7883544652336678,0.0,0.0855759293354951,0.947,7/11,15.28%,GSN;FCHSD2;WASF2;BRK1;NCKAP1;WASF1;WHAMM
prerank,excitatory postsynaptic potential (GO:0060079),0.651560610456465,1.7875314726899851,0.0021413276231263384,0.06726029577590341,0.987,8/19,7.97%,MPP2;GRIN1;MAPK8IP2;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7927558539629828,-1.7855496972785858,0.0,0.08682629822609918,0.953,5/10,9.89%,PID1;APPL2;GRB10;ENPP1;SELENOS
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6803842535606263,1.7850633972995438,0.002044989775051125,0.06816782636417129,0.988,9/15,17.07%,GRM5;GRM7;GRM1;GRM8;HOMER1;HOMER2;GRM3;HOMER3;GRIK3
prerank,axon development (GO:0061564),0.49041887127761113,1.7849728915199345,0.0019880715705765406,0.06717653797131941,0.988,22/78,11.46%,DCC;CTNNA2;ACTB;PLP1;GRM7;SPTBN4;ADGRB1;ANK3;MAP1B;APBB1;PAX2;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CNTN4;BRSK2;SLITRK5
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.47579116713606573,-1.7844898849829196,0.0,0.08617762426087465,0.954,20/86,7.30%,BMP6;SULF1;TGFBR1;BMPR1A;FOXD1;RBPJ;RBPMS;ZNF423;BMP5;BMP7;DAB2;EP300;BMP4;NUMA1;TGFB1I1;SMAD2;THBS1;CREBBP;TWSG1;ZEB2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.662792284750075,1.7840890132186733,0.0020920502092050207,0.06711235927876574,0.99,6/18,3.04%,GRIN1;NRXN1;RIMS1;NLGN1;RIMS2;SHANK3
prerank,presynapse assembly (GO:0099054),0.6799550945677073,1.7828287567880172,0.006134969325153374,0.06689499963780096,0.991,5/16,1.68%,PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN1
prerank,circulatory system development (GO:0072359),-0.4487664176447125,-1.7814099253402216,0.0,0.08768987584045251,0.958,35/118,12.78%,AKAP13;CACNA1C;FBN1;COL3A1;NXN;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FOXC1;ADAP2;KAT2B;SH3PXD2B;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;HSPG2;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;PDLIM2;MEF2C;PKD2;FBXW7;FN1
prerank,embryonic skeletal system development (GO:0048706),-0.5632761243116519,-1.7813086264327362,0.003738317757009346,0.08610295230383974,0.958,13/35,9.48%,SULF1;COL1A1;PDGFRA;OSR1;HOXB3;PCSK5;RBP4;SULF2;DYNC2I1;HOXC4;HOXA3;WNT9A;HOXB4
prerank,actin cytoskeleton reorganization (GO:0031532),-0.504628835209439,-1.779113032172278,0.0,0.0871403573821465,0.963,25/63,19.11%,AUTS2;PARVA;PHACTR1;SIPA1L1;GSN;MCU;PTK7;KIT;FLNA;NRK;CXADR;DTNBP1;NRP1;MKLN1;ANXA1;FER;RHOA;RALA;RICTOR;CTTN;FARP2;WHAMM;EFS;PTPN1;GAB1
prerank,axonogenesis (GO:0007409),0.41359948176053585,1.7788907571082127,0.0,0.06897628505632201,0.993,71/237,12.13%,DSCAM;BSG;NRXN3;NRXN1;DCC;CTNNA2;ACTB;EPHA6;SEMA3C;EPHB1;SPTBN4;SEMA6A;DAB1;UNC5C;SPTB;ADGRB1;CXCL12;EPHA5;SEMA4A;SEMA4F;ANK3;SHANK3;MAP1B;ROBO4;APBB1;CNTN6;PAX2;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;NRCAM;RAP1GAP;VSTM2L;ZDHHC17;UNC5B;EFNA2;HSP90AB1;SHTN1;ROBO2;B4GALT6;EPHA10;PLPPR4;NTNG1;NTNG2;SPTBN5;RELN;TAOK2;TUBB3;ROBO3;FEZ1;CNTN4;BRSK2;DOK5;SPTBN1;SLITRK5;DOK2;CNTN2;RET
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.45876079184668317,-1.7785856696509366,0.0,0.08633771708064783,0.963,41/108,22.41%,WLS;TRABD2B;SULF1;NXN;LRP1;MDFIC;WWOX;GRB10;PTK7;RNF43;PRKN;LRRK2;BTRC;VGLL4;DCDC2;GPC3;SULF2;RSPO3;AXIN1;SKI;FGFR2;RUNX1;DACT1;RSPO2;TLE1;TCF7L1;FZD7;EMD;CSNK2A1;SALL1;FOXL1;SFRP4;DACT3;BMP2;MDFI;CDC73;TERT;FRZB;PPP2CA;SPIN1;SENP2
prerank,alanine transport (GO:0032328),0.7699488665358578,1.7774942643558933,0.0,0.06905061593008954,0.993,3/10,9.57%,SLC6A6;SLC6A17;SLC36A1
prerank,cell differentiation in hindbrain (GO:0021533),0.7282703512127988,1.7770374484256157,0.0,0.0683923004254252,0.993,7/11,19.82%,PROX1;GRID2;CEND1;LHX1;KNDC1;FAIM2;CBLN1
prerank,chondrocyte differentiation (GO:0002062),-0.5765096224573667,-1.7767040762752744,0.006198347107438017,0.08660876328752917,0.965,15/32,15.57%,SULF1;SOX5;CREB3L2;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;EIF2AK3;RUNX1;CCN3;MEF2C;SOX6;RUNX2
prerank,positive regulation of dendrite extension (GO:1903861),0.6650369068510318,1.7750286089020504,0.004338394793926247,0.06904664503158396,0.993,7/17,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,central nervous system neuron differentiation (GO:0021953),0.5680437172748344,1.7741681513453027,0.0,0.06875079445020166,0.993,15/33,17.37%,SPOCK1;MDGA2;PROX1;GRID2;CEND1;MAP2;TOX;NTRK2;LHX1;SIN3A;KNDC1;CHD5;SOX4;CTNNB1;FAIM2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6880787792112858,-1.7731122928006546,0.005847953216374269,0.08902843726023683,0.974,7/16,8.22%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP3;IGFBP6;IGFBP4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5388205294629325,-1.7694547037892763,0.0,0.09192064584767506,0.979,17/43,17.42%,IGF1;FOXP1;BMPR1A;IGFBP5;PDGFRB;BMP4;THBS1;GJA1;JUN;ID2;MMP2;IL6R;STAT1;ERN1;ADAMTS1;IL18;CCN4
prerank,heart development (GO:0007507),-0.4305296484035335,-1.7689532441037765,0.0,0.09094970226607223,0.979,53/150,19.51%,AKAP13;TGFBR3;CACNA1C;FBN1;COL3A1;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FLRT2;BMP5;FOXC1;ADAP2;KAT2B;BMP7;SH3PXD2B;BMP4;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;GPC3;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;NIPBL;PDLIM2;MEF2C;PKD2;SCUBE1;FN1;CHD7;VEGFA;ACVR1;SALL1;FOXL1;CITED2;TBX2;WDR11;EEF1AKMT4-ECE2;ZDHHC16;BMP2;PTPN11;MEGF8
prerank,negative regulation of cell differentiation (GO:0045596),-0.4252388721055783,-1.7656540970713832,0.0,0.09311632808383584,0.98,58/181,21.02%,RANBP3L;EGFR;COL5A2;SMAD3;TGFBR1;CRIM1;EFEMP1;ADAMTS12;COL5A1;LDLRAD4;ABCA1;SMAD6;BMP5;ITGAV;BMP7;TMEM64;BMP4;JAG1;ENPP1;OSR1;YAP1;SKI;ZBTB16;ADGRV1;REST;WNT9A;CTR9;NBR1;RUNX1T1;IGF2;MED1;NR1H3;LIMD1;ID2;RORA;IL17RD;HES1;SUFU;RB1;EIF2AK4;TRPM4;NELFB;TRIB2;ANKRD26;PTCH1;ANP32B;VASN;TRIO;PDCD4;TWIST2;WNT5A;HNRNPU;PTPN11;ITGB3;CDC73;SPRED2;CDK6;PPP2CA
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.4801270970871933,-1.7651259129901051,0.001968503937007874,0.09209888083874232,0.98,16/74,7.20%,PHLDB2;SMAD3;TGFBR1;DAG1;EPHA3;COL1A1;LDLRAD4;BMP5;FOXC1;DAB2;PDPN;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,synapse organization (GO:0050808),0.4469460445993428,1.7608503881933397,0.00199203187250996,0.07919368788135432,0.996,40/125,12.45%,SPOCK2;DNM3;DSCAM;KIRREL3;GRM5;ADGRL3;NRXN1;PTPRD;LRRC4C;LRFN5;CTNND2;NLGN1;GPM6A;DNER;ANK3;SHANK3;CDH2;SNCA;UNC13A;PPFIA3;NRXN2;ELFN1;NRCAM;WNT7B;ARHGAP39;RAB39B;CACNB2;PCDHB6;LRRC4B;NTNG1;SHANK2;APBB2;CACNB4;F2R;PPFIA2;DVL1;CNTN2;PPFIA4;SNCB;DCTN1
prerank,regulation of transmembrane transport (GO:0034762),0.5743834095459159,1.7604561127003076,0.011441647597254004,0.07836776718279606,0.996,9/31,7.24%,ACTB;SLC2A1;KCNJ3;KCNJ6;SNCA;KCNJ11;OCLN;KCNJ10;TRIB3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5537226053001526,1.759808708587605,0.0,0.0777557376877792,0.996,14/37,11.91%,HMCN1;PTPRD;CADM1;IL1RAPL1;NLGN1;TENM2;GRID2;TENM1;TENM4;TENM3;DCHS1;CADM3;CRB1;NECTIN1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7241552313967443,1.759646820869856,0.0021929824561403508,0.07684500436451946,0.996,6/12,4.96%,SYT1;RIMS1;SYT7;RIMS2;RIMS3;UNC13A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.7237400106113799,-1.7576551835812704,0.007692307692307693,0.09978262963375642,0.988,4/13,1.77%,FSTL1;FBN1;LTBP1;NBL1
prerank,regulation of catecholamine secretion (GO:0050433),0.5741526464538802,1.7545717798737572,0.005917159763313609,0.08018619964282174,0.997,10/29,11.72%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;GRK2;SYT10;SYT2;KCNA2
prerank,negative regulation of translation (GO:0017148),-0.46585172776332034,-1.7514354228105118,0.0,0.10663477380882685,0.992,26/87,19.57%,SAMD4A;ROCK2;IGFBP5;CELF1;FTO;ROCK1;YTHDF3;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;PUM1;DHX36;LSM14A;CNOT8;TPR;EIF2AK4;YBX1;EIF2AK2;DDX3X;DAPK1;CPEB1;CNOT1;CNOT10;RBM4
prerank,positive regulation of developmental growth (GO:0048639),0.5213891180425574,1.7489828445289584,0.0,0.08353266327535608,0.998,15/49,13.88%,SYT1;RIMS1;RIMS2;CPNE9;SEMA4D;SEMA7A;UNC13A;PLCB1;RNF157;SHTN1;CDKL5;NTN1;SYT2;DLL1;INSR
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.6177093787797324,-1.748955728359296,0.00998003992015968,0.10806634564721035,0.994,6/21,8.55%,ROCK2;ERRFI1;ROCK1;BMP4;RUNX1;MAFG
prerank,cellular response to BMP stimulus (GO:0071773),-0.48226610194917646,-1.7476104777331962,0.001996007984031936,0.10825955965467704,0.994,26/66,21.84%,BMP6;TGFBR3;SMAD3;BMPR1A;ADAMTS12;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,glucose transmembrane transport (GO:1904659),0.648781049708403,1.7451842933204853,0.00796812749003984,0.08596537084001497,0.999,4/18,2.66%,SLC2A1;RAB4B;SLC2A3;SLC2A5
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.6165752081527156,-1.744135998602242,0.001949317738791423,0.11110697159523342,0.995,9/24,9.06%,ROCK2;ERRFI1;FOXC1;ROCK1;NUMA1;HOXA7;RUNX1;SRSF6;MED1
prerank,regulation of dopamine secretion (GO:0014059),0.5928057823855695,1.7431777014954928,0.005928853754940711,0.08638254072910578,0.999,9/25,11.72%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;SYT10;SYT2;KCNA2
prerank,camera-type eye development (GO:0043010),-0.5938199180630852,-1.7431766871408922,0.007590132827324478,0.11067861908186366,0.995,11/25,15.74%,CACNA1C;FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;CYP1B1;NES;VEGFA;FBN2
prerank,positive regulation of B cell proliferation (GO:0030890),0.5829514326914135,1.7431122349264747,0.0087527352297593,0.08535198156605081,0.999,9/29,14.85%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;CD40;NFATC2;CD38
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.46023448895760316,-1.7425104468940005,0.0,0.10989403430712488,0.995,35/95,16.74%,TGFBR3;SMAD3;TGFBR1;LDLRAD4;SMAD6;SMURF2;NREP;DAB2;EP300;DKK3;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;THBS1;SNX6;SKI;CREBBP;SKIL;ZEB2;PDPK1;PMEPA1;SMAD4;GIPC1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;LATS1;VASN;CITED2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6506889058572256,1.7411926683099075,0.008492569002123142,0.0858928224363271,0.999,8/18,10.73%,NRXN1;NLGN1;SHANK3;CACNG2;CACNG3;CCL2;RELN;CACNG8
prerank,BMP signaling pathway (GO:0030509),-0.4900832115177332,-1.7356773573602005,0.0,0.11721541606106964,0.996,25/62,21.84%,BMP6;TGFBR3;SMAD3;BMPR1A;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5947803070452322,1.7345439838901555,0.0,0.09100177515270841,0.999,7/26,3.04%,GRIN1;NRXN1;RIMS1;TMEM108;NLGN1;RIMS2;SHANK3
prerank,response to cadmium ion (GO:0046686),0.5771781402883389,1.7342881509842016,0.0021691973969631237,0.0901710516332103,0.999,10/26,7.97%,MT2A;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;AKT1
prerank,cellular defense response (GO:0006968),-0.5376205764033295,-1.7339633009175612,0.003976143141153081,0.11821957563541781,0.996,12/40,19.72%,ZNF148;DCDC2;CCR9;LBP;ITGB1;LSP1;VEZF1;BECN1;TCIRG1;CX3CR1;LGALS3BP;NCF2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5305215501813173,1.7338928439000305,0.003992015968063872,0.08952887043161632,0.999,12/41,7.78%,KCNJ3;KCNJ6;KCNN2;ANK3;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.6163838760799725,-1.7334297003430301,0.009523809523809525,0.11717689781331864,0.996,11/22,15.20%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;SMAD4;PARP1;LMCD1;P2RX4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4986176624232126,-1.7314099928637086,0.005893909626719057,0.11815369904182034,0.996,17/56,15.82%,BMP6;TGFBR1;BMPR1A;LDLRAD4;RBPMS;SMAD6;BMP5;BMP7;DAB2;BMP4;TWSG1;PMEPA1;SMAD4;BMPER;EMILIN1;ACVR1;TGFB3
prerank,cellular response to cadmium ion (GO:0071276),0.5840846004014377,1.7298043921165267,0.00641025641025641,0.09231147755940722,0.999,10/24,7.97%,MT2A;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;AKT1
prerank,DNA conformation change (GO:0071103),-0.6573520253000853,-1.7290791956739546,0.0,0.11985631716086045,0.996,6/17,17.19%,ABL1;TOP1;HMGB1;HAT1;ERCC3;TOP2B
prerank,carbohydrate transport (GO:0008643),0.7256595231231981,1.7263203146556163,0.0021691973969631237,0.0943425459717771,0.999,3/11,2.66%,AQP9;AQP11;SLC2A5
prerank,neuropeptide signaling pathway (GO:0007218),0.5000877425550863,1.7259196551319609,0.0,0.09361119371854659,0.999,16/58,15.06%,GLRA1;NXPH2;HCRTR1;GPR149;GLRA3;SORCS3;SORCS1;ADCYAP1;GLRA2;HCRTR2;OPRM1;GRP;PNOC;SORL1;OPRK1;OPRL1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.44165662364842523,-1.7223416908534424,0.0,0.12743604795592386,0.996,38/112,15.93%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ZMIZ1;WNT4;LIMS1;SMAD6;WWOX;TGFBR2;CLEC3B;NR3C1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;MEF2C;PDE3A;ZYX;APPL1;SOX6;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,cellular transition metal ion homeostasis (GO:0046916),0.46452476906392737,1.7219953193979414,0.0,0.09645838914951196,1.0,26/91,11.74%,SLC39A10;TFRC;ALAS2;MT2A;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SLC30A1;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1;SLC39A8;ATOX1;SLC30A5
prerank,skeletal system morphogenesis (GO:0048705),-0.5255745177077302,-1.7184124057564132,0.001949317738791423,0.1318517651191382,0.997,18/42,19.51%,TGFBR1;PDGFRA;LRP6;ANKRD11;WWOX;HOXB3;CYP26B1;SKI;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;HOXB9;FBN2;SIX1;SFRP4;MEGF8
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5312667474519964,-1.7166856654917446,0.003875968992248062,0.1327883551745707,0.997,13/40,7.20%,TCF7L2;SMAD3;TGFBR1;COL1A1;FOXC1;DAB2;PDPN;JAG1;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.419641668181453,-1.7130325599097214,0.0,0.13644597893763633,0.997,58/152,23.09%,RNF220;WLS;SULF1;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;WNT5B;TBL1XR1;RNF146;GPC3;SULF2;UBR5;RSPO3;AXIN1;LYPD6;SKI;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;RSPO2;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X;CSNK2A1;SALL1;PRDM15;USP34;SFRP4;VCP;CSNK1D;BMP2;CDC73;TERT;DKK2;PSMC1;GID8;SPIN1;PLEKHA4;PSMB6;CCAR2;PSMA3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.7191042426254204,-1.7120036704706136,0.005597014925373134,0.1363809540965445,0.997,9/11,25.78%,PUM2;WTIP;STAT3;DHX9;PUM1;LIMD1;AJUBA;XPO5;FXR1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.6726058469033916,-1.7110906773769043,0.009560229445506692,0.13604545430965934,0.997,6/15,3.93%,LRP6;ANKRD11;GLI2;FOXC1;EDA;WNT6
prerank,glucose import (GO:0046323),0.6794270245524172,1.7096698442834823,0.00641025641025641,0.10746232926538583,1.0,3/13,1.71%,SLC2A1;RAB4B;SLC2A3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.42865218950294093,-1.7092050803138468,0.0,0.13737544640243546,0.998,64/138,28.17%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;TBP;MED1;TEAD3;MNAT1;NR1H3;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;POLR2E;PPARA;NR2C1;TAF7;HDAC3;GTF2H4;GTF2E2;THRA;POLR2D;CDK9;ESR1
prerank,positive regulation of nervous system development (GO:0051962),0.5147474362719493,1.7049672921985257,0.004246284501061571,0.11134369995606105,1.0,10/42,9.59%,NRXN1;PTPRD;IL1RAPL1;EPHB1;MME;NLGN1;GRID2;CLSTN3;LRRC4B;OPRM1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5852006308956939,1.7046300172307978,0.004098360655737705,0.11040574205235791,1.0,8/24,4.44%,DSCAM;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4285398032894472,-1.7037633567653083,0.0,0.1449095486212751,0.999,41/128,15.93%,BMP6;COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;SMURF2;DDX5;BMP5;BMP7;BMP4;TGFBR2;RGMB;TGFB1I1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;RGMA;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;SLC33A1;PARD3;SMURF1;ACVR1;PRKCZ;ZFYVE16;RUNX2;TGFB3;LRRC32
prerank,regulation of microtubule depolymerization (GO:0031114),0.5804805728468435,1.70209136740654,0.002150537634408602,0.11183373824571363,1.0,14/25,19.69%,NAV3;MAP1B;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;TRPV4;CLASP1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3646177839561848,-1.702087719613191,0.0,0.1457203196819744,1.0,183/476,24.95%,IGF1;MLLT3;NR2F2;EGFR;ZIC1;TCF4;GLI3;SMAD3;TGFBR1;TEAD1;CREB3L2;NFKB1;COL1A1;ZMIZ1;LRP6;WNT4;GLI2;ZNF423;NR1D2;MDFIC;ZFHX3;FOXC1;TRIM44;BMP7;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;KAT6B;TFEB;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;RREB1;NIBAN2;YAP1;RGMB;CREBL2;TGFB1I1;ZKSCAN3;SMAD2;SMARCC2;AXIN1;MED17;LBH;CREBBP;ZBTB16;FZD2;CDH1;STAT3;NSD3;TRIP4;NSD1;PHF8;MED12;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HIVEP3;REST;MAP3K5;HNRNPD;AR;ZNF496;FOXK1;PPARGC1A;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;PRMT2;NR1H3;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;PARP9;ATF7IP;GLIS2;ID2;ZXDC;RORA;MEF2C;HES1;TEAD2;TCF3;FZD7;IRF1;PPM1A;DTX3L;KAT8;GLI1;BICRA;MMS19;ING5;APOE;STAT1;NAA15;HINFP;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;KDM3A;ILF2;RXRA;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ATOH8;KLF6;ARHGEF11;AFAP1L2;CITED2;EPC1;MYBL1;SIX1;RNF20;PICALM;WNT5A;PHIP;FBXW11;NEK4;FZD1;INPP5K;BMP2;RNF14;INHBA;KARS1;SPP1;PML;ING1;MED16;NOS1;CDKN1C;NFYA;ZIC3;XRCC6;GATA6;KMT2A;NIF3L1;DVL3;FGF2;MAP3K12;SPIN1;MYRF;WAC;CAND2;MAFB;MED13;CD80;SMARCD3;MED14;HDAC2;GTF2H1;TFAP4;RNF6;CXXC1;DYRK1B;KMT2E;FOXE1;SNAI1;NAA16;ELF2;SOX11
prerank,rRNA metabolic process (GO:0016072),0.4196321850039573,1.7015358124916056,0.0,0.11129176041383981,1.0,51/160,16.10%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;DIS3L;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6997640999579229,1.6972523995455784,0.014373716632443531,0.11485830968013845,1.0,6/12,8.33%,PROM1;PODXL;MYO1E;MAGI2;CD24;BASP1
prerank,negative regulation of secretion by cell (GO:1903531),0.5299289610037293,1.6969101680285847,0.004246284501061571,0.11408865127779919,1.0,9/38,6.03%,GRM7;IL1RAPL1;SYT11;RHBDF2;SNCA;TRH;IL12A;NOTCH1;SLC30A1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.7327126224288686,-1.6964545167133618,0.003861003861003861,0.15328890058213063,1.0,5/11,10.88%,PDK1;MAP3K5;CYP1B1;PRKCD;PRODH
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.36018790598340555,-1.6950089754164586,0.0,0.15389530556089892,1.0,162/572,19.43%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;RBPJ;PHF21A;THRB;SMURF2;GLI2;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;ZMYM5;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;TBL1X;WWP2;FRK;NFIB;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;YAP1;EZH1;TAF3;RARG;MEF2A;HMGB1;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;CBX5;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;JDP2;FGFR2;DNMT3A;FOXC2;CHD8;RUNX1;SKIL;ZEB2;REST;GTF2IRD1;AR;CTR9;MBD2;IGF2;SP100;SP2;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BAG3;CHD3;NR1H3;JUN;HCFC1;PCGF2;SMAD4;PARP9;GLIS2;ID2;NIPBL;RTF1;WWC1;NFATC4;FNIP1;PARP1;MEF2C;ARID5B;HES1;ZNF692;TPR;SUFU;TCF3;RB1;BHLHE41;CGGBP1;KDM1B;PPM1A;SOX13;TCERG1;TRPS1;STAT1;VEGFA;USP2;MCPH1;HDAC1;CBX7;CNOT2;PRDM2;PTCH1;RXRA;MNT;SALL1;NOP53;SFPQ;CITED2;EPC1;TBX2;CNOT1;ZFP37;NR4A2;CC2D1A;NFIC;HNRNPU;TRAF6;HSBP1;ZNF436;NFATC3;BMP2;MDFI;UBE2D3;KMT5A;BPTF;ELK4;IFI27
prerank,sensory perception of smell (GO:0007608),0.723236050136269,1.6945656072698974,0.012578616352201259,0.11536135762993144,1.0,3/11,7.62%,SLC24A4;ADCY3;SYT10
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6522619986364698,-1.6937857208251363,0.00539568345323741,0.15253831606722007,1.0,9/15,16.30%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,stress fiber assembly (GO:0043149),-0.6522619986364698,-1.6937857208251363,0.00539568345323741,0.15253831606722007,1.0,9/15,16.30%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5450607671066084,1.6925233535514388,0.00796812749003984,0.11622622063216138,1.0,9/32,6.13%,CAMK2A;RIMS1;RIMS2;SYT11;PREPL;MCTP1;RIMS3;SLC30A1;KCNMB4
prerank,cell projection assembly (GO:0030031),-0.5991783603838226,-1.6923833952786307,0.011583011583011582,0.15303634407256297,1.0,6/22,11.54%,PARVA;RHOQ;GSN;RHOJ;CDC42;NCKAP1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.6517640806202672,-1.6904610697125415,0.009242144177449169,0.15413377969141684,1.0,7/16,10.32%,RBFOX2;DDX5;DDX17;PPARGC1B;TRIP4;AR;TADA3
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.47780113849676004,-1.6866716015342915,0.005836575875486381,0.15856135570832694,1.0,19/55,16.29%,GPC6;DCN;CEMIP;SDC2;BGN;FMOD;GPC4;SLC9A1;GNS;GPC3;HSPG2;OGN;PRELP;CEMIP2;LUM;GUSB;HEXA;SDC4;GALNS
prerank,protein export from nucleus (GO:0006611),-0.5543079898466238,-1.6861794863249353,0.015594541910331383,0.15766211970415472,1.0,14/27,23.68%,RANBP3L;PKD1;XPO4;STYX;DUSP16;NUP42;NUP214;TPR;SMURF1;RANBP3;DESI1;CHP1;XPO5;XPO1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3911613881371068,1.686015837507792,0.0,0.1222568740968699,1.0,68/268,12.77%,KCND2;SLC6A6;HCN1;SLC24A4;SLC24A2;TRPC5;CACNA1A;SCN1A;KCNH7;SLC6A17;ASIC2;SLC40A1;KCNQ3;KCNC2;KCNN2;UCP2;KCNH5;SLC39A2;ASIC4;KCNH8;RYR3;GAS6;SLC8A1;KCNJ11;KCNN1;SCN4B;ASIC1;KCNK13;KCNK10;SLC30A1;HCN2;KCNJ10;TRPM2;KCND3;KCNC3;SLC6A2;SLC6A5;KCNH1;KCNQ5;ATP1A3;KCNK9;SLC6A8;KCNN3;SLC30A3;SLC25A14;KCNAB1;LRRC55;SCN3A;KCNC1;KCNK1;SLC25A27;ATP6V1F;ATP6V1A;SLC12A3;SLC36A1;SLC39A8;KCNQ2;ATP1A4;ATP1A1;ATP5F1B;P2RX7;KCNA2;SLC30A5;SCN2A;TRPC1;TMCO1;MCOLN2;KCNJ8
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.3518084890219147,-1.6858883773124436,0.0,0.1563364216136302,1.0,213/807,17.29%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;RBFOX2;FOXD1;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;WNT4;RBPJ;PHF21A;THRB;MIDEAS;LIMS1;SMURF2;GLI2;ZNF423;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;BMP7;ZMYM5;ZIC2;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;KAT6B;DKK3;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;BTRC;TBL1X;BRD7;FOXN3;WWP2;FRK;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;NIBAN2;VGLL4;YAP1;FLNA;RCOR1;KHDRBS1;EZH1;TAF3;RARG;MEF2A;HMGB1;RCOR3;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;TFDP2;JDP2;FGFR2;L3MBTL3;DNMT3A;NAB1;SHC1;FOXC2;CHD8;RUNX1;SKIL;WWP1;ZEB2;SCMH1;REST;BCL7A;GTF2IRD1;AR;CTR9;FOXK1;MBD2;RUNX1T1;IGF2;SP100;CBFA2T2;SP2;PTPRK;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BTAF1;CHD3;PRMT2;NR1H3;JUN;MPHOSPH8;HCFC1;PCGF2;SMAD4;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;RTF1;WWC1;FNIP1;PARP1;MEF2C;ARID5B;PCGF6;PBXIP1;HES1;ZNF692;TPR;SUFU;TCF3;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;CGGBP1;KDM1B;IRF1;PPM1A;TSHZ3;SOX13;TCERG1;KAT8;TRPS1;STAT1;HINFP;VEGFA;ZNF318;USP2;MCPH1;HDAC1;CBX7;CNOT2;CBFA2T3;PRDM2;SCML4;PHC2;PTCH1;RXRA;RUNX2;JARID2;MNT;FOXK2;KDM2A;SALL1;LOXL3;ATOH8;L3MBTL2;NOP53;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZFP37;ZMYND15;TWIST2
prerank,positive regulation of proteolysis (GO:0045862),-0.48271929739914743,-1.6842499017449972,0.004032258064516129,0.15737623548158008,1.0,22/55,24.44%,CCBE1;CYFIP2;BTRC;CTSC;CTSH;SNX9;WDR48;ASPH;NRDC;ADAM9;RCN3;OGT;APOE;ADRA2A;ATP5IF1;FBXW11;TANK;FGFR4;TBC1D10A;PERP;HDAC2;NKD2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.33656288420416464,-1.6840901256509613,0.0,0.15591517456672288,1.0,425/1667,18.34%,ZBTB20;NFIA;BMP6;PBX1;FOXP2;PRDM6;IGF1;AUTS2;FOXP1;FHL2;NR2F2;EGFR;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;ZBTB7C;MAF;SOX5;TEAD1;BMPR1A;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;HOXB6;CDK8;ZNF148;KANK2;HIVEP2;ZKSCAN2;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;PHF21A;THRB;CCNL2;DCN;MIDEAS;SMAD6;SMURF2;GLI2;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;ZNF462;ZFHX3;ZEB1;RARB;BMP5;MDM4;BRWD1;WWOX;FOXC1;PER3;FGF1;KLF9;KAT2B;PIAS1;ZMYM5;ZIC2;DAB2;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;DICER1;HDAC4;CREB5;GTF2H2;ABL1;BCOR;KAT6B;NCOR1;PRKN;PPM1D;ARNT;TNRC6B;JAG1;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;TBL1X;BRD7;ELF1;RBBP8;WWP2;FRK;NFIB;KCNIP3;CCNH;TBL1XR1;NR6A1;SSBP3;NFIX;KIT;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;RCOR1;TNRC6A;MED15;DDX17;EZH1;GMEB1;BAZ1A;TAF3;RARG;ANXA4;MEF2A;KMT2D;CDK7;HMGB1;RCOR3;DLG1;PPARGC1B;ZKSCAN3;NR3C1;SS18;LCOR;KLF3;ZNF182;MOV10;SMAD2;SMARCC2;BCL9L;BCAS3;CBX5;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;GABPB2;PBX3;MED17;TBX15;SKI;CREBBP;ZBTB16;DCAF1;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;PHF8;JDP2;MED26;HOXC8;MED12;FGFR2;DNMT3A;FHOD1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;SKIL;CAMK2D;HIVEP3;DHX9;AKAP8L;ZEB2;HOXA3;REST;KDM5B;MYSM1;VEZF1;HDGFL2;CEBPG;HOXB5;CRTC3;ZBTB37;GTF2IRD1;ZBTB8A;AR;ZFX;RGMA;DHX36;ZNF496;PRPF6;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;SP2;SSU72;NCOA6;IMPACT;NFYC;PIAS3;ZBTB1;CDK13;NCOA1;DACT1;CHD2;MED1;UBE2I;JUP;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;MIER1;UBP1;CHD3;ZNF467;MNAT1;WASL;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;PCGF2;SMAD4;MED21;SENP1;PARP9;THAP3;MAML2;CRTC1;GLIS2;ID2;NIPBL;MAVS;BCLAF1;ZBTB24;CREBRF;VGLL3;DCAF6;ZXDC;RTF1;WWC1;NFATC4;ZBED4;FNIP1;TBX18;PARP1;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;PKD2;TPR;SUFU;TCF3;TCF7L1;PIAS4;RB1;BHLHE41;OGT;ZBTB34;PATZ1;CGGBP1;KDM1B;IRF1;MAML1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;SOX6;SIX5;TRPS1;APOE;KDM3B;ZFP3;STAT1;CC2D1B;PRKDC;HINFP;VEGFA;CRLF3;USP2;MCPH1;ACVR1;ZNF367;HDAC1;MED8;CBX7;ZSCAN18;ZBED3;NCK1;ZKSCAN1;KDM3A;MKX;CIAO1;DDX3X;CNOT2;PRDM2;ZNF18;CARF;HOXB9;MED13L;NCK2;PTCH1;EFCAB7;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;TGFB3;KDM2A;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;IKZF2;BRD3;KLF6;TNRC6C;ARRB1;NOP53;SFPQ;ZNF112;PTOV1;FOXL1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;STAT5A;TBX2;NR4A1;CNOT1;SMARCD2;ZFP37;NFYB;TWIST2;TLR4;CRTC2;WNT5A;PHIP;BAZ2B;MED27;NR4A2;PRKD1;CC2D1A;STAT5B;BAZ1B;LPIN2;BCL2L12;NFIC;ZFHX4;HNRNPU;TAF6L;POU6F2;SOD2;TFCP2L1;TRAF6;LPIN3
prerank,negative regulation of cell development (GO:0010721),-0.5807955391406933,-1.6840561551841404,0.0038022813688212928,0.15430732417629642,1.0,6/25,7.45%,FBN1;IGF1;APPL2;PCM1;GSK3B;REST
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6464173342407089,-1.6809501930487698,0.007619047619047619,0.15793799820668702,1.0,11/15,28.52%,WNT5B;GPC3;RSPO3;RNF213;DACT1;CSNK1E;SFRP4;CSNK1D;SPEF1;ZNRF3;DAAM2
prerank,androgen receptor signaling pathway (GO:0030521),-0.720511335390724,-1.6808632338480474,0.012302284710017574,0.15637989579064457,1.0,7/11,18.81%,ZMIZ1;DDX5;DDX17;AR;PMEPA1;KDM3A;RNF14
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46195541579505756,1.6802546344443188,0.006109979633401222,0.12737017947447155,1.0,25/75,11.92%,DCC;CTNNA2;ACTB;SPTBN4;MAPK8IP2;ADGRB1;ANK3;MAP1B;MAP2;APBB1;PAX2;MFSD2A;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5144694942401878,1.6793583332843105,0.0042643923240938165,0.12705730275479563,1.0,11/41,6.46%,SLC24A2;GRIN1;GRIN2A;RYR2;HTR2C;RYR3;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2
prerank,histone modification (GO:0016570),-0.4314902684759231,-1.6788576783794538,0.0,0.15862153462851653,1.0,37/109,19.97%,EYA2;EYA1;PRDM5;MIDEAS;UBE2N;EYA4;EP300;HDAC4;KAT6B;HLCS;TBL1X;TBL1XR1;RCOR1;HUWE1;BAZ2A;RCOR3;CREBBP;NSD3;UFL1;NSD1;TRRAP;ENY2;MIER1;PRMT2;PRKCD;EHMT1;KAT8;UBE2B;HDAC1;BAZ1B;ATXN7;TAF6L;MSL3;PRMT8;PARK7;CDK2;NTMT1
prerank,ganglioside biosynthetic process (GO:0001574),0.6481432434056001,1.6768445758926322,0.00909090909090909,0.12866884080271376,1.0,6/15,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;B4GALT6;ST8SIA6;ST8SIA3
prerank,cellular response to drug (GO:0035690),0.5729394785438869,1.6767649778307323,0.006507592190889371,0.1274845934945442,1.0,5/25,3.84%,TFRC;PDE4B;ACER2;GAS6;PPM1F
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.5059433932109235,-1.6763150920169065,0.004016064257028112,0.1617314380819361,1.0,18/45,21.05%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;KIF16B;REPS2;NCK2;HBEGF;GAB1;PTPN11;PIK3R1;AAMP;DGKD
prerank,melanocyte differentiation (GO:0030318),-0.7179078086541342,-1.6761878360107676,0.010948905109489052,0.16035112556393513,1.0,5/11,14.78%,LRMDA;ENPP1;KIT;MEF2C;USP13
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4534016241186264,-1.6759964859699283,0.0,0.1590223054856273,1.0,16/74,7.97%,EYA2;IGF1;EYA1;TCF7L2;TGFBR1;BMP5;EYA4;ITGAV;CFLAR;BMP4;BIRC6;GSK3B;THBS1;SH3RF1;BCL2;AR
prerank,maturation of 5.8S rRNA (GO:0000460),-0.6322072135264537,-1.6720719123960506,0.011673151750972763,0.16384506901015022,1.0,9/17,17.08%,NSA2;LAS1L;MPHOSPH6;URB1;PRKDC;MAK16;MTREX;EXOSC10;WDR12
prerank,potassium ion transmembrane transport (GO:0071805),0.41977040646041813,1.670984355328685,0.0020325203252032522,0.1328302817451482,1.0,34/135,10.90%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;SLC12A6;KCNJ11;KCNN1;KCNK13;KCNK10;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;ATP1A3;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1;SLC12A3;KCNQ2;ATP1A4;ATP1A1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6400326198230597,-1.6704040053597762,0.005607476635514018,0.16522451847081554,1.0,8/16,11.61%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,regulation of interleukin-4 production (GO:0032673),0.5950977697960942,1.6690895743200538,0.012578616352201259,0.13397633376511145,1.0,3/21,6.51%,LEF1;SLC7A5;PRKCQ
prerank,rRNA processing (GO:0006364),0.4037271764147249,1.667767179662057,0.0,0.1340054706571375,1.0,55/172,16.10%,TSR3;EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TFB1M;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;ERI1;RPL21;DKC1;RPS7;RPL23A;NHP2;NOP2;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,negative regulation of metabolic process (GO:0009892),-0.48060265804848307,-1.667716864456466,0.004,0.16830487289857635,1.0,21/54,20.35%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;CCDC3;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;FIS1;TLE3
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41763683241298777,-1.6673535549953469,0.0,0.1673755815053163,1.0,43/132,18.02%,ZBTB20;IGF1;RNF152;DCN;FOXO3;ROCK1;ARNT;LRRK2;TFEB;PRKAA2;GSK3B;VGLL4;IRS1;TPCN1;HMGB1;MOV10;SNX9;RC3H1;UFL1;PFKFB4;TRIM8;ZSWIM8;ZC3HAV1;ABHD5;ABCD2;DACT1;NRDC;UPF1;PRKCD;HIF1A;ADAM9;CNOT8;TRIM5;DTX3L;ATF6;APOE;DAPK1;ADRA2A;PRXL2C;CNOT1;PRKD1;PRKAA1;PTPN1
prerank,protein autoubiquitination (GO:0051865),-0.46771382635894015,-1.6669512194318334,0.0019157088122605363,0.1663843702693887,1.0,25/61,20.02%,RNF220;PRKN;WWP2;RNF115;RNF146;UHRF2;RNF213;SH3RF1;RNF8;RNFT1;DDB2;TRAF2;CUL3;DTX3L;SH3RF2;UBE2B;SH3RF3;ERCC8;RNF181;BFAR;TRAF6;UBE2D3;LRSAM1;RNF11;NFX1
prerank,adherens junction organization (GO:0034332),0.48596170644868764,1.6664645420409128,0.004123711340206186,0.13451699647479706,1.0,19/48,14.24%,CDH12;CDH8;ACTB;CADM1;CADM2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;DCHS1;CADM3;TJP1;NECTIN1;SMAD7;CTNND1;JAM3
prerank,nuclear migration (GO:0007097),-0.6754462191920244,-1.6656591125718696,0.005747126436781609,0.16705685341651816,1.0,8/13,18.25%,SYNE2;PCM1;SYNE3;CLMN;DOCK7;DYNC1H1;FBXW11;TMEM201
prerank,embryonic digit morphogenesis (GO:0042733),-0.619918349694994,-1.6655289257719585,0.015180265654648957,0.1656741627440885,1.0,9/18,17.03%,GLI3;OSR1;WDPCP;CREBBP;ECE1;MAP3K20;HDAC1;SALL1;TBX2
prerank,calcium ion import across plasma membrane (GO:0098703),0.6439776442977443,1.665052193277698,0.01680672268907563,0.13481287019273996,1.0,4/14,6.46%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,response to histamine (GO:0034776),0.7008652049884769,1.6647195454789814,0.019693654266958426,0.13395109140815817,1.0,4/10,8.57%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,ethanol metabolic process (GO:0006067),-0.6889685292458949,-1.6622309850008454,0.009107468123861567,0.1700895732099994,1.0,3/12,10.51%,ALDH1A1;ALDH2;SULT1A1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.4355075984463377,-1.6615833211607032,0.0,0.16943854671938186,1.0,40/95,19.49%,GPC6;UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;CEMIP;SDC2;BGN;FMOD;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;OGN;GLCE;HS2ST1;SLC10A7;NDST1;ABCC5;PRELP;CHST15;ST3GAL3;LUM;NDST2;HEXA;PXYLP1;CHST11;SDC4;CHPF2;HS6ST1;CHSY1;XYLT2;B4GALT5;GCNT2;OMD;CHST12;B4GALT7
prerank,endoderm formation (GO:0001706),-0.5231585547942187,-1.6613908603175584,0.005988023952095809,0.1682782038522335,1.0,14/35,16.00%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;SETD2;LAMA3;MMP14;MMP2;FN1;DUSP1;ITGA5;ITGA4
prerank,positive regulation of secretion (GO:0051047),0.7068851856255137,1.6613641599021913,0.012958963282937365,0.13653715929895663,1.0,5/11,16.58%,TRH;XBP1;ACSL3;NPR1;GPLD1
prerank,positive regulation of DNA binding (GO:0043388),-0.5492963171018911,-1.6594183716486952,0.005825242718446602,0.17021599786074934,1.0,18/31,26.05%,IGF1;FOXC1;PRKN;NIBAN2;HMGB1;SKI;CEBPG;NGF;HES1;RB1;TXN;TRAF6;PARK7;H1-0;NME1;TWIST1;EDF1;EGF
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7077569191717553,-1.658910315584833,0.010101010101010102,0.16964526165246263,1.0,5/11,9.45%,MLLT3;DAB2;WNT5B;RSPO3;CSNK1E
prerank,calcium ion import into cytosol (GO:1902656),0.6303083005189195,1.657731360685861,0.01440329218106996,0.13970625700311204,1.0,4/15,6.46%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.6479484294646602,-1.656982755805254,0.009765625,0.1714521076826552,1.0,4/15,2.90%,UST;DSE;DCN;BGN
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.6808856910694674,-1.655187302501504,0.022944550669216062,0.17337392424331127,1.0,3/13,3.12%,RHOQ;OPA1;LRRK2
prerank,response to sterol (GO:0036314),-0.7046266857219382,-1.6550721552311882,0.013207547169811321,0.17198056319887595,1.0,4/11,11.64%,TGFBR1;TGFBR2;SMAD2;RORA
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.40265394600821075,-1.654875428502704,0.0,0.1708686199023315,1.0,86/166,31.96%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;CAVIN1;TAF1D;TBP;NCOA6;MED1;TEAD3;MNAT1;NR1H3;BRF1;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;TBPL1;GTF3C1;POLR2E;POLR3H;PPARA;NR2C1;TAF7;HDAC3;TAF1C;GTF2H4;GTF2E2;POLR1G;THRA;POLR2D;CDK9;ESR1;BRF2;TAF1A;RRN3;POLRMT;NR1H4;POLR1C;SNW1;GTF2A1;HDAC10;NR5A2;NR2C2AP;MAML3;E2F3
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5334909545349131,-1.65461650964873,0.0055147058823529415,0.1698471385960409,1.0,9/32,10.52%,ZBTB20;IGF1;PID1;ARNT;PRKAA2;NUPR1;PFKFB4;PPARGC1A;HIF1A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.7072184091891813,-1.6544995035187808,0.01584507042253521,0.1685696963322316,1.0,3/11,6.91%,HMGB1;TWSG1;RUNX1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6027265643531962,1.6541356632979933,0.010482180293501049,0.1428892053375477,1.0,7/20,4.44%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,positive regulation of wound healing (GO:0090303),-0.5185694856342233,-1.6540074646011063,0.007858546168958742,0.1679158965266336,1.0,11/36,7.20%,ST3GAL4;MYLK;PLPP3;VTN;RREB1;ITGB1;THBS1;ARFGEF1;FOXC2;ANXA1;MTOR
prerank,metal ion transport (GO:0030001),0.44434735024232613,1.6524691678303451,0.008403361344537815,0.14365966249748047,1.0,32/86,19.30%,CAMK2A;TRPC5;CACNA1A;CACNA1B;RAMP2;SLC39A2;RYR2;RYR3;CACNA2D1;SLC8A1;SLC30A1;CACNA1E;TRPM2;TPT1;CACNG3;NIPA1;GRIN3A;SLC39A8;CACNG8;SLC30A5;TRPC1;NIPAL3;PSEN1;ATP2B2;SLC3A2;NIPAL4;CALCRL;FYN;MMGT1;MAGT1;ATP2C1;TRPV4
prerank,nervous system development (GO:0007399),0.362391340865416,1.6509876156111012,0.0,0.1441795178293081,1.0,104/429,14.75%,SPOCK2;PAX8;DNM3;DSCAM;KIRREL3;ST8SIA4;NELL1;ADGRL3;NAV3;SPOCK1;RBFOX3;NRXN1;TRPC5;LSAMP;MYT1L;LY6H;ERBB4;SLC2A1;MAL;MBP;LRCH4;PROX1;ASIC2;EPHB1;FGF12;NLGN1;CHRM3;GPM6A;SEMA6A;SH3GL2;PCDH1;TENM1;NRG1;ADGRB1;GPM6B;SH3GL3;DOC2A;DNER;MPZ;SEMA4F;AHI1;SHANK3;MOBP;CDH2;GRIK1;FGF13;CNTN6;ADAM22;APBA2;ADAM23;MOG;EFNB3;RBFOX1;NAB2;GJB1;DSCAML1;NRXN2;NPAS2;CYP26C1;NRCAM;NFASC;LHX1;ARHGAP26;FGF5;SRRM4;NINJ1;MTF1;PCDHB6;IL1RAPL2;ROBO2;RELN;SHANK2;ACVR1C;DCHS1;FEZ1;DPF3;HAP1;CNTN4;SMPD1;KCNQ2;PCDHA4;APC;NRGN;MBD5;SCN2A;NPTX1;DVL1;DPYSL2;DCTN1;SH3GL1;KALRN;DPYSL5;VCAN;HAPLN3;PTPRZ1;SERF1A;NHEJ1;STMN3;DCX;LGI1;PPT1;CHRM2;HPCAL4;HAPLN4
prerank,cytosolic transport (GO:0016482),-0.4265444927136139,-1.6506849137376263,0.0,0.1722492828288742,1.0,51/108,26.33%,DENND2A;VTI1A;VPS13A;ERC1;GBF1;EEA1;TMEM87A;SNX6;VTI1B;STX16;CORO7;MON2;CCDC91;KIF16B;GOSR1;VPS54;WDR91;VPS13C;STX5;BECN1;TMEM87B;DENND5A;PIK3C3;HEATR5A;DOP1B;ANKRD27;EHD3;GOSR2;LAMP1;ANKFY1;TBC1D17;HEATR5B;SNF8;CLN5;TBC1D10A;WDR81;STX8;VPS26B;BET1L;RGP1;TBC1D23;SPAG9;AP2A1;PTPN23;MYO1D;RAB9A;RAB7A;BAIAP3;RAB5A;PHETA1;TBC1D10B
prerank,regulation of protein sumoylation (GO:0033233),-0.609368389521713,-1.6505171892969537,0.014814814814814815,0.17112184482202206,1.0,12/17,29.71%,ZMIZ1;PIAS1;HDAC4;SAE1;PIAS3;PIAS4;PARK7;GNL3L;GNL3;MUL1;EGR1;UBA2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3807186273757171,-1.6499764602244167,0.0,0.17062962298249135,1.0,65/248,15.23%,RNF220;BICC1;WLS;MLLT3;LRRK1;EGFR;TCF7L2;GLI3;RBMS3;IGFBP2;NFKB1;COL1A1;LRP6;SMURF2;LGR4;PTK7;TNKS2;DAB2;TMEM64;STK3;DKK3;PRKN;LRRK2;CSNK1A1;BTRC;TBL1X;TBL1XR1;GSK3B;RNF146;GPC3;IGFBP6;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;CHD8;ZEB2;IGFBP4;XIAP;DACT1;JUP;WNK1;CSNK1E;LIMD1;USP47;TLE4;TLE1;LZTS2;PSMF1;CUL3;FZD7;TRPM4;PPM1A;SOX13;GLI1;UBAC2;APOE;PSMB2;UBE2B;HDAC1;ZBED3;DDX3X;LATS1;EMD
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5045051057670878,-1.647028536170934,0.0038684719535783366,0.17440802146444276,1.0,20/43,18.76%,BMP6;IGF1;BMPR1A;WNT4;BMP7;IL6ST;BMP4;YAP1;MEF2C;IL6R;ATRAID;CCN1;ACVR1;RUNX2;FBN2;SUCO;CCN4;PRKD1;NPNT;BMP2
prerank,histone lysine demethylation (GO:0070076),-0.5703872885852721,-1.6467425640967095,0.009708737864077669,0.1736082914235965,1.0,10/25,15.83%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;KDM1B;KDM3B;KDM3A;KDM2A
prerank,protein K63-linked ubiquitination (GO:0070534),-0.5037907244458816,-1.6461742244008157,0.007936507936507936,0.17312710028686845,1.0,19/41,22.75%,RNF152;UBE2N;UBE2E2;PRKN;WWP2;RNF115;TRAF3IP2;RNF8;TRAF2;TRIM5;UBE2B;TRAF3;HECTD1;BFAR;UBE2S;TRAF6;ARIH2;TRAF5;UBE2V2
prerank,regulation of dendrite development (GO:0050773),0.510445002693251,1.64429224331996,0.016227180527383367,0.15213754532042906,1.0,14/37,9.89%,ADGRB3;DCC;CSMD3;LRP8;HECW1;TNIK;MFSD2A;SEMA4D;ALK;HECW2;ZDHHC15;CDKL5;LZTS1;DAB2IP
prerank,regulation of monocyte differentiation (GO:0045655),-0.6524916618587784,-1.6422458740895054,0.011538461538461539,0.17850187203269577,1.0,4/14,6.19%,FOXP1;IL34;ACIN1;HOXA7
prerank,embryonic organ morphogenesis (GO:0048562),-0.5052882091861921,-1.6421265442991113,0.009578544061302681,0.17737846582771205,1.0,21/42,20.42%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;RARG;MFAP5;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;ID2;NIPBL;HES1;ACVR1;HOXB9;FBN2;SIX1;MEGF8;RBPMS2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.49575388186541475,-1.641721698281219,0.008146639511201629,0.17660851238217903,1.0,8/45,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;BMP5;BMP7;DAB2;BMP4
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.3288657797731034,-1.6406483610614364,0.0,0.1771929370727437,1.0,423/1645,18.68%,ZBTB20;NFIA;PBX1;FOXP2;IGF1;BNC2;MLLT3;FOXP1;DENND4A;NR2F2;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;TGFBR1;ZBTB7C;MAF;SOX5;RBFOX2;EFEMP1;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;COL1A1;HOXB6;ZNF148;HIVEP2;ZKSCAN2;ZMIZ1;LRP6;WNT4;RBPJ;CCNL2;MIDEAS;LIMS1;SMAD6;SMURF2;GLI2;ZNF423;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;MDM4;BRWD1;FOXC1;TRIM44;KLF9;BMP7;PIAS1;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;GTF2H2;ERC1;ABL1;BCOR;KAT6B;DKK3;NCOR1;ARNT;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;BTRC;TBL1X;BRD7;FOXN3;ELF1;RBBP8;WWP2;NFIB;SETD5;CCNH;TBL1XR1;NR6A1;NFIX;KIT;GON4L;RREB1;CCNT1;NIBAN2;VGLL4;YAP1;WTIP;RCOR1;RGMB;CREBL2;DDX17;KHDRBS1;GMEB1;BAZ1A;ANXA4;TGFB1I1;CDK16;MEF2A;KMT2D;BAZ2A;HMGB1;RCOR3;PPARGC1B;ZKSCAN3;NR3C1;LCOR;KLF3;ZNF182;SRSF10;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;PRRX2;AXIN1;HOXA5;FUS;SNX6;PBX3;MED17;LBH;TBX15;CREBBP;ZBTB16;FZD2;CDH1;ZIC5;STAT3;TEF;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;JDP2;MED26;TRRAP;HOXC8;MED12;L3MBTL3;NAB1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;CAMK2D;HIVEP3;DHX9;WWP1;ZEB2;SCMH1;HOXA3;REST;KDM5B;POFUT1;VEZF1;HDGFL2;CEBPG;HOXB5;MAP3K5;ZBTB37;HNRNPD;BCL7A;GTF2IRD1;ZBTB8A;AR;ZFX;DHX36;ZNF496;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;RUNX1T1;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;CBFA2T2;SP2;PTPRK;NCOA6;MAP2K1;NFYC;PIAS3;ZBTB1;NCOA1;CHD2;MED1;UBE2I;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;UBP1;BTAF1;CHD3;ZNF467;ZFAT;MNAT1;PRMT2;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;TULP3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;SMAD4;MED21;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;CDK11B;BCLAF1;ZBTB24;CREBRF;TLE1;GPBP1L1;VGLL3;ZXDC;WWC1;NFATC4;TBX18;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;SPTY2D1;PBXIP1;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;SUFU;TCF3;TCF7L1;PIAS4;RB1;EHMT1;BHLHE41;OGT;ZBTB34;CCAR1;FZD7;CRABP2;PATZ1;IRF1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;DTX3L;KAT8;GLI1;BICRA;ATF6;MMS19;SOX6;CHD7;SIX5;TRPS1;ING5;APOE;KDM3B;PHF1;ZFP3;STAT1;CC2D1B;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;KDM3A;MKX;USP13;CIAO1;ILF2;CNOT2;CBFA2T3;PRDM2;ZNF18;TAF5L;SCML4;CARF;HOXB9;PHC2;MED13L;RXRA;HOXC5;KLF15;RUNX2;BBX;JARID2;MNT;MAP2K7;FOXK2;TGFB3;KDM2A;SALL1;VSX1;LOXL3;PRDM15;ATOH8;L3MBTL2;PRMT5;IKZF2;BRD3;KLF6;ARRB1;SFPQ;ZNF112;DAP;FOXL1;ARHGEF11;GLRX2;AFAP1L2;HEYL;CITED2;CAMTA2;EPC1;PDCD4;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ATXN1L;RNF20;SMARCD2;ZFP37;NFYB;ZMYND15;TWIST2;PICALM;WNT5A;PHIP;BAZ2B;MED27;NR4A2;CC2D1A;STAT5B;BAZ1B;NFIC;ZFHX4;FBXW11;TAF6L;MSL3;POU6F2;SOD2;TFCP2L1;TRAF6;NEK4;RHOH;ZKSCAN7;FZD1;RRP8;HMG20A;ZNF436;NFATC3;INPP5K
prerank,mRNA metabolic process (GO:0016071),-0.4337990949871425,-1.6400447982681603,0.0,0.17683129703269038,1.0,50/90,33.41%,SON;DDX5;CELF1;DIS3L2;HNRNPR;PCF11;U2AF2;AKAP8L;CPSF3;PCBP2;PPARGC1A;PRPF3;SLBP;SF3A1;USP39;SCAF11;SF3A3;TCERG1;SRSF1;ERN1;SFPQ;PRKACA;CSTF3;SNRPF;CNOT10;RNASE4;SRSF7;SRSF11;GEMIN2;SRSF2;NUDT21;HSF1;DHX15;NONO;KIN;PRMT9;NCBP2;PCBP3;PRPF8;LSM11;LSM6;PRPF18;ZFP36L2;SF3A2;TBRG4;SF3B4;NUDT16;NUDT16L1;HNRNPA2B1;HSPA1A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6898262155034423,-1.639280442749868,0.015209125475285171,0.17661193120698818,1.0,6/11,18.76%,EFNB2;FRS2;MEF2C;FZD7;SOX6;BMP2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5729863361715247,-1.6379735425933226,0.013108614232209739,0.17756305517560717,1.0,7/23,10.52%,ZBTB20;IGF1;NFKB1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,regulation of ossification (GO:0030278),-0.51247302679881,-1.6377405674096586,0.014112903225806451,0.1766051449682693,1.0,19/36,24.95%,PTN;LRP6;RBPJ;SMAD6;BMP4;ENPP1;ZBTB16;NBR1;MEF2C;BMP2K;ACVR1;ECM1;WNT5A;CHSY1;BMP2;PTPN11;LRP4;TWIST1;SOX11
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7086965950927191,-1.6368593124384918,0.014311270125223614,0.17690040518093333,1.0,6/10,19.35%,GRB10;ARNT;VTN;HIF1A;ITGA5;ITGB3
prerank,long-term synaptic potentiation (GO:0060291),0.5895175819345673,1.6367300123125084,0.019867549668874173,0.16084061092705637,1.0,7/21,9.15%,MPP2;SLC24A2;GRIN2A;GRIN2B;GRIN2D;NPTN;SHANK2
prerank,RNA destabilization (GO:0050779),-0.6169266348117397,-1.6367201586495024,0.013513513513513514,0.17585543391292469,1.0,6/18,7.62%,ROCK2;CELF1;FTO;ROCK1;YTHDF3;PUM1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5680861960398312,-1.6365828758103096,0.005836575875486381,0.17479948480768104,1.0,13/23,19.43%,TCF7L2;XPO4;PTPN14;GSK3B;RAPGEF3;SP100;BAG3;TPR;YWHAE;EMD;ANP32B;PARK7;IFI27
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5605063832838593,-1.6364946112481062,0.02131782945736434,0.17363690479497215,1.0,8/25,5.30%,SULF1;BMPR1A;FOXD1;RBPJ;ZNF423;BMP4;NUMA1;SMAD2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.683700467127963,-1.6361358902739827,0.018796992481203006,0.17041089932841,1.0,9/12,24.32%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.683700467127963,-1.6361358902739827,0.018796992481203006,0.17041089932841,1.0,9/12,24.32%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.683700467127963,-1.6361358902739827,0.018796992481203006,0.17041089932841,1.0,9/12,24.32%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.516774420060875,-1.6361102848000786,0.01364522417153996,0.16923619250953217,1.0,9/38,12.04%,BMP6;SASH1;ANKRD17;PUM2;PLSCR1;DHX9;PUM1;DDX60;RIOK3
prerank,retinoid metabolic process (GO:0001523),-0.45271863954955793,-1.635475796628799,0.00196078431372549,0.16901161079232258,1.0,15/71,9.27%,GPC6;ALDH1A1;ALDH1A2;LRP1;RBP1;SDC2;CYP26B1;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1;CYP1B1
prerank,neutral amino acid transport (GO:0015804),0.5442908689885786,1.6332684199111156,0.008213552361396304,0.16443062813094578,1.0,7/28,9.57%,SLC7A5;SLC6A6;SLC6A17;SLC1A1;SLC7A8;SLC43A2;SLC36A1
prerank,negative regulation of axon extension (GO:0030517),0.5365506149464241,1.6310484942340175,0.00816326530612245,0.16613509652356195,1.0,9/30,4.44%,SEMA3C;MAG;SEMA6A;SEMA4A;SEMA4F;MAP2;SEMA6D;SEMA4D;SEMA7A
prerank,intracellular cholesterol transport (GO:0032367),-0.6307400085572364,-1.6295724060206391,0.007434944237918215,0.1773006690049018,1.0,5/15,11.62%,LRP6;ABCA1;LDLR;RELCH;NPC2
prerank,neural crest cell development (GO:0014032),0.49532690281262926,1.6291848533286273,0.003976143141153081,0.16735682660009962,1.0,11/44,6.01%,ERBB4;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;CDH2;SEMA6D;SEMA4D;SEMA7A;CYP26C1
prerank,regulation of autophagy (GO:0010506),-0.38012780652019235,-1.6289948586639462,0.0,0.17702320316921336,1.0,71/216,22.58%,PRKAG2;ITPR1;RNF152;LEPR;DCN;EIF4G3;FOXO3;EP300;ROCK1;ATP6V1B2;ABL1;PRKN;LRRK2;TFEB;PRKAA2;NUPR1;GSK3B;RPTOR;TPCN1;HMGB1;ZKSCAN3;ATP6V0D1;DNM1L;SNX6;UBQLN1;STAT3;UFL1;BCL2;TRIM8;MTOR;TPCN2;PIP4K2C;FOXK1;VDAC1;PTPN22;EIF4E;USP33;RB1CC1;ABL2;PRKAB2;TRIM5;FBXW7;MTMR3;KLHL22;KAT8;ATF6;GFAP;CTSA;ERN1;USP13;FOXK2;DAPK1;DAP;RUBCN;DAPK2;PRKACA;RMC1;PRKD1;PRKAA1;GPR137B;EIF4G1;PLEKHF1;ORMDL3;PRKAG3;BMF;PRKAB1;BNIP3;DCAF12;VPS26B;TICAM1;ATP6V1G2
prerank,organelle disassembly (GO:1903008),-0.51796530606614,-1.6282315269957088,0.013725490196078431,0.1771037389799919,1.0,16/33,22.87%,GBF1;UFL1;DENR;UBA5;TEX264;RB1CC1;ULK2;STX5;ATG2A;GFM2;MRRF;ATG2B;VCP;KIF9;ZFAND1;PLK5
prerank,regulation of neurotransmitter transport (GO:0051588),0.6138834516392552,1.627496371901012,0.022,0.1684322782786964,1.0,5/16,10.56%,CAMK2A;RIMS1;MCTP1;KCNMB4;CPLX1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5372874109890451,-1.6272840167468738,0.014925373134328358,0.177453118220758,1.0,11/29,17.73%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;FER;PKD2;STAT1;STAT5A;STAT5B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6744366616250238,-1.6251700409865444,0.01593625498007968,0.17996699997251991,1.0,5/12,9.10%,ELF1;RC3H1;RUNX1;LYN;PTPN22
prerank,cellular response to misfolded protein (GO:0071218),-0.585909849329771,-1.6247957694727275,0.009523809523809525,0.17953376360963738,1.0,14/20,31.80%,UGGT2;KLHL15;DNAJB14;POMT2;CUL3;AUP1;DERL1;VCP;TOR1A;BAG6;DNAJC18;RNF126;UFD1;UBE2W
prerank,mesonephric tubule development (GO:0072164),-0.6230583345083679,-1.6241271350903161,0.028735632183908046,0.17953917948786458,1.0,10/15,18.07%,PKD1;FOXC1;BMP7;BMP4;OSR1;FGFR2;PKD2;SALL1;SIX1;NPNT
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4478818029032212,-1.623215417763095,0.004032258064516129,0.1799267021837129,1.0,26/73,17.69%,ITGBL1;COL3A1;PTN;FBLN1;PLPP3;ITGAV;DAB2;ABL1;ITGA10;ITGB1;FYB1;ITGA11;NRP1;ITGB5;CDC42;ITGB8;LAMA3;ADAM9;TEC;ZYX;CUL3;FN1;ITGA5;DOCK1;ADAMTS1;PRKD1
prerank,regulation of DNA repair (GO:0006282),-0.4868410494789348,-1.6230833688875863,0.0019047619047619048,0.17895659597763827,1.0,11/44,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;TRIP12;UBR5;DHX9;BRCC3;CEBPG;RNF8
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5683826508324394,-1.6219388139166595,0.02247191011235955,0.17957857145058068,1.0,7/22,9.06%,NOTCH2;KLF9;STXBP4;FGFR2;SRSF6;PTPRK;MED1
prerank,axon guidance (GO:0007411),0.3862253608708859,1.6212068251162413,0.0,0.17607907062172834,1.0,60/201,12.13%,DSCAM;BSG;NRXN3;NRXN1;DCC;EPHA6;SEMA3C;TMEFF1;EPHB1;SPTBN4;PLXNB3;SEMA6A;DAB1;UNC5C;SPTB;CXCL12;EPHA5;SEMA4A;SEMA4F;SHANK3;ROBO4;CNTN6;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;LHX1;RAP1GAP;VSTM2L;UNC5B;EFNA2;PLXNA4;ROBO2;EPHA10;SPTBN5;RELN;TUBB3;ROBO3;FEZ1;NTN1;PTPRM;CHN1;CNTN4;DOK5;SPTBN1;DOK2;CNTN2;RET
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5363887174418648,1.6210131654259283,0.02044989775051125,0.17491676647743618,1.0,11/27,13.71%,CTNNA2;IL1RAPL1;MBOAT1;HOMER1;AKT1;NTNG1;NTNG2;BRSK2;CCDC88A;EFHC2;PSEN1
prerank,regulation of biosynthetic process (GO:0009889),0.681916888866027,1.6203992788137467,0.021052631578947368,0.1744255141652726,1.0,3/11,10.32%,THRSP;SNCA;MID1IP1
prerank,neuronal action potential (GO:0019228),0.5635308433782,1.6201892575570644,0.010526315789473684,0.17332756752040926,1.0,10/22,15.66%,SCN1A;ANK3;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3952854101960398,1.6189349360469634,0.0,0.17368272410650187,1.0,54/168,14.45%,EXOSC5;RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;CNOT6L;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;ERI1;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;ATM;RPS28
prerank,diterpenoid metabolic process (GO:0016101),-0.4646842568920676,-1.6187837824589424,0.005714285714285714,0.18416564213648695,1.0,12/55,7.97%,GPC6;ALDH1A1;LRP1;RBP1;SDC2;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.48258270656272223,-1.6184411449952492,0.00404040404040404,0.1835979371018303,1.0,19/46,20.35%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;TLE3
prerank,retrograde axonal transport (GO:0008090),0.62565162143772,1.6178070877692223,0.017543859649122806,0.173843183418351,1.0,6/16,11.45%,DLG2;TMEM108;KIF1A;DST;HAP1;ACTR10
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43064670545886413,-1.6166533853062783,0.0,0.18541076578201396,1.0,30/87,15.93%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;FMOD;TGFBR2;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,Golgi to endosome transport (GO:0006895),-0.6190056593879417,-1.6165589741038808,0.007434944237918215,0.18436769600050437,1.0,8/16,14.38%,VPS13A;GBF1;CORO7;MON2;KIF16B;WIPI1;VPS13C;DOP1B
prerank,cardiac conduction system development (GO:0003161),-0.5643171440797434,-1.6150411179145714,0.01107011070110701,0.18570371146545295,1.0,11/24,21.35%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;SMAD4;TBX18;MAML1;CACNA1G;GATA6;SMAD1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4456218499083964,-1.614354590834021,0.0,0.18569244530342768,1.0,20/73,10.80%,FSTL1;SULF1;CRIM1;BMPR1A;FOXD1;RBPJ;SMAD6;SMURF2;ZNF423;NBL1;BMP4;NUMA1;HTRA3;SMAD2;SKI;TWSG1;SKIL;XIAP;SMAD4;BMPER
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5063217752543311,-1.6136269966973475,0.007677543186180422,0.18556865014973054,1.0,17/37,25.93%,APPL2;STAT3;ABCD2;IL17RA;HIF1A;APOD;APPL1;IL17D;PDCD4;TLR4;CHID1;ADCY7;TICAM1;NLRC3;SIRPA;MAPK14;PPARA
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6515573102131332,1.6125383228122523,0.035196687370600416,0.18005156851699233,1.0,5/13,13.71%,TMSB4X;HEY1;PER2;SIN3A;PSEN1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5956470521508417,1.611429877175161,0.008565310492505354,0.1800539309063045,1.0,11/20,17.04%,TMEM35A;CLU;PFDN6;BBS10;HSP90AB1;CCT2;HOPX;HSPD1;NDUFAF1;PTGES3;HSP90AA1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5532697580437875,-1.6113945601891846,0.01303538175046555,0.18809627656460395,1.0,6/25,5.45%,PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;BCAS3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5864361591570345,-1.607452747686676,0.025048169556840076,0.19404190701156818,1.0,10/19,13.55%,TGFBR3;TGFBR1;BMPR1A;RBPJ;VGLL4;RBP4;FGFR2;RUNX1;MEF2C;GLI1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4794685468153266,-1.6071130817264703,0.005952380952380952,0.19348550587939384,1.0,15/44,11.38%,ROCK2;CELF1;FTO;ROCK1;TNRC6B;YTHDF3;TNRC6A;MOV10;EIF4ENIF1;RC3H1;ZC3HAV1;PUM1;DHX36;UPF1;CNOT8
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5167235937294539,1.6067996034438734,0.01511879049676026,0.18547074194975746,1.0,17/32,19.69%,NAV3;MAP2;STMN1;FGF13;SNCA;TUBB4A;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;FKBP4;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.48128166252163634,-1.6038072057616684,0.011627906976744186,0.19835062314062588,1.0,17/46,17.42%,IGF1;FOXP1;TCF7L2;IGFBP5;PDGFRB;BMP4;ELN;IGFBP3;THBS1;OGN;ID2;APOD;IL6R;STAT1;PRKDC;IL18;CCN4
prerank,Golgi localization (GO:0051645),-0.6800764906809561,-1.602830277642612,0.017374517374517374,0.1991219740661782,1.0,6/11,18.60%,UVRAG;ARHGAP21;CDC42;ARCN1;TBCCD1;COPG1
prerank,cellular response to metal ion (GO:0071248),0.403388316127063,1.6026144086592484,0.0,0.19041894835046447,1.0,28/123,7.97%,DLG2;SYT1;MT2A;ADCY8;SYT6;NLGN1;SYT7;GLRA1;SYT12;SYT11;ANK3;RYR3;CPNE9;SNCA;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;TRPM2;CPNE8;CPNE1;KCNH1;SYT10;AKT1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.6024353185625413,-1.6019881064904993,0.017208413001912046,0.19955101628071595,1.0,7/17,9.06%,ATP1A2;BMP7;BMP4;NR3C1;TFPI;AR;MED1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.5490507142726068,-1.6016080842540132,0.020754716981132074,0.19908275452962249,1.0,11/24,22.06%,TGFBR1;SOX5;EFEMP1;ADAMTS12;ZBTB16;WNT9A;SOX6;TRPS1;PTPN11;PKDCC;PTHLH
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5141627462283533,-1.5998708570419364,0.005780346820809248,0.20109453828132043,1.0,15/34,22.00%,DOCK5;LIMS1;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL
prerank,negative regulation of immune system process (GO:0002683),-0.6134703007428703,-1.599545767760932,0.021696252465483234,0.20055157359472098,1.0,4/16,15.21%,COL3A1;HOXA7;LYN;IL17D
prerank,negative regulation of cartilage development (GO:0061037),-0.6427978645331217,-1.5993185739967746,0.01845018450184502,0.19972529080895102,1.0,4/13,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.6353488454398692,-1.5981719512933759,0.017077798861480076,0.2008125987939816,1.0,3/13,5.68%,ERRFI1;CBLB;SNX6
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3610156218978513,1.5975369091074147,0.0,0.19717511802184406,1.0,82/306,14.46%,PAX8;ALAS2;CHEK1;RPS6;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;HOXD3;RPL10A;TBRG1;RPS24;EEF1B2;FUT9;RPL27A;RPS17;RPS6KB2;RPS8;RPA3;RPS16;RPS27A;RPLP1;XAB2;RPL41;RPLP0;RPL30;RPL7A;TUFM;ING4;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;PIF1;POLR2J;EIF4EBP2;SET;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;RPS7;POLR2I;RPL23A;MCM3;EEF1A2;RPL8;BCL3;MED20;MRPL36;BRIP1;MRPL23;RPS14;POLD1;RNASEH2A;RPS3;RPS2;RPS5;EEF1A1;RPL18A;ATM;RPS28;POLR3A
prerank,neuron development (GO:0048666),0.40096704716075326,1.5971987481479342,0.0019801980198019802,0.19624109686144417,1.0,37/141,10.81%,CNTNAP2;GPRIN1;MYT1L;FRY;PLP1;TMEM108;NLGN1;TENM2;GPM6A;SH3GL2;PBX2;TENM1;GPM6B;EPHA5;MAP2;STMN1;NTRK2;TENM4;STX3;TGFB2;ALK;PPP1R9A;TENM3;GPRIN3;SRRM4;ADCYAP1;STMN4;RASGRF1;BICDL1;B4GALT6;CAMSAP1;RAB35;STMN2;ATP8A2;PTPRM;MICALL2;CNTN4
prerank,pharyngeal system development (GO:0060037),-0.6308409219407398,-1.5961455331901602,0.017408123791102514,0.20322816877683933,1.0,5/15,2.70%,TGFBR1;BMPR1A;BMP5;BMP7;BMP4
prerank,positive regulation of glucose import (GO:0046326),-0.5707381329495602,-1.5951929065974326,0.02321083172147002,0.20397000339013976,1.0,6/21,4.55%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2
prerank,cell-cell junction assembly (GO:0007043),0.44512475030428095,1.5950110813098286,0.00202020202020202,0.19809559204194324,1.0,16/63,7.08%,CLDN5;CDH12;CDH8;ACTB;CTNND2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;GJB1;WDR1;EPB41L3;CNTNAP1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6571186407598147,-1.5945743149791596,0.02186878727634195,0.20389554969808932,1.0,7/12,19.57%,BMP4;PTPN14;KHDRBS1;NUP214;TPR;IFI27;RBM4
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5659885256206204,1.5944167645201215,0.029473684210526315,0.19773123941019113,1.0,12/21,19.69%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5858744081389743,-1.591339677547246,0.019417475728155338,0.20759828380740505,1.0,6/20,10.52%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),-0.5858744081389743,-1.591339677547246,0.019417475728155338,0.20759828380740505,1.0,6/20,10.52%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,GTP metabolic process (GO:0046039),-0.6321032978071419,-1.5911423517091334,0.02111324376199616,0.2067851839630424,1.0,3/15,3.12%,RHOQ;OPA1;LRRK2
prerank,embryonic digestive tract development (GO:0048566),-0.5950999366553157,-1.590423059645924,0.016666666666666666,0.2069461657764252,1.0,11/18,20.83%,GLI3;PDGFRA;GLI2;RARB;PCSK5;FGFR2;ID2;NIPBL;SALL1;RBPMS2;PKDCC
prerank,regulation of acrosome reaction (GO:0060046),0.6880677088909013,1.5899782352696141,0.03253796095444685,0.20302043410877055,1.0,2/10,5.65%,GLRA1;PLCB1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3964129721634727,-1.5894511321525508,0.0,0.20764881670875518,1.0,34/129,14.84%,RNF220;WLS;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;TBL1XR1;RNF146;GPC3;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X
prerank,anterior/posterior pattern specification (GO:0009952),-0.46391364161107485,-1.5892532119197138,0.011928429423459244,0.20690243888877807,1.0,19/53,16.73%,WLS;TGFBR1;HOXB6;HOXC6;HOXB3;PCSK5;SMAD2;HOXA5;SKI;HOXA7;HOXC4;HOXA3;HOXB5;HOXB4;HES1;BHLHE41;HOXB9;HOXC5;HEYL
prerank,keratan sulfate catabolic process (GO:0042340),-0.6790183978306334,-1.5891324259543684,0.025390625,0.20599847784087583,1.0,8/11,18.89%,FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;OMD
prerank,supramolecular fiber organization (GO:0097435),-0.3577886777656372,-1.5889912081029667,0.0,0.20508471012830967,1.0,100/334,19.99%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;CGNL1;COL8A1;COL5A1;COL4A6;TNXB;COL1A1;GSN;COL12A1;TPM1;COL22A1;COL4A3;PCM1;MPRIP;MYO1B;LOXL1;VIM;COL6A3;COL4A4;PRKN;FIGN;COL23A1;COL25A1;COL6A1;SHROOM2;TSPAN5;FAT1;COL8A2;FBLN5;SNCAIP;COL26A1;PLOD2;HSPG2;DLG1;RND3;SLK;COL6A2;SHROOM3;VPS4B;TMOD3;CENPJ;CORO7;TUBGCP6;INPPL1;CDC42;COL15A1;TUBGCP2;ARHGAP17;FIGNL2;CYP1B1;COL13A1;COL18A1;LAMA3;NCSTN;COL5A3;COL27A1;RHOA;GGA3;TPM3;CLIP4;P4HA2;RHOBTB2;LUM;MYO1F;EFEMP2;LOX;KATNA1;GFAP;EMILIN1;ZBED3;WHAMM;CARMIL1;LOXL3;DYNC1H1;MYH11;COL9A2;IAPP;TSPAN15;DPT;RHOBTB1;RHOH;MAP7D3;COL14A1;RHOC;MFAP4;TRIOBP;B4GALT7;TUBGCP4;ADAMTS14;NCKAP5L;AVIL;LMOD1;COL20A1;MARCKS;TPM2
prerank,sensory perception of chemical stimulus (GO:0007606),0.6193721935102907,1.5885930776719535,0.026915113871635612,0.20355840524818392,1.0,5/15,13.89%,SLC24A4;ADCY3;SYT10;GNAL;CD36
prerank,skin development (GO:0043588),-0.4470190416967914,-1.588120510381118,0.007547169811320755,0.2055590332037847,1.0,16/65,11.73%,COL1A2;COL3A1;COL5A2;ERRFI1;COL5A1;COL1A1;PKD1;JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;COL5A3;ADAM9;UGCG
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.32398081998529665,-1.5877373460175832,0.0,0.20513407189082683,1.0,290/1082,18.81%,NFIA;BMP6;PBX1;IGF1;AUTS2;MLLT3;NR2F2;EGFR;HLF;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TGFBR1;TEAD1;BMPR1A;CREB3L2;NFKB1;COL1A1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;WNT4;INO80;RBPJ;THRB;DCN;GLI2;ZNF423;GLIS3;NR1D2;ZNF462;MDFIC;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;TRIM44;KAT2B;BMP7;ZIC2;DAB2;IL31RA;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;HDAC4;CREB5;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;SSBP3;NFIX;RREB1;RPTOR;KMT2C;CCNT1;BCLAF3;NIBAN2;YAP1;SLC9A1;TBK1;RGMB;CREBL2;DDX17;RARG;TGFB1I1;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;ZKSCAN3;NR3C1;SS18;SMAD2;SMARCC2;BCL9L;BCAS3;SBNO2;AXIN1;HOXA5;PLSCR1;GABPB2;MED17;LBH;SKI;CREBBP;ZBTB16;FZD2;CDH1;STAT3;SCAF8;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;MED12;FGFR2;EIF2AK3;FHOD1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;HIVEP3;DHX9;MTOR;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;MAP3K5;HNRNPD;AR;RGMA;DHX36;ZNF496;PRPF6;FOXK1;PPARGC1A;CDC5L;IGF2;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;PRMT2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;SENP1;PARP9;THAP3;ATF7IP;MAML2;CRTC1;GLIS2;ID2;MAVS;BCLAF1;CREBRF;DCAF6;ZXDC;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;WDR43;PKD2;TCF3;OGT;FZD7;KDM1B;IRF1;MAML1;PPM1A;YBX1;DTX3L;MLLT10;TCERG1;KAT8;GLI1;BICRA;ATF6;MMS19;CCN1;ING5;APOE;STAT1;PRKDC;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;ZBED3;NCK1;KDM3A;ILF2;DDX3X;PRDM2;NCK2;EFCAB7;RXRA;KLF15;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;ICE1;ARHGEF11;AFAP1L2;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;RNF20;SMARCD2;NFYB;PICALM;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;FBXW11;TAF6L;TRAF6;LPIN3;NEK4;FZD1;NFATC3;INPP5K;BMP2;RNF14
prerank,regulation of bone mineralization (GO:0030500),-0.46379605778243976,-1.585549189774056,0.003937007874015748,0.20819280512545085,1.0,22/55,16.42%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;BCOR;ENPP1;OSR1;ADGRV1;NBR1;KL;ATP2B1;MEF2C;TRPM4;ATRAID;CCN1;BMP2K;ACVR1;FBN2;TGFB3;ECM1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5193982744371323,-1.5853443531392455,0.015384615384615385,0.20746123794891433,1.0,10/31,9.48%,TGFBR1;PDGFRA;OSR1;TGFBR2;HOXB3;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.3553699253011835,-1.5850860165793978,0.0,0.20677606319793165,1.0,126/327,26.09%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ZMIZ1;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;ATF2;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;COPS2;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;PML;NFYA;PPP2CA;NIF3L1;EZH2;ZNF205;SPIN1;DRAP1;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219
prerank,limb development (GO:0060173),-0.5323172604767779,-1.5848792181108808,0.01764705882352941,0.20602796302111331,1.0,15/28,25.75%,SMOC1;GLI3;KAT2B;PCSK5;MAP3K20;RSPO2;CHD7;PTCH1;SALL1;IQCE;MEGF8;LRP4;KREMEN1;ZNRF3;COMP
prerank,modification-dependent protein catabolic process (GO:0019941),-0.37374299573338166,-1.5840858087609575,0.0,0.20643766185396992,1.0,99/193,33.23%,FBXL7;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;BTRC;TRIP12;KLHL15;RNF146;RNF217;RBBP6;RNF213;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;UBE2H;ASB2;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;UBE2K;UBE2I;ANAPC4;ANAPC16;NUB1;NTAN1;USP33;UBE2R2;PSMF1;WDR91;UBR3;CUL3;TRIM25;DTX3L;TRPC4AP;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;AREL1;RNF14;SPSB4;RNF11;ANAPC11;TTC3;ARIH2;WDR81;FBXW4;RNF144A;SIAH2;RNF6;CNOT4;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;SPSB2;UBE3C;LONP1;PSMD13;FZR1;CDC34;MIB1;KCTD6;RBX1;UBA52;RNF126;UBE2L3;UBA1;ADRM1;HERPUD1;UFD1;MAD2L1;RC3H2;BUB1B;RNF130;DDB1;ANKIB1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6982770213263533,-1.5840659811016549,0.022641509433962263,0.2053833136790809,1.0,6/10,18.02%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6196281614533512,-1.583395742097398,0.031067961165048542,0.20552808753339355,1.0,9/15,15.51%,TCF7L2;XPO4;GSK3B;RAPGEF3;BAG3;TPR;YWHAE;EMD;ANP32B
prerank,central nervous system myelination (GO:0022010),0.6682832266563807,1.5817739930809698,0.028985507246376812,0.21326703148887435,1.0,5/11,8.37%,PLP1;TENM4;CLU;CNTNAP1;B4GALT6
prerank,calcium ion transport into cytosol (GO:0060402),0.5721261902925054,1.581279140230319,0.021141649048625793,0.21253239111145672,1.0,10/21,11.22%,GRIN1;GRIN2A;RYR2;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2;ADRA1A;JPH3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.5201690021892091,-1.5811823076318319,0.021314387211367674,0.2087040160663497,1.0,8/29,8.00%,SMAD3;DICER1;PUM2;ZC3H7A;SMAD2;PUS10;PUM1;TUT4
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.5428857255874422,-1.5794357269846022,0.02462121212121212,0.21110041859375914,1.0,11/24,26.24%,AUTS2;PLCE1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;AVIL;PIK3R1;ACTR2;TWF2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.544810039853449,-1.579326811122071,0.01642710472279261,0.2102232186597659,1.0,17/23,35.96%,OS9;SELENOS;SURF4;FAF2;AUP1;DERL1;SYVN1;VCP;SEC16A;LMAN1;PREB;SEL1L;DERL2;HERPUD1;UFD1;SEC13;TMEM129
prerank,cartilage development (GO:0051216),-0.46758567114897265,-1.5789415495114378,0.00998003992015968,0.2098106233670136,1.0,15/49,11.67%,SULF1;SOX5;CREB3L2;PKD1;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;ZBTB16;RUNX1;ITGB8;CCN3;MEF2C
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5947227161810806,-1.5789358720532798,0.014056224899598393,0.20873467145231095,1.0,10/19,30.77%,IRS1;ABHD5;ABCD2;PRKCD;AKT2;DAGLB;TWIST1;PNPLA2;PPARA;ANGPTL3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5745657339764751,1.5786754245077097,0.028017241379310345,0.21533530370929102,1.0,4/18,15.88%,NAV3;CD34;HOMER2;HOMER3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5908421024526709,-1.5784502559419928,0.015810276679841896,0.20860808464829642,1.0,9/20,20.11%,IGF1;FOXC1;EP300;NIBAN2;RB1;GTF2B;TRAF6;PARK7;H1-0
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.48001812436894586,1.577141688469992,0.016,0.21648310218321137,1.0,10/39,7.09%,FGF12;HECW1;FGF14;NETO1;ANK3;FGF13;WNK2;SCN4B;HECW2;GLRX
prerank,Ras protein signal transduction (GO:0007265),-0.39084698838943854,-1.5770725944272719,0.0,0.20999234165548028,1.0,47/137,22.48%,COL1A2;ROCK2;PLD1;IGF1;ARHGAP29;ARHGAP6;PLCE1;KSR1;ROCK1;PDPN;RREB1;SHOC2;RAP1B;CTNNAL1;MRAS;SHC1;RAPGEF3;BRK1;CDC42EP5;RHOA;JUN;NCKAP1;RALA;AGTR1;SETDB1;RB1;ARHGDIB;USP50;WASF1;RAPGEF2;FARP2;GNB1;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1;PRKD1;RASSF1;RHOH;PARK7;CDK2;RTKN;RAPGEF1;FGF2;CRKL;RIT1;CDC42EP1
prerank,regulation of protein import into nucleus (GO:0042306),-0.4968453170810373,-1.5763180647766588,0.00796812749003984,0.2105362506275802,1.0,14/36,12.62%,ZIC1;SMAD3;MDFIC;BMP4;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;SUFU;APOD
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.44516202652904857,-1.5762330915836649,0.007722007722007722,0.20962831839661983,1.0,22/63,20.26%,IGF1;TCF7L2;TGFBR1;WWOX;ITGAV;CFLAR;BMP4;BIRC6;DEPTOR;THBS1;PAK2;SH3RF1;AR;SP100;TRAF2;STX4;LTBR;ACVR1;PHIP;BCL2L12;PARK7;PML
prerank,detection of calcium ion (GO:0005513),0.613694188889955,1.5752073803848596,0.0518018018018018,0.21829518172157533,1.0,8/13,14.32%,SYT1;RYR2;KCNMB2;KCNMB3;KCNMB4;CALM1;CALM2;CALM3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5957053832314413,-1.5749833095873673,0.025830258302583026,0.21059855980329023,1.0,7/17,6.42%,IGF1;DOCK5;IGFBP5;PDGFRB;VTN;DOCK7;NRP1
prerank,ribosome biogenesis (GO:0042254),0.3810482741902868,1.574723581537301,0.0,0.21756247819442573,1.0,53/187,16.10%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPF2;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;MRPL36;RPS14;URB2;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.34026453495899806,-1.5746517079483155,0.0,0.21019846613195947,1.0,131/497,17.29%,SAMD4A;FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;IGFBP5;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;ENPP1;BTRC;BRD7;FOXN3;WWP2;GSK3B;NIBAN2;VGLL4;SYNCRIP;RCOR1;KHDRBS1;DDX6;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;EIF4ENIF1;ATP8B1;CBX5;EIF2AK1;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;EIF2AK3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;LARP1;BCL7A;PDS5A;DHX36;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;SELENOS;PRMT2;JUN;LSM14A;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;CNOT8;ARID5B;PCGF6;PBXIP1;HES1;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;YBX1;SOX13;KAT8;EIF2AK2;HINFP;ZNF318;HDAC1;DDX3X;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;DAPK1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZMYND15;TWIST2
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.6412256945827619,-1.5740924024410696,0.027777777777777776,0.21031080217090262,1.0,10/13,30.58%,SAE1;SENP6;UBA5;UBA7;DESI1;DESI2;NAE1;UBA2;ATG10;UBA1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5342778043728338,1.5740822307433615,0.029350104821802937,0.2170453041315095,1.0,6/25,7.34%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;CIB2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5582846668999046,-1.5736431986616344,0.0166358595194085,0.20905099233065982,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5582846668999046,-1.5736431986616344,0.0166358595194085,0.20905099233065982,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,limb morphogenesis (GO:0035108),-0.5752077760167557,-1.5699872255139729,0.020072992700729927,0.2150339629969685,1.0,10/20,21.89%,GLI3;LRP6;PCSK5;CYP26B1;SKI;NIPBL;PTCH1;IQCE;MEGF8;FBXW4
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.5827695431893345,-1.5693878873046074,0.014285714285714285,0.21501048971121606,1.0,8/18,22.24%,SETD7;KMT2D;SETD3;SETD2;EHMT1;ASH1L;KMT2A;PRDM9
prerank,regulation of B cell proliferation (GO:0030888),0.4788746092510001,1.5690303040299542,0.01603206412825651,0.2242182188249529,1.0,11/44,14.85%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;TNFRSF21;CD40;ATM;NFATC2;CD38
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5338913520795135,1.5690280478568284,0.017204301075268817,0.22266114786089072,1.0,11/24,18.89%,LIG3;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.6400268880093691,-1.568464493660406,0.0196078431372549,0.21583537603015127,1.0,7/13,19.76%,IRAK2;PIK3AP1;PIK3C3;PIK3R4;TNIP2;TRAF6;IRAK1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6509942442961764,-1.5653038514306947,0.03220035778175313,0.220792220776121,1.0,7/13,18.76%,NFKB1;BMP5;DKK3;REST;ERLIN1;APOE;BMP2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5785187893819462,-1.564676730913392,0.027624309392265192,0.22102153852359532,1.0,8/18,15.93%,SMAD3;LTBP1;ITGAV;ITGB8;HIF1A;SMAD4;FN1;LRRC32
prerank,atrial septum development (GO:0003283),-0.6380257563715572,-1.5640209830245562,0.022727272727272728,0.2212031747890304,1.0,3/13,2.12%,NOTCH2;ANK2;MDM4
prerank,regulation of synapse maturation (GO:0090128),0.6672788390762994,1.5639911945689504,0.04782608695652174,0.2298104564795721,1.0,4/10,9.89%,ARHGEF15;NRXN1;RELN;DAB2IP
prerank,regulation of synapse assembly (GO:0051963),0.46851446956882736,1.5639611252643097,0.018072289156626505,0.22830114334233736,1.0,15/46,9.22%,NRXN1;PTPRD;LRFN5;IL1RAPL1;EPHB1;NLGN1;GRID2;SNCA;SLIT1;TLR2;CLSTN3;LRRC4B;IL1RAPL2;ROBO2;LHFPL4
prerank,cell proliferation in forebrain (GO:0021846),-0.6828001324493005,-1.5637043830491657,0.024667931688804556,0.22080574547091067,1.0,4/10,14.48%,PCM1;DOCK7;NUMBL;NUMB
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4856328639253316,1.5632976516060446,0.02575107296137339,0.22789459249582833,1.0,14/39,15.80%,TSR3;RPS6;RPS19;RPS27;RPS24;RPS17;RPS16;MRPS7;RPS15;RPS7;RPS14;RPS5;RPS28;RPS25
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.555538315341807,-1.5611004111570104,0.015985790408525755,0.22477242174632964,1.0,8/21,16.80%,IGF1;BMPR1A;IGFBP5;GJA1;JUN;MMP2;ERN1;ADAMTS1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5424901174629922,-1.5610649549465074,0.030947775628626693,0.22378443720104127,1.0,17/23,28.54%,GLI3;ENPP1;BTRC;GPC3;TULP3;GLIS2;HERC4;SUFU;PTCH1;GPR161;VCP;MEGF8;KIF7;MGRN1;PTCH2;IFT122;KCTD6
prerank,P-body assembly (GO:0033962),-0.6323333323309079,-1.5608903265206695,0.040697674418604654,0.22303450245586315,1.0,7/12,16.12%,DDX6;EIF4ENIF1;RC3H1;LSM14A;LIMD1;EDC3;DYNC1H1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.42036707617908187,-1.5586143226650409,0.008247422680412371,0.22628553690146674,1.0,37/80,26.33%,DENND2A;VTI1A;ERC1;GBF1;TMEM87A;SGSM2;SNX6;VTI1B;STX16;GOSR1;VPS54;STX5;SURF4;TMEM87B;DENND5A;HEATR5A;EHD3;SNX8;GOSR2;ANKFY1;TBC1D17;HEATR5B;CLN5;TBC1D10A;VPS26B;BET1L;RGP1;LMAN1;TBC1D23;SPAG9;RAB9A;SNX12;RAB7B;RAB7A;BAIAP3;PHETA1;TBC1D10B
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5508726758554295,1.558398448373474,0.02586206896551724,0.23501261971277582,1.0,9/20,21.18%,LY6H;CHRM3;GRK2;PLCB1;CHRM2;GNAQ;LY6G6D;CDK5R1;RGS10
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6642179056976381,1.5576173879160924,0.03177966101694915,0.23487305003717415,1.0,4/10,9.09%,KDR;TLR2;CCL2;NAMPT
prerank,energy reserve metabolic process (GO:0006112),-0.5800269872646115,-1.5576080125769962,0.030797101449275364,0.22713996708493517,1.0,7/19,9.03%,PRKAG2;PID1;LEPR;PHKB;GSK3B;GFPT1;PHKA1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5820756643511881,-1.557090535137188,0.03508771929824561,0.22708941430327767,1.0,12/18,32.23%,ANKRD17;PUM2;PUM1;DDX60;NOP53;SEC14L1;GPATCH3;DHX58;BIRC3;C1QBP;UFD1;ZCCHC3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.48806248200058794,-1.5570099097492567,0.016293279022403257,0.2262394666749739,1.0,15/39,14.39%,ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;ROBO1;JAG1;TSPAN5;YAP1;CREBBP;STAT3;CCN3;MAML2;MAML1;BMP2K
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6063089095088842,-1.556129681947265,0.03518518518518519,0.2268151827753821,1.0,10/16,16.35%,DDX5;DDX17;HNRNPM;DHX9;SRSF6;CDK13;SLU7;RSRC1;SRSF1;SFPQ
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6375377102430376,1.5554885031432186,0.04899777282850779,0.23715053000386824,1.0,4/12,8.37%,EPHB1;SPTBN4;HSP90AB1;B4GALT6
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5826194364242837,1.5546791689131754,0.028953229398663696,0.23708210081602268,1.0,3/16,9.43%,KLRC1;IL12A;CYRIB
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.43924822076626907,-1.5544935207430899,0.007936507936507936,0.22890026664395846,1.0,15/61,8.31%,EYA2;EYA1;EGFR;UBE2N;EYA4;PDGFRB;HMGB1;USP7;NBN;DHX9;BRCC3;CEBPG;RNF8;DHX36;WRN
prerank,ceramide biosynthetic process (GO:0046513),0.4743112246060394,1.5541846884162913,0.030303030303030304,0.23637726892641317,1.0,10/40,11.96%,ST6GALNAC3;ST8SIA4;SGMS1;FA2H;DEGS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA6;ST8SIA3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.585862229784937,-1.5528081444932105,0.03571428571428571,0.2299368509660647,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.585862229784937,-1.5528081444932105,0.03571428571428571,0.2299368509660647,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,RNA biosynthetic process (GO:0032774),-0.5070442138150433,-1.5527976868147368,0.01338432122370937,0.22893787789805528,1.0,16/31,28.48%,TAF4;TBP;NCOA6;BRF1;TTF1;TAF13;PRMT5;GTF2B;HELB;PRIM2;POLA2;TERT;TAF12;TBPL1;TAF7;BRF2
prerank,Notch signaling pathway (GO:0007219),-0.44124118315017424,-1.5510238678456496,0.010141987829614604,0.231285492652655,1.0,22/59,16.73%,PBX1;NOTCH2;GMDS;RBPJ;ZNF423;KAT2B;EP300;JAG1;DTX4;CREBBP;POFUT1;NCSTN;NOTCH3;MAML2;WWC1;HES1;MAML1;YBX1;DTX3L;STAT1;PLXND1;HEYL
prerank,protein localization to synapse (GO:0035418),0.6250279043847377,1.5508972451871577,0.051224944320712694,0.24063865549336588,1.0,5/12,8.72%,NRXN1;PCLO;NLGN1;NRXN2;ZDHHC15
prerank,sodium ion transport (GO:0006814),0.4158122928564821,1.550362940993955,0.0020833333333333333,0.240088645940256,1.0,19/85,9.07%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;FGF13;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;SLC6A8;SCN3A;KCNK1;SLC12A3
prerank,regulation of hemopoiesis (GO:1903706),-0.673147574681886,-1.549078023655028,0.03745318352059925,0.23415896805417327,1.0,5/10,15.21%,PTN;CREBBP;RUNX1;MYSM1;IL17D
prerank,sodium ion transmembrane transport (GO:0035725),0.41534917659264486,1.5489691970471784,0.008438818565400843,0.24105480281022929,1.0,22/84,11.75%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;ATP1A3;SLC6A8;SCN3A;KCNK1;SLC12A3;ATP1A4;ATP1A1;SCN2A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3212479240090256,-1.5488955526016666,0.0,0.233429370625023,1.0,218/834,18.34%,NFIA;BMP6;PBX1;IGF1;AUTS2;NR2F2;EGFR;HLF;NFAT5;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TEAD1;BMPR1A;NFKB1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;THRB;DCN;GLI2;GLIS3;NR1D2;ZNF462;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;KAT2B;DAB2;FOXO3;PPP1R12A;EP300;BMP4;HDAC4;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;TBL1X;ELF1;NFIB;TBL1XR1;MICAL2;SSBP3;NFIX;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;DDX17;RARG;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;NR3C1;SS18;SMAD2;BCL9L;BCAS3;SBNO2;HOXA5;PLSCR1;GABPB2;MED17;SKI;CREBBP;STAT3;HOXA7;TFDP2;MED12;FGFR2;FHOD1;ELF4;FOXC2;CHD8;RUNX1;HOXC4;DHX9;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;AR;RGMA;DHX36;PRPF6;PPARGC1A;CDC5L;IGF2;SETD3;GCN1;NCOA6;CDK13;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;GABPA;NR1H3;SSBP2;JUN;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;NOTCH3;SENP1;THAP3;MAML2;CRTC1;GLIS2;MAVS;BCLAF1;CREBRF;DCAF6;WWC1;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;PKD2;TCF3;OGT;KDM1B;IRF1;MAML1;YBX1;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;STAT1;PRKDC;HINFP;VEGFA;CRLF3;ACVR1;HDAC1;ZBED3;NCK1;DDX3X;PRDM2;NCK2;PLXND1;EFCAB7;RXRA;KLF15;RUNX2;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;SMARCD2;NFYB;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;TAF6L;TRAF6;LPIN3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5955957746102056,-1.5481641019895134,0.02830188679245283,0.2337584564037585,1.0,9/16,25.93%,APPL2;ABCD2;APOD;PDCD4;CHID1;ADCY7;NLRC3;SIRPA;PPARA
prerank,receptor clustering (GO:0043113),0.5192721502808266,1.54757377319331,0.021231422505307854,0.2419580883397579,1.0,7/27,5.91%,DLG2;NRXN1;LRRC7;NLGN1;MAGI2;THY1;NRXN2
prerank,positive regulation of telomerase activity (GO:0051973),0.5028997117418478,1.5458907561417592,0.03418803418803419,0.24346687385645066,1.0,15/33,18.94%,PRKCQ;KLF4;HSP90AB1;CCT2;DKC1;CCT4;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,regulation of myoblast differentiation (GO:0045661),-0.5010293877660396,-1.5445848822783046,0.014112903225806451,0.24007191739667655,1.0,7/32,6.24%,RANBP3L;BOC;BMP4;FLOT2;RIPOR2;IGFBP3;TRIP4
prerank,ureteric bud development (GO:0001657),-0.5703606736902336,-1.5445296363695287,0.035916824196597356,0.23908615231459457,1.0,11/17,18.76%,FOXC1;BMP7;BMP4;OSR1;GPC3;FGFR2;PKD2;SALL1;SIX1;NPNT;BMP2
prerank,protein localization to cell surface (GO:0034394),-0.5241292450391042,-1.5444124759196514,0.02973977695167286,0.23822839004945745,1.0,10/26,14.59%,ANK2;VCL;ANGPT1;FBLN5;FLNA;PIGK;PTPRK;GGA3;USP4;SMURF1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3386682477317702,-1.543488521914293,0.0,0.23906870016582563,1.0,114/417,17.53%,FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;BTRC;BRD7;FOXN3;WWP2;NIBAN2;VGLL4;RCOR1;KHDRBS1;EIF4A2;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;BCL7A;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;PRMT2;JUN;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;ARID5B;PCGF6;PBXIP1;HES1;COPS2;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;SOX13;KAT8;HINFP;ZNF318;HDAC1;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;ZMYND15;TWIST2;WNT5A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6228264061530683,1.5430988290090164,0.03837953091684435,0.24707001709864895,1.0,5/13,6.73%,SHISA6;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.37135145034937544,-1.5412373680834601,0.00392156862745098,0.2424963005880702,1.0,76/186,29.67%,BICC1;TRABD2B;MLLT3;NXN;TCF7L2;LRP1;GLI3;RBMS3;IGFBP2;LRP6;WWOX;GRB10;RNF43;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;VGLL4;IGFBP6;AXIN1;RNF213;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;MDFI;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;CXXC4;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;TSKU;RBX1;HIC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.44806586938078913,1.5407778750288221,0.00819672131147541,0.24799820572331824,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.44806586938078913,1.5407778750288221,0.00819672131147541,0.24799820572331824,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,peroxisome organization (GO:0007031),-0.5221939015437692,-1.540660651846588,0.028790786948176585,0.2427523692338926,1.0,18/25,37.99%,ABCD3;DNM1L;ABCD2;LONP2;PEX6;ABCD4;SEC16B;PEX7;FIS1;ACOT8;PEX11B;PEX10;PEX11A;PEX16;PEX19;PLAAT3;PEX12;PEX11G
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5578913022637192,1.5400724736679594,0.030837004405286344,0.2476563074054759,1.0,5/19,7.54%,GRM5;RYR2;KDR;TRPM2;PTPRJ
prerank,positive regulation of cell division (GO:0051781),-0.4805748360577794,-1.5395520675505783,0.016544117647058824,0.24407806544683777,1.0,11/38,14.97%,SVIL;FGF1;CDC14A;CSPP1;FGFR2;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5830534866831535,-1.537775213609329,0.034220532319391636,0.24671384280406125,1.0,5/16,11.67%,RANBP3L;BOC;RIPOR2;IGFBP3;MEF2C
prerank,positive regulation of cell differentiation (GO:0045597),-0.35726565807828176,-1.5372276543270371,0.0,0.24662490486505473,1.0,75/237,18.36%,BMP6;RANBP3L;IGF1;TCF4;SMAD3;TGFBR1;SOX5;PTN;BMPR1A;NFKB1;COL1A1;WNT4;BOC;NBL1;ZEB1;MEDAG;FOXC1;CCN2;BMP7;IL6ST;CDON;DAB2;TMEM64;CTNNA1;BMP4;PDPN;ABL1;TGFBR2;RIPOR2;YAP1;CREBL2;IGFBP3;TGFB1I1;MEF2A;SMAD2;BCL9L;HOXA5;ZBTB16;MTOR;REST;CDC42;AR;DHX36;GJA1;IMPACT;HOXB4;NGF;RHOA;SMAD4;ID2;MEF2C;AGTR1;TCF3;IL6R;TRPM4;ATRAID;CCN1;SOX6;WDFY2;ACVR1;BLOC1S5;RAPGEF2;GLIPR2;RUNX2;FBN2;TGFB3;CMKLR1;SUCO;HEYL;IL18;CCN4;PRKD1;NPNT;SYAP1;GCNT2
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6822010049619338,-1.5370595411396295,0.0273972602739726,0.24587657171822416,1.0,2/10,2.69%,ROCK2;ROCK1
prerank,brain morphogenesis (GO:0048854),0.6516797754502298,1.5369414293296546,0.044543429844097995,0.2520148303303577,1.0,4/12,10.52%,CTNNA2;SHANK3;PAX2;SPEF2
prerank,positive regulation of cytokinesis (GO:0032467),-0.4967431483323644,-1.536770624750986,0.01834862385321101,0.24554099375245675,1.0,9/32,14.97%,SVIL;CDC14A;CSPP1;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,ganglioside metabolic process (GO:0001573),0.5534710112225963,1.535810541724536,0.037037037037037035,0.25264297671866065,1.0,6/20,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;NEU2;ST8SIA6;ST8SIA3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4436728358130714,-1.5355591135784765,0.015748031496062992,0.24690224451107803,1.0,13/53,11.12%,EYA2;EYA1;EGFR;DDX5;UBE2N;EYA4;PLA2R1;DHX9;BRCC3;CEBPG;RNF8;PRKCD;BCLAF1
prerank,ceramide transport (GO:0035627),0.6206059649912501,1.5346047819034456,0.04938271604938271,0.2534699575783776,1.0,7/12,20.86%,PLTP;CERT1;ABCB4;PLEKHA3;CPTP;SGPP1;PSAP
prerank,spliceosomal complex assembly (GO:0000245),-0.4645817928672923,-1.5344671386977857,0.01764705882352941,0.24800831333060128,1.0,15/46,14.45%,CELF2;CELF1;LUC7L2;SRSF10;SF3B1;SRSF6;PRPF6;SF3A1;YTHDC1;USP39;SCAF11;SF3A3;DDX23;RBM5;SRSF1
prerank,cellular response to glucose starvation (GO:0042149),-0.4778447479559165,-1.5340987844060077,0.00931098696461825,0.24765815600114757,1.0,20/41,23.63%,PRKAG2;FOXO3;PRKAA2;EIF2AK3;SESN1;IMPACT;BRSK1;SIK1;MTMR3;BECN1;PIK3C3;PIK3R4;PRKAA1;RRP8;PRKAG3;TBL2;ATG14;SIK2;SZT2;NUAK1
prerank,epithelial cell migration (GO:0010631),-0.480836991038908,-1.5338456070626443,0.021032504780114723,0.24716777280444513,1.0,15/37,15.45%,FSTL1;KANK2;ROCK1;ABL1;KIT;DPP4;ADGRA2;NRP1;ZEB2;CYP1B1;RHOA;GIPC1;FAP;STAT1;PLXND1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4713912126545336,1.5337765621156094,0.02528735632183908,0.25348980669028426,1.0,11/40,16.08%,TIRAP;PGLYRP1;MBL2;IL12A;TLR2;PPP1R11;GBP4;DROSHA;DEFA6;STAB2;RNASE3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6291123342746141,-1.5329025542095842,0.03377110694183865,0.2480526698858959,1.0,5/13,7.80%,LRRK2;NUPR1;SEC22B;CHMP4B;CHMP4A
prerank,smooth muscle contraction (GO:0006939),-0.6017345606655088,-1.5325548558679447,0.040229885057471264,0.24760384705084068,1.0,8/14,16.23%,ROCK2;MYLK;ROCK1;EDNRA;TPCN2;SMTN;BDKRB2;MYH11
prerank,regulation of neuron projection development (GO:0010975),0.3710751033871153,1.5305324979220933,0.0,0.25790742596195654,1.0,56/163,16.55%,SPOCK1;DCC;CSMD3;CTNNA2;RIT2;LRRC4C;LRRC7;MINAR1;MAG;IL1RAPL1;PLXNB3;S100A9;ITGA6;MBOAT1;MAGI2;SHANK3;CDH2;TOX;KIF1A;MFSD2A;NTRK2;SCARF1;FUT9;PAK1;NPTN;PLPPR5;TENM3;ITM2C;NDNF;AKT1;SCARB2;STMN2;ZDHHC15;CDKL5;NTNG1;NTNG2;RTN4R;RELN;DAB2IP;CHN1;PPFIA2;BRSK2;CCDC88A;RET;EFHC2;PSEN1;CIB1;PRAG1;KNDC1;PAK3;RTN4RL1;FKBP4;CRMP1;RAP1A;STX1B;RAB29
prerank,sphingolipid metabolic process (GO:0006665),0.3941507680450593,1.5301865110422177,0.00199203187250996,0.25701858540909983,1.0,35/108,18.02%,ST6GALNAC3;GAL3ST1;SGMS1;ACER2;FA2H;DEGS2;CERT1;ENPP2;ORMDL1;B4GALNT1;ORMDL2;NEU2;SPNS2;PPP2R1A;ELOVL7;SGPP2;ELOVL4;TECR;ARSA;SERINC1;GLA;SMPD1;HACD3;CPTP;HACD1;PPM1L;PPT1;SAMD8;PRKD3;GALC;KDSR;GLB1;SGPP1;HEXB;SPTLC2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6055231227885314,-1.5295233691679444,0.028089887640449437,0.2528718745855581,1.0,5/14,4.83%,LRP1;BMPR1A;TPM1;IGFBP5;IGFBP3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.6038513236488507,-1.529400555209533,0.05065666041275797,0.25218378429320265,1.0,4/14,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,positive regulation of cellular senescence (GO:2000774),0.6552226975968447,1.5286076995606606,0.05139186295503212,0.25839518997752076,1.0,5/10,19.57%,SIRT1;HMGA2;YPEL3;B2M;EEF1E1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3655943193163057,-1.5277628471663673,0.002044989775051125,0.25447978635731106,1.0,53/182,17.87%,SLC24A3;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;CELF1;BMP4;DICER1;ROBO1;SMO;PRKN;TNRC6B;PRKAA2;WWP2;FLOT2;DLG4;YAP1;TNRC6A;MOV10;RUNX1;ANXA7;REST;PARP10;MAP2K1;PTPN22;LDLR;ITGB8;PARP14;HIF1A;PARP9;ID2;MEF2C;SETDB1;RB1;FBXW7;APOBEC1;APOE;HINFP;VEGFA;EMILIN1;HDAC1;CCDC3;ATOH8;TNRC6C;CITED2;PICALM;PRKAA1;MYADM
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5198162442071946,-1.5271535049956075,0.033073929961089495,0.2547876248085498,1.0,7/26,7.41%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2;BRAF
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.50417625170515,-1.5263985055256033,0.015873015873015872,0.2554767045466569,1.0,11/28,15.48%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5402085762119587,-1.5258784510808356,0.015209125475285171,0.25553445348632986,1.0,7/24,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;ARAP1;WASF2;PAK2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.44266909712961117,-1.5255557069610723,0.020599250936329586,0.2551206799754906,1.0,23/54,21.12%,RNF152;UBE2E2;PRKN;RNF115;RNF146;UBR5;UBE2H;RNF8;UBE2K;RNF216;UBE2R2;CUL3;DTX3L;UBE2B;FBXO38;TOPORS;UBE2E1;BFAR;SYVN1;UBE2D3;IFI27;TTC3;ARIH2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5226831293716574,-1.5253290770688237,0.018726591760299626,0.2545253567734687,1.0,8/27,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;PRKN;ARAP1;WASF2;PAK2
prerank,regulation of sodium ion transport (GO:0002028),0.4911815078432856,1.5252501880865836,0.031914893617021274,0.26317603690676017,1.0,9/34,5.57%,NKAIN2;SPTBN4;FGF12;NKAIN1;NKAIN3;CNKSR3;ANK3;WNK2;SCN4B
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6170887118202202,-1.5247267502581985,0.03076923076923077,0.25499687260861004,1.0,7/14,20.78%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1;PIK3R1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5123574910190909,-1.524708119550146,0.025145067698259187,0.25402115994794605,1.0,18/26,41.85%,ERRFI1;CBLB;SNX6;SHC1;FBXW7;NCK2;ADRA2A;HBEGF;EGF;APP;GPRC5A;ZGPAT;CBL;ADAM17;TSG101;SOCS4;BTC;CHMP6
prerank,cellular response to calcium ion (GO:0071277),0.4249146426634969,1.5234076780075143,0.007797270955165692,0.26512100962409696,1.0,14/67,7.62%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR3;CPNE9;TRPM2;CPNE8;CPNE1;KCNH1;SYT10
prerank,negative regulation of ossification (GO:0030279),-0.5268231056793267,-1.5232788711921024,0.0234375,0.25620514021427315,1.0,8/23,17.74%,RBPJ;SMAD6;BCOR;ENPP1;MEF2C;TRPM4;ECM1;CHSY1
prerank,cellular glucan metabolic process (GO:0006073),-0.6591088747848131,-1.522589556258759,0.03558718861209965,0.25654327176394826,1.0,5/11,14.94%,PRKAG2;PHKB;GSK3B;PHKA1;PYGM
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5447098212345866,-1.522116746780292,0.02697495183044316,0.256507002455911,1.0,12/21,28.14%,SAMD4A;PAN3;TUT4;CNOT8;CNOT2;PAN2;CNOT1;CNOT10;CNOT4;TNKS1BP1;PNLDC1;PARN
prerank,epidermis development (GO:0008544),-0.43549331658520873,-1.5220294543781965,0.011834319526627219,0.25568406620711437,1.0,12/56,14.62%,SVEP1;CCN2;FLOT2;FGFR2;LAMA3;ATP2A2;EMP1;UGCG;CRABP2;YBX1;GLI1;HDAC1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.6584844145496713,-1.5217068611761428,0.03275529865125241,0.25533783049151004,1.0,5/10,19.34%,SETD7;SETD3;SETD2;EHMT1;KMT5A
prerank,metal ion homeostasis (GO:0055065),0.47290549903220414,1.5214865073119774,0.025477707006369428,0.2671491634520476,1.0,9/40,9.07%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;SLC12A6;CIB2;SLC7A8;SLC12A3
prerank,cellular response to leucine (GO:0071233),-0.6939294606303427,-1.520596072022244,0.0248565965583174,0.2555730740683168,1.0,6/10,13.10%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,response to leucine (GO:0043201),-0.6939294606303427,-1.520596072022244,0.0248565965583174,0.2555730740683168,1.0,6/10,13.10%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4677617690319445,1.5205288332970297,0.018404907975460124,0.2672351975611933,1.0,12/44,7.78%,KCNJ3;KCNJ6;KCNN2;AKAP6;WNK2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6624551807532728,-1.5200240684391568,0.036297640653357534,0.2557007451250463,1.0,5/10,12.62%,PIAS1;HDAC4;SAE1;PIAS3;PIAS4
prerank,negative regulation of ion transport (GO:0043271),0.5181421873347801,1.5194272404780849,0.056795131845841784,0.267871074894337,1.0,5/24,4.15%,CD33;GPM6B;SYT11;SNCA;WNK2
prerank,regulation of telomere maintenance (GO:0032204),-0.5131541879537082,-1.5180925964547427,0.034482758620689655,0.2585430234781581,1.0,16/26,27.52%,SMG6;HDAC8;SMG1;USP7;NBN;YLPM1;HNRNPD;DHX36;UPF1;MRE11;TERF2;PML;ERCC1;PPP1R10;GNL3;ATRX
prerank,negative regulation of gene expression (GO:0010629),-0.3420652644611107,-1.5177602299552508,0.0,0.2581563246776057,1.0,79/302,17.87%,SLC24A3;SAMD4A;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;IGFBP5;CELF1;LGR4;DIS3L2;KAT2B;BMP4;DICER1;ROBO1;SMO;NCOR1;PRKN;PPM1D;TNRC6B;PRKAA2;WWP2;FLOT2;YAP1;SYNCRIP;TNRC6A;DDX6;MOV10;EIF4ENIF1;TWSG1;DNMT3A;EIF2AK3;RUNX1;ANXA7;PTBP3;REST;LARP1;PARP10;DHX36;MAP2K1;PTPN22;ITGB8;LSM14A;PARP14;HIF1A;MPHOSPH8;PARP9;ID2;CNOT8;ATP2B1;MEF2C;SETDB1;RB1;FBXW7;YBX1;EIF2AK2;APOE;PHF1;HINFP;VEGFA;EMILIN1;HDAC1;ERN1;DDX3X;CCDC3;JARID2;DAPK1;ATOH8;TNRC6C;CITED2;EPC1;CNOT1;PICALM;PRKAA1;MYADM
prerank,response to amyloid-beta (GO:1904645),0.461050104979015,1.5174314472134522,0.030042918454935622,0.26979866720699763,1.0,8/44,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;CACNA1B;MMP12;GRIN2A;CACNA2D1
prerank,muscle contraction (GO:0006936),-0.37823291129034464,-1.5165763964451655,0.00199203187250996,0.25967442584886885,1.0,21/126,8.80%,CALD1;ROCK2;SORBS1;VCL;TPM1;MYLK;VIM;ROCK1;PABPN1;TLN1;SNTA1;MYOF;TMOD3;EDNRA;SNTB1;ITGB5;TPCN2;SSPN;ASPH;SMTN;ACTN2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5722516277665068,-1.5154344919006382,0.03415559772296015,0.2609880476614521,1.0,10/18,30.87%,KLF9;NR3C1;ANXA1;REST;PCK2;FAM107A;HNRNPU;ZFP36L2;UBE2L3;BCL2L11
prerank,autophagy of nucleus (GO:0044804),-0.5768192226975101,-1.5154150932551653,0.037037037037037035,0.2600731873051666,1.0,12/16,34.08%,RB1CC1;WIPI1;ULK2;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;WIPI2;ATG3;WDR45;ATG12
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.4409236445838778,-1.5150897412009852,0.013779527559055118,0.259775678134123,1.0,22/51,19.89%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;SYNPO2;RHOA;SYNPO;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4850170828008531,-1.5146693507201967,0.034220532319391636,0.2598000474015238,1.0,17/33,28.73%,APPL2;PKD1;INO80;STXBP4;MN1;ID2;FBXW7;APPL1;GLI1;TRIM39;CDC73;EZH2;PLK5;PHB2;TCIM;PSME1;E2F1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4435537482683143,-1.5138721167792355,0.02862595419847328,0.26043908436274227,1.0,18/50,17.26%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;ADAP2;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3;PLCL1;PIK3CD
prerank,positive regulation of autophagy (GO:0010508),-0.40740433993028846,-1.5136466070820274,0.006024096385542169,0.25989672390137636,1.0,32/81,25.24%,RNF152;DCN;FOXO3;ROCK1;PRKN;LRRK2;TFEB;PRKAA2;GSK3B;TBK1;TPCN1;HMGB1;UFL1;TRIM8;LARP1;SESN1;PAFAH1B2;TRIM5;EIF2AK4;ATF6;DAPK1;PRKD1;PRKAA1;PARK7;PLEKHF1;ORMDL3;BNIP3;WAC;TICAM1;IRGM;TRIM68;PHB2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4496741146404792,-1.5134537849594172,0.021611001964636542,0.2593276154791874,1.0,13/51,11.08%,FSTL1;FBN1;CRIM1;BMPR1A;SMAD6;SMURF2;NBL1;HTRA3;SKI;SKIL;SMAD4;BMPER;GREM2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6478463390682991,-1.512409470796111,0.05350553505535055,0.26039446181124065,1.0,1/10,1.19%,NFKB1
prerank,negative regulation of autophagy (GO:0010507),-0.4409006021120429,-1.5106825792456775,0.02127659574468085,0.26281782336373233,1.0,27/54,28.58%,LEPR;EIF4G3;SMG1;LRRK2;NUPR1;ZKSCAN3;STAT3;BCL2;MTOR;FOXK1;PTPN22;EIF4E;SNRNP70;KLHL22;CTSA;FOXK2;DAP;RUBCN;EIF4G1;NRBP2;BMF;WDR6;DAPL1;RRAGA;HGF;MET;MT3
prerank,protein stabilization (GO:0050821),-0.36671321314880645,-1.5103396905790327,0.0039447731755424065,0.2625352784327083,1.0,70/168,25.24%,IGF1;PARVA;ANK2;PLPP3;MDM4;PER3;TRIM44;STK3;EP300;PRKN;TBL1X;FLOT2;CCNH;FLNA;CREBL2;COA8;CDK7;USP7;CCT6A;STXBP4;EPHA4;PPARGC1A;LAMP2;BAG3;USP33;PRKCD;HCFC1;RPL11;COG3;ATF7IP;COG7;CCT8;TELO2;PEX6;FBXW7;RASSF2;RAB21;NAA15;USP2;UBE2B;ZBED3;USP13;TRIM39;PDCL3;CCT5;TNIP2;NOP53;ZSWIM7;LAMP1;SYVN1;MORC3;PARK7;ATP1B3;SEC16A;PIK3R1;SUGT1;WDR81;DVL3;TAF9B;RABL3;WFS1;CHP1;HIP1R;USP9X;BAG5;BAG6;NAA16;IRGM;STX12;PHB2
prerank,chordate embryonic development (GO:0043009),-0.4329496635355593,-1.5101339212757585,0.014736842105263158,0.2619518763538434,1.0,19/55,15.82%,SULF1;ALDH1A2;TGFBR1;COL1A1;PKD1;BMP5;BMP7;PCSK5;RBP4;SULF2;FGFR2;IGF2;DACT1;PKD2;CHD7;HINFP;VEGFA;PTCH1;TGFB3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6156464039770478,-1.5099538551448464,0.041970802919708027,0.2613899329104456,1.0,6/13,16.91%,IL6ST;JAK1;STAT3;TYK2;STAT1;OAS2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.48012378969849157,-1.509404845642834,0.028901734104046242,0.2616654712059636,1.0,11/34,17.33%,ROCK2;CTNNA1;GSK3B;RIPOR2;UBXN2B;ACTN2;LEPROTL1;LEPROT;ILRUN;LATS1;PICALM
prerank,intraciliary retrograde transport (GO:0035721),-0.6177113546180608,-1.5087605265897308,0.055350553505535055,0.2619518763538434,1.0,9/12,32.83%,IFT43;DYNC2I1;DYNC2LI1;DYNC2I2;IFT140;TTC21B;IFT122;WDR35;DYNC2H1
prerank,artery morphogenesis (GO:0048844),-0.49096582089666563,-1.5055103361748912,0.03639846743295019,0.26775991703396423,1.0,12/30,17.03%,LRP1;TGFBR1;BMPR1A;PDGFRB;BMP4;JAG1;NRP1;ADAMTS9;HES1;PKD2;VEGFA;TBX2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6381864777545116,1.50526651072813,0.06986899563318777,0.2922978389963421,1.0,5/10,14.32%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5809902410226109,-1.5050867727069301,0.04364326375711575,0.26765707709196357,1.0,6/16,13.71%,SOX5;PTN;FOXC1;DHX36;HOXB4;SOX6
prerank,neuron projection morphogenesis (GO:0048812),0.37889197849666545,1.502795284303609,0.002004008016032064,0.2958546510024649,1.0,40/137,12.47%,NYAP2;CNTNAP2;DCC;CTNNA2;ACTB;EPHB1;SPTBN4;CTNND2;NLGN1;MAPK8IP2;GPM6A;ADGRB1;ANK3;SHANK3;MAP1B;MAP2;APBB1;PAX2;TNIK;DSCAML1;PAK1;NRCAM;CPNE1;EPB41L3;CNTNAP1;ZDHHC17;UBB;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;DAB2IP;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1;SRGAP2;DOCK10
prerank,positive regulation of cell communication (GO:0010647),0.510775164766487,1.502604506213141,0.03896103896103896,0.2945480148161753,1.0,10/28,8.17%,SYT1;RIMS1;RIMS2;ANK3;RIMS3;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4287523562709964,1.5014434995444563,0.025052192066805846,0.29518956775357164,1.0,13/63,14.85%,TFRC;TIRAP;SLC7A1;MIF;IL7;VAV3;FGF10;IL12A;TNFSF13B;AIF1;CD40;NFATC2;CD38
prerank,protein K11-linked ubiquitination (GO:0070979),-0.49547053455629475,-1.501199181116488,0.04356435643564356,0.27470811789134875,1.0,18/27,31.80%,UBE2E2;PRKN;UBE2H;ANAPC5;ANAPC7;ANAPC4;CDC26;UBE2B;CDC27;UBE2S;UBE2D3;ANAPC11;ANAPC13;CDC16;ANAPC1;FZR1;UBE2L3;UBE2W
prerank,regulation of focal adhesion assembly (GO:0051893),-0.43190687563617153,-1.5001420475452425,0.024734982332155476,0.275990991168043,1.0,15/54,7.95%,PHLDB2;ROCK2;ARHGAP6;EPHA3;VCL;LIMS1;ROCK1;ABL1;SLC9A1;SLK;THBS1;BCAS3;MAP4K4;NRP1;S100A10
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5266311160733654,-1.4991328181038743,0.038817005545286505,0.27705035905969155,1.0,12/24,22.76%,IGF1;SORBS1;ENPP1;GSK3B;IRS1;IGF2;SELENOS;PPP1R3B;INPP5K;AKT2;PPP1R3C;PPP1R3F
prerank,urogenital system development (GO:0001655),0.6316156884440395,1.4988993866823037,0.0718954248366013,0.2986310154099287,1.0,4/11,6.58%,PAX8;AMH;PAX2;LHX1
prerank,Wnt signaling pathway (GO:0016055),-0.39400868509950054,-1.4982137224612175,0.01968503937007874,0.2780310532786507,1.0,18/92,6.01%,WLS;NXN;TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;BTRC;WNT5B;GPC4;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6234529271973451,-1.4979739575262148,0.05084745762711865,0.2776017846681157,1.0,5/11,18.51%,LRP6;RYK;WNT5A;NR4A2;FZD1
prerank,positive regulation of signal transduction (GO:0009967),-0.34551323699559616,-1.4964812418438629,0.0,0.27975554883301473,1.0,66/238,15.96%,BMP6;WLS;SULF1;IGF1;SASH1;TGFBR1;SORBS1;ZMIZ1;RBPJ;NTRK3;LIMS1;GRB10;ITGAV;FGF1;CCBE1;TRIM44;KAT2B;AXL;IL6ST;EP300;ROBO1;PTGIS;SMO;ARNT;JAG1;LRRK2;VTN;TSPAN5;NLGN2;DLG4;YAP1;DCDC2;FLNA;TTC23;IRS1;SULF2;SLC39A14;RSPO3;SKI;CREBBP;STAT3;NRP1;FGFR2;F3;IGF2;DACT1;MN1;RSPO2;CCN3;HIF1A;EVC;MAML2;PKD2;ARMC9;MAML1;GLI1;ING5;TPD52L1;BMP2K;ERN1;PRKCZ;TRIM39;ITGA5;CSNK2A1;SALL1;LOXL3
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5835923082111993,-1.4959711269383553,0.04283054003724395,0.2797835801963195,1.0,8/16,19.20%,LRP1;ROCK1;APOE;HDAC1;IFNGR1;HMGCR;CYP51A1;ABCA7
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5485612511463298,1.4958537885456884,0.04121475054229935,0.30333370129494663,1.0,6/19,11.67%,SLCO1C1;PAX8;KLF4;PDGFB;KLF2;MAPK8
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5602278342939395,1.494829732417177,0.059734513274336286,0.3037768436551434,1.0,7/16,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;ST8SIA1;B4GALT6;ST8SIA6;ST8SIA3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4615849538826197,1.4944978370909912,0.022494887525562373,0.3027914473869107,1.0,19/38,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFAF1;NDUFB9;NDUFAB1;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.4227520413698833,-1.4931048019436448,0.018108651911468814,0.2849523206039045,1.0,25/62,24.46%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;HOXA5;CREBBP;ZBTB16;RUNX1;LYN;CTR9;MEF2C;HSPA9;HDAC1;TNRC6C;CDC73;CDK6;KMT2A;MAFB;AGO1;CNOT4;KMT2E
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5789748069432106,-1.4929896820501587,0.052930056710775046,0.2842127065967631,1.0,4/16,10.15%,PRKAG2;APPL2;PPARGC1A;LONP2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4944493162916008,-1.4929803947124243,0.028735632183908046,0.2832524472540479,1.0,13/28,18.68%,PID1;APPL2;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.578647775710985,1.4923081607664508,0.06896551724137931,0.3053156594360004,1.0,6/15,13.24%,KCNJ3;KCNN2;KCND3;ATP1A1;KCNJ8;ATP1B1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.4224040720171636,-1.4910427693828485,0.028056112224448898,0.2865361095762094,1.0,26/58,26.91%,UBE2N;UVRAG;HMGB1;NBN;NSMCE2;BRCC3;RNF8;SMC5;HERC2;XRCC4;PAXX;POLM;PIAS4;PRKDC;ERCC8;KDM2A;MRE11;DCLRE1A;XRCC6;UBE2V2;SMARCAL1;ERCC1;PAXIP1;ZBTB7A;IFFO1;ABRAXAS1
prerank,positive regulation of protein import (GO:1904591),-0.4883753074878356,-1.4906766684633859,0.03206412825651302,0.2861940487134878,1.0,11/30,15.48%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,regulation of gene expression (GO:0010468),-0.3073448281303748,-1.489155641792052,0.0,0.28842979847521233,1.0,233/903,18.98%,NFIA;BMP6;SLC24A3;ROCK2;NOTCH2;PRDM6;IGF1;BNC2;FOXP1;DENND4A;PID1;AHNAK;AFDN;SMAD3;TGFBR1;EFEMP1;ANK2;BMPR1A;RBMS3;FOXD1;SON;NFKB1;PRDM5;ZNF148;ANGPT1;GSN;WNT4;RBPJ;NTRK3;CLK1;LIMS1;ZNF423;CELF1;ATXN1;NR1D2;ZNF462;ZFHX3;HNRNPH1;FOXC1;FGF1;TRIM44;BMP7;AFF3;EP300;ROCK1;BMP4;DICER1;ROBO1;HDAC4;ERC1;ABL1;SMO;KAT6B;PRKN;TNRC6B;OSR1;WWC2;TFEB;PRKAA2;MBNL2;PABPN1;FOXN3;WWP2;FLOT2;WNT6;GSK3B;GON4L;RREB1;PUM2;YAP1;ZC3H7A;WTIP;TNRC6A;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;CTSH;SRSF10;MOV10;UBR5;AFF1;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;CREBBP;RC3H1;CDH1;STAT3;NSD3;TRIP4;NSD1;DTNBP1;MED26;TRRAP;ZUP1;EIF2AK3;NAB1;RUNX1;LYN;ANXA7;MTOR;PTBP3;F3;BRAF;REST;LARP1;PARP10;POFUT1;PUM1;HNRNPD;GTF2IRD1;AR;FUBP1;DHX36;CTR9;PCBP2;PPARGC1A;IGF2;GJA1;MAP2K1;NFYC;KDM6A;MED1;PTPN22;HNRNPK;ATF2;CLK2;ITGB8;NGF;CHD3;ZFAT;GABPA;SSBP2;TADA3;TULP3;PARP14;HIF1A;HCFC1;CALCOCO1;RPL11;LIMD1;PARP9;ID2;AFF4;CLK3;CDK11B;YTHDC1;TLE1;GPBP1L1;ADAM19;NFKBIZ;WWC1;RORA;MEF2C;TRIM5;SPTY2D1;TRIM11;TEAD2;SUFU;SETDB1;TCF3;TCF7L1;RB1;SNRNP70;FBXW7;YBX3;FN1;CCAR1;FZD7;CRABP2;PATZ1;ADNP2;CGGBP1;YBX1;SOX13;ATRAID;SOX6;CHD7;APOE;PHF1;HINFP;VEGFA;EMILIN1;BRCA2;HDAC1;USP13;DDX3X;PRDM2;TAF5L;TRIM39;PDCL3;CCDC3;FOXK2;EPHX2;VSX1;ATOH8;IFNGR1;PRMT5;TNRC6C;SFPQ;TRAF3;GLRX2;CITED2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;PIK3CD;PICALM;TLR4;CCN4;WNT5A;PRKAA1;MYADM;SFRP4;TAF6L;MSL3;POU6F2;GCNT2;SEC16B;RHOH;HMG20A;MYOM1;BMP2;RNF14;PARK7;MUSK
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.486811872020114,-1.4888876350529712,0.023076923076923078,0.2879783762114511,1.0,10/30,10.61%,FSTL1;TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2;TWSG1;XIAP;SMAD4
prerank,regulation of metal ion transport (GO:0010959),-0.5828832651459689,-1.4888773518257215,0.042801556420233464,0.28702161560893485,1.0,7/16,8.15%,STIM1;ANK2;DLG1;SLC30A10;BCL2;IL16;CAMK2G
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.41328271560303126,-1.4888484742835364,0.009433962264150943,0.28611151027871357,1.0,24/67,22.00%,DOCK5;PLEKHA2;LIMS1;ECM2;ABL1;GSK3B;RREB1;FLNA;VIT;NRP1;CDC42;S100A10;RSU1;JUP;FN1;CARMIL1;DOCK1;MYADM;NPNT;MYOC;TRIOBP;P4HB;CDK6;CRKL
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5781560084387007,-1.488012226039713,0.03969754253308128,0.286854698241973,1.0,7/16,10.24%,PDGFRA;PDGFRB;ABL1;PLAT;NRP1;FER;PDGFC
prerank,cation transport (GO:0006812),0.3602128482683426,1.4879359426146017,0.004291845493562232,0.3128031776153934,1.0,33/167,11.75%,SLC6A6;GRIN1;SCN1A;SLC6A17;KCNJ3;SLC7A1;KCNJ6;KCNN2;FGF13;SLC1A1;KCNMB2;KCNMB3;SLC8A1;KCNN1;SCN4B;ASIC1;KCNMB4;KCNJ10;TRPM2;KCND3;KCNH1;KCNK9;SLC7A8;KCNAB1;SCN3A;KCNC1;KCNK1;SLC66A1;SLC12A3;SLC36A1;ATP1A4;KCNA2;SCN2A
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.33116390427561526,-1.4868776647379518,0.0,0.2882599708373579,1.0,156/366,30.93%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ANKRD17;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;FOXO3;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;RBBP6;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;GEMIN5;ATF2;EIF4E;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;ESCO1;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;EIF2B4;PML;NFYA;PPP2CA;EZH2;ZNF205;SPIN1;DRAP1;RABL3;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219;NFIL3;JMJD1C;SOX12;OBI1;ATRX;SAP30L;APP;ESR1;MYBL2;ZBTB4;E2F1;SP3;ZFPL1;UTP4;FOXO4;HIC1;ZBTB38;CALR;MLX;MLXIPL;DDX25;UBE2L3;HDAC10;SKOR2;NR5A2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5237208960270594,1.4860909620086225,0.039735099337748346,0.3148500741117143,1.0,3/23,4.90%,CADM1;KLRC1;IL12A
prerank,positive regulation of binding (GO:0051099),-0.3965288430424629,-1.4857028642649668,0.005714285714285714,0.2897116093905509,1.0,32/84,20.69%,IGF1;TCF7L2;LRP1;PKD1;FOXC1;STK3;BMP4;PRKN;LRRK2;VTN;GSK3B;MARK3;HMGB1;SKI;DHX9;CEBPG;DACT1;NGF;USP33;RPL11;PARP9;HES1;DTX3L;TXN;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;CLN5;NME1
prerank,mitochondrion distribution (GO:0048311),-0.614955056105377,-1.4854230172125218,0.06818181818181818,0.28932444415226183,1.0,5/12,13.34%,TRAK1;LRRK2;MEF2A;DNM1L;ARMC1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4079679281240446,-1.4852702742009967,0.015748031496062992,0.2887262908983336,1.0,28/67,20.89%,ROCK2;SULF1;ITGAV;AXL;ROCK1;CYFIP2;WASF2;SHB;PAK2;NRP1;CDC42;VAV2;BRK1;RHOA;ABI1;NCKAP1;VEGFA;NCK1;VEGFD;NCK2;CYBA;DOCK1;PRKD1;ITGB3;NCF2;BAIAP2;PIK3R1;AAMP
prerank,negative regulation of phosphorylation (GO:0042326),-0.3915433946664765,-1.4841887129006444,0.00816326530612245,0.29013442647467136,1.0,34/85,22.55%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;BMP7;ROCK1;BMP4;HDAC4;NCOR1;PRKN;LRRK2;NUPR1;IBTK;IGFBP3;LYN;IMPACT;ANKLE2;FKBP8;PRKDC;ZBED3;CBFA2T3;MYADM;HNRNPU;INPP5K;PARK7;INHBA;CDKN1C;CDK5RAP3;ATG14;CRKL;PRKRIP1;CHP1
prerank,organic anion transport (GO:0015711),0.4067763694700728,1.4836041161963538,0.02286902286902287,0.3187761175816597,1.0,15/76,10.65%,SLCO1C1;SLC4A1;CA4;SLCO4C1;AQP9;ABCG2;SLC35A1;SLC52A2;SLC25A42;CA2;SLCO5A1;SLC52A3;SLCO2B1;ABCC4;SLC39A8
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3801017394394869,1.4833789215925692,0.0021321961620469083,0.3176105120156002,1.0,19/107,6.24%,SLC39A10;SLC24A4;SLC24A2;MT2A;CXCL12;RYR2;HTR2C;SLC8A1;ATP2B3;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SLC30A1;NPTN
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5362252876746747,-1.483340178901356,0.045454545454545456,0.29109328925029043,1.0,11/21,24.87%,MED17;MED12;DHX36;MED1;JUN;BCLAF1;MED16;MED13;MED14;PAXIP1;TWIST1
prerank,defense response to bacterium (GO:0042742),0.3875769839681232,1.482842425793849,0.004228329809725159,0.3170731126041287,1.0,21/105,14.42%,TIRAP;PGLYRP1;MBL2;RPS19;S100A9;S100A8;ADGRB1;ISG15;IL12A;TLR2;RPL30;EPX;NOD1;SLPI;PPP1R11;GBP4;DROSHA;DEFA6;LCN2;LPO;STAB2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5524124085987059,-1.4824279097606068,0.053465346534653464,0.29201453825120616,1.0,12/17,31.45%,HM13;OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,negative regulation of vascular permeability (GO:0043116),0.5941026287159682,1.481873053251294,0.07066381156316917,0.31735813044167044,1.0,5/12,7.54%,CLDN5;SH3GL2;RAMP2;PDE2A;PTPRJ
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5251998745951099,-1.4816152443474608,0.05330882352941176,0.29278145307651776,1.0,4/23,7.01%,ATP1A2;ANK2;DIAPH1;CAMK2D
prerank,positive regulation of ossification (GO:0045778),-0.46204555675719455,-1.4816067392631034,0.0300187617260788,0.2918355480793086,1.0,22/39,20.83%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ZBTB16;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;WNT5A;BMP2;PTPN11;TMEM119;PKDCC
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5436812472410579,-1.4814302592259037,0.05555555555555555,0.2912486494829449,1.0,6/19,15.88%,ENPP1;TPST1;SLC35B3;SLC26A2;SULT1A1;ABHD14B
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5104598115772354,-1.4807658210256853,0.05128205128205128,0.29177096222851373,1.0,8/24,6.61%,PARVA;BMPR1A;SMAD6;BMP4;ROBO1;TGFBR2;NRP1;FGFR2
prerank,organelle organization (GO:0006996),-0.3267308877553239,-1.479646183189988,0.0,0.29318371100883645,1.0,141/388,25.24%,ARHGAP10;MICAL3;PLCE1;TPM1;OPA1;BRWD1;DIAPH1;GBF1;PRKN;LRRK2;FBXW8;SYNE3;CSNK1A1;RAB30;NUMA1;ATL3;MICAL2;ABCD3;WDPCP;YTHDF3;ODF2;PACSIN2;WTIP;HPS3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;CXADR;GOLGB1;SEC23IP;VPS4B;VPS13D;ARFGEF1;AFG1L;RAB3GAP1;EIF2AK3;ARHGAP21;OBSL1;CDC42;CHMP4B;CHMP4A;ABCD2;PPARGC1A;MARK4;USP6NL;SEC31A;PALLD;MTX3;CHMP5;ATP8B2;ATL2;RANBP10;TBC1D20;WASL;CHMP3;GABPA;LONP2;FAM161A;HCFC1;COG3;LIMD1;RHOT1;COG7;STX4;ZMYM4;PARP1;NRF1;YME1L1;PEX6;ABCD4;PKD2;VPS13C;FGD1;SURF4;SIRT5;ZMYM3;CAPZB;APOE;TTC17;FGD4;NECTIN2;DOP1B;RANBP9;STOML2;ZFYVE16;MARK1;FAF2;AUP1;TJAP1;TMED3;MIA3;PHIP;PRKD1;ATXN7;MICAL1;SEC16B;CSNK1D;SMPD4;PARK7;TMED5;TMED4;SIPA1L3;AJUBA;TMCC1;PLEKHF1;TRIP11;PEX7;CNN2;TERT;SEC16A;KIF9;SPRYD3;STX17;PYROXD2;DES;KIFAP3;MAST2;WDR81;CUL7;PPID;COG4;PLEKHM2;SIRT4;SSBP1;TOR1A;PI4K2B;VAPA;ARMC2;LMAN1;SPTSSB;RHOT2;BAG5;KIF3A;SAR1B;SIRT3;RAB7A;CENPT;CLUH;PHB2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.4438567104713544,-1.479463482952458,0.03195488721804511,0.2925827779912281,1.0,20/44,19.89%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;RHOA;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,regulation of secretion by cell (GO:1903530),0.42689615461443664,1.4791025585836883,0.03917525773195876,0.32124220585777635,1.0,11/54,6.13%,CAMK2A;SYT1;RIMS1;RIMS2;SCG5;MCTP1;RAB3C;LGI3;RHBDF2;STXBP5L;KCNMB4
prerank,regulation of actin filament-based process (GO:0032970),-0.40386144210402897,-1.4774457182649483,0.023952095808383235,0.2960892219425092,1.0,31/70,27.47%,ROCK2;LRP1;RHOQ;EPHA3;PDGFRB;ROCK1;ABL1;RND3;MTOR;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;CNN2;BAIAP2;F11R;ARHGAP35;HIP1R;ARHGAP44;TWF2;TESK1;EFNA5
prerank,cellular response to interleukin-6 (GO:0071354),-0.5040761918191883,-1.4774367901727354,0.04007633587786259,0.2951585127282093,1.0,13/26,14.16%,PID1;NFKB1;IL6ST;PTGIS;JAK1;YAP1;SBNO2;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,action potential (GO:0001508),0.4409692855545126,1.477247787214144,0.028925619834710745,0.3236960384006805,1.0,13/44,16.40%,KCND2;SCN1A;ANK3;AKAP6;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A;GNAQ
prerank,positive regulation of organelle organization (GO:0010638),-0.47524989834352577,-1.4771648933742778,0.044,0.2947966545314066,1.0,15/32,27.38%,UVRAG;ATL3;GSK3B;ANXA2;RAB3GAP1;STX18;ANXA1;PPARGC1A;SURF4;SORBS3;AKT2;LMAN1;IRGM;HTRA2;ADRB2
prerank,membrane depolarization (GO:0051899),0.47940591545590217,1.477048185470789,0.03640256959314775,0.32244081924952533,1.0,11/32,15.66%,CACNA1A;SCN1A;CACNA1B;CACNG2;CACNA1E;SCN3A;CACNB4;P2RX7;SCN2A;CACNA1I;SCN8A
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.49910793664937514,-1.4769815540739755,0.04570383912248629,0.2942399379985001,1.0,9/26,17.08%,FOXP1;KANK2;DAB2;NCOR1;STRN3;HDAC1;CNOT2;HEYL;CNOT1
prerank,cell-cell junction organization (GO:0045216),0.39276716177681575,1.4763161055485128,0.01882845188284519,0.3222228456117103,1.0,21/79,12.08%,CLDN5;CDH12;CDH8;CADM1;CSF1R;CADM2;CTNND2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;OCLN;TGFB2;DCHS1;CADM3;F2R;TJP1;NECTIN1;MARVELD2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5297062673034276,-1.4761175960420894,0.047524752475247525,0.2953232513141036,1.0,13/21,33.66%,OPA1;PRKN;LRRK2;EIF2AK3;SELENOS;NCK1;SYVN1;PARK7;TMBIM6;BCL2L11;HERPUD1;HSPA1A;CREB3L1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.48315239793821907,1.4751389972688105,0.036885245901639344,0.3229124089327283,1.0,11/28,19.66%,FGF10;THY1;IL12A;PRKCQ;CCL2;CYRIB;HSPD1;SH3KBP1;NCKAP1L;NOD2;CD47
prerank,modified amino acid transport (GO:0072337),-0.5786987795113068,-1.4750220920745776,0.047080979284369114,0.29683676422434796,1.0,6/15,18.62%,SLC6A13;SLC16A12;PDPN;SLC5A6;CTNS;MGST1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5095067755331526,-1.4731539715812052,0.0496031746031746,0.3000233073712047,1.0,10/25,17.73%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;PKD2;STAT1;STAT5A;STAT5B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5447380238779304,1.4724174012330564,0.05102040816326531,0.32712882978288427,1.0,8/18,21.18%,CHRM3;GRK2;PLCB1;OPRM1;CHRM2;GNAQ;CDK5R1;RGS10
prerank,RNA metabolic process (GO:0016070),-0.3745200109904443,-1.4722675566831946,0.009727626459143969,0.3010371200176772,1.0,39/127,19.57%,RBMS1;CELF2;RBFOX2;TENT2;RBPMS;ATXN1;HNRNPH1;FTO;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;WTAP;RBMS2;RBM6;HNRNPM;DHX9;HNRNPUL1;HNRNPD;DHX36;PCBP2;HNRNPK;DUSP11;XRN2;ALKBH1;APOBEC1;RBM5;PAPOLG;DDX3X;MTREX;RNGTT;HNRNPU;POLR2H;HNRNPA3;RNASE4;SIDT2;RBM4
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.39684289273030343,-1.4719944457810854,0.006036217303822937,0.30069353375095137,1.0,15/85,7.39%,BMP6;TGFBR3;IGF1;EGFR;TCF7L2;ANGPT1;LIMS1;BMP5;FGF1;BMP4;OSR1;NUPR1;YAP1;FGFR2;SRSF6
prerank,regulation of glycolytic process (GO:0006110),-0.4141469040455968,-1.4714566342551902,0.01020408163265306,0.30089157379325665,1.0,16/68,12.86%,ZBTB20;PRKAG2;IGF1;EP300;HDAC4;NCOR1;ARNT;PRKAA2;NUPR1;RANBP2;PFKFB4;NUP42;NUP214;HIF1A;TPR;OGT
prerank,"transcription, DNA-templated (GO:0006351)",-0.3453746513581477,-1.4713848632553403,0.00199203187250996,0.3000980712651193,1.0,87/207,28.73%,MLLT3;MAF;SOX5;NFKB1;THRB;DDX5;GLIS3;FOXO3;GTF2H2;CCNT2;CCNH;NFIX;RREB1;CCNT1;CREBL2;TAF3;MEF2A;CDK7;BAZ2A;CTR9;TAF4;TBP;NCOA6;CCNK;MNAT1;BRF1;AFF4;RTF1;PARP1;ERCC3;IRF9;COPS2;NELFB;TTF1;MMS19;TAF5L;SNAPC3;TOPORS;TAF13;MNT;PRMT5;GTF2B;PIR;PMF1;EPC1;RNGTT;NR4A2;NFIC;POLR2H;GTF3C4;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;RPAP1;GTF2F1;POLR2K;HSF1;GTF2H1;EAF2;TBPL1;GTF3C1;CTDP1;POLR2E;POLR3H;NCBP2;TAF7;GTF3C6;ZBTB7B;TAF1C;GTF2H4;GTF2E2;THRA;NFKBIB;POLR2D;NELFA;CDK9;NELFE;BRF2;MRPL12;TAF1A;E2F1
prerank,muscle cell migration (GO:0014812),-0.6416661178520502,-1.4710828567051049,0.07522935779816514,0.2998493247344695,1.0,7/10,20.89%,ROCK1;PLAT;CCN3;DDR1;SIX1;ITGB3;AAMP
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.5208113304314776,-1.470754793184318,0.044145873320537425,0.2997163840264362,1.0,6/20,11.54%,ROCK2;RHOQ;ROCK1;DLG1;FHOD1;NCKAP1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5533422803141175,1.4702131831335528,0.045951859956236324,0.3301329381383958,1.0,6/17,16.58%,HCAR2;MFSD2A;ALK;AKT1;SORL1;GPLD1
prerank,regulation of peptide hormone secretion (GO:0090276),0.41127959493098437,1.4700107748871916,0.017204301075268817,0.3289088849177664,1.0,11/67,6.27%,PAX8;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;HTR2C;KCNJ11;CACNA1E
prerank,myelination (GO:0042552),0.4427180746277211,1.4694557925637606,0.03319502074688797,0.3283694074859471,1.0,17/46,16.78%,GAL3ST1;MAL;MBP;PLP1;MPZ;CMTM8;NFASC;EPB41L3;CNTNAP1;B4GALT6;TPPP;TNFRSF21;SCN2A;MAL2;SCN8A;PLLP;HES5
prerank,inorganic cation import across plasma membrane (GO:0098659),0.40448617136601844,1.4693495462878559,0.022727272727272728,0.3269290625310324,1.0,20/75,14.15%,SLC39A10;SLC24A2;KCNJ3;KCNJ6;CACNA2D1;SLC8A1;SLC12A6;KCNJ11;HCN2;KCNJ10;TRPM2;ATP1A3;KCNK9;SLC12A3;SLC39A8;ATP1A4;ATP1A1;KCNJ8;ATP1B1;ATP2B4
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.41256716521701575,-1.4682233972761936,0.02529182879377432,0.3025912691229968,1.0,27/61,27.36%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,COPII vesicle coating (GO:0048208),-0.41256716521701575,-1.4682233972761936,0.02529182879377432,0.3025912691229968,1.0,27/61,27.36%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,vesicle coating (GO:0006901),-0.41256716521701575,-1.4682233972761936,0.02529182879377432,0.3025912691229968,1.0,27/61,27.36%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.39538222934922373,-1.4675101558033636,0.007532956685499058,0.3032089570354166,1.0,24/76,20.07%,UACA;EGFR;SASH1;NFAT5;LIMS1;TRIM44;BMP7;EP300;NR3C2;DLG1;PTPN22;CCN3;RHOA;RASSF2;PPM1A;EIF2AK2;DDX3X;C1QTNF3;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,transport along microtubule (GO:0010970),-0.600229410067145,-1.4673539992270852,0.05850091407678245,0.30263947089933907,1.0,9/13,30.15%,ARHGAP21;CDC42;SPG11;BAG3;COPG2;COPG1;CLIP3;APP;APBA1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.39042890458400537,-1.4670997050488845,0.01443298969072165,0.30226886865256986,1.0,29/87,20.53%,ROCK2;NOTCH2;LRP1;RHOQ;EPHA3;PDGFRA;PDGFRB;ROCK1;ABL1;RND3;MTOR;RAPGEF3;ARHGAP17;IQGAP2;SEMA3E;RHOA;PRKCD;ABL2;RHOBTB2;RICTOR;ARHGDIB;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2
prerank,kidney development (GO:0001822),-0.4073079643145469,-1.4664107468180076,0.026168224299065422,0.30281698486206915,1.0,16/65,5.92%,SULF1;TGFBR1;KANK2;PKD1;WNT4;GLI2;FOXC1;BMP7;BMP4;OSR1;PCSK5;ARL3;SULF2;CTSH;PYGO1;ZBTB16
prerank,COPII-coated vesicle budding (GO:0090114),-0.4065335147862362,-1.4663886904267487,0.0273972602739726,0.3019516506397935,1.0,31/68,27.36%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;SEC23B;STX5;GOSR2;MIA3;SEC16B;NAPA;CSNK1D;SEC16A;VAPA;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SCAP;SEC24A;TMED2
prerank,ncRNA processing (GO:0034470),0.34992814745016115,1.4653320000392551,0.006134969325153374,0.33390640262483406,1.0,62/200,18.35%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;LIN28B;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;INTS2;RPL21;DKC1;RPS7;RPP30;RPL23A;RPL8;POP5;DROSHA;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;INTS11;RRP1B;RRP1;NOP56;INTS10;RPS25;MDN1;UTP15;EXOSC4;RPS9;ADAR;AGO4;RPL31;NVL
prerank,transition metal ion transport (GO:0000041),0.45969129650533347,1.4653195665686252,0.04439746300211417,0.33225301317433187,1.0,10/35,11.89%,TFRC;TRPC5;FTH1;SLC39A2;SLC30A1;MELTF;SLC39A8;ATOX1;SLC30A5;TRPC1
prerank,mRNA splice site selection (GO:0006376),-0.48279291472051633,-1.4646473860597855,0.050100200400801605,0.30481072958679656,1.0,12/30,14.45%,CELF2;CELF1;LUC7L2;PRPF39;SFSWAP;SRSF10;SRSF6;SLU7;SF3A1;YTHDC1;SF3A3;SRSF1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.4093764015764556,-1.4637936002676215,0.02247191011235955,0.30574679924151466,1.0,33/68,28.63%,GTF2H2;PABPN1;CCNH;PCF11;WDR33;CDK7;SCAF8;CPSF3;CAVIN1;TAF1D;TBP;SSU72;SLBP;MNAT1;ERCC3;TTF1;PRMT5;CSTF3;POLR2H;SNRPF;CSTF1;POLR2K;CPSF4;NUDT21;GTF2H1;POLR2E;CPSF1;NCBP2;LSM11;TAF1C;GTF2H4;POLR1G;TAF1A
prerank,lamellipodium organization (GO:0097581),-0.4773164496111279,-1.4632477814308258,0.05,0.3060498223128255,1.0,11/29,16.69%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;CTTN;WASF1;WHAMM;CARMIL1;ARHGEF6
prerank,sensory perception of taste (GO:0050909),0.6183989855213101,1.4627355727607718,0.07538802660753881,0.33613282349449014,1.0,3/10,13.89%,ASIC2;ASIC1;CD36
prerank,positive regulation of potassium ion transport (GO:0043268),0.4625406523296837,1.4624985242413338,0.030927835051546393,0.33494643000914753,1.0,11/38,7.78%,KCNJ3;KCNJ6;KCNN2;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5682426555727901,-1.4623876824352184,0.06262230919765166,0.30716146595632576,1.0,11/15,31.45%,OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5814364093828017,1.4616368710680587,0.0709812108559499,0.3334074535779546,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),0.5814364093828017,1.4616368710680587,0.0709812108559499,0.3334074535779546,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.47628398229561897,1.461153437119576,0.04480651731160896,0.3328709121283261,1.0,6/31,2.79%,SYT1;SYT6;SYT7;DOC2A;SYT12;SYT11
prerank,positive regulation of cation channel activity (GO:2001259),0.4419187542323749,1.4611246136463745,0.030612244897959183,0.33133512834607276,1.0,13/40,15.65%,TMSB4X;ANK3;SHANK3;AKAP6;ATPSCKMT;LRRC55;CCL2;RELN;HAP1;CALM1;CALM2;CALM3;NLGN3
prerank,neuron projection development (GO:0031175),0.3585194693073541,1.4605991036311763,0.013861386138613862,0.3308629316469798,1.0,38/168,10.81%,NYAP2;CNTNAP2;GPRIN1;FRY;PLP1;GRM7;TMEM108;EPHB1;CTNND2;NLGN1;GPM6A;SH3GL2;GPM6B;SHANK3;MAP2;STMN1;TNIK;STX3;OMG;PAK1;PPP1R9A;GPRIN3;EPB41L3;CNTNAP1;ADCYAP1;STMN4;RASGRF1;BICDL1;UBB;SHTN1;CAMSAP1;RAB35;STMN2;TAOK2;DAB2IP;PTPRM;MICALL2;CNTN4
prerank,epidermal cell differentiation (GO:0009913),-0.4493427253108575,-1.4588907085435339,0.03777335984095427,0.3140502305562065,1.0,15/41,23.36%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG;ERCC3;GLI1;HDAC1;WNT5A;GATA6;WNT16;HDAC2
prerank,cardiac muscle tissue development (GO:0048738),-0.42875484201460146,-1.4580360704015545,0.017408123791102514,0.3150185558610574,1.0,14/50,13.06%,AKAP13;NOTCH2;BMPR1A;GJB6;BMP5;BMP7;BMP4;RBP4;GJA1;ADAMTS9;SMAD4;TBX18;SIK1;MAML1
prerank,peptidyl-lysine modification (GO:0018205),-0.3808686862927349,-1.4580135870500042,0.014705882352941176,0.3141350970622536,1.0,30/99,15.96%,EYA1;LOXL1;KAT2B;PIAS1;EP300;HDAC4;PLOD2;SAE1;RANBP2;SENP3;SENP7;NSMCE2;P3H3;NNAT;SENP6;NUP42;PIAS3;UBE2I;NUP214;SENP1;SENP5;TPR;PIAS4;TRPM4;SIRT5;LOX;ESCO1;METTL21A;TOPORS;LOXL3
prerank,neural crest cell migration (GO:0001755),0.45397937325741244,1.45759691540071,0.03508771929824561,0.3354333864708014,1.0,8/36,4.44%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5407193709713632,-1.4573801221540483,0.05813953488372093,0.3146127275920613,1.0,3/17,3.68%,BMP6;SASH1;CD55
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6470228253414051,1.4571745809767849,0.06638115631691649,0.3346911514420009,1.0,7/10,17.03%,GALNT13;MGAT5B;GALNT3;GALNT2;POGLUT1;GALNT16;GALNT4
prerank,T cell differentiation (GO:0030217),-0.44901844084033554,-1.4568752816541946,0.05426356589147287,0.314782850248969,1.0,15/40,25.97%,GLI3;LEPR;KIT;ANXA1;PTPN22;PTPN2;SOX13;CHD7;PIK3CD;RHOH;RABL3;GPR89B;GPR89A;LMBR1L;FCER1G
prerank,hemopoiesis (GO:0030097),0.3900707609449046,1.455296452892075,0.023391812865497075,0.3372069759806591,1.0,18/87,9.01%,FLT1;KIRREL3;MECOM;KITLG;TEK;TIRAP;CSF1R;ARMC6;FST;TOX;KDR;FLT3;TAL1;TGFB2;RTKN2;MELK;CD34;TPO
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4054693312294284,-1.4549585537284473,0.016701461377870562,0.3182206144716043,1.0,22/66,20.86%,SULF1;TGFBR3;NR2F2;KLF9;ROBO1;SPARC;NFIB;NUPR1;THBS1;FGFR2;PTPRK;MED1;FBXW7;APOE;STAT1;BRCA2;DUSP10;ATOH8;ATP5IF1;CDC73;CDKN1C;CDK6
prerank,signal peptide processing (GO:0006465),-0.62657402967041,-1.4543785494537638,0.07751937984496124,0.31861599926128004,1.0,8/11,27.44%,PCSK5;HM13;SEC11C;SEC11A;SPPL3;CLN5;PARL;SPCS3
prerank,positive regulation of bone mineralization (GO:0030501),-0.4708560855857037,-1.4541524799582812,0.04580152671755725,0.3182279235870674,1.0,19/35,20.83%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;BMP2;TMEM119;PKDCC
prerank,histone H2A ubiquitination (GO:0033522),-0.5433116204449123,-1.4528522040788765,0.07254901960784314,0.32020648419423564,1.0,6/17,14.55%,UBR2;BCOR;RNF8;DDB2;DTX3L;UBE2B
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5462113306941866,-1.4523461140608531,0.06203007518796992,0.3204201132110079,1.0,5/17,3.07%,NOTCH2;BMPR1A;RBPJ;BMP4;JAG1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.4069450560075072,-1.4519368852035974,0.02028397565922921,0.32056367465611807,1.0,25/68,22.08%,TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;WNT5B;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2;WNT9A;CSNK1E;TCF7L1;FZD7;WNT5A;NR4A2;SFRP4;FZD1;FRZB;DVL3;WNT16
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5396870435826221,-1.4516141510275848,0.08206106870229007,0.3204146975162966,1.0,7/19,21.47%,MYO9A;CYTH3;CDC42;RHOA;PARD3;SIPA1L3;MSN
prerank,glycerolipid metabolic process (GO:0046486),0.6154054378244243,1.4515664299353104,0.07268722466960352,0.3438709135236009,1.0,6/11,18.09%,GAL3ST1;PGP;DGKB;PIP5K1A;PNPLA3;DGKG
prerank,response to purine-containing compound (GO:0014074),0.5402050388705195,1.4515163823593626,0.08026030368763558,0.3423563278333372,1.0,6/17,13.32%,RYR2;KCNJ11;TRPM2;P2RY1;P2RX7;VGF
prerank,histone ubiquitination (GO:0016574),-0.5228083983098512,-1.4514181067609584,0.056451612903225805,0.31987987792532097,1.0,11/21,22.37%,UBE2N;UBR2;HUWE1;RNF8;CTR9;DTX3L;UBE2B;UBE2E1;RNF20;CDC73;WAC
prerank,activin receptor signaling pathway (GO:0032924),-0.5699334612119955,-1.4509139441261125,0.06037735849056604,0.3201704818219074,1.0,5/15,19.35%,SMAD3;TGFBR1;SMAD2;ACVR1;INHBA
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.5764845887126561,-1.450709700839858,0.07485604606525911,0.31974488573048376,1.0,9/15,30.87%,NR3C1;ANXA1;REST;FAM107A;HNRNPU;ZFP36L2;GPER1;UBE2L3;BCL2L11
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4560068621940655,-1.4504740314490652,0.03441682600382409,0.3194167096880638,1.0,14/37,18.22%,IGF1;BMPR1A;TPM1;IGFBP5;GJA1;JUN;MEF2C;MMP2;EFEMP2;ERN1;TGFB3;ADAMTS1;PDCD4;SOD2
prerank,lipid modification (GO:0030258),0.4599891778526523,1.4504007921622688,0.06521739130434782,0.34324434311903446,1.0,10/37,8.86%,DGKI;PLPPR1;MBOAT1;PLPPR5;DGKH;CYP2E1;DGKB;SGPP2;PLPPR4;PLPP4
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.45543637834771433,-1.4499085641632714,0.032567049808429116,0.31976367227439734,1.0,17/40,15.82%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5411855958982785,-1.4498416647735433,0.0690978886756238,0.3189818402645818,1.0,5/18,8.85%,EGFR;DDX5;BMP4;NCOR1;MAP2K1
prerank,protein modification by small protein conjugation (GO:0032446),-0.32244395061664577,-1.4496956869689472,0.002061855670103093,0.3184029038112523,1.0,118/361,22.82%,RNF220;PDZRN3;FBXL7;EYA1;RNF152;FBXL17;SMURF2;UBE2N;RNF43;UBR2;TRIM44;PIAS1;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;SAE1;HUWE1;USP7;RANBP2;UHRF2;RNF213;DTX4;OS9;UFL1;NSMCE2;WWP1;UBE2H;ASB2;ZSWIM8;RNF8;NUP42;UBA5;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;PIAS3;VCPIP1;UBE2I;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;UBR1;UBE2R2;NUP214;HIF1A;RFWD3;RTF1;TRIM5;UBR3;TRIM11;TPR;CUL3;PIAS4;FBXW7;TRPM4;DTX3L;TRPC4AP;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;CUL2;TOPORS;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;DERL1;ASB5;KLHL18;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;FBXW5;EIPR1;AREL1;SDE2;VCP;RNF14;DCUN1D3;SPSB4;UBE2D3;CDC73;DTX2;NFX1;NUP98;PCNA;ANAPC11;CUL1;TRIM63;HIF3A;ARIH2;CUL7;CDK5RAP3;NAE1;DET1;NUP43;ARRDC4;WAC;CAND2;UBE2V2;RNF144A
prerank,regulation of organelle assembly (GO:1902115),-0.3933435526124268,-1.4489635651252413,0.023668639053254437,0.3189946908615855,1.0,33/73,28.23%,GSN;ALMS1;TBC1D16;DCDC2;SPICE1;CENPJ;STX18;TBC1D19;TBC1D24;SENP6;ATXN2L;USP6NL;TBC1D2B;TBC1D20;IFT88;MTMR3;TBC1D22B;DYNC2LI1;CEP295;CEP76;NPRL3;ATG5;TBC1D17;RABGAP1;KIF9;TBC1D10A;MSN;RAB5A;IFT140;TBC1D10B;ATG3;TBC1D9B;RABEP2
prerank,keratinocyte differentiation (GO:0030216),-0.48175997683779637,-1.4486082124646744,0.044921875,0.3188739367885788,1.0,8/29,11.73%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG
prerank,mRNA processing (GO:0006397),-0.3275413412750436,-1.4485249964507574,0.0,0.3181633747059279,1.0,115/287,28.04%,SRRM2;SON;DDX5;CELF1;HNRNPH1;GTF2H2;PABPN1;CCNH;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;CDK7;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;AKAP8L;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;PPARGC1A;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;RPRD2;PRPF3;MNAT1;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;ERCC3;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;TCERG1;RBM5;SRSF1;ERN1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;RNGTT;PPWD1;PRKACA;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;GTF2H1;SMU1;DHX15;NONO;PRPF38A;POLR2E;KIN;CPSF1;PRMT9;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;GTF2H4;SUGP1;PRPF18;POLR2D;HNRNPL;ISY1
prerank,oligodendrocyte development (GO:0014003),0.5597458420706757,1.4480051120913935,0.07399577167019028,0.34664063163872016,1.0,6/15,9.18%,PLP1;CNTNAP1;NSUN5;EIF2B3;B4GALT6;TPPP
prerank,ribosomal small subunit assembly (GO:0000028),0.5628141096595284,1.4479445153512691,0.05982905982905983,0.34516707415580894,1.0,8/16,16.70%,RPS19;RPS27;MRPS7;RPS15;RPS14;RPS5;RPS28;XRCC5
prerank,regulation of cytoplasmic translation (GO:2000765),-0.58613069218038,-1.447797842532946,0.06355140186915888,0.31903698566179595,1.0,6/14,25.05%,DHX9;DHX36;YBX3;CPEB1;PKM;UNK
prerank,positive regulation of DNA repair (GO:0045739),-0.4340663046323591,-1.4470088890763875,0.03578528827037773,0.31998868138087155,1.0,11/46,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;SPIDR;HMGB1;DHX9;BRCC3;CEBPG;RNF8
prerank,epithelial to mesenchymal transition (GO:0001837),-0.4299627383796781,-1.4468819758627456,0.03968253968253968,0.3193570280499903,1.0,11/47,4.59%,ROCK2;TGFBR3;TGFBR1;WNT4;RBPJ;LIMS1;DDX5;BMP7;ROCK1;GSK3B;DDX17
prerank,phospholipid transport (GO:0015914),0.423214283674476,1.4461251040117922,0.0407725321888412,0.34784451790367793,1.0,18/52,14.95%,PLTP;TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;PITPNM1;PRELID3A;SCARB2;ATP11C;ATP8A2;ABCB4;PRELID2;CPTP;SCARB1;ATP11B;SCP2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6271188190650764,-1.4458989087261596,0.0705244122965642,0.32067209179790407,1.0,3/11,3.07%,BMPR1A;BMP4;JAG1
prerank,protein monoubiquitination (GO:0006513),-0.45787420840421184,-1.4451838770730179,0.04462474645030426,0.3213942706627295,1.0,21/36,31.80%,PRKN;HUWE1;CTR9;UBE2R2;CUL3;TRIM25;KLHL22;DTX3L;UBE2B;TOPORS;UBE2E1;RNF20;UBE2D3;CDC73;WAC;MGRN1;OBI1;RBX1;RNF126;KBTBD8;UBE2W
prerank,response to cholesterol (GO:0070723),-0.5606408299744478,-1.4443877224265493,0.061601642710472276,0.3222404432403847,1.0,6/17,5.30%,TGFBR1;LRP6;SMO;TGFBR2;GRAMD1C;SMAD2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.32194030116114297,-1.4438278534032998,0.0,0.32260098338857646,1.0,141/341,29.54%,FBXL7;FBXL17;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;RAD23B;BTRC;TBL1X;WWP2;TRIP12;RNF115;TBL1XR1;KLHL15;RNF146;RNF217;UBXN2B;TGFB1I1;HUWE1;RBBP6;RNF213;VPS4B;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;PCBP2;UBE2K;MAEA;UBE2I;ANAPC4;ANAPC16;NUB1;TNFAIP1;NTAN1;RNF216;USP33;VPS37C;SPOPL;UBE2R2;GID4;KCTD5;PSMF1;WDR91;FBXL19;UBR3;CUL3;FBXW7;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;PSMB2;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;ERCC8;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;RNF14;SPSB4;UBE2D3;IFI27;COP1;RNF11;PML;ANAPC11;TTC3;PSMC1;ARIH2;WDR81;APPBP2;SHARPIN;KCTD17;GID8;FBXW4;PSMB6;RNF144A;RMND5A;PSMA3;SIAH2;ARMC8;USP9X;RNF6;PSMA4;CNOT4;PTPN23;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;PCNP;SPSB2;PSME1;UBE3C;PSMD13;FZR1;CDC34;TNFAIP3;MIB1;KCTD6;PSMB10;PSMA5;SPSB3;PSMB9;KBTBD7;VPS28;RBX1;NFE2L2
prerank,regulation of feeding behavior (GO:0060259),-0.6287700100795383,-1.4437571485248812,0.07262569832402235,0.3218631381239437,1.0,4/11,12.76%,LEPR;AGRP;STAT3;EIF2AK4
prerank,clathrin coat assembly (GO:0048268),0.5658232840924516,1.4435703117875207,0.08849557522123894,0.3517943456160713,1.0,6/15,14.07%,NSG2;HIP1;FCHO1;CALY;SGIP1;CLTB
prerank,aminoglycan catabolic process (GO:0006026),-0.4794753762264372,-1.443158049868382,0.043824701195219126,0.32234640302568607,1.0,6/28,4.72%,GPC6;SDC2;GPC4;GNS;GPC3;HSPG2
prerank,regulation of cellular component movement (GO:0051270),-0.4277939173699128,-1.4426437006974098,0.02414486921529175,0.3225609181826744,1.0,15/49,10.56%,ROCK2;TGFBR3;EGFR;TGFBR1;DIAPH1;ROCK1;PDPN;ABL1;ARAP1;CD9;LYN;ZSWIM8;SP100;RHOA;ABL2
prerank,regulation of water loss via skin (GO:0033561),0.5548827365478272,1.4423455499860267,0.08189655172413793,0.35148155428672045,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,establishment of skin barrier (GO:0061436),0.5548827365478272,1.4423455499860267,0.08189655172413793,0.35148155428672045,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6058943432012326,-1.440670222150503,0.07587548638132295,0.3261079800072634,1.0,3/11,3.24%,TGFBR3;TGFBR1;TGFBR2
prerank,RNA processing (GO:0006396),-0.34992085507436266,-1.4406691346352516,0.004098360655737705,0.3252266070883248,1.0,65/176,24.23%,RBMS1;CELF2;SON;TENT2;RBPMS;CELF1;ATXN1;HNRNPH1;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;RBMS2;RBM6;FUS;U2AF2;AKAP8L;SF3B1;HNRNPUL1;HNRNPD;TUT4;PRPF6;RNPC3;PPARGC1A;TSEN2;SLU7;HNRNPK;PRPF3;SF3A1;USP39;SCAF11;DUSP11;XRN2;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;APOBEC1;RBM5;SRSF1;SFPQ;RNGTT;PRKACA;CSTF3;HNRNPU;ZMAT5;SNRPF;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;NUDT21;SMU1;DHX15;NONO;PABPC4
prerank,sterol metabolic process (GO:0016125),-0.41076707739412527,-1.4398393869504085,0.036468330134357005,0.3261366209613904,1.0,21/60,26.33%,PRKAG2;ABCA1;CYP7B1;CYP26B1;CYP27A1;SOAT1;INSIG2;OSBPL5;CYP1B1;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;SC5D;ARV1;LBR;GBA2;SCAP;CLN8
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49278622049659604,1.4396640036931538,0.05485232067510549,0.3560205782199915,1.0,9/24,18.36%,PRKAR2B;PDE2A;PDE11A;PEX5L;APLNR;RNF157;PDE4D;GNAI1;PRKAR1A
prerank,mitotic cytokinetic process (GO:1902410),-0.5177614217751128,-1.4394847201959253,0.075,0.32611069458424846,1.0,7/20,10.27%,VPS4B;KLHDC8B;CHMP4B;CHMP4A;CHMP5;CHMP3;RHOA
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.44374878700515386,-1.4393989336677366,0.04380952380952381,0.3253932963785703,1.0,12/43,11.49%,SMAD3;TEAD1;DDX5;FOXO3;BMP4;NFIB;NR3C1;STAT3;REST;JUN;HIF1A;NFATC4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.43318331676800087,-1.4388809305094132,0.02895752895752896,0.32572395697505474,1.0,22/47,27.69%,DOCK5;LIMS1;FBLN1;PDPN;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL;KANK1;AP1AR;TESK1;EFNA5;FERMT2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.49070215460430755,-1.438075847983381,0.05523809523809524,0.32671529769919794,1.0,14/25,24.27%,NGLY1;FBXL17;UGGT2;KLHL15;POMT2;YME1L1;CUL3;CLPP;AUP1;DERL1;VCP;ZYG11B;TOR1A;BAG6
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5127131194601383,-1.4379356937188472,0.06321839080459771,0.32619259672623685,1.0,6/23,5.30%,TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.5828111707482335,-1.4375142474282667,0.06994328922495274,0.32616686572342074,1.0,6/13,21.62%,MYO9A;RAB10;CDC42;RHOA;MSN;SCRIB
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.618816410635735,-1.4374248375465526,0.04878048780487805,0.325531477934733,1.0,7/11,24.27%,UGGT2;POMT2;AUP1;DERL1;VCP;TOR1A;BAG6
prerank,cellular response to interleukin-4 (GO:0071353),0.623366762996667,1.4372803312667137,0.06956521739130435,0.3598304805945544,1.0,3/10,13.68%,LEF1;TCF7;XBP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4640109032929404,1.4367183368330847,0.047619047619047616,0.35948475911996924,1.0,9/32,9.61%,ADGRB3;PTPRD;IL1RAPL1;HECW1;TNIK;SEMA4D;HECW2;CDKL5;LZTS1
prerank,negative regulation of proteolysis (GO:0045861),-0.45404494316288657,-1.4358414380413032,0.0521415270018622,0.32824287938008856,1.0,8/34,8.09%,TIMP3;DNAJC1;ROCK1;LRRK2;PLAT;GAS1;PTPN3;EPHA4
prerank,actin filament capping (GO:0051693),-0.5284396022722145,-1.4353797695053956,0.0625,0.3275511262456282,1.0,10/18,26.24%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),-0.5284396022722145,-1.4353797695053956,0.0625,0.3275511262456282,1.0,10/18,26.24%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,regulation of cellular localization (GO:0060341),-0.43073592746248335,-1.4347992693057976,0.032567049808429116,0.32816622737795986,1.0,16/46,11.61%,ADCY5;GSN;PARD6G;PRKN;LRRK2;NUMA1;CDK16;STXBP4;LYN;CAMK2D;CSNK1E;BRSK1;FER;GOSR1;WWC1;PARP1
prerank,anterior/posterior axis specification (GO:0009948),-0.5515146865914462,-1.4339608128682526,0.06525911708253358,0.3291336028626008,1.0,2/15,5.85%,WLS;SKI
prerank,negative chemotaxis (GO:0050919),0.4579722808649356,1.432466427069571,0.053061224489795916,0.3675627042700465,1.0,10/33,6.18%,SEMA3C;SEMA6A;UNC5C;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;SLIT3;SLIT1
prerank,regulation of RNA metabolic process (GO:0051252),-0.40570307724332494,-1.4322536349741704,0.03529411764705882,0.3320522437210936,1.0,14/59,12.67%,AHNAK;SON;CLK1;CELF1;HNRNPH1;MBNL2;FUS;RC3H1;PTBP3;PCBP2;MED1;CLK2;CLK3;SNRNP70
prerank,regulation of histone modification (GO:0031056),-0.5761148286140186,-1.4319595250249542,0.07818930041152264,0.33184741609306917,1.0,5/13,8.58%,UBE2N;SETD5;MTHFR;AKAP8L;IGF2
prerank,connective tissue development (GO:0061448),-0.44825267087910375,-1.4314650243265936,0.044145873320537425,0.3320211257971391,1.0,11/35,13.71%,SULF1;SOX5;CREB3L2;PKD1;SH3PXD2B;SULF2;ZBTB16;PGRMC2;ITGB8;ARID5B;SOX6
prerank,epithelial structure maintenance (GO:0010669),-0.6131616520036408,-1.4304338086515211,0.07339449541284404,0.33353329257904313,1.0,3/11,12.97%,RBP4;CXADR;STRAP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4017734070043604,-1.430001793786162,0.032586558044806514,0.3336309651345892,1.0,11/62,6.93%,AKAP13;NOTCH2;IGF1;COL3A1;AUTS2;LPAR1;ROBO1;SHOC2;MAP4K4;SHC1;LYN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4848141818076147,-1.429239912589446,0.0599250936329588,0.3345847225129802,1.0,11/26,19.24%,EGFR;FOXC1;GAREM1;PDPK1;MED1;PLCG1;PTPN12;STAT5B;SYAP1;INPP5K;PTPN11
prerank,positive regulation of protein binding (GO:0032092),-0.411342618201307,-1.4291580209395403,0.033797216699801194,0.33392892687781744,1.0,23/56,21.02%,TCF7L2;LRP1;PKD1;STK3;BMP4;ABL1;PRKN;LRRK2;VTN;GSK3B;MARK3;DACT1;PPP2CB;USP33;RPL11;DTX3L;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;PPP2CA
prerank,myoblast differentiation (GO:0045445),-0.5779157568437091,-1.428991238604061,0.07259528130671507,0.33350251868972136,1.0,8/14,14.35%,IGF1;TCF7L2;DDX5;JAG1;DDX17;REST;RB1;HINFP
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.621476425945837,-1.428990194299161,0.08082706766917293,0.33265174695837,1.0,7/10,31.08%,ERRFI1;ENPP1;IMPACT;MVP;CHP1;TESK1;CAV1
prerank,neutrophil migration (GO:1990266),0.41326947298728745,1.4288509748028404,0.03861788617886179,0.37420723907269965,1.0,7/58,9.00%,BSG;PDE4B;S100A9;S100A8;TGFB2;PECAM1;CCL2
prerank,dendritic spine organization (GO:0097061),0.48349302907707015,1.4279376413683489,0.05393258426966292,0.3747817175884959,1.0,4/26,3.04%,IGF1R;EPHB1;CTNND2;SHANK3
prerank,hexose transmembrane transport (GO:0008645),0.5133157067633842,1.4277960705896604,0.060542797494780795,0.3734325375714273,1.0,3/21,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,response to interleukin-4 (GO:0070670),0.6202248729877173,1.4257331469847532,0.08333333333333333,0.3766271255214708,1.0,3/10,13.68%,LEF1;TCF7;XBP1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4177833265392726,-1.4255926286598841,0.02702702702702703,0.3393358363004115,1.0,16/50,20.07%,EGFR;SASH1;NFAT5;LIMS1;TRIM44;EP300;NR3C2;RHOA;EIF2AK2;DDX3X;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.5514002087999492,-1.4252831190964783,0.059033989266547404,0.33910507623128616,1.0,10/17,28.24%,CCNT1;CTR9;ZC3H3;CPEB1;RNF20;NUDT21;HSF1;NCBP2;CDK9;NELFE
prerank,histone H3-K36 demethylation (GO:0070544),-0.6234411339667026,-1.4252192645039032,0.062381852551984876,0.3384128786222607,1.0,4/10,15.83%,KDM7A;KDM4B;PHF8;KDM2A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4102758291700659,1.4249863350505096,0.043568464730290454,0.37675705839282636,1.0,18/57,17.11%,RPS6;RPS19;RPL38;RPL35A;RPF2;RPL7;RPS24;RPS17;RPS16;RPS15;RPL14;RPL5;RPS7;MRPL36;URB2;RPS28;RPS25;NAF1
prerank,cell part morphogenesis (GO:0032990),-0.5726744364439929,-1.4246953726782359,0.09375,0.33874959417960415,1.0,7/13,28.79%,PID1;PACSIN2;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4995943014788292,-1.4244657191641847,0.06321839080459771,0.3384378211564782,1.0,4/22,7.20%,ZBTB20;SORBS1;CREBL2;MTOR
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.467393594055899,-1.4237342918151725,0.04504504504504504,0.3393099211884021,1.0,6/32,7.20%,ZBTB20;PRKAG2;SORBS1;PRKAA2;CREBL2;MTOR
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5996060652581545,-1.4236008960690856,0.07622504537205081,0.33874986629385945,1.0,4/11,10.04%,LRRK2;USP7;MAP2K1;CHMP3
prerank,epithelial cell morphogenesis (GO:0003382),-0.5376975363404244,-1.423490495803629,0.07341269841269842,0.33814483929512323,1.0,8/17,28.13%,COL22A1;COL15A1;COL18A1;RILPL2;SIPA1L3;RILPL1;DACT2;MET
prerank,negative regulation of histone acetylation (GO:0035067),0.5904419657284324,1.4233552116232078,0.08771929824561403,0.37876573656000045,1.0,4/11,12.75%,SIRT1;SNCA;SET;SIN3A
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.34466893883017574,-1.4229720781605477,0.008298755186721992,0.3385465263718522,1.0,69/173,24.81%,ANK2;SEC24D;VTI1A;GBF1;PROS1;CD55;ATL3;CTSC;GOLGB1;TFG;SEC23A;VTI1B;VAMP7;SEC22B;KDELR1;COPB1;COPZ2;SEC31A;BCAP29;ARCN1;DCTN5;ARFGAP1;ARFGAP3;ATL2;TBC1D20;COG3;COG7;GOSR1;CAPZA1;DYNC1LI1;TRAPPC6B;KDELR3;CUL3;STX5;COPB2;CAPZB;WHAMM;COPG2;DYNC1H1;GOSR2;TMED3;MIA3;VAMP4;SEC16B;NAPA;COPG1;TMED5;TMED4;TRIP11;NRBP2;SEC16A;MPPE1;STX17;COPE;COG4;ERGIC1;VAPA;BET1L;F5;ACTR1A;NSF;TRAPPC2;LMAN1;USO1;PREB;HYOU1;SAR1B;MCFD2;TEX261
prerank,negative regulation of signal transduction (GO:0009968),-0.331956427470739,-1.4224853007651903,0.0,0.3387174542369238,1.0,70/249,18.76%,TRABD2B;SULF1;EGFR;NXN;PID1;LRP1;GLI3;ADAMTS12;KANK2;DCN;IGFBP5;LGR4;BMP5;WWOX;GRB10;RNF43;DKK3;ENPP1;LRRK2;TNS2;BTRC;CYP26B1;WWP2;NIBAN2;VGLL4;IRAK3;IRS1;GPC3;IGFBP3;SULF2;THBS1;ASAH2;BCL2;LYN;PIP4K2C;DACT1;PTPN12;LEPROT;PTPN2;PRKCD;MMP14;TULP3;NOTCH3;GLIS2;TLE1;HERC4;SUFU;APOD;RB1;FBXW7;APPL1;EMILIN1;ACVR1;OTUD4;NCK1;PRKCZ;CSNK2A1;PTCH1;ARRB1;TSPAN15;CNOT1;NR4A2;LRRC14;PTPN1;CX3CR1;SFRP4;VCP;DACT3;INPP5K;BMP2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6184701677362445,-1.421796787678253,0.08710801393728224,0.3394150452020827,1.0,5/10,25.98%,ABCA1;APOE;PRKACA;ABCA7;ZDHHC8
prerank,regulation of membrane depolarization (GO:0003254),-0.5207960271988344,-1.4216127443659476,0.07352941176470588,0.33902720931890623,1.0,4/18,7.01%,FHL1;LRRK2;PTPN3;CAMK2D
prerank,positive regulation of dendritic spine development (GO:0060999),0.5229705147481667,1.4210683716695243,0.06564551422319474,0.3824992051559313,1.0,5/20,13.71%,LRP8;NLGN1;SHANK3;RELN;PSEN1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.36708566577622065,-1.4204678858905175,0.010101010101010102,0.3407851478901183,1.0,43/100,24.44%,FHIT;ARAF;PIAS1;DAB2;PRKN;LRRK2;ARIH1;RAD23B;CSNK1A1;GSK3B;RNF217;USP7;UFL1;RNF19A;NUB1;CSNK1E;RPL11;GIPC1;OGT;TRIB2;SH3RF2;CBFA2T3;TRIM39;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;PARK7;COP1;ZYG11B;DESI1;ARIH2;DET1;WAC;RNF144A;CCAR2;XPO1;EIF3H;BAG5;BAG6;NKD2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36843497815939996,-1.4196134201080046,0.020161290322580645,0.34187255565556524,1.0,29/104,14.59%,SMAD3;TGFBR1;CRIM1;BMPR1A;LDLRAD4;SMAD6;SMURF2;NBL1;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CCN3;SMAD4;BMPER;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;ACVR1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.47831745190540503,-1.419363809797159,0.060240963855421686,0.34152262230243613,1.0,13/25,28.83%,RNF8;CDK13;WDR43;NELFB;TCERG1;HNRNPU;CDC73;EAF2;RECQL5;LDB1;NELFA;NELFE;ZMYND11
prerank,V(D)J recombination (GO:0033151),-0.5998122789316991,-1.4187484912594475,0.07326732673267326,0.34207013640887535,1.0,5/11,14.30%,HMGB1;DCAF1;XRCC4;TCF3;PRKDC
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6065146193244915,-1.4179895851952953,0.07592592592592592,0.3429799821904233,1.0,4/10,18.51%,LRP6;RYK;WNT5A;FZD1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4003511311202184,-1.4177176302730905,0.04563492063492063,0.34274642628166224,1.0,26/66,20.86%,EGFR;APPL2;KANK2;PKD1;INO80;ANKRD17;FHL1;UBE2E2;BRD7;RPTOR;DLG1;ANXA1;DACT1;PRMT2;ID2;PKD2;RB1;APPL1;CCND3;DDX3X;ADAMTS1;FAM107A;DCUN1D3;EIF4G1;CDC73;CDK6
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4395579529366168,-1.4172200758837732,0.04436229205175601,0.34299347420213777,1.0,10/40,10.56%,EGFR;LPAR1;ARHGAP6;PDGFRA;NTRK3;PDGFRB;KIT;EDNRA;PLCG1;ABL2
prerank,stress granule assembly (GO:0034063),-0.502184535144437,-1.416365650760604,0.0610236220472441,0.3441321561514724,1.0,9/20,16.12%,PRRC2C;YTHDF3;DDX6;ATXN2L;UBAP2L;CSDE1;LSM14A;DDX3X;DYNC1H1
prerank,postsynaptic membrane organization (GO:0001941),0.5313551715820503,1.4160753674639561,0.09368191721132897,0.3926401621069761,1.0,6/17,9.22%,NRXN1;NLGN1;SHANK3;NRXN2;SHISA7;LHFPL4
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5132043963608709,-1.415984618575948,0.07183364839319471,0.34417222710251244,1.0,8/20,18.04%,GSN;PLA2R1;THBS1;PLCG1;PIAS4;ITGA4;PDCD4;SFRP4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5048203117410615,-1.4142300232701017,0.08839779005524862,0.3472844223049765,1.0,9/22,19.70%,TIMP3;ROCK1;SNX9;PTPN3;NRDC;ADAM9;APOE;ADRA2A;TIMP2
prerank,filopodium assembly (GO:0046847),0.5385662778846738,1.4132005085216484,0.06320541760722348,0.3977929381890618,1.0,5/16,12.14%,DNM3;FGD5;SPATA13;FGD3;SRGAP2
prerank,muscle cell differentiation (GO:0042692),0.459382470181944,1.4128424659262346,0.08024691358024691,0.39687716425708897,1.0,8/32,12.16%,MRTFA;SGCZ;SYNE1;TMEM204;MRTFB;NINJ1;NRAP;MEGF10
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.385709149715449,-1.412457755630685,0.019267822736030827,0.35053990095385346,1.0,36/76,31.08%,ANGPT1;PIAS1;HDAC4;LRRK2;SAE1;HUWE1;AXIN1;UBQLN1;WDR48;XIAP;PIAS3;CUL3;PIAS4;FBXW7;FANCI;SPRTN;DERL1;FAM107A;TRAF6;TANK;DCUN1D3;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;PAXIP1;FBXO4;HDAC3;GNL3;MUL1;DCUN1D5;BIRC3;UBA2;UBE2L3;CAV1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5691042158843125,-1.4122947930355896,0.07421150278293136,0.3500589949246351,1.0,4/14,16.17%,IRAK3;PIBF1;THBS1;CMKLR1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.45219867419318766,-1.4121518065528504,0.055865921787709494,0.349623356171336,1.0,15/34,26.24%,AUTS2;PLCE1;WASF2;CDC42;BRK1;FER;NCKAP1;ARPC2;CAPZB;AVIL;PIK3R1;SLIT2;ACTR2;TWF1;TWF2
prerank,reticulophagy (GO:0061709),-0.5919834133086057,-1.4115561167457997,0.0945945945945946,0.3501041057119063,1.0,7/12,17.31%,UFL1;UBA5;TEX264;RB1CC1;ULK2;ATG2A;ATG2B
prerank,response to calcium ion (GO:0051592),0.36903826738804435,1.4110745209205278,0.014344262295081968,0.3991596462018496,1.0,34/102,19.44%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR2;RYR3;CPNE9;KCNMB2;KCNMB3;KCNMB4;TRPM2;CPNE8;CPNE1;KCNH1;HOMER1;SYT10;SMPD1;CALM1;SYT2;TRPC1;CALM2;CALM3;PPP3CA;HPCA;GPLD1;KCNMA1;CPNE7;SYT4;SYT5;PDCD6;ALG2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3442878387677808,-1.4099313591473477,0.007797270955165692,0.35288851840151214,1.0,65/161,29.45%,BICC1;MLLT3;TCF7L2;GLI3;RBMS3;IGFBP2;LRP6;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;IGFBP6;AXIN1;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;TBX18;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;RBX1
prerank,zinc ion transmembrane transport (GO:0071577),0.5056339844019695,1.4097561200430113,0.07628865979381444,0.4007486857976623,1.0,7/22,11.74%,SLC39A10;SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,aorta development (GO:0035904),-0.5544641240098213,-1.4087130909251946,0.0925589836660617,0.3548862144237122,1.0,9/14,17.03%,LRP1;PDGFRB;ROBO1;JAG1;ADAMTS9;PKD2;EFEMP2;HECTD1;TBX2
prerank,regulation of endothelial cell migration (GO:0010594),-0.3778148949692275,-1.4076222288400286,0.036585365853658534,0.35659357308428846,1.0,27/85,17.69%,ROCK2;FOXP1;NR2F2;SASH1;PTN;ANGPT1;DCN;FGF1;BMP4;ABL1;SPARC;RHOJ;THBS1;BCAS3;NRP1;FOXC2;SP100;GLUL;ADAMTS9;BMPER;ANXA3;APOE;VEGFA;ATOH8;PIK3CD;WNT5A;PRKD1
prerank,regulation of vasculogenesis (GO:2001212),0.5488877176632231,1.407461654627808,0.09276018099547512,0.40437795725270836,1.0,4/14,9.06%,HEY1;KDR;CD34;RIN2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.45691215186677936,1.407385835102966,0.06224066390041494,0.4028344170635636,1.0,10/30,21.01%,MIF;CXCL12;SIRT1;CLU;TPT1;RPS3;THOC1;MDM2;THOC5;RTEL1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.48819759781529204,-1.4069394224173242,0.08076923076923077,0.3575145577622762,1.0,6/23,8.29%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K
prerank,glycine transport (GO:0015816),0.6181728269721964,1.406488245393386,0.09829059829059829,0.40330729735491594,1.0,4/10,9.57%,SLC6A17;SLC6A5;SLC7A8;SLC36A1
prerank,phosphorylation (GO:0016310),-0.30961112263299273,-1.4064225013871925,0.0,0.3579032071220107,1.0,130/385,22.24%,PRKAG2;ROCK2;GRK5;TGFBR1;BMPR1A;EPHA7;CDK8;TLK1;PI4KA;PDK1;STK3;FAM20A;ROCK1;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;GK5;TOP1;GSK3B;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;DGKA;PAK2;STAT3;MAP4K4;NADK;TAOK3;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;PANK2;BRSK1;FER;PRKCD;DMPK;LIMD1;FAM20C;CLK3;CDK11B;MKNK2;TEC;SIK1;COPS2;EIF2AK4;MAML1;GMFB;PGK1;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;PRKACA;PXK;PRKD1;MORC3;PRKAA1;NEK4;CSNK1D;MAP3K1;BMP2;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;SHPK;GNPTG;NRBP2;BCKDK;PRKAG3;CDK6;DGKD;MAST2;PPP4R1;PRKAB1;MKNK1;MAP3K12;PRKCA;SIK2;SPHK1
prerank,regulation of RNA splicing (GO:0043484),-0.38803692960197356,-1.4062672973102792,0.03792415169660679,0.35745344324986494,1.0,19/69,14.71%,AHNAK;SON;CLK1;CELF1;HNRNPH1;RBM39;MBNL2;KHDRBS1;SRSF10;FUS;U2AF2;PTBP3;HNRNPK;CLK2;CLK3;YTHDC1;SNRNP70;CWC22;ERN1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4981519487823639,-1.4062280413658745,0.08139534883720931,0.3566770095427668,1.0,4/22,7.81%,CACNA1C;STIM1;ADGRV1;CACNA1D
prerank,cellular response to leucine starvation (GO:1990253),-0.6375385481907865,-1.4046266792272701,0.0825515947467167,0.35954602387464535,1.0,6/10,21.40%,MTOR;GCN1;SESN1;IMPACT;EIF2AK4;LARS1
prerank,response to cytokine (GO:0034097),-0.351358269955475,-1.404318879663476,0.014,0.3593668794243491,1.0,29/141,10.53%,PTPN13;COL3A1;DPYSL3;TIMP3;ALDH1A2;NFAT5;PID1;SMAD3;AFF3;IL6ST;HDAC4;PTPN14;TBK1;IRAK3;PTPN9;PLSCR1;STAT3;ASAH2;BCL2;ANXA1;IRAK2;SP100;NUB1;SETD2;PTPN12;CXCL16;PTPN2;RHOA;ADAM9
prerank,neuron migration (GO:0001764),0.4156911108563148,1.403315759837636,0.03747534516765286,0.40922353760768676,1.0,13/48,9.85%,ADGRL3;SPOCK1;GPM6A;DNER;MAP1B;FGF13;NTRK2;ASTN1;NRCAM;NDNF;CDKL5;RELN;ASTN2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3944822056224808,-1.402484121671667,0.030360531309297913,0.3627798718256663,1.0,29/62,28.24%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4792540689889259,-1.4019989945117648,0.0842911877394636,0.3630867814931979,1.0,13/26,31.72%,IRAK3;TRAFD1;MAPKBP1;PCBP2;ILRUN;CARD16;NLRC3;DHX58;CACTIN;MUL1;TNFAIP3;C1QBP;TYRO3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5334579648385178,-1.4015812657300062,0.07553956834532374,0.3631895088109595,1.0,5/17,10.82%,PRKAG2;NCOR1;PRKAA2;PANK2;PRKAB2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5710548729091246,-1.4009437724537666,0.09980806142034548,0.3638431923450311,1.0,5/12,13.58%,RESF1;MPHOSPH8;ATF7IP;SETDB1;APOBEC1
prerank,protein polyubiquitination (GO:0000209),-0.3175764052143279,-1.4007594690511742,0.001976284584980237,0.3634101243096618,1.0,120/297,29.45%,FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;TNKS2;UBE2E2;UBR2;SPSB1;PRKN;FBXW8;ARIH1;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;RBBP6;RNF213;RC3H1;BCL2;RNF19A;UBE4B;WWP1;UBE2H;TRAF3IP2;FBXL4;ANAPC5;RNF8;FBXL12;FBXO10;ANAPC7;UBE2K;DDB2;ANAPC4;RNF216;TRAF2;UBE2R2;TRIM5;PSMF1;FBXL19;FBXL18;NPEPPS;CUL3;FBXO30;FBXW7;DTX3L;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;TRAF3;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;AREL1;TRAF6;RNF14;UBE2D3;TPP2;LRSAM1;IFI27;ANAPC11;CUL1;TTC3;PSMC1;ARIH2;SHARPIN;FBXW4;TRAF5;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;ANKRD39;SIAH2;ANAPC13;RNF6;PSMA4;CDC16;FBXL14;TRIM68;FBXO4;ANAPC1;FBXW9;FBXO11;PSME1;UBE3C;PSMD13;SHPRH;FZR1;CDC34;MUL1;TNFAIP3;PSMB10;PSMA5;FBXL3;PSMB9;KBTBD7;RBX1
prerank,defense response to fungus (GO:0050832),0.515287109532582,1.4006828258908621,0.10927835051546392,0.4142508326509159,1.0,3/17,11.59%,S100A9;S100A8;BCL10
prerank,regulation of chromatin organization (GO:1902275),-0.5525434592698779,-1.4005009476804549,0.08875739644970414,0.36316109914004363,1.0,4/14,8.58%,MLLT3;TLK1;SETD5;IGF2
prerank,spindle assembly (GO:0051225),-0.39090574044077386,-1.400031058247397,0.03180914512922465,0.3634030535450902,1.0,34/67,30.46%,INO80;NCOR1;NUMA1;FLNA;PIBF1;CEP63;SPICE1;TUBGCP6;TUBGCP2;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;MAP9;RCC1;STAG2;CSNK1D;NEK6;TUBGCP4;SMC1A;HAUS7;HAUS8;BCCIP;NEK7;HDAC3;ABRAXAS1;HAUS3;KIF11;MZT1;HAUS5;HAUS4
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.47673923933199747,-1.399989996277888,0.06976744186046512,0.36267197470874074,1.0,12/26,20.62%,ANK2;FHL1;WWP2;DLG1;ITGB1;CACNA1D;VAMP2;ACTN2;YWHAE;AKAP9;ATP1B3;CAB39
prerank,regulation of cellular catabolic process (GO:0031329),-0.39427412236915294,-1.3996028721957428,0.033962264150943396,0.362798892916589,1.0,20/62,17.67%,ITPR1;EP300;ROCK1;ABL1;PRKN;LRRK2;NUPR1;RPTOR;TPCN2;PIP4K2C;USP33;LONP2;ABL2;WDR91;MTMR3;KAT8;USP13;DAPK1;DAPK2;RMC1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5979398389987604,1.3991362525660251,0.09978308026030369,0.4163531933477948,1.0,5/10,17.11%,TSR3;RPUSD1;DKC1;NHP2;NAF1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.47423102654173227,-1.3990705837309838,0.07407407407407407,0.36323405628076855,1.0,14/26,29.48%,KMT5B;SETD5;KMT2D;CTR9;SETD3;SETD2;OGT;KMT5C;EEF2KMT;KMT2A;PRDM9;TET2;ANTKMT;TET3
prerank,wound healing (GO:0042060),-0.39164497589863656,-1.3986984115320664,0.04106776180698152,0.3631846006898637,1.0,12/62,5.64%,IGF1;COL3A1;SMAD3;TGFBR1;PDGFRA;TPM1;DCBLD2;CFLAR;FGF1;ANXA6;MYOF;FUT10
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5539194361415996,-1.3984078227201888,0.07514450867052024,0.36305647525077817,1.0,7/15,22.53%,STAT3;IL17RA;HIF1A;APPL1;IL17D;TLR4;TICAM1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.47717817282168395,-1.3982192742921942,0.07259528130671507,0.36270364200520516,1.0,11/27,19.52%,DICER1;PCF11;ZC3H12C;NYNRIN;CPSF3;XRN1;KHNYN;ZC3H12B;ERN1;CSTF3;RNASE4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4629143338990049,-1.3978075415452396,0.06095238095238095,0.36291029496512617,1.0,8/29,14.16%,ZBTB20;SORBS1;CREBL2;MTOR;LDLR;NR1H3;APOE;SLC27A1
prerank,maintenance of blood-brain barrier (GO:0035633),0.45597114707117814,1.3973750187614384,0.07773109243697479,0.4189146767793924,1.0,9/30,7.13%,CLDN5;ACTB;MBP;MFSD2A;JAM2;SLC1A1;OCLN;ESAM;PECAM1
prerank,regulation of cation transmembrane transport (GO:1904062),0.46800264654639157,1.3973476280872281,0.06910569105691057,0.4172752784191761,1.0,8/29,7.96%,DPP10;KCNIP4;FGF12;KCNN2;KCNIP1;DPP6;HOMER1;KCNAB1
prerank,regulation of gastrulation (GO:0010470),-0.5576686912958306,-1.3962475692325735,0.07930367504835589,0.3659558753991164,1.0,3/14,3.11%,PHLDB2;DAG1;OSR1
prerank,regulation of interferon-alpha production (GO:0032647),-0.4861804630961199,-1.3957555497696037,0.07749077490774908,0.3663321872427524,1.0,9/23,17.41%,TBK1;PTPRS;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5943371202584422,-1.3951982246827859,0.08949416342412451,0.3668117095492542,1.0,4/11,17.53%,TGFBR2;FGFR2;STAT1;WNT5A
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47445290590070033,-1.3950549014275062,0.07462686567164178,0.3663121583940103,1.0,4/26,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,aorta morphogenesis (GO:0035909),-0.5277545396148235,-1.3947501284109378,0.09392265193370165,0.3662941778594893,1.0,6/17,3.07%,LRP1;BMPR1A;RBPJ;MYLK;PDGFRB;JAG1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4579369551139274,-1.3943649862621743,0.08187134502923976,0.36643124410379446,1.0,5/30,8.58%,IGF1;IGFBP2;HMGB1;RC3H1;IGF2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5916819007211359,-1.3938613097178811,0.09566787003610108,0.3667409799526626,1.0,7/11,29.13%,PARP10;PARP14;PARP9;PARP4;PARP6;PARP12;PARP3
prerank,phosphate ion homeostasis (GO:0055062),-0.6243948432165938,-1.3929435776749295,0.07835820895522388,0.3679909520587678,1.0,3/10,20.61%,ENPP1;SFRP4;FGFR4
prerank,epithelial cell-cell adhesion (GO:0090136),-0.6005304179083983,-1.3923678970834668,0.08514492753623189,0.3685373612005542,1.0,5/11,10.17%,VCL;KIT;ITGB5;JUP;CCN3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.46149346884151454,-1.3920323485851929,0.07074569789674952,0.3685067016670667,1.0,12/27,18.68%,PID1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.49967566231192384,-1.391786544646293,0.0784313725490196,0.3682119500371214,1.0,5/21,6.01%,LRP6;CSNK1A1;GSK3B;AXIN1;FZD2
prerank,aminoglycan metabolic process (GO:0006022),0.609311187218899,1.391328415790363,0.13107822410147993,0.43042970350213566,1.0,3/10,5.44%,B3GAT1;CHST9;B3GAT2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4338377863725441,-1.3908469623000166,0.07777777777777778,0.3696480074875031,1.0,9/40,7.20%,ZBTB20;SORBS1;WNT4;VIM;SLC5A3;BMP4;CREBL2;RUNX1;MTOR
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5272514427729136,-1.3907283189060817,0.08695652173913043,0.36908634603664786,1.0,5/15,10.95%,TGFBR1;PDGFRA;TGFBR2;FGFR2;NIPBL
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4449760168869087,-1.3902799876735292,0.0637065637065637,0.3692883616588318,1.0,12/35,10.56%,NOTCH2;PDGFRA;NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42;RAPGEF3;IQGAP2;SEMA3E;ABL2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5984375872942355,-1.3896740325547685,0.08932038834951456,0.37000545388997935,1.0,4/11,8.85%,EGFR;DDX5;BMP4;MAP2K1
prerank,hippo signaling (GO:0035329),-0.4717643284750585,-1.3894141217260276,0.08743169398907104,0.3697942753647603,1.0,10/26,14.88%,TEAD1;STK3;YAP1;AMOTL2;TEAD3;WWC1;TEAD2;MOB1B;YWHAE;LATS1
prerank,positive regulation of gene expression (GO:0010628),-0.30212675296191804,-1.3890901506258508,0.0022271714922048997,0.3698265316374664,1.0,80/442,11.32%,BMP6;SLC24A3;SAMD4A;ROCK2;PLD1;IGF1;EGFR;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;DDX5;CELF1;FGF1;VIM;KAT2B;BMP7;EP300;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;ZCCHC4;WNT6;GSK3B;PLA2R1;YTHDF3;YAP1;TNRC6A;CTSH;MOV10;UBR5;THBS1;HOXA5;PLSCR1;STAT3;DTNBP1;MED26;U2AF2;EIF2AK3;MTOR;SF3B1;F3;BRAF;HNRNPD;AR;FUBP1;DHX36;PPARGC1A;TAF1D;GJA1;TBP;MAP2K1;MED1;PTPN22;PHF2;ATF2;PLXNB2;ITGB8;NGF;GABPA;TADA3;HIF1A;HCFC1;CALCOCO1;RPL11;ID2;TLE1;ADAM19
prerank,cellular response to lipid (GO:0071396),-0.3266483631383182,-1.3888266954221022,0.006237006237006237,0.3695125838325885,1.0,38/191,12.99%,ATP1A2;ROCK2;EGFR;PID1;NFKB1;EPHA3;ADCY5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;IRS1;LBP;HMGB1;NR3C1;LCOR;SBNO2;TFPI;ADCY1;LYN;WNT9A;ADCY6;AR;CTR9;MED1;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;ABL2;RORA;MEF2C;FZD7;ADNP2
prerank,regulation of defense response to virus by host (GO:0050691),-0.4562255814024994,-1.3887449704571508,0.07194244604316546,0.3688910383517918,1.0,11/30,17.52%,TRIM44;DHX9;TRAF3IP2;PTPN22;RNF216;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6020991615515622,-1.3887247078521177,0.09124767225325885,0.368142654731361,1.0,5/10,16.74%,IMPACT;BAG3;JUN;NCK1;CITED2
prerank,angiogenesis involved in wound healing (GO:0060055),0.5829823689259016,1.3881602159817836,0.12837837837837837,0.43676370015772725,1.0,4/11,8.97%,KDR;NDNF;CD34;ADIPOR2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4474267735784762,1.3881331312950969,0.06623931623931624,0.43505600772470765,1.0,8/32,11.89%,GRIN1;AKAP6;SNCA;THY1;APLNR;F2R;P2RX7;TRPC1
prerank,skeletal muscle organ development (GO:0060538),-0.4658899510089738,-1.3877940613423718,0.07514450867052024,0.36951211074505963,1.0,5/26,6.08%,LARGE1;SVIL;CFLAR;DISP1;IGSF8
prerank,regulation of cartilage development (GO:0061035),-0.5142067324865904,-1.3877702243251537,0.09883720930232558,0.36876819797627947,1.0,8/18,22.06%,SOX5;BMP4;ZBTB16;SOX6;TRPS1;BMP2;TAPT1;PTHLH
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4877555770946035,-1.3873121935764905,0.07889546351084813,0.36814525099573003,1.0,8/23,10.69%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4877555770946035,-1.3873121935764905,0.07889546351084813,0.36814525099573003,1.0,8/23,10.69%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.44841382441922983,-1.3860450743159962,0.06903353057199212,0.37016161068456205,1.0,4/30,2.75%,AKAP13;COL3A1;LPAR1;ROBO1
prerank,female gonad development (GO:0008585),-0.5039873534355693,-1.3860390528491908,0.07279693486590039,0.36938431784969133,1.0,12/19,38.27%,NR2F2;KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;COL9A3;LHCGR
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.5052113247316776,-1.3857518346982054,0.09090909090909091,0.3692253651155355,1.0,11/19,39.28%,PRKN;DNM1L;VDAC1;FBXW7;PARK7;HTRA2;USP36;HTT;SREBF1;FZD5;HAX1
prerank,negative regulation of type I interferon production (GO:0032480),-0.42760392228088007,-1.3852531652729276,0.056640625,0.36972408774996446,1.0,24/40,37.83%,TAX1BP1;TBK1;PTPRS;PCBP2;RNF216;MAVS;TRIM25;ILRUN;IKBKE;UBA7;NLRX1;NLRC3;SIRPA;GPATCH3;DHX58;CACTIN;TNFAIP3;IFIH1;UFD1;PYCARD;OTUD5;PIN1;TRAF3IP1;NLRC5
prerank,positive regulation of locomotion (GO:0040017),0.46560972837687675,1.3848970878551308,0.07862903225806452,0.44158384837236536,1.0,7/27,10.48%,SPOCK2;CSF1R;PPM1F;STX3;NTN1;PDGFB;AIF1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3593548159850402,-1.3848319294742089,0.03838771593090211,0.369984367351057,1.0,51/107,31.64%,ITPR1;CREB3L2;PRKN;GSK3B;THBS1;UBQLN1;OS9;UFL1;EIF2AK3;BCL2;MAP3K5;UBA5;AIFM1;SELENOS;ERLEC1;TRAF2;JUN;TMEM259;ATP2A2;RCN3;MBTPS2;ERP44;ATF6;ERN1;NCK1;MBTPS1;DERL1;SYVN1;VCP;TMTC3;SEC16A;P4HB;ATP2A3;PIK3R1;CDK5RAP3;WFS1;EIF2B5;BAG6;HYOU1;QRICH1;ATF6B;SEL1L;PPP1R15B;USP19;CCDC47;BAK1;UFM1;ATG10;BCL2L11;HERPUD1;CEBPB
prerank,DNA methylation (GO:0006306),-0.4831184631915594,-1.3844799081465544,0.08872458410351201,0.370033079553137,1.0,6/23,12.82%,PPM1D;BAZ2A;DNMT3A;ATF7IP;N6AMT1;EHMT1
prerank,response to molecule of bacterial origin (GO:0002237),0.38368465781636396,1.3833666180388915,0.038834951456310676,0.4435078467190016,1.0,19/69,15.14%,TIRAP;S100A9;S100A8;SNCA;NOS3;IL12A;CD24;HNRNPA0;IFNAR1;TRIM6;CYRIB;SLPI;GGT7;F2R;GGT1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,regulation of coagulation (GO:0050818),0.5726969269304285,1.382623130693266,0.09894736842105263,0.4435672585901257,1.0,3/11,11.24%,HS3ST5;F2R;PROC
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4377080099646751,-1.381944332889205,0.0610236220472441,0.37501064221421565,1.0,15/36,19.95%,ERRFI1;EPHA7;ENPP1;NBN;IMPACT;PDGFC;PPP2R5E;RASSF2;MOB1B;VEGFA;PPP2R5D;DDX3X;MRE11;PPP2R5C;MVP
prerank,regulation of response to stress (GO:0080134),0.6074810447626084,1.3815493669944037,0.09954751131221719,0.4445110271531833,1.0,5/10,19.33%,ADCY8;MLC1;OPRM1;STOX1;SLC38A2
prerank,sensory perception of pain (GO:0019233),0.49654174485159325,1.381239081176033,0.08547008547008547,0.4434752764030016,1.0,8/21,15.06%,MME;CCL2;OPRM1;RETREG1;P2RX7;KCNA2;OPRK1;OPRL1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5334620441328173,1.381012461374585,0.10736842105263159,0.4423916813596793,1.0,2/16,6.05%,CLDN5;CLDN14
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4381762301412092,-1.3806953598917322,0.06930693069306931,0.3773841166940803,1.0,16/35,25.74%,FOXO3;ARNT;HOXA5;STAT3;LYN;MED1;HIF1A;HSPA9;STAT1;PRKDC;STAT5B;INHBA;CDK6;MAFB;LDB1;MAPK14
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4799894696244456,-1.3805860506389174,0.08285163776493257,0.37682983313312074,1.0,16/24,35.67%,SEC24D;SEC23A;SEC31A;MFSD6;TAP2;SAR1B;TAPBPL;TAP1;FCER1G;SEC24A;ERAP1;CALR;SEC24C;IDE;SEC13;TAPBP
prerank,regulation of neuron migration (GO:2001222),0.46744552281245916,1.3805827036084741,0.07644628099173553,0.4417010974213468,1.0,11/26,14.03%,CAMK2A;CTNNA2;SEMA6A;SHTN1;NEXMIF;NTNG1;NTNG2;ARHGEF2;DAB2IP;SRGAP2;ADGRG1
prerank,monocyte chemotaxis (GO:0002548),0.45105582139734307,1.3805776607677858,0.08641975308641975,0.439978201684835,1.0,8/32,20.51%,FLT1;RPS19;CCL2;PDGFB;CCL25;PTPRO;CCL13;CCL19
prerank,neutrophil chemotaxis (GO:0030593),0.4072564729448238,1.3803560306068303,0.05668016194331984,0.43879175615438987,1.0,13/53,20.51%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,actin crosslink formation (GO:0051764),-0.5712206526725786,-1.3802620030279513,0.09486166007905138,0.37675057851290605,1.0,7/12,26.98%,DPYSL3;BAIAP2L1;FLNA;GAS2;BAIAP2;GAS2L3;GAS2L1
prerank,response to axon injury (GO:0048678),-0.5116372346880727,-1.380069009339681,0.08811475409836066,0.3763755885821338,1.0,5/18,15.20%,DPYSL3;NREP;APOD;P2RY12;P2RX4
prerank,ceramide metabolic process (GO:0006672),0.4051515719070503,1.3795930662955773,0.06570841889117043,0.4390854757165241,1.0,8/49,5.78%,ST6GALNAC3;SGMS1;ACER2;FA2H;DEGS2;ORMDL1;ORMDL2;PPP2R1A
prerank,regulation of autophagosome assembly (GO:2000785),-0.4372842041090265,-1.3792308693448976,0.07251908396946564,0.37748942423429027,1.0,12/33,19.37%,LRRK2;NUPR1;RAB3GAP1;SEC22B;CHMP4B;CHMP4A;PIP4K2C;IFT88;MTMR3;NPRL3;FEZ2;LRSAM1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5949464847371256,-1.3790540927850379,0.09289617486338798,0.3770494951570893,1.0,4/11,19.23%,OPA1;MEF2A;PARP1;MGME1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5928666677475691,-1.3777080791684708,0.10106382978723404,0.379451316269197,1.0,8/11,32.96%,WIPI1;UGCG;APOE;PIK3C3;WDR45B;WIPI2;ATG10;WDR45
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.31837355688974145,-1.376841648673612,0.0,0.38066623733973426,1.0,77/260,20.58%,PARVA;VCL;GSN;PKD1;MYLK;PCM1;ASAP1;GBF1;BBS9;CDC14A;KIT;WDPCP;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;ITGB1;IFT43;ATP6V0D1;PDE6D;ARL13B;RAP1B;IFT81;CFAP44;MAP4K4;CENPJ;NRP1;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;ACTN2;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;EMP1;ARFIP2;RAB11A;CC2D2A;POC1B;ARMC9;FGD1;SNX10;P2RY12;EMP3;RILPL2;FGD4;CDC14B;DZIP1L;RAPGEF2;EHD3;WHAMM;CARMIL1;CCDC57;ARHGEF6;FXYD5;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;INPP5K;EHD4;RILPL1;AVIL;CEP89;GALNT11;SPEF1
prerank,positive regulation of sodium ion transport (GO:0010765),0.57421488161536,1.3765615623996335,0.09544468546637744,0.4452439465766335,1.0,3/12,5.57%,CNKSR3;ANK3;SCN4B
prerank,MAPK cascade (GO:0000165),0.31129777905395967,1.376557347389466,0.005825242718446602,0.4435370210923521,1.0,56/295,11.67%,CAMK2A;DLG2;GRIN1;KITLG;TEK;RIT2;ERBB4;MBP;LRRC7;RASGRP3;SPTBN4;NRG2;NRG1;SPTB;SHANK3;DUSP6;RASAL3;FGF13;YWHAB;IL2RG;GRIN2B;TNIK;KDR;FGF10;PSMA1;FRS3;FLT3;LYPLA1;PEBP1;RASGEF1A;PAK1;NCAM1;PRKG2;PRKCQ;FGF5;IL5;RPS27A;UBC;RASGRF1;UBB;PSMD12;GOLGA7;PSMA6;WDR83;PSMB3;SPTBN5;CCL2;TAOK2;DAB2IP;PDGFB;SHC2;MEN1;SCG2;CALM1;SPTBN1;MAPK8
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5494817289310935,-1.3747818442088449,0.08382066276803118,0.38477621790074223,1.0,10/14,33.66%,OPA1;PRKN;LRRK2;SELENOS;SYVN1;PARK7;TMBIM6;HERPUD1;HSPA1A;CREB3L1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5604823479068748,-1.3747122133613165,0.12830957230142567,0.3841488966046815,1.0,4/13,15.88%,ENPP1;TPST1;SULT1A1;ABHD14B
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5671370704083969,-1.374711267100156,0.1103448275862069,0.3833560299646442,1.0,8/12,35.40%,TNKS2;PARP10;PARP1;PARP6;PARP12;PARP3;PARP2;TIPARP
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5124057650852702,-1.3746146633409477,0.10789980732177264,0.3828107302057624,1.0,4/18,8.58%,IGF1;IGFBP2;HMGB1;IGF2
prerank,organelle assembly (GO:0070925),-0.3029011579027662,-1.374450557088701,0.0,0.38244251616162406,1.0,110/385,20.55%,PARVA;GSN;PKD1;INO80;PCM1;ASAP1;SH3PXD2B;GBF1;NCOR1;BBS9;CDC14A;WDPCP;PRRC2C;YTHDF3;DCDC2;FLNA;NUDCD3;CYS1;ARL3;UBXN2B;DDX6;PIBF1;IFT43;CEP63;ATP6V0D1;EIF4ENIF1;PDE6D;ARL13B;IFT81;CFAP44;VPS4B;RC3H1;UBQLN1;TMOD3;CENPJ;CEP162;DYNC2I1;ABLIM3;ZFYVE1;PCNT;TUBGCP6;CHMP4B;CHMP4A;EHD2;ATXN2L;TUBGCP2;UBAP2L;CHMP5;RB1CC1;CHMP3;CSDE1;RFX2;RAB3IP;IFT88;VPS37C;LSM14A;FAM161A;RPGR;WIPI1;RP2;LIMD1;EXOC2;ATP2A2;IFT80;ULK2;RAB11A;CC2D2A;POC1B;ARMC9;BECN1;SNX10;MAPRE1;SYNPO;ATG2A;RILPL2;PIK3C3;CDC14B;EDC3;RCC1;DDX3X;DZIP1L;EHD3;FARP2;ATG9A;CCDC57;DYNC1H1;WDR45B;AUP1;ATG2B;CCDC66;TCTN1;WDR11;AMBRA1;PTPDC1;CPLANE1;ATG5;SQLE;DYNC2I2;CSNK1D;EHD4;HPS1;NEK6;TUBGCP4;RILPL1;AVIL;LMOD1;CEP89;SNF8;GALNT11;WIPI2
prerank,heart trabecula morphogenesis (GO:0061384),-0.5093107022844228,-1.3744237833142658,0.1,0.3816973736611541,1.0,7/18,4.49%,TGFBR3;TGFBR1;BMPR1A;RBPJ;BMP5;BMP7;RBP4
prerank,negative regulation of chemotaxis (GO:0050922),0.45044527442831295,1.374409203802379,0.06841046277665996,0.4472864876575043,1.0,10/31,10.48%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;NOTCH1;ROBO2;AIF1
prerank,cilium organization (GO:0044782),-0.3253673494129807,-1.374016009885908,0.0063025210084033615,0.38180626744391105,1.0,62/210,21.15%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;IFT43;ATP6V0D1;PDE6D;ARL13B;IFT81;CFAP44;CENPJ;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;MARK4;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;PKD2;CC2D2A;POC1B;ARMC9;SNX10;RILPL2;TTC17;CDC14B;DZIP1L;EHD3;CCDC57;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;EHD4;RILPL1;AVIL;CEP89;GALNT11;KIFAP3;TRAPPC14
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.517800005598207,1.3736231091560351,0.13402061855670103,0.4476125608809336,1.0,4/16,13.23%,CXCL12;CLU;TPT1;RPS3
prerank,histone H3-K9 demethylation (GO:0033169),-0.5783753534451029,-1.373439030142975,0.11460258780036968,0.3823674757015993,1.0,7/11,27.06%,KDM7A;KDM4B;PHF8;KDM3B;KDM3A;KDM1A;JMJD1C
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3772896589511352,1.3730977092434895,0.05930470347648262,0.44728084570169063,1.0,15/75,8.00%,CAMK2A;MRAP2;RGS12;GIT1;METAP2;GNG4;YWHAB;RGS20;PLCB1;RGS5;KCTD8;RGS11;GUCA1B;ADCYAP1;RNF157
prerank,positive regulation of macroautophagy (GO:0016239),-0.40806210947633303,-1.3726150794906458,0.05719921104536489,0.38331472238195274,1.0,12/48,11.15%,DCN;PRKAA2;UVRAG;TBK1;VPS13D;RAB3GAP1;LARP1;PIP4K2C;VDAC1;SESN1;BAG3;PAFAH1B2
prerank,positive regulation of cell cycle process (GO:0090068),-0.36627183928008455,-1.3724736317294284,0.027079303675048357,0.38285661715069497,1.0,23/91,17.57%,IGF1;INO80;SVIL;PDGFRB;CDC14A;NUMA1;CSPP1;UBXN2B;PLSCR1;CDC42;IGF2;MAP3K20;RHOA;GIPC1;RAD21;DYNC1LI1;TPR;CUL3;CDC14B;CDC25B;DYNC1H1;CEP295;PHIP
prerank,cellular protein modification process (GO:0006464),-0.28328822831969075,-1.3724687610329334,0.0,0.382084165646111,1.0,287/983,21.49%,UST;PTPN13;FSTL1;PRKAG2;CP;ROCK2;FBN1;COL3A1;FBXL7;GRK5;TGFBR1;LARGE1;BMPR1A;ST3GAL4;CDK8;NGLY1;TLK1;LTBP1;IGFBP5;PDK1;SDC2;ARAF;B3GALT1;TNKS2;UBE2E2;LOXL1;PPP1R12A;STK3;FAM20A;ROCK1;BMP4;SPSB1;ABL1;PPM1D;BIRC6;LRRK2;JAK1;PTPN14;PRKAA2;PPM1E;TGFBR2;FBXW8;HLCS;CSNK1A1;KLHL13;BTRC;WWP2;FRK;GSK3B;CCNT1;STK17B;RYK;TBK1;PLOD2;IRAK3;NRK;GPC3;ASB3;PLAT;IGFBP3;MARK3;PTPN9;CDK16;BCR;CDK7;PTPRS;PIGK;THBS1;STT3A;FUT10;PAK2;ZBTB16;PTPN21;UFL1;MAP4K4;DUSP16;TAOK3;EIF2AK3;WDTC1;ITIH2;LYN;PTPN3;CAMK2D;ANXA1;MTOR;OBSL1;ASB2;MERTK;ZC3HAV1;BRAF;FBXL4;GRK4;PARP10;OGA;MAP3K5;PDPK1;FBXL12;DCLK1;FBXO10;IGFBP4;ASB13;SETD3;PTPRK;MARK4;MAP2K1;KTN1;DDB2;DAPP1;CDK13;GRK3;WNK4;PTPN22;UBE2I;PPP4R2;PPP2CB;PMM2;CLK2;PPM1H;TNC;MAP3K20;WNK1;NUB1;CSNK1E;HIPK1;PTPN12;BRSK1;FER;EGLN3;MAN2A1;ST3GAL3;DCAF10;PRKCD;PARP14;HIF1A;ABL2;GGCX;WIPI1;DMPK;COG3;FAM20C;PARP9;DNAJC3;COG7;CLK3;CDK11B;YES1;DCAF6;DUSP11;SERPIND1;LGALS1;PARP1;PPP2R5E;UGCG;PSMF1;PPM1M;FBXL19;FBXL18;RAB11A;LRRC41;MKNK2;TEC;SIK1;CUL3;COPS2;FBXO30;FBXW7;EIF2AK4;WSB2;FN1;MTMR3;MAML1;DCAF8;PPM1A;KLHL22;MXRA8;GMFB;SIRT5;TBCK;PARP4;CCN1;TRIB2;COPS8;MAPK6;LOX;TYK2;IGFBP7;EIF2AK2;APOE;PIK3C3;PSMB2;PRKDC;BMP2K;PPP2R5D;DUSP1;ACVR1;CDC14B;ERN1;MSLN;LATS1;CDC25B;PRKCZ;MBTPS1;PPP1CB;CUL2;CSNK2A1;PIK3R4;ERCC8;GRK6;MARK1;KLHL11;DAPK1;UBE2E1;DUSP10;DCAF4;MANBA;SIK3;FEM1A;UBL5;WDR45B;IKBKE;ASB5;DAPK2;PIK3CD;PIGS;FBXO22;UBE2S;PRKACA;MIA3;MAN2A2;PXK;UBA7;PRKD1;MORC3;PRKAA1;RPN1;PPP2R5C;PTPN1;RABGGTB;FBXW11;ATG5;FBXW5;B4GALT5;GCNT2;NEK4;RCN1;CSNK1D;MAP3K1;BMP2;DCUN1D3;PARK7;CHM;SPSB4;CDK10;ABCA7;UBE2D3;TRIOBP;GPAA1;CDK2;NEK6;B4GALT7;FASTK;IRAK1;TAOK1;COP1;NRBP2;SPP1;PPP2R1B;P4HB;PIGH;WIPI2;CUL1;BCKDK;PRKAG3;CDK6;PSMC1;HIF3A;PPP2CA;CHML;MAST2;PPP4R1;PTPRA;PARP6;CUL7;AKT2;NAE1;PRKAB1;MKNK1
prerank,cellular response to organonitrogen compound (GO:0071417),0.36077911746210606,1.370675891344949,0.018633540372670808,0.4515033395205837,1.0,17/99,9.42%,GABRB3;HCN1;GABRB1;ACTB;IPO5;AQP9;GLRA1;AKAP6;PDE2A;RYR3;GABRB2;HCN2;TRPM2;P2RY1;CIB2;GABRG2;GLRA2
prerank,positive regulation of chemokine production (GO:0032722),0.41194723431958585,1.3704200810177953,0.06060606060606061,0.4504404513160221,1.0,8/44,10.48%,TIRAP;MBP;IL17F;CSF1R;IL7;TLR2;ADCYAP1;AIF1
prerank,response to amino acid starvation (GO:1990928),-0.3755590283767379,-1.370388377390011,0.04408817635270541,0.3861382137619749,1.0,21/72,17.76%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;LARP1;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,protein ubiquitination (GO:0016567),-0.2964397750181188,-1.3700123123922372,0.0,0.3862755350268195,1.0,148/471,24.03%,RNF220;PDZRN3;FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;RNF43;TNKS2;UBE2E2;UBR2;TRIM44;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;USP7;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;SH3RF1;OS9;BCL2;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;RNF8;FBXL12;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;RNFT1;DDB2;VCPIP1;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;HIF1A;RFWD3;RTF1;TRIM5;PSMF1;FBXL19;UBR3;FBXL18;TRIM11;NPEPPS;CUL3;FBXO30;FBXW7;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;SH3RF2;PSMB2;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;SH3RF3;CUL2;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;BFAR;DERL1;ASB5;KLHL18;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;EIPR1;AREL1;SDE2;TRAF6;VCP;RNF14;SPSB4;UBE2D3;TPP2;LRSAM1;CDC73;DTX2;RNF11;NFX1;PCNA;ANAPC11;CUL1;TRIM63;PSMC1;HIF3A;ARIH2;CUL7;FBXW4;DET1;ARRDC4;WAC;CAND2;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;SIAH2;USP9X;RNF6;PSMA4;CNOT4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3799622373853338,1.369992807537896,0.04680851063829787,0.44982840252811507,1.0,31/69,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;COA6;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.4076210072081695,-1.369394684181106,0.05521472392638037,0.3869756082414654,1.0,19/47,21.74%,MEDAG;BMP7;TMEM64;RREB1;CREBL2;ZBTB16;ID2;NAPEPLD;TRPM4;SOX13;WDFY2;CMKLR1;SIX1;HNRNPU;SYAP1;BMP2;METRNL;FRZB;CCDC71L
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5049244318350312,-1.3693589185888615,0.10526315789473684,0.38630000017740784,1.0,9/18,14.16%,IL6ST;JAK1;YAP1;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,sensory perception (GO:0007600),0.413439531037073,1.369266285954229,0.07422680412371134,0.4499641057828703,1.0,15/45,19.10%,PCDH15;MME;GNAL;CCL2;OPRM1;RETREG1;TTC8;P2RX7;PNOC;KCNA2;OPRK1;OPRL1;NTSR2;TMEM150C;ADORA2A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4642910542734958,-1.369236352163736,0.08905380333951762,0.3858077074886074,1.0,7/25,10.04%,VPS4B;CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT;CHMP3
prerank,tRNA methylation (GO:0030488),-0.42722461076145474,-1.36884126625233,0.0900735294117647,0.3860839647097502,1.0,20/34,33.27%,NSUN6;METTL2B;METTL2A;METTL1;NSUN2;THUMPD3;TRMT1L;FTSJ1;DALRD3;LCMT2;WDR6;GTPBP3;TRMT1;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;ALKBH8;TRMT12
prerank,stem cell differentiation (GO:0048863),-0.43105510397113106,-1.3681632506029877,0.07007575757575757,0.3870450010333471,1.0,12/39,13.08%,MLLT3;LRP6;FBXL17;OSR1;KIT;UFL1;FGFR2;PUM1;HOXB4;SETD2;MEF2C;NELFB
prerank,cyclooxygenase pathway (GO:0019371),-0.6090377319083501,-1.367906063613737,0.08468468468468468,0.38697302103768455,1.0,4/10,10.31%,PTGDS;PTGIS;PTGS1;PTGES
prerank,melanosome organization (GO:0032438),-0.46371022958497976,-1.3674167092127045,0.0975177304964539,0.3873360576078684,1.0,6/26,19.01%,KIF13A;SHROOM2;DTNBP1;AP3B1;BLOC1S5;HPS1
prerank,response to amino acid (GO:0043200),0.4499166918671793,1.367329743044893,0.09513274336283185,0.453184145970702,1.0,6/31,9.42%,GRIN1;IPO5;GLRA1;GLRA3;MEAK7;GLRA2
prerank,histone lysine methylation (GO:0034968),-0.4398379316770255,-1.366924006668308,0.08064516129032258,0.3876618871618042,1.0,17/33,33.02%,PRDM5;KMT2D;SMYD3;SETD3;KDM6A;N6AMT1;SETDB1;KMT2A;EZH2;PRDM9;PAXIP1;CXXC1;SMYD1;WDR5;SETDB2;WDR5B;DPY30
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3025323139577126,-1.366760766686053,0.0,0.3872845833456759,1.0,68/348,11.67%,BMP6;SLC24A3;ROCK2;IGF1;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;CELF1;FGF1;BMP7;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;WNT6;GSK3B;YAP1;TNRC6A;RESF1;CTSH;MOV10;UBR5;HOXA5;PLSCR1;ANXA2;STAT3;DTNBP1;MED26;EIF2AK3;MTOR;F3;BRAF;ECE1;AR;FUBP1;DHX36;PPARGC1A;GJA1;MAP2K1;MED1;PTPN22;ATF2;ITGB8;NGF;GABPA;TADA3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;RPL11;ATF7IP;ID2;TLE1;ADAM19;MEF2C
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4881762942625672,-1.3664313569127797,0.09433962264150944,0.3872910537477669,1.0,6/21,5.26%,ROCK2;EPHA3;VCL;ROCK1;SLC9A1;SLK
prerank,lipid droplet formation (GO:0140042),-0.6028006484210111,-1.3663456281404922,0.11776447105788423,0.386716931371811,1.0,7/10,31.15%,ZFYVE1;AUP1;SQLE;CDS2;BSCL2;PLA2G4C;FITM2
prerank,central nervous system development (GO:0007417),0.31787039156124974,1.3662162745795539,0.0075046904315197,0.45430252165482704,1.0,58/250,14.97%,PAX8;ADGRL3;CNTNAP2;SPOCK1;GRIN1;SLC6A17;SLC2A1;MAL;MBP;PROX1;ASIC2;SH3GL2;PBX2;GRIN2A;SH3GL3;DNER;AHI1;CDH2;GRIK1;CNTN6;GRIN2B;MFSD2A;ADAM22;ADAM23;GRIN2D;MOG;AATK;PITPNM1;DSCAML1;NPAS2;CYP26C1;NRCAM;MTF1;IL1RAPL2;ROBO2;UBE3A;RELN;TPPP;ADGRL2;PHGDH;FOXJ1;HAP1;CNTN4;NPTX1;ITGAM;SH3GL1;VCAN;HAPLN3;DLL1;PTPRZ1;ADGRG1;NHEJ1;LSR;DCX;PPT1;HPCAL4;HAPLN4;ELP3
prerank,histone deacetylation (GO:0016575),-0.41491768157459497,-1.365865091957551,0.06666666666666667,0.3871005303211663,1.0,11/43,9.54%,PRDM5;HDAC8;MIDEAS;HDAC4;TBL1X;TBL1XR1;RCOR1;BAZ2A;RCOR3;REST;MIER1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.354157954910184,-1.3653661416447351,0.029880478087649404,0.3875723042939095,1.0,37/102,21.32%,RHOQ;SORBS1;NFKB1;ADCY9;ADCY5;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;SLC30A10;RAB10;ADCY1;RAB12;ADCY6;PDPK1;VAMP2;SELENOS;FER;PRKCD;DENND4C;PARP1;PCK2;PRKDC;CPEB1;NR4A1;PRKACA;NR4A2;LPIN2;SYAP1;LPIN3;INPP5K;ADCY7;PKM;PIK3R1;USF1;AKT2
prerank,water transport (GO:0006833),0.5577409906611202,1.3650076728790477,0.11914893617021277,0.455570680133103,1.0,4/12,15.98%,AQP9;AQP11;AQP4;CFTR
prerank,positive regulation of signaling (GO:0023056),0.4282050103629521,1.363260840204443,0.07474747474747474,0.45834039623796874,1.0,10/37,8.17%,SYT1;RIMS1;RIMS2;RIMS3;SNCA;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3727851417592272,-1.363167090341343,0.03777335984095427,0.39204444954063283,1.0,24/77,18.92%,IGF1;TCF7L2;TGFBR1;OPA1;ITGAV;CFLAR;BMP4;PRKN;BIRC6;THBS1;SH3RF1;ASAH2;BCL2;AR;ACAA2;RB1;ACVR1;DDX3X;CSNK2A1;PHIP;NR4A2;CX3CR1;TMEM14A;PARK7
prerank,response to ATP (GO:0033198),0.4988385055056073,1.3622270422101808,0.11206896551724138,0.45920068639736644,1.0,5/18,11.50%,RYR3;KCNJ11;P2RY1;CIB2;P2RX7
prerank,smooth muscle cell differentiation (GO:0051145),0.5605424689781991,1.361649349774341,0.11258278145695365,0.4590788853131314,1.0,5/12,7.29%,MRTFA;HEY1;TMEM204;MRTFB;APLNR
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4728654830890925,-1.3613807345936195,0.08317214700193423,0.39547395065752017,1.0,9/24,19.35%,GRB10;ARNT;VTN;NIBAN2;HIF1A;EMILIN1;ITGA5;PTPN1;ITGB3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3856465670154173,-1.3613073870533028,0.05185185185185185,0.3948448102758738,1.0,26/56,25.24%,EGFR;ANKRD17;UBE2E2;RPTOR;VPS4B;RAD51B;NSMCE2;ANXA1;ANAPC5;ANAPC7;ANAPC4;RAB11A;CUL3;RB1;CCND3;DDX3X;CDC25B;CDC27;ADAMTS1;KLHL18;EIF4G1;ANAPC11;RAD51C;CDC16;KMT2E;PHB2
prerank,phospholipid homeostasis (GO:0055091),-0.5822509971935921,-1.361164122055304,0.10153256704980843,0.3943844037234354,1.0,3/11,11.10%,ABCA1;TLCD2;RCN3
prerank,nuclear export (GO:0051168),-0.3667976565118747,-1.3611434947501515,0.0440251572327044,0.39366870709618756,1.0,27/80,23.68%,RANBP3L;PKD1;ATXN1;XPO4;CASC3;U2AF2;SRSF6;NUP42;PHAX;SLU7;EIF4E;NUP214;TPR;SRSF1;SMURF1;NXF1;RANBP3;SRSF7;SRSF11;SRRM1;UPF3B;DESI1;SRSF2;CHP1;WASHC4;XPO5;XPO1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5713930460744497,-1.3608528713004078,0.11877394636015326,0.3935529608922194,1.0,6/12,25.93%,IRS1;ABCD2;PPARGC1A;AKT2;TWIST1;PPARA
prerank,positive regulation of B cell activation (GO:0050871),0.39870720212001165,1.3608294140212371,0.060542797494780795,0.45960129604174055,1.0,15/50,18.99%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;SHLD3;CD40;XBP1;NFATC2;SH3KBP1;CD38;BTK;NCKAP1L;NOD2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5838984112007134,-1.3607963923250241,0.09242144177449169,0.3929278145307652,1.0,5/11,20.36%,PRKN;UBQLN1;REST;PARK7;P4HB
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.36984098966131196,-1.3606100344083336,0.04238921001926782,0.3926164575880954,1.0,29/76,22.82%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;AXIN1;RNF19A;NUB1;CSNK1E;FBXW7;TRIB2;SH3RF2;SMURF1;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;CDK5RAP3;DET1;RNF144A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.34408611039984344,-1.360327978871754,0.014227642276422764,0.39243849550656124,1.0,21/122,9.32%,SAMD4A;PLD1;IGF1;EGFR;SORBS1;NFKB1;GLI2;PDGFRB;VIM;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;SLC6A9;BRPF3;HNRNPD;AR;IGF2;PLXNB2
prerank,negative regulation of neuron projection development (GO:0010977),0.3921121866089188,1.3602368924751034,0.0498960498960499,0.4594932934984135,1.0,22/56,16.55%,SPOCK1;DCC;MINAR1;MAG;NLGN1;MCF2;THY1;EFNB3;OMG;LINGO1;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4;GDI1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5407249056819061,-1.360031521628349,0.1157495256166983,0.39234686167004545,1.0,6/14,26.17%,MOXD1;DAGLA;NOS1;SLC5A7;DAGLB;SLC22A2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5064733024919594,1.3597962169182627,0.1346153846153846,0.45891067564582955,1.0,4/17,10.77%,ANK3;AKAP6;KCNAB1;RNF207
prerank,regulation of type I interferon production (GO:0032479),-0.36566277323951796,-1.359564761217007,0.04038461538461539,0.39269218674430634,1.0,46/84,34.83%,NFKB1;EP300;TAX1BP1;TBK1;DTX4;CREBBP;DHX9;DHX36;PCBP2;PTPN22;RNF216;MAVS;TRIM25;IRF1;ILRUN;PRKDC;NLRP4;MRE11;TRAF3;IKBKE;UBA7;POLR2H;IRAK1;XRCC6;NLRX1;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;GPATCH3;DHX58;TNFAIP3;POLR3E;CGAS;POLR1C;IFIH1;DHX33;UFD1;POLA1;IRF5;OTUD5;MYD88;ZBP1;IRF8
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5046170293907986,-1.359328839268734,0.0933572710951526,0.39245977433437185,1.0,7/18,18.76%,SMAD3;PDPN;RUNX1;RB1;EFEMP2;EMILIN1;BMP2
prerank,cellular component maintenance (GO:0043954),0.5546279238923285,1.3583434139382826,0.12222222222222222,0.4609203894950979,1.0,1/12,0.11%,IGF1R
prerank,positive regulation of lipid localization (GO:1905954),-0.5736761346026996,-1.3579241117065732,0.1266294227188082,0.3950287866753886,1.0,2/11,1.19%,LRP1;NFKB1
prerank,actin filament organization (GO:0007015),-0.33231664830837243,-1.3578616813818694,0.020491803278688523,0.39442299811306314,1.0,44/151,20.81%,DPYSL3;CGNL1;GSN;TPM1;SVIL;MCU;MPRIP;MYO1B;BAIAP2L1;SHROOM2;FAT1;FLNA;DLG1;RND3;SHROOM3;TMOD3;FHOD1;CORO7;INPPL1;CDC42;ARHGAP17;WASL;RHOA;TPM3;ABI1;RHOBTB2;MYO1F;ZBED3;WHAMM;CARMIL1;EFS;RHOBTB1;RHOH;RHOC;TRIOBP;AVIL;LMOD1;VILL;MARCKS;TPM2;GAS2;BAIAP2;ARHGAP12;PLS1
prerank,gene expression (GO:0010467),0.3086899477841288,1.3577646298723771,0.007889546351084813,0.46072918547575015,1.0,90/348,14.48%,PAX8;ADARB2;BICD1;RPS6;LMF2;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;NUP210;HOXD3;RPL10A;NXT1;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;XAB2;DHX38;RPL41;RPLP0;RPL30;RPL7A;RBM15B;GLE1;MRPL13;RPL13;MRPS18A;TSPAN17;RPL12;MRPS7;RPS15;ALYREF;NUP62;POLR2J;EIF4EBP2;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;DKC1;RPS7;POLR2I;TSPAN14;RPL23A;EEF1A2;RPL8;BCL3;MAGOHB;MAGOH;MED20;HSPD1;DROSHA;MRPL36;NUP205;MRPL23;SORL1;TASP1;RPS14;GALNT2;RPS3;CPSF2;RPS2;DDX20;RPS5;EEF1A1;RPL18A;RPS28;POLR3A;THOC1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.41887001420335146,1.3575409457924297,0.06485355648535565,0.4596129806846714,1.0,8/41,10.22%,GRM5;LRP8;CSF1R;DOCK3;GAS6;NTRK2;RELN;PDGFB
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5540931189338529,1.3575350361743117,0.11883408071748879,0.4579769135357936,1.0,3/12,4.60%,SMS;DDC;TRH
prerank,negative regulation of macroautophagy (GO:0016242),-0.4661802179665512,-1.357408763717761,0.08364312267657993,0.394713547879186,1.0,7/26,7.80%,SMG1;LRRK2;NUPR1;MTOR;SEC22B;CHMP4B;CHMP4A
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4027874952144358,-1.356934531822612,0.06554307116104868,0.39505331930955073,1.0,20/48,22.00%,DOCK5;LIMS1;ABL1;CUX1;FBXW8;RREB1;FLNA;NRP1;OBSL1;CDC42;S100A10;PRKDC;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CUL7;CRKL
prerank,DNA geometric change (GO:0032392),-0.46873764160979614,-1.3567814879253994,0.08888888888888889,0.3946815997514038,1.0,10/24,16.77%,HMGB1;NBN;ANXA1;DHX9;DHX36;WRN;MCM9;ASCC3;MRE11;ZRANB3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5833681218054261,1.3564798930847344,0.11860940695296524,0.45889241853747315,1.0,3/10,6.24%,NETO1;SHANK3;NPTN
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5589727999067166,1.3564614184832728,0.11607142857142858,0.4573013900837957,1.0,4/11,22.08%,KLRC1;SMAD7;HFE;CEACAM1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3267092045989383,-1.3552419726579261,0.014553014553014554,0.39749308525923405,1.0,50/166,23.04%,SAMD4A;PLD1;IGF1;EGFR;SMAD3;SORBS1;GLI2;PDGFRB;VIM;ARNT;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;ZEB2;SLC6A9;BRPF3;HNRNPD;PPARGC1A;IGF2;LDLR;PLXNB2;PTPN2;NR1H3;HIF1A;GIPC1;PKD2;APPL1;GLI1;SLC27A1;PRKDC;CTC1;DDX3X;P2RX4;UPF3A;TLR4;PARK7;PCNA;UPF3B;FGFR4;ASS1;STN1;AKT2;FGF2;ZNF205;PYM1;CHP1;PTH1R
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5111304851694658,-1.3550811523337138,0.09586466165413533,0.39708856122508723,1.0,6/18,6.51%,ROCK2;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3892975366588087,-1.3549702086635773,0.05313092979127135,0.3965947532924649,1.0,25/57,31.79%,DCN;MCU;PRKN;GSK3B;DNM1L;DDHD1;FAM162A;PPARGC1A;RALA;PARK7;FIS1;BMF;BNIP3;ZNF205;HIP1R;HTRA2;PDCD5;CHCHD10;MUL1;PLAUR;GPER1;BAK1;PPIF;BCL2L11;HTT
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5542987341525057,-1.3549332267528995,0.12195121951219512,0.39591472131834843,1.0,7/13,10.58%,BMP7;BMP4;NR3C2;NR3C1;AR;MED1;CALCOCO1
prerank,ribosome assembly (GO:0042255),0.4039939535327832,1.3541842321807671,0.07708333333333334,0.4614831329337282,1.0,15/47,17.49%,RPS19;RPF2;RPS27;RPL10;RPLP0;MRPS7;RPS15;RPL5;RPL23A;NOP2;RPS14;RPS5;RPS28;MDN1;PPAN
prerank,camera-type eye morphogenesis (GO:0048593),-0.5904253832624508,-1.3540575458632065,0.12745098039215685,0.39719837565396965,1.0,5/10,17.03%,LRP6;SHROOM2;SKI;VEGFA;TBX2
prerank,regulation of protein processing (GO:0070613),-0.49171843263001536,-1.3540295512400646,0.09369024856596558,0.3965265466476918,1.0,4/21,6.91%,CCBE1;LRRK2;GAS1;RUNX1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5179440003703829,-1.3540289622192498,0.10227272727272728,0.39578289018030627,1.0,10/16,30.12%,AUTS2;BCOR;CTR9;SMAD4;PIH1D1;KMT2A;PAXIP1;KDM1A;WDR5;SNW1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4399317321824741,-1.3532061006320035,0.08560311284046693,0.3970303012862939,1.0,11/32,20.78%,AUTS2;PLCE1;RREB1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;CARMIL1;AVIL;PIK3R1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5036006020604603,-1.3528808035813258,0.1,0.39702258984502414,1.0,3/19,6.13%,IGF1;NUPR1;DAGLA
prerank,regulation of nervous system process (GO:0031644),0.49468411208514035,1.3527799343060478,0.11578947368421053,0.4636678104397821,1.0,5/18,4.75%,DLGAP1;TMEM108;HTR2C;NOS3;DLGAP2
prerank,calcium ion homeostasis (GO:0055074),0.3545554340077854,1.3527486170994383,0.0392156862745098,0.46212668973654025,1.0,14/95,8.10%,TMTC2;SLC24A4;SLC24A2;GRIN1;CXCL12;RYR2;HTR2C;SNCA;SLC8A1;ATP2B3;SLC30A1;NPTN;CIB2;TPT1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4353012397895491,-1.3518481314918513,0.07584830339321358,0.39878956605943233,1.0,15/34,26.05%,IGF1;PDGFRB;NSMCE2;ANAPC5;ANAPC7;IGF2;ANAPC4;CUL3;RB1;CDC27;PHIP;ANAPC11;CDC16;EDN3;EGF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.47292850378559453,1.3517668275838244,0.10239651416122005,0.4629203812928576,1.0,5/24,8.10%,MIF;CXCL12;SIRT1;CLU;TPT1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.48929004421453204,1.3512531122737494,0.10084033613445378,0.46253819509982946,1.0,5/18,3.46%,RIMS1;NLGN1;RIMS2;PREPL;RIMS3
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5589428940516742,-1.3509387956111043,0.11992619926199262,0.40012945588402643,1.0,4/12,8.58%,IGF1;SORBS1;IRS1;IGF2
prerank,relaxation of muscle (GO:0090075),-0.5487915552195288,-1.350555232502719,0.126232741617357,0.4002387743500321,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4095613413464148,-1.3503188243475441,0.0703125,0.40006247668046974,1.0,16/43,19.24%,PID1;SORBS1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;IGF2;PTPN2;PRKCD;OGT;NCK1;PRKCZ;PTPN1;INPP5K;PTPN11
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.43720849491901725,-1.3496832054368346,0.09073724007561437,0.4008409487623708,1.0,16/30,25.24%,FOXP1;DDX5;DAB2;EP300;NCOR1;AR;SAFB2;PRMT2;HDAC1;HEYL;RNF14;PARK7;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,lipid translocation (GO:0034204),0.49064569042882844,1.349478838142137,0.09829059829059829,0.4654708212673401,1.0,8/21,11.06%,TMEM30A;ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.46843451142176346,-1.3489242752619688,0.10968921389396709,0.4019406331825031,1.0,9/24,17.52%,TRIM44;TRAF3IP2;PTPN22;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,granulocyte chemotaxis (GO:0071621),0.39459090055426027,1.348553100196473,0.07385229540918163,0.46616259597536575,1.0,14/55,20.51%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;SCG2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,glucan biosynthetic process (GO:0009250),0.5504696737171931,1.3483426633248436,0.12578616352201258,0.46342293417196595,1.0,4/12,16.81%,PGM2L1;GYS1;PER2;GBE1
prerank,glycogen biosynthetic process (GO:0005978),0.5504696737171931,1.3483426633248436,0.12578616352201258,0.46342293417196595,1.0,4/12,16.81%,PGM2L1;GYS1;PER2;GBE1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5624835486490944,-1.3481249149412606,0.12849162011173185,0.4031581054538894,1.0,7/11,29.48%,KMT2D;CTR9;OGT;KMT2A;PRDM9;TET2;TET3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4849602251218881,-1.3478407554876146,0.13523809523809524,0.4031059852077357,1.0,6/20,10.95%,ATP1A2;CACNA1C;ANK2;SLC9A1;CAMK2D;ATP2A2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3310705118619449,-1.3470330174033869,0.0248565965583174,0.40429914181867604,1.0,43/140,18.96%,AKAP13;ARHGAP29;ARHGAP10;ARHGAP6;RHOQ;CGNL1;PLCE1;ARHGAP28;ITGAV;ARHGAP20;TIAM2;ARHGEF17;ARAP1;RHOJ;MYO9A;ARHGAP24;BCR;INPP5B;GMIP;ARHGAP21;PLEKHG2;CDC42;VAV2;ARHGAP17;TRIP10;RHOA;ARHGEF12;RHOT1;ARHGEF18;ARHGAP32;SOS2;FGD1;ARHGDIB;FGD4;NGEF;ARHGAP18;ARHGEF11;TRIO;ARHGEF6;ARHGEF1;ARHGAP15;RHOH;RHOC
prerank,selective autophagy (GO:0061912),-0.38704248271962066,-1.3466377752220704,0.050100200400801605,0.4045007173331496,1.0,22/56,18.92%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;UFL1;PCNT;UBA5;NBR1;TEX264;RB1CC1;IFT88;ULK2;DYNC1LI1;BECN1;ATG2A;DYNC1H1;AUP1;ATG2B;AMBRA1;ATG5;PARK7
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.53621935981437,1.346504791187466,0.14502164502164502,0.4665774358957587,1.0,4/13,9.08%,ADCY8;SHANK3;SHISA7;RELN
prerank,regulation of stem cell proliferation (GO:0072091),-0.49962399328100926,-1.3462211254705436,0.12815533980582525,0.40473234290564203,1.0,8/17,25.22%,FBLN1;YAP1;GJA1;EIF2AK2;HNRNPU;TERT;SOX11;KDM1A
prerank,negative regulation of transposition (GO:0010529),-0.5168567386925178,-1.3460968915047777,0.1252408477842004,0.404253995667701,1.0,4/16,16.92%,UBR2;MOV10;TUT4;MYBL1
prerank,base conversion or substitution editing (GO:0016553),0.5706998406975571,1.345832447010882,0.12087912087912088,0.4666976388517041,1.0,1/11,0.14%,ADARB2
prerank,positive regulation of response to wounding (GO:1903036),-0.4705053971537357,-1.3457311175011148,0.08587786259541985,0.4043581231144214,1.0,6/24,7.02%,PTN;MYLK;VTN;ITGB1;ARFGEF1;ANXA1
prerank,endomembrane system organization (GO:0010256),-0.32021784139695864,-1.3455434705776435,0.024096385542168676,0.4040768902662234,1.0,60/178,24.57%,GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;A4GALT;ATL3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;MYOF;GOLGB1;SEC23IP;ARFGEF1;RAB22A;EIF2AK3;ARHGAP21;OBSL1;CDC42;TLCD2;USP6NL;SEC31A;ATP8B2;ATL2;TBC1D20;DMPK;COG3;COG7;SNX10;SURF4;USP50;DOP1B;TJAP1;TMED3;MIA3;PRKD1;SEC16B;CSNK1D;SMPD4;TMED5;TMED4;TMCC1;PLEKHF1;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;ALS2;TOR1A;PI4K2B;VAPA;WASHC4;LMAN1;SPTSSB;BAG5;ARFGEF2
prerank,negative regulation of protein processing (GO:0010955),-0.5617084779768801,-1.3455139352376524,0.122040072859745,0.403412410616498,1.0,5/12,24.66%,LRRK2;THBS1;GAS1;SERPINE1;SNX12
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5068146130770672,-1.3454174613164038,0.1147227533460803,0.4029312460124516,1.0,7/18,19.98%,LBP;THBS1;NECTIN2;TNIP2;TLR4;WNT5A;KARS1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.3091387978309279,-1.3449334589752768,0.010395010395010396,0.40331547883549385,1.0,94/241,28.04%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.32730864112508506,-1.344810725379207,0.024896265560165973,0.4028557834063367,1.0,48/151,19.24%,BMP6;EGFR;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ADAMTS12;WNT4;NTRK3;LIMS1;WWOX;FOXC1;BMP7;BMP4;TGFBR2;CLEC3B;NR3C1;GAREM1;NRP1;SHC1;GAS1;ANXA1;PDPK1;MED1;PLCG1;PTPN12;SMAD4;MEF2C;PDE3A;APPL1;CPNE3;SOX6;VEGFA;ACVR1;ERN1;ACAP2;RAPGEF2;EMD;RUNX2;NR4A1;WNT5A;PRKD1;STAT5B;SYAP1;INPP5K;BMP2;PTPN11
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.3766983970673679,-1.3446422881048916,0.053231939163498096,0.40251046816433833,1.0,29/64,28.24%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5624965395063227,-1.3446145912841092,0.13059033989266547,0.40185051786500636,1.0,3/12,2.75%,ANK2;DIAPH1;ANXA6
prerank,regulation of tau-protein kinase activity (GO:1902947),0.592309626124993,1.3446053461240193,0.12009237875288684,0.4681367916667842,1.0,5/10,17.04%,NAB2;CLU;HSP90AB1;SORL1;HSP90AA1
prerank,regulation of transferase activity (GO:0051338),-0.5206945823802218,-1.3438167314420524,0.13883677298311445,0.4030286922442615,1.0,11/17,30.54%,SMG6;NABP2;PARP4;FEM1A;PPP1R3F;SPTSSB;BAG5;LDB1;LDB2;JMJD8;PINX1
prerank,regulation of chromosome segregation (GO:0051983),-0.516747666102983,-1.3437052202860258,0.11153119092627599,0.4025857683405697,1.0,6/16,15.43%,NUMA1;PUM2;SMC6;PUM1;SMC5;CSNK2A1
prerank,aerobic electron transport chain (GO:0019646),0.37422339522941334,1.3436876989266247,0.04477611940298507,0.4688991379229234,1.0,30/68,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.380555309804863,-1.3436162709256272,0.06513409961685823,0.40202608556686187,1.0,15/64,10.27%,ROCK2;PLEKHA2;EPHA3;VCL;ROCK1;JAG1;GSK3B;SLC9A1;SLK;THBS1;HOXA7;MAP4K4;JUP;SEMA3E;RHOA
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4720501049909448,1.3434165810722722,0.11728395061728394,0.46808920175636076,1.0,7/22,8.71%,TMEM108;SH3GL2;MAGI2;NTRK2;AKT1;RAB35;STMN2
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5304441551325569,-1.3433591651293442,0.12681159420289856,0.40194957668897957,1.0,4/15,12.19%,LARGE1;OGA;RENBP;MGAT3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3595214162034844,-1.342902917531137,0.036290322580645164,0.402300034779896,1.0,31/80,25.11%,PLPP3;GBF1;UVRAG;STX18;SEC22B;KDELR1;COPB1;COPZ2;ARCN1;ARFGAP1;ARFGAP3;COG3;COG7;KDELR3;RINT1;COPB2;KIF1C;SURF4;COPG2;TMED3;NAPA;COPG1;RER1;KIFAP3;COPE;COG4;ERGIC1;NSF;KIF3A;ATP9A;KIF23
prerank,response to metal ion (GO:0010038),0.37354380264478637,1.342718983415023,0.06553911205073996,0.46825588664830103,1.0,18/67,14.52%,MT2A;AQP9;KHK;SNCA;MT1X;MT1A;ATP5F1D;HOMER1;MTF1;SLC30A3;CALM1;SLC30A5;TRPC1;SNCB;CALM2;NDRG1;CALM3;PPP3CA
prerank,protein heterooligomerization (GO:0051291),0.4950913168451362,1.342458542074249,0.1090146750524109,0.46732893947625526,1.0,5/17,13.62%,GRIN1;KCNC2;GRIN2B;FARSB;MAT2A
prerank,activation of protein kinase activity (GO:0032147),-0.35133076915449407,-1.3422345971202434,0.03898635477582846,0.40319288299330264,1.0,40/106,19.82%,IGF1;ADCY9;ADCY5;ANGPT1;NTRK3;FGF1;STK3;GHR;ABL1;TGFBR2;OSBPL8;NRK;MAPKAP1;PIBF1;AXIN1;PAK2;MAP4K4;TAOK3;ADCY1;MTOR;ADCY6;PDPK1;PRRC1;TRAF2;PRKCD;RICTOR;CARD14;COPS8;TXN;VEGFA;ADRA2A;IL18;PRKACA;WNT5A;TRAF6;PARK7;ITGB3;IRAK1;TAOK1;ADCY7
prerank,histone methylation (GO:0016571),-0.4518987589549618,-1.3422001514239033,0.08487084870848709,0.4025378395415551,1.0,11/26,21.57%,CREBBP;NSD3;NSD1;SMYD3;PRMT2;N6AMT1;EHMT1;PRMT5;PRMT8;NTMT1;EZH2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.477263983796933,1.3419144771582203,0.12153518123667377,0.46714820413202074,1.0,5/22,10.29%,SLA2;THY1;PTPRJ;GPS2;LPXN
prerank,regulation of histone methylation (GO:0031060),-0.5493920680219273,-1.3412815366933921,0.14528301886792452,0.4039346558833123,1.0,8/13,35.48%,NSD1;MTHFR;CTR9;JARID2;PIH1D1;NNMT;AASS;TTLL12
prerank,dicarboxylic acid transport (GO:0006835),-0.4537590674558446,-1.341196133980856,0.09561752988047809,0.40342539025285934,1.0,7/28,10.69%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;GIPC1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.34446577708289555,-1.340090470125326,0.035269709543568464,0.4054170613911818,1.0,30/101,23.36%,SAMD4A;PLD1;VIM;CYFIP2;BTRC;ZCCHC4;YTHDF3;VGLL4;THBS1;MTOR;HNRNPD;ASPH;DACT1;PLXNB2;NR1H3;AGTR1;OGT;PRKDC;DDX3X;UPF3A;FBXW11;EIF4G1;INHBA;UPF3B;FGFR4;TBC1D10A;MSN;PYM1;PERP;HDAC2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5162549282863886,-1.3400520084664744,0.12619502868068833,0.40479666260528796,1.0,12/16,41.53%,PDS5A;NIPBL;RAD21;PDS5B;RB1;SMC1A;BOD1;POGZ;MAU2;REC8;SGO1;DSCC1
prerank,phospholipid catabolic process (GO:0009395),0.452091295644085,1.3395580837402057,0.1134453781512605,0.4715465437773951,1.0,8/24,19.73%,GPCPD1;ENPP2;SMPDL3A;SMPD1;PNPLA6;PLA2G4E;PLBD2;PRDX6
prerank,peptide catabolic process (GO:0043171),-0.47857015916606394,-1.3394051891233933,0.09386973180076628,0.4056247641089328,1.0,8/23,18.00%,CPQ;XPNPEP1;CTSH;ECE1;ANPEP;NPEPPS;LNPEP;CHAC2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5748128678525665,1.3390744744959189,0.12391304347826088,0.47124794644952606,1.0,3/10,14.32%,GPR35;CALM1;CALM3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5254362269223091,-1.3386353472864676,0.11306042884990253,0.40662115386707687,1.0,10/15,21.55%,FGF1;JAK1;PDPK1;BMPER;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.35660812708208767,-1.3382411837845802,0.049586776859504134,0.40685017117566824,1.0,29/92,17.69%,ROCK2;FOXP1;DOCK5;SASH1;ANGPT1;FGF1;BMP4;ABL1;SPARC;RREB1;CTSH;THBS1;BCAS3;MAP4K4;NRP1;FOXC2;MTOR;PLCG1;HIF1A;ADAM9;RAB11A;ANXA3;VEGFA;GLIPR2;ATOH8;DOCK1;PIK3CD;WNT5A;PRKD1
prerank,catecholamine biosynthetic process (GO:0042423),0.5534727806624222,1.337703743838228,0.13305613305613306,0.4733820463391804,1.0,3/11,5.82%,DDC;SNCA;TGFB2
prerank,response to reactive oxygen species (GO:0000302),-0.39162446768272285,-1.3374921407147966,0.07088122605363985,0.4078830124377809,1.0,17/54,18.22%,EGFR;PDGFRA;TPM1;COA8;PTPRK;FER;JUN;HIF1A;ADAM9;PKD2;APOD;APTX;ERCC6L2;APOE;TXNRD2;GLRX2;SOD2
prerank,myoblast fusion (GO:0007520),0.5476353526795803,1.3370224225257803,0.12636165577342048,0.4735122467173586,1.0,4/12,6.90%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,intestinal lipid absorption (GO:0098856),-0.5803907849406209,-1.336842457173722,0.13133208255159476,0.40875241496399506,1.0,3/11,11.73%,LIMA1;LDLR;UGCG
prerank,protein deacetylation (GO:0006476),-0.4042152731550015,-1.336832672365767,0.07341269841269842,0.4080445399769464,1.0,9/41,5.05%,PRDM5;MIDEAS;HDAC4;TBL1X;TBL1XR1;FLNA;RCOR1;BAZ2A;RCOR3
prerank,histone H2B ubiquitination (GO:0033523),-0.5871597290493203,-1.3367580395264873,0.12790697674418605,0.4074858183454069,1.0,7/10,22.37%,RNF8;CTR9;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,sulfur compound catabolic process (GO:0044273),-0.4119688984171418,-1.3364929259880087,0.08317214700193423,0.40741430729097405,1.0,14/38,24.79%,DCN;BGN;FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;CHAC2;OMD;TXN2;CSPG4;GGT5
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3974201748700208,1.3363163267648885,0.05793991416309013,0.47382873102261097,1.0,7/48,12.68%,SLC7A5;PDE4B;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,negative regulation of hippo signaling (GO:0035331),-0.5576740488227551,-1.3361576745873671,0.1301989150090416,0.40748711507449287,1.0,9/12,25.74%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;DLG5;MAPK14
prerank,neurotransmitter uptake (GO:0001504),-0.5538299323757453,-1.3359610977601142,0.12849162011173185,0.4072595281306715,1.0,2/12,0.95%,ATP1A2;SLC1A3
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.4051811170240845,-1.3357586011383982,0.07918968692449356,0.40701816942312374,1.0,8/41,6.61%,TGFBR3;BMPR1A;TPM1;RBPJ;BMP4;JAG1;TGFBR2;FGFR2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.48982938144546373,-1.3355274192926319,0.12568306010928962,0.40686904086157266,1.0,8/19,17.41%,TBK1;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,positive regulation of reproductive process (GO:2000243),0.43337243302675343,1.335358073573807,0.1101511879049676,0.47474416699878424,1.0,6/31,9.30%,GLRA1;PGAM4;PLCB1;TACR1;CFAP69;TACR3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5361700285277311,-1.3351867522952798,0.12754158964879853,0.40695058349433094,1.0,9/13,27.54%,BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL;ZBTB7B;PIM1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.34717030497365364,-1.3345617539499566,0.04811715481171548,0.4076776399370235,1.0,29/101,19.91%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;LYN;CTR9;PTPN22;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;IL18;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,nucleotide metabolic process (GO:0009117),-0.46798741399247384,-1.3341400979570164,0.11413043478260869,0.40791867124462333,1.0,8/23,14.92%,FHIT;NMNAT2;NUDT5;ENPP3;ME1;CTPS2;NMNAT3;NMNAT1
prerank,regulation of telomere capping (GO:1904353),-0.4666361258769637,-1.3340623063448087,0.10116731517509728,0.4073709145058003,1.0,8/23,19.59%,SMG6;TNKS2;USP7;NBN;HNRNPD;NABP2;MAP2K7;TERF2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5330397406581384,1.3337792287934358,0.16279069767441862,0.477360413807633,1.0,2/12,0.98%,DSCAM;PROM1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5548920032557018,-1.3331726534590982,0.12355212355212356,0.40873594172997224,1.0,7/12,21.67%,INSIG2;OS9;KDELR1;KDELR3;GPAA1;RER1;TAPT1
prerank,aortic valve morphogenesis (GO:0003180),-0.43321675981756835,-1.3327070130595526,0.08704061895551257,0.4090684650164887,1.0,7/30,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,endochondral bone morphogenesis (GO:0060350),-0.5663854519167106,-1.3325578327867864,0.11089494163424124,0.40873907645620594,1.0,5/11,11.67%,FOXC1;BMP4;INPPL1;COL13A1;MEF2C
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.5191527485967661,-1.3322058038423858,0.11720226843100189,0.4088225780844635,1.0,8/15,25.68%,STXBP4;CUL3;GLI1;KLHL18;CDC73;EZH2;PHB2;ATAD5
prerank,regulation of steroid metabolic process (GO:0019218),-0.4638291814077111,-1.3321436512802685,0.11560693641618497,0.40824524245075644,1.0,13/23,41.25%,PANK2;RORA;APOE;EPHX2;ARV1;ACADVL;NR1H4;ASAH1;STAR;ACADL;ABCG1;RORC;FMO5
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3643410360175722,1.3318231308237503,0.04893617021276596,0.48077285980620704,1.0,19/72,11.24%,NAV3;KANK3;SHANK3;MAP2;STMN1;FGF13;SNCA;PFDN5;HSPA8;CLU;PFDN6;TUBB4A;CAMSAP1;STMN2;CYRIB;ARHGEF2;MID1IP1;CORO1A;APC
prerank,respiratory tube development (GO:0030323),-0.44346492542440075,-1.331769005233712,0.12316176470588236,0.4083762585208637,1.0,10/28,15.96%,GLI2;FGF1;BMP4;PDPN;PCSK5;RBP4;FGFR2;CCDC39;VEGFA;LOXL3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4511410712860842,1.3316567554614158,0.11434511434511435,0.4796454987736689,1.0,6/24,10.55%,TEK;RAMP2;GAS6;KDR;NDNF;SCG2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.44097756294337087,-1.3312292488845643,0.09578544061302682,0.40898781213703106,1.0,18/30,29.72%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;POLR1C
prerank,oligosaccharide metabolic process (GO:0009311),0.3968469776343838,1.331086127291522,0.06638115631691649,0.47955849353005786,1.0,11/46,12.68%,ST6GALNAC3;ST8SIA4;ST3GAL6;NEU2;ST8SIA1;FUT9;B3GALT5;GLA;ST8SIA6;ST8SIA3;ST6GAL2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.43567807227778715,-1.331056640831783,0.09195402298850575,0.40875292361368276,1.0,14/32,19.89%,PHLDB2;ARHGAP6;JAG1;THBS1;BCAS3;HOXA7;MAP4K4;SEMA3E;APOD;RASA1;SERPINE1;FAM107A;MYOC;NF2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.46922813486157583,-1.3309671136568808,0.11026615969581749,0.4082832219592363,1.0,8/22,26.83%,ROCK2;ROCK1;GSK3B;BOD1L1;PTPA;CRY2;MASTL;BOD1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.596521433072805,-1.330660784036884,0.14766355140186915,0.40830784391040426,1.0,3/10,8.85%,LYN;NBR1;MAP2K1
prerank,negative regulation of developmental process (GO:0051093),0.3667326231694938,1.3305969901228187,0.07485604606525911,0.47932932182825416,1.0,17/69,13.73%,TFRC;ARHGEF15;DCC;OMA1;MIF;HEY1;SPRY3;GAS6;THY1;NOS3;NOTCH1;FOXJ1;GRIN3A;WDR77;HOPX;VAT1;DLL1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3377054871194845,1.3304838828328942,0.03529411764705882,0.4781032038664038,1.0,26/124,10.81%,CNTNAP2;GPRIN1;FRY;PLP1;CSF1R;TMEM108;NLGN1;GPM6A;SH3GL2;GPM6B;MAP2;STMN1;STX3;PPP1R9A;GPRIN3;ADCYAP1;STMN4;RASGRF1;BICDL1;CAMSAP1;RAB35;STMN2;IQCG;PTPRM;MICALL2;CNTN4
prerank,bone morphogenesis (GO:0060349),-0.5349570547714123,-1.329315633002936,0.15028901734104047,0.4108707960773145,1.0,4/14,6.61%,LRP6;CYP26B1;SKI;FGFR2
prerank,relaxation of cardiac muscle (GO:0055119),-0.541038372493797,-1.3290990036327606,0.1232876712328767,0.4106181446003619,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34310221388718537,1.328904199322836,0.03777335984095427,0.48058980218902075,1.0,20/110,11.17%,ADGRL4;ADGRL3;ADGRB3;ADCY8;ADCY3;RAMP2;ADGRB1;ADRB1;S1PR5;GPR101;LGR5;ADCYAP1;GPR26;GNG2;GNAL;ADRA1D;ADRA1A;ADGRL2;ADCY4;CNR1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.44931501507515736,1.3286639004737502,0.10526315789473684,0.4796779849470638,1.0,6/30,4.46%,FLT1;CSF1R;ARMC6;FST;KDR;FLT3
prerank,protein-containing complex assembly (GO:0065003),-0.3049370645494369,-1.3282832722335718,0.013071895424836602,0.41180476331374993,1.0,93/259,24.48%,FBXL7;AFDN;TCF7L2;TEAD1;SEC24D;OPA1;MCU;MDM4;SH3PXD2B;EP300;LRRK2;CSNK1A1;TRAPPC9;DLG4;GSK3B;YAP1;SLC9A1;KMT2D;CTSC;BCL9L;DNM1L;SNX9;AXIN1;TFG;SEC23IP;DNAJB14;PYGO1;CREBBP;SEC23A;TRRAP;DHX9;SEC22B;TUBGCP2;PPARGC1A;VAMP2;SEC31A;GEMIN5;TBC1D20;MNAT1;WASL;TRAF2;TLE4;TLE1;CAPZA1;WIPF1;HES1;TEAD2;TRAPPC6B;CUL3;TCF7L1;GSDMD;FN1;CDC123;STX5;PARD3;HDAC1;RANBP9;WASF1;REPS2;FARP2;STOML2;GOSR2;PPIH;PICALM;SEC16B;NAPA;CSNK1D;GPAA1;TUBGCP4;CDC73;TERT;PML;SEC16A;TLE3;CUL1;FANCC;KIFAP3;CLDN1;KMT2A;PPID;DET1;CAND2;LAMC1;F5;NSF;TRAPPC2;LMAN1;HSF1;USO1;PREB;TFAP4;SAR1B;MCFD2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3941686890148766,1.3282782302340614,0.07484407484407485,0.4792601311960034,1.0,9/47,13.00%,SPOCK2;SPOCK1;SPOCK3;BIN1;TIMP1;AKT1;SERPINB8;TIMP4;SORL1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5667866357636934,-1.3282452329541141,0.1252371916508539,0.4112069928096789,1.0,6/13,21.55%,HMGB1;PDPK1;IGF2;PLCG1;ITGA4;FGF2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5380154258685225,-1.3280352510585927,0.13619402985074627,0.4110334656204335,1.0,4/13,8.58%,IGF1;SORBS1;IRS1;IGF2
prerank,regulation of telomerase activity (GO:0051972),0.40998822966360376,1.3279936604420877,0.08064516129032258,0.4784636989541372,1.0,19/45,18.94%,PRKCQ;KLF4;TERF1;HSP90AB1;PIF1;MEN1;CCT2;DKC1;CCT4;ATM;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,renal system development (GO:0072001),-0.3925374733961675,-1.327825769649743,0.08858267716535433,0.410822384102637,1.0,20/52,17.00%,SULF1;TGFBR1;PKD1;WNT4;GLI2;FOXC1;BMP4;PCSK5;RBP4;ARL3;SULF2;PYGO1;IFT88;TBX18;AGTR1;STAT1;VEGFA;GREB1L;SALL1;SIX1
prerank,negative regulation of locomotion (GO:0040013),0.5446051740959799,1.327189490694465,0.1320754716981132,0.478882417976917,1.0,2/12,0.66%,SPOCK3;FRMD5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5367225200161361,-1.3263202022504865,0.13457943925233645,0.413752082949421,1.0,10/14,37.27%,FUS;WDR48;PARP1;MMS19;ARID2;ACTR2;FANCB;TIMELESS;ERCC6;MRNIP
prerank,cellular response to amyloid-beta (GO:1904646),0.4201289514876147,1.3259107439680042,0.10615711252653928,0.48052219800157275,1.0,6/35,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;CACNA2D1
prerank,electron transport chain (GO:0022900),0.5117640177816911,1.3247675538917154,0.14072494669509594,0.48194790986825203,1.0,6/15,13.39%,CYB561;NDOR1;ENOX2;ETFB;ETFA;ETFDH
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.33140480594410854,1.3246263796139448,0.03968253968253968,0.4807444030877061,1.0,19/138,5.87%,FLT1;PTPRG;IGF1R;TEK;MPZL1;PTPRD;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;PTPRT;AHI1;KDR;NTRK2;FLT3;SRMS;ALK
prerank,cellular response to starvation (GO:0009267),-0.3265611481875437,-1.324572770029578,0.02610441767068273,0.41713008576634125,1.0,51/147,23.63%,PRKAG2;RNF152;FOXO3;ATP6V1B2;LRRK2;TFEB;PRKAA2;RPTOR;ATP6V0D1;EIF2AK3;ZFYVE1;MTOR;MAP3K5;WRN;LAMP2;GCN1;SESN1;IMPACT;ATF2;BRSK1;USP33;WIPI1;FNIP1;WDR59;SIK1;CASTOR2;EIF2AK4;MTMR3;BECN1;EIF2AK2;PIK3C3;PIK3R4;DAP;WDR45B;TCIRG1;PRKD1;NPRL3;PRKAA1;ATG5;RRP8;WIPI2;PRKAG3;LARS1;TBL2;ATG14;SIK2;ATP6V1G2;SZT2;MAP1LC3A;DAPL1;NUAK1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.36471633236414513,-1.3243829841424188,0.0531496062992126,0.41690387664989503,1.0,18/72,16.30%,AKAP13;COL3A1;LPAR1;KANK2;ABCA1;ROBO1;ABL1;RIPOR2;BCR;NRP1;TNFAIP1;ABL2;ARHGEF18;CUL3;ARHGDIB;APOE;GPR4;ARRB1
prerank,regulation of secretion (GO:0051046),0.5441742261717133,1.3241191886228243,0.1545253863134658,0.48053104209168634,1.0,6/13,16.58%,NRG1;FGF10;MYO6;OPRK1;ACSL3;GPLD1
prerank,negative regulation of growth (GO:0045926),0.3345537108811477,1.323397602547245,0.04338842975206612,0.4808949189757804,1.0,37/121,17.97%,MT2A;MINAR1;SIRT1;GNG4;APBB1;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SCGB3A1;NOTCH1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;ING4;TMPRSS4;APBB2;SOX17;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2;PNPT1;CDKN2AIP;RERG
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.49804528002892234,-1.323075043155462,0.1312127236580517,0.4193082962559127,1.0,9/18,20.73%,HDAC4;FRS2;CCN3;BHLHE41;FZD7;SOX6;HDAC1;BMP2;TMEM119
prerank,endothelial cell migration (GO:0043542),-0.41769955396213865,-1.3227749180071644,0.08754863813229571,0.4192762718810374,1.0,14/37,17.04%,FSTL1;ABL1;DPP4;ADGRA2;NRP1;CYP1B1;CCN3;RHOA;GIPC1;FAP;STAT1;VEGFA;PLXND1;NR4A1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5830255622749955,-1.3221291255559302,0.1277445109780439,0.4201306469585408,1.0,3/10,14.16%,TGFBR2;FGFR2;STAT1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5793612220884276,-1.3217756743422167,0.15892857142857142,0.4203314634725573,1.0,4/10,12.86%,USP7;SELENOS;ZNF692;OGT
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5349087052290442,1.321372313552239,0.15682281059063136,0.484814049675442,1.0,3/11,7.40%,ITM2A;NECAB2;ITM2C
prerank,cellular response to amino acid starvation (GO:0034198),-0.3633605307125829,-1.3199044527434578,0.06626506024096386,0.4240670076233201,1.0,20/71,17.76%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,regulation of DNA replication (GO:0006275),-0.3918499027155664,-1.3194761169549347,0.0854368932038835,0.4243575313727231,1.0,21/49,29.74%,EGFR;ANKRD17;GLI2;RBBP6;DHX9;BRPF3;PDS5A;GLI1;ESCO1;CTC1;S100A11;CDAN1;PCNA;PPP2CA;STN1;ATR;ATAD5;EGF;OBI1;WAPL;ZBTB38
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5067341058803987,-1.3189374700887877,0.15572232645403378,0.4249254379110519,1.0,3/16,1.01%,ATP1A2;CACNA1C;ANK2
prerank,protein secretion (GO:0009306),-0.37707972053111305,-1.318321636558198,0.0925553319919517,0.4257220546713649,1.0,17/56,18.92%,WLS;ABCA1;STEAP3;TANGO6;PCSK5;CYB5R4;RAB10;ANXA1;RAB12;CAMK2G;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;PARK7
prerank,sodium-independent organic anion transport (GO:0043252),0.5688177631959845,1.318074096767202,0.16170212765957448,0.4916193914544863,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,negative regulation of lipid storage (GO:0010888),-0.4927299417242784,-1.3179669956354967,0.12260536398467432,0.4259100379073756,1.0,6/19,10.23%,ABCA1;ITGAV;OSBPL8;ABHD5;PTPN2;NR1H3
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5820385956866472,-1.3177691861948861,0.14048059149722736,0.42567114430006875,1.0,3/10,4.74%,PCM1;NIN;NINL
prerank,phospholipid biosynthetic process (GO:0008654),0.4126875686304883,1.317485146175616,0.10947368421052632,0.4915871335833311,1.0,15/36,19.21%,SGMS1;MBOAT1;CPNE1;MVD;GPAM;CRLS1;FADS1;DHDDS;FAR1;IDI1;PIP5K1A;SAMD8;CPNE7;FDPS;PCYT2
prerank,activation of phospholipase C activity (GO:0007202),-0.4431201518546485,-1.3167718252682576,0.08587786259541985,0.42731176835495205,1.0,5/29,9.47%,EGFR;LPAR1;ARHGAP6;EDNRA;PLCG1
prerank,homocysteine metabolic process (GO:0050667),-0.555421229455464,-1.316638071038399,0.15384615384615385,0.4269303924118544,1.0,3/11,7.13%,MMUT;NOX4;MTHFR
prerank,lung development (GO:0030324),-0.42551307130982635,-1.3163799311887752,0.11900191938579655,0.4268649683116672,1.0,12/33,15.96%,ERRFI1;PKD1;GLI2;FGF1;BMP4;PDPN;RBP4;FGFR2;RCN3;CCDC39;VEGFA;LOXL3
prerank,regulation of ion transmembrane transport (GO:0034765),0.4250005756092033,1.3163107871276847,0.09401709401709402,0.49303539883482944,1.0,8/33,12.77%,KCNJ3;CHRM3;KCNJ6;AKAP6;KCNJ11;KCNJ10;P2RX7;KCNJ8
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5314829305198319,1.3158265412545627,0.16143497757847533,0.4927106138420309,1.0,5/12,8.71%,MAP2;STMN1;SNCA;TUBB4A;STMN2
prerank,primary miRNA processing (GO:0031053),-0.5726809531449096,-1.3157658408183277,0.15257352941176472,0.4276252366176844,1.0,3/10,6.96%,SMAD3;SMAD2;PUS10
prerank,cellular response to oxidative stress (GO:0034599),-0.3343189125659767,-1.3152190704819722,0.06015037593984962,0.4283245753631603,1.0,51/118,30.09%,EGFR;PDGFRA;TPM1;FOXO3;ABL1;ARNT;LRRK2;PRKAA2;PLA2R1;NOX4;PPARGC1A;PTPRK;SELENOS;FER;JUN;PRKCD;HIF1A;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;ERCC6L2;TXNRD2;GPX8;CYBA;DAPK1;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;WNT16;ZFAND1;GPX7;NUDT2;CCS;GSR;MAPK9;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.4273521865912179,-1.3150366037599839,0.10789980732177264,0.42803351038460735,1.0,15/33,26.60%,PABPN1;PCF11;WDR33;SCAF8;CPSF3;SSU72;SLBP;CSTF3;SNRPF;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11
prerank,mitochondrion morphogenesis (GO:0070584),-0.5501041946857482,-1.3146773274499597,0.14154411764705882,0.42825412917790556,1.0,6/11,28.79%,PID1;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5280806392917743,1.3145337916232012,0.1504237288135593,0.49443886355735817,1.0,6/13,18.99%,KDR;TLR2;CCL2;NAMPT;EDN1;NOD2
prerank,embryonic organ development (GO:0048568),-0.37374677028267883,-1.3143983102740862,0.07303370786516854,0.4282258634755561,1.0,18/61,12.14%,PBX1;GLI3;TEAD1;BMPR1A;RBPJ;GLI2;RARB;TGFBR2;PCSK5;KIT;RBP4;PBX3;FGFR2;COL13A1;TEAD3;NES;ERCC3;TEAD2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.527565292167383,1.314023404820238,0.13478260869565217,0.4942032939886173,1.0,6/13,16.47%,ELOVL7;ELOVL4;TECR;HACD3;HACD1;TECRL
prerank,carnitine metabolic process (GO:0009437),-0.5497656744825481,-1.3127315977960907,0.1431159420289855,0.43144961792781217,1.0,6/12,18.82%,ACADM;CPT1C;TMLHE;CPT2;BBOX1;CPT1A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5648960700918798,-1.3112561022513478,0.15247524752475247,0.4343305427082724,1.0,3/10,2.52%,LRP6;BMP5;BMP7
prerank,cellular response to ATP (GO:0071318),0.5056998156815404,1.3111442579827872,0.15592515592515593,0.5002168288657899,1.0,4/14,11.50%,RYR3;P2RY1;CIB2;P2RX7
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3586795716166962,-1.3111313075911182,0.06573705179282868,0.4339202199082032,1.0,23/76,16.41%,EGFR;ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;JAG1;WWP2;TSPAN5;NIBAN2;YAP1;CREBBP;STAT3;POFUT1;CCN3;MMP14;NOTCH3;MAML2;FBXW7;MAML1;BMP2K;ARRB1;TSPAN15
prerank,regulation of interleukin-2 production (GO:0032663),0.40136207682846153,1.311116023804376,0.09224318658280922,0.498770620898554,1.0,8/43,13.23%,NAV3;PDE4B;IL17F;CD34;HOMER2;SPTBN1;PDE4D;RPS3
prerank,retina homeostasis (GO:0001895),0.45536590768688606,1.3108714554985645,0.11702127659574468,0.49786060540282906,1.0,3/23,8.42%,POTEF;ACTB;HSPB1
prerank,macroautophagy (GO:0016236),-0.3365299432875876,-1.310252710905295,0.04040404040404041,0.43547797873887417,1.0,39/118,21.99%,PRKAG2;PRKN;PRKAA2;UVRAG;VPS4B;UBQLN1;VTI1B;VAMP7;ZFYVE1;CHMP4B;CHMP4A;LIX1L;NBR1;LAMP2;VDAC1;RB1CC1;CHMP3;VPS39;VPS37C;WIPI1;PRKAB2;MTMR3;BECN1;ILRUN;PIK3C3;CSNK2A1;PIK3R4;TCIRG1;AMBRA1;PRKAA1;ATG5;VCP;SNF8;TOMM7;WIPI2;STX17;PRKAG3;PRKAB1;ATG14
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5590654325777119,1.3101140879380184,0.1488469601677149,0.49826948416505934,1.0,5/10,12.59%,PDE2A;PDE11A;APLNR;RNF157;PDE4D
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4354456330016649,1.310043959869089,0.12311015118790497,0.49693235242374584,1.0,11/28,17.02%,MAP1B;MAP2;STMN1;MAPRE3;STMN4;CAMSAP1;STMN2;STMN3;FKBP4;CAMSAP3;CLASP2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5535417276166533,-1.3095653046086304,0.17373737373737375,0.4364614523524881,1.0,5/11,12.50%,RESF1;MPHOSPH8;ATF7IP;TPR;SETDB1
prerank,regulation of microtubule polymerization (GO:0031113),0.40304327372206994,1.3089219683829898,0.11422845691382766,0.498271027520729,1.0,12/40,13.23%,NAV3;MAP2;STMN1;SNCA;OCLN;PAK1;MAPRE3;TUBB4A;CAMSAP1;STMN2;DCTN1;RPS3
prerank,negative regulation of protein depolymerization (GO:1901880),0.4486054089622545,1.3084581540539617,0.14105263157894737,0.4979133810289572,1.0,12/24,19.69%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.32453428155489433,-1.3074554750751806,0.045889101338432124,0.4407789177761116,1.0,48/136,25.24%,TCF7L2;PKD1;BMP7;PTGIS;HDAC4;TAX1BP1;BTRC;WWP2;NUPR1;FLNA;IRAK3;TAF3;ANXA4;USP7;UFL1;IRAK2;PARP10;CEBPG;SP100;CYP1B1;PRMT2;GLIS2;ID2;HES1;PKD2;SUFU;SIK1;RB1;EIF2AK4;PTCH1;CMKLR1;ARRB1;DAP;TRAF3;HEYL;LRRC14;SFRP4;MDFI;IRAK1;CDK5RAP3;WFS1;CHP1;COMMD7;HDAC2;NLRC3;PAXIP1;KDM1A;PHB2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5590302873277626,-1.307451915773433,0.1579925650557621,0.44007715856362983,1.0,6/11,16.81%,KHDRBS1;DHX9;AKAP8L;SETD2;TPR;NSUN2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.47259178622598963,-1.3061984365817385,0.13909774436090225,0.4424208409703989,1.0,6/20,15.59%,WNT4;EP300;NCOR1;CLK2;SIK1;C1QTNF3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4086107174969691,-1.3053803594135946,0.10276679841897234,0.4437748234880861,1.0,20/38,32.51%,PRKN;LRRK2;SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;ATP5IF1;UBE2D3;TOMM7;ARIH2;PARL;LMAN1;HTRA2;USP36;UBE2L3;RNF31;SREBF1
prerank,mammary gland epithelium development (GO:0061180),0.5187047700151908,1.3051560504595767,0.14414414414414414,0.5049444916776457,1.0,5/14,7.97%,ERBB4;CSF1R;IRF6;WNT7B;AKT1
prerank,primary alcohol metabolic process (GO:0034308),-0.4435665345194606,-1.304491993863231,0.11842105263157894,0.4452332272111475,1.0,5/25,11.18%,IGF1;RBP4;DHRS3;CYP1B1;NAPEPLD
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.49160784067126617,-1.3043334088251233,0.1618181818181818,0.4449040863277673,1.0,7/16,16.97%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5040031835218607,-1.3034483424477583,0.15591397849462366,0.44637316316374925,1.0,5/16,19.76%,NFAT5;ST3GAL4;RHOA;TRAF6;IRAK1
prerank,regulation of cytokinesis (GO:0032465),-0.3492044930829177,-1.3032046409566542,0.06299212598425197,0.446255915771752,1.0,19/78,15.50%,SVIL;KIF13A;BIRC6;CDC14A;KLHL13;UVRAG;CSPP1;CDC42;SETD2;RHOA;GIPC1;RAB11A;CUL3;BECN1;PIK3C3;CDC14B;MAP9;CDC25B;PIK3R4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.45914755646651273,1.3028139310966533,0.1364562118126273,0.5095476265349532,1.0,3/23,3.78%,CD33;GIT1;GAS6
prerank,regulation of muscle cell differentiation (GO:0051147),-0.41444884565363954,-1.3027449156235251,0.10039370078740158,0.4467229252218421,1.0,11/31,12.57%,BOC;CDON;CTNNA1;ABL1;MEF2A;FGFR2;CDC42;IGF2;ID2;MEF2C;TCF3
prerank,transcription by RNA polymerase I (GO:0006360),-0.42340850706806743,-1.3026171741751507,0.1206896551724138,0.446325371857833,1.0,19/34,29.72%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,regulation of mast cell degranulation (GO:0043304),-0.5242689446618398,-1.3021525908985239,0.14981949458483754,0.4468248086740838,1.0,11/14,42.26%,GAB2;LYN;FER;CD84;CD300A;SYK;SPHK2;FES;FGR;STXBP2;UNC13D
prerank,platelet degranulation (GO:0002576),-0.33063769006148414,-1.3018372789393984,0.04285714285714286,0.4469377715490536,1.0,36/118,19.35%,IGF1;TIMP3;VCL;PHACTR2;SERPING1;SPARC;PROS1;TLN1;FLNA;NHLRC2;CLEC3B;ANXA5;THBS1;CD9;VTI1B;STXBP1;LYN;ISLR;BRPF3;LAMP2;IGF2;ACTN2;TEX264;GTPBP2;CD109;FN1;VEGFA;VEGFD;TGFB3;ECM1;SERPINE1;SYTL4;TMX3;CHID1;LGALS3BP;ITGB3
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.48536041530237406,-1.3017846349671867,0.14492753623188406,0.4463628024349374,1.0,7/18,24.97%,PTN;CAMK1D;LYN;IL6R;SLC8B1;EDN3;SLIT2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5680226993804698,-1.301710677766744,0.138671875,0.4458385451072172,1.0,3/10,13.01%,GLI3;BMP4;IRF1
prerank,response to interleukin-6 (GO:0070741),-0.5750515475178667,-1.3016940931936452,0.14444444444444443,0.4451638309365034,1.0,4/10,5.53%,PID1;NFKB1;PTGIS;SBNO2
prerank,fatty acid elongation (GO:0030497),0.5214196667429991,1.3014603606734458,0.15086206896551724,0.5117210298501521,1.0,5/13,13.74%,ELOVL7;ELOVL4;TECR;HACD3;HACD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4163958467108577,1.301428168431328,0.10995850622406639,0.5102979347912484,1.0,8/34,9.89%,FLT1;SEMA6A;RAMP2;KDR;MT1G;NOTCH1;HSPB1;DAB2IP
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.42712499778373125,-1.3010543582096878,0.10058027079303675,0.4460267759204757,1.0,11/31,17.29%,RANBP3L;CRIM1;SMAD6;TMEM64;SKI;NBR1;LIMD1;SUFU;TRPM4;PTCH1;TWIST2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3459119026230115,-1.3006761301265777,0.06358381502890173,0.4462580377214302,1.0,28/88,16.30%,MYO1B;VPS13A;DNAJC6;GBF1;CCDC93;ARL3;GOLGB1;RAB10;OSBPL5;DTNBP1;VAMP7;CORO7;AP4E1;PUM1;MON2;VAMP2;ACBD3;KIF16B;RP2;EXOC2;STX4;SCAMP2;ARF1;AP4S1;VPS13C;DOP1B;TXNDC5;ARRB1
prerank,generation of neurons (GO:0048699),0.311066269247375,1.3006560550296522,0.030360531309297913,0.5107534038248399,1.0,43/190,16.99%,ADGRL3;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;GPM6A;HEY1;DNER;MAP1B;FGF13;NTRK2;ASTN1;NEUROD6;FUT9;TGFB2;TAFA1;SNPH;NRCAM;LHX1;WNT7B;ITM2C;NDNF;CDKL5;RELN;RNF112;ASTN2;BRSK2;FZD4;PER2;HES6;BHLHE40;POMGNT2;CIT;DLL1;ATP2B2;DCX;ELP3;ACSL3;LMX1B;DDIT4;HES5;CTNNB1
prerank,DNA methylation or demethylation (GO:0044728),-0.4789900819315601,-1.3003340423535157,0.13909774436090225,0.4457144268485451,1.0,5/19,12.82%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,DNA alkylation (GO:0006305),-0.4789900819315601,-1.3003340423535157,0.13909774436090225,0.4457144268485451,1.0,5/19,12.82%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29227022194792235,-1.3000584381365887,0.012072434607645875,0.44567120358252654,1.0,131/314,30.19%,FBXL7;FBXL17;SMURF2;UBR2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;ECPAS;KLHL15;UBXN2B;HUWE1;DNAJB14;UBQLN1;OS9;UBE4B;WWP1;ZSWIM8;FBXL4;ANAPC5;FBXL12;ANAPC7;PCBP2;UBE2K;JKAMP;EDEM1;MAEA;ANAPC4;ANAPC16;TNFAIP1;RNF216;FAM8A1;SELENOS;RNF103-CHMP3;UBR1;SPOPL;MAN1B1;GID4;RHBDD2;KCTD5;ERLIN1;PSMF1;FBXL19;UBR3;FBXL18;AMN1;CUL3;RB1;FBXW7;TRIM25;KLHL22;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;FBXO45;CUL2;TOPORS;ERCC8;FAF2;CDC27;UBE2E1;ARRB1;FEM1A;AUP1;BFAR;DERL1;UBE2S;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;CDK2;COP1;PML;ANAPC11;CUL1;PSMC1;UBXN4;APPBP2;SHARPIN;KCTD17;GID8;ECRG4;FBXW4;DCAF12;WFS1;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;DNAJC18;CDC16;FBXL14;FBXO4;ANAPC1;PCNP;TMUB2;SPSB2;PSME1;SEL1L;PSMD13;FZR1;USP19;CDC34;DERL2;PSMB10;PSMA5;SPSB3;FBXL3;PSMB9;LTN1;KBTBD7;RBX1;NFE2L2;FBXL8;UBA52;ZFAND2B
prerank,arachidonic acid secretion (GO:0050482),-0.5669207749800514,-1.2992759817320325,0.18029739776951673,0.4461981030280842,1.0,3/10,15.54%,ANXA1;PNPLA8;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5669207749800514,-1.2992759817320325,0.18029739776951673,0.4461981030280842,1.0,3/10,15.54%,ANXA1;PNPLA8;BDKRB2
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.4032110346391601,-1.29902859358677,0.0872093023255814,0.4460857129039167,1.0,6/39,7.79%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT
prerank,actin filament depolymerization (GO:0030042),-0.5481423439995334,-1.2989710057454704,0.15576923076923077,0.445536683626442,1.0,3/11,3.91%,MICAL3;GSN;MICAL2
prerank,bile acid and bile salt transport (GO:0015721),0.44102368297558964,1.2983382782334985,0.12903225806451613,0.5156211709506184,1.0,4/24,10.49%,SLCO1C1;NCOA2;SLCO2B1;ABCC4
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.38191510777804655,-1.298230430673088,0.10845588235294118,0.4467068672794333,1.0,24/52,34.77%,ME2;MTHFR;MTHFD2L;ADHFE1;D2HGDH;ME1;MDH1;DLST;ALDH1L1;ALDH18A1;SDHA;NIT2;ASS1;ACOT8;DGLUCY;ME3;GCLC;GOT1;SLC25A32;MDH2;IDH2;SLC19A1;GOT2;SDHAF3
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.49428786950811704,-1.2979619744736828,0.1444866920152091,0.4466366680731241,1.0,4/17,2.69%,ROCK2;VCL;PPP1R12A;ROCK1
prerank,phospholipid translocation (GO:0045332),0.4354961740942575,1.2977391631610211,0.11422413793103449,0.5156657319621962,1.0,10/28,11.50%,TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;ATP11C;ATP8A2;ABCB4;P2RX7
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4705756529812341,-1.2975794278039352,0.14201183431952663,0.44695925947609105,1.0,14/20,42.17%,MBTPS2;APOE;MBTPS1;EPHX2;LPCAT3;ARV1;ACADVL;NR1H4;SREBF1;RAN;ACADL;FMO5;LDLRAP1;KPNB1
prerank,regulation of dendritic spine development (GO:0060998),0.47390197243607607,1.2972422721237706,0.1440677966101695,0.5154014556405188,1.0,6/19,13.71%,NLGN1;SHANK3;KIF1A;GRIN3A;PPFIA2;PSEN1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5808647161453941,-1.2972100682121095,0.14340344168260039,0.44716492225162274,1.0,9/10,39.66%,MLLT3;UFL1;HOXB4;LMBR1L;BATF;SP7;TP53;SFRP1;ACE
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.2948911153305362,-1.2969333544224035,0.023206751054852322,0.447178862703949,1.0,102/264,28.04%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;DDX17;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;CDK13;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;SF3A3;TGS1;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;STRAP;DDX23;YBX1;CWC22;COIL;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;PRMT5;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,osteoclast differentiation (GO:0030316),-0.45276798894276826,-1.2967099399441193,0.11673151750972763,0.4469872877320504,1.0,7/22,15.22%,FOXP1;GAB2;SBNO2;ANXA2;SNX10;GLO1;FARP2
prerank,regulation of cellular metabolic process (GO:0031323),-0.3901646127411684,-1.2964274288229645,0.09917355371900827,0.44699046728992103,1.0,10/45,12.81%,PID1;PRKN;TBC1D16;MKLN1;CYP1B1;PANK2;KIF16B;NPC2;ARF1;MBOAT7
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5506348166956889,-1.2963119014703806,0.14933837429111532,0.4466022401326605,1.0,6/12,21.89%,LRP6;CYP26B1;SKI;PTCH1;MEGF8;FBXW4
prerank,regulation of spindle assembly (GO:0090169),-0.4318628309416012,-1.2961267410390687,0.11428571428571428,0.44640694714713325,1.0,10/25,20.14%,NUMA1;VPS4B;CHMP4B;SENP6;CHMP5;CHMP3;TPR;DYNC1H1;HNRNPU;EML3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.4411353769196797,-1.295891525679161,0.12199630314232902,0.4462870087785589,1.0,11/29,17.08%,KANK2;YAP1;KMT2D;STRN3;AXIN1;UFL1;RUNX1;UBA5;CNOT2;LATS1;CNOT1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3717542220332724,1.2954813447769673,0.08924949290060852,0.5185874591472077,1.0,15/57,16.22%,RGS1;ADCY8;ADCY3;GRM7;CHRM3;GRM8;PDE2A;MTNR1A;GNAL;OPRM1;ADCY4;OPRK1;CHRM2;OPRL1;GNAI1
prerank,pyroptosis (GO:0070269),-0.49208774613960826,-1.2954168386942053,0.16634799235181644,0.4467336407161858,1.0,9/15,41.55%,GSDME;DHX9;GSDMD;APIP;ZBP1;CASP1;CASP4;TREM2;NLRC4
prerank,protein localization to organelle (GO:0033365),-0.3215075471583647,-1.2951783385111322,0.04061895551257253,0.4466299306099677,1.0,38/133,19.20%,ANK2;COL1A1;ZNF423;TRAM2;BMP7;BMP4;GBF1;BBS9;LRRK2;LMNA;PACSIN2;CNTLN;ARL3;DHX9;OBSL1;DCP1A;LAMP2;VAMP2;TULP3;RPL11;COG3;COG7;RAB11A;STX5;SNX10;YBX1;UBAC2;DDX3X;YWHAE;EMD;TOPORS;SIX1;AUP1;LAMP1;GBP2;GET4;CSNK1D;ABCA7
prerank,ERAD pathway (GO:0036503),-0.35003602745946444,-1.2951315584130998,0.07630522088353414,0.4460455448374089,1.0,36/83,29.09%,PRKN;UGGT2;ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;ERLEC1;RNF103-CHMP3;MAN1B1;RCN3;RHBDD2;ERLIN1;POMT2;TRIM25;USP13;FAF2;AUP1;DERL1;SYVN1;GET4;VCP;UBXN4;TOR1A;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2;CCDC47
prerank,protein sumoylation (GO:0016925),-0.3900356191210529,-1.294838780456685,0.10303030303030303,0.44607730425565795,1.0,13/49,15.41%,EYA1;PIAS1;SAE1;RANBP2;NSMCE2;NUP42;PIAS3;UBE2I;NUP214;TPR;PIAS4;TRPM4;TOPORS
prerank,heart contraction (GO:0060047),0.3985176943475084,1.2947819265535505,0.11,0.5189000288062816,1.0,9/41,10.09%,SGCZ;RYR2;GPX1;MYH6;GRK2;SLC8A1;SCN4B;TCAP;SGCG
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3776582382252017,1.2946885119534393,0.10144927536231885,0.5176744707735296,1.0,12/53,20.07%,MTNR1B;CHRM3;HTR2C;MTNR1A;CCL2;OPRM1;CNR1;CHRM2;CALCRL;HTR1B;HTR4;AGT
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.43657990421676374,-1.2946475060484866,0.137524557956778,0.44581762830577304,1.0,8/27,18.14%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;KAT8;TAF6L;MSL3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4271175672566048,1.2945428576343458,0.1284796573875803,0.5165720825513255,1.0,5/29,10.48%,CXCL12;GAS6;JAM2;IL12A;AIF1
prerank,histone H3-K4 methylation (GO:0051568),-0.4377756251077848,-1.2943735320818857,0.12144212523719165,0.4457990454133243,1.0,14/26,33.02%,KMT2C;KMT2D;CTR9;KDM6A;OGT;KMT2A;PRDM9;PAXIP1;CXXC1;TET2;TET3;WDR5;WDR5B;DPY30
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.48230877671605243,-1.2942347944380639,0.17115384615384616,0.44549005971370464,1.0,6/18,12.21%,DCN;MCU;PRKN;DNM1L;DDHD1;RALA
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5424560327244515,-1.294217431052073,0.1621129326047359,0.4448703687858304,1.0,3/12,11.50%,FOXP1;LYN;FNIP1
prerank,visual system development (GO:0150063),-0.4046360250069455,-1.2940101570149842,0.10748560460652591,0.44468781983504535,1.0,6/37,5.76%,PBX1;SMOC1;FOXC1;SH3PXD2B;RBP4;PBX3
prerank,sulfur compound biosynthetic process (GO:0044272),-0.3348623291377879,-1.2937857874023075,0.086,0.4445902297456656,1.0,29/104,19.05%,UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;BGN;FMOD;SLC35B3;OGN;GLCE;SLC26A2;SLC10A7;PRELP;CHST15;ST3GAL3;TPK1;AKR1A1;LUM;GGTA1;CHST11;CHPF2;CHSY1;CHAC2;B4GALT5;GSTT1;MGST1;OMD;CHST12
prerank,potassium ion import across plasma membrane (GO:1990573),0.39895107420147985,1.2936713598991183,0.12446351931330472,0.5174392779196082,1.0,13/41,13.24%,KCNJ3;KCNJ6;SLC12A6;KCNJ11;HCN2;KCNJ10;ATP1A3;KCNK9;SLC12A3;ATP1A4;ATP1A1;KCNJ8;ATP1B1
prerank,mesenchymal to epithelial transition (GO:0060231),0.5577303604992466,1.2935663017845604,0.17802197802197803,0.5162035884158177,1.0,3/10,8.33%,PAX8;PAX2;BASP1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.48133033084486976,-1.2933745678583854,0.1580952380952381,0.4449251077668618,1.0,11/17,30.46%,PID1;HDAC4;NCOR1;NUPR1;PARP1;CBFA2T3;FIS1;PPARA;PDE12;MLXIPL;PPIF
prerank,stem cell development (GO:0048864),0.49547417680862493,1.2921348091284712,0.15274949083503056,0.5186036305177859,1.0,3/16,6.01%,NRG1;CDH2;CYP26C1
prerank,ovarian follicle development (GO:0001541),-0.5258288559439583,-1.2916416062572604,0.1586998087954111,0.44839605839606983,1.0,10/13,38.27%,KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;LHCGR
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47564250137917036,1.2916046429102284,0.14437367303609341,0.5185125145158206,1.0,5/19,9.08%,LRP8;PTPRD;IL1RAPL1;CDKL5;RELN
prerank,positive regulation of interleukin-4 production (GO:0032753),0.49389061601841844,1.2915284132110474,0.1479028697571744,0.5172259909150349,1.0,2/17,6.51%,SLC7A5;PRKCQ
prerank,regulation of translation (GO:0006417),-0.31183553278141735,-1.2912417719315812,0.037698412698412696,0.44871887277491157,1.0,46/173,20.54%,SAMD4A;PLD1;IGFBP5;EIF4G3;VIM;FOXO3;ZCCHC4;YTHDF3;SYNCRIP;EIF4A2;DDX6;EIF4ENIF1;THBS1;EIF2AK3;DHX9;MTOR;LARP1;HNRNPD;DHX36;IMPACT;GEMIN5;PLXNB2;EIF4E;UPF1;CSDE1;LSM14A;NSUN3;CNOT8;ALKBH1;EIF2AK4;YBX1;EIF2AK2;PRKDC;DDX3X;DAPK1;CNOT1;UPF3A;SHFL;PAIP1;MIF4GD;EIF4G1;CNOT10;MTG2;RBM4;EIF2B4;UPF3B
prerank,midbody abscission (GO:0061952),-0.48115294280222987,-1.290818303743732,0.1569767441860465,0.44899966212162934,1.0,5/17,10.04%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5463065553325156,1.2906308792001442,0.1828193832599119,0.5181349452413244,1.0,3/11,10.77%,AKAP6;LRRC55;RNF207
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.44402183650625243,-1.2905944349075353,0.14285714285714285,0.4488571485992553,1.0,6/22,13.52%,CCNT2;CCNT1;SCAF8;CDK13;CCNK;TCERG1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3164602033372069,-1.2903329821939835,0.04627766599597585,0.4488058344954272,1.0,45/158,22.68%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;TRIM8;TRAF3IP2;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;LGALS1;TRIM5;TRIM25;PPM1A;LTBR;MAP3K14;TNIP2;ECM1;IKBKE;PRKD1;CC2D1A;TRAF6;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;TICAM1;VAPA
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.28896253617593637,-1.2903039833118257,0.011061946902654867,0.44820905851949117,1.0,154/336,33.65%,FOXP1;INO80;SETD7;RNF169;UBE2E2;ABL1;KMT5B;RBBP8;UVRAG;TRIP12;YAP1;SPIDR;CEP63;SMC6;CBX1;UBR5;CBX5;RBBP6;NBN;STXBP4;WDR48;RAD51B;UFL1;TAOK3;TRRAP;BCL2;LYN;RNF8;PDS5A;WRN;NCOA6;XIAP;DDB2;VCPIP1;ZBTB1;ATF2;CCNK;CSNK1E;SMC5;BRSK1;HERC2;UPF1;MNAT1;SUSD6;MCM9;NIPBL;USP47;RFWD3;PARP1;RAD51D;PDS5B;ERCC3;PAXX;ALKBH1;WDR76;NABP2;CASP2;KMT5C;APTX;SLF1;STK33;DTX3L;PARP4;MMS19;PHF1;PRKDC;HINFP;UBE2B;MSH3;FBXO45;TOPORS;ERCC8;MTREX;BOD1L1;NOP53;MRE11;SPRTN;HELB;ZRANB3;IKBKE;UBA7;BAZ1B;VCP;NEK4;TANK;ZDHHC16;PARK7;MSH6;TAOK1;MAP2K6;PML;SMC1A;FANCC;RPAIN;ATR;SIRT4;WAC;MACROD1;PLK5;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;AATF;BRAT1;USP28;MASTL;POLE2;UBQLN4;RECQL5;BCL2L2;KIN;MAPK14;OGG1;HTRA2;ENDOV;RAD54L;GTF2H4;SHPRH;POLH;TIMELESS;CGAS;ZBTB4;DCUN1D5;IGHMBP2;E2F1;NUDT1;PARP3;BAK1;MGMT;SAMHD1;HIC1;ZBTB38;GNL1;BATF;UBA1;FANCG;BCL2L11;PARP2;FAAP20;TNFRSF1B;BCL6;RAD9A;PNKP;RMI2;RAD51;PSME4;POLA1;ALKBH8;DDB1;TIGAR;BRCA1;PCLAF
prerank,regulation of exocytosis (GO:0017157),0.3844930846340359,1.2900393675004196,0.10460251046025104,0.5183493544583576,1.0,11/46,10.81%,SYT1;IL1RAPL1;CADPS;RIMS2;RAB3C;LGI3;SNCA;STXBP5L;CPLX1;ATP6AP1;HAP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.40590954211698116,-1.289994610880098,0.11089108910891089,0.4482759838556139,1.0,16/37,27.85%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K;PARD3;INPP5K;EIF4G1;SPRED2;CAB39;SPHK1;IRGM;EGF;TNKS1BP1;APP
prerank,regulation of lamellipodium organization (GO:1902743),-0.5240233102763042,-1.2894640203495793,0.15428571428571428,0.44886189854345593,1.0,7/14,26.24%,PDPN;CDC42;FER;CAPZB;CARMIL1;TWF1;TWF2
prerank,regulation of protein localization to membrane (GO:1905475),-0.4276887727940253,-1.289044783172615,0.1266294227188082,0.44915236552634835,1.0,10/28,12.96%,GPC6;GSN;SLC5A3;PRKN;GPC4;GPC3;VTI1B;AR;MMP14;APPL1
prerank,regulation of lipid metabolic process (GO:0019216),-0.3418065311255849,-1.2884820493185427,0.08183632734530938,0.44995432483374553,1.0,37/88,26.85%,PRKAG2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;PANK2;ID2;NPC2;RORA;TGS1;MBOAT7;LACTB;C1QTNF2;CCDC3;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;SC5D;FDFT1;SMARCD3;MVK;PPARA;EDF1;ZFP69;BBS4;HDAC3
prerank,cellular response to nitrogen compound (GO:1901699),-0.47020525097298105,-1.2883630118406388,0.15168539325842698,0.4495507849168058,1.0,9/20,29.40%,ROCK2;SPIDR;DDI2;RIOK3;HSF1;PDE12;ATRX;TIMELESS;NR1H4
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.503718074490912,-1.288208106569789,0.15922330097087378,0.4492594110415081,1.0,4/14,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4865419856676714,-1.2881717007244455,0.17115384615384616,0.44866636046442143,1.0,8/17,14.79%,FCHSD2;WASF2;BRK1;NCKAP1;ARFIP2;ARF1;GMFB;WASF1
prerank,negative regulation of blood coagulation (GO:0030195),-0.39968249312320153,-1.2871560104335853,0.14124293785310735,0.4505005561735262,1.0,6/38,7.35%,PDGFRA;SERPING1;VTN;PLAT;TFPI;F3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5330282279649028,-1.287116125974391,0.1656441717791411,0.4499389924193793,1.0,7/12,28.24%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.485942080514303,-1.2865899696039573,0.1537037037037037,0.45046130898473913,1.0,6/17,7.78%,NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42
prerank,regulation of fat cell differentiation (GO:0045598),-0.3540676828296509,-1.2864784649433114,0.08943089430894309,0.45007281214483774,1.0,21/74,18.76%,SMAD3;MEDAG;FTO;TMEM64;ENPP1;YAP1;CREBL2;ZBTB16;RUNX1T1;ID2;RORA;TRPM4;TRIB2;WDFY2;ANKRD26;TAF8;CMKLR1;TRIO;WNT5A;SYAP1;BMP2
prerank,regulation of cell motility (GO:2000145),0.32554695292777025,1.2856720025397756,0.06570841889117043,0.5288809433078802,1.0,23/121,9.96%,SPOCK2;SPOCK3;FRMD5;ERBB4;CSF1R;PLXNB3;TMSB4X;NRG2;NRG1;TMSB10;ROBO4;FGF10;ENPP2;MEAK7;PKN1;FGF5;AKT1;PLXNA4;SGK3;SST;SPATA13;CYRIB;NTN1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3514687870893879,-1.2852742439720548,0.07331975560081466,0.45225566110698556,1.0,13/79,6.97%,SULF1;CRIM1;BMPR1A;ADAMTS12;SMAD6;SMURF2;NBL1;HTRA3;NIBAN2;SULF2;THBS1;SKI;SKIL
prerank,regulation of exosomal secretion (GO:1903541),-0.4729344250299137,-1.2852102944021566,0.16283524904214558,0.4517453763668771,1.0,8/19,25.10%,PRKN;VPS4B;CHMP3;SDC4;SNF8;RAB7A;SDC1;ATP9A
prerank,mitotic recombination (GO:0006312),-0.4899709809098262,-1.284954516697453,0.16824196597353497,0.45171360673368516,1.0,6/15,15.91%,SMC6;NSMCE2;SMC5;RAD51D;MSH3;DMC1
prerank,regulation of cell communication (GO:0010646),-0.410876131396661,-1.2847563664500903,0.11798839458413926,0.45153416204168734,1.0,16/35,19.18%,GRK5;ANK2;CXADR;CAMK2D;ANXA1;GRK4;GRK3;TBX18;UGCG;CDC42SE2;SRI;IGFBP7;GRK6;GLRX2;PTPN1;MGLL
prerank,sprouting angiogenesis (GO:0002040),-0.3732046759512818,-1.2843071059475712,0.08955223880597014,0.4518899007873566,1.0,18/51,17.46%,PARVA;ANGPT1;EFNB2;CCBE1;BMP4;ROBO1;THBS1;RSPO3;RNF213;ADGRA2;NRP1;RECK;SEMA3E;BMPER;VEGFA;VEGFD;NR4A1;MIA3
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4001876731168835,-1.2842759962207042,0.130859375,0.45131030676086253,1.0,5/37,3.78%,NFKB1;ITGAV;NCOR1;PRKN;DLG4
prerank,negative regulation of RNA splicing (GO:0033119),-0.4702321870010247,-1.283798326761685,0.14147286821705427,0.4519128551174328,1.0,5/19,7.39%,SFSWAP;SRSF10;U2AF2;PTBP3;SRSF6
prerank,Golgi ribbon formation (GO:0090161),-0.51000898711057,-1.2833388932083172,0.16792452830188678,0.45233390813211355,1.0,6/13,19.82%,VTI1A;STX16;PRMT5;VAMP4;TMED5;TRIP11
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5161044578162852,-1.2828886532636186,0.15819209039548024,0.4527951653681388,1.0,11/14,35.27%,SEC24D;SEC23A;SEC31A;TBC1D20;SEC23B;MIA3;SCAP;SEC24A;SEC24C;SEC13;SEC31B
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3149975294764009,-1.2825945593159318,0.05295315682281059,0.45283803096577524,1.0,36/150,15.39%,PTPN13;PRKAG2;PID1;ERRFI1;LDLRAD4;LRP6;NTRK3;SMAD6;FBLN1;PLPP3;PRKN;ENPP1;LRRK2;PPM1E;IBTK;DEPTOR;IGFBP3;PAK2;DTNBP1;LYN;PDPK1;IMPACT;PMEPA1;PRKCD;DNAJC3;RB1;RASSF2;FKBP8;TRIB2;PARD3;PRKDC;EMILIN1;ZBED3;NCK1;PRKCZ;NCK2
prerank,sulfation (GO:0051923),-0.5434603181705697,-1.2824494388496106,0.15839694656488548,0.45250389439569755,1.0,2/11,10.51%,UST;SULT1A1
prerank,regulation of cilium assembly (GO:1902017),-0.3590682113593257,-1.2821007694887172,0.11045364891518737,0.45266734589613017,1.0,30/62,28.23%,TBC1D16;YAP1;DCDC2;TBC1D19;TBC1D24;MARK4;USP6NL;TBC1D2B;TBC1D20;IFT88;ODF2L;TBC1D22B;DYNC2LI1;ATG5;TBC1D17;CDK10;RABGAP1;TBC1D7;TBC1D10A;KCTD17;TAPT1;TCHP;ARHGAP35;IFT140;TBC1D10B;BBS4;ATG3;TESK1;TBC1D9B;RABEP2
prerank,activation of protein kinase B activity (GO:0032148),-0.4312871179247832,-1.2811008348617092,0.13799621928166353,0.45440558071178094,1.0,13/29,18.92%,IGF1;NTRK3;FGF1;OSBPL8;MAPKAP1;MTOR;PDPK1;RICTOR;TXN;ADRA2A;IL18;WNT5A;PARK7
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.4808023090347319,-1.2806472052007245,0.15487571701720843,0.45479201680372283,1.0,8/18,31.89%,KAT2B;NCOR1;PTBP3;TERT;TMBIM6;ESR1;ZC3H10;NUDT16
prerank,regulation of MAPK cascade (GO:0043408),-0.3136995738582276,-1.280306382543507,0.03319502074688797,0.45501308530113305,1.0,30/157,8.85%,ROCK2;TGFBR3;IGF1;ROR1;EGFR;LPAR1;DAG1;EPHA7;NTRK3;PELI2;KSR1;STK3;ROCK1;ADRA1B;GSDME;KIT;STYX;RYK;NRK;HMGB1;LBH;PAK2;MAP4K4;TAOK3;FGFR2;SHC1;LYN;NBR1;IGF2;MAP2K1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4626134261888554,-1.2802972502539036,0.15867158671586715,0.4543843484452896,1.0,8/20,18.76%,WNT4;BMP5;WDTC1;ERLIN1;SIK1;FBXW7;SLC27A1;BMP2
prerank,digestive tract morphogenesis (GO:0048546),-0.5044954721580386,-1.280205051169108,0.16729323308270677,0.4539928575610327,1.0,8/14,25.76%,PDGFRA;FGFR2;ID2;NIPBL;GLI1;RBPMS2;SOX11;EPHB3
prerank,protein phosphorylation (GO:0006468),-0.27893107773049286,-1.280099150583574,0.012269938650306749,0.4535888538465837,1.0,154/479,22.13%,PRKAG2;ROCK2;TGFBR3;GRK5;EGFR;TGFBR1;EFEMP1;BMPR1A;EPHA3;PDGFRA;CDK8;PKD1;TLK1;PDK1;PDGFRB;STK3;FAM20A;ROCK1;BMP4;SMG1;ERC1;MAP3K3;CAMK1D;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;CCNH;TOP1;GSK3B;KIT;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;SLK;SMAD2;EIF2AK1;PAK2;MAP4K4;TAOK3;EEF2K;FGFR2;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;EPHA4;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;FER;PRKCD;ABL2;DMPK;FAM20C;CLK3;CDK11B;ULK2;ABI1;MKNK2;TEC;SIK1;COPS2;EIF2AK4;RICTOR;MAML1;GMFB;STK33;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;EPHA8;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;DDR1;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;TLR4;PRKACA;PXK;PRKD1;MORC3;BAZ1B;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;BMP2;MUSK;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;MAP2K6;NRBP2;FGFR4;CAB39;BCKDK;PRKAG3;PKDCC;CDK6;MAST2;PPP4R1;AKT2;PRKAB1;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,regulation of embryonic development (GO:0045995),-0.41137445162836056,-1.2800331948686328,0.13680154142581888,0.45313666356930804,1.0,9/34,14.73%,PHLDB2;DAG1;TRIP12;WDPCP;NIBAN2;DHX36;NIPBL;EHMT1;ZBED3
prerank,cellular iron ion homeostasis (GO:0006879),0.37649061096544684,1.279880302912977,0.098,0.54363043487719,1.0,12/55,10.62%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,lamellipodium assembly (GO:0030032),-0.43622175368948235,-1.2791428152267452,0.133086876155268,0.45465645531461973,1.0,9/26,16.69%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;WHAMM;CARMIL1;ARHGEF6
prerank,protein kinase B signaling (GO:0043491),0.44288509741921117,1.2790096110816218,0.13785557986870897,0.5445036759802924,1.0,6/23,11.13%,PAX2;GAS6;KDR;AKT1;CCL2;PIK3R3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.3285075366807361,-1.2779728333162814,0.05788423153692615,0.4568640860924685,1.0,19/113,7.39%,BMP6;NOTCH2;IGF1;EGFR;TCF7L2;TGFBR1;PTN;BMP5;FGF1;BMP4;ARNT;OSR1;RREB1;YAP1;STXBP4;NRP1;FGFR2;F3;SRSF6
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.48015253801505375,-1.2774396529520844,0.16252390057361377,0.4574848998576245,1.0,5/16,9.94%,CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT
prerank,response to estradiol (GO:0032355),-0.4103149475073019,-1.2772779969372692,0.14457831325301204,0.4572006103894575,1.0,5/31,7.02%,EGFR;LCOR;STRN3;STAT3;ANXA1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4324412838635482,-1.2770580476788462,0.14473684210526316,0.45712321531148653,1.0,4/26,4.33%,IGF1;FHL2;GSK3B;SLC9A1
prerank,negative regulation of viral transcription (GO:0032897),0.5242229736728252,1.2762860514048888,0.16772823779193205,0.5504084479142957,1.0,4/13,10.91%,TRIM13;TRIM62;IFITM3;MID2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.32565528986355624,-1.2760500104212966,0.08498023715415019,0.4589454632414448,1.0,33/108,20.58%,PHLDB2;ROCK2;LRP1;RHOQ;EPHA3;DIAPH1;PDGFRB;ROCK1;ABL1;PRKAA2;GSK3B;RND3;PAK2;MTOR;CLIC4;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;PLXNB1;SORBS3;ARHGAP18;FAM107A;PRKAA1;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2;SPEF1
prerank,ion transport (GO:0006811),0.3279638434187348,1.2755289258860323,0.07203389830508475,0.5509564922972745,1.0,20/111,10.90%,SLC24A4;SLC24A2;GRIN1;SLC4A1;GABRB1;GLRA1;KCNN2;AQP11;SLC17A6;SLC1A1;SLC8A1;SLC12A6;SLC15A3;KCNN1;SLC1A2;KCNN3;SLC12A3;SLC36A1;VDAC2;ATP1A4
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4895797269786475,-1.2748857988552247,0.1555977229601518,0.46121401644813736,1.0,10/16,22.68%,ANK2;GBF1;LRRK2;BCAP29;UBAC2;MIA3;SEC16B;SEC16A;TAPT1;VAPA
prerank,cellular response to heat (GO:0034605),-0.4004607843707384,-1.2748548459287181,0.13133208255159476,0.46065188979436006,1.0,16/35,27.97%,FGF1;THBS1;DHX36;SLU7;BAG3;TPR;YWHAE;PRKACA;ANO1;VCP;HSBP1;ZFAND1;HSF1;HTRA2;TCIM;POLR2D
prerank,DNA recombination (GO:0006310),-0.3964968657868434,-1.274683958113284,0.12475633528265107,0.46038362263496563,1.0,23/37,39.78%,HMGB1;RAD51B;WRN;RAD21;RAD51D;MSH3;DMC1;MRE11;RPAIN;RAD51C;ERCC1;RECQL5;RAD54L;IGHMBP2;SUPV3L1;HDAC10;RAD51;LIG4;GEN1;MSH2;RAD52;XRCC3;EXO1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.3061374334985533,-1.2745787954134236,0.040160642570281124,0.4599735299554207,1.0,39/170,15.48%,ROCK2;PRDM6;IGF1;FOXP1;PRDM5;ZNF462;TRIM44;AFF3;TFEB;TBC1D16;AFF1;CDH1;ZUP1;MKLN1;REST;HNRNPD;FUBP1;PCBP2;KDM6A;LDLR;HNRNPK;KIF16B;HIF1A;AFF4;NFKBIZ;TRIM5;TRIM11;ARF1;YBX3;ADNP2;CGGBP1;MTMR3;YBX1;ATRAID;APOE;HINFP;PRDM2;TRIM39;RASA1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3839425397213079,-1.2743118409550203,0.13793103448275862,0.4600252258995646,1.0,8/43,10.02%,EGFR;ERRFI1;CBLB;RNF115;SNX6;PTPN3;CDC42;PTPN2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3438337052083929,-1.2740424401160804,0.08979591836734693,0.45999648732509807,1.0,15/85,7.81%,EYA1;ROR1;PIEZO2;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,regulation of mitochondrial fission (GO:0090140),-0.4468818171200022,-1.2738764041218422,0.14807302231237324,0.45974233014804405,1.0,6/24,6.92%,DCN;MCU;PRKN;LRRK2;DNM1L;DDHD1
prerank,microtubule depolymerization (GO:0007019),0.47268059083617897,1.273103760773705,0.16304347826086957,0.556303634495293,1.0,6/17,18.20%,STMN1;STMN4;STMN2;KIF19;STMN3;KIF18A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.36295584280413873,-1.2728198751253426,0.10323886639676114,0.46165398582305345,1.0,23/52,28.14%,SAMD4A;PAN3;DDX6;RC3H1;TUT4;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9;CNOT2;PAN2;CNOT1;CNOT10;EXOSC3;CNOT4;TNKS1BP1;LSM6;PNLDC1;PDE12;DIS3;POLR2D;PARN
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.40036954908855266,-1.272545933964692,0.14119922630560927,0.4616597413407298,1.0,21/37,33.43%,PCM1;IFT43;IFT81;DYNC2I1;IFT88;IFT80;DYNC2LI1;DYNLRB1;DYNC2I2;TRIP11;KIFAP3;IFT27;KIF3A;SSX2IP;IFT140;TTC21B;IFT122;WDR35;DYNC2H1;IFT52;IFT74
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.531477886039599,-1.272358890528902,0.16820702402957485,0.46150745937878496,1.0,4/13,12.19%,LARGE1;OGA;RENBP;MGAT3
prerank,nucleoside catabolic process (GO:0009164),-0.5373940719485187,-1.2712042553639593,0.18584070796460178,0.46369604890842037,1.0,5/11,14.77%,DERA;UPP2;NT5M;UPB1;DPYD
prerank,regulation of fibrinolysis (GO:0051917),-0.5078692128451403,-1.2710454648809117,0.19074074074074074,0.46340368440567486,1.0,4/13,21.28%,THBS1;FAP;SERPINE1;USF1
prerank,positive regulation of protein acetylation (GO:1901985),-0.5201212548470058,-1.2710149306533582,0.1834862385321101,0.46286200506179215,1.0,7/12,19.79%,PRKAA2;RAPGEF3;FAM161A;DDX3X;CEP295;PRKAA1;TAOK1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5285803360262538,-1.2709512388559492,0.181640625,0.46234333040177966,1.0,5/12,16.73%,FOXP1;DAB2;NCOR1;HDAC1;HEYL
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5537784686931825,1.2707549143283285,0.18222222222222223,0.5612491662886557,1.0,4/10,19.94%,ANK3;KCNAB1;KCNRG;SUMO1
prerank,intracellular lipid transport (GO:0032365),-0.4622797505953627,-1.2697902138275956,0.17077798861480076,0.46450544039493546,1.0,9/21,14.22%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;NPC2;ABCD4;PLEKHA8
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3787727766798794,-1.269757796285799,0.12745098039215685,0.46393644063822,1.0,17/44,22.48%,GSN;FCHSD2;BAIAP2L1;SNX9;VASP;CDC42EP5;FER;NCKAP1;CTTN;NCK1;WHAMM;CARMIL1;NCK2;CDC42EP4;LMOD1;BAIAP2;CDC42EP1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5615289834914906,-1.2689146570854801,0.17712177121771217,0.46536556649957905,1.0,3/10,12.94%,HMGB1;ZBTB1;TRPM4
prerank,autophagosome assembly (GO:0000045),-0.3678379356210072,-1.2688086474383635,0.1130952380952381,0.4649811955771262,1.0,24/52,26.43%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;SMURF1;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;STX17;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;MFN2;ATG3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5134410420996575,-1.2685247434801696,0.1762295081967213,0.4650693632499635,1.0,5/13,17.08%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.43646756394274705,-1.2684716702154504,0.13523809523809524,0.46456997718048015,1.0,7/25,13.19%,CCNT2;SETD5;CCNT1;SCAF8;CCNK;WDR43;HTATSF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.34167052768538975,1.2683599459899062,0.08651911468812877,0.5666319821368156,1.0,36/87,21.30%,OMA1;NDUFC1;CHCHD4;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;COA5;DMAC2;FASTKD3;COX16;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;COX17;NDUFAF1;NDUFB9;BCS1L;UQCC3;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;COA3;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;SCO1;NDUFA6;NDUFB7
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4253975348541899,-1.2681597819094046,0.15630885122410546,0.46468959445951424,1.0,14/28,29.52%,PDK1;PRKN;FOXK1;PANK2;RORA;APOE;FOXK2;EPHX2;BCKDK;ARV1;PPARA;ACADVL;NR1H4;PDK3
prerank,positive regulation of cell aging (GO:0090343),0.5334679885124685,1.268150652893391,0.19696969696969696,0.5656562837787339,1.0,3/11,4.97%,SIRT1;HMGA2;YPEL3
prerank,pulmonary valve morphogenesis (GO:0003184),-0.47392219121838275,-1.2680023369320557,0.18164435946462715,0.4644309586955946,1.0,5/17,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,negative regulation of cell population proliferation (GO:0008285),-0.27856585162679975,-1.267988310954889,0.027777777777777776,0.46382829827239025,1.0,102/351,20.86%,TGFBR3;ALDH1A2;ZBTB7C;APPL2;KANK2;SMAD6;IGFBP5;CELF1;COL4A3;FBLN1;BMP5;MDM4;DIS3L2;KAT2B;BMP4;PDPN;PPM1D;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;VGLL4;RBP4;RARG;IGFBP3;TGFB1I1;IGFBP6;OGN;SKI;SPEG;TMEM127;NOX4;LYN;TES;REST;PARP10;WNT9A;P3H3;AR;PTPRK;MAP2K1;CYP1B1;BTG3;MN1;COL18A1;NGF;PTPN2;CCN3;ABI1;ROR2;PDS5B;FAP;HES1;PKD2;APOD;IRF1;ATRAID;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;CD164;RBM5;CBFA2T3;RAPGEF2;EMD;NCK2;MNT;TGFB3;PLXNB1;DUSP10;ADAMTS1;WNT5A;ARID2;MORC3;S100A11;PPP2R5C;SFRP4;SOD2;FGFBP1;IFI35;BMP2;CDK10;INHBA;B4GALT7;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;CDKN1C;NME1;ZBTB49;CDK6
prerank,response to UV (GO:0009411),-0.33282648806901427,-1.2677675433920315,0.08421052631578947,0.46373633439897266,1.0,35/95,24.04%,EGFR;INO80;SCARA3;EP300;GTF2H2;CREBBP;UBE4B;DHX36;WRN;PTPRK;DDB2;ZBTB1;BRSK1;PRKCD;USP47;PARP1;ERCC3;EIF2AK4;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;SDE2;DCUN1D3;MFAP4;MSH6;PCNA;USF1;BMF;ATR;CCAR2;PRIMPOL;USP28
prerank,positive regulation of type I interferon production (GO:0032481),-0.3509825090438896,-1.267766533849517,0.09297912713472485,0.4631036790996562,1.0,34/73,31.03%,NFKB1;EP300;TBK1;CREBBP;DHX9;DHX36;PTPN22;SETD2;MAVS;RIOK3;IRF1;STAT1;PRKDC;DDX3X;MRE11;OAS2;TLR4;POLR2H;PTPN11;IRAK1;XRCC6;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;DHX58;POLR3E;CGAS;POLR1C;TLR3;IFIH1;DHX33
prerank,aortic valve development (GO:0003176),-0.39937727682610924,-1.2673566138709897,0.123046875,0.4634278698051454,1.0,7/34,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,keratan sulfate metabolic process (GO:0042339),-0.418878299522075,-1.2669807571313392,0.14177693761814744,0.46365368370871557,1.0,12/31,18.89%,ST3GAL4;B4GALT1;FMOD;GNS;OGN;PRELP;ST3GAL3;LUM;HEXA;GALNS;B4GALT5;OMD
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4974289453148495,1.2667910894151293,0.16,0.5678687511821109,1.0,4/13,13.00%,TMEM30A;SAR1A;BRSK2;SORL1
prerank,negative regulation of organelle assembly (GO:1902116),-0.4042409405864486,-1.2667231330769049,0.1450381679389313,0.46372797260113574,1.0,13/35,22.36%,KAT2B;LRRK2;NUPR1;YAP1;SEC22B;CHMP4B;CHMP4A;SMAD4;ODF2L;FEZ2;CDK10;TBC1D7;TCHP
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5015403548665461,1.2665044808589716,0.17718940936863545,0.5671070518852684,1.0,3/14,6.83%,TIRAP;HNRNPC;HNRNPA0
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5130262665607803,-1.266354983738315,0.17536534446764093,0.46401110456467415,1.0,7/13,28.24%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,positive regulation of lyase activity (GO:0051349),-0.5050013880734403,-1.2663499778749538,0.18036072144288579,0.4633936913691484,1.0,7/14,22.08%,CACNA1C;STIM1;CACNA1D;PARK7;NOS1;FXN;ORAI1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4541373348649979,-1.2662487660212045,0.14990859232175502,0.4630171342324271,1.0,9/22,12.25%,PDGFRA;NTRK3;PDGFRB;KIT;FGFR2;PDPK1;PLCG1;ABL2;AGTR1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5069129013251736,-1.2662345794246535,0.1864406779661017,0.46242532796832897,1.0,4/14,10.33%,ANKRD17;PUM2;PUM1;DDX60
prerank,response to steroid hormone (GO:0048545),-0.41267036592653905,-1.266220460506281,0.14395393474088292,0.4618399542830813,1.0,8/31,10.23%,ATP1A2;YAP1;NR3C1;THBS1;TFPI;AR;MED1;NR1H3
prerank,respiratory system development (GO:0060541),-0.40946718919317343,-1.2658001076352932,0.13430127041742287,0.46214947615223545,1.0,14/32,21.55%,GLI2;FGF1;BMP4;PDPN;DISP1;RBP4;FGFR2;CHD7;CCDC39;VEGFA;LOXL3;SMCHD1;ZIC3;FGF2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5206012877595159,-1.2655484098709662,0.17723880597014927,0.46211417800846466,1.0,4/13,9.15%,DDO;ASPA;GLUD1;GLUL
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3364717158869527,-1.2649510908703276,0.10141987829614604,0.4628366549514552,1.0,19/86,15.35%,BMP6;IGF1;EGFR;EPHA7;ANGPT1;GHR;ABL1;VTN;PAK2;NRP1;IGF2;PRKCD;TEC;IL6R;VEGFA;ACVR1;PRKCZ;PDCL3;ITGA5
prerank,positive regulation of neuron projection development (GO:0010976),0.33852028209306173,1.2646912225035143,0.09207708779443255,0.5707361361588262,1.0,21/85,9.89%,RIT2;LRP8;LRRC7;PLXNB3;S100A9;ITGA6;MAGI2;TOX;NTRK2;SCARF1;FUT9;ALK;NPTN;PLPPR5;TENM3;NDNF;SCARB2;STMN2;ZDHHC15;RELN;DAB2IP
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.35057280713455236,-1.2645337131677503,0.09343936381709742,0.46316443286999287,1.0,23/66,21.29%,ZIC1;SMAD3;YAP1;FLNA;UBR5;CCT6A;CDH1;EIF2AK3;JUP;BAG3;PRKCD;PARP9;MAVS;CCT8;TPR;DTX3L;CCT5;EFCAB7;PARK7;ORMDL3;TERT;PIK3R1;CDK5RAP3
prerank,dopamine metabolic process (GO:0042417),-0.4720370080030623,-1.2645177013707352,0.19101123595505617,0.4626028042069854,1.0,4/18,8.28%,MOXD1;PRKN;SNCAIP;COMT
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.44055597884212433,1.2643245037329391,0.14945054945054945,0.5702268298579208,1.0,5/23,11.40%,KIF1A;HOOK1;MAP6D1;MYO10;CCDC88A
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.48392093896533894,1.264069842089832,0.16268980477223427,0.569452056037899,1.0,2/16,4.90%,CADM1;IL12A
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33783004584149534,-1.2637372541968663,0.0872093023255814,0.4639100868082129,1.0,33/85,24.44%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;NUPR1;GSK3B;RNF217;RNF19A;RNFT1;NUB1;CSNK1E;TMEM259;FBXW7;TRIB2;SH3RF2;USP13;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;TMTC3;ARIH2;DET1;RNF144A;BAG6;NKD2
prerank,regulation of potassium ion transport (GO:0043266),0.41141968160105485,1.2632314408640173,0.1609442060085837,0.5702673165834033,1.0,7/31,7.96%,DPP10;KCNIP4;KCNN2;ANK3;KCNIP1;DPP6;KCNAB1
prerank,neuron differentiation (GO:0030182),0.30644866577490726,1.263176093441212,0.03288201160541586,0.5688947560628312,1.0,36/165,16.99%,PHOX2A;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;TENM2;PBX2;TENM1;EPHA5;NTRK2;TENM4;NEUROD6;FUT9;TGFB2;ALK;SNPH;LHX1;WNT7B;TENM3;ITM2C;RNF112;ERCC2;ATP8A2;BRSK2;FZD4;RORB;XBP1;ATP2B2;PPT1;ACSL3;SOX4;LMX1B;PBX4;DDIT4;CTNNB1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.436409307673598,-1.2631188200206294,0.146484375,0.4647923530131832,1.0,4/25,7.57%,ERRFI1;CBLB;SNX6;SLC6A9
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.417785400233068,-1.263079487883126,0.15851272015655576,0.46423558402206594,1.0,15/30,31.37%,SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;UBE2D3;TOMM7;ARIH2;HTRA2;PDCD5;USP36;UBE2L3;RNF31
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.474628389435248,-1.2624794323252873,0.18882466281310212,0.4650402201276272,1.0,7/16,13.55%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1
prerank,retinoic acid metabolic process (GO:0042573),-0.4991664791000253,-1.262290336652087,0.17523809523809525,0.46482174578071694,1.0,2/14,3.51%,ALDH1A2;CYP26B1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4806862333548152,1.2617866193744878,0.16808510638297872,0.5713248099784971,1.0,3/17,7.54%,SLA2;THY1;PTPRJ
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5434360783006191,1.2617442878908551,0.19775280898876405,0.5699100965572063,1.0,3/10,10.18%,SIRT1;SNCA;SET
prerank,fluid transport (GO:0042044),0.5151066514599689,1.2613093870069825,0.19238900634249473,0.569567890877647,1.0,3/12,12.21%,AQP9;AQP11;AQP4
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.45838459834485273,-1.261268871173723,0.14492753623188406,0.46679394923063705,1.0,11/19,35.42%,DDO;ASPA;DLST;ALDH7A1;PIPOX;PHYKPL;GOT1;GCDH;HYKK;GOT2;AASS
prerank,central nervous system neuron development (GO:0021954),0.48876752514853805,1.2610775886776455,0.19254658385093168,0.5686975523980524,1.0,4/15,8.37%,MAP2;NTRK2;HSP90AB1;B4GALT6
prerank,negative regulation of cell migration (GO:0030336),-0.311771223624765,-1.2607803057444928,0.05660377358490566,0.46736517427742347,1.0,25/137,9.27%,PHLDB2;SULF1;COL3A1;DPYSL3;AFDN;LRP1;DAG1;BMPR1A;VCL;LDLRAD4;TPM1;IGFBP5;FOXO3;ROBO1;JAG1;PODN;IGFBP3;CDH1;HOXA7;CLIC4;EPHA4;RECK;GJA1;PTPRK;CYP1B1
prerank,positive regulation of protein secretion (GO:0050714),-0.35035029408637286,-1.2606638017956895,0.1102803738317757,0.4670098486894322,1.0,12/69,10.53%,BMP6;WLS;IGF1;TCF7L2;MCU;NLGN2;RBP4;DNM1L;GLUD1;NNAT;UNC13B;ADAM9
prerank,cellular response to dsRNA (GO:0071359),-0.48629678586032277,-1.2603122357982564,0.17712177121771217,0.4672929566991092,1.0,11/15,38.68%,DHX9;MAVS;RIOK3;PDE12;MUL1;CGAS;IFIH1;CAV1;ZCCHC3;NPM1;FLOT1
prerank,intracellular protein transport (GO:0006886),-0.2847397248517385,-1.2594726752026801,0.01680672268907563,0.46880280047541917,1.0,109/304,26.38%,WLS;RANBP3L;APPL2;TRAK1;PKD1;TLK1;KIF13A;KIF13B;XPO4;TBC1D16;SGSM2;EIF4ENIF1;SNX9;FUT10;SNX6;SEC23IP;STAT3;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;AP4E1;NUP42;LAMP2;COPZ2;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;BAG3;TBC1D2B;HERC2;TBC1D8B;GGA3;NUP214;RPGR;RPL11;GIPC1;IPO13;COG7;STX4;ARFIP2;ARF1;TPR;AP4S1;APPL1;STX5;COPB2;SURF4;TBCK;RAB21;CTTN;GRTP1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;SNX8;FAM53C;TMED3;WDR11;NAPA;TBC1D17;RANBP3;TMED5;TMED4;RABGAP1;SNF8;SEC16A;DESI1;STX17;RPAIN;TBC1D10A;RAB24;AKT2;GGA2;STX8;IFT27;IPO9;RABL3;VPS26B;CHP1;TNPO3;ARL5A;XPO5;NSF;LMAN1;USO1;XPO1;AP2A1;PREB;SAR1B;PPP1R10;SYK;RAB7A;STX12;PHB2;RAB5A;CLIP3;STX1A;VPS45;TBC1D10B;NUP93
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.41391020016771085,-1.2594160717798097,0.16195856873822975,0.4683554780598187,1.0,18/32,29.72%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,sensory perception of sound (GO:0007605),-0.3358627404926333,-1.258831225590697,0.09054325955734406,0.46910206977494623,1.0,15/88,7.81%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;KIT;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,mitochondrial protein processing (GO:0034982),0.5335934605643531,1.2580490285540278,0.17718940936863545,0.5758001378028065,1.0,3/11,7.90%,OMA1;PMPCA;ATP23
prerank,positive regulation of kinase activity (GO:0033674),0.3199536738671013,1.2577501576210393,0.08835341365461848,0.5751971436284046,1.0,19/107,9.08%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;MMD2;EPHB1;TIE1;EPHA5;GAS6;KDR;NTRK2;FLT3;ALK;MAPRE3;ADCYAP1;EPHA10;RELN
prerank,regulation of signal transduction (GO:0009966),-0.2968003474750564,-1.2573928063303839,0.04918032786885246,0.4719646659152288,1.0,55/190,18.46%,SULF1;GRK5;ZIC1;PLCE1;IGFBP2;FBXL17;IGFBP5;MDFIC;LRRK2;ELF1;CD55;DCDC2;IGFBP3;IGFBP6;RSPO3;AXIN1;PLSCR1;IFT81;CREBBP;DTNBP1;FGFR2;GAS1;RUNX1;IRAK2;GRK4;DHRS3;POFUT1;IGFBP4;SP100;GRK3;USP33;PTPN2;TULP3;RORA;TRIM5;UGCG;TCF7L1;CDC42SE2;CASTOR2;OGT;GLI1;IGFBP7;ACVR1;NCK1;NCK2;PTCH1;GRK6;TSPAN15;FOXL1;GLRX2;RIC8B;WDR11;PRKD1;PTPN1;SLC8A3
prerank,receptor internalization (GO:0031623),0.37195531249882446,1.2573528460747045,0.13755458515283842,0.5747900580969479,1.0,6/44,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,response to peptide hormone (GO:0043434),-0.3817015671613179,-1.2568083742106266,0.12786259541984732,0.4727391161000681,1.0,13/43,17.73%,ROCK2;TGFBR3;IGFBP5;ROCK1;IRS1;STAT3;ANXA1;OGT;SLC27A1;STAT1;ZBED3;STAT5A;STAT5B
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3334445282013479,-1.2567930255904527,0.09108910891089109,0.47216812896055826,1.0,23/84,18.41%,SMURF2;PRKN;WWP2;GSK3B;VGLL4;GPC3;HUWE1;SNX9;AXIN1;WWP1;SEC22B;DACT1;NRDC;ADAM9;STX5;APOE;SMURF1;CSNK2A1;ADRA2A;ASB5;WNT5A;AREL1;VCP
prerank,gas transport (GO:0015669),0.5466197539523779,1.256684451846925,0.19298245614035087,0.5751894058885296,1.0,2/10,9.12%,CA2;MB
prerank,brain development (GO:0007420),0.3134131516414004,1.2559656024329537,0.07692307692307693,0.575686648543048,1.0,26/136,10.81%,ADGRL3;CNTNAP2;GRIN1;CTNNA2;SLC6A17;PROX1;PBX2;GRIN2A;SHANK3;CDH2;PAX2;GRIN2B;MFSD2A;GRIN2D;AATK;PITPNM1;DSCAML1;ROBO2;UBE3A;RELN;ADGRL2;PHGDH;FOXJ1;SPEF2;HAP1;CNTN4
prerank,synaptic vesicle endocytosis (GO:0048488),0.405369678871049,1.255802375267857,0.13445378151260504,0.5746061441518913,1.0,14/33,18.86%,DNM3;SYT1;NLGN1;SNCA;SNAP91;AMPH;SYT2;SNCB;NLGN3;PACSIN1;DNM1;GAK;SYNJ1;SYT5
prerank,liver development (GO:0001889),-0.40205845900704335,-1.2555938057602412,0.14893617021276595,0.4744135745984741,1.0,12/32,21.29%,TGFBR3;WNT4;ANXA1;CEBPG;PHF2;ARID5B;PKD2;PCK2;CCDC39;CITED2;ZIC3;CDK5RAP3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.518124251128961,-1.255081137895315,0.19557195571955718,0.47451759724454257,1.0,2/12,4.00%,FHL2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.518124251128961,-1.255081137895315,0.19557195571955718,0.47451759724454257,1.0,2/12,4.00%,FHL2;GSK3B
prerank,motor neuron axon guidance (GO:0008045),0.5024837055540982,1.254920300031131,0.17805383022774326,0.5756100745774052,1.0,5/15,10.68%,TMEFF1;SLIT1;LHX1;NTN1;CHN1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5016472195281483,-1.2547182628733917,0.18115942028985507,0.474780945690143,1.0,10/14,33.54%,AUTS2;CTR9;SMAD4;KMT2A;PRDM9;PAXIP1;KMT2E;WDR5;SNW1;BRCA1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.386958342159236,-1.2546708500005064,0.13346613545816732,0.47426559032274884,1.0,23/39,33.79%,ABCA1;STEAP3;TANGO6;RAB10;RAB12;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;RAB3D;PREB;RAB8A;TVP23B;AFM;SEL1L;PPY;RAB8B;MIA2;LTBP2;TVP23A;RAB15
prerank,positive regulation of macrophage activation (GO:0043032),-0.47937355730164255,-1.254670011704378,0.17738791423001948,0.4736488089917761,1.0,6/17,19.98%,LBP;THBS1;TNIP2;TLR4;WNT5A;KARS1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3929197231410137,1.254045948500367,0.15476190476190477,0.5764950450412843,1.0,8/35,4.44%,SEMA3C;PLXNB3;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,regulation of monooxygenase activity (GO:0032768),0.4347112883474074,1.253892394016545,0.17558886509635974,0.5754250334243401,1.0,9/23,18.04%,NOSTRIN;SNCA;NOS3;LYPLA1;AKT1;CALM1;HSP90AA1;NOSIP;DDAH1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4487642377562021,-1.2537669837215129,0.16475095785440613,0.4753476084538375,1.0,10/20,21.35%,RBPJ;EP300;HIF1A;SMAD4;VEGFA;CARF;RUNX2;BMP2;SMAD9;SMAD1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4185680816201377,-1.253087556065211,0.1626984126984127,0.47630272923572514,1.0,10/27,20.26%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,mesenchyme development (GO:0060485),-0.4815334484579251,-1.252805840609901,0.21401515151515152,0.47634955525125894,1.0,5/15,12.33%,TGFBR1;BMP7;BMP4;FGFR2;PKD2
prerank,regulation of interleukin-17 production (GO:0032660),0.40050546275577825,1.251622691396701,0.15502183406113537,0.5803732201292007,1.0,3/31,6.51%,SLC7A5;IL12A;PRKCQ
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.45274270394482174,-1.2514102282929747,0.18484288354898337,0.47850967942139755,1.0,8/20,24.24%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.45274270394482174,-1.2514102282929747,0.18484288354898337,0.47850967942139755,1.0,8/20,24.24%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.4110895889829216,-1.2513300005546364,0.16698292220113853,0.4780976843232227,1.0,13/29,23.11%,VTI1A;VTI1B;COPB1;COPZ2;COG3;GOSR1;COPB2;COPG2;GOSR2;NAPA;COPG1;COPE;NSF
prerank,regulation of intracellular signal transduction (GO:1902531),-0.27350005046555115,-1.251077319508527,0.016260162601626018,0.47810183035777093,1.0,122/420,20.82%,AKAP13;PTPN13;PRKAG2;ARHGAP29;EGFR;ARHGAP10;ARHGAP6;RHOQ;NTRK3;ZFAND6;ARHGAP28;ARAF;MDM4;ITGAV;FGF1;ARHGAP20;STK3;EP300;TIAM2;LRRK2;WWC2;PRKAA2;ARHGEF17;ARAP1;BRD7;RHOJ;RBBP8;MYO9A;AKAP12;NRK;MAPKAP1;TAF3;ARHGAP24;BCR;INPP5B;USP7;DLG1;LBH;PAK2;NBN;UFL1;MAP4K4;TAOK3;TMBIM4;TMEM127;GMIP;LYN;ARHGAP21;MTOR;PLEKHG2;CDC42;VAV2;PDPK1;PIP4K2C;TTI1;WRN;TAF4;TBP;ARHGAP17;XIAP;PTPN22;CHD4;HIPK1;CHD3;TRIP10;TRAF2;RHOA;RPL11;ARHGEF12;RHOT1;PRKAB2;ARHGEF18;RCN3;WWC1;ARHGAP32;SOS2;TELO2;CASTOR2;RASSF2;EHMT1;RICTOR;FGD1;TBCK;ARHGDIB;ING5;FGD4;VEGFA;USP2;HDAC1;CSNK2A1;TAF13;NGEF;PRMT5;CMKLR1;ARHGAP18;NOP53;MRE11;ARHGEF11;TRAF3;TRIO;ARHGEF6;TTC5;DAPK2;WNT5A;ARHGEF1;PRKAA1;PPP2R5C;ARHGAP15;TRAF6;RHOH;MYOC;RHOC;KMT5A;CDK2;TAOK1;NF2;MAP2K6;PML;GPAT3;TAF12;ARHGAP12;PRKAG3
prerank,polyol metabolic process (GO:0019751),-0.3754653388012154,-1.2510558114627854,0.14102564102564102,0.47754810759360994,1.0,11/46,10.26%,PLCE1;SLC5A3;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5376163206831653,1.2505469331223071,0.18895966029723993,0.5818397985966749,1.0,4/10,16.45%,SACS;DNAJA4;SORL1;DNAJB2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4656659224203295,-1.2503070194720696,0.17726396917148363,0.47879804956010086,1.0,8/18,31.47%,VGLL4;CTSC;DACT1;APOE;ATP5IF1;MSN;CD81;RDX
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4999536010514027,-1.2502359760227064,0.17518248175182483,0.4783447661030941,1.0,6/14,16.10%,PIAS1;JAK1;PTPN2;PARP9;STAT1;IFNGR1
prerank,positive regulation of cartilage development (GO:0061036),-0.47260575558187556,-1.2501516917629456,0.19047619047619047,0.4779294903506037,1.0,7/17,21.67%,SOX5;BMP4;ZBTB16;SOX6;BMP2;PKDCC;TAPT1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4760288472513826,1.2500793254697427,0.16846652267818574,0.5817727301459842,1.0,2/17,4.90%,CADM1;IL12A
prerank,vasculature development (GO:0001944),-0.4736463174721416,-1.2500439081277586,0.15643564356435644,0.47757200664146565,1.0,3/16,2.43%,ERRFI1;PDGFRA;PDGFRB
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5068091331837701,1.249873522002137,0.185589519650655,0.5808490769579514,1.0,6/13,14.32%,ANK3;SLC8A1;CALM1;PDE4D;CALM2;CALM3
prerank,mitochondrion localization (GO:0051646),-0.45613791117230834,-1.2498214896149715,0.1853932584269663,0.47757067006525467,1.0,6/19,15.66%,TRAK1;LRRK2;MEF2A;NECTIN2;ZBED3;MARK1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5368707277287326,-1.2494097589795985,0.19854280510018216,0.47793481701744817,1.0,2/11,11.85%,PTGIS;FAP
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5288865458270071,1.2492576917080855,0.19736842105263158,0.5811227322118406,1.0,3/10,8.88%,PODXL;FERMT3;SKAP1
prerank,response to chemokine (GO:1990868),-0.5089695058001406,-1.2490907204016288,0.19569120287253142,0.4780460364045481,1.0,6/13,14.50%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA;DUSP1
prerank,cilium assembly (GO:0060271),-0.2813030172712602,-1.249005805578123,0.02748414376321353,0.47765819878734206,1.0,83/297,21.15%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;ALMS1;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;NINL;ARL3;PIBF1;IFT43;CEP63;ATP6V0D1;PDE6D;ARL13B;CEP135;IFT81;CFAP44;CENPJ;CEP162;DYNC2I1;ABLIM3;PCNT;SPATA6;EHD2;MARK4;CSNK1E;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;CC2D2A;POC1B;ARMC9;SNX10;C2CD3;MAPRE1;TOGARAM1;CCDC39;RILPL2;CDC14B;YWHAE;DZIP1L;DYNC2LI1;EHD3;AKAP9;CCDC57;DYNC1H1;CEP76;CCDC66;TCTN1;PRKACA;WDR11;CFAP74;PTPDC1;CPLANE1;DYNLRB1;DYNC2I2;CEP57;CSNK1D;EHD4;GORAB;RILPL1;AVIL;TRIP11;CEP89;GALNT11;NPHP1;KIFAP3;TRAPPC14
prerank,homotypic cell-cell adhesion (GO:0034109),-0.39393234052922665,-1.2489967957085295,0.1375968992248062,0.4770733145433105,1.0,11/39,15.56%,VCL;PDGFRA;PLPP3;MEGF11;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42977143813281815,-1.2488850777673073,0.1705989110707804,0.47673182517021745,1.0,8/23,15.59%,EP300;HDAC4;NCOR1;NUPR1;CLK2;SIK1;CBFA2T3;C1QTNF3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5253901596280178,-1.2484125793555887,0.2122905027932961,0.47725730701180863,1.0,3/12,17.41%,RBP4;STRAP;TLR4
prerank,regulated exocytosis (GO:0045055),0.3031491526237566,1.2479981735059946,0.06274509803921569,0.5831081261942636,1.0,35/173,12.38%,SYT1;PCYOX1L;RIMS1;PCLO;SYT6;STEAP2;SYT7;TMSB4X;RIMS2;SYT12;SYT11;SNAP25;RIMS3;GAS6;SNCA;PCDH7;FERMT3;TGFB2;WDR1;CLU;PECAM1;SYT10;ITIH3;TIMP1;SELENOP;CYRIB;SCG3;PDGFB;ABCC4;CPLX1;CALM1;SYT2;ITGA2B;TUBA4A;VWF
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4344605471834325,1.247845100409799,0.16322314049586778,0.5820828852519757,1.0,8/23,15.73%,FAR2;ELOVL7;DGAT2;TECR;ACOT7;HACD1;FAR1;ACSL3
prerank,myelination in peripheral nervous system (GO:0022011),-0.502625968216546,-1.2476312696841096,0.20074349442379183,0.4786115516419375,1.0,7/13,23.61%,DICER1;SKI;PARD3;LGI4;MYOC;ADGRG6;PRX
prerank,iron ion homeostasis (GO:0055072),0.3618046881168219,1.2471961575760384,0.1267605633802817,0.5823209810260962,1.0,12/58,10.62%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,regulation of macroautophagy (GO:0016241),-0.3217516608369528,-1.247011359931783,0.09730848861283643,0.4795273758327372,1.0,17/105,11.15%,PRKAG2;DCN;SMG1;ATP6V1B2;LRRK2;PRKAA2;RPTOR;TBK1;ATP6V0D1;SNX6;UBQLN1;MTOR;LARP1;SESN1;RB1CC1;PRKAB2;PAFAH1B2
prerank,post-translational protein modification (GO:0043687),-0.2798294275859954,-1.246889144251773,0.03807615230460922,0.4791890484680129,1.0,122/332,29.46%,FSTL1;CP;FBN1;FBXL7;LTBP1;IGFBP5;SDC2;BMP4;SPSB1;FBXW8;KLHL13;BTRC;GPC3;ASB3;IGFBP3;STT3A;ZBTB16;WDTC1;ITIH2;OBSL1;ASB2;FBXL4;FBXL12;FBXO10;IGFBP4;ASB13;KTN1;DDB2;TNC;NUB1;DCAF10;HIF1A;FAM20C;DNAJC3;DCAF6;SERPIND1;LGALS1;PSMF1;FBXL19;FBXL18;RAB11A;LRRC41;CUL3;COPS2;FBXO30;FBXW7;WSB2;FN1;DCAF8;KLHL22;MXRA8;CCN1;COPS8;IGFBP7;APOE;PSMB2;ESCO1;MSLN;MBTPS1;CUL2;ERCC8;KLHL11;DCAF4;FEM1A;ASB5;FBXO22;MIA3;RABGGTB;FBXW11;ATG5;FBXW5;RCN1;DCUN1D3;CHM;SPSB4;COP1;SPP1;P4HB;CUL1;PSMC1;HIF3A;CHML;CUL7;NAE1;FBXW4;SUMF1;WFS1;BTBD1;LAMC1;LAMB2;PSMB6;F5;PSMA3;CALU;PSMA4;RAB8A;FBXL14;KCTD7;FBXO4;PNPLA2;RAB5A;FBXW9;FBXO11;CCDC8;EVA1A;SPSB2;PSME1;PSMD13;MGAT4A;APP;GPS1;KCTD6;PSMB10;PSMA5;SPSB3;ASB6;FBXL3;PSMB9;ICMT;KBTBD7;RBX1;PENK
prerank,early endosome to Golgi transport (GO:0034498),-0.514447665670275,-1.2468490821026625,0.20315581854043394,0.47865958104311623,1.0,5/11,23.31%,STX5;SURF4;EHD3;SNX8;LMAN1
prerank,aggrephagy (GO:0035973),-0.41150729130719427,-1.245760049258507,0.16030534351145037,0.4807450423434234,1.0,12/27,21.14%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;PCNT;IFT88;DYNC1LI1;DYNC1H1;ATG5;PARK7;WDR81
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4840557196180993,1.2455203004522621,0.18947368421052632,0.585839029618963,1.0,1/15,0.37%,PLTP
prerank,erythrocyte development (GO:0048821),0.5282822098667402,1.2454668807294407,0.20043103448275862,0.584509287313887,1.0,1/10,0.29%,ALAS2
prerank,regulation of presynapse organization (GO:0099174),0.4564357477157003,1.2453929510345787,0.19873150105708245,0.5817501193575777,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),0.4564357477157003,1.2453929510345787,0.19873150105708245,0.5817501193575777,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4743016529443247,1.2453176918693603,0.20781893004115226,0.5804727292595087,1.0,4/16,10.83%,MRAP2;NECAB2;GRP;PDE6H
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.47797572280426237,-1.245180216847977,0.1941747572815534,0.48152386223927707,1.0,5/17,7.81%,ATP1A2;CACNA1C;ANK2;KCNJ2;CACNA1D
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.49383962973327883,-1.2450944749031858,0.1851179673321234,0.48111996301577087,1.0,6/14,19.11%,FOXC1;NRP1;VEGFA;VEGFD;PIK3CD;GAB1
prerank,negative regulation of translational initiation (GO:0045947),-0.4999524947009488,-1.2449942412123396,0.2150101419878296,0.4807591978772944,1.0,6/13,24.30%,EIF2AK1;LARP1;TPR;EIF2AK4;RBM4;EIF4EBP1
prerank,negative regulation of protein modification process (GO:0031400),-0.33689365972247876,-1.2445674266418243,0.09523809523809523,0.48118052387459087,1.0,13/79,4.83%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;PRKN;LRRK2;PRKAA2;IBTK;GSK3B;SNTA1;IGFBP3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.34117813165322075,1.244542307132532,0.13238289205702647,0.581101086757337,1.0,19/76,15.06%,GRM5;GRM1;HTR2C;TACR1;GPR35;P2RY1;HOMER1;GPR17;ADRA1D;ADRA1A;TRHR;OPRM1;F2RL2;F2R;GRPR;OPRK1;CCKBR;CHRM2;OPRL1
prerank,neuron projection regeneration (GO:0031102),-0.5379879405672945,-1.24412416996314,0.21183206106870228,0.4816398013720614,1.0,2/10,1.86%,PTN;NREP
prerank,negative regulation of neurogenesis (GO:0050768),0.39499586238594064,1.2440571539264031,0.16772823779193205,0.5810577441218027,1.0,12/34,14.97%,MAG;MCF2;THY1;EFNB3;OMG;NOTCH1;LINGO1;RTN4R;SORL1;B2M;RTN4;GDI1
prerank,cellular response to peptide (GO:1901653),0.3593441866940582,1.2426026702827813,0.14285714285714285,0.5837968090395624,1.0,14/56,13.89%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;RPL23;CACNA2D1;ATP1A3;DDX11;ARHGEF2;NOD1;XBP1;PSEN1;CD36
prerank,activation of GTPase activity (GO:0090630),-0.33262500719747845,-1.2422312899477568,0.09411764705882353,0.4856523831354289,1.0,28/89,21.62%,ARHGAP29;ARHGAP42;SIPA1L1;NTRK3;TIAM2;TBC1D16;DOCK7;ARHGAP24;BCR;SGSM2;BCAS3;GMIP;USP6NL;TBC1D2B;TBC1D8B;TBCK;GRTP1;TBC1D22B;TBC1D9;NGEF;TBC1D17;SIPA1L3;RALGAPB;RABGAP1;TBC1D7;TBC1D10A;RALGAPA2;SCRIB
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4919300567601582,-1.2417943295167988,0.1989247311827957,0.4861572877219687,1.0,6/15,20.61%,LRP1;PDPN;DPP4;FAP;DDR1;FGFR4
prerank,cell cycle G2/M phase transition (GO:0044839),-0.3087101393796657,-1.2414984618029334,0.07291666666666667,0.48618858579957575,1.0,39/130,19.48%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;CENPJ;PHLDA1;PCNT;AKAP8L;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.42712404045646557,-1.2414410146559405,0.17343173431734318,0.48572416720332534,1.0,10/25,15.43%,CACNA1C;ANK2;DLG1;CXADR;CAMK2D;JUP;ATP2A2;TBX18;TRPM4;AKAP9
prerank,dendritic spine morphogenesis (GO:0060997),0.4785520185597574,1.2414248090780953,0.2,0.5856872106491472,1.0,3/15,3.04%,EPHB1;CTNND2;SHANK3
prerank,protein localization to centrosome (GO:0071539),-0.4691178551050562,-1.2413324879279461,0.20637898686679174,0.4853861541406478,1.0,7/17,13.27%,PCM1;NUDCD3;PIBF1;GOLGB1;CCDC14;SNX10;C2CD3
prerank,positive regulation of axon extension (GO:0045773),0.43875215703432446,1.2407522817891972,0.17718940936863545,0.5860343841574901,1.0,5/22,9.96%,DSCAM;SEMA7A;SHTN1;CDKL5;NTN1
prerank,thyroid hormone generation (GO:0006590),-0.5373071505943543,-1.2407344416281922,0.1989051094890511,0.4862209560111197,1.0,2/10,11.33%,CPQ;SLC5A5
prerank,nucleic acid metabolic process (GO:0090304),-0.3498663760898368,-1.2406487441470664,0.13682092555331993,0.4858236737811335,1.0,33/69,33.60%,RBFOX2;HNRNPH1;ENPP1;HNRNPR;WTAP;HNRNPM;HNRNPD;PCBP2;WRN;HNRNPK;DUSP11;XRN2;MMS19;HNRNPU;POLR2H;HNRNPA3;GTF2F1;POLR2K;DNASE2;POLR2E;RECQL5;NCBP2;PDE12;DNASE1L1;POLR2D;HNRNPL;KPNA2;LSM1;WDR74;PCBP1;RBMX;HNRNPA2B1;RAN
prerank,negative regulation of reproductive process (GO:2000242),-0.4651561674357099,-1.240531387052845,0.17870036101083034,0.485503138251719,1.0,5/17,14.50%,SULF1;IGF1;GJA1;ARHGDIB;DUSP1
prerank,catecholamine metabolic process (GO:0006584),-0.4987629143474241,-1.2401272279135385,0.1926605504587156,0.48584805826531313,1.0,3/14,8.28%,PRKN;SNCAIP;COMT
prerank,early endosome to late endosome transport (GO:0045022),-0.4415999750319524,-1.2400424867098148,0.1803921568627451,0.4854823528762314,1.0,12/20,25.61%,EEA1;KIF16B;WDR91;BECN1;PIK3C3;ANKRD27;SNF8;WDR81;STX8;PTPN23;RAB7A;RAB5A
prerank,RNA stabilization (GO:0043489),-0.39599847448777226,-1.2391663123097763,0.16023166023166024,0.48694675642341795,1.0,11/33,18.05%,TENT2;EIF4ENIF1;FUS;LARP1;DHX36;PHAX;YBX1;NSUN2;TENT5A;HNRNPU;PAIP1
prerank,regulation of macrophage differentiation (GO:0045649),-0.49185285077461643,-1.2391536410430821,0.18585858585858586,0.48638105219104544,1.0,6/15,23.39%,IL34;PTPN2;ID2;INHBA;PRKCA;HSF1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4241926041789532,1.2387605763243212,0.15665236051502146,0.5902331820759646,1.0,9/25,19.30%,STMN1;FGF13;STMN4;STMN2;TPPP;STMN3;TPPP3;KIF18A;TRPV4
prerank,fat cell differentiation (GO:0045444),-0.3591918546451157,-1.2387296954621836,0.12162162162162163,0.48682504483653793,1.0,24/57,28.22%,PID1;TCF7L2;SMAD6;EP300;BBS9;WNT5B;OSBPL8;OSBPL11;PPARGC1A;MED1;FAM120B;C1QTNF3;NR4A1;NR4A2;METRNL;AKT2;SENP2;MAFB;ZBTB7A;BSCL2;CLIP3;BBS4;ERAP1;BBS2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4150115286369753,-1.238578887351234,0.1727447216890595,0.48660885931303355,1.0,14/29,20.35%,TCF7L2;EP300;KMT2D;BCL9L;PYGO1;CREBBP;TRRAP;TLE4;TLE1;TCF7L1;HDAC1;CDC73;TERT;TLE3
prerank,regulation of trophoblast cell migration (GO:1901163),-0.49593086338866454,-1.2380592297653432,0.21637426900584794,0.48728120767293515,1.0,5/14,14.35%,SMURF2;YTHDF3;GJA1;ARHGDIB;VEGFA
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.36165775133357714,-1.2379348067582598,0.14538310412573674,0.4869590934876219,1.0,9/52,5.13%,EGFR;LRP1;SORBS1;EPHA3;EPB41L2;NUMA1;PTPN9;DLG1;ITGB1
prerank,diol metabolic process (GO:0034311),0.4551817473935476,1.2376388459998164,0.18976545842217485,0.5920425285168289,1.0,9/19,17.88%,DEGS2;NOS3;PRKG2;SGPP2;AKT1;CALM1;GCH1;HSP90AA1;SGPP1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5352862443939639,-1.2375225488359904,0.20229007633587787,0.4873766864242028,1.0,4/10,16.46%,ATP1A2;VDAC1;YWHAE;ADRA2A
prerank,positive regulation of neuron migration (GO:2001224),0.5222558183048925,1.237506947650498,0.21008403361344538,0.5909701524956932,1.0,4/11,9.89%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,regulation of gluconeogenesis (GO:0006111),-0.4162664372312782,-1.237182160121411,0.19274809160305342,0.4876069175817434,1.0,10/27,15.59%,EP300;USP7;PPARGC1A;CLK2;SELENOS;PTPN2;ZNF692;SIK1;OGT;C1QTNF3
prerank,negative regulation of wound healing (GO:0061045),-0.41089899983712097,-1.2369144830309522,0.1840607210626186,0.4876490112251154,1.0,7/28,16.99%,PHLDB2;VTN;TFPI;SLC12A2;CD109;APOE;SERPINE1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5379203799240462,-1.2355682039708709,0.22043010752688172,0.49036648908143554,1.0,3/10,10.27%,MYO9A;CDC42;RHOA
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5099548355385883,-1.2349029517050387,0.2261029411764706,0.49138890893322246,1.0,2/12,0.78%,NOTCH2;DOCK11
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.5380078758711215,-1.2344224209237435,0.2126126126126126,0.49202483950697157,1.0,6/10,26.20%,DHX36;CPEB1;CDC73;NUDT21;HSF1;NCBP2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.5171679674452556,-1.2339894622599579,0.2335216572504708,0.4924871432452955,1.0,7/12,33.60%,CLCN2;MBTPS2;MBTPS1;H6PD;LPCAT3;SREBF1;RAN
prerank,lymphocyte differentiation (GO:0030098),-0.34432706648506617,-1.2338721862214013,0.12139917695473251,0.4921720182601978,1.0,24/68,26.69%,PBX1;LEPR;AXL;HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN22;PTPN2;TCF3;CHD7;ITGA4;KLF6;PIK3CD;BLNK;RHOH;RABL3;VCAM1;GPR89B;GPR89A;ZBTB7A;LMBR1L;NFIL3
prerank,protein localization to membrane (GO:0072657),0.2955381759889762,1.2326292682784,0.0658682634730539,0.6034709770912806,1.0,27/187,7.35%,BSG;DLG2;DPP10;EFR3B;NRXN1;LRRC7;MRAP2;KCNIP4;SPTBN4;NLGN1;RAMP2;MAGI2;ANK3;SHANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;THY1;NRXN2;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.45886211460246323,-1.2322443112784771,0.1883495145631068,0.4955496919064647,1.0,7/19,16.48%,WNT4;VIM;BMP4;RUNX1;EMILIN1;TGFB3;SUCO
prerank,mRNA polyadenylation (GO:0006378),-0.4163564360860483,-1.2321743743409306,0.1811320754716981,0.49452393331665434,1.0,10/26,21.30%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,RNA polyadenylation (GO:0043631),-0.4163564360860483,-1.2321743743409306,0.1811320754716981,0.49452393331665434,1.0,10/26,21.30%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5314896485989136,-1.232174238615637,0.2,0.49392378291214384,1.0,5/11,26.42%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5401845091461495,-1.2320200917434574,0.21915285451197053,0.4937188476297428,1.0,6/11,24.18%,DAB2;PRKN;RAB21;EIPR1;MSN;PTPN23
prerank,chromatin organization (GO:0006325),-0.31171376877675355,-1.231657473879003,0.100418410041841,0.4939987834634379,1.0,52/132,29.11%,HDAC8;INO80;SETD7;BRWD1;KAT2B;HDAC4;SETD5;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;KDM5B;MYSM1;ZBTB1;KDM6A;SETD2;HCFC1;MCM3AP;SETDB1;TCF7L1;RB1;EHMT1;PHF1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;HMG20A;BPTF;CDAN1;PBRM1;PIH1D1;EZH2;HMGN3;SMARCD3;HDAC2;SNAI1;FAM50A;INO80C;ZBTB7A;HDAC3;MPND;ATRX;SAFB;ESR1;SUPV3L1;RUVBL2
prerank,photoperiodism (GO:0009648),-0.4121729857126222,-1.2313959476427243,0.16733870967741934,0.4939964336651308,1.0,10/28,20.26%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,cellular protein metabolic process (GO:0044267),0.27219004976147976,1.2308115168644458,0.03213610586011342,0.6071904990181335,1.0,87/396,14.10%,ST8SIA4;RPS6;CHRM3;RPS19;OMA1;TMEM132A;RPS20;RPL38;RPL29;ST3GAL6;CDH2;RPL23;RPL17;LCMT1;RPL35A;RPL37;QPCT;PHEX;GAS6;RPS27;SLC35A1;RPL7;PDIA6;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;PSENEN;RPS24;RPL27A;RPS17;AMELX;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;MELTF;RPL30;RPL7A;TIMP1;ATP23;MSRB2;MRPL13;RPL13;MRPS18A;FBXL2;RPL12;MRPS7;RPS15;FDX2;DAB2IP;SCG3;EIF4EBP2;RPL14;MRPS14;VWA1;MEN1;SCG2;RPL5;FARSB;PROC;RPS4X;RPL21;RPS7;CSNK1G3;RPL23A;SERP1;EEF1A2;RABGGTA;SPARCL1;RPL8;MRPL36;MRPL23;RPS14;VCAN;RPS3;VGF;RPS2;PSEN1;RPS5;EEF1A1;RPL18A
prerank,vascular process in circulatory system (GO:0003018),-0.5036626255722166,-1.2307888314132744,0.20075757575757575,0.49427123965997816,1.0,4/13,12.25%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.5036626255722166,-1.2307888314132744,0.20075757575757575,0.49427123965997816,1.0,4/13,12.25%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2949419314406736,-1.2306675031841396,0.06719367588932806,0.4939620786289,1.0,68/171,29.10%,SMAD3;FOXC1;GBF1;BTRC;ASAH2;GAS1;PTPN3;OBSL1;ANAPC5;ANAPC7;MAEA;CDK13;ANAPC4;ANAPC16;BTG3;EIF4E;CDK11B;PSMF1;ERCC3;SIK1;RB1;TTL;PSMB2;CDC26;USP2;RCC1;CDC25B;TMEM8B;CDC27;UBE2E1;CCDC57;PRMT5;AFAP1L2;TTC28;RNF20;UBE2S;HNRNPU;CDK10;NEK6;CDKN1C;ANAPC11;CUL1;PSMC1;CUL7;CDK5RAP3;SCRIB;PRKCA;SPHK1;PSMB6;ANGEL2;PSMA3;HSF1;BORA;TFAP4;PSMA4;EIF4EBP1;CDC16;ANAPC1;NEK7;CCDC8;PSME1;PSMD13;APP;FZR1;CDK9;PSMB10;PSMA5;PSMB9
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.3499030454672346,-1.2306490688832883,0.13911290322580644,0.4934050268449099,1.0,14/60,10.76%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;DHX36;MED1;ATF7IP
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.34990929125150744,-1.2304518127539974,0.1362763915547025,0.49329718017770535,1.0,30/63,28.58%,TIMP3;LEPR;EIF4G3;ROCK1;NUPR1;ZKSCAN3;STAT3;BCL2;PTPN3;MTOR;FOXK1;PTPN22;EIF4E;KLHL22;ATRAID;FOXK2;DAP;RUBCN;EIF4G1;TIMP2;CDK5RAP3;BMF;RGP1;WDR6;DAPL1;RRAGA;HGF;RIC1;MET;MT3
prerank,dendritic cell differentiation (GO:0097028),0.4268004688716988,1.2303197191419002,0.16740088105726872,0.6071284730988766,1.0,5/22,7.11%,GAS6;CAMK4;FLT3;TRPM2;BATF2
prerank,actomyosin structure organization (GO:0031032),-0.33674906699259133,-1.229808142419831,0.12922465208747516,0.49435379327071843,1.0,16/75,12.56%,ROCK2;PHACTR1;SORBS1;FRMD6;TPM1;EPB41L5;EPB41L2;ROCK1;ITGB1;TMOD3;ITGB5;ACTN2;TNFAIP1;RHOA;ZYX;CUL3
prerank,carbohydrate derivative transport (GO:1901264),0.4571051790724248,1.2295162718791057,0.208067940552017,0.6079510655437989,1.0,7/18,18.88%,PLTP;MFSD2A;SLC15A3;CPTP;SCARB1;SLC15A2;VLDLR
prerank,response to fatty acid (GO:0070542),-0.46878841052606957,-1.2291734999951165,0.20599250936329588,0.49539212023625057,1.0,3/17,4.52%,PID1;FOXO3;IRS1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.364456365670654,-1.2291669866161197,0.17391304347826086,0.4948188606102589,1.0,13/47,15.59%,ROCK2;NFKB1;WNT4;EP300;PTGIS;WDTC1;CLK2;ERLIN1;SIK1;FBXW7;SLC27A1;RAPGEF2;C1QTNF3
prerank,regulation of leukocyte migration (GO:0002685),-0.47058058488395643,-1.2290347994113953,0.2023121387283237,0.4945041203900694,1.0,5/16,18.44%,HOXA7;ANXA1;VEGFA;MIA3;RHOH
prerank,visual perception (GO:0007601),-0.3309659611998812,-1.2290323720363625,0.13026819923371646,0.4939175956684564,1.0,20/84,18.20%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,regulation of actin filament polymerization (GO:0030833),-0.33992834033786734,-1.228634531312841,0.11976047904191617,0.4942574192682095,1.0,35/69,30.40%,ARHGAP28;FCHSD2;BAIAP2L1;SNX9;ARFGEF1;PLEKHG2;VASP;CDC42EP5;FER;PRKCD;NCKAP1;CTTN;NCK1;LATS1;CARMIL1;NCK2;RASA1;ARHGAP18;CDC42EP4;MYADM;LMOD1;BAIAP2;CDC42EP1;HIP1R;GBA2;SLIT2;ABITRAM;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4;ARF6
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.532091735682548,1.2285728638098128,0.21443298969072164,0.6092464092503258,1.0,3/10,11.89%,DLGAP1;DLGAP2;NPTX1
prerank,response to glucocorticoid (GO:0051384),-0.42857688117523446,-1.228201547877871,0.1947565543071161,0.49466903087225356,1.0,11/26,30.87%,NR3C1;ANXA1;REST;ADAM9;FAM107A;HNRNPU;SLIT2;ZFP36L2;GOT1;UBE2L3;BCL2L11
prerank,response to insulin (GO:0032868),-0.3313349935958525,-1.228138974156554,0.10982658959537572,0.49425359840089655,1.0,29/80,21.32%,RHOQ;SORBS1;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;RAB10;RAB12;PDPK1;VAMP2;SELENOS;FER;DENND4C;PARP1;OGT;PCK2;SLC27A1;PRKDC;ZBED3;CPEB1;LPIN2;SYAP1;LPIN3;INPP5K;PKM;PIK3R1;USF1;AKT2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.32153327735281223,-1.227671047892492,0.1111111111111111,0.4947792643027511,1.0,25/98,15.43%,INO80;EML4;DIS3L2;PIBF1;VPS4B;PHF8;SMC4;AKAP8L;CHMP4B;CHMP4A;PDS5A;CHMP5;CHMP3;NIPBL;RAD21;PDS5B;RAB11A;CUL3;RB1;KLHL22;BECN1;NUDC;MCPH1;ZWINT;CSNK2A1
prerank,mRNA catabolic process (GO:0006402),-0.36758909291295566,-1.2276353166733494,0.1539961013645224,0.4942923482787963,1.0,21/44,33.69%,DDX5;DIS3L2;RC3H1;TUT4;UPF1;XRN1;XRN2;EXOSC9;ERN1;EXOSC10;CNOT10;AGO1;LSM6;PDE12;ZFP36L2;SUPV3L1;THRAP3;NUDT16;NUDT16L1;HSPA1A;MRTO4
prerank,hepaticobiliary system development (GO:0061008),-0.4473836001917793,-1.2261800653669481,0.17647058823529413,0.4972407584460976,1.0,7/20,12.33%,TGFBR3;WNT4;CEBPG;PHF2;NIPBL;ARID5B;PKD2
prerank,modulation by host of viral genome replication (GO:0044827),-0.5042201627013102,-1.2256661370189792,0.22137404580152673,0.4978982772632544,1.0,6/13,22.68%,PRKN;CCNK;TBC1D20;EIF2AK4;IFI27;VAPA
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.47825005893658024,-1.2255105940847275,0.2205607476635514,0.4976821819045973,1.0,5/15,13.43%,EGFR;RBPJ;PTPN12;FER;RHBDF1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.497966423051169,-1.2252947585365142,0.22440944881889763,0.4975823579017124,1.0,7/13,17.03%,TGFBR3;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1;TBX2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2629999949846114,-1.2252588558260986,0.012578616352201259,0.49706398577180044,1.0,138/509,22.24%,WLS;AKAP13;ROCK2;IGF1;ROR1;EGFR;LPAR1;SASH1;NFAT5;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;NTRK3;DCN;LIMS1;PELI2;ANKRD17;UBE2N;ITGAV;CFLAR;KSR1;FGF1;PDGFRB;TRIM44;AXL;EP300;ROCK1;MAP3K3;PRKN;NR3C2;NUPR1;ADRA1B;GSDME;KIT;RPTOR;OSBPL8;PUM2;FLNA;RYK;TBK1;IRS1;HMGB1;ITGB1;DNM1L;THBS1;TFG;ALPK1;ADGRV1;FGFR2;SHC1;BCL2;LYN;TRIM8;TRAF3IP2;F3;PUM1;PDPK1;DHX36;IGF2;GJA1;MIER1;FRS2;TRAF2;PDGFC;RHOA;DDX60;ZDHHC13;KL;MAVS;BCLAF1;WWC1;FNIP1;LGALS1;ROR2;TRIM5;WDR59;TRIM25;FN1;RICTOR;PPM1A;PIK3AP1;BECN1;LTBR;P2RY12;EIF2AK2;EPHA8;TXN;VEGFA;DDX3X;RAPGEF2;P2RX4;MAP3K14;PLXNB1;TNIP2;IAPP;ECM1;ADRA2A;IL18;PDCD4;IKBKE;PIK3CD;TLR4;WNT5A;PRKD1;CC2D1A;CX3CR1;TRAF6;GCNT2;IFI35;BMP2;PARK7;MYOC;RHOC;TMED4;HBEGF;NRG4;GAB1;PTPN11;NEK6;IRAK1;CARD16;FIS1;TRIP6;FGFR4;PIK3R1;SHARPIN;CDK5RAP3;AKT2;LARS1;BMF;FGF2;CXXC5;DLG5;WNT16;TRAF5;SPHK1
prerank,hemidesmosome assembly (GO:0031581),0.5020051302306089,1.2250356242308376,0.23940677966101695,0.6179989603646101,1.0,2/11,4.92%,ITGA6;DST
prerank,natural killer cell activation (GO:0030101),-0.42591486507028053,-1.224959722939738,0.2,0.49715384963763115,1.0,3/23,6.72%,PBX1;AXL;ELF4
prerank,negative regulation of mRNA processing (GO:0050686),-0.47389067920026395,-1.224877071511088,0.20634920634920634,0.496752554809003,1.0,4/15,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,regulation of heart contraction (GO:0008016),-0.32321473047102967,-1.224738159506964,0.13555992141453832,0.4964969264094608,1.0,26/90,21.30%,ATP1A2;ITPR1;CELF2;STIM1;ANK2;ITPR2;TPM1;TMEM65;ASB3;CAMK2D;ASPH;DMPK;ATP2A2;ATP2B1;SRI;P2RX4;TBX2;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;DES;S100A1;AHCYL1
prerank,T cell activation (GO:0042110),-0.34122285641671357,-1.2247208573359394,0.13188976377952755,0.4959598115868877,1.0,19/69,23.37%,LEPR;KIF13B;KIT;CXADR;DPP4;PTPN22;PTPN2;EIF2AK4;CHD7;NCK1;NCK2;CTPS1;PIK3CD;RHOH;MSN;SCRIB;GPR89B;GPR89A;NLRC3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3604822600928182,-1.2238997573969281,0.16322701688555347,0.4972897156959673,1.0,13/49,14.35%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4405382418379129,1.2236820231791021,0.20935412026726058,0.6204025611666798,1.0,6/20,15.73%,FAR2;DGAT2;SCD;FAR1;PPT1;ACSL3
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.46179645732579366,-1.2229184657858556,0.21071428571428572,0.49904074050865693,1.0,12/18,35.08%,ABL1;POR;ABL2;AGTR1;RFK;PARK7;FXN;SIRT3;EDN3;GDNF;ATP7A;PDP2
prerank,cellular response to organic substance (GO:0071310),-0.30868896723938016,-1.2228649781191676,0.09361702127659574,0.498601826508685,1.0,24/116,10.27%,PTPN13;DPYSL3;NFAT5;PID1;SMAD3;TGFBR1;BMPR1A;IGFBP5;GHR;LRRK2;PTPN14;TGFBR2;TBK1;CLEC3B;PTPN9;STAT3;ASAH2;SHC1;RAMP1;NCOA1;CYP1B1;PTPN12;PTPN2;RHOA
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4995227876458552,-1.222520676426745,0.2424812030075188,0.4988400161459794,1.0,2/13,4.33%,ATP1A2;SLC9A1
prerank,proteoglycan metabolic process (GO:0006029),-0.4044963236348077,-1.222402140879903,0.16929133858267717,0.4985614173697944,1.0,4/26,4.87%,SULF1;IGF1;ADAMTS12;SULF2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5343877568157172,-1.2212687086778393,0.21346153846153845,0.5007612776709395,1.0,8/10,36.85%,RIOK3;SEC14L1;GPATCH3;DHX58;C1QBP;UFD1;TKFC;TSPAN6
prerank,B cell activation involved in immune response (GO:0002312),-0.49241973711472964,-1.2211002367508135,0.2076923076923077,0.5006049743243116,1.0,8/13,37.26%,RNF8;MSH6;EXOSC3;BATF;GPR183;LIG4;FCGR2B;MSH2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4926555831722781,-1.2210985806241499,0.21481481481481482,0.5000305399616523,1.0,3/13,7.27%,IGF1;SOAT1;RAMP1
prerank,calcium ion transmembrane transport (GO:0070588),0.3282359936096882,1.2210747900047005,0.11836734693877551,0.6264160989595416,1.0,15/86,6.46%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;GRIN2A;RYR3;GRIN2B;CACNA2D1;GAS6;GRIN2D;SLC8A1;ATP2B3;SLC25A23;TRPM2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49961525060200573,-1.2206442281498953,0.23076923076923078,0.5005142664976588,1.0,4/12,9.06%,THRB;KLF9;CTSH;MED1
prerank,regulation of proteolysis (GO:0030162),-0.36062725452331423,-1.2206228222532898,0.15863453815261044,0.49997456268523394,1.0,21/48,32.59%,DNAJC1;CYFIP2;BTRC;PLAT;ASPH;SPOPL;OGT;TRAF3;FBXW11;FGFR4;TBC1D10A;PARL;PERP;HDAC2;BAG6;CLN8;PLAUR;BAK1;CAV1;CLN6;LTBP4
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.40053809568458754,-1.2193085126731493,0.18761726078799248,0.5025507371659343,1.0,5/31,1.51%,TGFBR3;TGFBR1;BMPR1A;TPM1;RBPJ
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38647632248617336,1.2191734864907484,0.18181818181818182,0.6304946223642566,1.0,11/32,16.35%,AKAP6;SNCA;THY1;APLNR;HAP1;F2R;CALM1;TRPC1;CALM2;CALM3;NPSR1
prerank,regulation of cell-cell adhesion (GO:0022407),0.3809514964183176,1.2191141144979742,0.16317991631799164,0.6291243691527916,1.0,10/39,12.16%,PTPRG;PTPRR;PODXL;MAGI1;FERMT3;FUT9;TENM3;CELSR2;SMAD7;MEGF10
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5135486082696237,1.2189635832633834,0.24425887265135698,0.6280384746147961,1.0,4/11,16.96%,EXOSC5;FBL;DKC1;EXOSC4
prerank,membrane assembly (GO:0071709),0.3854108162097741,1.2186716526011112,0.20425531914893616,0.6273942931914336,1.0,6/34,5.91%,NRXN1;PTPRD;IL1RAPL1;NLGN1;ANK3;NRXN2
prerank,response to nutrient levels (GO:0031667),-0.4593262318175636,-1.2185214451935868,0.20260223048327136,0.5038449815455674,1.0,7/17,22.36%,PRKAA2;RPTOR;MTOR;FAM107A;PRKAA1;EIF4G1;KCNB1
prerank,ameboidal-type cell migration (GO:0001667),0.35491652856396816,1.2183169020474585,0.16403162055335968,0.6269141288197216,1.0,10/51,7.97%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;PKN1;AKT1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.3231934800920242,-1.217697534430118,0.10894941634241245,0.5053021063039504,1.0,20/88,17.08%,SAMD4A;NFKB1;IGFBP5;DNAJC1;SYNCRIP;PLAT;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;LSM14A;CNOT8;YBX1;ATRAID;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5090371611069104,1.2175891101765228,0.2260127931769723,0.6275165676323601,1.0,7/12,20.31%,SEPHS2;PHGDH;MTHFD1;GGT1;SEPHS1;SERINC3;SRR
prerank,actin polymerization or depolymerization (GO:0008154),-0.35972594048326934,-1.2175413714361207,0.16862745098039217,0.5050755445069108,1.0,16/50,19.88%,ARHGAP6;MICAL3;GAS7;GSN;SVIL;DIAPH1;MICAL2;CORO7;WASL;ABI1;TTC17;WASF1;FAM107A;MICAL1;AVIL;VILL
prerank,regulation of axonogenesis (GO:0050770),0.36050089009116476,1.2171711329276351,0.1390728476821192,0.6271646441153792,1.0,16/51,11.20%,LRRC4C;MAG;PLXNB3;MCF2;CDH2;NTRK2;THY1;EFNB3;OMG;PAK1;LINGO1;PLXNA4;ROBO2;RTN4R;CHN1;BRSK2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.31667846336200045,-1.2167953617221026,0.11545988258317025,0.5062892970364138,1.0,19/86,13.80%,AKAP13;NOTCH2;IGF1;DENND4A;PLCE1;KANK2;SHOC2;MAPKAP1;BCR;SHC1;LYN;ARHGAP17;ARFGAP1;LZTR1;NGF;ARHGEF18;DENND4C;OGT;ARHGDIB
prerank,regulation of establishment of protein localization (GO:0070201),-0.483102874612388,-1.2164609108939783,0.23985890652557318,0.5065208332615876,1.0,3/14,6.28%,SPIDR;CEP135;CENPJ
prerank,modulation by symbiont of host process (GO:0044003),0.5307000535840682,1.2162354020587969,0.2446351931330472,0.6284910230756918,1.0,6/10,19.23%,RPS27A;UBC;TLR2;UBB;B2M;HGS
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.32814873772852193,-1.2159122659768113,0.132,0.5072774422330899,1.0,17/80,17.33%,SAMD4A;ROCK2;PLD1;VIM;ZCCHC4;YTHDF3;THBS1;MTOR;HNRNPD;EPHA4;PLXNB2;PRKCD;PRKDC;DDX3X;IFNGR1;UPF3A;PICALM
prerank,transport across blood-brain barrier (GO:0150104),0.32472404873879257,1.2152340973426523,0.13729508196721313,0.6299442213483907,1.0,24/83,14.15%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1;SLC1A2;SLC7A8;SLCO2B1;ABCC4;ATP1A4;FABP5;KCNJ8;SLC16A1;SLC27A4;INSR;CD36;ATP2B4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.303231205742237,-1.2150450122789387,0.08842105263157894,0.5086823770501466,1.0,38/129,19.48%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;CENPJ;PHLDA1;PCNT;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2
prerank,regulation of axon extension (GO:0030516),0.3757359696664616,1.2148464684951255,0.18275154004106775,0.6295628495067489,1.0,12/37,15.90%,MAG;MAP2;SEMA7A;NRCAM;SHTN1;CDKL5;RTN4R;NTN1;DIP2B;SIN3A;RTN4;MACF1
prerank,hyaluronan catabolic process (GO:0030214),-0.45415717533658106,-1.214826161120233,0.22328244274809161,0.5086138459954497,1.0,7/18,22.55%,CEMIP;SLC9A1;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,mitotic spindle assembly (GO:0090307),-0.37594355656187095,-1.214717542382126,0.162109375,0.5083068846478833,1.0,24/42,36.81%,FLNA;PIBF1;SPICE1;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;TOGARAM1;MAP9;STAG2;SMC1A;BCCIP;KIF23;ABRAXAS1;KIF11;RACGAP1;MZT1;KIF2A;PRC1;SMC3;MISP;TPX2;KIFC1
prerank,regulation of centrosome duplication (GO:0010824),-0.39712225621457986,-1.2146899374902804,0.19844357976653695,0.5077842272303204,1.0,20/30,36.30%,ALMS1;VPS4B;SPICE1;CENPJ;CHMP4B;CHMP5;CHMP3;CENATAC;CEP295;CEP76;FBXW5;NAT10;STIL;CEP295NL;CCNF;CHMP1B;CHMP1A;NPM1;GEN1;CEP131
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.36163430399231333,-1.213533123679999,0.154,0.5098292328989968,1.0,16/49,16.39%,LDLRAD4;SMAD6;EP300;GSK3B;HMGB1;CDC42;IMPACT;DACT1;PMEPA1;RIOK3;PPM1A;ANKRD27;DDX3X;PRKCZ;NOP53;IAPP
prerank,regulation of cell size (GO:0008361),-0.42536384916209286,-1.2134908194545275,0.21388367729831145,0.5093401918467091,1.0,6/23,10.27%,RPTOR;DEPTOR;RARG;MTOR;VAV2;RHOA
prerank,protein localization to cilium (GO:0061512),-0.39655230827118104,-1.213152884984832,0.1835564053537285,0.509624816211831,1.0,17/32,33.87%,ZNF423;BBS9;ARL3;TULP3;SNX10;TCTN1;CSNK1D;INVS;IFT140;TTC21B;BBS4;RABEP1;IFT122;EHD1;TULP1;WDR35;TMEM107
prerank,pulmonary valve development (GO:0003177),-0.4484487265072089,-1.213151362513637,0.2222222222222222,0.5090444160899759,1.0,5/18,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3255920217682461,-1.212872387392259,0.12598425196850394,0.5091435221421683,1.0,20/80,13.83%,DPYSL3;AUTS2;DOCK11;RHOQ;PLCE1;ARAP1;RIPOR2;WASF2;BCAS3;NRP1;CDC42;BRK1;NDEL1;MARK4;CDC42EP5;WASL;NCKAP1;RALA;ARPC2;P2RY12
prerank,secretory granule organization (GO:0033363),-0.5377173705480738,-1.212503768406872,0.244140625,0.5093947517116288,1.0,2/10,6.34%,ABCA1;DTNBP1
prerank,DNA repair (GO:0006281),-0.2734404825226683,-1.212497253511868,0.04904051172707889,0.5088247464949679,1.0,127/284,33.54%,EYA1;INO80;UBE2N;FTO;GTF2H2;ABL1;KMT5B;RAD23B;RBBP8;UVRAG;WDR33;HUWE1;KDM4B;NBN;WDR48;RAD51B;TDP2;MLH1;TRRAP;APEX2;BRCC3;RNF8;PDS5A;WRN;TEX264;DDB2;VCPIP1;ZBTB1;CSNK1E;SETD2;HERC2;UPF1;MNAT1;PARP9;USP47;ASCC3;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;PIAS4;FANCE;KMT5C;APTX;DTX3L;PARP4;MMS19;ERCC6L2;PRKDC;FANCM;HINFP;UBE2B;BRCA2;MSH3;FANCI;ERCC8;NOP53;MRE11;SPRTN;ZRANB3;BAZ1B;VCP;DCLRE1A;PARK7;MGME1;MSH6;PCNA;POLN;SMC1A;FANCC;RPAIN;FAAP100;ATR;UBE2V2;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;EYA3;POLE2;ACTR5;RECQL5;SLC30A9;OGG1;TNKS1BP1;ENDOV;ABRAXAS1;RAD54L;GTF2H4;FANCB;MPG;POLH;TIMELESS;IGHMBP2;NUDT1;KPNA2;PARP3;MGMT;MAD2L2;UBA52;FANCD2;FANCG;MDC1;PARP2;POLD2;FAAP20;NEIL3;NSD2;RPA2;EME2;RAD9A;PNKP;EXO5;RMI2;RAD51;PSME4;POLA1;DDB1;LIG4;BRCA1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.4155598926368117,-1.2123285172852398,0.19066147859922178,0.5086197582640999,1.0,14/25,31.42%,SRSF10;SF3B1;PRPF6;SLU7;PRPF3;SCAF11;SF3A3;DDX23;GEMIN2;SRRM1;PRPF8;MPHOSPH10;LSM1;SF3B4
prerank,regulation of peptidase activity (GO:0052547),-0.4525300940234286,-1.211931583001005,0.23260437375745527,0.508975110312678,1.0,9/19,34.02%,CTSH;NRDC;RCN3;HDAC1;ECM1;PSMA3;CAV1;PSMB8;FURIN
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44469409658824843,-1.2116484024419054,0.2018867924528302,0.509077795394254,1.0,8/20,25.46%,HOXA5;ZBTB16;CTR9;HSPA9;CDC73;CDK6;MAFB;LDB1
prerank,spinal cord development (GO:0021510),-0.5071407155282944,-1.2115136640476023,0.2176360225140713,0.5088123518856891,1.0,5/12,15.96%,PKD1;GLI2;VIT;PKD2;LOXL3
prerank,substantia nigra development (GO:0021762),0.3761980769381339,1.211185619351616,0.19438877755511022,0.6386508198939893,1.0,11/37,14.32%,ACTB;MBP;PLP1;HSPA5;DYNLL1;BASP1;CALM1;COX6B1;CALM2;INA;CALM3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5037731469659119,-1.2106635460714943,0.2250453720508167,0.5103106015230598,1.0,4/12,4.53%,DOCK5;TPM1;IGFBP5;DOCK7
prerank,negative regulation of developmental growth (GO:0048640),0.4012604188613868,1.2105889161185859,0.18105263157894738,0.6389898217528288,1.0,9/30,16.15%,DCC;MAG;MAP2;FGF13;RTN4R;DIP2B;CDKN1A;RTN4;CDKN1B
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5090118681990989,1.210232717911602,0.24074074074074073,0.6385099437060737,1.0,4/11,13.24%,KCNJ3;KCND3;ATP1A1;ATP1B1
prerank,regulation of microtubule-based process (GO:0032886),-0.38267264711088955,-1.210002749406976,0.1801125703564728,0.5113209939877691,1.0,6/36,4.00%,PHLDB2;EPHA3;DIAPH1;ROCK1;PRKAA2;GSK3B
prerank,regulation of cellular protein localization (GO:1903827),-0.3610419536207584,-1.2088244069637426,0.17159763313609466,0.5134843237301278,1.0,18/45,22.46%,GPC6;GBF1;PRKAA2;GPC4;GPC3;SPIDR;NDEL1;VCPIP1;CSNK1E;SETD2;PARP1;CCDC66;PRKAA1;PTPN1;VCP;DVL3;TOR1A;GPC1
prerank,hyaluronan metabolic process (GO:0030212),-0.41993709219702713,-1.2086185714786506,0.2,0.5134440074538407,1.0,8/23,22.55%,CEMIP;SLC9A1;ABCC5;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,regulation of leukocyte activation (GO:0002694),0.46789173487096286,1.2085888914775,0.2434077079107505,0.6417848229967313,1.0,2/14,2.15%,CD33;MIF
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.45452266021959437,-1.2085383159686103,0.22262773722627738,0.5130527518326827,1.0,10/17,33.60%,FGF1;MBTPS2;ERLIN1;APOE;MBTPS1;PRKAA1;LPCAT3;SCAP;SREBF1;RAN
prerank,response to thyroid hormone (GO:0097066),-0.4863566999849718,-1.208185861242219,0.24007561436672967,0.5132534857239794,1.0,4/13,9.06%,THRB;KLF9;CTSH;MED1
prerank,regulation of DNA metabolic process (GO:0051052),-0.36996213942073986,-1.20742884303086,0.16122840690978887,0.5145970850060748,1.0,10/44,13.00%,SMG6;HDAC8;UBE2N;SMG1;NBN;YLPM1;HNRNPD;UPF1;MPHOSPH8;KDM1B
prerank,purine nucleotide catabolic process (GO:0006195),0.47197173341649284,1.2072796151814622,0.20210526315789473,0.644208698594246,1.0,3/13,12.85%,GPX1;NT5C;HINT1
prerank,regulation of cell migration (GO:0030334),0.26809490983651524,1.2071392838643118,0.03505154639175258,0.6430781164314329,1.0,78/382,13.89%,FLT1;CAMK2A;CLDN5;IGF1R;PRR5L;LEF1;NAV3;LIMCH1;CTNNA2;FRMD5;SRGAP1;ERBB4;PTP4A1;SEMA3C;CSF1R;PODXL;PLXNB3;TMSB4X;SEMA6A;MIF;ITGA6;DACH1;TMSB10;CXCL12;MAGI2;SEMA4A;PTPRT;MCTP1;SEMA4F;ROBO4;PPM1F;SEMA6D;KDR;FGF10;SEMA4D;SEMA7A;THY1;FERMT3;ENPP2;MEAK7;HSPA5;NOTCH1;PAK1;FGF5;PECAM1;PTPRJ;ACVRL1;AKT1;GPNMB;PLXNA4;SGK3;SST;NTNG1;NTNG2;SPATA13;CYRIB;PDGFB;AIF1;F2R;CEP43;PIK3R3;TMEFF2;APC;TJP1;SMAD7;RET;SRGAP3;SRGAP2;DOCK10;EPHA1;BCAR1;SORL1;ACTN4;RFFL;HRAS;XBP1;INSR;CIB1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.41272904845037767,-1.206808561461381,0.19607843137254902,0.5155207993917672,1.0,9/25,19.35%,FOXO3;ARNT;STAT3;MED1;HIF1A;STAT1;PRKDC;STAT5B;INHBA
prerank,positive regulation of developmental process (GO:0051094),-0.29108059375225076,-1.2066204494970965,0.09561752988047809,0.5154021080774983,1.0,28/164,8.60%,PHLDB2;SOX5;PTN;DAG1;BMPR1A;FOXD1;DCN;SMURF2;MCU;BMP5;CCN2;BMP7;BMP4;PRKN;KMT5B;NUMA1;DLG4;LMNA;RREB1;NIBAN2;ADGRL1;DNM1L;ZBTB16;DDHD1;REST;RAPGEF3;AR;GJA1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.449990987571585,-1.2062083482513892,0.2003780718336484,0.5158520829513129,1.0,8/18,22.72%,PTN;REST;WDR43;CNOT2;TAF5L;CNOT1;TAF6L;ZC3H13
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4037491580868318,1.2060556238544675,0.20396039603960395,0.6449208939027611,1.0,11/28,21.50%,NAV3;GIT1;OCLN;PAK1;DCTN1;RPS3;MECP2;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,positive regulation of cell growth (GO:0030307),0.3173812914596369,1.205919911246968,0.14342629482071714,0.6438416533925764,1.0,21/96,11.21%,SYT1;RIMS1;S100A9;S100A8;RIMS2;AKAP6;MFSD2A;CPNE9;SEMA4D;SEMA7A;UNC13A;TGFB2;RPS6KA1;AKT1;RNF157;SHTN1;H3-3A;CDKL5;NTN1;CEP43;SYT2
prerank,epithelial tube morphogenesis (GO:0060562),0.3900326892648552,1.205705888358418,0.16533864541832669,0.6429597441437852,1.0,8/32,7.56%,CSF1R;PODXL;RYR2;FGF10;CSNK2B;PAK1;LHX1;ACVRL1
prerank,mononuclear cell differentiation (GO:1903131),0.41512105892885703,1.2054304079057674,0.2150313152400835,0.6422482105756421,1.0,6/24,6.46%,CSF1R;PPARG;GAS6;FLT3;MT1G;TRPM2
prerank,antibacterial humoral response (GO:0019731),0.45149135201217533,1.2054249775669792,0.21797752808988763,0.6407724632576929,1.0,4/16,21.92%,SLPI;DEFA6;RNASE3;RNASE7
prerank,regulation of insulin secretion (GO:0050796),-0.31674470421985923,-1.2050705701002853,0.14942528735632185,0.5181539675348684,1.0,18/101,7.84%,ITPR1;CACNA1C;TCF7L2;ITPR2;ADCY5;MCU;PRKN;NLGN2;RBP4;IRS1;CDK16;DPP4;STXBP4;GLUD1;REST;NNAT;CACNA1D;RAPGEF3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5339063064769186,-1.2049447935825486,0.25650557620817843,0.5179246436384771,1.0,3/10,6.72%,DCN;LRRK2;BCL2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2657068774853537,-1.204886294925218,0.035864978902953586,0.5175092207716175,1.0,115/390,20.89%,ROCK2;SULF1;IGF1;ROR1;EGFR;RHOQ;SORBS1;RBFOX2;EPHA7;COL4A6;SIPA1L1;EPHA3;COL1A1;PDGFRA;ANGPT1;NTRK3;EFNB2;SDC2;FLRT2;HNRNPH1;FOXC1;GRB10;ITGAV;FGF1;PDGFRB;AXL;IL31RA;ROCK1;GHR;ATP6V1B2;CYFIP2;FRK;GSK3B;KIT;SHOC2;RYK;WASF2;IRS1;PLAT;SULF2;ATP6V0D1;SLC39A14;SHB;PAK2;STAT3;NRP1;HNRNPM;FGFR2;EIF2AK3;SHC1;FOXC2;LYN;ATP6V0A4;MERTK;CDC42;VAV2;BRK1;EPHA4;IGF2;FRS2;NGF;NCSTN;WASL;FER;PTPN2;PDGFC;RHOA;KIF16B;KL;YES1;ABI1;NFATC4;NCKAP1;ROR2;ANGPT2;MMP2;ARPC2;FLRT1;APPL1;EPHA8;VEGFA;NCK1;RAPGEF2;VEGFD;DDR1;NCK2;CYBA;RASA1;BDKRB2;FIBP;NGEF;EFS;DOCK1;STYK1;ZFYVE27;TCIRG1;PHIP;PRKD1;BLNK;FGFBP1;CEP57;POLR2H;MUSK;GAB1;PTPN11;ITGB3;NCF2;MVP;RAPGEF1;SPRED2;GFRA2;BAIAP2;FGFR4;PIK3R1;AAMP
prerank,cellular response to alkaloid (GO:0071312),0.4532567167989592,1.2048406117387678,0.2345132743362832,0.6409423151069964,1.0,3/17,4.70%,RYR2;RYR3;SLC8A1
prerank,positive regulation of nervous system process (GO:0031646),0.4477550874167971,1.2047185027343972,0.22933884297520662,0.639821162448318,1.0,5/18,9.18%,RIMS1;RIMS2;TENM4;ATPSCKMT;TPPP
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4696866770376651,-1.2044058901999932,0.19696969696969696,0.5181279283304672,1.0,5/14,19.60%,ANK2;ACTN2;AKAP9;LRRC38;ATP1B3
prerank,negative regulation of bone mineralization (GO:0030502),-0.5036529315645598,-1.204144747423328,0.2345924453280318,0.5181853422361083,1.0,4/13,16.42%,BCOR;ENPP1;TRPM4;ECM1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.47378274534590203,-1.2039681940212008,0.2332089552238806,0.5180553118006926,1.0,5/15,16.46%,SNX9;NRDC;ADAM9;APOE;ADRA2A
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.45735556509143904,-1.20340728140681,0.22242990654205608,0.5187682220010539,1.0,8/16,18.76%,FTO;BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL
prerank,regulation of protein catabolic process (GO:0042176),-0.3115442827142727,-1.2031263721719574,0.14457831325301204,0.5188751045241706,1.0,27/99,19.00%,EGFR;SMURF2;MDM4;PRKN;WWP2;GSK3B;FLNA;IRAK3;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;WDR91;STX5;GFAP;CTSA;SMURF1;CSNK2A1;CENATAC;ASB5;WNT5A;HMGCR;AREL1;VCP;CYP51A1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3193553512160911,-1.2027989692248238,0.13188976377952755,0.5191313697575826,1.0,25/84,17.69%,ROCK2;FOXP1;SASH1;ANGPT1;PLPP3;FGF1;BMP4;ABL1;SPARC;HMGB1;THBS1;BCAS3;NRP1;FOXC2;PDPK1;PLCG1;HIF1A;ANXA3;VEGFA;P2RX4;ATOH8;STAT5A;PIK3CD;WNT5A;PRKD1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3309365368321098,1.2027781094626773,0.15587044534412955,0.6441619701980521,1.0,23/82,14.65%,GRIN1;ANKS1B;ACTB;EPHA6;EPHB1;GIT1;EPHA5;AP2M1;VAV3;GRIN2B;EFNB3;PSENEN;PAK1;EFNA2;EPHA10;AP2B1;CHN1;KALRN;EPHA1;HRAS;PSEN1;ARHGEF7;PAK3
prerank,response to iron ion (GO:0010039),-0.503760271231846,-1.2024506858724933,0.23684210526315788,0.5193394537382077,1.0,4/12,14.11%,BMP6;BCL2;HIF1A;ACO1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.47242641109359823,-1.202177258520584,0.2399232245681382,0.5194176057545697,1.0,10/16,39.24%,COA8;SLC30A10;ABCD2;EMILIN1;PARK7;PPARA;GPER1;CIITA;SLC18A2;TRAP1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4192957674679925,-1.2018002824845193,0.23483365949119372,0.5197674389268422,1.0,5/23,5.70%,MCU;CAMK1D;RIPOR2;DNM1L;DPP4
prerank,telomere maintenance via recombination (GO:0000722),-0.5130877629347516,-1.2017768549155579,0.23837209302325582,0.5192398819648182,1.0,4/11,11.74%,SMC6;NSMCE2;SMC5;RAD51D
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3717520562766466,1.2017195233616909,0.20787746170678337,0.6457878159555469,1.0,7/38,10.22%,GRM5;LRP8;CSF1R;GAS6;THY1;RELN;PDGFB
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.34083509107451054,-1.2016830464631563,0.15694164989939638,0.5188965191921984,1.0,18/59,17.59%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;MED1;JUN;BCLAF1;MED8;RUNX2;TNRC6C;MED27
prerank,neuron remodeling (GO:0016322),0.5242009675729197,1.2016726153179882,0.26666666666666666,0.6444740408615106,1.0,2/10,5.01%,ADGRB3;SCARF1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4501790490090315,1.2015857830540635,0.23492723492723494,0.6432417843399392,1.0,5/18,9.08%,LRP8;ADCY8;EPHA5;RPS6KA5;RELN
prerank,response to muscle stretch (GO:0035994),0.46050012224164727,1.201421128716594,0.23809523809523808,0.6423183260251704,1.0,4/15,9.53%,RYR2;CDH2;SLC8A1;TCAP
prerank,protein targeting to peroxisome (GO:0006625),-0.392097206454185,-1.2014003492190362,0.21621621621621623,0.5190274274917618,1.0,11/29,20.63%,ZFAND6;ABCD3;PXMP4;ABCD2;LONP2;PEX6;SLC25A17;PEX7;FIS1;PXMP2;PEX26
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3884785432527511,-1.2013721063719394,0.20076481835564053,0.5185339586590237,1.0,12/31,20.86%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.46014311695568,1.2009000214884855,0.22048997772828507,0.6423262399666861,1.0,5/16,13.88%,IGF1R;ETF1;GLE1;OGFOD1;INSR
prerank,protein localization to cell-cell junction (GO:0150105),-0.4621210082258278,-1.2007636779642346,0.2209737827715356,0.5194852451570443,1.0,5/15,10.93%,CGNL1;MPP7;JAK1;PAK2;ARHGEF18
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.45826904129681567,-1.199997370849125,0.2380038387715931,0.5208801789060724,1.0,9/18,33.41%,GSK3B;ACAA2;TMEM14A;ZNF205;HIP1R;CHCHD10;MUL1;BAK1;HSPA1A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4073557452175963,1.1997664218637392,0.21374045801526717,0.6442253372182659,1.0,10/30,14.52%,DACH1;HNRNPC;TERF1;ACVRL1;TEN1;PIF1;MEN1;BMPR2;TINF2;CDKN1A
prerank,positive regulation of cell migration (GO:0030335),-0.2722734530868869,-1.1993940581019422,0.055445544554455446,0.5217469240984905,1.0,72/253,19.11%,SYNE2;ROCK2;IGF1;EGFR;DOCK5;TGFBR1;COL1A1;PDGFRA;NTRK3;SMURF2;MYLK;CEMIP;SEMA3D;FGF1;PDGFRB;DAB2;PDPN;SMO;VTN;WNT5B;KIT;RREB1;ITGB1;CTSH;THBS1;STAT3;MAP4K4;NRP1;MTOR;F3;PLCG1;SEMA3E;CXCL16;FER;PDGFC;MMP14;HIF1A;ADAM9;NIPBL;STX4;ROR2;RAB11A;FN1;CCAR1;MAPRE1;CPNE3;CCN1;SH3RF2;SEMA3B;VEGFA;SEMA4B;NUMB;ACVR1;RAPGEF2;GLIPR2;CARMIL1;DOCK1;ADRA2A;PIK3CD;TWIST2;CCN4;MIA3;FAM107A;S100A11;MYADM;SOD2;GCNT2;BMP2;MYOC;RHOC;HBEGF;GAB1
prerank,regulation of kinase activity (GO:0043549),0.31904368971495733,1.1991647213832983,0.14285714285714285,0.6445603181434808,1.0,13/89,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5038602461854361,1.1991420780649868,0.26282051282051283,0.6431657736155182,1.0,3/12,6.58%,PAX8;PAX2;LHX1
prerank,negative regulation by host of viral process (GO:0044793),-0.5345227356086504,-1.198985315996405,0.24581005586592178,0.5222311090004567,1.0,4/10,22.68%,PRKN;CCNK;EIF2AK4;VAPA
prerank,positive regulation of calcium ion transport (GO:0051928),0.38060898075778654,1.1984209347228847,0.18762475049900199,0.6439291147482901,1.0,8/36,11.50%,CAMK2A;GRIN1;CXCL12;CACNB2;CCL2;PDGFB;F2R;P2RX7
prerank,regulation of actin nucleation (GO:0051125),-0.5036433453540513,-1.1982575131150557,0.24171539961013644,0.5234289907388108,1.0,4/12,15.28%,GSN;ARFIP2;ARF1;WHAMM
prerank,establishment of spindle orientation (GO:0051294),-0.403965316966573,-1.1980267485345277,0.20637898686679174,0.5234286394335188,1.0,6/28,8.60%,NUMA1;MAP4;UBXN2B;ITGB1;NDEL1;GJA1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4522495970075851,1.1977850662031175,0.23399558498896247,0.644356302507555,1.0,4/16,5.82%,PROX1;MYH6;NOTCH1;TGFB2
prerank,Notch signaling involved in heart development (GO:0061314),-0.49599526957649004,-1.1975316965236975,0.23684210526315788,0.5241545229268507,1.0,3/11,3.07%,NOTCH2;RBPJ;JAG1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.41158232243074444,-1.1973291411975402,0.22562141491395793,0.5240726317998463,1.0,6/26,11.69%,PRKAG2;PRKAA2;WDTC1;NR1H3;PRKAB2;ERLIN1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5223355978541493,-1.1969579799830692,0.23863636363636365,0.5244709846548147,1.0,3/10,7.01%,ATP1A2;OSR1;CAMK2D
prerank,histone H4 deacetylation (GO:0070933),-0.5166921719793921,-1.1967859155122986,0.24100719424460432,0.5243603367402797,1.0,5/10,14.62%,HDAC8;HDAC4;RCOR1;REST;HDAC1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2828737210738037,-1.1967655971725844,0.10240963855421686,0.5238384118636777,1.0,61/208,23.37%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;ZFAND6;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;UFL1;MAPKBP1;TRIM8;TRAF3IP2;PDPK1;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;TLE1;LGALS1;RORA;TRIM5;RIOK3;TRIM25;PPM1A;LTBR;STAT1;TRIM39;MAP3K14;TNIP2;ECM1;TRAF3;IKBKE;WNT5A;PRKD1;CC2D1A;TRAF6;RHOH;TANK;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;NLRX1;TICAM1;VAPA;GPR89A;NLRC3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5099851158506623,1.1967651816134175,0.2260127931769723,0.6459929360937784,1.0,1/10,1.24%,KLRC1
prerank,calcium ion transport (GO:0006816),0.30986157556767824,1.196751843270046,0.11812627291242363,0.6445847612753935,1.0,27/113,14.43%,CAMK2A;SLC24A4;SLC24A2;TRPC5;CACNA1A;CACNA1B;RAMP2;RYR2;RYR3;CACNA2D1;GAS6;SLC8A1;CACNA1E;TRPM2;CACNB2;TPT1;CACNG3;GRIN3A;CACNG8;P2RX7;TRPC1;TMCO1;MCOLN2;PSEN1;ATP2B4;ATP2B2;CACNA1I
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.49310985965292975,-1.1966165607762698,0.25,0.5236456988706998,1.0,6/12,17.46%,NBL1;BMP5;WASL;CCN3;DUSP1;MIA3
prerank,neuron maturation (GO:0042551),0.4362124925279126,1.1964422286572292,0.21739130434782608,0.6440636058312154,1.0,4/18,8.37%,ADGRB3;SCARF1;SRRM4;B4GALT6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5212316406411359,-1.1964097383463044,0.2490842490842491,0.5235790525200775,1.0,4/10,21.91%,GFPT1;PFKP;PFKM;PFKL
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.45628972346778357,-1.1961885573494289,0.24431818181818182,0.5235474870451877,1.0,6/17,16.48%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,cellular protein localization (GO:0034613),-0.27095563967305786,-1.1961858418757874,0.06759443339960239,0.5229938026378516,1.0,103/285,27.91%,WLS;EGFR;ANK2;VCL;ANGPT1;TLK1;KIF13A;SH3PXD2B;LRRK2;TBC1D16;FBLN5;CNTLN;FLNA;SGSM2;PIGK;SNX9;SNX6;SEC23IP;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;GJA1;COPZ2;PTPRK;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;GGA3;RPGR;WIPI1;COG3;TM9SF2;COG7;NIPBL;STX4;ARFIP2;ARF1;STX5;USP4;COPB2;TBCK;RAB21;CTTN;GRTP1;TM9SF1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;ATG9A;SNX8;WDR45B;TMED3;WNT5A;WDR11;NAPA;TBC1D17;TMED5;TMED4;RABGAP1;WIPI2;STX17;TBC1D10A;NPHP1;RAB24;GGA2;STX8;IFT27;RABL3;VPS26B;ARL5A;NSF;USO1;AP2A1;SAR1B;STX12;PRRT1;RAB5A;CD63;STX1A;VPS45;RRAGA;TBC1D10B;BBS4;MFN2;GAS8;STX7;TMED2;TBC1D9B;FERMT2;ARL4C;RIC1
prerank,negative regulation of cellular process (GO:0048523),-0.2569106739789383,-1.1960087269151314,0.03138075313807531,0.5228854693930509,1.0,152/521,22.08%,PLXNA2;TGFBR3;ALDH1A2;SMAD3;ZBTB7C;APPL2;KANK2;ANGPT1;DCBLD2;SMAD6;CELF1;COL4A3;FBLN1;BMP5;MDM4;CCN2;FHL1;DIS3L2;UBR2;KAT2B;BMP7;BMP4;ANXA6;PDPN;PRKN;PPM1D;ENPP1;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;RIPOR2;VGLL4;RARG;IGFBP3;TGFB1I1;IGFBP6;PLSCR1;SKI;VPS4B;SPEG;CD9;TMEM127;EIF2AK3;BCL2;NOX4;LYN;TES;SRSF6;REST;WNT9A;P3H3;CHMP4B;AR;GJA1;SP100;PTPRK;IMPACT;MAP2K1;TXNIP;CYP1B1;PLXNB2;BTG3;COL18A1;NGF;PTPN2;CCN3;NR1H3;SMAD4;ABI1;ROR2;PDS5B;PKD2;RB1;VPS13C;ADNP2;IRF1;BECN1;CCN5;FKTN;CCN1;COPS8;ARHGDIB;IGFBP7;EIF2AK2;ING5;CD164;RBM5;EMILIN1;CRLF3;DUSP1;NCK1;DDX3X;CBFA2T3;RAPGEF2;NCK2;PLXND1;RASA1;ANP32B;MNT;TGFB3;PLXNB1;ADAMTS1;PDCD4;MYBL1;NR4A1;CCN4;MIA3;OSGIN2;ARID2;PRKD1;S100A11;PPP2R5C;SFRP4;ATG5;SOD2;NDRG3;FGFBP1;DACT3;NME6;IFI35;BMP2;DCUN1D3;PARK7;CDK10;INHBA;PBRM1;CDC73;NF2;IFIT3;PML;ING1;FRZB;NOS1;SPEF1;NME1;ZBTB49;CDK6;PPP2CA;BNIP3;FGF2;TGFBI;DLG5;LPCAT3;PTHLH;WNT16
prerank,mRNA 3'-end processing (GO:0031124),-0.3228109142259241,-1.1957042202447954,0.146484375,0.523039189591254,1.0,31/78,27.97%,TENT2;PABPN1;PCF11;WDR33;CASC3;SCAF8;U2AF2;CPSF3;SRSF6;SSU72;SLU7;RPRD2;SLBP;SRSF1;PAPOLG;CSTF3;SRSF7;CDC73;SRSF11;SRRM1;UPF3B;SRSF2;AHCYL1;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11;APP;POLR2D
prerank,somite development (GO:0061053),-0.5095292989787161,-1.1956346219044678,0.2523719165085389,0.5226553321325063,1.0,4/11,15.96%,SMO;MEOX2;PTCH1;LOXL3
prerank,recombinational repair (GO:0000725),-0.3233770132034817,-1.1954094390756709,0.154,0.522663541260808,1.0,19/77,17.03%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;RFWD3;PARP1;RAD51D;NABP2;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,response to UV-B (GO:0010224),0.49197904552241767,1.1948552494422833,0.2575107296137339,0.6473562889853945,1.0,2/12,4.90%,MME;IL12A
prerank,embryonic hemopoiesis (GO:0035162),0.4952078089959087,1.1944934401912641,0.2611464968152866,0.6469800524608129,1.0,4/12,9.01%,KITLG;KDR;TAL1;TPO
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5194312529219388,-1.1943679707913026,0.2572992700729927,0.5246425361739661,1.0,6/10,27.05%,EMC2;EMC7;EMC9;EMC4;EMC10;EMC3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4436134125788912,-1.1942726402308688,0.21663442940038685,0.524310845289333,1.0,7/18,14.88%,MDFIC;CTNNA1;GSK3B;SUFU;APOD;ILRUN;LATS1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4082452093186232,-1.1941935647620794,0.21509433962264152,0.5239490791679324,1.0,12/26,30.82%,FBN1;HOXA7;PTPN2;TLR4;GPR137B;INHBA;TCTA;CDK6;MAFB;INHA;TLR3;FSTL3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.49568970145540076,-1.194173454871269,0.2254335260115607,0.523424064034204,1.0,3/13,6.91%,GLI3;TGFBR2;RUNX1
prerank,response to acidic pH (GO:0010447),-0.49482866526905556,-1.1939351945465149,0.2340036563071298,0.5234493262761072,1.0,8/13,41.30%,SLC9A1;IMPACT;GPR4;CHP1;PKD2L1;PKD1L3;LGMN;RAB11FIP5
prerank,negative regulation of cell motility (GO:2000146),0.30760720380298967,1.193744067580791,0.13404255319148936,0.6477492821884394,1.0,13/108,4.49%,CLDN5;NAV3;LIMCH1;SPOCK3;FRMD5;SRGAP1;PLXNB3;MIF;DACH1;MAGI2;PTPRT;MCTP1;THY1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.44811015354216605,-1.1936352032318764,0.22977941176470587,0.5236267001904391,1.0,7/18,24.66%,DAB2;MAP2K1;CHMP3;RAB21;MSN;PTPN23;SNX12
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5194110897926101,-1.1935084587977376,0.24581005586592178,0.5233617363258485,1.0,2/11,5.41%,BMPR1A;THBS1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3589880288140715,-1.193280915039408,0.16984732824427481,0.5233984679333312,1.0,9/48,5.51%,EGFR;NFKB1;MDM4;ITGAV;ROCK1;FLOT2;FLNA;IRAK3;EIF2AK1
prerank,regulation of interleukin-1 production (GO:0032652),-0.47017141135741947,-1.193201607261863,0.2261904761904762,0.5230463651218749,1.0,3/15,7.02%,FOXP1;HMGB1;ANXA1
prerank,regulation of protein secretion (GO:0050708),0.3006332287791784,1.1925122859713038,0.14038876889848811,0.6498062212953103,1.0,16/119,6.27%,CD33;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;APBB1;RHBDF2;IL12A;KCNJ11;STXBP5L;APBB3;TGFB2;CACNA1E
prerank,double-strand break repair (GO:0006302),-0.2888259620905689,-1.1924726131432999,0.1087866108786611,0.5242140015421316,1.0,69/158,33.54%,EYA1;INO80;UBE2N;RBBP8;SPIDR;HMGB1;KDM4B;SMC6;NBN;RAD51B;TDP2;NSMCE2;BRCC3;RNF8;WRN;SMC5;HERC2;PARP9;MCM9;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PAXX;POLM;NABP2;PIAS4;APTX;DTX3L;PRKDC;BRCA2;KDM2A;SFPQ;MRE11;ZSWIM7;BAZ1B;VCP;DCLRE1A;POLN;XRCC6;UBE2V2;SMARCAL1;RAD51C;ERCC1;PAXIP1;EYA3;ACTR5;RECQL5;IFFO1;TNKS1BP1;ABRAXAS1;SFR1;HELQ;KPNA2;PARP3;MAD2L2;SAMHD1;MDC1;ZFYVE26;PARP2;RNF138;NSD2;RPA2;EME2;RAD51;POLA1;LIG4;BRCA1
prerank,apical protein localization (GO:0045176),0.5189497583205522,1.19237334962435,0.27789473684210525,0.6487664205173643,1.0,5/10,14.24%,ACTB;MAL;INSC;VANGL2;JAM3
prerank,regulation of defense response to virus (GO:0050688),-0.4796711331178106,-1.1917615412199414,0.2401500938086304,0.525377879088792,1.0,5/14,16.55%,DHX9;PCBP2;RNF216;ILRUN;TRAF3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4361680065313933,1.191572644960504,0.23983739837398374,0.6497347985427739,1.0,2/19,1.77%,CD33;GIT1
prerank,carboxylic acid transport (GO:0046942),0.3427521980916012,1.1911649611513655,0.17634854771784234,0.6494267051710343,1.0,10/55,10.55%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;AQP9;SLC1A1;SLC7A8;SLC66A1;SLC36A1;SLC16A4
prerank,regulation of plasminogen activation (GO:0010755),-0.494813353044584,-1.1904595307256298,0.2667946257197697,0.5281147523626476,1.0,4/12,16.99%,CLEC3B;THBS1;RUNX1;SERPINE1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.46071811727564405,1.189350135100772,0.24074074074074073,0.6534308262355881,1.0,2/13,3.31%,MIF;SIRT1
prerank,regulation of cardiac conduction (GO:1903779),-0.34207552176436745,-1.1891994641030628,0.16226415094339622,0.5306731986077962,1.0,17/54,21.30%,ATP1A2;ITPR1;STIM1;ANK2;ITPR2;TMEM65;ASPH;DMPK;ATP2A2;ATP2B1;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;AHCYL1
prerank,cytoskeleton organization (GO:0007010),-0.3027420129948494,-1.1889442184937145,0.14760914760914762,0.5307425056409755,1.0,40/114,21.23%,ARHGAP10;MICAL3;PLCE1;TPM1;BRWD1;DIAPH1;SYNE3;MICAL2;WDPCP;PACSIN2;WTIP;RND3;LRCH3;OBSL1;PALLD;RANBP10;RHOA;LIMD1;ZMYM4;RHOBTB2;FGD1;ZMYM3;CAPZB;APOE;FGD4;NECTIN2;RANBP9;MARK1;PHIP;MICAL1;RHOBTB1;RHOH;RHOC;SIPA1L3;AJUBA;CNN2;SPRYD3;DES;MAST2;PPP2R3C
prerank,chromatin remodeling (GO:0006338),-0.3095696385970617,-1.1889117793676054,0.15247524752475247,0.5302708701966049,1.0,40/100,28.17%,INO80;KAT2B;ARID1B;HDAC4;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;CHD8;KDM5B;MYSM1;MBD2;ZBTB1;KDM6A;CHD4;CHD3;HCFC1;RB1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;BPTF;PBRM1;PIH1D1;SMARCD3;HDAC2;MBD3;INO80C;ZBTB7A;ACTR5;MPND;CECR2;ATRX;ESR1
prerank,heart process (GO:0003015),0.4647292816000934,1.1888854376377744,0.2560483870967742,0.6534537661686434,1.0,3/14,10.09%,SGCZ;GPX1;SGCG
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3847948255305717,1.1885254540679644,0.19375,0.6530742273254748,1.0,7/31,11.12%,LRP8;NLGN1;SHANK3;KIF1A;ZDHHC15;RELN;PPFIA2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3818413036283166,-1.188496881014499,0.20658135283363802,0.5307756710548642,1.0,19/33,30.04%,DDX5;EP300;AXIN1;UFL1;RUNX1;AR;UBA5;SAFB2;PRMT2;LATS1;RNF14;PARK7;RNF6;TRIM68;KDM1A;ESR1;KCTD6;UFM1;CALR
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4895760388358096,-1.1883295024176683,0.23925233644859814,0.5306209535704296,1.0,5/13,26.42%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,covalent chromatin modification (GO:0016569),-0.4722547432594386,-1.1882648763244834,0.25239005736137665,0.5302367911727148,1.0,6/14,18.92%,HLCS;SETD5;UFL1;MBD2;HDAC1;PARK7
prerank,mitochondrial membrane organization (GO:0007006),-0.383288949731699,-1.1873077768866045,0.20275590551181102,0.5319305548746648,1.0,12/32,30.46%,OPA1;BCL2;MICOS10;MTX3;RCC1L;HSPA9;BNIP3;APOO;MFN2;SAMM50;BAK1;PPIF
prerank,vascular transport (GO:0010232),0.3184039799233881,1.1872185379928664,0.16427104722792607,0.6555857837021235,1.0,12/81,4.33%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1
prerank,mesenchymal cell development (GO:0014031),0.44094182448637365,1.186921238756361,0.24008350730688935,0.6550320511773435,1.0,4/18,6.01%,NRG1;CDH2;NOTCH1;CYP26C1
prerank,positive chemotaxis (GO:0050918),0.4399556621389016,1.186132968005193,0.23340040241448692,0.6560592607896211,1.0,6/17,10.67%,PLXNB3;FGF10;PTPRJ;GPNMB;SCG2;CORO1A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5034736743443231,-1.1853303197211136,0.26256983240223464,0.536246210349941,1.0,4/11,14.16%,IL6ST;JAK1;STAT3;STAT1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5108988119632254,1.1850712180809464,0.2669491525423729,0.6563993716024804,1.0,2/10,6.76%,MBP;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5108988119632254,1.1850712180809464,0.2669491525423729,0.6563993716024804,1.0,2/10,6.76%,MBP;KLF4
prerank,aminoglycan biosynthetic process (GO:0006023),-0.34973757903833014,-1.1849633622569684,0.19960861056751467,0.536598586947248,1.0,18/49,19.49%,GPC6;SDC2;B3GALT1;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3186727283828894,-1.1845814474634138,0.15458015267175573,0.5369376500204907,1.0,41/80,35.63%,ANGPT1;UBE2N;LRRK2;HUWE1;AXIN1;UBQLN1;XIAP;CUL3;FBXW7;FANCM;FANCI;TOPORS;SPRTN;DERL1;FAM107A;TRAF6;DCUN1D3;SPSB4;TBC1D7;CDK5RAP3;SPHK1;ARRDC4;SENP2;WFS1;MAGEC2;PAXIP1;KDM1A;FBXO4;HDAC3;DCUN1D5;BIRC3;RBX1;PEF1;UBE2L3;CAV1;DCUN1D4;BRCA1;PSMD10;CENPX;RIPK2;PIN1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.41690771372015045,-1.1836789884489012,0.22692307692307692,0.5386611980733107,1.0,10/24,12.21%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;RALA
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.32120265782781604,-1.1835136318255757,0.16346153846153846,0.5384504085575451,1.0,13/78,7.97%,EGFR;PID1;LRP1;RHOQ;SORBS1;EPHA3;DAB2;PTPN9;DLG1;ITGB1;VTI1B;PDPK1;AR
prerank,lipid droplet organization (GO:0034389),-0.42083288133634256,-1.182969915593268,0.220675944333996,0.5392275911705924,1.0,10/22,31.15%,RAB3GAP1;ZFYVE1;FAF2;AUP1;SQLE;CDS2;PPID;BSCL2;PLA2G4C;FITM2
prerank,neutrophil activation involved in immune response (GO:0002283),0.2595267498478286,1.182378597679189,0.05394990366088632,0.6629163450734413,1.0,91/428,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;DNASE1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.43121309821115783,-1.1823455793971,0.24845995893223818,0.5402046998411932,1.0,4/20,2.70%,TGFBR3;TGFBR1;RBPJ;BMP4
prerank,ribosomal large subunit assembly (GO:0000027),0.41604958445087226,1.1822454740395367,0.2314410480349345,0.6618802650915555,1.0,9/24,19.14%,RPF2;RPL10;RPLP0;RPL5;RPL23A;NOP2;MDN1;PPAN;RPL3
prerank,fatty acid beta-oxidation (GO:0006635),-0.344929989758053,-1.1821647472175363,0.19245283018867926,0.5400592373081631,1.0,21/51,24.24%,ABCD3;IVD;ACADM;ACAD10;ABCD2;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1;DECR2;AMACR;MECR;ACOT8;ACOX3;AUH
prerank,replicative senescence (GO:0090399),0.4772893109631199,1.181153605080038,0.2741228070175439,0.6637453710201456,1.0,2/12,1.59%,CHEK1;MME
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.29195005473301167,1.1807401103638953,0.116600790513834,0.6635568530597264,1.0,32/149,14.06%,CAMK2A;TFRC;TIRAP;PRKCH;S100A9;S100A8;TRIM13;TRAF1;RPS6KA5;ALK;CLU;PRKCQ;RTKN2;TRIM37;RPS27A;UBC;TRIM62;TLR2;UBB;TRIM6;PSMA6;ARHGEF2;NOD1;TERF2IP;MID2;BCL10;CD40;RPS3;NFKBIA;CD36;CIB1;TAB2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.458539763853795,-1.180388759681313,0.25,0.5439767301209913,1.0,6/16,16.48%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.4553629619649351,-1.1798219474720224,0.22789783889980353,0.5447873207485117,1.0,4/16,9.94%,MOV10;RC3H1;DHX36;UPF1
prerank,endocrine system development (GO:0035270),-0.42251642862588734,-1.1797658859609175,0.2570356472795497,0.5443582762177365,1.0,4/21,2.97%,TGFBR1;WNT4;GLI2;DKK3
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.42168462968036263,-1.1795816948270494,0.219959266802444,0.5442726031076001,1.0,7/19,20.14%,VPS4B;CHMP4B;CHMP5;CHMP3;TPR;HNRNPU;EML3
prerank,negative regulation of defense response to virus (GO:0050687),-0.516863176567792,-1.1795553908600707,0.2619047619047619,0.5437728323868626,1.0,8/10,41.26%,PCBP2;ILRUN;MUL1;C1QBP;TSPAN6;TRAF3IP1;TARBP2;RNF26
prerank,positive regulation of ruffle assembly (GO:1900029),0.46676589130517304,1.1787377709143725,0.27309236947791166,0.6682358671522047,1.0,4/13,13.64%,NLGN1;FAM98A;HRAS;PFN1
prerank,regulation of cholesterol efflux (GO:0010874),0.3820087577712838,1.1786861965362707,0.2215568862275449,0.6669756222981921,1.0,5/30,8.56%,PLTP;SIRT1;NAXE;PPARG;GPS2
prerank,substrate-dependent cell migration (GO:0006929),-0.4658658584101042,-1.1778733208155088,0.2756183745583039,0.5474684768496997,1.0,4/14,13.95%,ITGA11;NRP1;P2RY12;EPHA8
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.49335521483592226,1.1777712695298055,0.24733475479744135,0.6683096392830793,1.0,3/11,7.35%,CACNA2D1;BIN1;CACNB2
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.27825078389459645,-1.177673680329343,0.102,0.5473810793405665,1.0,53/199,21.12%,ROCK2;ALDH1A1;EGFR;LDLRAD4;RBPJ;SMAD6;ZNF423;LGR4;BMP5;ROCK1;BMP4;ROBO1;NPR3;WWC2;NFIB;GSK3B;DOCK7;ADAMTS5;HOXA7;TWSG1;FOXC2;SRSF6;GJA1;LAMA4;NRDC;NR1H3;ATP2B1;WWC1;TBX18;MEF2C;IL17RD;RB1;ACOT11;ARHGDIB;BRCA2;IL17D;PTCH1;LNPEP;DUSP10;IFNGR1;VASN;PLCL1;TLR4;HMGCR;CHSY1;BMP2;ABHD6;CYP51A1;MAP2K6;SPRED2;TLE3;PPP2CA;SFMBT1
prerank,secondary palate development (GO:0062009),-0.4690081285859438,-1.1776676727601734,0.25475285171102663,0.5468300297592504,1.0,8/14,17.53%,TGFBR3;TGFBR2;SMAD2;SMAD4;CHD7;TGFB3;LRRC32;WNT5A
prerank,regulation of complement activation (GO:0030449),-0.3659434998890153,-1.1774102702698668,0.2037037037037037,0.5469379847691777,1.0,5/40,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,regulation of defense response (GO:0031347),-0.32253214918301687,-1.1773116095842069,0.18467583497053044,0.5466224478126622,1.0,46/76,37.77%,FOXP1;APPL2;ADAMTS12;CELF1;NR1D2;SBNO2;UFL1;ANXA1;CASP12;XIAP;PTPN22;PTGES;AGTR1;APPL1;IRF1;PIK3AP1;APOE;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;DAGLB;USP18;IL1RL2;DHX58;ERAP1;GRN;BIRC3;SAMHD1;BCL6B;ACE2;BCL6;TKFC;HCK;MYD88;ZBP1;LACC1;FGR;CASP1;FCGR2B;CASP4;SETD6;LRRC19;CCR2
prerank,epithelial cell differentiation (GO:0030855),-0.3092709380597497,-1.177045417012424,0.1627450980392157,0.5467007219165096,1.0,29/88,21.62%,FSTL1;MAF;DAB2;BMP4;JAG1;ANXA4;RAB10;FGFR2;ANXA7;ANXA1;CNN3;VDAC1;SCUBE1;FZD7;PGK1;PCK2;GLI1;VEGFA;HDAC1;LATS1;BDH2;SIX1;TAGLN;CPT1A;PCNA;PIH1D1;AKT2;GATA6;SCRIB
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.530890094763149,-1.1766873167257768,0.265625,0.5470542539964245,1.0,3/10,6.91%,HMGB1;SH3RF1;RUNX1
prerank,DNA double-strand break processing (GO:0000729),-0.44067867395218197,-1.1763889891964496,0.2514851485148515,0.5472281559763131,1.0,3/18,5.93%,UBE2N;RBBP8;NBN
prerank,cellular response to cAMP (GO:0071320),0.3829759607266098,1.1760082147054722,0.23625254582484725,0.6721929683581511,1.0,5/30,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.42008642495949894,-1.1749853946822906,0.2485981308411215,0.5501169350987093,1.0,3/21,1.01%,ATP1A2;CACNA1C;ANK2
prerank,cellular component assembly (GO:0022607),-0.264335298612157,-1.1749225985253056,0.1019522776572668,0.5496975538625241,1.0,68/253,21.46%,CALD1;DPYSL3;PARVA;PAWR;RHOQ;TEAD1;GSN;LIMS1;MDM4;MYO1B;LIMA1;BAIAP2L1;SHROOM2;RHOJ;NLGN2;DLG4;MYO9A;YTHDF3;YAP1;FLNA;DNM1L;SNX9;CREBBP;CDC42;TUBGCP2;PPARGC1A;VAMP2;VASP;TLCD2;VCPIP1;GEMIN5;FLNC;MNAT1;WASL;TRAF2;RHOA;NCKAP1;RAD21;CAPZA1;WIPF1;HES1;TEAD2;TOGARAM1;PARD3;RANBP9;WASF1;REPS2;PPIH;ZFYVE27;PICALM;WNT5A;FAM107A;CFAP74;MICAL1;RHOH;FZD1;GPAA1;TUBGCP4;CDAN1;PML;BAIAP2;SPEF1;FBLIM1;PLS1;FANCC;KIFAP3;KMT2A;PPID
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4231375612937648,-1.1749071030525327,0.23541247484909456,0.5491757182157034,1.0,2/19,0.80%,BMP6;AFDN
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.31811321776669577,-1.174814046166357,0.19721115537848605,0.5488220613330385,1.0,23/84,20.15%,SAMD4A;IGF1;IGFBP5;ROCK1;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;GGA3;LSM14A;CNOT8;YBX1;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1;ABCA7;CNOT10;RBM4;ORMDL3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4160747571511311,1.1742659947033918,0.2356687898089172,0.6757778555732796,1.0,8/22,15.63%,RPS20;RPL23;RPL37;UBB;RPS15;RPS7;ATM;CHD5
prerank,protein tetramerization (GO:0051262),0.3235617974026424,1.1741004433301159,0.17391304347826086,0.6748719707255553,1.0,15/67,15.56%,HCN1;GRIN1;RYR3;GRIN2B;SNCA;TRPM2;KCNC3;HPRT1;HOMER1;KCNC1;FARSB;AQP4;GOLGA2;B2M;GLS
prerank,amino sugar biosynthetic process (GO:0046349),-0.4922989729782806,-1.1736906963242468,0.25892857142857145,0.5510430953705676,1.0,5/12,26.42%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5208429029930461,-1.1735341243472215,0.27552986512524086,0.5508402950695004,1.0,5/11,25.93%,COA8;SLC30A10;ABCD2;PARK7;PPARA
prerank,cellular response to alcohol (GO:0097306),-0.3520460213676543,-1.173439508866965,0.19649805447470817,0.5504933687002652,1.0,12/42,9.18%,ADCY5;LRP6;KLF9;CTNNA1;SMO;SPIDR;GRAMD1C;CDH1;ADCY1;LARP1;ADCY6;JUP
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3612285417664471,-1.1733330246968579,0.2169811320754717,0.5501936529995461,1.0,14/39,17.65%,KMT5B;SPIDR;FUS;WDR48;SHLD2;PARP9;PARP1;KMT5C;SLF1;DTX3L;MMS19;PRKDC;SMCHD1;ARID2
prerank,membrane organization (GO:0061024),0.272760002278365,1.1732982968155772,0.10795454545454546,0.6757826289295162,1.0,48/227,15.25%,TFRC;DNM3;ACTB;SYT1;RIMS1;SGCZ;SH3GL2;AP2M1;ANK3;REEP1;BIN1;LPCAT2;SLC18A3;CERT1;HIP1;ATP10B;HSPA8;FNBP1L;AMPH;FCHO1;NAPG;RPS27A;UBC;DYSF;UBB;SCARB2;AP2B1;SAR1A;SUN1;SYT2;SPTBN1;CCDC88A;FZD4;PLEKHA3;SERP1;LEMD2;CNTN2;CPTP;SGIP1;TTPA;CLTB;SNAP29;NECAP1;SH3KBP1;PPT1;CHRM2;CORO1C;REEP3
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.47272017133565647,-1.173181490989317,0.2681992337164751,0.5500424642966437,1.0,2/13,2.90%,DCN;BGN
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3394457275545091,-1.1730677733262334,0.20114942528735633,0.5497548131368294,1.0,14/59,14.01%,EGFR;PDGFRA;TPM1;ABL1;ANXA1;MAP3K5;PTPRK;IMPACT;CYP1B1;FER;JUN;PRKCD;PKD2;ERCC6L2
prerank,regulation of autophagosome maturation (GO:1901096),-0.47481312784515783,-1.172931807765627,0.26151012891344383,0.5495006876745835,1.0,5/13,27.38%,UVRAG;RUBCN;IRGM;UBQLN4;ADRB2
prerank,fatty acid catabolic process (GO:0009062),-0.32465646956958766,-1.1728748590913929,0.1752988047808765,0.5490752465145065,1.0,24/67,24.47%,PCCA;ABCD3;ACADM;MMUT;ACAD10;ABCD2;ACAD11;CPT2;ABHD3;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;LPIN2;ECI1;LPIN3;MECR;MCEE;ACOT8;AUH;ILVBL
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3269392545655594,-1.172613073202705,0.18452380952380953,0.5491339967311714,1.0,30/67,28.23%,PLD1;TBC1D16;DCDC2;ATP8B1;TBC1D19;TBC1D24;CDC42;USP6NL;TBC1D2B;TBC1D20;FER;IFT88;CAPZB;TBC1D22B;DYNC2LI1;P2RX4;ATG5;TBC1D17;RABGAP1;TBC1D10A;ABITRAM;RAB5A;IFT140;FXR1;TWF1;TWF2;TBC1D10B;ATG3;TBC1D9B;RABEP2
prerank,lipid phosphorylation (GO:0046834),0.505078499125023,1.1724224954988098,0.2683982683982684,0.6771122489766607,1.0,3/10,7.01%,DGKI;DGKH;DGKB
prerank,positive regulation of cyclase activity (GO:0031281),-0.47343759270100993,-1.171864009330526,0.2732793522267207,0.5504149093852688,1.0,3/14,7.81%,CACNA1C;STIM1;CACNA1D
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.34297960618370293,-1.1716213503470163,0.19731800766283525,0.5504989064431975,1.0,18/49,24.75%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;RUNX1;MEF2C;PITHD1;HDAC1;TNRC6C;KMT2A;AGO1;CNOT4;KMT2E;RAB7B
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4584215488337684,-1.1714787888328861,0.26806083650190116,0.5502987201583274,1.0,6/15,25.22%,PTN;LRRK2;VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.45625169410004773,1.1710673739775903,0.2554112554112554,0.6798244423208635,1.0,4/15,12.04%,FST;MAGI2;CSNK2B;SMAD7
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38450024021585916,1.1708722175986428,0.23779193205944799,0.6790002242016305,1.0,4/29,12.48%,CADM1;IL12A;CYRIB;ITGAM
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4780792934120377,-1.1707614263887174,0.26811594202898553,0.5514751243478,1.0,7/13,19.13%,PKD1;FLNA;PKD2;SUFU;LATS1;GET4;MDFI
prerank,regulation of multicellular organism growth (GO:0040014),-0.46230744307500243,-1.1706580714536352,0.250501002004008,0.5511713963286491,1.0,5/15,17.73%,IGF1;GHR;PTCH1;STAT5A;STAT5B
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.44584546808984993,-1.1700999029944774,0.24949698189134809,0.5519682101141904,1.0,7/16,30.62%,VAMP7;CEBPG;VAMP2;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.35996456204871713,-1.1698627680104716,0.20588235294117646,0.5520115278310749,1.0,17/41,28.62%,ACSL1;DAGLA;PTGS1;CYP1B1;PLA2G4A;PNPLA8;EPHX1;ACOX1;DECR2;MGLL;ELOVL1;ACOT8;DAGLB;GSTM2;ALOX12;ELOVL5;PLA2G4C
prerank,positive regulation of viral process (GO:0048524),-0.33366778545377807,-1.1698487102731807,0.201171875,0.55148960442983,1.0,27/60,31.72%,MDFIC;AXL;CCNT1;KPNA6;DHX9;LARP1;TBC1D20;NELFB;DDX3X;PPIH;POLR2H;PPID;GTF2F1;POLR2K;RAB7A;CTDP1;POLR2E;PPARA;PDE12;POLR2D;NELFA;CDK9;NELFE;KPNA2;ADARB1;NR5A2;TYRO3
prerank,protein dephosphorylation (GO:0006470),-0.2924807334349237,-1.169783984328232,0.14785992217898833,0.5510905791123577,1.0,34/135,15.19%,EYA2;PTPN13;EYA1;EYA4;PPP1R12A;PPM1D;PTPN14;PPM1E;TNS2;BTRC;PTPN9;PTPRS;PTPN21;DUSP16;PTPN3;SSU72;PTPRK;DAPP1;PTPN22;PPP4R2;PPP2CB;PPM1H;PTPN12;PTPN2;DUSP11;PPP2R5E;PPM1M;MTMR3;PPM1A;PPP2R5D;DUSP1;CDC14B;NCK1;PPP1CB
prerank,heterochromatin organization (GO:0070828),0.4620486254162164,1.1691956525403855,0.27155172413793105,0.6826626240285413,1.0,3/14,3.68%,MECOM;SIRT1;HMGA2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3870187856733973,-1.1685450365199066,0.2467289719626168,0.5536919920523515,1.0,12/29,24.09%,UBE2N;ABL1;AXIN1;FBXW7;DTX3L;TOPORS;FEM1A;DCUN1D3;PARK7;ARRDC4;MAGEC2;BAG5
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.510123510026406,-1.1682411017281622,0.25405405405405407,0.553885093982939,1.0,5/11,24.06%,PRKN;REST;HIF1A;PARK7;NONO
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4713337508711831,1.1679506151547412,0.2760084925690021,0.6850239843532763,1.0,2/12,2.58%,GRIN1;ADGRB1
prerank,negative regulation of cell growth (GO:0030308),0.29386694372101846,1.1675013943479646,0.14688128772635814,0.6849504724441587,1.0,28/121,16.45%,DCC;MINAR1;MAG;MAP2;SIRT1;GNG4;FGF13;APBB1;SCGB3A1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;RTN4R;APBB2;SOX17;DIP2B;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.38045079798708686,-1.1674572131438592,0.2357563850687623,0.5553081983108384,1.0,15/33,21.55%,FGF1;JAK1;RHOJ;THBS1;PDPK1;GLUL;ADAMTS9;BMPER;CEMIP2;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.42420937679113796,-1.1670474852579016,0.26136363636363635,0.5557323803484805,1.0,5/20,10.52%,TGFBR1;ZMIZ1;PRKN;UBQLN1;HIF1A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3196866475319704,1.1666004269451926,0.1843137254901961,0.6862706443016848,1.0,12/72,7.73%,FLT1;IGF1R;TEK;SIRT1;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4130223740199282,-1.1663981976810576,0.2563600782778865,0.5567354599824248,1.0,9/21,23.47%,SMO;DCDC2;TTC23;EVC;ARMC9;GLI1;PDCL;DLG5;KIF7
prerank,blood vessel morphogenesis (GO:0048514),0.3382163273027016,1.1662440377965304,0.20118343195266272,0.6860396262055556,1.0,10/54,7.29%,FLT1;EGFL7;PROX1;RAMP2;CDH2;KDR;SLC1A1;TGFBR3L;ID1;APLNR
prerank,negative regulation of catalytic activity (GO:0043086),0.39484160882120567,1.165907262805631,0.2484725050916497,0.6856905336663529,1.0,4/24,7.74%,CAMK2A;SIRT1;NOTCH1;TIMP1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.47512780175039493,-1.1658720173746442,0.27431906614785995,0.5575158899164364,1.0,8/13,31.29%,UBQLN1;RNFT1;TMEM259;USP13;BAG6;NFE2L2;CAV1;HERPUD1
prerank,muscle tissue morphogenesis (GO:0060415),-0.4412992458484617,-1.1656366984492492,0.25390625,0.557621532708893,1.0,3/16,2.70%,TGFBR3;MYLK;BMP4
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.313463103746121,-1.1651533486790104,0.17943548387096775,0.5583217251199313,1.0,23/76,17.54%,NTRK3;FCHSD2;ABL1;BAIAP2L1;NUMA1;BCAS3;SNX9;NRP1;CDC42;VASP;CDC42EP5;SYNPO2;FER;NES;NCKAP1;SYNPO;CTTN;NCK1;CARMIL1;NCK2;DYNC1H1;SORBS3;CDC42EP4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3984086683698098,-1.1648676410495242,0.25,0.5584335228032904,1.0,6/26,16.46%,ATP1A2;UBQLN1;PKD2;SRI;YWHAE;ADRA2A
prerank,lipid homeostasis (GO:0055088),-0.33564271115960964,-1.1648607542396887,0.20866141732283464,0.557893003922487,1.0,15/57,17.80%,ZBTB20;RBP1;ABCA1;NR1D2;PRKAA2;ABHD5;TLCD2;NR1H3;RCN3;PNPLA8;FBXW7;APOE;DDX3X;ACOX1;PRKAA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45479284671219544,1.164093053314434,0.2891304347826087,0.6897460686148413,1.0,4/15,5.70%,IGF1R;KDR;AATK;SRMS
prerank,regulation of osteoblast proliferation (GO:0033688),-0.438760487841932,-1.163809176927219,0.27289719626168224,0.5598674611495875,1.0,10/17,20.73%,NPR3;FGFR2;MN1;RHOA;ATRAID;CCN1;EIF2AK2;PLXNB1;BMP2;TMEM119
prerank,prostanoid biosynthetic process (GO:0046457),-0.46235585328758133,-1.163736689308278,0.2555970149253731,0.5594851161794436,1.0,6/15,12.45%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,regulation of chemotaxis (GO:0050920),-0.3824268646501605,-1.1635683628714726,0.25502008032128515,0.5593595421218343,1.0,10/30,15.20%,PDGFRA;EFNB2;PDGFRB;THBS1;ADGRA2;ZSWIM8;PTPN2;STX4;P2RY12;P2RX4
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49965599200593214,-1.1634800002668517,0.27848101265822783,0.5590212885359214,1.0,5/10,24.97%,BMP5;HOXA7;EMILIN1;CD300A;SLIT2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.45666244241958937,-1.1634694514635715,0.2678227360308285,0.5584840623298821,1.0,4/16,11.69%,APPL2;NCOR1;WDTC1;ERLIN1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.40263993679121846,-1.1634681626134276,0.26053639846743293,0.5579312835591101,1.0,3/24,3.72%,EPHA7;FOXO3;NUPR1
prerank,negative regulation of DNA binding (GO:0043392),0.395759949179053,1.1634073591568648,0.2520833333333333,0.6904836166055991,1.0,7/28,13.26%,LEF1;HEY1;HMGA2;CPNE1;PER2;SIN3A;NFKBIA
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.39847925072789153,1.163291524081063,0.2505050505050505,0.6893999317971181,1.0,11/26,21.50%,NAV3;OCLN;PAK1;STMN2;DCTN1;RPS3;TRPV4;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,plasma membrane organization (GO:0007009),-0.3290210388369291,-1.162616821214283,0.18774703557312253,0.5595049279480147,1.0,16/61,11.73%,ANK2;COL5A1;ANXA6;A4GALT;PLSCR4;PLSCR2;PACSIN2;SNX9;MYOF;PLSCR1;CHMP4A;EHD2;ABCD2;TLCD2;STX4;UGCG
prerank,regulation of phospholipase activity (GO:0010517),-0.5103084269444448,-1.1621914946231715,0.26895306859205775,0.5599368276085096,1.0,3/10,7.95%,LRP1;FGFR2;PDPK1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.31830775492606483,-1.1619886705196951,0.18108651911468812,0.5599133470564,1.0,26/78,22.82%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;UBQLN1;RNF19A;NUB1;CSNK1E;TRIB2;SH3RF2;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;DET1;RNF144A
prerank,vasculogenesis (GO:0001570),0.37353510435330406,1.161851761114366,0.23689727463312368,0.6922617394632651,1.0,7/32,7.29%,EGFL7;RAMP2;KDR;TGFBR3L;NOTCH1;WNT7B;APLNR
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3590918693469696,1.1617660397356062,0.23578947368421052,0.6911094565004211,1.0,17/38,24.15%,MAGI2;SIRT1;PHLPP1;TRIB3;PTPRJ;AKT1;CIB1;PPP2R5B;PDCD6;ARRB2;HYAL2;RACK1;EPHA2;PHLDA3;DDIT3;FLCN;PIK3CB
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3184192791766729,1.1617257679855573,0.19747899159663865,0.689812104709336,1.0,11/70,9.41%,MBOAT1;MFSD2A;LPCAT2;PCYT1B;CHKA;ENPP2;CSNK2B;PLAAT1;TMEM86B;SLC44A5;PLA2G12A
prerank,sphingolipid biosynthetic process (GO:0030148),0.32173227845778246,1.1616975686302726,0.19750519750519752,0.688487902862829,1.0,22/71,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ST8SIA1;ELOVL7;SGPP2;ELOVL4;B4GALT6;SMPD1;HACD3;ST8SIA3;HACD1;PPM1L;SAMD8;PRKD3;TLCD3B;KDSR;SGPP1;SPTLC2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4035641207676497,1.1616321000581196,0.2489539748953975,0.6872717505928136,1.0,6/23,16.28%,CHEK1;BUB1;WEE2;NABP1;CHFR;PLK2
prerank,methylguanosine-cap decapping (GO:0110156),-0.5058625172920908,-1.1610503306057387,0.28823529411764703,0.5617984431778462,1.0,3/10,14.65%,DCP1A;DCP1B;EDC3
prerank,positive regulation of translation (GO:0045727),-0.30501680750317256,-1.16061635097641,0.17365269461077845,0.5623366549710691,1.0,18/94,14.84%,SAMD4A;PLD1;VIM;ZCCHC4;YTHDF3;KHDRBS1;THBS1;DHX9;MTOR;LARP1;HNRNPD;DHX36;PLXNB2;RCC1L;YBX3;CDC123;PRKDC;DDX3X
prerank,membrane lipid biosynthetic process (GO:0046467),0.3352471731223245,1.1605441813647979,0.25363825363825365,0.6892796197767203,1.0,18/58,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ELOVL7;SGPP2;ELOVL4;HACD3;ST8SIA6;HACD1;PPM1L;SAMD8;PRKD3;KDSR;SGPP1;SPTLC2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4280073253937785,-1.160501362502998,0.2765957446808511,0.5620795637063394,1.0,4/19,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,regulation of response to external stimulus (GO:0032101),-0.2910972323539594,-1.1602976007191392,0.155893536121673,0.5620010064119898,1.0,37/121,24.14%,FOXP1;APPL2;ADAMTS12;PDGFRA;EFNB2;CELF1;NR1D2;NMT2;CD55;SBNO2;ADGRA2;UFL1;ANXA1;GRK4;CASP12;XIAP;PTPN22;PTGES;TRIM5;AGTR1;APPL1;IRF1;PIK3AP1;P2RY12;P2RX4;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;GATA6;CAMKMT;DAGLB;USP18;FNTA;IL1RL2
prerank,intracellular sterol transport (GO:0032366),-0.4768253018139442,-1.160273795241086,0.2616822429906542,0.5615091892476121,1.0,3/13,11.62%,ABCA1;RELCH;NPC2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4041507158902975,1.1602062737373242,0.25957446808510637,0.6888974889810167,1.0,3/22,9.29%,SLC7A5;TRIM6;TRIL
prerank,regulation of developmental growth (GO:0048638),-0.38448939117561926,-1.1600748303706763,0.24339622641509434,0.5614572352018476,1.0,12/29,18.98%,IGF1;GHR;ABL1;GSK3B;NIPBL;CTTN;APOE;LATS1;SIX1;STAT5A;STAT5B;MUSK
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.45739832666042335,-1.159898972799232,0.2604735883424408,0.5613407308484308,1.0,6/14,15.87%,ADK;GMPS;PPAT;ATIC;RFK;PAICS
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3524321682145801,1.1597509705045843,0.22267206477732793,0.6888963377549154,1.0,7/46,4.15%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2
prerank,lung epithelium development (GO:0060428),-0.49754694666619736,-1.1596606804345468,0.29111531190926276,0.5613677257709622,1.0,3/10,2.70%,ERRFI1;PKD1;BMP4
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.461942135062258,1.1596166856196213,0.2422907488986784,0.6878546553314251,1.0,3/13,7.89%,TMEM35A;STX3;HSP90AB1
prerank,neutrophil degranulation (GO:0043312),0.2547883083709464,1.1596050695565614,0.08704061895551257,0.6865123107098584,1.0,90/425,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.4628563811815384,-1.159455712990378,0.2647058823529412,0.5613277957136855,1.0,5/14,22.91%,ANXA1;NFKBIZ;PRKCZ;IL18;CD80
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.30850194860606545,-1.1593333649964281,0.18801652892561985,0.5610863530281941,1.0,31/88,25.00%,TRABD2B;SMAD3;MPP7;BMP7;GSK3B;SPIDR;VPS4B;STX18;BRK1;SYNPO2;FNIP1;TPR;SLF1;SYNPO;VEGFA;EMILIN1;SDC4;ICE1;VCP;PARK7;RHOC;AJUBA;SNF8;PIH1D1;BMF;PRKCA;ERCC1;GNL3L;SYK;RAB7A;SDC1
prerank,endoplasmic reticulum organization (GO:0007029),-0.3162491035666188,-1.1592712693266456,0.21083172147001933,0.5606896551724138,1.0,25/72,23.65%,TRAM2;LRRK2;ATL3;DNM1L;RAB10;EIF2AK3;STX18;VAMP2;VCPIP1;SEC31A;ATL2;STX5;DOP1B;ZBED3;EMD;MIA3;GET4;SEC16B;SMPD4;TMCC1;SEC16A;LPCAT3;VAPA;LMAN1;SPTSSB
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4030203890037591,-1.1590634484440185,0.26519337016574585,0.560686768655036,1.0,4/26,5.66%,LARGE1;ST3GAL4;GK5;RRM2B
prerank,regulation of chromosome organization (GO:0033044),-0.41672309286365344,-1.1589171873082664,0.26692456479690524,0.5605085977472823,1.0,7/22,12.65%,SMG6;HDAC8;SMG1;YLPM1;HNRNPD;UPF1;RB1
prerank,positive regulation of protein processing (GO:0010954),-0.4358999265921855,-1.1580631779492128,0.2685370741482966,0.5620819620710086,1.0,3/19,4.69%,GSN;CCBE1;CLEC3B
prerank,DNA dealkylation (GO:0035510),-0.5038085221909435,-1.157762058766945,0.27893738140417457,0.5617052979990604,1.0,3/10,12.13%,FTO;ASCC3;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5038085221909435,-1.157762058766945,0.27893738140417457,0.5617052979990604,1.0,3/10,12.13%,FTO;ASCC3;ALKBH1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.43546901043491576,-1.1573212816980467,0.2706766917293233,0.5623102308197166,1.0,4/19,11.49%,NFAT5;PLCE1;INPP5A;NFATC4
prerank,error-prone translesion synthesis (GO:0042276),0.40151407025797725,1.15726745993051,0.26180257510729615,0.6920669274834675,1.0,9/21,19.15%,RPA3;RPS27A;UBC;POLK;UBB;RFC4;RFC5;RFC2;POLI
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3622264224977926,-1.157150095532477,0.25139664804469275,0.5622185648801942,1.0,15/36,24.27%,FHIT;USP7;RPL11;GIPC1;PSMF1;OGT;TRIM39;NOP53;PSME3IP1;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,chemokine-mediated signaling pathway (GO:0070098),0.35626811396970387,1.1570638134291897,0.23404255319148937,0.6912892555704413,1.0,11/42,21.32%,CXCL12;GPR35;CCL2;THPO;GPR75;STK39;CIB1;CCL25;CCL13;CCL19;RBM15
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4270711966163468,-1.157053072939621,0.26587301587301587,0.561929574740815,1.0,2/18,5.19%,EGFR;LCOR
prerank,regulation of vasoconstriction (GO:0019229),0.380191924001548,1.1569849272868602,0.24109014675052412,0.6901879966948482,1.0,8/27,12.87%,CHRM3;KCNMB2;KCNMB4;ADRA1D;ADRA1A;F2R;PER2;BMPR2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.4665142747040114,-1.1565767926583757,0.30093457943925234,0.5625371685553127,1.0,2/14,3.11%,ZEB1;OSR1
prerank,import into cell (GO:0098657),-0.3529094401077482,-1.1565759714756818,0.2538167938931298,0.5619921754882362,1.0,12/41,14.16%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;SLC5A3;SLC39A14;SLC12A7;LRRC8D;GLUL;SLC5A6;SLC22A4;SLC27A1
prerank,protein autophosphorylation (GO:0046777),0.28156173556570535,1.1565508620310143,0.1411530815109344,0.6901338743296682,1.0,23/157,9.10%,FLT1;CAMK2A;IGF1R;TEK;ERBB4;CSF1R;EPHB1;HTATIP2;TNIK;MEX3B;KDR;CAMK4;NTRK2;WNK2;FLT3;AATK;SRMS;ALK;PAK1;MELK;AKT1;CDKL5;TAOK2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.413305963647151,-1.1565269438804076,0.274703557312253,0.5615768219332193,1.0,4/21,7.81%,ANK2;FLNA;SNTA1;CACNA1D
prerank,regulation of protein binding (GO:0043393),-0.2892942533676335,-1.1561260357785859,0.14484126984126985,0.5619908833832777,1.0,40/114,25.22%,TCF7L2;LRP1;PKD1;DAB2;STK3;ROCK1;BMP4;HDAC4;PRKN;LRRK2;VTN;GSK3B;STYX;MARK3;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;RPL11;DTX3L;RAPGEF2;PSME3IP1;DERL1;PRKACA;PRMT8;BMP2;PARK7;CARD16;SPPL3;TERT;PPP2CA;BTBD1;GTF2F1;HIP1R;TMBIM6;GNL3L;CFHR2;KDM1A
prerank,regulation of cell population proliferation (GO:0042127),-0.24254496389993188,-1.1556356137054153,0.04201680672268908,0.5626330621145543,1.0,178/691,21.76%,BMP6;IGF1;GRK5;EGFR;ALDH1A2;TCF7L2;GAB2;TGFBR1;ZBTB7C;RBFOX2;PTN;BMPR1A;IL34;PDGFRA;KANK2;NTRK3;LIMS1;EFNB2;SMAD6;CELF1;COL4A3;BMP5;MDM4;ITGAV;DIS3L2;KSR1;FGF1;PDGFRB;KAT2B;PIAS1;IL6ST;IL31RA;BMP4;HDAC4;PDPN;PPM1D;ELN;BIRC6;JAG1;NPR3;PTPN14;TGFBR2;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;KIT;CLMN;NIBAN2;YAP1;IRS1;RARG;IGFBP3;TGFB1I1;KMT2D;CTSH;IL13RA1;IGFBP6;THBS1;DPP4;GAREM1;SKI;SPEG;STAT3;UFL1;TMEM127;FGFR2;SHC1;BCL2;NOX4;RUNX1;LYN;TES;REST;WNT9A;P3H3;AR;ACER3;IGF2;PTPRK;XIAP;MAP2K1;CDK13;JUP;CYP1B1;BTG3;COL18A1;NGF;FER;PTPN2;EGLN3;PDGFC;RHOA;JUN;ID2;STX4;ABI1;CNOT8;ROR2;PDS5B;HES1;AGTR1;PKD2;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;IRF1;GLI1;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;STAT1;CD164;PRKDC;RBM5;VEGFA;HDAC1;CIAO1;CBFA2T3;CDC25B;RAPGEF2;VEGFD;NCK2;CSNK2A1;MNT;TGFB3;ADRA2A;ADAMTS1;SIX1;STAT5A;TBX2;TCIRG1;CACUL1;PHIP;ARID2;STAT5B;S100A11;PPP2R5C;SFRP4;PTGFR;SOD2;DHPS;SQLE;FGFBP1;GCNT2;IFI35;BMP2;HBEGF;CDK10;INHBA;CDK2;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;FGFR4;NME1;ZBTB49;CDK6;FXN;TRAPPC14;XRCC6;AKT2;GID8;FGF2;EZH2;ECRG4;DLG5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42156500024485927,1.1553461746513054,0.24793388429752067,0.692321610240754,1.0,2/18,8.61%,CAMK2A;HEBP2
prerank,gland development (GO:0048732),-0.33251520375860044,-1.1548855366967972,0.20883534136546184,0.5639439208585965,1.0,17/59,17.00%,TGFBR3;TGFBR1;WNT4;GLI2;DKK3;FGFR2;ANXA1;CEBPG;ZBTB1;PHF2;ARID5B;HES1;PKD2;TGFB3;SALL1;CITED2;SIX1
prerank,L-amino acid transport (GO:0015807),0.39464864622753343,1.1544544765786042,0.2603305785123967,0.693596973807018,1.0,6/28,9.57%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC7A8;SLC36A1
prerank,glycerolipid catabolic process (GO:0046503),0.4211295758737189,1.154268491378436,0.2894168466522678,0.6928036359163802,1.0,2/19,2.01%,GPCPD1;ABHD2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.4888694169089177,-1.153568911147393,0.2940074906367041,0.5666000276601937,1.0,7/11,32.96%,WIPI1;ATG9A;WDR45B;WIPI2;STX17;MFN2;WDR45
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2861688072098046,1.153546455516504,0.15637065637065636,0.6936932649463643,1.0,31/152,16.95%,ADGRL4;ADGRL3;ADGRB3;RGS1;ADCY8;ADCY3;RAMP2;ADGRB1;GRM8;S1PR5;PDE2A;LGR5;MTNR1A;ADCYAP1;GPR26;GNAL;ADRA1D;ADGRL2;ADCY4;CNR1;PTGER2;OPRK1;ADGRG1;CHRM2;OPRL1;GNAI1;GNAQ;CALCRL;ADCYAP1R1;ADGRE1;PTGER4
prerank,regulation of immune effector process (GO:0002697),-0.3581658023662951,-1.1534486831941144,0.2095435684647303,0.5663320960610346,1.0,5/41,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3180719964430219,-1.153399301207095,0.23300970873786409,0.5659034436690753,1.0,24/72,26.62%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K;POLR2E;NCBP2;FGFRL1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.3723838787888687,-1.1530295926975211,0.24299065420560748,0.5663385575630293,1.0,13/31,27.52%,TNKS2;NBN;HNRNPD;DHX36;NABP2;MAP2K7;MRE11;PML;ERCC1;PPP1R10;NEK7;GNL3;ATRX
prerank,fatty acid biosynthetic process (GO:0006633),0.3192034183594907,1.1527414772166402,0.2268041237113402,0.6947446806394296,1.0,16/63,17.68%,ABHD2;ELOVL7;CYP2E1;ELOVL4;TECR;HPGD;HACD3;SCD;ACOT7;FADS1;XBP1;HACD1;LTA4H;TECRL;NDUFAB1;LIAS
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.3045881328658709,-1.1524578204260745,0.18857142857142858,0.5672280278775887,1.0,26/94,21.52%,ITPR1;FHIT;DDX5;PDK1;ABL1;BCL2;MAP3K5;AIFM1;CYP1B1;TRAF2;PRKCD;PRODH;CUL3;CASP2;PRKDC;ERN1;DDX3X;CUL2;TOPORS;IKBKE;RRP8;MSH6;PML;ATP2A3;CUL1;BNIP3
prerank,regulation of hydrolase activity (GO:0051336),0.31388043811808436,1.1520110404985866,0.19246861924686193,0.6955833768120672,1.0,15/71,10.93%,CAMK2A;PLXNB3;EPHA5;CHN2;VAV3;NTRK2;PRKG1;RAP1GAP;SCARB2;PLXNA4;FGD5;CFAP100;DAB2IP;CHN1;FGD3
prerank,cellular response to insulin stimulus (GO:0032869),-0.28770345762408445,-1.1512578911915805,0.17408123791102514,0.5696856155962766,1.0,41/124,21.32%,RHOQ;SORBS1;GRB10;KAT2B;ATP6V1B2;ENPP1;GSK3B;IRS1;ATP6V0D1;SLC39A14;INSIG2;RAB10;SHC1;FOXC2;ATP6V0A4;RAB12;PDPK1;VAMP2;IGF2;SELENOS;FER;PTPN2;DENND4C;PARP1;APPL1;PCK2;SLC27A1;PRKDC;CPEB1;TCIRG1;PHIP;LPIN2;SYAP1;LPIN3;INPP5K;GAB1;PKM;BAIAP2;PIK3R1;USF1;AKT2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43479303385277057,-1.1508444268798892,0.28517110266159695,0.5700997805506127,1.0,4/17,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.48209699072454953,-1.1506763267106859,0.2906764168190128,0.5699606964715147,1.0,5/12,16.87%,DPYSL3;CTPS2;ALDH6A1;DPYD;CTPS1
prerank,microtubule nucleation (GO:0007020),-0.4222817828473617,-1.1506358205714817,0.2727272727272727,0.5695253056007518,1.0,9/20,19.55%,CENPJ;TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;TUBGCP4
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4136121576982086,1.1502774073724993,0.23956043956043957,0.699449400728744,1.0,3/21,4.74%,CSF1R;MIF;MTUS1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.37156392126827276,-1.1502015251561064,0.2560747663551402,0.5700791428534898,1.0,14/30,24.27%,FHIT;STYX;USP7;RPL11;GIPC1;OGT;TRIM39;NOP53;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.45548480958233795,1.1501249402253007,0.26526315789473687,0.6985081711837675,1.0,2/13,4.08%,RPP40;RPS21
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.29755843994162606,-1.1500083297283614,0.16536964980544747,0.5700364797171036,1.0,46/110,24.93%,TRABD2B;GSN;ABCA1;MPP7;EP300;GSK3B;SPIDR;STXBP1;CDC42;BRK1;IMPACT;TRAF2;HCFC1;ATF7IP;HJURP;FNIP1;RIOK3;RB1;SLF1;EIF2AK2;GFAP;APOE;VEGFA;DDX3X;LATS1;PRKCZ;FARP2;NOP53;IAPP;ICE1;VCP;NAPA;PARK7;RHOC;PTPN11;AJUBA;KIF9;FBLIM1;PIH1D1;BMF;HSF1;PREB;SAR1B;GNL3L;SYK;IRGM
prerank,neural tube development (GO:0021915),-0.4432603513897183,-1.1496979608389168,0.25775193798449614,0.5702439495630034,1.0,6/15,15.44%,ALDH1A2;PKD1;ARL13B;DACT1;PKD2;PTCH1
prerank,fatty acid transmembrane transport (GO:1902001),-0.4207383811290913,-1.1495437618956348,0.27087198515769945,0.5700825780551086,1.0,8/19,14.16%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;SLC27A1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3855679988393669,-1.1495301694140898,0.25440313111545987,0.5695670963362265,1.0,10/27,20.46%,AHNAK;ANK2;JPH1;CAMK2D;SELENON;YWHAE;CACNB1;ADRA2A;PRKACA;NOS1
prerank,positive regulation of phosphorylation (GO:0042327),-0.26750212073735885,-1.1492833697602647,0.10547667342799188,0.5696617066365055,1.0,38/240,8.58%,ZBTB20;ROCK2;IGF1;ROR1;EGFR;LMO4;EPHA7;LEPR;EPHA3;IL34;PDGFRA;ANGPT1;SLCO3A1;NTRK3;PELI2;FGF1;PDGFRB;AXL;DAB2;FAM20A;BMP4;ABL1;ARNT;LRRK2;PRKAA2;KIT;RYK;THBS1;AXIN1;NBN;NRP1;FGFR2;PFKFB4;LYN;MERTK;AR;EPHA4;IGF2
prerank,neutrophil mediated immunity (GO:0002446),0.2521426409491491,1.149091013315505,0.09215686274509804,0.700312406280344,1.0,90/432,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,positive regulation of vasculogenesis (GO:2001214),0.4881945021853511,1.1490767405556244,0.2986425339366516,0.6989824833720183,1.0,4/10,16.17%,KDR;CD34;RIN2;RAP1A
prerank,amino acid import (GO:0043090),0.4118174614967852,1.1489481562285584,0.2559652928416486,0.6980291987733203,1.0,6/21,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC7A8;SLC36A1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.4513557960207132,-1.1488913921842625,0.2877442273534636,0.5701599270701783,1.0,9/14,31.46%,UPP2;NT5M;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,protein destabilization (GO:0031648),-0.3678221589146899,-1.1486839921875278,0.26476190476190475,0.5701572030640819,1.0,11/32,19.85%,GSN;EP300;PRKN;BTRC;CTSH;CREBBP;GGA3;CUL3;DERL1;FBXW11;CDC73
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.36997931067839185,-1.1483927488640326,0.2553191489361702,0.570339534087527,1.0,13/33,22.87%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6;PLK5
prerank,regulation of macrophage cytokine production (GO:0010935),0.4535148550500357,1.1483655173346203,0.2840909090909091,0.6984486413954728,1.0,3/13,5.82%,SIRT1;SEMA7A;TGFB2
prerank,synaptic vesicle recycling (GO:0036465),0.3804851133352488,1.1482759543793362,0.25316455696202533,0.6973235650510157,1.0,12/31,18.86%,SYT1;NLGN1;SYT7;SNCA;AMPH;SYT2;PLD2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3645645524670329,1.148240457320113,0.24329896907216494,0.6960956109732961,1.0,9/35,14.53%,FAR2;HPGD;GGT7;SCD;GGT1;HMGCLL1;BDH1;FAR1;PPT1
prerank,calcium ion import (GO:0070509),0.38073002495674546,1.1479769634475003,0.2783300198807157,0.6955284720557772,1.0,6/28,7.35%,CACNA1A;CACNA1B;SLC8A1;SLC25A23;CACNA1E;CACNB2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3266945759364877,-1.1479380489192397,0.21714285714285714,0.5709116825796178,1.0,14/55,15.14%,TGFBR1;WWOX;NUPR1;GSDME;DNM1L;PAK2;BCL2;TRAF2;BCLAF1;BECN1;LTBR;ING5;TPD52L1;TRIM39
prerank,ERBB2 signaling pathway (GO:0038128),0.3704697002874832,1.1478509300884552,0.27044025157232704,0.694546856351921,1.0,5/31,6.84%,ERBB4;PTPRR;NRG2;NRG1;PTPN18
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3954815266290608,-1.1478045190366823,0.2571428571428571,0.5706952263503496,1.0,8/26,17.96%,APPL2;LGR4;FLOT2;IRAK3;APPL1;IRF1;OTUD4;LRRC14
prerank,cortical cytoskeleton organization (GO:0030865),-0.3521650681979346,-1.147224817694263,0.23668639053254437,0.5716191516806873,1.0,12/41,18.96%,ROCK2;RHOQ;ROCK1;DLG1;RND3;FHOD1;RHOA;NCKAP1;RHOBTB2;RHOBTB1;RHOH;RHOC
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.32179635406397483,-1.14704786285463,0.22676579925650558,0.5715358904896988,1.0,27/69,29.28%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,neutrophil activation (GO:0042119),0.46778426457488986,1.1468794371007693,0.28475336322869954,0.6961069055454584,1.0,2/12,6.96%,DNASE1;PREX1
prerank,protein-containing complex disassembly (GO:0032984),-0.3357144604221482,-1.1466366698357962,0.24517374517374518,0.5720053103314238,1.0,12/54,10.04%,LRP6;CSNK1A1;UVRAG;GSK3B;AXIN1;UBQLN1;FZD2;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3995690879385926,-1.1465877791429826,0.27884615384615385,0.5715741597718156,1.0,5/23,10.83%,TGFBR3;TPM1;FGFR2;ADAMTS9;ID2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.41511232669572695,1.1464620281000069,0.26907630522088355,0.6959672179618915,1.0,5/19,5.98%,HS6ST3;HS3ST5;HS6ST2;CSGALNACT1;NDST4
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.49804719996370517,-1.1462984177361717,0.3104125736738703,0.5717539475715857,1.0,4/11,23.39%,IL34;ID2;PRKCA;HSF1
prerank,regulation of cell cycle (GO:0051726),-0.2614807911829523,-1.1462518782015236,0.10619469026548672,0.5713159606889703,1.0,76/271,21.34%,NOTCH2;GRK5;TCF7L2;SMAD3;TGFBR1;SON;PKD1;LRP6;FBXL17;ANKRD17;KAT2B;BMP7;EP300;BMP4;GBF1;ABL1;CDC14A;NUPR1;CDK7;THBS1;UHRF2;NBN;STAT3;FGFR2;ASAH2;PUM1;FBXL12;MAEA;PTPRK;XIAP;MAP2K1;PRCC;MAP3K20;JUN;HCFC1;ID2;CDK11B;FAP;PKD2;SIK1;RB1;CDC123;IRF1;CDC26;CRLF3;DUSP1;CDC14B;ERN1;TMEM8B;WHAMM;CSNK2A1;NOP53;AFAP1L2;CITED2;PDCD4;TTC28;NR4A1;WDR12;RNF20;PRKACA;RASSF1;HNRNPU;RRP8;BMP2;DCUN1D3;CDK10;INHBA;NEK6;NF2;MAP2K6;PML;ZBTB49;CDK6;CDK5RAP3;AKT2;GATA6
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38985807743459,1.1459151515975954,0.2555066079295154,0.696195293898762,1.0,10/27,17.13%,TIRAP;RPS27A;UBC;TLR2;UBB;HSPD1;CD36;TAB2;TNIP1;BTK
prerank,negative regulation of cell adhesion (GO:0007162),0.3154068621523856,1.1458104228555648,0.20194174757281552,0.6951654232442183,1.0,12/72,8.51%,DSCAM;SPOCK1;PODXL;PLXNB3;SEMA6A;ACER2;ADAM22;SEMA4D;NOTCH1;ACVRL1;PLXNA4;NEXMIF
prerank,positive regulation of interleukin-17 production (GO:0032740),0.39814117742186916,1.145603770634054,0.25690021231422505,0.694444856182326,1.0,3/22,13.36%,SLC7A5;PRKCQ;RFTN1
prerank,amino acid import across plasma membrane (GO:0089718),0.3977678789983521,1.1455266080699804,0.28778467908902694,0.6933694788711399,1.0,8/24,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8;SLC36A1
prerank,positive regulation of vacuole organization (GO:0044090),-0.5013430655427954,-1.1455148932097206,0.2978723404255319,0.5725864030567666,1.0,3/10,8.27%,ANXA2;RAB3GAP1;PIP4K2C
prerank,sensory organ development (GO:0007423),-0.33275318377904667,-1.1449248739214264,0.22990654205607478,0.5735485657073625,1.0,14/51,19.03%,PBX1;SMOC1;FOXC1;SH3PXD2B;SHROOM2;RBP4;PBX3;ECE1;HIPK1;ATF6;CHD7;SMCHD1;ZDHHC16;SIPA1L3
prerank,long-chain fatty acid transport (GO:0015909),-0.3768514563103037,-1.1448290977074762,0.2509578544061303,0.5732483205057547,1.0,10/30,14.16%,PRKAG2;ACSL1;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;APOE;SLC27A1
prerank,positive regulation of histone modification (GO:0031058),-0.3702860533230525,-1.1447251678972525,0.24910394265232974,0.5729598643878592,1.0,15/33,29.43%,UBE2N;BRD7;AKAP8L;PPARGC1A;NIPBL;ARRB1;SAP30BP;NOS1;PAXIP1;RPS6KA4;KDM1A;ZBTB7B;CDK9;RUVBL2;GLYR1
prerank,regulation of interleukin-13 production (GO:0032656),0.4711583192976576,1.1446552195006459,0.2968421052631579,0.6944786902026188,1.0,2/13,11.19%,LEF1;TNFRSF21
prerank,peptide metabolic process (GO:0006518),-0.3154427978744787,-1.1444299848828352,0.20348837209302326,0.5731238811594466,1.0,26/75,23.50%,CPQ;AEBP1;PCSK5;HM13;ANPEP;SEC11C;MGAT3;NPEPPS;NLN;CPM;CPXM2;LNPEP;GSTT2;GLRX2;CTNS;CPXM1;SEC11A;GSTT1;ETHE1;CARNMT1;SPPL3;CLN5;DNPEP;PARL;GSTM2;APEH
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.38460596121407,-1.1441279672367533,0.26285714285714284,0.5733346455521002,1.0,8/24,12.57%,BOC;CDON;CTNNA1;ABL1;MEF2A;CDC42;MEF2C;TCF3
prerank,neuromuscular process (GO:0050905),0.43259976383966353,1.1441220533172054,0.28270042194092826,0.6947840825258613,1.0,4/16,18.46%,NRXN1;DCTN1;GCH1;KCNA1
prerank,positive regulation of catabolic process (GO:0009896),-0.3181982528105012,-1.1439658457616422,0.2191780821917808,0.5732125782293057,1.0,17/65,18.41%,SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;STX5;SMURF1;CSNK2A1;ASB5;WNT5A;AREL1;VCP
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5016021031772192,-1.1438834469997867,0.32397003745318353,0.5728737956425728,1.0,4/10,14.46%,KAT2B;EP300;CREBBP;ESCO1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3973461377885794,-1.1436270433378448,0.2903225806451613,0.5729858870317398,1.0,8/23,16.10%,PIAS1;JAK1;PTPN2;NR1H3;PARP14;PARP9;STAT1;IFNGR1
prerank,peptidyl-proline modification (GO:0018208),-0.4004631215049266,-1.1436063606673785,0.25140712945590993,0.572501730348034,1.0,11/25,30.46%,FKBP5;FKBP10;FKBP7;PPIH;PPWD1;NKTR;NTMT1;PPID;PPIC;PPIL1;PPIF
prerank,Golgi to lysosome transport (GO:0090160),-0.4897834458170439,-1.143558507133139,0.3069852941176471,0.5720786950691523,1.0,4/11,17.97%,CCDC91;EHD3;LAMP1;ANKFY1
prerank,negative regulation of cell projection organization (GO:0031345),0.3413025723298795,1.143425331695341,0.24688796680497926,0.6955818500129272,1.0,20/48,19.42%,SPOCK1;DCC;MINAR1;MAG;SPRY3;GRIN2B;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29;FYN;GAK;TRPV4;PTPRO
prerank,cellular response to glucose stimulus (GO:0071333),0.3697970194201468,1.1433581218316136,0.24896265560165975,0.6944406201573322,1.0,5/30,3.78%,IGF1R;PTPRN2;ADCY8;PAX2;GAS6
prerank,regulation of mitochondrion organization (GO:0010821),-0.334961899049188,-1.1430944244573682,0.23828125,0.5726869865880481,1.0,10/47,12.69%,PID1;EP300;PRKN;LRRK2;GSK3B;DNM1L;PPARGC1A;VDAC1;RHOT1;FBXW7
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2680966663008837,-1.143080599891184,0.15126050420168066,0.5721822009958253,1.0,69/204,24.97%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;CENPJ;PHF8;PHLDA1;PCNT;CHMP4B;FBXL12;ANAPC7;CSNK1E;BRSK1;EIF4E;MNAT1;NES;CUL3;RB1;MAPRE1;TPD52L1;HINFP;CRLF3;ACVR1;CCND3;RCC1;YWHAE;LATS1;CDC25B;PPP1CB;CUL2;AKAP9;CDC27;CCDC57;DYNC1H1;NASP;CEP76;CACUL1;UBE2S;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;INHBA;CDK2;CUL1;CDK6;TAF2;HAUS7;HAUS8;ACTR1A;BORA;DBF4;EIF4EBP1;CDC16;CCNE2;CCNJ;MASTL;CTDP1
prerank,metal ion export (GO:0070839),-0.36934494836692866,-1.1430216838547196,0.2706333973128599,0.5717895574127743,1.0,4/31,6.27%,ATP1A2;KCNT2;SLC9A1;KCNK5
prerank,regulation of blood circulation (GO:1903522),-0.36156846460831366,-1.1426489517420275,0.2471264367816092,0.5722231065933453,1.0,11/34,20.92%,CELF2;TPM1;CAMK2D;ECE1;DMPK;AGTR1;SRI;BDKRB2;TBX2;DES;S100A1
prerank,histone mRNA catabolic process (GO:0071044),-0.44635609449844,-1.1424576384015341,0.27944111776447106,0.5721807900210434,1.0,5/15,15.97%,TENT2;TUT4;UPF1;XRN1;EXOSC10
prerank,positive regulation of GTPase activity (GO:0043547),-0.2734949482950487,-1.142018051149578,0.16432865731462926,0.5726597455773156,1.0,32/188,9.97%,ARHGAP29;ARHGAP42;DOCK11;AFDN;ASAP3;SIPA1L1;NTRK3;LIMS1;TIAM2;ARAP1;TBC1D16;GSK3B;DOCK7;ARHGAP24;BCR;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;S100A10;RSU1;NDEL1;USP6NL;TBC1D2B;TBC1D20;TBC1D8B
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.39988328862568884,-1.1418889061080901,0.26990291262135924,0.5724442710433828,1.0,7/23,18.61%,UACA;BMP7;CCN3;PPM1A;DDX3X;C1QTNF3;IFI35
prerank,regulation of glucose metabolic process (GO:0010906),-0.36363065303920467,-1.1418440763489726,0.26062846580406657,0.5720222117817416,1.0,10/34,15.75%,PDK1;PRKN;IRS1;USP7;FOXK1;SELENOS;RORA;ZNF692;OGT;FOXK2
prerank,nitrogen compound transport (GO:0071705),0.2829588502929753,1.1410633716271923,0.17794970986460348,0.7000630018601778,1.0,18/141,9.57%,SLC7A5;SLC6A6;LRP1B;TMEM30A;SLC7A1;AQP9;RAMP2;ABCG2;CERT1;SLC52A2;SLC15A3;SLC6A2;SLC6A8;SLC7A8;SLC52A3;SCARB2;SLC43A2;SLC36A1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.43224664952060976,1.1406198928390883,0.28936170212765955,0.7000989501203436,1.0,6/16,20.07%,KCNC2;NOS3;NDNF;CD36;DDAH1;AGT
prerank,positive regulation of cellular component movement (GO:0051272),0.39380722728879347,1.140579369359811,0.28772635814889336,0.6988901472625444,1.0,6/24,13.02%,SPOCK2;CSF1R;RPS19;ETS1;NTN1;ACTN4
prerank,response to UV-A (GO:0070141),0.4516305230690102,1.1404942334955852,0.2928416485900217,0.697824100685219,1.0,4/14,7.97%,MME;CCND1;TIMP1;AKT1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4438346446235832,1.140292013217143,0.3068893528183716,0.6970631521966955,1.0,2/14,3.31%,PRKAR2B;SIRT1
prerank,snRNA transcription (GO:0009301),-0.3181573653716867,-1.1399692525890486,0.24399260628465805,0.5762233540841352,1.0,27/70,29.28%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4081351380620645,-1.1388796725534973,0.2784090909090909,0.578429154096867,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,protein targeting to mitochondrion (GO:0006626),0.328468452986144,1.1383580728308802,0.23700623700623702,0.7013783226632022,1.0,14/52,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;PMPCA;PITRM1;TIMM22;NDUFA13;HSPD1;TSPO;HSP90AA1;TOMM70;TIMM10B;DNAJC19
prerank,regulation of DNA binding (GO:0051101),-0.3481070175520273,-1.138309185336093,0.26990291262135924,0.5793526787284377,1.0,14/44,13.99%,IGF1;FOXC1;SMO;PRKN;HMGB1;SKI;CEBPG;SP100;NGF;JUN;HJURP;HES1;ILRUN;TXN
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4703384380418026,1.1380841418562597,0.2991967871485944,0.70096670791263,1.0,3/12,9.70%,ACTB;AHI1;VANGL2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3998937996317096,-1.137770681000611,0.26833976833976836,0.5801476783019022,1.0,8/23,20.38%,AGMO;PLCE1;GPAT4;PLA2G4A;MOGAT3;LPIN2;LPIN3;GPAT3
prerank,positive regulation of vascular permeability (GO:0043117),-0.4699082609982355,-1.137758063063451,0.3216374269005848,0.5796444378002705,1.0,2/12,1.37%,BMP6;ANGPT1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3634005106142009,-1.1376794541155995,0.23985239852398524,0.5793138413150463,1.0,16/33,26.60%,EGFR;ANKRD17;UBE2E2;RPTOR;STXBP4;ANXA1;GLI1;CCND3;DDX3X;ADAMTS1;EIF4G1;CDC73;EZH2;KMT2E;PHB2;LSM11
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.41492680867187637,1.1376207069929445,0.27312775330396477,0.7010344811161221,1.0,8/17,21.28%,NDUFA4;COX4I1;COX6A1;COX6B1;COX7C;COX10;COX8A;COX5B
prerank,regulation of primary metabolic process (GO:0080090),-0.28683515685652816,-1.1374879592002498,0.1761252446183953,0.5792521883867604,1.0,48/126,29.30%,ROCK2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;LDLR;PRKAB2;ID2;PSMF1;TGS1;LACTB;APOE;PSMB2;C1QTNF2;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;PSMC1;PRKAB1;SC5D;FDFT1;PSMB6;PSMA3;SMARCD3;MVK;PSMA4;PPARA;EDF1;ZFP69;BBS4;HDAC3;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;PLPP1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.39874524344705087,-1.1372920246783058,0.262,0.5791840565707622,1.0,2/22,1.50%,ALDH1A2;RBP1
prerank,negative regulation of synaptic transmission (GO:0050805),0.3968238397487881,1.1372419292650862,0.2709677419354839,0.7008120016669328,1.0,4/23,9.15%,SLC24A2;SYT11;SLC30A1;SHANK2
prerank,plasma membrane invagination (GO:0099024),-0.3722028815503913,-1.136537967982836,0.2655935613682093,0.5804552573034365,1.0,6/29,10.27%,GULP1;GSN;SNX9;VAMP7;CDC42;RHOA
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.396365161358835,-1.1364902971483144,0.27169811320754716,0.5800297174232062,1.0,5/23,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,peptidyl-lysine methylation (GO:0018022),-0.3823043766939041,-1.1362089056457503,0.26147704590818366,0.5801955389028746,1.0,9/26,19.34%,SETD7;SMYD3;SETD3;SETD2;N6AMT1;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.44950434590782884,-1.1360778595454597,0.29783393501805056,0.5800074707393805,1.0,3/15,2.99%,IGF1;OPA1;PRKN
prerank,positive regulation of translational initiation (GO:0045948),-0.4275809040412838,-1.135677549349742,0.28515625,0.5804726799457787,1.0,6/18,14.84%,YTHDF3;KHDRBS1;MTOR;LARP1;CDC123;DDX3X
prerank,positive regulation of lymphocyte migration (GO:2000403),0.467460888260611,1.1356374204755915,0.3057324840764331,0.7043680029460558,1.0,3/12,10.48%,CXCL12;JAM2;AIF1
prerank,presynapse organization (GO:0099172),0.49821561148719073,1.1354263332297025,0.3073770491803279,0.7036591012491042,1.0,4/10,15.65%,LRRTM3;NLGN1;DVL1;NLGN3
prerank,positive regulation of transferase activity (GO:0051347),0.28234059963867386,1.1344953826261248,0.20082815734989648,0.7049963960372165,1.0,43/142,18.94%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;PRKCQ;KLF4;TRIB3;HSP90AB1;EPHA10;SERINC1;CCT2;DKC1;RET;EPHA1;CCT4;SORL1;RPS2;INSR;PARM1;DBI;RFC4;DCUN1D2;DDR2;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;FGFR3;RFC2;TCP1
prerank,cellular response to hormone stimulus (GO:0032870),-0.31273042941195084,-1.1341941049203064,0.224609375,0.5834906529263479,1.0,15/69,11.67%,ATP1A2;THRB;KLF9;GHR;NR3C1;CTSH;BCAS3;TFPI;STAT3;RAMP1;AR;NCOA1;MED1;SLC5A5;MEF2C
prerank,response to alcohol (GO:0097305),0.3837251947784615,1.1341769923579166,0.2908704883227176,0.704619179530713,1.0,6/27,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;SLIT3;GRIN3A
prerank,negative regulation of peptidase activity (GO:0010466),0.33585882936445666,1.133934422641789,0.25667351129363447,0.7040552204218901,1.0,7/47,12.00%,SPOCK2;SPOCK1;SPOCK3;TIMP1;AKT1;SERPINB8;TIMP4
prerank,organic hydroxy compound transport (GO:0015850),0.3528366553378886,1.1336137736710876,0.26534653465346536,0.7036607576069044,1.0,6/36,13.58%,SLCO1C1;AQP9;NCOA2;SLCO2B1;ABCC4;SLC16A1
prerank,regulation of humoral immune response (GO:0002920),-0.345292888960523,-1.1334982157867295,0.2434077079107505,0.5846952690305478,1.0,5/44,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.32211950554254287,-1.133148925835619,0.23238095238095238,0.5849934999474703,1.0,14/57,14.35%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PTPN2;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,regulation of cell morphogenesis (GO:0022604),-0.37551978218328347,-1.132581042961757,0.2947976878612717,0.5859428263016447,1.0,9/30,13.56%,PDPN;SPARC;MYO9A;WTIP;MOV10;BCL9L;ZMYM4;ZMYM3;CAPZB
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.417130237708169,-1.1324216783636956,0.29714285714285715,0.5858028055182618,1.0,8/18,30.41%,PABPN1;ENY2;MCM3AP;DDX19B;NXF1;NUP93;THOC2;DDX25
prerank,T cell differentiation in thymus (GO:0033077),-0.4577527013484115,-1.131308341918587,0.30725190839694655,0.5880288167308259,1.0,1/14,0.85%,GLI3
prerank,regulation of lipid storage (GO:0010883),-0.4034175156676648,-1.1312741376988937,0.26996197718631176,0.5875752629485406,1.0,7/22,19.35%,NFKB1;FTO;ITGAV;PTPN2;FBXW7;IKBKE;ITGB3
prerank,glycerophospholipid metabolic process (GO:0006650),0.3091808029211724,1.1310937829599241,0.23689727463312368,0.7098995416189144,1.0,23/75,20.45%,GPCPD1;CSF1R;PGP;PLCB1;DGKH;PLAAT1;CPNE1;PIGM;SERINC1;CRLS1;FAR1;PIP5K1A;GPLD1;PIGW;PNPLA3;PNPLA6;CPNE7;PLA2G4E;PIGG;SYNJ1;ACP6;PRDX6;ABCA3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.31089192288185796,-1.1307957597974045,0.24949698189134809,0.5882191270470646,1.0,13/75,5.60%,ROCK2;SULF1;WNT4;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5
prerank,peptide cross-linking (GO:0018149),-0.38833564681409527,-1.1307911715323244,0.2727272727272727,0.5876946308237702,1.0,4/25,12.78%,COL3A1;THBS1;ANXA1;FN1
prerank,proteasomal protein catabolic process (GO:0010498),-0.2650497581158926,-1.1306689454952812,0.17714285714285713,0.5874604518600443,1.0,77/201,29.54%,FBXL17;SMURF2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;UBXN2B;HUWE1;UBE4B;WWP1;ZSWIM8;DDI2;PCBP2;UBE2K;MAEA;TNFAIP1;RNF216;ERLEC1;SPOPL;RCN3;GID4;KCTD5;PSMF1;FBXL19;CUL3;FBXW7;KLHL22;NHLRC3;PSMB2;UBE2B;SMURF1;FBXO45;TOPORS;ERCC8;ARRB1;BFAR;DERL1;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;COP1;PML;PSMC1;APPBP2;SHARPIN;KCTD17;GID8;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;PCNP;SPSB2;PSME1;SEL1L;PSMD13;CDC34;PSMB10;PSMA5;SPSB3;CCDC47;PSMB9;KBTBD7;RBX1;NFE2L2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4097615044817353,1.130587153751391,0.2775423728813559,0.7100396647722272,1.0,2/21,2.10%,SLC39A10;PRKCH
prerank,carnitine shuttle (GO:0006853),-0.4752826081382816,-1.1293932345165516,0.3339317773788151,0.5901697012628697,1.0,4/11,10.82%,PRKAG2;PRKAA2;CPT2;PRKAB2
prerank,positive regulation of viral life cycle (GO:1903902),-0.4043736378433839,-1.1290956957224256,0.2621184919210054,0.5904075339240397,1.0,5/22,12.11%,AXL;KPNA6;CHMP3;LGALS1;TRIM11
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.38974580955599175,-1.1288897441647616,0.2835820895522388,0.5903844577645878,1.0,9/26,18.89%,ST3GAL4;B4GALT1;FMOD;OGN;PRELP;ST3GAL3;LUM;B4GALT5;OMD
prerank,sulfate transport (GO:0008272),-0.44794551002770666,-1.128816205536612,0.31226765799256506,0.5900363897451489,1.0,3/14,7.01%,SLC13A4;SLC26A7;SLC26A2
prerank,glycoprotein catabolic process (GO:0006516),-0.4203624644838328,-1.12859673594547,0.27715355805243447,0.5900471355278508,1.0,5/17,9.28%,ADAMTS12;NGLY1;OGA;EDEM1;ADAMTS9
prerank,cell differentiation in spinal cord (GO:0021515),0.48720661077096084,1.1282719022222638,0.3034188034188034,0.7156067878440835,1.0,2/10,6.58%,MDGA2;LHX1
prerank,striated muscle tissue development (GO:0014706),-0.37873682477430737,-1.1275667835051915,0.27599243856332706,0.5920465811972134,1.0,6/29,6.08%,SVIL;BMP5;CFLAR;BMP7;RBP4;IGSF8
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4939349610179034,1.1275235141212652,0.30785123966942146,0.7165682833877569,1.0,3/10,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,myofibril assembly (GO:0030239),-0.34800083556204053,-1.1273230670840464,0.24951267056530213,0.592119033540344,1.0,7/42,8.80%,PDGFRA;TPM1;CFLAR;PDGFRB;TMOD3;OBSL1;ACTN2
prerank,ventricular septum morphogenesis (GO:0060412),-0.37266814171840656,-1.1272970595962697,0.2774674115456238,0.5916609097827996,1.0,6/27,3.24%,TGFBR3;TGFBR1;BMPR1A;BMP4;ROBO1;TGFBR2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3605603909965019,1.12720294375427,0.2826552462526767,0.7162324058733279,1.0,11/34,14.32%,PDE4B;RYR2;SLC8A1;ADRA1A;RNF207;CALM1;SMAD7;PDE4D;ATP1B1;CALM2;CALM3
prerank,mRNA export from nucleus (GO:0006406),-0.2923469624791432,-1.1268131261499452,0.20892494929006086,0.5923807204208507,1.0,36/102,26.61%,SMG6;SMG1;PABPN1;WDR33;CASC3;RANBP2;U2AF2;ENY2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.31516571812782784,-1.1267569307914833,0.23340040241448692,0.5920037367448117,1.0,19/65,17.26%,FOXP1;GAB2;IL31RA;EP300;BMP4;TGFBR2;KIT;SBNO2;RUNX1;CDC42;PARP1;SNX10;GLO1;VEGFA;CBFA2T3;FARP2;RXRA;PIR;PIK3CD
prerank,natural killer cell mediated immunity (GO:0002228),-0.4349908944569202,-1.1266789862093116,0.3035019455252918,0.5916735718238657,1.0,5/15,30.62%,CEBPG;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,positive regulation of neutrophil migration (GO:1902624),-0.421010577852101,-1.1265679165213787,0.29389312977099236,0.5913997483949378,1.0,4/18,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3420784681893416,-1.1263767515762826,0.2540650406504065,0.5913117215441174,1.0,14/43,21.29%,CTNNA1;BMP4;GSK3B;YAP1;EIF2AK3;GLUL;PARP9;TPR;ILRUN;DTX3L;LATS1;PARK7;ORMDL3;CDK5RAP3
prerank,membrane repolarization (GO:0086009),-0.4355578208627686,-1.126296963652825,0.3005671077504726,0.5910066079835924,1.0,2/15,7.68%,ATP1A2;KCNJ2
prerank,regulation of neuron projection arborization (GO:0150011),0.43857845321193517,1.1262468557857175,0.3084886128364389,0.7178227468779479,1.0,7/15,11.92%,SPRY3;MFSD2A;GRIP1;NTNG1;NTNG2;FZD4;DVL1
prerank,receptor metabolic process (GO:0043112),0.3251156692974827,1.1262110808630912,0.22844827586206898,0.716614889436789,1.0,6/53,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3196225306524505,-1.126142498065047,0.2490118577075099,0.590864560910134,1.0,16/59,15.43%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1
prerank,cellular response to fatty acid (GO:0071398),-0.4644153793413035,-1.126132188479287,0.3162705667276051,0.5903713119400888,1.0,2/12,4.52%,PID1;IRS1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4817654366457215,-1.1255006356301216,0.33695652173913043,0.5908952721068522,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4817654366457215,-1.1255006356301216,0.33695652173913043,0.5908952721068522,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,regulation of extracellular matrix organization (GO:1903053),-0.44818555328549936,-1.1252116700560812,0.29563492063492064,0.5911267199821013,1.0,7/15,15.36%,AEBP1;LRP1;RUNX1;FAP;RB1;EFEMP2;DDR1
prerank,amide transport (GO:0042886),0.38953987383240596,1.1249242685078784,0.31027253668763105,0.7191240173735669,1.0,4/26,4.27%,PLTP;ABCG2;AQP11;CERT1
prerank,negative regulation of protein polymerization (GO:0032272),0.37405917561125424,1.1247187746807277,0.2776617954070981,0.7184651834805869,1.0,7/27,9.43%,KANK3;MAP2;STMN1;SNCA;TUBB4A;STMN2;CYRIB
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.40417148801535435,-1.1245529826719955,0.3182711198428291,0.5922444395952973,1.0,7/20,22.53%,LBP;LYN;PTPN22;IL18;TLR4;IRAK1;TICAM1
prerank,cellular amide metabolic process (GO:0043603),-0.29114482297564376,-1.1245301321196526,0.2144212523719165,0.5917723644863667,1.0,29/102,23.24%,AEBP1;PCCA;PLPP3;HLCS;ASAH2;MCCC2;MTHFR;GPAT4;MTHFD2L;PANK2;ACSF2;SLC5A6;NAPEPLD;ACSL6;NLN;CPM;ACOT11;CPXM2;ACOT9;CPXM1;ALDH1L1;NIT1;ORMDL3;PPP2CA;SMPD2;ACOT8;ST6GAL1;DNPEP;ACOT6
prerank,negative regulation of programmed cell death (GO:0043069),-0.250822327022576,-1.1242497008365344,0.13025210084033614,0.5919790381229398,1.0,50/355,10.02%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;KANK2;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;FLNA;ANXA4;ANXA5;CTSH;THBS1;PAK2;SH3RF1;MAP4K4;TMBIM4;SHC1;BCL2;ANXA1;BRAF;VDAC1;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.24581383492299966,-1.1241188192731084,0.11864406779661017,0.5918021037019691,1.0,94/416,19.24%,PTPN13;COL1A2;DPYSL3;NFAT5;PID1;SMAD3;GAB2;ADAMTS12;LEPR;NFKB1;IL34;ZFAND6;ZEB1;FOXC1;GRB10;VIM;AXL;IL6ST;IL31RA;FOXO3;GHR;PTGIS;JAK1;PTPN14;GSK3B;GSDME;KIT;RIPOR2;SYNCRIP;TBK1;IRAK3;LBP;PTPN9;ITGB1;IL13RA1;SBNO2;RC3H1;STAT3;ASAH2;SHC1;BCL2;IL16;ANXA1;IRAK2;DHX9;F3;INPPL1;UBE2K;WNK1;PTPN12;UPF1;FER;PTPN2;SLC12A2;RHOA;HIF1A;ABL2;GREM2;STX4;CNTFR;RORA;NUMBL;MMP2;TPR;TEC;IL6R;YBX3;FN1;IRF1;TYK2;GBP3;STAT1;VEGFA;DUSP1;DAPK1;IFNGR1;IL18;STAT5A;PIK3CD;GBP7;GBP2;NPR2;TLR4;PRKACA;WNT5A;STAT5B;HNRNPU;NPNT;TRAF6;TANK;INPP5K;SMPD4;GBP6;PTPN11
prerank,smooth muscle tissue development (GO:0048745),-0.5057974693970226,-1.1239132904430824,0.30694980694980695,0.5917814013950664,1.0,5/10,15.44%,MYLK;BMP4;SMO;EFEMP2;PTCH1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4567627795323841,-1.1231712671649472,0.3057199211045365,0.5926083105902166,1.0,6/13,17.73%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),-0.4567627795323841,-1.1231712671649472,0.3057199211045365,0.5926083105902166,1.0,6/13,17.73%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,autophagy of peroxisome (GO:0030242),-0.47036686484344326,-1.1230998928781468,0.3102766798418972,0.5922399753293445,1.0,4/12,15.50%,NBR1;RB1CC1;PIK3C3;PIK3R4
prerank,peroxisomal membrane transport (GO:0015919),-0.37276026252939026,-1.1230644352488193,0.2815533980582524,0.591807820416309,1.0,14/27,32.17%,ABCD3;PXMP4;ABCD2;PEX6;ABCD4;SLC25A17;PEX7;FIS1;PXMP2;PEX26;PEX11B;PEX10;PEX16;RAB8B
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3402031987891644,-1.1228258815286016,0.2549407114624506,0.5918949141840476,1.0,10/45,16.52%,EGFR;NFKB1;DDX5;BMP4;U2AF2;MAP2K1;WDR43;DIMT1;ERN1;BUD23
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.29186518352639884,-1.1227294664038603,0.23106796116504855,0.5916484602671577,1.0,23/95,17.03%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;NIPBL;RFWD3;PARP1;RAD21;RAD51D;NABP2;FANCM;MCM6;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,glial cell development (GO:0021782),0.3775244673558915,1.1225415277777808,0.2905982905982906,0.7237919217499004,1.0,8/25,16.78%,S100A9;TLR2;NSUN5;EIF2B3;TPPP;DLL1;SOX4;HES5
prerank,macrophage chemotaxis (GO:0048246),0.4793547355537415,1.1223784002661192,0.31236897274633124,0.722925847977755,1.0,3/10,18.29%,CCL2;EDNRB;CKLF
prerank,embryonic axis specification (GO:0000578),-0.44022938123454464,-1.1223077355778193,0.3280943025540275,0.5921540236120167,1.0,6/15,30.05%,SMAD6;SMAD2;PTCH1;CXXC4;COBL;STIL
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.42421627289039754,-1.121779643544372,0.3078393881453155,0.5929514801711979,1.0,3/17,3.94%,AKAP13;ADCY9;ADRA1B
prerank,heart morphogenesis (GO:0003007),-0.32918929976042366,-1.1216785874444495,0.2529182879377432,0.5926910674637327,1.0,14/50,19.51%,TGFBR3;TGFBR1;BMPR1A;FLRT2;MDM4;NIPBL;HES1;CHD7;VEGFA;ACVR1;HEYL;TBX2;BMP2;MEGF8
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.31036251530327386,-1.1215788642229687,0.24224806201550386,0.5924521398044611,1.0,27/69,28.47%,ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;RNF103-CHMP3;MAN1B1;RHBDD2;ERLIN1;TRIM25;FAF2;AUP1;DERL1;SYVN1;VCP;UBXN4;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2
prerank,negative regulation of cellular component organization (GO:0051129),-0.30757049844397777,-1.1215381529871464,0.24236252545824846,0.5920203580673121,1.0,23/74,19.59%,BMP6;EPHA3;EP300;GSK3B;IRAK3;CDC42;RAPGEF3;AR;IMPACT;WASL;FAP;RIOK3;VEGFA;DDX3X;PRKCZ;CARMIL1;NOP53;IAPP;RUBCN;PRKD1;ABCA7;LRSAM1;TERF2
prerank,apoptotic cell clearance (GO:0043277),-0.3698392652568956,-1.1214244451735154,0.27893738140417457,0.591786637615933,1.0,11/30,19.35%,LRP1;ITGAV;HMGB1;THBS1;ANXA1;NR1H3;RHOBTB2;TXNDC5;RHOBTB1;RHOH;ITGB3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.36583836817654336,-1.1214170300805446,0.27380952380952384,0.5912838477246692,1.0,11/33,19.35%,FOXO3;ARNT;HOXA5;STAT3;MED1;HIF1A;STAT1;PRKDC;PITHD1;STAT5B;INHBA
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.45938931917475917,-1.1204917394676535,0.31123388581952116,0.5931139863005679,1.0,5/13,29.36%,GAB2;STX4;LAMP1;SYK;SPHK2
prerank,proton transmembrane transport (GO:1902600),0.356002250972166,1.1204506250545894,0.25625,0.7272539766462911,1.0,14/36,18.00%,UCP2;ATP1A3;SLC25A14;SLC25A27;ATP6V1F;ATP6V1A;SLC36A1;ATP1A4;ATP1A1;ATP5F1B;ATP5MF;DMAC2L;NNT;ATP6V0E2
prerank,regulation of calcium ion import (GO:0090279),0.4011366626977705,1.1202026925067912,0.302713987473904,0.7267529724241744,1.0,5/21,10.22%,CXCL12;SLC30A1;PLPP4;CCL2;PDGFB
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2921359720906093,-1.1200581629443218,0.2157258064516129,0.5937172992466015,1.0,34/96,26.61%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,T cell mediated immunity (GO:0002456),-0.44970621066019767,-1.1200499202973704,0.31417624521072796,0.593212047962264,1.0,3/13,5.14%,JAG1;CD55;CTSH
prerank,ERBB signaling pathway (GO:0038127),-0.3197045820900767,-1.120025014632912,0.26239669421487605,0.5927557457050788,1.0,23/64,22.02%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;PTPN12;KIF16B;CPNE3;REPS2;NCK2;HBEGF;NRG4;GAB1;PTPN11;MVP;PIK3R1;AAMP;DGKD;PRKCA
prerank,positive regulation of cell projection organization (GO:0031346),0.2860493390153904,1.11976725289517,0.21621621621621623,0.7267745575579169,1.0,27/115,12.13%,RIT2;PTPRD;LRRC7;IL1RAPL1;PLXNB3;S100A9;ITGA6;MAGI2;TOX;GRIP1;NTRK2;SCARF1;FUT9;NPTN;PLPPR5;TENM3;NDNF;SCARB2;PLXNA4;ROBO2;STMN2;CDKL5;RELN;DAB2IP;FZD4;DVL1;RET
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.4578880754779583,-1.1196773370700024,0.33519553072625696,0.5931041033201329,1.0,4/13,6.88%,CBLB;KPNA4;RANBP2;KPNA6
prerank,thymus development (GO:0048538),-0.4559093487668707,-1.1191187291408948,0.32447817836812143,0.594034925805608,1.0,6/13,25.76%,TGFBR1;ZBTB1;HES1;SIX1;FOXE1;EPHB3
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4268236993470048,-1.1187736211548662,0.3026315789473684,0.594341957369123,1.0,2/16,6.74%,SLC5A3;SLC2A12
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4107029475042624,-1.1184661924209405,0.30642201834862387,0.5946015974861456,1.0,4/20,7.62%,DICER1;PUM2;ZC3H7A;PUM1
prerank,autophagy of mitochondrion (GO:0000422),-0.34102335997721206,-1.1183694315135952,0.26195028680688337,0.5943333332653372,1.0,18/38,26.43%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;ATG14;MAP1LC3A;PHB2;ATG3
prerank,endothelial tube morphogenesis (GO:0061154),-0.4787326482850056,-1.1183453529359226,0.30844793713163066,0.593874280172968,1.0,3/10,10.27%,RBPJ;BMP4;RHOA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3129746621904577,1.118233796463548,0.25219298245614036,0.7300482975811386,1.0,9/67,5.70%,FLT1;IGF1R;TEK;ERBB4;CSF1R;KDR;FLT3;AATK;SRMS
prerank,heme biosynthetic process (GO:0006783),0.38890008044254565,1.118232630633759,0.2875,0.7287376184113342,1.0,8/22,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,regulation of Golgi organization (GO:1903358),-0.42039850343965085,-1.1181254455670389,0.3155893536121673,0.5939030959902053,1.0,7/17,15.43%,STX18;MAP2K1;USP6NL;STX5;ARMH3;EHD3;AKAP9
prerank,cellular protein-containing complex assembly (GO:0034622),0.2736186277195123,1.1179848883593686,0.19834710743801653,0.7281923819418006,1.0,34/160,15.33%,NSG2;MAPK8IP2;OMA1;DNAAF3;RPL38;NRG1;ANLN;AP2M1;PDE4DIP;TMEM35A;COX7A1;SNCA;BIN1;HIP1;CSNK2B;CHCHD4;CLU;PFDN6;BBS10;FCHO1;HSP90AB1;DNAAF2;MID1IP1;CCT2;HOPX;CALY;HSPD1;SGIP1;NUP205;HIGD1A;CLTB;HIGD1B;RTN4;NDUFAF1
prerank,negative regulation of apoptotic process (GO:0043066),-0.2446333002096808,-1.1178606712281867,0.12681912681912683,0.594083355378683,1.0,99/444,18.34%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;YAP1;FLNA;ANXA4;ANXA5;ITGB1;CTSH;THBS1;SLC30A10;SNX6;RNF213;PAK2;SH3RF1;MAP4K4;TMBIM4;ASAH2;SHC1;BCL2;ANXA1;MERTK;BRAF;PPARGC1A;VDAC1;MAEA;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2;PRKCD;DNAJC3;USP47;TLE1;NFATC4;FNIP1;MEF2C;YME1L1;HSPA9;RB1;CASP2;CARD14;SH3RF2;APOE;GLO1;PRKDC;NAA15;VEGFA;HDAC1;DDX3X;YWHAE;ITGA5;TOPORS;CSNK2A1;RASA1;TXNDC5;TGFB3;SFPQ;MRE11;CITED2;SIX1;BFAR;WNT5A;PHIP;NR4A2;PRKAA1;CX3CR1;SOD2;AREL1;TRAF6
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.37616819140454427,1.117514154726725,0.2835164835164835,0.7282647749259029,1.0,5/29,6.76%,RPS19;RPP40;RPS21;RPS8;RPS16
prerank,epithelium development (GO:0060429),-0.2887722786464829,-1.117474919507066,0.242914979757085,0.5945577322756278,1.0,30/107,18.82%,ALDH1A2;ERRFI1;DAG1;VCL;KANK2;PKD1;WNT4;SMO;OSR1;MEOX2;ANXA4;FGFR2;ANXA7;CNN3;VDAC1;DACT1;RCN3;PKD2;PGK1;STAT1;VEGFA;BDH2;PTCH1;SALL1;LOXL3;SIX1;TBX2;TAGLN;BMP2;CPT1A
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39784363412714413,1.1169716894322375,0.3055555555555556,0.7286308385800994,1.0,7/20,10.22%,PROX1;CCND1;MAPRE3;HSP90AB1;AKT1;CCNY;PDGFB
prerank,positive regulation of insulin secretion (GO:0032024),-0.35109469809863214,-1.1168422008131274,0.2682926829268293,0.5956652129364941,1.0,11/36,20.68%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT;STX4;TRPM4;ANO1;C2CD2L;ACSL4
prerank,necroptotic process (GO:0070266),-0.4309529548993454,-1.1166641138037179,0.3236994219653179,0.5955795695441143,1.0,8/16,32.31%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;TLR3;LY96;ITPK1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.27946600651661896,-1.1165584095686303,0.22857142857142856,0.595304846198822,1.0,28/128,17.53%,BMP6;SASH1;PTN;ANKRD17;PDGFRB;PUM2;THBS1;PLSCR1;IL16;DHX9;PUM1;IL17RA;DDX60;NAPEPLD;STX4;NFKBIZ;RIOK3;AGTR1;P2RY12;CYBA;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.47233928093086897,-1.1164222562628356,0.33962264150943394,0.595129779562431,1.0,3/11,11.67%,EFNB2;DHX36;MEF2C
prerank,vasodilation (GO:0042311),0.4415200191079747,1.11625998928751,0.3258655804480652,0.7294546571278279,1.0,4/13,17.01%,ADRB1;NOS3;KLF2;KCNMA1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3370155482537614,1.1157474957528257,0.2804123711340206,0.7297136005627287,1.0,9/44,7.97%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1
prerank,RNA export from nucleus (GO:0006405),-0.28977303640952007,-1.1152268037692135,0.20824742268041238,0.5975955026831583,1.0,35/100,26.61%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;XPO5;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4772077607421978,-1.1151080020882158,0.33568904593639576,0.5973971018308681,1.0,4/10,14.77%,UPP2;NT5M;UPB1;DPYD
prerank,histone mRNA metabolic process (GO:0008334),-0.3687238642451377,-1.1143260944701712,0.3035019455252918,0.5988374834235235,1.0,8/27,18.73%,TENT2;CPSF3;TUT4;UPF1;SLBP;XRN1;EXOSC10;SNRPF
prerank,regulation of programmed cell death (GO:0043067),0.27802769917732034,1.1136394762691861,0.1892430278884462,0.7347389593280512,1.0,38/161,17.04%,PAX8;MECOM;LRP8;OMA1;HTATIP2;LCMT1;ACER2;SIRT1;PAX2;FLT3;HIP1;NME2;ALK;PHLPP1;CLU;AKT1;TPT1;NUP62;TRIM24;APEX1;RABGGTA;BCL3;CTSB;TNFRSF25;BCAR1;ACTN4;RPS3;MADD;ANP32A;NDRG1;ATM;USP42;RTN4;GLS2;FANK1;RAF1;MAGED1;HSP90AA1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41099330342431883,1.1136136159558276,0.294478527607362,0.7322315057073768,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41099330342431883,1.1136136159558276,0.294478527607362,0.7322315057073768,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,negative regulation of glycolytic process (GO:0045820),-0.4916981558157859,-1.1135398930433003,0.3219047619047619,0.5997840657986637,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4916981558157859,-1.1135398930433003,0.3219047619047619,0.5997840657986637,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.33486941518032703,-1.1133995025605539,0.26844262295081966,0.599620437641405,1.0,17/45,23.37%,IGF1;PDGFRA;SKI;DHX9;PARP10;PDGFC;S100A6;FN1;EMD;WNT5A;MORC3;B4GALT7;CDC73;CDK6;SPHK1;CD300A;NLRC3
prerank,inositol phosphate metabolic process (GO:0043647),-0.3363185437734864,-1.113260005223336,0.2891791044776119,0.5994509293461537,1.0,10/46,10.26%,PLCE1;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3732568544079136,1.1131919478385186,0.296218487394958,0.7322819525960309,1.0,7/25,11.89%,AKAP6;SNCA;THY1;APLNR;CACNB2;F2R;TRPC1
prerank,regulation of JNK cascade (GO:0046328),0.2913827322768186,1.1129050391229405,0.24596774193548387,0.7318391274575395,1.0,22/101,13.63%,IGF1R;MECOM;TIRAP;EPHB1;MAPK8IP2;MAP4K2;TRAF1;PLCB1;TNFRSF19;PHLPP1;WNT7B;ANKRD6;GPS2;MAPK8IP1;TAOK2;DAB2IP;MEN1;HIPK2;PJA2;DUSP15;MAP3K11;HRAS
prerank,hexose metabolic process (GO:0019318),0.3478708874935059,1.1123978180061906,0.3019271948608137,0.7320814316993107,1.0,7/39,10.71%,OMA1;KHK;KCNJ11;SLC37A4;PMM1;ALDOC;GDPGP1
prerank,regulation of cilium movement (GO:0003352),-0.49374223315903953,-1.1123014447042583,0.33586337760910817,0.6012948009393689,1.0,9/10,46.73%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,protein ADP-ribosylation (GO:0006471),-0.37590112819945737,-1.111997726749552,0.311787072243346,0.6015557380851099,1.0,12/28,24.52%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3;PARP12
prerank,steroid hormone biosynthetic process (GO:0120178),0.3683780639431345,1.1119290218432514,0.3125,0.7322010821208105,1.0,10/29,19.40%,SRD5A2;HSD17B7;FDX2;TSPOAP1;TSPO;HSD17B2;DHCR7;STARD3NL;STARD3;SRD5A1
prerank,positive regulation of neuron death (GO:1901216),-0.3316254904940843,-1.1118676609108662,0.28893058161350843,0.601366569115795,1.0,7/46,7.74%,EPHA7;EFNB2;FOXO3;NUPR1;GSK3B;REST;MAP3K5
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4557206637648808,-1.1113648782049639,0.3063583815028902,0.6021131132488495,1.0,2/12,5.46%,LIMA1;PLEKHH2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.44780627969339853,1.1113024723246347,0.31919642857142855,0.7328052848205973,1.0,2/13,3.17%,USP44;LCMT1
prerank,ventricular septum development (GO:0003281),-0.3422383408981305,-1.1111344796256277,0.30357142857142855,0.6021098905857907,1.0,13/37,16.74%,TGFBR3;TGFBR1;BMPR1A;MDM4;ROBO1;TGFBR2;SMAD4;HES1;ACVR1;SALL1;HECTD1;HEYL;CITED2
prerank,mRNA transport (GO:0051028),-0.2860053639190753,-1.110939961140094,0.22560975609756098,0.6020933919794124,1.0,34/101,26.61%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,multivesicular body organization (GO:0036257),-0.3600094115702982,-1.1108944430960381,0.29980657640232106,0.6017022962986315,1.0,7/31,12.09%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,cAMP-mediated signaling (GO:0019933),0.38657120201801476,1.1106908727532039,0.33260869565217394,0.7334390943679323,1.0,7/24,12.59%,RIMS2;EPHA5;AKAP6;PDE2A;ADCYAP1;CAP2;PDE4D
prerank,regulation of protein acetylation (GO:1901983),-0.4536861149002215,-1.1103375226964902,0.3384321223709369,0.6026122482364257,1.0,7/12,19.79%,GSK3B;RAPGEF3;FAM161A;DDX3X;CEP295;PARK7;TAOK1
prerank,calcium-mediated signaling (GO:0019722),-0.2877818424104488,-1.1102683563812363,0.25096525096525096,0.6022458340934471,1.0,24/93,18.06%,CACNA1C;EGFR;ANK2;PLCE1;MCU;LRRK2;NUDT4;SLC9A1;CCR9;ADGRL1;EIF2AK3;TPCN2;PDPK1;PLCG1;DMPK;ATP2A2;AGTR1;TRPM4;P2RY12;P2RX4;PRKACA;PRKAA1;CX3CR1;PTGFR
prerank,nucleosome organization (GO:0034728),-0.319365065107094,-1.1101574102064016,0.27647058823529413,0.6020388786930813,1.0,28/55,37.34%,INO80;KAT6B;SMARCC2;RNF8;SETD2;MCM3AP;SPTY2D1;ANP32B;ANP32E;NASP;SMARCD2;ARID2;BPTF;H1-0;PRDM9;NAP1L4;SMARCD3;NAP1L1;ACTR6;ATRX;DMAP1;NAP1L2;CHAF1A;NAP1L3;SMARCA4;NPM1;ARID1A;SART3
prerank,programmed necrotic cell death (GO:0097300),-0.4162642810502534,-1.1100259980695126,0.333976833976834,0.60185669104229,1.0,9/18,32.31%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;PPIF;TLR3;LY96;ITPK1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4822897113564284,1.1099290705469087,0.3412526997840173,0.7344534537197692,1.0,6/10,16.45%,ISG15;RPS27A;UBC;UBB;CHFR;NEDD8
prerank,glycosphingolipid metabolic process (GO:0006687),0.33536232141440614,1.1094719156763442,0.28991596638655465,0.7344444284658218,1.0,18/42,21.61%,ST6GALNAC3;B4GALNT1;NEU2;ST8SIA1;B4GALT6;ARSA;GLA;SMPD1;ST8SIA3;CPTP;GALC;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3630567855145009,-1.109396182329319,0.3106060606060606,0.6028823366014497,1.0,8/29,11.93%,GTF2H2;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;ERCC3
prerank,glycogen metabolic process (GO:0005977),-0.37512683395263746,-1.1092040852441596,0.3278985507246377,0.6028348122809806,1.0,6/27,9.54%,PRKAG2;PHKB;GSK3B;PYGB;PHKA1;AGL
prerank,C-terminal protein amino acid modification (GO:0018410),0.47098607600305914,1.108952350700976,0.3370288248337029,0.7347180786946583,1.0,2/11,3.17%,AGBL4;LCMT1
prerank,regulation of microtubule nucleation (GO:0010968),0.48332535930370607,1.1087166575890028,0.32421052631578945,0.7341593860480491,1.0,5/10,19.28%,GIT1;PAK1;DCTN1;ARHGEF7;MECP2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3997131954123918,-1.108545398949011,0.3138401559454191,0.6039684869986014,1.0,4/21,3.09%,ROCK2;ROCK1;BCOR;ENPP1
prerank,regulation of angiogenesis (GO:0045765),0.262213442450617,1.1085451112954412,0.2069672131147541,0.733426252337252,1.0,27/192,8.42%,FLT1;CLDN5;TEK;IL17F;MINAR1;ADAM12;TIE1;SEMA6A;RAMP2;ADGRB1;HTATIP2;SIRT1;NAXE;TSPAN12;HMGA2;PPARG;PPP1R16B;KDR;NOS3;TGFB2;ETS1;KLF4;APLNR;NINJ1;GPNMB;CD34;HSPB1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.34126507235864434,-1.1082571557682563,0.2912621359223301,0.6041948733434194,1.0,7/39,10.02%,EGFR;ERRFI1;RNF115;PTPN3;CDC42;PTPN12;PTPN2
prerank,positive regulation of cellular component organization (GO:0051130),0.285045215599427,1.1082161141209221,0.24795081967213115,0.7330969476720051,1.0,23/107,13.88%,IGF1R;TFRC;NRXN1;TIRAP;TMEM30A;NRG1;SHANK3;ATP10A;SNCA;GPX1;TAL1;TGFB2;CLU;RELN;TPPP;DAB2IP;SMPD1;ABCB4;DCTN1;CALY;RPS3;DLL1;INSR
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.30998964234295884,-1.108067186676124,0.25296442687747034,0.6041706683303457,1.0,13/68,16.47%,RHOQ;OPA1;ENPP1;LRRK2;TPST1;AMPD3;GPAT4;ACSF2;SULT1A1;ACSL6;ACOT11;ABHD14B;ACOT9
prerank,establishment of endothelial barrier (GO:0061028),0.3692052761182085,1.1077241440238317,0.31868131868131866,0.7333723979724944,1.0,11/29,16.87%,ROBO4;PDE2A;PPP1R16B;PECAM1;RAB1B;TJP1;MARVELD2;PDE4D;RAP1A;SOX18;RAP2B
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2710211029534867,-1.1076194569022957,0.21568627450980393,0.6047800956360472,1.0,56/153,25.74%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;MKNK2;RICTOR;PRKDC;ERN1;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;CSNK1D;CDK2;NEK6;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN;DYRK1B;MAP3K13;CSNK1G2;MASTL;RPS6KA4;MAPK9;MAPK14
prerank,ncRNA transcription (GO:0098781),-0.45170746496510905,-1.1074419820783938,0.329608938547486,0.604683635936776,1.0,9/13,38.97%,CAVIN1;BRF1;SNAPC3;SPIN1;GTF3C1;POLR1G;GTF3A;ANG;SNAPC2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3258455079606732,1.1071974126372788,0.2633663366336634,0.7337502727569329,1.0,11/52,8.49%,KHDRBS2;RBFOX3;NOVA2;CELF5;RBFOX1;CELF4;RBM11;KHDRBS3;SRRM4;RBM15B;SRSF12
prerank,polyol biosynthetic process (GO:0046173),-0.4292411849752763,-1.1069465185290184,0.32447817836812143,0.6053845561770923,1.0,7/16,25.69%,CYP27A1;ISYNA1;ACER3;ITPKC;FGF2;CYP2R1;IP6K2
prerank,organonitrogen compound catabolic process (GO:1901565),-0.31551964089638057,-1.1068540401112301,0.2821011673151751,0.6050949226407338,1.0,16/57,24.01%,CPQ;MTOR;ANPEP;RENBP;PLA2G4A;PDXDC1;GGACT;PNPLA8;NPEPPS;LNPEP;LRSAM1;CLN5;BCKDK;SMPD2;TXN2;CLPX
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3610430037819387,1.1068148634756014,0.3182751540041068,0.7337004750031499,1.0,4/33,7.97%,IGF1R;NYAP2;PIK3R5;AKT1
prerank,response to cAMP (GO:0051591),0.34362651960774243,1.1067758606851565,0.31512605042016806,0.7325596489503472,1.0,5/37,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,response to interleukin-1 (GO:0070555),-0.30605904387819627,-1.106727953137701,0.27364185110663986,0.6048773965699205,1.0,15/73,19.76%,ADAMTS12;NFKB1;PTGIS;HDAC4;IRAK3;RC3H1;ANXA1;IRAK2;UPF1;HIF1A;GBP3;GBP2;TRAF6;TANK;IRAK1
prerank,cellular response to ketone (GO:1901655),-0.3535491328685103,-1.106529964191365,0.2979591836734694,0.6048265338865674,1.0,8/35,7.97%,ROCK2;ADCY5;KLF9;NR3C1;ADCY1;LARP1;ADCY6;AR
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.37140508906240427,1.1062116524118941,0.32577319587628867,0.7329626831744263,1.0,6/27,10.86%,GRM1;HTR2C;GPR35;GPR17;F2RL2;F2R
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.44661673236620386,-1.1062081386374139,0.3419593345656192,0.6050919569518631,1.0,7/13,31.92%,LRRK2;TXN;PARK7;HGF;MET;NFE2L2;PDE8A
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.27396055796601043,-1.1061971634513055,0.23745173745173745,0.6046013081927347,1.0,44/144,22.87%,ZIC1;TCF7L2;SMAD3;CEMIP;PCM1;XPO4;GSK3B;FLNA;SAE1;HUWE1;UBR5;BCAS3;CDH1;TFDP2;BCL2;ABLIM3;PCNT;RAPGEF3;VAMP2;JUP;BAG3;LEPROT;PRKCD;MAVS;TPR;NPEPPS;FBXW7;YWHAE;EMD;EFCAB7;ANP32B;ICE1;UBL5;SEC16B;UBE2D3;FIS1;SEC16A;TOMM7;PIK3R1;ARIH2;AKT2;KCNB1;CHP1;ZFAND1
prerank,regulation of cell projection organization (GO:0031344),0.4455097628473915,1.1060733100704934,0.33986928104575165,0.7321093696519066,1.0,4/13,8.90%,MFSD2A;SEMA4D;NTNG1;NTNG2
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.249707828663655,-1.105947526384101,0.1732283464566929,0.6046915498879669,1.0,78/308,19.35%,LRP1;SMAD3;TGFBR1;SOX5;APPL2;PTN;BMPR1A;FOXD1;LEPR;COL1A1;ABCA1;SMURF2;FOXC1;GRB10;DAB2;ROCK1;BMP4;GHR;PDPN;ACSL1;SMO;TGFBR2;KMT5B;NUMA1;ALMS1;ADRA1B;PLA2R1;RREB1;NIBAN2;LBP;TGFB1I1;PPARGC1B;SMAD2;BCL9L;ZBTB16;VAMP7;MTOR;REST;PPARGC1A;GJA1;MED1;CPT2;PDGFC;SMAD4;SHLD2;PRKAB2;GNAS;EHMT1;OGT;KMT5C;TRPM4;SOX6;EIF2AK2;APOE;SLC27A1;VEGFA;ACVR1;ZBED3;KDM3A;GLIPR2;C1QTNF3;TGFB3;DYNC1H1;CMKLR1;ADRA2A;IL18;SERPINE1;SIX1;PIK3CD;WNT5A;TRPV2;B4GALT5;GCNT2;INPP5K;BMP2;ABCA7;PTPN11;INHBA
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.38804092617620073,-1.1057909541101831,0.32616487455197135,0.6045747198981511,1.0,4/24,3.96%,ITPR1;ITPR2;ANXA6;IBTK
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4455172575288089,-1.1055298212752824,0.34099616858237547,0.6047109988541989,1.0,2/13,6.27%,KCNT2;KCNK5
prerank,negative regulation of cell communication (GO:0010648),0.3930938782976864,1.1055019807102642,0.3090507726269316,0.7325670857832887,1.0,4/21,11.29%,GLRA1;SRMS;OPRM1;UBASH3B
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.41451104999251565,1.1053920332275295,0.31473214285714285,0.7316500528549386,1.0,6/17,14.32%,CD33;MAGI2;HSP90AB1;CALM1;CALM2;CALM3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4848053868439238,-1.105202928646782,0.34501845018450183,0.6050044852228019,1.0,6/10,32.25%,LRRK2;TXN;PARK7;NFE2L2;PDE8A;STK26
prerank,positive regulation of viral transcription (GO:0050434),-0.3828558255846286,-1.1048186442964063,0.31309297912713474,0.6054447639730004,1.0,13/25,28.24%,MDFIC;CCNT1;DHX9;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3970844753636732,-1.1047414645013125,0.33458646616541354,0.6051314792056565,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,regulation of protein kinase A signaling (GO:0010738),0.3960857694547372,1.1047228315779714,0.3277661795407098,0.7324738921674113,1.0,3/20,3.16%,PRKAR2B;MIF;AKAP6
prerank,peripheral nervous system development (GO:0007422),0.37929412620291464,1.1045409763890313,0.3232931726907631,0.7317613932935992,1.0,3/23,6.54%,ASIC2;ADGRB1;NFASC
prerank,histone deubiquitination (GO:0016578),-0.4153419306266054,-1.1038461648544935,0.3231357552581262,0.6068682502730854,1.0,4/18,7.43%,USP7;TRRAP;ENY2;BRCC3
prerank,negative regulation of TOR signaling (GO:0032007),-0.3468110207426404,-1.1036072059381954,0.27566539923954375,0.6069820513090594,1.0,12/36,19.74%,RNF152;UBR2;PRKAA2;DEPTOR;TMEM127;SESN1;UBR1;FNIP1;CASTOR2;NPRL3;PRKAA1;TBC1D7
prerank,peptidyl-threonine modification (GO:0018210),-0.30686264700766996,-1.1034985397976333,0.2703252032520325,0.6067421624175505,1.0,23/66,23.08%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1;PRKD1;GALNT1;CDK10;GALNT11;MAP3K12;PRKCA;CDC42BPG
prerank,regulation of endopeptidase activity (GO:0052548),0.31846523683184563,1.1027249971257607,0.30278884462151395,0.7360217955445119,1.0,7/59,9.80%,SPOCK2;SPOCK1;SPOCK3;PSENEN;TIMP1;AKT1;SERPINB8
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4598449978582637,-1.10249612330821,0.3433395872420263,0.6086867540609618,1.0,3/13,10.07%,ATP1A2;KCNJ2;SLC12A2
prerank,protein oxidation (GO:0018158),-0.47157272845164944,-1.102311730815161,0.33271028037383177,0.6086213005126608,1.0,5/11,22.09%,LOXL1;LOX;LOXL3;TMX3;SUMF1
prerank,mesonephros development (GO:0001823),-0.45379726028374756,-1.101353937069634,0.34234234234234234,0.6105142650782449,1.0,5/11,5.92%,FGF1;BMP7;BMP4;OSR1;ZBTB16
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.41431881223004596,-1.1012761863364584,0.3220338983050847,0.6101856448685674,1.0,2/17,0.36%,ATP1A2;CACNA1C
prerank,ion homeostasis (GO:0050801),0.3619349019616858,1.1010944360829442,0.2939958592132505,0.7396419607771042,1.0,5/30,7.92%,SLC4A1;KLHL3;WNK2;UNC80;SLC30A3
prerank,glycolipid metabolic process (GO:0006664),0.327471548577782,1.1010888901179523,0.28662420382165604,0.7384110227861735,1.0,18/47,21.61%,ST6GALNAC3;ST3GAL6;B4GALNT1;NEU2;ARSA;GLA;SMPD1;ST8SIA6;CPTP;GALC;PIGW;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,positive regulation of phospholipid transport (GO:2001140),0.48101513760040254,1.1008063353042645,0.345372460496614,0.7379997963630774,1.0,3/10,14.67%,TMEM30A;ABCB4;DBI
prerank,protein glycosylation (GO:0006486),0.2783007800920796,1.1007674074525198,0.24789915966386555,0.7368795574266692,1.0,30/125,16.10%,ST8SIA4;GAL3ST1;GALNT9;MGAT5B;AQP11;ST3GAL6;EOGT;GALNT6;ST8SIA1;FUT9;ALG3;PMM1;PLOD3;B3GALT5;ALG1;MGAT4C;MPI;SLC39A8;ST8SIA6;B3GNT2;TMEM258;ST8SIA3;SERP1;ALG8;GALNT2;POMGNT2;GOLGA2;POMGNT1;POGLUT1;MGAT1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4161755507866234,-1.1005710981220784,0.32299270072992703,0.6114088814519018,1.0,6/18,12.45%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.48377737419686084,-1.1005699872618397,0.35564053537284895,0.6109041962242933,1.0,4/10,20.83%,SOX5;ZBTB16;SOX6;PKDCC
prerank,regulation of cell killing (GO:0031341),-0.4239060487700982,-1.1005414922042809,0.3233644859813084,0.6104628949259076,1.0,6/16,17.53%,CFH;CD55;FZD7;CR1L;CYBA;WNT5A
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.294263279942076,-1.1004099889710848,0.2540983606557377,0.6102951133168306,1.0,21/84,14.33%,CELF2;RBFOX2;SON;DDX5;CELF1;RBM39;MBNL2;SFSWAP;DDX17;KHDRBS1;WTAP;SRSF10;U2AF2;SRSF6;REST;HNRNPK;DAZAP1;YTHDC1;CWC22;NSRP1;RBM5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.27809527132477013,-1.10035202797484,0.2326454033771107,0.6099611006478529,1.0,24/121,12.72%,BMP6;IGF1;IL34;ANGPT1;IL6ST;IL31RA;GHR;ABL1;VTN;DLG4;KIT;PIBF1;PAK2;STAT3;NRP1;NOX4;LYN;EPHA4;IGF2;PARP14;PARP9;HES1;TEC;IL6R
prerank,cellular response to glucagon stimulus (GO:0071377),0.4133849520198603,1.1002682048260186,0.3522975929978118,0.7371881448089983,1.0,3/17,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,insulin secretion (GO:0030073),0.3983811690127873,1.099893052611883,0.3012295081967213,0.7370395969329562,1.0,3/19,7.52%,PTPRN2;RIMS2;ADCYAP1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.35903934668021914,-1.099727096612552,0.3148148148148148,0.611060615195785,1.0,17/34,31.72%,LGR4;IRAK3;PTPRS;LYN;OTUD4;TLR4;LRRC14;CD300A;TICAM1;RAB7B;CACTIN;GRAMD4;TNFAIP3;NLRP2B;TLR3;LY96;TYRO3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2590359919873392,1.0997016911764355,0.21595330739299612,0.7363303280553825,1.0,34/214,10.86%,TEK;ERBB4;TIRAP;PTPRR;CSF1R;EPHB1;NECAB2;SEMA6A;MIF;SPRY3;CNKSR3;DUSP6;HTR2C;CAMK2N1;GAS6;KDR;FGF10;NTRK2;WNK2;SEMA7A;NOTCH1;P2RY1;ZDHHC17;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;DAB2IP;PDGFB;LMO3;ATP6AP1;F2R
prerank,regulation of cellular amide metabolic process (GO:0034248),0.35706999991730215,1.0996057089464302,0.32150313152400833,0.7353802994713624,1.0,4/32,4.57%,GRM5;PGAM1;RPL10;NANOS3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3293227609055096,-1.0995842110629108,0.30357142857142855,0.6108947343683906,1.0,13/46,21.05%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,response to peptide (GO:1901652),0.35135298587984753,1.099413953092814,0.30753968253968256,0.7346972932735338,1.0,3/33,1.58%,CACNA1A;CACNA1B;MMP12
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.34699836400043477,1.0993976295318035,0.3022222222222222,0.7335029442880605,1.0,12/36,18.04%,NOSTRIN;NOS3;LYPLA1;AKT1;GLA;CALM1;SCARB1;ATP2B4;GCH1;HSP90AA1;NOSIP;DDAH1
prerank,multivesicular body assembly (GO:0036258),-0.3608277056590614,-1.0993109453895131,0.3093385214007782,0.6110751615500899,1.0,7/30,12.09%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,cellular response to sterol (GO:0036315),-0.4521616901956315,-1.0987735097181224,0.3464566929133858,0.6119369060830144,1.0,6/13,15.44%,LRP6;SMO;GRAMD1C;INSIG2;RORA;PTCH1
prerank,cholesterol transport (GO:0030301),-0.33301040580635344,-1.0985694120598113,0.29563492063492064,0.6119000135958904,1.0,8/45,14.08%,ABCA1;LIMA1;SOAT1;OSBPL5;LDLR;RELCH;NPC2;APOE
prerank,RNA interference (GO:0016246),-0.41997047593586534,-1.0984123961877934,0.35106382978723405,0.6117911881557592,1.0,3/17,7.10%,CELF1;DICER1;DHX9
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3872589987102666,-1.0977529760235567,0.30919765166340507,0.6129340051855429,1.0,9/24,17.99%,PKD1;CTSC;EPHA4;NUB1;RHBDF1;APOE;LATS1;PRKACA;ATP5IF1
prerank,erythrocyte differentiation (GO:0030218),-0.3329787947671323,-1.0972558935125667,0.3234714003944773,0.6136712554260523,1.0,15/44,19.35%,TGFBR3;KIT;ACIN1;UFL1;LYN;CEBPG;UBA5;MED1;PTPN2;ID2;HSPA9;VEGFA;SLC25A38;ATP5IF1;INHBA
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4845382564431703,1.0968688795626342,0.33958333333333335,0.7397990194917635,1.0,3/10,9.89%,SEMA6A;IL12A;DAB2IP
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4013413434262523,-1.0968426756594893,0.325187969924812,0.6141426541451348,1.0,5/20,12.96%,ITGAV;GSK3B;BCL2;CASP2;APPL1
prerank,fatty acid oxidation (GO:0019395),-0.3100908264805923,-1.0962175804570369,0.3045977011494253,0.6151706213170218,1.0,15/57,17.98%,ABCD3;ACADM;ACAD10;ABCD2;PPARGC1A;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1
prerank,protein modification by small protein removal (GO:0070646),-0.25452377237719487,-1.096204257084768,0.19635627530364372,0.6146971357833728,1.0,93/252,29.33%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;SENP3;WDR48;SENP7;TRRAP;BRCC3;MYSM1;SENP6;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;SENP1;RHOT1;USP47;WDR20;SENP5;PSMF1;COPS2;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;COPS8;USP50;PSMB2;USP2;OTUD4;USP13;FOXK2;TNIP2;TRAF3;USP34;ATXN7;TRAF6;VCP;DESI1;DESI2;PSMC1;SMAD1;TAF9B;TOR1A;CLSPN;SENP2;PSMB6;PSMA3;USP18;SIAH2;OTUD1;USP9X;PSMA4;USP28;INO80D;INO80C;ACTR5;MBD6;ABRAXAS1;PSME1;ADRB2;PSMD13;USP19;ESR1;TNFAIP3;GPS1;RCE1;PSMB10;PSMA5;PSMB9;BIRC3;FOXO4
prerank,cardiac muscle contraction (GO:0060048),-0.34757502391690503,-1.0957168338774552,0.297029702970297,0.6154020547945536,1.0,3/34,1.44%,ATP1A2;GSN;TPM1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.32309608655949973,-1.095611859937606,0.3173076923076923,0.6151821385383984,1.0,8/52,7.95%,EGFR;LRP1;SORBS1;EPHA3;PTPN9;DLG1;ITGB1;PDPK1
prerank,cellular response to UV-A (GO:0071492),0.4637562162313284,1.095572617581855,0.3348115299334812,0.7423620677340027,1.0,2/11,7.74%,MME;TIMP1
prerank,secondary alcohol metabolic process (GO:1902652),-0.3334047752483413,-1.0952408683807444,0.2918287937743191,0.6155778631170047,1.0,17/42,34.60%,ABCA1;CYP27A1;SOAT1;OSBPL5;APOE;RXRA;SQLE;FDX1;GBA2;SCAP;CLN8;TSKU;ANGPTL3;CLN6;IDH2;CH25H;LCAT
prerank,peptidyl-methionine modification (GO:0018206),0.4454505061502887,1.0951869469227637,0.3318872017353579,0.7423350621921162,1.0,3/12,15.11%,METAP2;NAA30;NAA60
prerank,autophagosome organization (GO:1905037),-0.32150879678135197,-1.0947167015231414,0.29051383399209485,0.6163811578582664,1.0,21/50,26.43%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;ATG3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.47280804586165315,-1.0942263367706557,0.3669064748201439,0.6171264046564088,1.0,4/10,29.39%,ADGRV1;IFT88;PLS1;TSKU
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3742258334093954,-1.0939101033343035,0.32612966601178783,0.6174443115027838,1.0,3/24,2.59%,PID1;RHOQ;DAB2
prerank,negative regulation of complement activation (GO:0045916),-0.4794324834367395,-1.0938314807172504,0.3609022556390977,0.6171542900564733,1.0,3/10,14.00%,SERPING1;CD55;CR1L
prerank,positive regulation of ATPase activity (GO:0032781),0.33595820853541664,1.0937939193578354,0.3094736842105263,0.7452569232870241,1.0,11/41,17.70%,DNAJC9;RYR2;DNAL4;FGF10;DYNLL1;VMP1;ATP1B1;PFN1;DYNLL2;DNAJB2;AHSA1
prerank,arachidonic acid metabolic process (GO:0019369),-0.34785956220041925,-1.0931652374852758,0.29764065335753176,0.6182590792888785,1.0,10/35,15.81%,PTGDS;PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PTGES;PNPLA8;EPHX1;EPHX2
prerank,regulation of mRNA processing (GO:0050684),-0.3555581495442777,-1.093033478208792,0.33088235294117646,0.6181151082059192,1.0,11/32,13.32%,SON;RBM39;PABPN1;KHDRBS1;SRSF10;DHX9;SAFB2;HNRNPK;CDK11B;YTHDC1;CWC22
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3561881133186543,-1.0928289644702411,0.31851851851851853,0.6180931408957971,1.0,7/33,10.52%,SMAD3;TEAD1;FOXO3;NR3C1;STAT3;JUN;HIF1A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.34423979661445636,-1.092713811001908,0.31309297912713474,0.6178843247812916,1.0,13/39,15.00%,ROCK2;ROCK1;SNCAIP;RAP1B;PARP10;TRAF2;HCFC1;HJURP;SPTY2D1;GFAP;APOE;LATS1;RAPGEF2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.27033543947835076,1.0926975413858673,0.2515463917525773,0.7472665974097653,1.0,23/140,11.50%,GRIN1;CACNA1A;ADCY8;GRM1;RYR2;HTR2C;CACNA2D1;SLC8A1;CD24;TACR1;NPTN;GPR35;P2RY1;CIB2;ADCYAP1;ACKR4;GPR17;ADRA1D;ADRA1A;F2RL2;F2R;JPH3;P2RX7
prerank,apoptotic DNA fragmentation (GO:0006309),-0.42282771128630237,-1.0926820818382423,0.3473282442748092,0.617465774780329,1.0,6/16,27.41%,DICER1;HMGB1;H1-0;EXOG;DNASE2;CECR2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.37467436210847926,-1.0923115787580637,0.32950191570881227,0.6179147277445916,1.0,13/26,24.55%,EIF4E;HES1;CUL3;TTL;USP2;CDC25B;CCDC57;KLHL18;PRKCA;SPHK1;HSF1;EIF4EBP1;PPP1R10
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3017484235766794,-1.0917783300692314,0.28488372093023256,0.6187358082936253,1.0,15/69,14.13%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4016867553602777,-1.091738040664522,0.34942084942084944,0.6183573645921132,1.0,5/17,17.41%,JAG1;CD55;STAT3;IL18;TLR4
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.42029009637271886,-1.0916738148675582,0.33269961977186313,0.618009586865333,1.0,7/15,24.79%,PRODH;GGACT;SARDH;CHAC2;ABHD12;ALDH4A1;GGT5
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.35143900210792495,-1.0915902714168748,0.3313008130081301,0.6177224277455166,1.0,9/34,17.53%,SMAD3;ENPP1;YAP1;RUNX1T1;RORA;TRIB2;ANKRD26;TRIO;WNT5A
prerank,axon extension (GO:0048675),-0.3700343145673115,-1.09125333401313,0.3352601156069364,0.6179999823512282,1.0,5/23,11.05%,ALCAM;AUTS2;NRP1;SPG11;ULK2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.40850460167879366,1.0910184062918056,0.35607675906183367,0.7510690125469668,1.0,5/17,13.89%,PODXL;TGFB2;SKAP1;RET;CIB1
prerank,morphogenesis of an epithelium (GO:0002009),-0.3737007722427459,-1.0908752552800087,0.33402489626556015,0.6184376181409512,1.0,6/25,11.58%,DAG1;VCL;LRP6;FGFR2;LAMA3;TBX18
prerank,cell junction organization (GO:0034330),0.3033386953324934,1.0908457634506528,0.2719665271966527,0.7503469762505912,1.0,22/71,15.67%,GRM5;ACTB;CTNND2;SNCA;OCLN;PPFIA3;TGFB2;ELFN1;WNT7B;RAB39B;VMP1;APBB2;PPFIA2;TJP1;DVL1;MARVELD2;PPFIA4;SNCB;PSEN1;PAK3;NLGN3;CBLN2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.395859543378355,-1.0905716765313287,0.3320754716981132,0.618655202538675,1.0,3/20,3.94%,AKAP13;ADCY9;ADRA1B
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.45453499317233836,-1.090224693241783,0.3572744014732965,0.6190394646800823,1.0,7/12,32.23%,DHX9;MAVS;MUL1;CGAS;IFIH1;CAV1;ZCCHC3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.325360646636922,-1.0902161701612623,0.3058350100603622,0.6185616211041962,1.0,13/48,21.05%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,protein heterotetramerization (GO:0051290),0.43589773149374356,1.0901257952301942,0.3620689655172414,0.751299916473418,1.0,3/13,11.07%,GRIN1;GRIN2B;FARSB
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3468047835312385,1.0898001547005722,0.3029661016949153,0.7510638334257169,1.0,11/35,18.89%,LIG3;RPA3;UNG;APEX1;POLG;POLD1;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,small GTPase mediated signal transduction (GO:0007264),-0.28061140661026496,-1.0894502164217978,0.25626204238921,0.6199728880467416,1.0,33/103,24.04%,PLD1;IGF1;PLCE1;KSR1;TIAM2;RREB1;SHOC2;ARL3;BCR;MRAS;SHC1;JUN;ARHGEF18;ARHGAP32;ARFIP2;RALA;SETDB1;RB1;USP50;RAPGEF2;GNB1;ARHGAP18;ADRA2A;PRKD1;RASSF1;PARK7;CDK2;FGF2;CRKL;RIT1;CHP1;SIAH2;USP28
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3673996790718996,-1.088976147385118,0.3333333333333333,0.620625803807664,1.0,6/27,12.88%,VPS13A;GBF1;VPS13D;OBSL1;COG7;VPS13C
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.45788513304070344,-1.0888401951533577,0.3659889094269871,0.6204692709114429,1.0,8/13,28.65%,ABCA1;ITGB1;CD9;LDLR;SYK;FCER1G;LPL;CD81
prerank,cGMP-mediated signaling (GO:0019934),0.4308407603670671,1.0887232761040253,0.3574561403508772,0.7530331811378354,1.0,3/13,3.45%,KCNC2;PDE2A;HTR2C
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4705397021911733,1.088688785879645,0.3652173913043478,0.7519078890377354,1.0,5/10,19.18%,RUVBL1;PIH1D2;ZNHIT6;NAF1;NUFIP1
prerank,detection of mechanical stimulus (GO:0050982),-0.3931311722975163,-1.0886673151013366,0.34806629834254144,0.6203956878380278,1.0,4/19,12.33%,PIEZO2;PKD1;JUP;PKD2
prerank,acidic amino acid transport (GO:0015800),-0.40704524337386794,-1.088575942098643,0.3572815533980582,0.6201300575182853,1.0,6/17,10.99%,SLC6A13;SLC1A3;LRRC8D;GJA1;GIPC1;SLC6A1
prerank,mucosal immune response (GO:0002385),0.4153585332161245,1.0884332206802112,0.3598233995584989,0.7514240821564049,1.0,15/15,58.50%,DEFA6;RNASE3;OTUD7B;PLA2G1B;RPL39;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;IFNLR1
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3077270828323009,-1.0883903330838998,0.3019230769230769,0.620070306206987,1.0,23/65,21.52%,MDM4;BMP7;PTGIS;LMNA;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;RORA;ACAA2;NPEPPS;PGK1;VEGFA;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;GATA6;TBL2;BNIP3
prerank,SNARE complex assembly (GO:0035493),-0.47013818064781343,-1.08833449756139,0.3562152133580705,0.619717109759805,1.0,4/10,17.92%,UVRAG;STXBP1;VAMP2;VAMP4
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.3937927539489242,-1.0882334330283685,0.36203866432337434,0.6194459540008739,1.0,5/20,13.70%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,negative regulation of cell cycle (GO:0045786),-0.29608132815606136,-1.0878399133806635,0.29458917835671344,0.619974951181941,1.0,23/73,23.93%,NR2F2;SMAD3;FOXC1;BMP7;BMP4;NUPR1;GAS1;PTPN3;PTPRK;BTG3;RB1;CDK5RAP1;DUSP1;LATS1;PDCD4;NR4A1;BMP2;INHBA;CDKN1C;CDK6;SCRIB;ANGEL2;TFAP4
prerank,response to lipid (GO:0033993),0.28217683462840626,1.0871531733478814,0.3067961165048544,0.7542467816490205,1.0,25/105,15.14%,TIRAP;S100A9;S100A8;ACER2;PPARG;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;SLPI;GGT7;F2R;SCD;GGT1;FOXO1;CD36;TAB2;PAQR8;RXRG;PELI1;HSD17B2;GCH1;MAPKAPK2
prerank,regulation of blood coagulation (GO:0030193),-0.36457465702648006,-1.0869274607482624,0.3057692307692308,0.6217567427596115,1.0,7/27,16.99%,ST3GAL4;VTN;THBS1;TFPI;FAP;APOE;SERPINE1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37558221787816404,1.086663275192233,0.3361884368308351,0.754436338375608,1.0,4/23,3.16%,PROX1;ATP11A;NRG1;AKAP6
prerank,regulation of cell division (GO:0051302),-0.29689999050043603,-1.086637353951926,0.2961460446247465,0.6219971352059693,1.0,15/72,16.03%,MLLT3;KIF13A;FGF1;BIRC6;KLHL13;UVRAG;CSPP1;FGFR2;TXNIP;SETD2;RAB11A;BECN1;PIK3C3;PIK3R4;PRDM15
prerank,mitochondrion disassembly (GO:0061726),-0.34285479340584796,-1.0865542080070145,0.32504780114722753,0.6216858497746034,1.0,15/34,23.00%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;MAP1LC3A
prerank,regulation of protein phosphorylation (GO:0001932),-0.24956991693931918,-1.0861641476447135,0.23790322580645162,0.6221636308422965,1.0,72/256,22.00%,PTPN13;ROCK2;EGFR;PID1;PLCE1;EPHA7;LEPR;IL34;ANGPT1;SLCO3A1;LRP6;NTRK3;PELI2;FBLN1;PLPP3;FGF1;BMP7;DAB2;FAM20A;BMP4;ABL1;PRKN;LRRK2;IBTK;IGFBP3;AXIN1;NSD1;EIF2AK3;LYN;AKAP8L;IGF2;IMPACT;PLXNB2;RB1CC1;FER;BMPER;MAVS;FNIP1;PPP2R5E;FN1;FKBP8;CARD14;MOB1B;CCN1;WDFY2;PRKDC;VEGFA;PPP2R5D;CCND3;ZBED3;VEGFD;PDCL3;ARRB1;NOP53;PHIP;MYADM;PPP2R5C;CSNK1D;INPP5K;BMP2;PARK7;MUSK;ITGB3;PML;TMEM119;PPP2CA;CDK5RAP3;AKT2;DVL3;FGF2;ATG14;CRKL
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40350562871609275,-1.086096540964728,0.33989266547406083,0.6218307694983851,1.0,11/18,37.87%,RNFT1;TMEM259;ERN1;NCK1;USP13;PIK3R1;BAG6;BAK1;BCL2L11;FCGR2B;RNF185
prerank,regulation of interferon-gamma production (GO:0032649),0.29416446696378085,1.0858746476682373,0.296969696969697,0.7555991292482779,1.0,8/71,12.68%,SLC7A5;PDE4B;GAS6;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.46618911919076333,-1.0858504464298047,0.37523452157598497,0.6214647406152896,1.0,4/11,23.34%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.46618911919076333,-1.0858504464298047,0.37523452157598497,0.6214647406152896,1.0,4/11,23.34%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4193727756516127,1.085709436091049,0.35528942115768464,0.7548738851380282,1.0,3/15,8.42%,TMSB4X;KDR;HSPB1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3439217230908013,1.0856305798566142,0.3305439330543933,0.7538718313906522,1.0,7/33,10.31%,PTPRG;PTPRR;ADGRB1;ACVRL1;DNAJA4;DAB2IP;PTPRM
prerank,sensory perception of light stimulus (GO:0050953),-0.28853547157620957,-1.0847796144064334,0.291044776119403,0.623618918156774,1.0,20/87,18.20%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3599063615423854,-1.0846065715178757,0.3567251461988304,0.6235426967125912,1.0,7/30,9.78%,NOTCH2;IGF1;ITGAV;SHOC2;SHC1;LYN;NGF
prerank,negative regulation of interferon-beta production (GO:0032688),-0.477627186807856,-1.0845707713096686,0.362763915547025,0.6231416531564682,1.0,5/10,34.01%,PTPRS;NLRC3;SIRPA;CACTIN;PYCARD
prerank,GPI anchor biosynthetic process (GO:0006506),-0.35572657497379645,-1.0845388296064904,0.348747591522158,0.6227355509598937,1.0,14/30,32.31%,PIGN;PIGK;DPM1;PIGS;GPAA1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.39540189662041886,-1.0843469366566685,0.35150375939849626,0.6227313590959563,1.0,3/20,3.72%,CFLAR;FLOT2;NUPR1
prerank,histone H4-K16 acetylation (GO:0043984),-0.4053581161440765,-1.0839690652190455,0.330188679245283,0.6231887839732813,1.0,9/19,23.96%,KANSL2;HCFC1;OGT;KAT8;MSL2;MSL3;KANSL3;KMT2A;JADE2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3346521405974452,-1.0838663230574601,0.3246753246753247,0.6229597735582862,1.0,16/37,24.27%,FHIT;USP7;RPL11;GIPC1;OGT;TRIM39;PDCL3;CSNK2A1;NOP53;PARK7;PML;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.45306678717148763,-1.0837920390701805,0.3862332695984704,0.6226431143639177,1.0,2/12,7.55%,GMDS;GFPT1
prerank,TOR signaling (GO:0031929),0.36972557456420035,1.0837223560464473,0.3518886679920477,0.7583156438287555,1.0,7/26,11.40%,PRR5L;RPS6;MEAK7;RPS6KB2;AKT1;EIF4EBP2;CCDC88A
prerank,muscle cell development (GO:0055001),0.35975723684203076,1.0835877104747742,0.3253012048192771,0.7575001726685291,1.0,9/30,12.16%,SGCZ;RAMP2;BIN1;MYH6;SLC8A1;DYSF;NRAP;TCAP;MEGF10
prerank,presynaptic endocytosis (GO:0140238),0.37842776141314827,1.0834905844136327,0.3391304347826087,0.7565382391175233,1.0,10/24,18.86%,SYT1;NLGN1;SNCA;AMPH;SYT2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,cellular response to increased oxygen levels (GO:0036295),0.46071884638194927,1.0833005182513613,0.3707865168539326,0.7558962194434165,1.0,4/11,14.85%,ATP6V1A;ATP6AP1;FOXO1;TMEM199
prerank,membrane depolarization during action potential (GO:0086010),-0.37218007040874324,-1.082925177109372,0.34674329501915707,0.6243959582823271,1.0,5/26,7.81%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1D
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4302066886690187,1.0827274166853564,0.38675213675213677,0.756463018316798,1.0,3/15,6.58%,PAX8;PAX2;LHX1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4303545717065323,-1.0826879982870696,0.3647912885662432,0.6244556650775641,1.0,7/15,10.56%,PDGFRA;NTRK3;PDGFRB;ABL1;KIT;PLCG1;ABL2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3742817331026594,-1.082529737715506,0.35526315789473684,0.6243623303335214,1.0,3/23,5.68%,ERRFI1;CBLB;SNX6
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3429279620745708,-1.0823917314903393,0.31640625,0.624236125003503,1.0,10/36,16.02%,NCOR1;PRKN;DLG1;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP1;DUSP10
prerank,bicellular tight junction assembly (GO:0070830),0.3313053773311213,1.082350608235723,0.3463917525773196,0.7563888113731659,1.0,9/46,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.40138229551017973,-1.0820076543073542,0.3539651837524178,0.6246681545708186,1.0,8/20,30.46%,FKBP5;PPIH;PPWD1;NKTR;PPID;PPIC;PPIL1;PPIF
prerank,response to glucagon (GO:0033762),0.39866156249425844,1.0820012475561671,0.3761261261261261,0.7562781239300421,1.0,3/19,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31564551643668914,1.0817437802582708,0.3277310924369748,0.7558618690438142,1.0,14/54,14.15%,TMSB4X;SIRT1;PPARG;KDR;NOS3;CSNK2B;ETS1;ACVRL1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;ATP2B4
prerank,superoxide anion generation (GO:0042554),-0.4394146614541103,-1.0817015602342162,0.3663551401869159,0.6249280797358734,1.0,4/13,27.13%,NOX4;CYBA;NCF2;ALOX12
prerank,blood circulation (GO:0008015),-0.31801105435537147,-1.0815683853775988,0.314453125,0.6247650223943405,1.0,12/49,15.54%,ROCK2;COL4A3;ROCK1;ELN;SERPING1;MEOX2;MYOF;ADCY6;GUCY1A1;AGTR1;STAT1;BDKRB2
prerank,platelet aggregation (GO:0070527),-0.34981720874922506,-1.0813272411700898,0.33962264150943394,0.6248645937582256,1.0,9/33,15.56%,VCL;PDGFRA;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,regulation of cell differentiation (GO:0045595),-0.2645876400764637,-1.0811293908957873,0.27037773359840955,0.6248427921371172,1.0,33/148,17.45%,PHLDB2;SMOC1;TGFBR1;DAG1;EPHA3;DDX5;NREP;NR1D2;ZFHX3;CCN2;ROCK1;FLOT2;DDX17;CREBBP;TRIP4;FGFR2;RUNX1;REST;ST7;AR;IGF2;NGF;ID2;SIK1;CDK5RAP1;TRPS1;EIF2AK2;TAF8;ANP32B;RUNX2;NSUN2;SIX1;PRKACA
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.42177357527241555,-1.0810463400158974,0.3603238866396761,0.6245590654075531,1.0,10/16,30.27%,PRPF39;SFSWAP;DDX23;SRSF1;WBP11;NCBP2;RBM22;CACTIN;SNRNP200;PSIP1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.42517596645935385,-1.0808395069505963,0.35714285714285715,0.6245957055134878,1.0,5/16,14.77%,DPYSL3;UPP2;NT5M;UPB1;DPYD
prerank,linoleic acid metabolic process (GO:0043651),-0.4188317279284639,-1.080587722697694,0.3730769230769231,0.6247532189639963,1.0,6/17,27.33%,ACSL1;PNPLA8;ELOVL1;GSTM2;ALOX12;ELOVL5
prerank,protein localization to cell junction (GO:1902414),-0.3812127496889429,-1.080330084508277,0.3333333333333333,0.6248842573619812,1.0,5/22,5.83%,CGNL1;JAK1;NLGN2;DLG4;PAK2
prerank,protein localization to cell periphery (GO:1990778),0.27084365738001476,1.0802092564517245,0.2627450980392157,0.7592850486826058,1.0,19/133,7.35%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,protein polymerization (GO:0051258),-0.3117127318985414,-1.0782176197603492,0.32061068702290074,0.6296070043545057,1.0,12/56,10.04%,ARHGAP6;GAS7;GSN;DIAPH1;PRKN;CENPJ;CORO7;CHMP4B;CHMP4A;UBE2K;WASL;CHMP3
prerank,cellular response to hexose stimulus (GO:0071331),0.3734947867176674,1.0778550796469286,0.33261802575107297,0.7653560818952683,1.0,5/23,3.78%,IGF1R;ADCY8;SLC2A5;PAX2;GAS6
prerank,superoxide metabolic process (GO:0006801),-0.3600626948751871,-1.077729561771127,0.341747572815534,0.6303821622499127,1.0,12/29,28.58%,SH3PXD2B;CYB5R4;NOX4;SH3PXD2A;SOD3;CYBA;SOD2;NCF2;PRDX2;CCS;ALOX12;MT3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.28047607505108424,1.0776857346143673,0.298828125,0.7646543157521349,1.0,18/100,10.86%,FLT1;IGF1R;TEK;PIP5K1B;SIRT1;PPP1R16B;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO;FBXL2;DAB2IP;PDGFB;F2R
prerank,regulation of cell growth (GO:0001558),0.2587093952133812,1.0776300385646465,0.2462526766595289,0.7636244393188432,1.0,41/204,14.84%,NRG3;TFRC;SPOCK1;MINAR1;S100A9;S100A8;AKAP6;SIRT1;GNG4;APBB1;OGFR;MFSD2A;PAK5;SCGB3A1;PPP2R1A;TGFB2;SLIT3;PRKCQ;WFDC1;MELTF;PTPRJ;ACVRL1;RPS6KA1;AKT1;SGK3;H3-3A;TAOK2;NET1;APBB2;IL17RB;CEP43;SOX17;NDUFA13;BMPR2;BCAR1;CIB1;LGI1;SMARCA2;CDKN1A;PPT1;RTN4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.43042074026881205,-1.077119668548255,0.3656307129798903,0.6314280507705209,1.0,4/15,9.06%,FOXC1;BMP4;NUMA1;MED1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3854273428519254,-1.0769829792089736,0.35645472061657035,0.631262120021519,1.0,9/22,28.17%,MED17;MED12;DHX36;MED1;MED16;MED13;MED14;PAXIP1;ESR1
prerank,regulation of centriole replication (GO:0046599),-0.38570475850229724,-1.0761145665255971,0.35435992578849723,0.6329644231895087,1.0,6/18,17.06%,KAT2B;ALMS1;SPICE1;CENPJ;CEP295;CEP76
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3098235740078836,-1.076018462258958,0.31985294117647056,0.6327257630573269,1.0,16/56,13.88%,EGFR;EFEMP1;EPHA3;PDGFRA;PDGFRB;ABL1;TPST1;KIT;FGFR2;LYN;EPHA4;FER;ABL2;ABI1;TEC;TTL
prerank,regulation of wound healing (GO:0061041),-0.3325693831353136,-1.075794706243958,0.3486973947895792,0.6328079451847355,1.0,12/42,21.55%,MYLK;VTN;ITGB1;ARFGEF1;ANXA1;SRSF6;CD109;ADRA2A;SERPINE1;HBEGF;CLDN1;FGF2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3663228566537674,1.0757027634138028,0.3555045871559633,0.7682775659964992,1.0,10/25,18.04%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.43470537271363147,-1.0750463533270613,0.366120218579235,0.6341727415606252,1.0,7/13,22.55%,MDFIC;SP100;TPR;SUFU;APOD;PARK7;CHP1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.41744547597498144,-1.074659476174103,0.376984126984127,0.6346620035269007,1.0,5/15,17.08%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3745772272864665,-1.0745030623085245,0.34791252485089463,0.634522213568356,1.0,8/25,19.35%,PARVA;ITGAV;ITGB1;CXADR;JUP;ITGA5;ITGA4;ITGB3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.41530700816010746,-1.0743042251354868,0.3372093023255814,0.6345238035622603,1.0,3/15,6.09%,PIEZO2;KIT;ADGRV1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.39602988667603106,-1.0740664416285908,0.38644688644688646,0.6346116931679838,1.0,9/21,28.58%,PRKN;COA8;SLC30A10;ABCD2;SIRT5;PARK7;AATF;PPARA;MT3
prerank,positive regulation of immune effector process (GO:0002699),-0.36659255286167813,-1.0735428565925027,0.36917562724014336,0.6353707817447085,1.0,4/27,10.33%,APPL2;ANKRD17;LBP;DDX60
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.46060990819811354,-1.073372001018942,0.37158469945355194,0.6353142642715135,1.0,8/11,31.87%,WNT4;BMP5;BMP2;FGFR4;EGR1;NR1H4;ASAH1;STAR
prerank,mitotic metaphase plate congression (GO:0007080),-0.3157913596255008,-1.0732988375648354,0.32193158953722334,0.6349986044605525,1.0,11/51,14.25%,EML4;PIBF1;VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;RAB11A;CUL3;BECN1;NUDC
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4142690730066915,-1.0727845327731547,0.36538461538461536,0.6357769067791134,1.0,8/16,32.68%,KAT2B;EP300;CREBBP;NAA15;NAA16;NAA80;NAA25;NAA40
prerank,negative regulation of catabolic process (GO:0009895),-0.32621521661318814,-1.0727587461803247,0.3235867446393762,0.6353513753354758,1.0,7/47,4.50%,EGFR;MDM4;HDAC4;NCOR1;NUPR1;FLNA;IRAK3
prerank,regulation of translational initiation (GO:0006446),-0.3011010762566167,-1.0720465357454607,0.319672131147541,0.636629755507775,1.0,20/63,19.57%,EIF4G3;YTHDF3;KHDRBS1;EIF4A2;EIF2AK3;LARP1;IMPACT;CSDE1;DNAJC3;ALKBH1;TPR;EIF2AK4;CDC123;NCK1;DDX3X;NCK2;PAIP1;MIF4GD;EIF4G1;RBM4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.36560274729639225,1.072021592416108,0.3658051689860835,0.778236007009783,1.0,6/27,7.53%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8
prerank,homologous chromosome segregation (GO:0045143),0.3873880209315341,1.0719186297778864,0.3619631901840491,0.7773019853008832,1.0,2/20,4.07%,MEI4;FMN2
prerank,acylglycerol homeostasis (GO:0055090),-0.3867563051428406,-1.0719074302638427,0.3638095238095238,0.6364801875453505,1.0,8/20,30.77%,NR1H3;RORA;PNPLA8;APOE;IL18;LPL;MLXIPL;ANGPTL3
prerank,cellular amino acid catabolic process (GO:0009063),-0.28174949386153664,-1.0718793870517471,0.31213872832369943,0.6360643212818144,1.0,25/87,26.75%,DDO;ACADSB;ABAT;ASPA;IVD;HIBCH;GLUD1;MCCC2;GLUL;PRODH;ALDH6A1;DLST;SARDH;ALDH7A1;CARNMT1;NOS1;BCKDK;ALDH4A1;AMT;HIBADH;AUH;PIPOX;CBS;HNMT;PHYKPL
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.43666627604519515,1.071846838308996,0.3788546255506608,0.7762760671840758,1.0,2/12,3.31%,MIF;SIRT1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4413577793649559,1.0715097181411566,0.38095238095238093,0.7760334803304948,1.0,4/12,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3301655767895012,1.0714958222579336,0.3277661795407098,0.7748560418148711,1.0,8/39,13.15%,TEK;RAMP2;GAS6;KDR;NDNF;CCL2;SCG2;CD40
prerank,protein trimerization (GO:0070206),-0.42911388729490585,-1.0714927573717274,0.3578154425612053,0.6360503631456759,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,protein homotrimerization (GO:0070207),-0.42911388729490585,-1.0714927573717274,0.3578154425612053,0.6360503631456759,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.34199280140723265,-1.0707870893863844,0.3472222222222222,0.6373564045291675,1.0,10/33,18.22%,TPM1;IGFBP5;IGFBP3;OGN;MEF2C;APOD;EFEMP2;TGFB3;PDCD4;SOD2
prerank,actin filament polymerization (GO:0030041),-0.35957450014101505,-1.070359107304692,0.3509803921568627,0.6379488141882861,1.0,9/29,17.55%,ARHGAP6;GAS7;GSN;DIAPH1;CORO7;WASL;TTC17;WASF1;FAM107A
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4185471656384704,-1.0703146854688195,0.39575289575289574,0.6375710843807559,1.0,7/15,28.32%,DAB2;SMAP1;WASL;BMP2K;DGKD;HIP1R;NEU3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3269950091271296,-1.0702430169442825,0.35946462715105165,0.6372526868295526,1.0,17/46,21.47%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2820051293114682,-1.0700163118177712,0.3094736842105263,0.6373255432168279,1.0,26/95,19.91%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;CTR9;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.46511234531937873,-1.069502024736049,0.3921200750469043,0.6381086406815291,1.0,4/10,25.22%,VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.3741985015224639,-1.0693315742437646,0.3508137432188065,0.6380699072589175,1.0,9/22,22.43%,PPM1D;PPM1E;DUSP16;PPP2CB;PPM1A;DUSP1;DUSP10;PPP2CA;DUSP7
prerank,regulation of TOR signaling (GO:0032006),-0.2964773903829722,-1.0691860764017682,0.3320754716981132,0.637963509902446,1.0,19/67,21.40%,ARAF;UBR2;PRKAA2;RPTOR;DEPTOR;TMEM127;TTI1;UBR1;FNIP1;TELO2;WDR59;RICTOR;TBCK;NPRL3;PRKAA1;TBC1D7;GPAT3;PIH1D1;LARS1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.440903290517018,-1.068926079020962,0.3796477495107632,0.6380968689586677,1.0,5/12,18.01%,JAG1;REST;HES1;NELFB;HNRNPU
prerank,protein O-linked mannosylation (GO:0035269),-0.39660481660514846,-1.068299940781308,0.36580882352941174,0.6391474583028871,1.0,11/18,23.77%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,regulation of apoptotic process (GO:0042981),-0.22712216982354658,-1.068135470796584,0.2,0.6390441334837946,1.0,153/676,19.05%,AKAP13;FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;PAWR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;STEAP3;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;FOXO3;STK3;BMP4;TIAM2;ERC1;PDPN;ABL1;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;ARHGEF17;NUPR1;GSK3B;STK17B;NIBAN2;FLNA;RARG;IGFBP3;ANXA4;ANXA5;HMGB1;ITGB1;CTSH;SLK;DNM1L;THBS1;HOXA5;PAK2;CREBBP;SH3RF1;MAP4K4;TMBIM4;PHLDA1;SHC1;BCL2;IFIT2;GAS1;ANXA1;BRAF;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;FBXO10;AIFM1;WRN;DDX42;VDAC1;ACTN2;XIAP;ADAMTSL4;MED1;UNC13B;HNRNPK;CYP1B1;MAP3K20;BAG3;NGF;NCSTN;PRMT2;ANKLE2;EGLN3;TRAF2;JUN;ARHGEF12;DNAJC3;ARHGEF18;USP47;BCLAF1;LGALS1;MEF2C;ERCC3;YME1L1;SOS2;HSPA9;RASSF2;CCAR1;CASP2;FGD1;CARD14;ATF6;SH3RF2;ING5;GLO1;STAT1;FGD4;PRKDC;NAA15;RBM5;VEGFA;HDAC1;DDX3X;LATS1;TOPORS;RASA1;ANP32B;ANP32E;TXNDC5;TGFB3;DAPK1;NGEF;PTPA;NOP53;MRE11;IAPP;ARHGEF11;TRIO;ARHGEF6;CITED2;BFAR;DAPK2;TMEM219;WNT5A;PHIP;ARHGEF1;PRKAA1;SFRP4;RABGGTB;AREL1;TRAF6;VCP;TMEM14A;BMP2;DCUN1D3;PARK7;CHM;APIP
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3736459677692975,-1.0681021738948757,0.3841698841698842,0.6386280191326733,1.0,9/22,23.31%,MDFIC;LRRK2;SP100;SUFU;APOD;INPP5K;PARK7;CHP1;LMAN1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2635485496420622,-1.0680221239729741,0.2898832684824903,0.6383319710173038,1.0,29/141,12.33%,ATP1A2;ROCK2;EGFR;ADCY5;IGFBP5;DIAPH1;CTNNA1;LRRK2;SPIDR;NR3C1;LCOR;TFPI;RAP1B;CDH1;ADCY1;LARP1;ADCY6;RAPGEF3;AR;IMPACT;MED1;JUP;CYP1B1;SLC5A5;RORA;MEF2C;RIOK3;PDE3A;PKD2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.43900642078971663,-1.0678609743744767,0.37153419593345655,0.6382395255772167,1.0,6/13,19.24%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;PTPN11
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4464475926089144,1.0678138655694245,0.3630434782608696,0.785017489579411,1.0,2/11,3.31%,MIF;SIRT1
prerank,positive regulation of cell motility (GO:2000147),0.2537341168234725,1.0674220623178008,0.28628230616302186,0.784902431531877,1.0,42/205,14.52%,SPOCK2;FLT1;IGF1R;LEF1;PTP4A1;SEMA3C;CSF1R;PODXL;SEMA6A;ITGA6;CXCL12;SEMA4A;SEMA4F;PPM1F;SEMA6D;KDR;SEMA4D;SEMA7A;FERMT3;HSPA5;NOTCH1;PAK1;PECAM1;GPNMB;NTN1;PDGFB;AIF1;F2R;CEP43;PIK3R3;APC;TJP1;RET;EPHA1;BCAR1;ACTN4;HRAS;XBP1;INSR;CIB1;ATM;PPP3CA
prerank,nucleic acid-templated transcription (GO:0097659),0.32094818505296685,1.0672844039492584,0.34108527131782945,0.7840620889803291,1.0,11/42,14.46%,PAX8;PTMA;HOXD3;XAB2;POLR2J;POLR2B;THAP1;POLR2I;BCL3;MED20;POLR3A
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.31978492062849717,-1.0672793546772898,0.36779324055666,0.639225922826818,1.0,10/45,11.05%,FOXO3;PUM2;ZC3H7A;RC3H1;LARP1;PUM1;GEMIN5;EIF4E;PARP9;YTHDC1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3649344945262753,1.0672307089102024,0.3487858719646799,0.7829672219160956,1.0,4/25,3.87%,DSCAM;MIF;ITGA6;SNCA
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.38087961772137746,-1.0671549898325217,0.3595505617977528,0.6390410673965848,1.0,4/21,8.85%,IGF1;ITGAV;CTSH;MAP2K1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.45810790643654903,-1.0669252852618696,0.3828264758497317,0.6391291667234736,1.0,2/11,7.02%,RC3H1;ANXA1
prerank,protein kinase A signaling (GO:0010737),-0.4452768713420754,-1.066611854599111,0.3672316384180791,0.639471433694477,1.0,10/12,53.21%,PRKACA;MYOM1;RDX;TTN;TCP11X2;TCP11;PRKACB;RAB13;LCP1;GAL
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4054211479621068,-1.0664363783193251,0.37373737373737376,0.6394302028471885,1.0,4/17,8.82%,FSTL1;SULF1;TWSG1;XIAP
prerank,negative regulation of telomere maintenance (GO:0032205),-0.4160041697372931,-1.0657171897478754,0.3861003861003861,0.6406567981928262,1.0,4/15,11.61%,SMG6;TNKS2;NBN;PARP1
prerank,macrophage activation involved in immune response (GO:0002281),-0.42911035854541374,-1.0654648439247334,0.3761814744801512,0.6407606211553466,1.0,6/13,28.00%,LBP;SBNO2;CX3CR1;IFI35;SYK;GRN
prerank,regulation of cell adhesion (GO:0030155),-0.26650792996504535,-1.0652529083275408,0.3135245901639344,0.6408009040810279,1.0,31/129,17.87%,PLXNA2;ROCK2;EPHA7;ANGPT1;TPM1;FBLN1;ZFHX3;ITGAV;PPP1R12A;ROCK1;ABL1;RIPOR2;LYN;EPHA4;RSU1;PLXNB2;ABL2;STX4;ARHGDIB;EPHA8;CD164;VEGFA;DUSP1;PPP1CB;PLXND1;RASA1;PLXNB1;GPR4;IL18;MIA3;MYADM
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24631385375163684,-1.0651607232764055,0.2857142857142857,0.6405407390455103,1.0,52/245,16.46%,ROCK2;NOTCH2;IGF1;ROR1;EGFR;LPAR1;IL34;PDGFRA;ANGPT1;NTRK3;PELI2;CCN2;KSR1;FGF1;PDGFRB;ROCK1;ROBO1;LRRK2;ADRA1B;GSDME;KIT;RYK;HMGB1;SLC30A10;GAREM1;TAOK3;NRP1;FGFR2;SHC1;BRAF;MID1;IGF2;MAP2K1;PTPN22;PDGFC;BMPER;WWC1;ROR2;TRIM5;FBXW7;EIF2AK2;EPHA8;APOE;TPD52L1;VEGFA;RAPGEF2;PRKCZ;GLIPR2;MAP2K7;ARRB1;IAPP;ADRA2A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3802186953093327,-1.0648510313833268,0.367816091954023,0.6407755078543029,1.0,6/22,17.33%,ROCK2;LYN;EPHA4;RANBP9;IFNGR1;PICALM
prerank,amino acid transport (GO:0006865),0.319024685300636,1.0646507063435608,0.3203285420944558,0.7895872242176973,1.0,7/49,9.57%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;SLC7A8;SLC43A2;SLC36A1
prerank,striated muscle cell differentiation (GO:0051146),-0.41655931914568806,-1.0644293281027783,0.3767258382642998,0.641318888085168,1.0,4/16,12.52%,AKAP13;SKI;MEF2C;SIK1
prerank,positive regulation of cellular process (GO:0048522),0.22940625973882603,1.0641968519943283,0.2144212523719165,0.789736882970913,1.0,92/565,14.28%,FLT1;CLDN5;IGF1R;LEF1;SLC6A6;CHEK1;GRIN1;KITLG;FRMD5;ERBB4;PROX1;CSF1R;RPS6;RPS19;S100A9;S100A8;IL7;NRG1;AQP11;CXCL12;CCND1;COPS9;RYR2;RPL23;AKAP6;ACER2;SIRT1;TRIM13;IL2RG;HMGA2;MFSD2A;GAS6;KDR;FGF10;NTRK2;FLT3;TENM4;IL12A;STX3;NOTCH1;TAL1;TGFB2;PAK1;SPAG5;ETS1;MLC1;RTKN2;FGF5;TLR2;PTPRJ;EPO;TIMP1;RPS6KA1;HSP90AB1;MVD;AKT1;ADRA1D;H3-3A;CNOT6L;THPO;NAMPT;SHANK2;TPPP;LIFR;PDGFB;AIF1;FAM98A;HMGN5;F2R;WDR77;CEP43;APC;RPS4X;P2RX7;TJP1;MAPK8;NOP2;DUSP26;EPHA1;ACTN4;AGPAT1;BMPR1B;HRAS;XBP1;DLL1;INSR;CD36;CIB1;ADGRG1;CCKBR;ATM;LGI1
prerank,negative regulation of macrophage activation (GO:0043031),0.4009749153863651,1.0637290008903435,0.37160751565762007,0.7899205298577658,1.0,2/16,2.79%,LRFN5;SYT11
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.38716559954326396,-1.063613776390872,0.34296724470134876,0.6428237551875344,1.0,3/19,5.41%,IL34;CAMK1D;THBS1
prerank,positive regulation of calcium ion import (GO:0090280),0.4389893946313516,1.0635054022109127,0.38095238095238093,0.7893430723996256,1.0,3/12,10.22%,CXCL12;CCL2;PDGFB
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.4247997287237184,-1.0634922627364505,0.38285714285714284,0.6426593672834129,1.0,5/15,14.52%,DICER1;ZC3H12C;NYNRIN;KHNYN;ZC3H12B
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.24270664093545122,-1.0631014093858215,0.28085106382978725,0.643139703941155,1.0,71/291,20.06%,ROCK2;EGFR;PID1;NFKB1;EPHA3;PDGFRA;TPM1;IGFBP5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;RPTOR;IRS1;LBP;HMGB1;LCOR;SBNO2;RAP1B;LYN;MTOR;WNT9A;ADCY6;RAPGEF3;DHX36;CTR9;PTPRK;IMPACT;CHMP5;SELENOS;UPF1;FER;NR1H3;RHOA;JUN;PRKCD;ADAM9;ABL2;SLC5A5;RORA;MEF2C;PDE3A;PKD2;FZD7;ADNP2;P2RY12;ERCC6L2;RAPGEF2;P2RX4;AKAP9;DAPK1;GNB1;TNIP2;CPEB1;PDCD4;SERPINE1;TLR4;WNT5A;PRKD1;CX3CR1;TRAF6;VCP;INPP5K;CDK2;IRAK1;SHPK;CDC73;CARD16;RAPGEF1
prerank,regulation of innate immune response (GO:0045088),-0.3085622862704923,-1.0628451323605403,0.34608030592734224,0.6432725520483848,1.0,27/57,32.33%,APPL2;IRAK3;TRAFD1;PLSCR1;DHX9;XIAP;PTPN22;PARP9;RIOK3;APPL1;IRF1;PTPN1;IFI35;PTPN11;USP18;NLRC3;POLR3D;DHX58;CACTIN;ERAP1;MUL1;TNFAIP3;BIRC3;SAMHD1;TYRO3;PTPN6;TKFC
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4154844203587806,-1.062670207751607,0.3761638733705773,0.6432089983772078,1.0,8/15,37.63%,IQGAP2;ARPC2;WHAMM;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,macromolecule catabolic process (GO:0009057),-0.36028474692226575,-1.0624793942154178,0.3622350674373796,0.6431860102431857,1.0,15/26,38.09%,UVRAG;MTOR;KIF16B;BECN1;SMURF1;PIK3R4;LRSAM1;CLN5;CLPX;CLN8;CLN6;SNX25;IDE;NEDD4;LGMN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.45380904344182643,1.0622782598829226,0.3796095444685466,0.7918796313497988,1.0,3/12,6.76%,TIRAP;MBP;KLF4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4718992568354469,-1.0620834863133244,0.40733590733590735,0.6438011001359476,1.0,4/10,12.62%,LRP1;PTPN12;PTPN2;APOD
prerank,cholesterol efflux (GO:0033344),-0.38509351060045427,-1.0618333635788624,0.3849129593810445,0.6439321534325833,1.0,5/20,19.20%,ABCA1;SOAT1;NPC2;APOE;ABCA7
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3658274250321321,1.0618321167010012,0.3642105263157895,0.7920737868671399,1.0,8/22,14.32%,RYR2;AKAP6;VMP1;HAP1;CALM1;ATP1B1;CALM2;CALM3
prerank,positive regulation of chromatin organization (GO:1905269),0.43893258425391773,1.06164944318039,0.36989247311827955,0.7914308610144456,1.0,6/12,14.35%,TAL1;TERF1;H3-3A;TERF2IP;SIN3A;TINF2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.32568302432354335,-1.0612291478709073,0.34022556390977443,0.6449064740410642,1.0,27/42,37.36%,KLHL15;SPIDR;FUS;WDR48;PPP4C;PPP4R2;SETD2;SHLD2;PARP1;MMS19;HELB;SMCHD1;ARID2;KDM1A;UBQLN4;ACTR2;FANCB;TIMELESS;CGAS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;ERCC6;MRNIP;SIRT6
prerank,long-term memory (GO:0007616),0.3869628443368809,1.0611317348427698,0.3630434782608696,0.7918485579590129,1.0,4/19,12.90%,LRRN4;CAMK4;RASGRF1;PJA2
prerank,histone H2A monoubiquitination (GO:0035518),-0.4061458781610513,-1.0610322234153984,0.39579349904397704,0.6448849704455348,1.0,4/17,11.84%,BCOR;DDB2;PCGF2;PCGF6
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.46774001138388654,-1.0607240595875265,0.3880597014925373,0.6451932109542227,1.0,8/10,33.54%,ZEB2;GIPC1;APPL1;RAPGEF2;CTNS;OPN3;CDH3;ATP7A
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41911328525962777,-1.0606717438928028,0.3885819521178637,0.6448438505412126,1.0,5/14,21.62%,MYO9A;CDC42;RHOA;MSN;SCRIB
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4690209289804587,1.0606418984324095,0.4073275862068966,0.7921198845989592,1.0,3/10,11.24%,KNSTRN;SPAG5;APC
prerank,striated muscle cell development (GO:0055002),0.4271990329513579,1.060505221063101,0.3974358974358974,0.7912875429147185,1.0,3/14,8.44%,MYH6;PGM5;TMOD1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.37669783160999626,1.0602834628210005,0.3763440860215054,0.7894897885320926,1.0,6/22,19.52%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.37669783160999626,1.0602834628210005,0.3763440860215054,0.7894897885320926,1.0,6/22,19.52%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,renal filtration (GO:0097205),-0.4520604550029864,-1.0602229830789718,0.39526411657559196,0.6454343580389276,1.0,3/10,9.97%,SULF1;SULF2;TBC1D8B
prerank,cellular sodium ion homeostasis (GO:0006883),-0.41670322704284435,-1.0601890733097243,0.3847583643122677,0.6450317034685387,1.0,3/15,10.07%,ATP1A2;SLC9A1;SLC12A2
prerank,diacylglycerol metabolic process (GO:0046339),0.3714534360208258,1.060118987788651,0.3709016393442623,0.7888010376374781,1.0,6/23,10.43%,DGKI;LIPE;DGAT2;DGKH;DGKB;GPAM
prerank,cellular response to chemical stress (GO:0062197),-0.28150855667704705,-1.060067573878056,0.32323232323232326,0.6448601163263762,1.0,39/96,30.09%,FOXO3;ABL1;LRRK2;PRKAA2;NOX4;LRRC8D;PPARGC1A;SELENOS;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;TXNRD2;DDX3X;GPX8;CYBA;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;ZFAND1;GPX7;NUDT2;CCS;GSR;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,receptor-mediated endocytosis (GO:0006898),0.26337016517916595,1.0600511562103714,0.32637571157495254,0.7877756665761132,1.0,31/132,17.14%,TFRC;DNM3;LRP1B;TMEM108;RAMP2;AP2M1;CAV2;SNCA;GRK2;SNAP91;SCARF1;FNBP1L;FCHO1;SCARB2;AP2B1;CD163;ITGAM;SGIP1;SORL1;SCARB1;DLL1;INSR;CD36;CLTB;STAB2;PPT1;NLGN3;M6PR;CALCRL;HSP90AA1;RAB31
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.37481843736990855,-1.060009727247826,0.3570057581573896,0.6444995527771528,1.0,7/22,11.95%,UGGT2;MAN1C1;OS9;EDEM3;EDEM1;MAN1B1;MAN1A2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4035615006590655,1.0597508806145117,0.3706140350877193,0.7875035569511956,1.0,4/14,11.59%,SIRT1;CAMK4;SEMA7A;BCL10
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.26917584488919555,-1.0596103319791341,0.3486238532110092,0.6449797365353911,1.0,22/109,15.50%,PTPN13;PLEKHA2;PI4KA;PDGFRB;INPP5B;SYNJ2;MTMR12;INPPL1;PIP4K2C;PLA2G4A;PLCG1;PLCB3;PLCD1;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;SACM1L;PIK3R4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4232868129972434,1.0590530487935772,0.37815126050420167,0.7884069896788523,1.0,5/14,13.24%,ANK3;WNK2;GLRX;ACTN4;ATP1B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4563934728266178,1.058931388658386,0.38306451612903225,0.7863531409956509,1.0,2/10,8.95%,AP2M1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4563934728266178,1.058931388658386,0.38306451612903225,0.7863531409956509,1.0,2/10,8.95%,AP2M1;AP2B1
prerank,cobalamin metabolic process (GO:0009235),-0.3976136562479011,-1.0582103498105198,0.40867992766726946,0.647963688378551,1.0,4/17,16.49%,TCN2;MMUT;ABCD4;CUBN
prerank,sulfur amino acid catabolic process (GO:0000098),-0.4573473102755633,-1.058064922127365,0.37816764132553604,0.6478456445254202,1.0,9/10,54.29%,TXN2;CBS;CTH;ADO;MPST;BLMH;MTRR;TST;GADL1
prerank,steroid biosynthetic process (GO:0006694),-0.30476425566244986,-1.0580046513655599,0.34285714285714286,0.6475293183150922,1.0,15/56,23.07%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;CYP51A1;AMACR;DHRS11;SC5D;ACOT8;FDFT1;OSBPL3;LBR
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3881674506508221,1.0579909839562547,0.38729508196721313,0.7879613204657331,1.0,6/21,14.11%,USP44;RPL23;UBE2C;RPL5;RPS7;GOLGA2
prerank,positive regulation of cellular protein localization (GO:1903829),0.2922293652759163,1.0579662404759294,0.32712215320910976,0.7868267192519266,1.0,12/69,11.40%,TFRC;BICD1;NECAB2;SYT11;TMEM35A;MEAK7;STX3;HSP90AB1;AKT1;NUP62;APC;CCDC88A
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.40966843953638404,1.0577621244934745,0.3710691823899371,0.7862640951391456,1.0,5/15,15.25%,REEP1;ARL6IP1;REEP2;RTN4;REEP3
prerank,lipid transport (GO:0006869),0.2754482467742261,1.0577480934597412,0.3029126213592233,0.7851068307248348,1.0,21/97,13.89%,SLCO1C1;PLTP;ATP8A1;MFSD2A;NCOA2;CERT1;CHKA;PITPNM1;SPNS2;PRELID3A;SLCO2B1;ABCC4;FABP5;PLEKHA3;PRELID2;CPTP;ABCG4;TTPA;SCARB1;SLC27A4;CD36
prerank,cellular response to nutrient levels (GO:0031669),-0.3015144432411107,-1.0577407927829596,0.325626204238921,0.6477061269498495,1.0,24/62,27.03%,LRRK2;TFEB;PRKAA2;RPTOR;ZFYVE1;MTOR;WRN;LAMP2;USP33;WIPI1;FNIP1;WDR45B;FAM107A;PRKAA1;EIF4G1;WIPI2;ATG14;KCNB1;MAP1LC3A;PPARA;LPL;RRAGA;GAS2L1;VPS41
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3884567617639402,-1.057528430602884,0.3853564547206166,0.6477653742253298,1.0,4/20,10.07%,ATP1A2;SLC9A1;KCNJ2;SLC12A2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4029766109903983,-1.056772757859956,0.4166666666666667,0.6492079788647531,1.0,5/17,12.94%,SLC9A1;SLC9A2;SLC12A2;SLC6A1;TRPM4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.35855942473063507,-1.0564664546884166,0.37406015037593987,0.6495206781985284,1.0,10/26,19.30%,EGFR;ANKRD17;UBE2E2;RPTOR;ANXA1;CCND3;DDX3X;ADAMTS1;CDK10;EIF4G1
prerank,cell cycle checkpoint signaling (GO:0000075),0.43167082325000494,1.0560842956934273,0.37344398340248963,0.7889194839553417,1.0,5/12,16.28%,BUB1;WEE2;NABP1;CHFR;PLK2
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.23547611913260139,-1.055809036284872,0.2755102040816326,0.6505732609814444,1.0,78/348,19.35%,BMP6;PRKAG2;ROCK2;IGF1;EGFR;TGFBR1;BMPR1A;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;RBPMS;CEMIP;ARAF;BMP5;FGF1;BMP7;DAB2;FAM20A;BMP4;GHR;ABL1;LRRK2;VTN;RPTOR;TBK1;DOCK7;CREBL2;SNX9;AXIN1;PAK2;NBN;TWSG1;NRP1;LYN;BRAF;RAPGEF3;UBE2K;IGF2;NGF;RB1CC1;PDGFC;SMAD4;MAVS;FNIP1;TEC;IL6R;RASSF2;CARD14;CCN1;WDFY2;TXN;VEGFA;ACVR1;CCND3;DDX3X;LATS1;RAPGEF2;VEGFD;ITGA5;AKAP9;TGFB3;ARRB1;MRE11;CACUL1;PRKD1;CX3CR1;CSNK1D;BMP2;PARK7;MUSK;MTCP1;PTPN11;EIF4G1;INHBA;ITGB3
prerank,response to exogenous dsRNA (GO:0043330),-0.395255373434268,-1.0557258010365356,0.39325842696629215,0.6503050485407545,1.0,10/18,32.23%,IRAK3;DHX9;MAVS;TICAM1;MUL1;CGAS;TLR3;IFIH1;CAV1;ZCCHC3
prerank,regulation of filopodium assembly (GO:0051489),-0.3270044620129849,-1.0552767747234924,0.36095764272559855,0.650964173710497,1.0,12/38,13.56%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;PRKCD;RALA;CAPZB
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.35223763606140734,1.0551627380850295,0.38493723849372385,0.7905473602571911,1.0,10/29,17.73%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1;PPIA
prerank,plasma membrane repair (GO:0001778),0.43082450964199925,1.055107790401096,0.39748953974895396,0.7895578031938931,1.0,4/13,10.84%,SYT7;SYT11;DYSF;SMPD1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.38600331831097173,1.0549289398485757,0.3821656050955414,0.7889252181549319,1.0,5/19,11.00%,DLG2;LRRC7;MTCL1;FOXJ1;CRB1
prerank,protein transport (GO:0015031),-0.23543345763666104,-1.0543153784518635,0.2755741127348643,0.6528741356543007,1.0,110/332,27.95%,WLS;LRP1;TLK1;ABCA1;KIF13A;STEAP3;TANGO6;ATP6V1B2;TBC1D16;SGSM2;ATP6V0D1;SNX9;SNX6;SEC23IP;RAB10;STX16;RAB22A;STXBP1;VAMP5;VPS26C;ATP6V0A4;RAB12;RAMP1;SIL1;AP3B1;SLC10A7;LAMP2;VAMP2;COPZ2;USP6NL;SEC31A;TXNIP;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;CHMP3;GGA3;RPGR;COG7;RCN3;STX4;ARFIP2;SCAMP2;ARF1;MON1A;STX5;COPB2;TBCK;RAB21;CTTN;GRTP1;APOE;TBC1D22B;CTSA;DNAJC27;FAM91A1;TBC1D9;COPG2;SNX8;TCIRG1;TOM1;TMED3;MIA3;WDR11;VAMP4;NAPA;COPG1;TBC1D17;TMED5;TMED4;LRSAM1;RABGAP1;STX17;TBC1D10A;RAB24;GGA2;STX8;IFT27;ARRDC4;RABL3;VPS26B;ATP6V1G2;ARL5A;NSF;RAB3D;USO1;AP2A1;PREB;RAB8A;KIF3A;SAR1B;TVP23B;RAB7A;STX12;ARRDC2;RAB5A;STX1A;VPS45;TBC1D10B;AFM;STX7;TMED2;SEL1L;TBC1D9B;ARL4C;RIC1;RUFY1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.32237131060264224,-1.0543061933225186,0.35714285714285715,0.6524129836195207,1.0,9/40,21.32%,PID1;ABL1;LRRK2;BCL2;STOML2;ATP5IF1;VCP;PARK7;AKT2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.4591691076355,-1.054170674723295,0.40152963671128106,0.6523014429334092,1.0,7/10,46.26%,FBXW7;ADRA2A;HBEGF;EGF;ADAM17;BTC;NCF1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.27682238926611186,1.0539560456002588,0.3440643863179074,0.790830391754614,1.0,18/90,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;LCN2;ESRRG;EBF2;CD36
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3191808573764889,-1.0539183293084762,0.3783783783783784,0.6524813621182287,1.0,25/42,35.31%,INO80;ARID1B;SMARCC2;CHD8;RNF8;MBD2;CHD4;CHD3;SPTY2D1;HDAC1;ANP32E;NASP;SMARCD2;PBRM1;HDAC2;MBD3;ACTR5;ACTR6;CECR2;DMAP1;INO80B;ACTL6B;ACTR8;ERCC6;SMARCA4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.37245263873255186,1.0539121803799512,0.3822314049586777,0.7897761836695866,1.0,6/21,9.89%,SPRY3;RASAL3;TGFB2;SPRY4;CYRIB;DAB2IP
prerank,regulation of receptor recycling (GO:0001919),-0.3950371716880113,-1.0533900244227086,0.38415841584158417,0.6532934526835686,1.0,7/16,25.56%,TBC1D16;ANXA2;ECE1;KIF16B;SCRIB;NSF;AP1AR
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.42580782635501613,1.0530359252592025,0.41123595505617977,0.7912167211919255,1.0,4/13,18.22%,SYT1;SYT10;CACNA1I;SYT4
prerank,dendrite morphogenesis (GO:0048813),0.3366186175226088,1.053005466342095,0.391025641025641,0.7901249493804764,1.0,10/35,12.47%,CTNNA2;EPHB1;CTNND2;MAPK8IP2;SHANK3;MAP2;TAOK2;CELSR2;DVL1;DOCK10
prerank,cellular protein catabolic process (GO:0044257),-0.30062308674130167,-1.052780720113488,0.3625254582484725,0.6543687673513935,1.0,21/59,27.55%,ADAMTS12;PRKN;CTSC;CTSH;AFG1L;RAB12;FAP;YME1L1;CLPP;TCIRG1;MYLIP;CTSF;BNIP3;CTSL;MAGEC2;SIAH2;AP2A1;CLPX;RAB7A;HTRA2;LONP1
prerank,negative regulation of immune effector process (GO:0002698),-0.43805113062596635,-1.0524702307169629,0.40398550724637683,0.6546577395677959,1.0,5/13,12.96%,CD55;RC3H1;FER;ENPP3;APPL1
prerank,proteasome assembly (GO:0043248),-0.44546461334839166,-1.0524316165462166,0.4267399267399267,0.6542756419551439,1.0,5/11,34.28%,PSMG1;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.33757662680068806,1.0518190895580857,0.358,0.7925368508426838,1.0,7/31,11.45%,DLG2;LRRC7;LIN7A;WDR1;MTCL1;CRB1;ANK1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.44997217792398825,1.051751220528011,0.4073226544622426,0.7915429018414012,1.0,3/10,23.10%,IL12A;NCKAP1L;DDIT3
prerank,response to prostaglandin E (GO:0034695),-0.4596204000623908,-1.051549690527202,0.3961904761904762,0.6559933829964979,1.0,3/10,16.02%,TGFBR3;ADCY6;GNB1
prerank,activation of protein kinase A activity (GO:0034199),0.40364320183146973,1.051291503250057,0.4031890660592255,0.791848457725565,1.0,3/16,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2915785817177497,-1.051155901660442,0.3592233009708738,0.6565090137331631,1.0,17/68,17.55%,PCCA;AOX1;ENPP1;HLCS;TCN2;MMUT;MCCC2;MTHFR;MTHFD2L;PANK2;SLC5A6;TPK1;ABCD4;RFK;PDXK;CUBN;ALDH1L1
prerank,microglial cell activation (GO:0001774),0.3757382082177935,1.0505791645253293,0.41163793103448276,0.7929089741432938,1.0,4/21,12.48%,SNCA;CLU;AIF1;ITGAM
prerank,regulation of urine volume (GO:0035809),-0.4762316500015431,-1.0504015928295884,0.4101123595505618,0.6578432176102101,1.0,4/10,24.89%,NPR3;ADCY6;INPP5K;ADM
prerank,cytoplasmic microtubule organization (GO:0031122),-0.30186889153072544,-1.0499594886992896,0.36699029126213595,0.6583962200073548,1.0,13/54,13.88%,PCM1;FIGN;NUMA1;DLG1;SLK;VPS4B;TUBGCP6;TUBGCP2;FIGNL2;RHOA;CLIP4;RAB11A;KATNA1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3974845934596845,1.0497592498357076,0.38461538461538464,0.7943554271643398,1.0,3/17,6.76%,CD33;TMSB4X;KLF4
prerank,innate immune response in mucosa (GO:0002227),0.44435377565752304,1.0496084267182628,0.3816091954022989,0.7936197926277476,1.0,10/10,55.59%,DEFA6;RNASE3;PLA2G1B;RPL39;LTF;DEFB1;BPIFB1;CAMP;IL4;NOS2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.258463878782148,-1.0491604180274627,0.32786885245901637,0.6598761485505573,1.0,48/148,24.23%,PRKAG2;MDM4;EP300;PRKAA2;BRD7;RBBP8;MAPKAP1;TAF3;USP7;NBN;MTOR;PDPK1;WRN;TAF4;TBP;CHD4;HIPK1;CHD3;RPL11;PRKAB2;EHMT1;RICTOR;ING5;USP2;HDAC1;CSNK2A1;TAF13;PRMT5;NOP53;MRE11;TTC5;PRKAA1;PPP2R5C;KMT5A;CDK2;MAP2K6;PML;TAF12;PRKAG3;CDK5RAP3;PRKAB1;TAF9B;TAF2;ATR;HDAC2;NUAK1;BOP1;MBD3
prerank,positive regulation of T cell activation (GO:0050870),0.2950935841703404,1.049064228464751,0.3684210526315789,0.7941050749340388,1.0,10/62,13.68%,TFRC;SLC7A1;IL7;THY1;PRKCQ;CCL2;CYRIB;AIF1;HSPD1;XBP1
prerank,negative regulation of dephosphorylation (GO:0035305),0.3794116589990315,1.0489405813089605,0.38293216630196936,0.7933253206342257,1.0,3/18,4.95%,YWHAB;PPP1R16B;ZCCHC9
prerank,positive regulation of cell death (GO:0010942),-0.30064468132711675,-1.0485716708411477,0.36470588235294116,0.6608255352995693,1.0,11/59,10.88%,SLC6A13;LRP1;EFNB2;CELF1;BMP4;LRRK2;GSK3B;RARG;MAP3K5;MARK4;PRODH
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4319553204692977,1.0483193830942357,0.42016806722689076,0.7940717349718671,1.0,4/12,13.24%,ANK3;WNK2;GLRX;ATP1B1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3661589688425729,-1.048279807673154,0.3789279112754159,0.6610292755528644,1.0,4/23,6.93%,IL34;BMP5;THBS1;LYN
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.27534385430991565,-1.047758866583595,0.35192307692307695,0.6618478085347708,1.0,37/91,25.61%,PLD1;ITGAV;STXBP5;ABL1;LRRK2;PACSIN2;STON2;USP7;RAB10;NRP1;GAS1;RAB12;VAMP2;MAP2K1;ARFGAP1;CHMP3;ABL2;STX4;RAB11A;RALA;RINT1;RAB21;MBTPS1;ZFYVE16;PICALM;PTPN1;STON1;SPHK1;BET1L;NSF;RAB3D;HIP1R;RAB8A;SYK;SNX12;ATP9A;RAB5A
prerank,apoptotic mitochondrial changes (GO:0008637),0.34196656274706394,1.0477322801869444,0.3925619834710744,0.7946274878654024,1.0,3/32,6.46%,CAMK2A;ERBB4;CLU
prerank,negative regulation of signaling (GO:0023057),0.3570716495827597,1.0472932084048547,0.3813559322033898,0.7948366075992641,1.0,7/25,20.01%,GLRA1;SRMS;OPRM1;UBASH3B;OPTN;BRAP;KIF26A
prerank,DNA packaging (GO:0006323),-0.4033602400196371,-1.046861793882186,0.4046242774566474,0.6635901646131348,1.0,8/16,37.92%,AIFM1;HAT1;CDAN1;H1-0;BANF1;CHAF1A;NAA10;TP53
prerank,cellular calcium ion homeostasis (GO:0006874),0.26199685503901443,1.0468084778237385,0.3618843683083512,0.7951031055914164,1.0,23/133,14.16%,SLC24A4;SLC24A2;TRPC5;ADCY8;CXCL12;RYR2;CAV2;HTR2C;HCRTR1;SLC8A1;ATP2B3;TMEM178A;SLC30A1;NPTN;TPT1;HCRTR2;TRPC1;TMCO1;CD40;ATP1B1;PSEN1;ATP2B4;ATP2B2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.34268144035955395,-1.0465705283885682,0.3881453154875717,0.6638202665067561,1.0,4/30,5.93%,FHIT;DDX5;MDM4;NBN
prerank,metanephric mesenchyme development (GO:0072075),-0.4559703680812799,-1.0458633804129853,0.41360294117647056,0.6650985449103702,1.0,5/10,17.00%,WNT4;OSR1;PKD2;STAT1;SIX1
prerank,regulation of neuron differentiation (GO:0045664),-0.28113915324796845,-1.0457746531979208,0.34285714285714286,0.6648596048330541,1.0,19/76,13.74%,TCF4;NBL1;NREP;ZFHX3;ZEB1;BMP7;ROCK1;LRRK2;REST;IMPACT;MED1;NGF;RHOA;ID2;MEF2C;HES1;TCF3;EIF2AK4;CDK5RAP1
prerank,tube closure (GO:0060606),-0.33708004628683985,-1.0455855359678892,0.37448559670781895,0.6648755671239269,1.0,6/31,9.32%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3272884172131268,1.0451593315267176,0.39574468085106385,0.7989093721459898,1.0,7/36,11.61%,CAMK2A;LEF1;PLCB1;FZD6;GNG2;CALM1;FZD4
prerank,regulation of hippo signaling (GO:0035330),-0.3992614130278146,-1.0450149777701836,0.3763837638376384,0.6658340610839049,1.0,12/17,27.39%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;NF2;DLG5;SOX11;MAPK14;NEK8
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4190846339880533,-1.044902271840634,0.3948919449901768,0.6656264449459897,1.0,3/14,5.41%,SULF1;SULF2;THBS1
prerank,organic cation transport (GO:0015695),-0.38503087440811146,-1.0441958802543378,0.4,0.6668517806827015,1.0,8/20,28.91%,SLC47A1;SLC22A5;SLC22A4;SEC14L1;SLC5A7;SLC22A2;SLC44A2;SLC25A29
prerank,apoptotic nuclear changes (GO:0030262),-0.3623954861277754,-1.0441825825439004,0.35658914728682173,0.6664020826531893,1.0,9/24,29.14%,DICER1;ACIN1;HMGB1;H1-0;CDK5RAP3;EXOG;DNASE2;CECR2;GPER1
prerank,positive regulation of neuron differentiation (GO:0045666),0.32346700269359174,1.0439538134891904,0.3673469387755102,0.8014485250996414,1.0,10/40,13.53%,PROX1;MMD2;BRINP1;HOXD3;NRCAM;CPNE1;BRINP3;ARHGEF2;SIN3A;BEND6
prerank,regulation of intracellular protein transport (GO:0033157),-0.34099289371742303,-1.0438622833017825,0.4158215010141988,0.6667469288044664,1.0,11/32,19.43%,PCM1;BMP4;PTPN14;BCAS3;PCNT;NDEL1;VAMP2;TPR;ICE1;PTPN1;IFI27
prerank,nucleocytoplasmic transport (GO:0006913),0.32177869364164957,1.0436348751549611,0.3818565400843882,0.8012295403892132,1.0,9/40,13.65%,GEMIN8;HTATIP2;NXT1;RBM15B;SNRPD2;SNRPD1;NUP205;ANP32A;DDX20
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.356599462166963,1.0436041183296705,0.3877551020408163,0.8001775117230194,1.0,8/24,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,positive regulation of cholesterol transport (GO:0032376),0.353764922882924,1.0434572615902284,0.3821656050955414,0.7994267732547793,1.0,7/27,14.95%,PLTP;SIRT1;PPARG;GPS2;ABCB4;NFKBIA;SCP2
prerank,primary neural tube formation (GO:0014020),-0.3399811621843277,-1.0433373283970737,0.35537190082644626,0.6675643105422454,1.0,6/30,9.32%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,negative regulation of cell death (GO:0060548),-0.2780265534420774,-1.0427781785365258,0.33669354838709675,0.6684620338387682,1.0,31/88,22.45%,KANK2;CCN2;BMP7;BMP4;PRKN;LRRK2;GSK3B;INPP5A;VPS4B;SRSF6;CHMP4B;CHMP4A;PPARGC1A;IMPACT;TRAF2;CCN3;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;SPEF1;BNIP3;FGF2;WNT16;WFS1
prerank,mitotic nuclear division (GO:0140014),-0.28825874898607357,-1.0426447190803094,0.38,0.6683253505091296,1.0,19/71,17.45%,INO80;FLNA;PIBF1;SPICE1;KLHDC8B;SMC4;CHMP4B;NDEL1;STAG1;RHOA;LSM14A;RAB11A;KLHL22;ABRAXAS2;TOGARAM1;MAP9;ZWINT;STAG2;UBE2S
prerank,regulation of synapse organization (GO:0050807),-0.35452604612645466,-1.0426015050946849,0.376865671641791,0.6679342410616242,1.0,10/26,19.54%,PDLIM5;ABL1;SETD5;ABHD17B;EPHA4;GRIPAP1;MEF2C;WNT5A;SLITRK4;MDGA1
prerank,oxoacid metabolic process (GO:0043436),-0.3505369691807117,-1.042584049509445,0.3875,0.6674883101742847,1.0,7/27,18.98%,DDO;ENPP1;TPST1;SULT1A1;PPA1;ABHD14B;THAP4
prerank,kinetochore organization (GO:0051383),-0.43142292544256206,-1.0425212462242823,0.4117647058823529,0.6671442084465206,1.0,12/13,53.47%,CENPT;POGZ;CENPE;CENPH;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW;CENPC;CDT1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3567149988315775,-1.042245730069452,0.37351778656126483,0.667356278347206,1.0,10/25,25.24%,IGF1;NIBAN2;NSD1;RB1;TRAF6;PARK7;H1-0;TWIST1;SOX11;ZBTB7A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3457416929629663,-1.0421251437338936,0.3844731977818854,0.6671889368265865,1.0,9/28,21.29%,PRKN;NUPR1;CTSC;AXIN1;FBXW7;SMURF1;ATP5IF1;TMTC3;CDK5RAP3
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.35632888056965367,-1.042046850969591,0.41064638783269963,0.6669122437024811,1.0,8/26,20.92%,NPR3;POR;HIF1A;APOE;PARK7;TERF2;TERT;S100A1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.42086272322078805,1.0419619610743542,0.391578947368421,0.8028873694780426,1.0,1/12,0.11%,IGF1R
prerank,xenobiotic transport (GO:0042908),0.3899831018557157,1.0416451977838597,0.4110169491525424,0.8026273824945391,1.0,2/17,2.21%,SLC7A5;ABCG2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.35772358723939335,1.041607447572804,0.3866943866943867,0.8015656879391405,1.0,4/26,4.98%,GRIN1;MBP;GRIN2B;PSENEN
prerank,synaptic membrane adhesion (GO:0099560),0.42375066128191813,1.0412017467303984,0.3870246085011186,0.8015922662414909,1.0,5/14,8.89%,PTPRD;LRRC4C;LRFN5;LRRC4B;NTNG1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.30786857914120463,1.0410243123588507,0.39869281045751637,0.8009958050747007,1.0,12/46,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;AKT1;PITRM1;TIMM22;HSPD1;TSPO;TOMM70;TIMM10B;DNAJC19
prerank,regulation of mitotic spindle organization (GO:0060236),-0.3250494673319828,-1.0407237122930886,0.4049586776859504,0.6697170098640223,1.0,18/35,36.42%,NUMA1;VPS4B;CHMP4B;CHMP5;CHMP3;TPR;MAP9;DYNC1H1;HNRNPU;EML3;BORA;PARP3;CHMP1B;TACC3;HSPA1A;CHMP1A;TPX2;FSD1
prerank,neuron projection extension (GO:1990138),-0.3321796684684775,-1.0407124131889105,0.38684719535783363,0.669257936022177,1.0,8/32,12.85%,ALCAM;AUTS2;NRP1;IMPACT;SPG11;ULK2;EIF2AK4;FLRT1
prerank,dephosphorylation (GO:0016311),0.25763712176672826,1.040690969276711,0.37103174603174605,0.8008610543741729,1.0,31/147,15.17%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PLPPR1;PTPRT;DUSP6;PGP;PPM1F;PPP2R1A;PLPPR5;PTPN18;SGPP2;PTPRJ;PLPPR4;PLPP4;NT5C;MTMR6;PTPRM;DUSP28;DUSP26;DUSP15;CTTNBP2NL;PTPRZ1;PPM1L;PPP3CA;CTDSP2;PDP1;PLPP6;FRA10AC1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.44742286429344674,1.0404626844996272,0.41517857142857145,0.8003802122035595,1.0,2/10,4.32%,CHEK1;SMARCB1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.31128881918257756,1.0404033751613415,0.3467741935483871,0.7994022742687276,1.0,9/47,11.79%,IGF1R;EPHB1;MAPK8IP2;TGFB2;PHLPP1;MAPK8IP1;TAOK2;DAB2IP;FOXO1
prerank,triglyceride biosynthetic process (GO:0019432),-0.3891263599123853,-1.0402287628378057,0.40313111545988256,0.6699628349540445,1.0,7/18,20.38%,AGMO;GPAT4;MOGAT3;PCK2;LPIN2;LPIN3;GPAT3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2709490490308584,1.0401403158382339,0.3656565656565657,0.7990317513606237,1.0,24/101,14.32%,FLT1;PROX1;CSF1R;TENM1;CCND1;SIRT1;HMGA2;SNCA;FLT3;CD24;DIRAS1;MAPRE3;PIK3R5;AKT1;CCNY;DAB2IP;PDGFB;CALM1;CD40;HRAS;CALM2;CIB1;ATP2B4;CALM3
prerank,positive regulation of vasculature development (GO:1904018),0.27459403093186907,1.0392827120793446,0.37280701754385964,0.8005143141500775,1.0,14/94,8.42%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;APLNR;NINJ1;CD34;HSPB1
prerank,tyrosine metabolic process (GO:0006570),-0.44118352145888917,-1.0391302191951102,0.43289224952741023,0.672307603017796,1.0,5/11,43.22%,THAP4;TYR;HGD;IL4I1;FAH
prerank,regulation of postsynapse organization (GO:0099175),0.3432846713993876,1.0388384362817806,0.3956989247311828,0.8007109816534019,1.0,7/28,11.12%,IL1RAPL1;SHANK3;KIF1A;HOMER1;ZDHHC15;CDKL5;PPFIA2
prerank,DNA modification (GO:0006304),0.3637879764102626,1.0384840628372112,0.40421052631578946,0.8005993013506132,1.0,6/22,16.96%,EXOSC5;TERF1;UNG;TERF2IP;TINF2;EXOSC4
prerank,negative regulation of angiogenesis (GO:0016525),-0.2797101444649511,-1.0381429734886398,0.38811881188118813,0.6743170989503323,1.0,16/84,10.07%,ROCK2;SULF1;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5;ATF2;ADAMTS9;SEMA3E;SLC12A2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3604105239362761,-1.0379802808867638,0.39464285714285713,0.6742650233188544,1.0,9/24,25.35%,PPM1D;DNMT3A;MPHOSPH8;PHF1;JARID2;EPC1;EZH2;PPHLN1;CREBZF
prerank,establishment of protein localization to membrane (GO:0090150),-0.2940130707984692,-1.037837654916708,0.37937743190661477,0.6741537793179039,1.0,16/66,18.93%,EGFR;AFDN;SYNE3;NACA;RAB10;RAB3GAP1;BRAF;RAB3IP;VPS37C;RAB11A;PARD3;SEC63;COX18;NECTIN3;ZDHHC1;CHM
prerank,zinc ion transport (GO:0006829),0.3750275544364867,1.0376701459847035,0.40461215932914046,0.8019206933425842,1.0,6/21,11.74%,SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2635389185072867,-1.0372508243486727,0.3564356435643564,0.6750739882385954,1.0,22/118,11.67%,PHLDB2;PID1;DAG1;SIPA1L1;PDLIM5;SDC2;KIF13B;LRRK2;SPARC;GSK3B;WTIP;BCL9L;PAK2;ADGRA2;RC3H1;FGFR2;EPHA4;SP100;BRSK1;BMPER;ZMYM4;MEF2C
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2565122215382351,1.0370623692296874,0.3684210526315789,0.8025545422466319,1.0,19/151,8.50%,ALAS2;SGMS1;GSTA4;PCSK1;ACER2;FA2H;DEGS2;MFSD2A;LPCAT2;CERT1;PCYT1B;CHKA;CSNK2B;SPNS2;ELOVL7;SGPP2;ELOVL4;GSTM5;SLC44A5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4314675052824225,1.0368429471296683,0.4,0.8021139615641607,1.0,2/11,5.60%,ATF3;HSPA5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3675633114048352,-1.036345302728842,0.4091743119266055,0.6768279494943081,1.0,6/23,18.68%,INPP5B;SYNJ2;MTMR12;MTMR3;SACM1L;INPP5K
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.43409893653974996,1.036131252829404,0.4067415730337079,0.8031496299335403,1.0,3/11,12.89%,STMN1;PAK1;BCAR1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3896688985389156,1.0353284869275556,0.424507658643326,0.8043755825363225,1.0,6/17,10.22%,PROX1;CCND1;MAPRE3;AKT1;CCNY;PDGFB
prerank,regulation of protein ubiquitination (GO:0031396),-0.2686629297661209,-1.0352159051093188,0.3885480572597137,0.6790908740420465,1.0,36/108,24.60%,NXN;SASH1;TGFBR1;ANGPT1;HDAC8;UBE2N;PRKN;LRRK2;HUWE1;AXIN1;UBQLN1;UFL1;U2AF2;XIAP;SPOPL;CUL3;FBXW7;OGT;USP4;SH3RF2;FANCI;ARRB1;SPRTN;DERL1;FAM107A;TRAF6;PARK7;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;CHP1;BAG5;PAXIP1;GNL3L
prerank,import into nucleus (GO:0051170),0.2855778656005726,1.034490551776298,0.39264990328820115,0.8056945242943345,1.0,11/73,10.97%,IPO5;IPO4;MMP12;GEMIN8;HTATIP2;NXT1;AKT1;NUP62;FAM53B;SNRPD2;SNRPD1
prerank,muscle tissue development (GO:0060537),-0.4265948349680204,-1.03426626964054,0.4179389312977099,0.6810038192470663,1.0,4/13,15.44%,BMP4;SMO;CSRP2;PTCH1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3637484296705976,-1.0339141909302847,0.418426103646833,0.6814296922349923,1.0,4/24,8.41%,PID1;LEPR;GFPT1;PPARGC1A
prerank,myotube cell development (GO:0014904),-0.4445982155323826,-1.0338496001536057,0.41541353383458646,0.6811231524459419,1.0,4/10,17.00%,IGF1;SKI;SELENON;SIX1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3022137591392256,-1.0330862887949146,0.38846153846153847,0.6825589660775607,1.0,20/52,24.42%,LMNA;TLN1;ATP6V0D1;SHC1;GFPT1;EDEM1;SEC31A;ARFGAP1;WIPI1;DNAJC3;KDELR3;ERN1;GOSR2;FKBP14;SYVN1;CUL7;WFS1;PREB;CXXC1;HYOU1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2991797799229316,1.032685271172715,0.39300411522633744,0.8099538271271213,1.0,12/54,12.13%,RPL35A;RPF2;RPL7;RPL10;RPL10A;RPLP0;RPL7A;RPL14;RPL5;RPL23A;NHP2;NOP2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.347370986698683,1.0325187179879465,0.4221218961625282,0.8092642270221395,1.0,10/26,18.04%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.34279505694450385,-1.0324430517397256,0.40038684719535783,0.683676862532677,1.0,5/27,7.01%,SLMAP;SNTA1;DLG1;PTPN3;CAMK2D
prerank,regulation of response to biotic stimulus (GO:0002831),-0.347203311813376,-1.03232987591446,0.3893129770992366,0.6835016016124851,1.0,8/28,13.01%,FOXP1;APPL2;CD55;XIAP;PTPN22;TRIM5;APPL1;IRF1
prerank,glycerophospholipid catabolic process (GO:0046475),0.3507667526432844,1.0321372966652127,0.4021276595744681,0.809250199693024,1.0,2/27,4.79%,GPCPD1;ENPP2
prerank,protein targeting to lysosome (GO:0006622),0.37964910324234247,1.0320163000496445,0.4013761467889908,0.808482116352132,1.0,10/20,20.67%,HSPA8;CLU;SCARB2;NCOA4;SORL1;M6PR;AP3M1;HGS;VPS4A;SNX16
prerank,positive regulation of metabolic process (GO:0009893),0.265208472972799,1.0320107975415589,0.36852589641434264,0.8073586283624754,1.0,20/103,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;AGPAT1;LCN2;ESRRG;EBF2;INSR;CD36
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42111620416638607,-1.031721368000244,0.4207436399217221,0.6845072608444435,1.0,4/13,11.49%,BMP4;NFIB;REST;NFATC4
prerank,lymphocyte mediated immunity (GO:0002449),-0.4185249214213442,-1.0313939058686445,0.43478260869565216,0.6848811081478775,1.0,2/12,3.68%,JAG1;CD55
prerank,regulation of stem cell differentiation (GO:2000736),-0.27577881579745206,-1.031332714269213,0.3724279835390947,0.6845470303897288,1.0,30/89,29.10%,PTN;BMPR1A;PDGFRA;ABL1;JAG1;YAP1;RUNX1;HOXB4;PSMF1;HES1;TCF3;NELFB;EIF2AK2;PSMB2;PRKDC;NSUN2;HNRNPU;PSMC1;KMT2A;PSMB6;PSMA3;NUDT21;PSMA4;LDB1;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9
prerank,regulation of interleukin-8 production (GO:0032677),0.2883221434099772,1.0311021209354772,0.3885480572597137,0.808983655696479,1.0,10/69,12.26%,CD33;TIRAP;IL17F;TMSB4X;KLF4;TLR2;NOD1;F2R;BCL10;BCL3
prerank,inorganic ion transmembrane transport (GO:0098660),0.41630789228593346,1.0309108992203813,0.4376417233560091,0.8083658247066382,1.0,3/12,12.77%,ASIC2;KCNJ11;KCNJ8
prerank,endothelial cell proliferation (GO:0001935),0.3812943815478307,1.0307904691927812,0.42971887550200805,0.8076121881272188,1.0,5/17,12.87%,TEK;ACVRL1;CD34;THAP1;BMPR2
prerank,negative regulation of cell activation (GO:0050866),-0.40704399213335274,-1.0304263415527366,0.4309090909090909,0.6864251127233388,1.0,4/14,14.41%,PDGFRA;LDLR;APOE;EMILIN1
prerank,cardiac myofibril assembly (GO:0055003),-0.4076153155023991,-1.030097631337196,0.437125748502994,0.6867517445139457,1.0,4/15,7.30%,PDGFRA;PDGFRB;MEF2A;OBSL1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3035419850231901,-1.0297133975270356,0.39615384615384613,0.6872044779026684,1.0,10/48,9.74%,ADCY9;ADCY5;SLC35B3;AMPD3;ADCY1;SLC26A2;ADCY6;GMPS;GUCY1A1;PANK2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.39115713807554076,-1.0293563875353193,0.43566176470588236,0.6876726955935153,1.0,6/18,22.71%,FBN1;FBXW7;TLR4;GPR137B;TCTA;MAFB
prerank,response to light stimulus (GO:0009416),-0.2933805197602922,-1.0290520977606001,0.40039840637450197,0.6879163151774167,1.0,16/55,24.89%,GTF2H2;UBE4B;DDB2;BRSK1;ERCC3;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;MSH6;USF1;CCAR2;PRIMPOL;CRY2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.31875570325460667,1.0286754891311611,0.40083507306889354,0.8129163661689228,1.0,7/38,7.35%,KCNJ3;CTNNA3;CACNA2D1;BIN1;SCN4B;KCND3;CACNB2
prerank,phospholipid metabolic process (GO:0006644),0.283880512476118,1.0285468724171465,0.39263803680981596,0.8121518185817431,1.0,17/71,19.21%,PLPPR1;MBOAT1;PGP;ENPP2;PLPPR5;PLPPR4;GPAM;SMPD1;FADS1;AGPAT1;PIP5K1A;PNPLA3;PLA2G4E;PIP4K2B;PLBD2;ACP6;PCYT2
prerank,cellular response to interleukin-12 (GO:0071349),-0.3100663494753825,-1.0281822663505529,0.4124293785310734,0.6896310731537608,1.0,17/48,21.47%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,histone monoubiquitination (GO:0010390),-0.35802460255827445,-1.0279425702194882,0.41222879684418146,0.6897459040591325,1.0,8/24,22.37%,BCOR;CTR9;DDB2;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3140751391589366,-1.0274935891472126,0.41472868217054265,0.6903574252516183,1.0,14/44,23.07%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;PARK7;AMACR;SC5D;ACOT8;PSAT1;OSBPL3;LBR
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4168639432712421,-1.0273418245484407,0.4150268336314848,0.6902415138136189,1.0,2/13,4.04%,DDX5;PLA2R1
prerank,anion transmembrane transport (GO:0098656),0.29133861633652186,1.027247769087804,0.42244897959183675,0.8149384130890488,1.0,12/67,7.95%,SLC7A5;SLC7A1;LRRC8B;SLC35A1;SLC1A1;SLC25A42;MFSD12;SLC1A2;SLC6A5;SLC6A8;SLC7A8;SLC25A14
prerank,negative regulation of neuron differentiation (GO:0045665),-0.37024197147392807,-1.0271433390122708,0.4101010101010101,0.6902390272103035,1.0,6/22,12.76%,BMP7;GSK3B;REST;MED1;HES1;EIF2AK4
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.25282106450304265,1.027076319519645,0.3884462151394422,0.8142989202126054,1.0,23/151,10.86%,TEK;ERBB4;TIRAP;CSF1R;NECAB2;MIF;HTR2C;GAS6;KDR;FGF10;NTRK2;SEMA7A;NOTCH1;P2RY1;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;PDGFB;ATP6AP1;F2R
prerank,insulin receptor signaling pathway (GO:0008286),-0.2810382453689563,-1.026777416276158,0.40789473684210525,0.6907019362854432,1.0,14/69,10.02%,RHOQ;SORBS1;GRB10;ATP6V1B2;GSK3B;IRS1;ATP6V0D1;SLC39A14;SHC1;FOXC2;ATP6V0A4;IGF2;FER;PTPN2
prerank,protein localization to plasma membrane (GO:0072659),0.25736959841925733,1.02668909491494,0.4123314065510597,0.8143705722530057,1.0,24/129,11.88%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2;TSPAN17;RAB40B;SPTBN1;CCDC88A;ANK1;TSPAN14
prerank,ureteric bud morphogenesis (GO:0060675),0.3874025878885544,1.0264106471141987,0.4260869565217391,0.8140460434870097,1.0,2/16,3.56%,PAX8;PAX2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3408962558425749,-1.0263745283522314,0.4038095238095238,0.6912047047501585,1.0,9/27,22.24%,IGF1;PDGFRA;DHX9;PDGFC;S100A6;FN1;WNT5A;CDK6;SPHK1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.37266634352025463,1.0259823010215827,0.4152542372881356,0.8142134102085242,1.0,5/18,15.38%,GINS2;LIG3;MCM3;RFC4;POLD3
prerank,glycerol metabolic process (GO:0006071),0.449171788969661,1.025891281489853,0.42567567567567566,0.8133788571296613,1.0,2/10,3.39%,COQ2;PGP
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2807566359384307,-1.0255718482571166,0.39215686274509803,0.6927197331954725,1.0,17/70,16.44%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2;NCK1;DOCK1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4435313831441428,-1.0254312539477135,0.44223826714801445,0.692573906956753,1.0,1/10,0.93%,APPL2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.40814134821251563,1.02525796659663,0.44341801385681295,0.8141392742606328,1.0,5/15,12.04%,USP44;RPL23;RPL5;RPS7;SMAD7
prerank,axonal transport (GO:0098930),0.32423779740974773,1.0252129277245574,0.4054621848739496,0.8131594745631848,1.0,7/36,12.45%,SYBU;TMEM108;KIF1A;DST;AP3B2;HAP1;DCTN1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3920979262514916,-1.0248874225702385,0.4090019569471624,0.6934330897774141,1.0,4/16,11.61%,SMG6;TNKS2;DHX36;PARP1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.316813082547595,1.024562456443217,0.4,0.8139879950043766,1.0,7/39,8.51%,MBP;PODXL;PPM1F;NOTCH1;KLF4;AKT1;NEXMIF
prerank,oogenesis (GO:0048477),0.38874949083967203,1.0244580268378476,0.42919389978213507,0.8131725581685884,1.0,3/15,4.57%,MEI4;FMN2;NANOS3
prerank,negative regulation of histone methylation (GO:0031061),-0.4605394330776602,-1.0241649757696356,0.46748681898066785,0.6947640721432626,1.0,7/10,35.42%,BCOR;PHF1;JARID2;KDM1A;WDR5;BRCA1;AASS
prerank,positive regulation of cholesterol efflux (GO:0010875),0.36228929814440586,1.0239443435921192,0.42948717948717946,0.8135325496162826,1.0,4/21,8.56%,PLTP;SIRT1;PPARG;GPS2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.38486019407615935,-1.0239272369960744,0.40681362725450904,0.6948652278992142,1.0,5/17,12.12%,PTN;IL34;DICER1;ID2;HES1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3469773528774476,-1.0234728625238962,0.42777777777777776,0.6954789286679386,1.0,5/28,10.12%,ITPR1;BCL2;MAP3K5;AIFM1;TRAF2
prerank,megakaryocyte differentiation (GO:0030219),-0.42952109007529193,-1.0232747772062298,0.44403669724770645,0.6955004907122849,1.0,3/11,9.06%,KIT;UBA5;MED1
prerank,protein mannosylation (GO:0035268),-0.3589735906752264,-1.023190712926219,0.424860853432282,0.695225753132022,1.0,11/22,23.77%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.27229112515794934,1.023017993081617,0.3890020366598778,0.8151903704731106,1.0,19/98,16.55%,SLCO1C1;PAX8;MAGI2;AHI1;PPARG;SNCA;KLF4;RAB1B;IFNAR1;AKT1;PDGFB;AGPAT1;NFKBIA;GHITM;INSR;CDKN1A;STARD4;TBC1D5;RAB29
prerank,acyl-CoA metabolic process (GO:0006637),-0.32547617714838384,-1.0229516407432362,0.4337121212121212,0.6953237844270097,1.0,11/35,23.24%,GPAT4;ACSF2;ACSL6;DLST;ACOT11;ACOT9;SUCLA2;MCEE;SUCLG2;ACOT8;ACOT6
prerank,organic acid transport (GO:0015849),-0.2673679262798493,-1.0225478786577882,0.412573673870334,0.6958432484231479,1.0,13/94,9.00%,SLC7A11;SLC7A2;SLC6A13;SLC13A3;PDPN;ACSL1;SLC1A5;SLC26A7;SLC6A12;ATP8B1;LRRC8D;SLC22A6;NCOA1
prerank,tetrapyrrole metabolic process (GO:0033013),-0.3778025477287503,-1.0224574501369323,0.44623655913978494,0.6955822488558558,1.0,4/18,16.49%,TCN2;MMUT;ABCD4;CUBN
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4153488599641537,-1.0222504059413327,0.43149284253578735,0.6956321188129259,1.0,8/13,27.66%,UFL1;NCK1;BFAR;PTPN1;ABCA7;WFS1;ATF6B;PPP1R15B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.34004071181679746,-1.0218746124161897,0.3996282527881041,0.6960925673471777,1.0,9/27,15.43%,CACNA1C;ANK2;DLG1;CAMK2D;JUP;ATP2A2;TRPM4;SRI;AKAP9
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3364173000677058,1.0207297816973229,0.4336099585062241,0.8210910188716327,1.0,5/30,5.57%,SCN1A;FGF12;RYR2;CACNA2D1;SCN4B
prerank,sodium ion homeostasis (GO:0055078),-0.36341916482045183,-1.0206439136055154,0.41312741312741313,0.698659337272877,1.0,3/21,10.07%,ATP1A2;SLC9A1;SLC12A2
prerank,myotube differentiation (GO:0014902),0.38160712090670634,1.0206325162119059,0.42946058091286304,0.820267036634832,1.0,4/17,6.90%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,metanephros development (GO:0001656),-0.34437026269608045,-1.0204897431060163,0.45555555555555555,0.6985382441456441,1.0,10/26,17.00%,FOXD1;PKD1;BMP7;BMP4;OSR1;CTSH;NIPBL;PKD2;PTCH1;SIX1
prerank,regulation of striated muscle contraction (GO:0006942),-0.34667936541061406,-1.0203697667578009,0.453125,0.6983622368055916,1.0,8/27,20.46%,ATP1A2;ANK2;ASB3;SRI;P2RX4;PRKACA;SLC8A3;NOS1
prerank,JNK cascade (GO:0007254),0.31560130157357463,1.0201341461507463,0.40869565217391307,0.8206391214931944,1.0,15/40,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;ADORA2B;NOD2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2451578898947668,-1.0200305177943987,0.41044776119402987,0.698677710115359,1.0,49/172,22.98%,PTPN13;PLD1;PLEKHA2;PI4KA;SYNJ2;MTMR12;GNPAT;PLSCR1;DGKA;AGPAT4;DDHD1;INPPL1;ABHD5;PIP4K2C;GPAT4;STARD7;ETNK2;PLA2G4A;ABHD3;PTDSS1;PITPNM2;ARF1;PCYT1A;MBOAT7;MTMR3;CPNE3;PIK3C3;SLC27A1;PLEKHA8;HDHD5;SACM1L;CSNK2A1;PIK3R4;TAMM41;PIK3CD;LPIN2;LPIN3;GPD1L;INPP5K;LPCAT1;GPAT3;PIK3R1;CDS2;DGKD;FGF2;LPCAT3;PLEKHA4;PI4K2B;PTDSS2
prerank,cellular senescence (GO:0090398),-0.34537259026452516,-1.0200191532436518,0.43204868154158216,0.6982226510498212,1.0,11/27,21.75%,OPA1;SMC6;NSMCE2;MAP2K1;SMC5;PRKCD;ID2;TBX2;TERF2;PML;ECRG4
prerank,protein K48-linked deubiquitination (GO:0071108),0.364096046985216,1.0194593203334341,0.42557651991614254,0.8215456827129157,1.0,9/23,18.81%,OTUD7A;YOD1;OTUB2;MINDY1;MINDY2;OTUB1;USP8;ATXN3;OTUD7B
prerank,negative regulation of MAPK cascade (GO:0043409),0.27230137223680395,1.0192184299316331,0.43232323232323233,0.8211566001985373,1.0,18/87,13.00%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2;PEBP1;PTPRJ;SPRY4;DAB2IP;UCHL1;LMO3;SMPD1;P2RX7;FOXO1;DUSP26;SORL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.35488794432975246,1.0185607275263697,0.42071881606765327,0.8220448648940643,1.0,4/22,8.88%,MBP;THY1;KLF4;SKAP1
prerank,telomere maintenance via telomerase (GO:0007004),0.34346195160725934,1.018009666501675,0.4378947368421053,0.8225546952451538,1.0,9/28,17.04%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3003032702302817,1.0176514541374875,0.42531120331950206,0.8224907518279984,1.0,12/50,13.67%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;RNF34;RFFL;CAAP1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3887949207003464,1.0175148605962678,0.43412526997840173,0.8217898423745922,1.0,2/16,4.90%,FGF10;IL12A
prerank,regulation of intracellular transport (GO:0032386),-0.3158507260138378,-1.0174767555125401,0.4007707129094412,0.7041561998834498,1.0,12/38,19.57%,LRRK2;NUMA1;GAS1;NDEL1;GRIPAP1;NUP214;WWC1;RINT1;DYNC1H1;LAMP1;PTPN1;RBM4
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22278588196901164,-1.0173718120734385,0.3836477987421384,0.7039409805340286,1.0,84/423,18.36%,BMP6;TGFBR3;IGF1;FOXP1;GRK5;EGFR;PID1;TCF7L2;GAB2;TGFBR1;PTN;BMPR1A;IL34;PDGFRA;RBPJ;NTRK3;EFNB2;BMP5;ITGAV;FGF1;PDGFRB;IL6ST;IL31RA;BMP4;HDAC4;MAP3K3;OSR1;TGFBR2;YAP1;IRS1;KMT2D;CTSH;IL13RA1;THBS1;DPP4;GAREM1;UFL1;FGFR2;SHC1;BCL2;LYN;DHX9;AR;ACER3;IGF2;GJA1;CDK13;FER;PDGFC;NES;S100A6;ID2;STX4;CNOT8;MEF2C;HES1;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;GLI1;CCN1;STAT1;VEGFA;HDAC1;CIAO1;CDC25B;VEGFD;CSNK2A1;TGFB3;ADRA2A;IL18;TBX2;TCIRG1;CACUL1;CCN4;WNT5A;PHIP;HNRNPU;PTGFR;DHPS;GCNT2
prerank,positive regulation of histone methylation (GO:0031062),-0.3569410701999441,-1.017309633989392,0.45183887915936954,0.7036154459197281,1.0,6/24,15.68%,AUTS2;CTR9;SMAD4;OGT;PHF1;JARID2
prerank,regulation of GTPase activity (GO:0043087),-0.2423318597125898,-1.0170264779327391,0.3937007874015748,0.7038172900605355,1.0,30/177,9.96%,PLXNA2;DOCK11;AFDN;ASAP3;SIPA1L1;EPHA3;LIMS1;LRRK2;ARAP1;GSK3B;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;ARFGEF1;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;VAV2;S100A10;EPHA4;RSU1;NDEL1;USP6NL;PLXNB2;WNK1;TBC1D20
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3639591157553787,-1.0169971047277626,0.4442508710801394,0.7034150544582676,1.0,5/21,13.70%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,myelin assembly (GO:0032288),0.440918103527321,1.0168803058826315,0.4451476793248945,0.822629484777972,1.0,4/10,9.18%,TENM4;EPB41L3;CNTNAP1;TPPP
prerank,glycoprotein metabolic process (GO:0009100),-0.29517032706108604,-1.016755434959429,0.4294117647058823,0.7035412311506484,1.0,18/53,19.49%,LARGE1;ST3GAL4;NGLY1;MAN1C1;OGA;GANC;ADAMTS9;MAN2A1;MAN1B1;HIF1A;MAN1A2;ERP44;MANBA;GANAB;MAN2A2;B4GALT5;PARK7;B4GALT7
prerank,tight junction assembly (GO:0120192),0.30860382984572593,1.0165027073381403,0.43685300207039335,0.8226385634359605,1.0,9/49,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.37273434738426947,-1.016230211552589,0.4250936329588015,0.7043854770407666,1.0,5/19,8.19%,RPTOR;CHD8;MTOR;AR;DHX36
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.40118242213101146,1.0162175348023994,0.45701357466063347,0.8223833134839755,1.0,2/13,9.43%,IL12A;CYRIB
prerank,chromosome organization (GO:0051276),-0.2677968448806994,-1.0161959935103004,0.416,0.7039811981292873,1.0,30/99,25.46%,TCF7L2;HDAC8;SETD7;BRWD1;ABL1;RAD23B;EZH1;MTHFR;DDB2;RFWD3;PARP1;TCF7L1;COPS2;EHMT1;COPS8;PHF1;HDAC1;LATS1;MSH3;TOP2B;HMG20A;MSH6;CDAN1;EZH2;HMGN3;HDAC2;CENPT;FAM50A;ZBTB7A;LDB1
prerank,carboxylic acid metabolic process (GO:0019752),0.3280206733729434,1.0155609620750585,0.42379958246346555,0.8233052897898965,1.0,4/33,5.63%,SLC2A1;SLC2A3;MIF;CSGALNACT1
prerank,B cell mediated immunity (GO:0019724),0.43241286147536256,1.0154278180240057,0.44042553191489364,0.8226133611183191,1.0,1/10,3.14%,SLA2
prerank,positive regulation of protein kinase activity (GO:0045860),0.24963814951527222,1.0151631184699015,0.4074844074844075,0.8222472816545543,1.0,36/148,17.34%,GRM5;LRP8;CSF1R;MMD2;HMGA2;TNIK;GAS6;SNCA;PAK5;NAB2;TGFB2;PAK1;CLU;MAPRE3;ADCYAP1;HSP90AB1;RELN;TAOK2;DAB2IP;PDGFB;CALM1;CCDC88A;CALM2;PAK6;INSR;CIB1;TAB2;CALM3;CDKN1A;PAK3;STOX1;RAP1A;DDR2;XRCC5;HSP90AA1;RALB
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.29108424246237347,-1.0151513190392232,0.43673469387755104,0.7061168369588615,1.0,19/54,19.49%,GPC6;SDC2;HS3ST3A1;GPC4;GNS;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;GUSB;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3415772833892153,1.0150331886191406,0.45934959349593496,0.8215267246307746,1.0,5/27,6.35%,B3GAT1;CHST9;B3GAT2;CSGALNACT1;CHSY3
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3707540622927268,-1.014750238215401,0.44692737430167595,0.7066347564210687,1.0,8/19,18.76%,BMPR1A;SMAD6;MDM4;TGFBR2;SMAD4;ACVR1;HEYL;BMP2
prerank,autophagosome maturation (GO:0097352),-0.33612144665955995,-1.014572800813811,0.43148148148148147,0.7065887142588166,1.0,13/32,23.00%,UVRAG;UBQLN1;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3;ATP2A2;VCP;WIPI2;STX17;ATG14;MAP1LC3A
prerank,bicarbonate transport (GO:0015701),0.3514014645663205,1.0142947504775464,0.4495967741935484,0.8226117452618364,1.0,4/25,10.65%,SLC4A1;CA4;CA2;SLC39A8
prerank,protein localization to nucleus (GO:0034504),-0.26179867973979665,-1.0138336659739553,0.43232323232323233,0.7079577239244156,1.0,57/102,37.65%,APPL2;COL1A1;BMP7;BMP4;LMNA;TAF3;EIF4ENIF1;STAT3;WRN;NUP214;RPL11;IPO13;TPR;APPL1;YWHAE;TAF8;TOPORS;NOP53;FAM53C;SIX1;GBP2;MORC3;HNRNPU;ABCA7;PML;RPAIN;IPO9;TOR1A;TNPO3;PPP1R10;SYK;PHB2;ZBTB7A;NUP93;BBS4;RRS1;CHCHD10;RANBP17;TNPO2;CALR;SIX4;PINX1;E2F3;ARL2;RAN;IPO11;NUP133;SEC13;NUP88;FAM53A;MSX1;TOR1AIP1;SKP1;NUTF2;TSC2;IPO7;CSE1L
prerank,regulation of mast cell activation (GO:0033003),-0.44491052920793395,-1.013567028485505,0.44150943396226416,0.7081478753539701,1.0,4/10,20.53%,PLSCR1;LYN;NECTIN2;CD84
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4201721958178268,1.0134214256721679,0.44893617021276594,0.8241077887475412,1.0,5/11,23.23%,GPX1;PRDX5;PRDX1;PXDN;GPX3
prerank,eosinophil chemotaxis (GO:0048245),0.40051484899855605,1.0131641063900103,0.4476987447698745,0.8226535430050224,1.0,14/14,59.98%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,eosinophil migration (GO:0072677),0.40051484899855605,1.0131641063900103,0.4476987447698745,0.8226535430050224,1.0,14/14,59.98%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2711452214526116,1.012944760944035,0.4173728813559322,0.8221814735501043,1.0,17/79,14.11%,ST8SIA4;ST3GAL6;CHST9;CSGALNACT1;ST8SIA1;FUT9;ALG3;B3GALT5;ALG1;MPI;ST8SIA6;B3GNT2;ST8SIA3;SERP1;BMPR2;BMPR1B;GOLGA2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.44736468853300304,-1.012898056681707,0.4635514018691589,0.7088960756046668,1.0,5/10,29.36%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.44736468853300304,-1.012898056681707,0.4635514018691589,0.7088960756046668,1.0,5/10,29.36%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,regulation of axon regeneration (GO:0048679),-0.4129864169076285,-1.0128954110099277,0.44216417910447764,0.7084167351201915,1.0,3/12,8.09%,PTN;PTPRS;EPHA4
prerank,cell-cell junction maintenance (GO:0045217),0.4222261091630271,1.0127518798304644,0.42735042735042733,0.8216399369583696,1.0,3/11,11.64%,CSF1R;F2R;TJP1
prerank,C4-dicarboxylate transport (GO:0015740),0.3950316991245852,1.0126614677965828,0.46555323590814196,0.8208278410582714,1.0,3/14,7.95%,SLC1A1;SLC1A2;SLC25A14
prerank,response to retinoic acid (GO:0032526),-0.2862615544137544,-1.012359112272324,0.4256120527306968,0.7092147314317784,1.0,12/59,12.99%,EPHA3;PTK7;WNT5B;WNT6;RBP4;RARG;CTSH;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,Golgi inheritance (GO:0048313),-0.43103150791802186,-1.012129018575655,0.434,0.7093062362164528,1.0,3/11,12.99%,GBF1;VCPIP1;STX5
prerank,negative regulation of viral process (GO:0048525),0.2890766875580192,1.0119414435113214,0.40286298568507156,0.8218846900736784,1.0,9/57,10.91%,MBL2;PROX1;TRIM13;ISG15;TRIM62;TRIM6;IFITM3;SLPI;MID2
prerank,positive regulation of neurogenesis (GO:0050769),0.2813535292341414,1.0114094452382725,0.4329896907216495,0.8223204444539016,1.0,11/68,9.59%,PTPRD;IL1RAPL1;MME;PLXNB3;SHANK3;NTRK2;NPTN;PLXNA4;ROBO2;CDKL5;OPRM1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.35391455726151066,-1.0108223212183443,0.4346153846153846,0.7121506134359331,1.0,10/24,24.20%,OPA1;PRKN;LRRK2;SELENOS;NR1H3;SYVN1;PARK7;LPCAT3;WFS1;TMBIM6
prerank,mitotic spindle organization (GO:0007052),-0.24733547364714825,-1.0107236146431806,0.42549019607843136,0.7118988578487997,1.0,81/153,39.55%,EML4;FLNA;MAP4;PIBF1;RANBP2;SPICE1;PCNT;NDEL1;STAG1;RHOA;LSM14A;DYNC1LI1;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;NUDC;MAP9;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;STAG2;PMF1;EFHC1;VCP;NEK6;TAOK1;WDR62;NUP98;SMC1A;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;KIF23;SUN2;INCENP;ABRAXAS1;KIF11;MZT1;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;CKAP5;RAN;PRC1;AHCTF1;NUP133;SEC13;SMC3;TTK;B9D2;MISP;TPX2;CENPI;DCTN6;RCC2;CENPH;KIFC1;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA
prerank,response to X-ray (GO:0010165),-0.40892004915472546,-1.0106342944755387,0.4572564612326044,0.7116310206398239,1.0,4/14,11.47%,ANXA1;BRCC3;NIPBL;XRCC4
prerank,Rap protein signal transduction (GO:0032486),-0.436747403182533,-1.010598436183576,0.44343065693430656,0.7112363227484327,1.0,4/10,20.06%,RAP1B;RAPGEF3;RAPGEF2;RAPGEF1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.4236034978043641,-1.0102819086409527,0.47794117647058826,0.7115648226839024,1.0,2/12,16.81%,NUPR1;IL18
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3473667921468075,-1.0102440582466274,0.4346153846153846,0.7111715317267634,1.0,8/25,30.40%,ITGAV;DLG4;PICALM;ITGB3;ANKRD13B;APP;NEU3;ARF6
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3383287639731392,1.0101579755739087,0.43392070484581496,0.8249350071566989,1.0,3/26,3.87%,GRIN1;ADGRB1;SNCA
prerank,gliogenesis (GO:0042063),0.38833939104093806,1.0098908202512835,0.44251626898047725,0.8246325094195245,1.0,4/15,9.08%,CDH2;PAX2;TGFB2;RELN
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2471058602856636,-1.009304815004469,0.42570281124497994,0.7130215918681334,1.0,40/150,21.55%,EGFR;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;FGF1;PDGFRB;AXL;KIT;OSBPL8;IRS1;ITGB1;THBS1;FGFR2;F3;PDPK1;IGF2;FRS2;KL;RICTOR;PIK3AP1;P2RY12;TXN;P2RX4;IAPP;IL18;PIK3CD;CX3CR1;GCNT2;PARK7;MYOC;HBEGF;NRG4;GAB1;PTPN11;FGFR4;PIK3R1;AKT2;FGF2
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.44670373799755897,-1.0092732797745867,0.45692883895131087,0.712609014204344,1.0,2/10,8.68%,MTHFR;MTHFD2L
prerank,sphingolipid catabolic process (GO:0030149),0.3871425307507644,1.009161392771502,0.4444444444444444,0.8256713464732537,1.0,6/15,14.53%,ACER2;ENPP2;SMPDL3A;GLA;SMPD1;PPT1
prerank,regulation of MAP kinase activity (GO:0043405),-0.26904365748347236,-1.009083480424787,0.4361493123772102,0.712583107241644,1.0,29/92,22.46%,EGFR;IL34;KSR1;FGF1;PDGFRB;BMP7;BMP4;ROBO1;LRRK2;KIT;IRAK3;LYN;PDGFC;PRKCD;TRIB2;APOE;TPD52L1;VEGFA;DUSP1;ADRA2A;PTPN1;INPP5K;IRAK1;SNF8;CDK5RAP3;FGF2;EZH2;DUSP7;CD300A
prerank,RNA transport (GO:0050658),-0.27358789243709614,-1.0089053034870707,0.44171779141104295,0.7125482436805812,1.0,21/71,23.70%,TGFBR2;CASC3;U2AF2;SRSF6;SIDT1;SLU7;EIF4E;SLBP;NUP214;TPR;YBX1;SRSF1;NXF1;SIDT2;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;XPO5;RTRAF
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4005618808762722,-1.0087175763932228,0.4601113172541744,0.7125673432877276,1.0,2/15,3.68%,GLI3;CD55
prerank,skeletal muscle tissue development (GO:0007519),-0.3260810345186863,-1.0081820898775384,0.43103448275862066,0.7133856163525942,1.0,6/32,11.67%,SVIL;CFLAR;SKI;IGSF8;SELENON;MEF2C
prerank,negative regulation of defense response (GO:0031348),-0.27367067089541003,-1.0080066152241425,0.42994241842610365,0.7133290656572685,1.0,31/77,29.40%,PTGIS;IRAK3;TRAFD1;MAPKBP1;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;METRNL;SHARPIN;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.27553866400432614,-1.0078381900318665,0.42412451361867703,0.7132668855661232,1.0,15/71,12.70%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,miRNA metabolic process (GO:0010586),-0.36895559334658024,-1.0077175223138912,0.45185185185185184,0.7131029562777403,1.0,4/20,8.00%,DIS3L2;DICER1;DDX17;TUT4
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.37028677742598587,-1.0076827024335644,0.46548323471400394,0.7127080412838671,1.0,2/18,7.01%,ATP1A2;CAMK2D
prerank,positive regulation of blood coagulation (GO:0030194),-0.3728068251032408,-1.0069882763135662,0.43238095238095237,0.7139261448137716,1.0,3/17,7.35%,ST3GAL4;THBS1;F3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3787585048122986,1.0069668660629914,0.4642857142857143,0.8309872408112563,1.0,5/17,13.41%,ALG3;MVD;ALG1;ALG8;DHDDS
prerank,regulation of mRNA stability (GO:0043488),-0.25062335239964384,-1.006962523326809,0.45228215767634855,0.7135051908399928,1.0,57/145,31.69%,SAMD4A;ROCK2;CELF1;FTO;VIM;ROCK1;PUM2;YTHDF3;EIF4ENIF1;FUS;RC3H1;LARP1;PUM1;HNRNPD;DCP1A;DHX36;CSDC2;PRKCD;NUP214;XRN1;PSMF1;YBX1;SERBP1;PSMB2;EXOSC9;TENT5A;HNRNPU;PAIP1;EIF4G1;PSMC1;PRKCA;PSMB6;PSMA3;XPO1;EXOSC3;PSMA4;FXR1;PCBP4;PSME1;PDE12;PSMD13;DIS3;TENT5D;PARN;FASTKD1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;UBA52;THRAP3;TBRG4;YWHAZ;GDNF;GIGYF2;TNFSF13
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4202756177332777,-1.006895382311117,0.4664246823956443,0.7131774295105314,1.0,3/12,22.91%,IL17D;IL18;CD80
prerank,protein hydroxylation (GO:0018126),-0.39095499993107485,-1.0067685957656523,0.45436893203883494,0.7129978801767131,1.0,4/15,10.09%,PLOD2;P3H3;ASPH;EGLN3
prerank,negative regulation of protein kinase activity (GO:0006469),0.2723686328819566,1.0067634563266674,0.44967880085653106,0.8304752846143875,1.0,29/88,20.39%,PTPRB;PTPRT;CAMK2N1;PPM1F;SNCA;THY1;SLC8A1;TRIB3;AKT1;YWHAG;HSPB1;DAB2IP;CEP43;UBASH3B;DVL1;DUSP26;EPHA1;SORL1;CDKN1A;CORO1C;CDKN1B;GNAQ;PPIA;ADAR;PTPRO;HYAL2;SH3BP5;DBNDD2;GSKIP
prerank,cardiac muscle cell differentiation (GO:0055007),-0.363116002036157,-1.006497533425661,0.44422700587084146,0.7131617764971504,1.0,8/21,18.76%,AKAP13;CXADR;MEF2C;SIK1;VEGFA;ACVR1;MYH11;BMP2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.38392872304361103,-1.0063596654111517,0.4709090909090909,0.7130076163996847,1.0,9/16,21.55%,FOXD1;FGF1;BMP4;PKD2;SALL1;SIX1;NPNT;BMP2;FGF2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4126359968668147,-1.0060924075818969,0.4651600753295669,0.713182627240929,1.0,5/13,15.98%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3948691671248947,1.0060717654091076,0.44666666666666666,0.8314375811361346,1.0,1/14,1.04%,IL17F
prerank,regulation of platelet aggregation (GO:0090330),-0.37583774161513867,-1.0059564264658967,0.42777777777777776,0.7130189456220064,1.0,8/17,27.13%,PDPN;CD9;LYN;PRKCD;PRKCA;F11R;SYK;ALOX12
prerank,renal water homeostasis (GO:0003091),0.35565983329073647,1.005459592556943,0.4449152542372881,0.8321327278914447,1.0,3/23,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,receptor catabolic process (GO:0032801),-0.35077629215473644,-1.0052688163793797,0.4637096774193548,0.714210816658837,1.0,7/24,17.46%,RNF43;UVRAG;KIF16B;BECN1;SMURF1;PIK3R4;MYLIP
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3356230557013369,-1.005180297916238,0.4529058116232465,0.713951245166356,1.0,14/29,36.25%,EIF4ENIF1;FUS;LARP1;YBX1;TENT5A;HNRNPU;PAIP1;TENT5D;E2F1;THRAP3;GDNF;SLC11A1;RBM24;ELAVL1
prerank,glycolipid biosynthetic process (GO:0009247),-0.31791603602955876,-1.0050802316701353,0.4397705544933078,0.7137186908290745,1.0,16/38,30.47%,LARGE1;ST3GAL4;A4GALT;PIGN;GBGT1;ST6GALNAC5;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;ST3GAL2;PIGZ;PIGP;PIGF
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2903949848996858,1.005018185285107,0.45233265720081134,0.8322944080167839,1.0,12/56,15.14%,S100A9;S100A8;RPS27A;UBC;TLR2;UBB;NOD1;BCL10;CTSB;CD36;TAB2;MAPKAPK2
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.43505461935044504,-1.004998104918279,0.44548872180451127,0.7134307326753461,1.0,6/10,47.71%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,positive regulation of behavior (GO:0048520),0.43270425751190894,1.004827796279673,0.463265306122449,0.8317616099535642,1.0,4/10,18.27%,NLGN1;NPAS2;SGIP1;NR4A3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4000565784382333,-1.0046205415866782,0.45579567779960706,0.7138670120269558,1.0,6/14,27.13%,LIMS1;FLNA;LOXL3;PRKD1;CD63;SLC2A10
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3777142263799677,-1.0044875265200464,0.4584837545126354,0.713727724053494,1.0,9/17,25.21%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,protein insertion into ER membrane (GO:0045048),-0.3182731338769654,-1.0043540594590041,0.4344262295081967,0.7135845946688403,1.0,19/37,33.19%,EMC2;TRAM2;EMC7;VAMP2;STX5;EMD;EMC9;GET4;EMC4;VAPA;BAG6;EMC10;STX1A;EMC3;APP;CCDC47;GET3;EMC6;WDR83OS
prerank,nucleotide catabolic process (GO:0009166),0.37969151488987707,1.0042503238083549,0.44946236559139785,0.8323238783673709,1.0,3/16,9.52%,NUDT3;GPX1;NT5C
prerank,regulation of neuron death (GO:1901214),0.2737647289849604,1.0042204378159876,0.4552683896620278,0.8313085077883933,1.0,16/82,13.00%,DCC;EPHB1;GRID2;TRIM2;GRIN2B;SNCA;CLU;AKT1;UBB;GPNMB;CD34;GPR75;CD200R1;SNCB;ITGAM;SORL1
prerank,anion transport (GO:0006820),0.3253348047004483,1.0041397801063112,0.45353982300884954,0.8304437969215586,1.0,6/33,10.28%,SLC4A1;ABCG2;LRRC8B;SLC17A6;SLCO2B1;VDAC2
prerank,positive regulation of apoptotic process (GO:0043065),-0.22930556437568053,-1.0037005778517316,0.448692152917505,0.7148437438008572,1.0,69/293,18.88%,AKAP13;PAWR;TGFBR1;EPHA7;FOXO3;STK3;BMP4;TIAM2;PTGIS;ABL1;ARHGEF17;NUPR1;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;FAP;ERCC3;SOS2;SIK1;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;TPD52L1;FGD4;RBM5;DDX3X;LATS1;TRIM39;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3383969868192658,1.0035430561429037,0.45073375262054505,0.8310551912691759,1.0,7/27,12.68%,THY1;ETS1;PRKCQ;SKAP1;CCL2;CYRIB;HSPD1
prerank,retinol metabolic process (GO:0042572),-0.40745626140306335,-1.0030729142342039,0.46210720887245843,0.7159812821452755,1.0,3/14,9.27%,RBP4;DHRS3;CYP1B1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3613258267529169,1.002502982253864,0.4517453798767967,0.833078052137603,1.0,7/19,16.63%,TMEM109;SIRT1;HIPK2;BCL3;AEN;DDIT4;CDIP1
prerank,glucose homeostasis (GO:0042593),-0.26786386118269606,-1.002248872301799,0.4530612244897959,0.7175580167934246,1.0,25/83,22.45%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3;LRRC8D;FOXK1;PPARGC1A;PTPN2;HIF1A;FOXK2;ADRA2A;CRTC2;PRKAA1;INPP5K;PARK7;FGFR4;PIK3R1;USF1;KCNB1;WFS1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.41512975032475474,-1.0021917193485286,0.4506517690875233,0.7172181978622483,1.0,3/12,10.23%,ABCA1;ITGAV;NR1H3
prerank,DNA duplex unwinding (GO:0032508),-0.29501192037197627,-1.0018820982803873,0.4737903225806452,0.7175294013290918,1.0,25/50,33.11%,GTF2H2;RAD23B;NBN;ANXA1;DHX9;WRN;DDB2;MCM9;ASCC3;PARP1;ERCC3;MCM6;MRE11;SSBP1;GTF2H1;RECQL5;GTF2H4;MCM4;MCMDC2;SUPV3L1;RBX1;UBA52;TWNK;RAD51;DDB1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3468521756259691,1.0017382201685752,0.4602510460251046,0.8342647607540513,1.0,6/24,13.89%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3183842193191923,-1.0017348111059974,0.42300194931773877,0.7174051624989849,1.0,13/36,18.03%,TGFBR1;DEPTOR;ASAH2;BCL2;RB1;ING5;TPD52L1;TRIM39;CSNK2A1;DAPK2;NR4A2;BCL2L12;CX3CR1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.36681916300896633,-1.0016630755100608,0.47674418604651164,0.7171142561796873,1.0,9/19,23.46%,ELF1;RUNX1;IRAK2;DHX9;PARP9;MAVS;WNT5A;IRAK1;MAPK7
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2806917827281856,-1.0005572921991237,0.454,0.7194095405664837,1.0,22/62,26.38%,PUM2;WTIP;TNRC6A;RANBP2;STAT3;DHX9;PUM1;NUP42;NUP214;LIMD1;TPR;POLR2H;AJUBA;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;FXR1;NUP93
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.36385050595805596,-0.9995017832055084,0.46123260437375746,0.7215591658963794,1.0,5/20,18.34%,CD55;TRAF2;PRKCZ;IL18;TRAF6
prerank,regulation of cell junction assembly (GO:1901888),-0.33719226043662515,-0.999234092594392,0.44776119402985076,0.7217543503882228,1.0,6/27,6.91%,ROCK2;PDLIM5;ROCK1;SETD5;RAP1B;RUNX1
prerank,negative regulation of cellular senescence (GO:2000773),-0.39909852035336363,-0.9989140834571438,0.4444444444444444,0.7220756638330121,1.0,8/13,24.87%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;TERF2;TERT;CDK6;TWIST1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3240149969879117,-0.9986560108434427,0.4619771863117871,0.7222150824479348,1.0,9/30,19.05%,DSE;DCN;BGN;CHST15;HEXA;CHST11;CHPF2;CHSY1;CHST12
prerank,rRNA modification (GO:0000154),0.3554575781713791,0.9985976512015694,0.44468085106382976,0.842397439249092,1.0,5/21,12.05%,TSR3;TFB1M;FBL;DKC1;NHP2
prerank,regulation of mitochondrial fusion (GO:0010635),0.4195990992138682,0.9984872111824279,0.42916666666666664,0.8416236266746291,1.0,2/11,2.11%,TFRC;OMA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36982737305023117,0.9983296982375447,0.47780126849894294,0.8409740219854921,1.0,8/17,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.334809412850947,-0.9981873161216944,0.4357976653696498,0.7228568032817861,1.0,5/25,16.17%,ITPR1;LRRK2;TMBIM4;P2RX4;CMKLR1
prerank,protein homooligomerization (GO:0051260),0.25699299045875507,0.9979210386810292,0.45322245322245325,0.8411382818102042,1.0,13/114,7.42%,MPP2;HCN1;ADCY8;KCNC2;MIF;AQP11;RYR3;GLRA3;ASIC1;SLC1A2;TRPM2;NINJ1;HPRT1
prerank,establishment of protein localization to organelle (GO:0072594),0.27845543145071877,0.9969320303392832,0.45849802371541504,0.8429335650532499,1.0,11/72,9.99%,IPO5;IPO4;MMP12;RYR2;NXT1;AKT1;ZDHHC15;TSPAN17;NEURL1B;NUP62;FAM53B
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3214191569200419,-0.9966036424720072,0.4457593688362919,0.7263189828145042,1.0,12/32,22.42%,MAP3K3;MEOX2;RHOJ;THBS1;FOXC2;ANXA1;RHOA;VEGFA;FGFBP1;FGF2;SRPX2;TBXA2R
prerank,error-free translesion synthesis (GO:0070987),0.3438093959525901,0.9965582843061497,0.4473684210526316,0.8429322270245971,1.0,8/22,18.89%,RPA3;RPS27A;UBC;UBB;POLD1;RFC4;RFC5;RFC2
prerank,nucleotide biosynthetic process (GO:0009165),-0.36751574457217023,-0.9961062687518993,0.45286506469500926,0.7271102828571492,1.0,10/18,27.60%,NMNAT2;RRM2B;ME1;PPAT;NMNAT3;NMNAT1;PRPSAP2;RRM1;PRPS1;PRPS1L1
prerank,rRNA transcription (GO:0009303),-0.3765337475246726,-0.9960051221950424,0.4669187145557656,0.7268712517105139,1.0,9/17,34.59%,CAVIN1;BRF1;GTF3C4;SPIN1;GTF3C1;GTF3C6;POLR1G;GTF3A;ANG
prerank,peptidyl-serine modification (GO:0018209),-0.241222311999357,-0.995917174767874,0.45759368836291914,0.7265990765109726,1.0,52/166,22.38%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;PARP1;MKNK2;POGLUT2;RICTOR;PRKDC;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;GALNT1;CSNK1D;CDK2;NEK6;NTMT1;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.3348140079294787,-0.9956559750976702,0.4646098003629764,0.726777120777472,1.0,15/28,32.70%,PRKAG2;PRKAA2;MED1;PRKAB2;SIRT5;CTNS;CX3CR1;AVIL;FGFR4;SIRPA;NR1H4;FITM2;TNFRSF1B;C3;PDK4
prerank,endothelial cell differentiation (GO:0045446),0.40181097623049,0.9955709984306508,0.4567901234567901,0.8447266553487338,1.0,4/12,7.56%,PROX1;TIE1;KDR;ACVRL1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2697204843302363,-0.9953456736404084,0.4657534246575342,0.7270567743199204,1.0,21/76,23.37%,BMP7;PTGIS;TAX1BP1;IRAK3;ANXA4;USP7;UFL1;IRAK2;PARP10;CYP1B1;PRMT2;CMKLR1;ARRB1;DAP;TRAF3;LRRC14;IRAK1;CDK5RAP3;CHP1;COMMD7;NLRC3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3443900142861779,-0.9949286380157617,0.45660377358490567,0.7276143566281782,1.0,6/24,16.99%,NBL1;HMGB1;LYN;CCN3;DUSP1;SERPINE1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.35404071591524366,-0.9945066178120404,0.45920303605313095,0.7281894731700466,1.0,9/20,25.24%,MCU;YME1L1;LETM1;MICU1;STOML2;SLC8A3;PARL;SLC8B1;PHB2
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.34768123030335374,-0.9943941939423191,0.47769516728624534,0.7279856179629725,1.0,8/22,28.10%,SASH1;RELL1;VEGFA;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,lytic vacuole organization (GO:0080171),-0.31638601248393955,-0.99437666562594,0.4710017574692443,0.7275399975220666,1.0,6/32,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.33164103663914024,0.9941770610153743,0.4608879492600423,0.8476885957833599,1.0,3/27,4.46%,FLT1;TEK;FLT3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2970328084248553,0.9941188676584456,0.4550898203592814,0.8467498938977746,1.0,11/51,9.89%,NYAP2;CNTNAP2;GPM6A;TNIK;PAK1;EPB41L3;CNTNAP1;UBB;SHTN1;TAOK2;DAB2IP
prerank,histone acetylation (GO:0016573),-0.27835548449789127,-0.9939817559273189,0.444015444015444,0.7280933989001549,1.0,18/69,18.14%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;BRPF3;ZZZ3;HAT1;ATF2;TADA3;KAT14;KAT8;ING5;BRCA2;TAF5L;EPC1;TAF6L;MSL3
prerank,negative regulation of transport (GO:0051051),0.29112117790539593,0.993738268992784,0.43415637860082307,0.8467731402461779,1.0,8/51,7.93%,NRG1;SYT11;MCTP1;PPM1F;SNCA;TLR2;DYSF;YRDC
prerank,regulation of interleukin-12 production (GO:0032655),-0.302447121618956,-0.9934441999854551,0.46520874751491054,0.7288901582828714,1.0,6/47,6.73%,FOXP1;IRAK3;PIBF1;HMGB1;THBS1;IL16
prerank,RNA 3'-end processing (GO:0031123),-0.2793655539594639,-0.9934096778995319,0.4550898203592814,0.728498679330517,1.0,21/69,23.23%,TENT2;PABPN1;PCF11;WDR33;CASC3;U2AF2;CPSF3;SRSF6;TUT4;SLU7;RPRD2;SRSF1;CSTF3;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;CPSF4;NUDT21
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4330732156935123,-0.9934025197763647,0.48141263940520446,0.7280309478530724,1.0,8/10,43.56%,HMGB1;ATF7IP;THRA;ESR1;TP53;PSMC6;PSMC2;PSMC5
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2777603358465861,-0.9933452971643535,0.44779116465863456,0.7276848487010276,1.0,12/66,10.24%,EGFR;SASH1;IL34;FGF1;PDGFRB;ROBO1;LRRK2;KIT;TAOK3;MAP3K5;TRAF2;PDGFC
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.41401956104622495,-0.9931291243364138,0.4934823091247672,0.7277691906794701,1.0,5/12,19.24%,SORBS1;IRS1;IGF2;PRKCZ;PTPN11
prerank,myeloid cell development (GO:0061515),-0.367384293390968,-0.992942795448756,0.46,0.7277531054183475,1.0,4/18,9.06%,FOXP1;KIT;ANXA2;MED1
prerank,response to muramyl dipeptide (GO:0032495),-0.4138707924833107,-0.9927530032262806,0.4697855750487329,0.7277591436440648,1.0,3/12,9.46%,VIM;PTPN22;CHMP5
prerank,DNA catabolic process (GO:0006308),0.41468264175524056,0.9924692996164004,0.47761194029850745,0.8495634621718654,1.0,1/11,1.05%,DNASE1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3009155040296295,-0.9919188365101312,0.4519230769230769,0.7294004470269368,1.0,15/44,22.46%,BMP7;BMP4;IRAK3;LYN;PTPN22;PRKCD;APOE;DUSP1;DUSP10;PDCD4;PTPN1;INPP5K;CDK5RAP3;DUSP7;CD300A
prerank,monocarboxylic acid transport (GO:0015718),-0.2846014626090272,-0.991790027958144,0.48303393213572854,0.7292485136342216,1.0,10/51,10.92%,SLC6A13;SLC16A12;SLCO3A1;SLC6A12;SLCO2A1;SLC16A6;ATP8B1;NCOA1;SLC16A9;SLC5A6
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3093844800093186,-0.991747089113574,0.47058823529411764,0.7288817104409704,1.0,10/36,14.08%,NR2F2;DCN;HMGB1;THBS1;SP100;JUP;ADAMTS9;MEF2C;ANGPT2;APOE
prerank,response to laminar fluid shear stress (GO:0034616),-0.43240499201497073,-0.9915701188901365,0.4833948339483395,0.7288743922333376,1.0,2/10,1.66%,ABCA1;SMAD6
prerank,glial cell differentiation (GO:0010001),0.33278257303123254,0.9914672609647389,0.46887966804979253,0.851427094153841,1.0,10/28,18.84%,CDH2;PAX2;FGF10;RELN;TPPP;PTPRZ1;SOX4;HES5;METRN;SOX2
prerank,fibrinolysis (GO:0042730),-0.4064992860607153,-0.9913770371026809,0.45315487571701724,0.7288694439630007,1.0,9/13,54.56%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.4224766527126637,-0.9907074307881886,0.48044692737430167,0.730008491854961,1.0,3/10,8.59%,IVD;ACADM;ACAD11
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36220754808367317,-0.9904631399653986,0.4791288566243194,0.7301379495222454,1.0,4/18,12.33%,FLNA;PHF8;EIF2AK3;WDR43
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24848441173744526,0.990355034981401,0.47560975609756095,0.8536862982633944,1.0,34/132,17.88%,RPS19;GEMIN8;RPL38;RPF2;RPS27;RPL10;CELF5;SNRPC;CELF4;XAB2;RPLP0;HSP90AB1;PRMT7;MRPS7;RPS15;LSM4;RPL5;WDR77;SNRPD2;SNRPD1;RPL23A;NOP2;RPS14;DDX20;DDX1;RPS5;RPS28;MDN1;PTGES3;XRCC5;HSP90AA1;NAF1;PPAN;CELF6
prerank,lipoprotein localization (GO:0044872),0.4131448720327243,0.9903123114599605,0.4802494802494803,0.8527084653110754,1.0,4/11,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,regulation of protein neddylation (GO:2000434),0.4207233903686505,0.9902018567757572,0.4789915966386555,0.8519383738965017,1.0,4/10,15.73%,COPS9;EPAS1;RPL5;DCUN1D2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3079764998116186,-0.9901402537464834,0.48088531187122735,0.7304509768804329,1.0,8/41,12.86%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27398178222395764,-0.9900445717480755,0.4461538461538462,0.7302111659211145,1.0,13/72,10.12%,CFLAR;TRIM44;PIAS1;AXL;TAX1BP1;JAK1;ELF1;IRAK3;RUNX1;IRAK2;HIPK1;PTPN2;TRAF2
prerank,negative regulation of inflammatory response (GO:0050728),0.2395248790921667,0.9900077856095107,0.5050301810865191,0.8514024867592688,1.0,37/182,18.47%,TEK;PRKAR2B;ADCY8;ADCY3;LRFN5;GIT1;RPS19;RAMP2;ADRB1;PPARG;RHBDF2;KLF4;ADCYAP1;GNG2;GPS2;POMC;CD163;GPR176;CD200R1;ADCY4;PROC;GGT1;PTGER2;MFHAS1;OTULIN;PLK2;NPSR1;AOAH;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;TNFRSF1A;FYN;PRKAR1A;ADORA2B
prerank,clathrin-dependent endocytosis (GO:0072583),0.33342052419411994,0.9896819673738498,0.45656565656565656,0.8512884753392947,1.0,8/26,14.07%,AP2M1;SNAP91;FNBP1L;FCHO1;AP2B1;SGIP1;DLL1;CLTB
prerank,long-chain fatty acid import into cell (GO:0044539),0.42633457879439135,0.989661103633306,0.45588235294117646,0.8502613049792106,1.0,4/10,15.73%,SLC2A1;SLC27A4;CD36;ACSL3
prerank,response to glucose (GO:0009749),-0.29397172032435287,-0.9886022063399976,0.4646098003629764,0.7332895447026706,1.0,17/46,23.16%,ZBTB20;TCF7L2;PRKAA2;SLC39A14;THBS1;VAMP2;UNC13B;SELENOS;PCK2;ERN1;ZBED3;PRKACA;PRKAA1;EIF2B4;PFKL;KCNB1;EIF2B5
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4197250708608006,-0.9880463975681186,0.48282442748091603,0.7342080139695669,1.0,4/11,6.65%,IGF1;GHR;IRS1;EIF2AK3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.2456407099882615,-0.9875836503241652,0.4716981132075472,0.7349122608669781,1.0,14/142,6.22%,ATP1A2;CACNA1C;LPAR1;SMAD3;PLCE1;PDGFRA;ADCY5;ABL1;CD55;DLG4;ADRA1B;CCR9;HMGB1;EDNRA
prerank,cellular response to unfolded protein (GO:0034620),0.3358504546622077,0.9873336226053679,0.4472049689440994,0.8560472042326027,1.0,6/26,12.68%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP;HSPD1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.31820339833318345,0.9867298863456028,0.48541666666666666,0.8567062253482364,1.0,5/31,13.15%,TIRAP;PLCB1;TLR2;HSPD1;CD40
prerank,cellular response to light stimulus (GO:0071482),-0.2781672606387468,-0.9865918719340409,0.47876447876447875,0.7369022458177262,1.0,29/66,39.13%,INO80;EP300;CREBBP;DHX36;PTPRK;ZBTB1;PRKCD;USP47;PARP1;EIF2AK4;GNB1;SDE2;PCNA;BMF;ATR;USP28;KDM1A;SAG;RUVBL2;BAK1;OPN3;PDE6A;GPR88;NPM1;TRIAP1;NEDD4;TP53;CDC25A;CNGB1
prerank,sterol transport (GO:0015918),-0.3633955693164001,-0.9860612312573562,0.4797047970479705,0.7377586672722791,1.0,7/19,34.60%,OSBPL5;LDLR;NPC2;ARV1;CAV1;MSR1;LCAT
prerank,protein alkylation (GO:0008213),0.34375301046440243,0.9858888343838497,0.469601677148847,0.8580267243411783,1.0,6/22,15.04%,LCMT1;EEF1AKMT1;ETF1;FAM98A;VCPKMT;METTL22
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3997003559660408,-0.9857374616449092,0.49625468164794007,0.7380801239306035,1.0,6/13,29.26%,RNF152;SESN1;CASTOR2;SZT2;KPTN;CASTOR1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3036839622038166,-0.985666830598381,0.47766990291262135,0.7377700273107218,1.0,15/40,21.29%,ARAF;RAD23B;AXIN1;UFL1;NUB1;RPL11;FBXW7;SMURF1;LATS1;TRIM39;PDCL3;CSNK2A1;PML;DESI1;CDK5RAP3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4240510443811396,-0.9856113728285867,0.4933837429111531,0.737419745135921,1.0,1/10,0.08%,BMP6
prerank,focal adhesion assembly (GO:0048041),-0.3533009173059747,-0.9855858268376166,0.48653846153846153,0.7369973726828382,1.0,6/21,15.28%,SORBS1;BCR;PTPRK;ACTN2;CTTN;WHAMM
prerank,"wound healing, spreading of cells (GO:0044319)",-0.33816024548449425,-0.985176475172986,0.48091603053435117,0.7376022523919589,1.0,11/24,23.13%,COL5A1;PDPN;FLNA;ARHGAP24;RHOA;CCN1;ITGA5;DDR1;RHOC;TOR1A;ARHGAP35
prerank,7-methylguanosine RNA capping (GO:0009452),-0.31997879486391134,-0.9846733741212013,0.4651600753295669,0.7379322099541513,1.0,14/31,27.97%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.31997879486391134,-0.9846733741212013,0.4651600753295669,0.7379322099541513,1.0,14/31,27.97%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,nuclear membrane organization (GO:0071763),-0.361562717037127,-0.9844993447287416,0.4970178926441352,0.7378918496598027,1.0,7/19,29.14%,UBXN2B;AKAP8L;CHMP4B;EMD;TOR1A;NEMP1;GPER1
prerank,proteolysis (GO:0006508),-0.22615961907686033,-0.9842904958072884,0.49710982658959535,0.737940182073649,1.0,48/252,17.09%,CPQ;TRABD2B;AEBP1;ADAMTS12;PCSK5;TBL1X;XPNPEP1;HTRA3;PLAT;HM13;CTSC;CTSH;DPP4;ADGRV1;DPP8;F3;DDI2;ECE1;SENP6;ANPEP;FBXO3;ADAMTS9;NCSTN;LONP2;MMP14;SENP1;LAP3;ADAM19;FAP;YME1L1;MMP2;SUFU;NPEPPS;ADAM33;NLN;CPM;OGT;CASP2;LACTB;CTSA;CPXM2;MBTPS1;PTCH1;LNPEP;ATG4D;SPRTN;CLPP;CPXM1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2695864632134598,-0.9842533393680508,0.4800796812749004,0.7375533095648171,1.0,15/73,12.70%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,regulation of protein kinase activity (GO:0045859),0.254008558504113,0.9840474337735227,0.49156118143459915,0.8624410041390831,1.0,26/106,16.87%,MMD2;SIRT1;CAMK2N1;GAS6;PPM1F;SNCA;THY1;MAPRE3;TRIB3;ADCYAP1;AKT1;YWHAG;HSPB1;RELN;SMG8;CEP43;UBASH3B;DVL1;EPHA1;TAB2;CDKN1A;RAP1A;GNAQ;DDR2;XRCC5;RAP2B
prerank,cation transmembrane transport (GO:0098655),-0.3024168672582002,-0.984013547719966,0.47808764940239046,0.7376763465196692,1.0,7/44,8.33%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC22A5;SLC6A9;SFXN2
prerank,mesenchyme morphogenesis (GO:0072132),0.36842530246985866,0.983751929629794,0.4934210526315789,0.8621987538047402,1.0,5/17,7.56%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4145959439870075,-0.9835918101648572,0.49554367201426025,0.7382904502831538,1.0,5/12,18.85%,AKAP8L;NIPBL;VEGFA;PRKD1;SAP30BP
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.44422823426024727,-0.9835752504504542,0.48417132216014896,0.7378467150787272,1.0,9/10,55.61%,PRKCZ;IL18;SPHK2;RARA;TSLP;GATA3;IL4;IRF4;LGALS9
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.40466582814394253,-0.9835008878098014,0.483271375464684,0.7370810218284726,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.40466582814394253,-0.9835008878098014,0.483271375464684,0.7370810218284726,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.35783501089106634,0.9829145907396992,0.4838012958963283,0.8635452341593172,1.0,3/19,5.51%,CLDN5;PRKCH;OCLN
prerank,mitochondrial fission (GO:0000266),0.3739612737612289,0.9828329090559824,0.4689507494646681,0.8626663597078852,1.0,4/16,12.49%,DNM3;GDAP1;MIEF1;SLC25A46
prerank,carboxylic acid catabolic process (GO:0046395),-0.41002972797777093,-0.9824378865062026,0.5,0.7392752378084323,1.0,8/12,46.18%,RENBP;BCKDK;ACOT8;PON3;NPL;IL4I1;NAGK;GNPDA1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4103719083995592,0.9824126511136763,0.4773662551440329,0.8628504260465908,1.0,3/11,14.55%,TIRAP;PJA2;MFHAS1
prerank,negative regulation of hemostasis (GO:1900047),-0.40605062356932586,-0.9820235677822298,0.4917431192660551,0.7397927218468056,1.0,4/12,16.99%,VTN;TFPI;APOE;SERPINE1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.3009624695919491,-0.9813517032194748,0.49165120593692024,0.7410578153322007,1.0,14/40,21.29%,TIMP3;EGFR;MDM4;ROCK1;FLNA;IRAK3;PTPN3;SNRNP70;ATRAID;CTSA;HMGCR;CYP51A1;TIMP2;CDK5RAP3
prerank,positive regulation of catalytic activity (GO:0043085),-0.30294320617155057,-0.981130886336049,0.4934823091247672,0.7411285077804083,1.0,14/37,22.09%,SLC5A3;ABL1;BCAS3;WRN;IGF2;NCSTN;ABL2;STX4;XRCC4;MSH3;MSH6;FGFR4;FXN;SSBP1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.30425834294747545,-0.9809302112203666,0.47802197802197804,0.7411481557491744,1.0,9/42,9.18%,PLEKHA2;LIMS1;ROCK1;ABL1;GSK3B;MAP4K4;NRP1;S100A10;JUP
prerank,neural tube closure (GO:0001843),-0.30708380060025225,-0.9808658894942681,0.4665314401622718,0.7408360257033405,1.0,6/34,9.32%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4102316222887104,0.9806782246281873,0.4957983193277311,0.8668702780605919,1.0,2/11,8.26%,MECOM;CD34
prerank,DNA metabolic process (GO:0006259),-0.22204018675790713,-0.9804608640284919,0.5113871635610766,0.7412906922165451,1.0,111/270,33.60%,TCF7L2;INO80;UBE2N;KMT5B;RBBP8;UVRAG;TOP1;HMGB1;USP7;UHRF2;NBN;RAD51B;TRRAP;PDS5A;WRN;SP100;DDB2;ZBTB1;CSNK1E;UPF1;MNAT1;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;KMT5C;DDX23;PARP4;MMS19;PRKDC;HINFP;UBE2B;MCM6;CTC1;MSH3;DMC1;NOP53;MRE11;GLRX2;HELB;ZRANB3;PRIM2;TOP2B;VCP;PARK7;MSH6;CDK2;TERF2;POLE4;POLA2;TERT;PCNA;SMC1A;FANCC;RPAIN;STN1;XRCC6;ATR;UBE2V2;SMARCAL1;DNASE2;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;DBF4;POLE2;CBS;RECQL5;OGG1;ENDOV;ORC1;RAD54L;LONP1;GTF2H4;DNASE1L1;MCM4;MPG;CDC34;POLH;TIMELESS;IGHMBP2;SUPV3L1;NUDT1;KPNA2;PARP3;MGMT;TOP1MT;SAMHD1;UBA52;FANCG;PARG;PARP2;POLD2;NEIL3;RPA2;RAD9A;PNKP;RMI2;RAD51;PSME4;CDC45;POLA1;DDB1;LIG4;BRCA1;RAN
prerank,membrane lipid metabolic process (GO:0006643),0.3424301115195088,0.9803414395562713,0.47193347193347196,0.8667084882166407,1.0,4/22,8.58%,GAL3ST1;ST3GAL6;TECR;SERINC1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4230468783080929,-0.9800500348395189,0.4850187265917603,0.7418634324877104,1.0,5/10,18.92%,PRKAA2;SETD5;KLF15;PRKAA1;PARK7
prerank,artery development (GO:0060840),-0.34008820623041097,-0.9798344209124885,0.498046875,0.7419110468869626,1.0,8/23,16.72%,TGFBR1;ROBO1;NRP1;HES1;PKD2;EFEMP2;VEGFA;HECTD1
prerank,glycolytic process (GO:0006096),0.3251798466348672,0.9792904932916807,0.4584221748400853,0.8688015385600105,1.0,9/28,21.41%,PGAM4;PGAM1;ALDOC;GCK;PFKFB2;GAPDHS;LDHA;ENO2;GPI
prerank,cardiac muscle cell development (GO:0055013),-0.3534818802241414,-0.9792760302923342,0.49606299212598426,0.7428712616719487,1.0,5/20,7.30%,PDGFRA;PDLIM5;PDGFRB;CXADR;OBSL1
prerank,positive regulation of angiogenesis (GO:0045766),0.251790703327395,0.9790882462255421,0.5021097046413502,0.8683034566269398,1.0,22/108,13.93%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;KLF4;APLNR;NINJ1;CD34;HSPB1;HIPK2;TJP1;EPHA1;CD40;XBP1;DLL1;ANGPTL4
prerank,acetyl-CoA metabolic process (GO:0006084),0.37909252731157267,0.978827456912021,0.4900662251655629,0.8679681026113378,1.0,7/15,24.94%,MVD;ACSS1;HMGCS1;PPCS;PMVK;ACAT1;DIP2A
prerank,protein localization to chromosome (GO:0034502),-0.3134008877783985,-0.9784929717208987,0.4569672131147541,0.7444354694515843,1.0,19/34,37.27%,TNKS2;MCM9;XRCC4;RAD21;RB1;SLF1;TERF2;ATR;IFFO1;BOD1;ATRX;ESR1;PARP3;WAPL;PINX1;RPA2;SLF2;MSH2;MRNIP
prerank,negative regulation of cilium assembly (GO:1902018),-0.401363982601163,-0.9783712075071606,0.4715127701375246,0.7442446268393227,1.0,7/12,27.41%,YAP1;MAP4;ODF2L;CDK10;TBC1D7;TCHP;TESK1
prerank,regulation of platelet activation (GO:0010543),-0.3552447532406595,-0.978319481274727,0.4805914972273567,0.7439004207491786,1.0,9/21,25.97%,PDGFRA;LYN;PLA2G4A;TEC;APOE;TLR4;PRKCA;SYK;FCER1G
prerank,spliceosomal snRNP assembly (GO:0000387),0.30483660053900496,0.9783105934919148,0.49707602339181284,0.8683805873751608,1.0,11/38,14.80%,GEMIN8;SNRPC;SRSF12;PRMT7;LSM4;WDR77;SNRPD2;SNRPD1;DDX20;LSM2;CD2BP2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.40648327563143083,-0.9782771460965198,0.4972875226039783,0.7435113715701189,1.0,3/12,4.74%,PCM1;NIN;NINL
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.36897895105142386,0.9778279800890172,0.4668192219679634,0.8686734581440518,1.0,4/17,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,positive regulation of chromosome organization (GO:2001252),-0.3855811068096609,-0.9776214641640432,0.5037453183520599,0.7446339265963747,1.0,8/15,27.52%,NBN;DHX36;RAD21;MRE11;PML;PPP1R10;GNL3;ATRX
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2887992419107147,-0.9775695464540433,0.5,0.744292433116573,1.0,9/45,9.76%,SMAD3;FOXC1;BMP7;BMP4;GAS1;PTPN3;PRCC;BTG3;TOM1L2
prerank,regulation of lipid catabolic process (GO:0050994),0.35227812758413024,0.9775210505506053,0.4809322033898305,0.8685125989793665,1.0,2/19,5.87%,HCAR2;ALK
prerank,response to hydroxyurea (GO:0072710),-0.4170266150858874,-0.9774810310799958,0.5113207547169811,0.7440494352100182,1.0,2/11,7.42%,SPIDR;DDI2
prerank,iron ion transport (GO:0006826),-0.28977537423981947,-0.9771669590571632,0.48526522593320237,0.7443426569332546,1.0,7/47,7.13%,CP;STEAP3;ATP6V1B2;SCARA5;ATP6V0D1;SLC39A14;ATP6V0A4
prerank,negative regulation of secretion (GO:0051048),0.42881498736906903,0.9770412039082795,0.47438752783964366,0.8688715979477196,1.0,1/10,2.45%,NRG1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3587171071221918,-0.9770095544358907,0.49607843137254903,0.7442407152175144,1.0,8/18,23.37%,SKI;PARP10;EMD;MORC3;B4GALT7;CDC73;CD300A;NLRC3
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3470613103135828,0.9770045900773373,0.501010101010101,0.8678859225462449,1.0,3/21,6.98%,GRIN1;GRIN2B;BEX3
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24892464766683914,-0.9769152518314018,0.4756335282651072,0.7439836896744374,1.0,32/110,23.46%,ROCK2;SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;SLC6A9;DACT1;NR1H3;AGTR1;STX5;APOE;SMURF1;RANBP9;IL17D;CSNK2A1;IL18;ASB5;WNT5A;AREL1;VCP;EIF4G1;INHBA;SNF8;WFS1;CD80;NSF;MAPK7
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.256115772950772,0.9767936840581765,0.4928131416837782,0.8674238163899414,1.0,13/93,8.21%,TFRC;SPTBN4;MIF;TENM1;CNKSR3;GAS6;PPM1F;SNCA;SH2D3C;PAK1;HSP90AB1;AKT1;TRIM6
prerank,regulation of inflammatory response (GO:0050727),-0.2345411050661793,-0.9765424386716275,0.500990099009901,0.744442967407973,1.0,55/190,24.14%,FOXP1;ADAMTS12;CELF1;NR1D2;PTGIS;SBNO2;SNX6;DAGLA;UFL1;IL16;ANXA1;DHX9;VAMP2;CASP12;XIAP;IL17RA;SELENOS;PTPN2;CCN3;NR1H3;PTGES;ENPP3;PRKCD;NAPEPLD;NFKBIZ;RORA;AGTR1;RB1;PIK3AP1;APOE;C1QTNF3;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A;AREL1;IFI35;METRNL;PARK7;MGLL;SHPK;SHARPIN;LPCAT3;SPHK1;DAGLB;USP18;NLRC3;MAPK7;MVK;SIRPA;IL1RL2
prerank,RNA splicing (GO:0008380),-0.2555341451049994,-0.9764465491209992,0.48282828282828283,0.744206759099228,1.0,34/95,26.78%,SYNCRIP;SRSF10;FUS;SF3B1;PRPF6;RNPC3;PPARGC1A;SLU7;PRPF3;USP39;SCAF11;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;SFPQ;ZMAT5;SNRPF;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;SMU1;DHX15;NONO;NCBP2;PRPF8;LSM6
prerank,lipoprotein transport (GO:0042953),0.418427031540863,0.9762546161228648,0.45435684647302904,0.8678407678724638,1.0,4/10,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,regulation of protein targeting to membrane (GO:0090313),0.33341758277589933,0.9761790059972284,0.48945147679324896,0.8669757900022953,1.0,7/28,14.97%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1;GDI1
prerank,T cell migration (GO:0072678),-0.4017894417131988,-0.9758070253734519,0.4990791896869245,0.74529871110269,1.0,9/13,47.48%,CXCL16;SLC12A2;PIK3CD;MSN;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,synaptic vesicle transport (GO:0048489),-0.4215254165040979,-0.9757315746501479,0.5111524163568774,0.7450050592836789,1.0,4/11,26.27%,TMEM230;SPG11;TOR1A;KIF5B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.33984009706621715,0.9756419501803877,0.5,0.8674902169538685,1.0,2/21,3.53%,PROX1;TOX
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30534975924049,-0.9755468170037673,0.5018939393939394,0.7449914960912805,1.0,5/40,7.89%,IGF1;OPA1;PRKN;DNM1L;FAM162A
prerank,purine nucleotide metabolic process (GO:0006163),0.3317848602523024,0.9752279817002242,0.5010570824524313,0.8676090958889315,1.0,6/24,12.98%,GPX1;GART;HPRT1;MTHFD1;NT5C;GUK1
prerank,regulation of epithelial cell migration (GO:0010632),-0.28623257996883,-0.9749502586195179,0.5,0.7459688919183386,1.0,14/51,16.44%,DOCK5;SASH1;PTN;RHOJ;RREB1;CTSH;GLUL;PLCG1;HIF1A;BMPER;RAB11A;GLIPR2;DUSP10;DOCK1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.38959990967754016,0.9749128365380892,0.4822222222222222,0.8674628793719086,1.0,3/13,13.00%,TMEM30A;SAR1A;SORL1
prerank,cardiac muscle cell action potential (GO:0086001),0.3233343470829132,0.9741450494929175,0.5121457489878543,0.8687057489764495,1.0,7/30,6.56%,SCN1A;FGF12;CACNA2D1;SLC8A1;SCN4B;HCN2;KCND3
prerank,phosphatidylserine metabolic process (GO:0006658),-0.31126035170532035,-0.9737063249582224,0.4932562620423892,0.748571708101417,1.0,10/32,22.98%,OSBPL8;PLSCR1;OSBPL5;PLA2G4A;PTDSS1;SLC27A1;PLA1A;ABHD12;LPCAT3;PTDSS2
prerank,positive regulation of cell adhesion (GO:0045785),0.26585871751931384,0.9732194564466858,0.4968017057569296,0.8703081323836305,1.0,18/74,14.52%,FRMD5;MAGI1;CXCL12;PPM1F;IL12A;STX3;TGFB2;PTPRJ;NDNF;PDGFB;SMAD7;RET;MEGF10;DUSP26;CIB1;ADGRG1;ATM;PPP3CA
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3429487135589179,-0.972963195638278,0.49803149606299213,0.7499335388484317,1.0,7/24,14.42%,GHR;KIT;PIBF1;CENPJ;CYP1B1;HES1;CRLF3
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3663976634573803,-0.9724892716957961,0.4900181488203267,0.7506352832430464,1.0,10/16,38.60%,WRN;MCM6;SSBP1;RECQL5;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3733472141286595,0.9721958940465046,0.5100806451612904,0.872251173414128,1.0,6/16,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,defense response to tumor cell (GO:0002357),-0.4268693531153245,-0.9721370562673533,0.4889705882352941,0.7510573106764312,1.0,4/10,22.87%,RBMS3;DAPK1;PRDX2;PLK5
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.27464701588270884,-0.9719500034293557,0.48854961832061067,0.7510574145186766,1.0,24/64,29.41%,ACSL1;DAGLA;ASAH2;CPT2;CYP1B1;PLA2G4A;ACSL6;PNPLA8;EPHX1;EPHX2;ACOX1;ACAD9;CPT1A;MGLL;ACSL4;ELOVL1;ACOT8;DAGLB;GSTM2;ACSBG1;ALOX12;ELOVL5;PLA2G4C;AIG1
prerank,regulation of TORC1 signaling (GO:1903432),-0.3122613016216601,-0.9718270936552739,0.5085714285714286,0.7508572020287223,1.0,12/33,26.23%,RNF152;SESN1;TELO2;CASTOR2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;SZT2;KPTN;RRAGA
prerank,negative regulation of cellular component movement (GO:0051271),-0.3815156133719866,-0.9715893211173539,0.514,0.7509681433840442,1.0,4/15,8.66%,TGFBR3;FBLN1;CD9;SP100
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3487522241023503,0.9713067391522361,0.48902195608782434,0.873829666480762,1.0,6/20,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;HSD17B10;STARD3
prerank,positive regulation of intracellular transport (GO:0032388),-0.30545046286124444,-0.9712738476510928,0.5176470588235295,0.7512987090176784,1.0,13/38,18.24%,PCM1;NUMA1;BCAS3;STX18;PCNT;EHD2;VAMP2;ACTN2;TBC1D20;TPR;DYNC1H1;ICE1;EIPR1
prerank,macrophage differentiation (GO:0030225),-0.39719410050768733,-0.9711315620275398,0.5189393939393939,0.7511471935149382,1.0,5/13,14.35%,IL31RA;BMP4;CDC42;PARP1;VEGFA
prerank,smoothened signaling pathway (GO:0007224),-0.30937261001674665,-0.9707844487363544,0.5183752417794971,0.7515377747226757,1.0,9/32,15.44%,GLI3;GLI2;SMO;ARL13B;EVC2;HIPK1;CC2D2A;GLI1;PTCH1
prerank,cardiac muscle cell contraction (GO:0086003),0.35938625529960655,0.9705481067623736,0.49148936170212765,0.874959503357442,1.0,4/19,5.57%,SCN1A;FGF12;CACNA2D1;SCN4B
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3821720683456082,-0.9703060175426309,0.4883720930232558,0.752240242344165,1.0,6/15,18.58%,PCM1;PIBF1;CCDC14;SNX10;C2CD3;CSNK1D
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3913023317589783,-0.9697006273229639,0.4981549815498155,0.753325058044359,1.0,8/14,30.54%,TNKS2;NABP2;BRCA2;TERF2;TERT;ATR;ATRX;PINX1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3954153626673187,-0.9696753535850936,0.503921568627451,0.7529067384813536,1.0,3/13,8.60%,CACNA1C;ANK2;GJA1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.39208603036998985,-0.9696458644198755,0.5156794425087108,0.7525032915599362,1.0,8/14,30.72%,AKAP8L;NIPBL;SAP30BP;FNTA;ZBTB7B;DYRK1A;NNMT;BRMS1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2576638477267556,-0.9690186260631752,0.501984126984127,0.7535451444000444,1.0,13/98,7.95%,EGFR;LRP1;SORBS1;EPHA3;CEMIP;SLC5A3;PRKN;PTPN9;DLG1;ITGB1;TFDP2;BCL2;PDPK1
prerank,negative regulation of binding (GO:0051100),-0.26026557364032954,-0.9690044769949192,0.5281124497991968,0.7531123985005491,1.0,16/81,10.43%,ARHGAP28;DAB2;ROCK1;SMO;LRRK2;GSK3B;STYX;IFIT2;SP100;DACT1;CSNK1E;BTAF1;USP33;NES;JUN;PRKCD
prerank,positive regulation of macrophage migration (GO:1905523),-0.3550681791685081,-0.9689893078500067,0.5096899224806202,0.752667389024313,1.0,5/19,16.17%,IL34;THBS1;P2RY12;P2RX4;CMKLR1
prerank,icosanoid secretion (GO:0032309),-0.40253825089334794,-0.968534543611728,0.5141776937618148,0.7533155908060052,1.0,3/12,15.54%,ANXA1;PNPLA8;BDKRB2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3917659692946398,-0.9685259373922015,0.4972375690607735,0.7528627359753356,1.0,4/14,16.81%,TGFBR2;CD55;PTPN22;IL18
prerank,plasma membrane tubulation (GO:0097320),-0.39683031442631744,-0.9684877141482778,0.4962121212121212,0.7524871640635956,1.0,5/13,15.28%,PACSIN2;SNX9;CHMP4A;EHD2;WHAMM
prerank,photoreceptor cell development (GO:0042461),0.38598272224877966,0.9682217309147302,0.5095541401273885,0.8807498527906026,1.0,4/14,14.27%,AHI1;MFSD2A;RORB;DCX
prerank,icosanoid metabolic process (GO:0006690),-0.2988665072054665,-0.9681994833032211,0.5439252336448598,0.7527359017812768,1.0,16/40,29.80%,PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PON2;PNPLA8;EPHX1;MGLL;DAGLB;ABCC10;PON3;GGT5;ALOX12;PLA2G4C;TBXAS1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3646068240313427,-0.9681112009633612,0.5236220472440944,0.7524915800740755,1.0,6/19,16.88%,CEP135;CCT6A;CENPJ;CCT8;CCT5;CEP295
prerank,positive regulation of axonogenesis (GO:0050772),0.2922223162839316,0.9680596774965217,0.4909456740442656,0.8801218135157834,1.0,9/43,9.96%,PLXNB3;NTRK2;SEMA4D;SEMA7A;SHTN1;PLXNA4;ROBO2;CDKL5;NTN1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3527298264077432,0.9676716596559374,0.491725768321513,0.8801483935480713,1.0,5/19,7.54%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2615711872749335,0.9674185894387888,0.506198347107438,0.8798202640783689,1.0,14/88,10.55%,EGFL7;TEK;PROX1;PLXNB3;TIE1;SIRT1;CAV2;PPP1R16B;KDR;ACVRL1;AKT1;PDGFB;PTPRM;SCG2
prerank,respiratory chain complex IV assembly (GO:0008535),0.3532510041115061,0.9671597604590284,0.5203426124197003,0.8795257539116021,1.0,11/21,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA6;COX10;COA3;OXA1L;SCO1
prerank,cellular response to retinoic acid (GO:0071300),-0.29072551742604663,-0.9661387713673939,0.5084427767354597,0.7568994421558742,1.0,9/42,12.99%,EPHA3;PTK7;WNT5B;WNT6;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3539817850362012,-0.9660008792995154,0.5080500894454383,0.7567675918377673,1.0,8/19,26.99%,GFPT1;UAP1;PMM2;RENBP;SLC35D1;UAP1L1;PGM3;NANS
prerank,response to growth factor (GO:0070848),-0.2918175604676747,-0.9659699921522439,0.497164461247637,0.7563682557827108,1.0,16/41,26.30%,TGFBR1;BMPR1A;TGFBR2;SHC1;CPNE3;ACVR1;EMD;STAT5B;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;TWF2;HTRA2
prerank,apical junction assembly (GO:0043297),-0.284025461198522,-0.9657898713174484,0.5088408644400786,0.7563627786624759,1.0,9/53,10.27%,AFDN;VCL;MPP7;PARD6G;CTNNA1;DLG1;PAK2;CLDN11;RHOA
prerank,cardiac cell development (GO:0055006),0.4138815746415085,0.9656753904581169,0.49800796812749004,0.88277261772956,1.0,4/11,9.53%,MYH6;SLC8A1;NOTCH1;TCAP
prerank,endocardial cushion development (GO:0003197),0.34686763059988307,0.964818618770988,0.5022026431718062,0.8842063133208659,1.0,7/21,12.87%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1;FOXF1;BMPR2
prerank,protein deubiquitination (GO:0016579),-0.22630109494455414,-0.9648082561514588,0.5602409638554217,0.7582951597578862,1.0,46/242,14.78%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;WDR48;TRRAP;ENY2;BRCC3;MYSM1;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;RHOT1;USP47;WDR20;PSMF1;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;USP50;PSMB2;USP2;OTUD4;USP13
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.43018971529119354,-0.964786542421028,0.5299625468164794,0.7578806509277114,1.0,5/10,27.52%,INO80;STOML2;SSBP1;DBF4;ATRX
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3834811850489974,0.9642857715071175,0.5074946466809421,0.8847306678145138,1.0,7/15,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,protein catabolic process (GO:0030163),-0.2734180256618526,-0.9641606389491224,0.5226415094339623,0.758950386931295,1.0,19/59,26.33%,NGLY1;PRKN;RAB12;MTOR;DDI2;OGA;LAMP2;ADAMTS9;APOE;MANBA;VCP;LRSAM1;CLN5;MAGEC2;SIAH2;CLPX;BAG6;HTRA2;CLN8
prerank,protein lipidation (GO:0006497),-0.27403965824284543,-0.9641116404470587,0.508411214953271,0.7586099772423508,1.0,26/59,34.08%,PIGN;GLUL;WIPI1;ZDHHC13;UGCG;PIK3C3;DPM1;WDR45B;ZDHHC1;ATG5;ZDHHC16;HHAT;PIGH;WIPI2;MPPE1;PIGC;DPM3;PIGA;ZDHHC8;PIGZ;PIGP;ATG10;PIGF;PIGO;WDR45;ATG12
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2580682634996674,-0.9636528104385944,0.534516765285996,0.7592439642787983,1.0,22/87,23.00%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;NR4A1;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K
prerank,pyruvate metabolic process (GO:0006090),0.28600678221936876,0.9636351664727993,0.5189873417721519,0.8854871305331492,1.0,16/52,21.41%,BSG;PGAM4;PGAM1;ALDOC;PDHB;GCK;SLC16A1;PFKFB2;DLAT;GAPDHS;NR4A3;LDHB;LDHA;ENO2;SRR;GPI
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.37056263048444527,-0.9633207576331356,0.4972677595628415,0.7596196358527018,1.0,4/16,12.86%,AUTS2;ARHGAP24;ARHGAP17;OGT
prerank,negative regulation of cell aging (GO:0090344),0.36215222362182686,0.9631200559237219,0.5136842105263157,0.88594053935649,1.0,3/16,3.68%,MIF;SIRT1;HMGA2
prerank,toll-like receptor signaling pathway (GO:0002224),0.25674438685313977,0.9629133539027549,0.5460122699386503,0.8854510287048178,1.0,18/84,17.13%,TIRAP;S100A9;S100A8;RPS27A;UBC;TLR2;UBB;TRIL;BCL10;ITGAM;CTSB;HSPD1;RFTN1;CD36;TAB2;MAPKAPK2;TNIP1;BTK
prerank,T cell proliferation (GO:0042098),0.3771569782471354,0.9628867102116352,0.5366379310344828,0.8844593572425409,1.0,1/13,0.98%,CADM1
prerank,activation of adenylate cyclase activity (GO:0007190),0.3076601372411306,0.9622324678444328,0.5202558635394456,0.885325258943041,1.0,7/35,11.11%,ADCY8;ADCY3;ADRB1;LGR5;ADCYAP1;CAP2;ADCY4
prerank,axoneme assembly (GO:0035082),0.3132276948732773,0.9621267220056638,0.5188284518828452,0.8845480696309305,1.0,6/31,16.18%,SPAG16;DNAAF3;FOXJ1;DNAAF2;DCX;SPAG1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3595657748894501,-0.9616141624935891,0.5149812734082397,0.7632808676124171,1.0,8/18,18.76%,BMPR1A;MDM4;BMP4;TGFBR2;ACVR1;HEYL;TBX2;BMP2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.36847898707521604,-0.9615417213600459,0.5238095238095238,0.7629803533593078,1.0,6/16,20.79%,PDK1;PRKN;FOXK1;RORA;FOXK2;BCKDK
prerank,tRNA 5'-leader removal (GO:0001682),0.38470201698837,0.961490483421104,0.5144628099173554,0.8853888841732274,1.0,3/13,12.31%,RPP40;RPP30;POP5
prerank,regulation of p38MAPK cascade (GO:1900744),-0.30210003497023297,-0.9614863279021085,0.5129151291512916,0.7626295508870929,1.0,12/35,28.10%,SASH1;DLG1;PTPN22;RELL1;VEGFA;DUSP1;DUSP10;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,synaptic vesicle membrane organization (GO:0048499),0.36244983796718244,0.9614670514694499,0.521551724137931,0.8843858950377371,1.0,4/17,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2238949040699934,-0.9607880175606822,0.5663900414937759,0.7638681237308346,1.0,55/234,18.51%,ROR1;SMAD3;NFKB1;SLCO3A1;LRP6;PLPP3;UBE2N;CFLAR;ZIC2;STK3;EP300;HDAC4;ERC1;CAMK1D;SMO;EDA;FLOT2;KIT;IRAK3;PPARGC1B;FZD2;STAT3;ADCY1;IRAK2;DHX9;TRIM8;CEBPG;CRTC3;AR;PPARGC1A;JUP;ATF2;FER;TRAF2;CRTC1;MAVS;MBTPS2;TRIM5;ARID5B;TCF3;TRIM25;ANXA3;CARD14;EIF2AK2;VEGFA;PRKCZ;IL18;IKBKE;TLR4;CRTC2;WNT5A;PRKD1;CX3CR1;TRAF6;FZD1
prerank,response to organic cyclic compound (GO:0014070),-0.2763678555652904,-0.9607245847643275,0.5212569316081331,0.7635655729408037,1.0,7/52,9.27%,IGFBP5;LRRK2;HLCS;STRN3;STAT3;ANXA1;CYP1B1
prerank,protein maturation (GO:0051604),0.25755587458000395,0.9605294360905808,0.5278350515463918,0.8860599940908348,1.0,19/95,13.71%,MME;LMF2;PCSK1;PCSK2;METAP2;PHEX;PCSK6;PSENEN;MMP16;PITRM1;PCSK7;TSPAN17;TMPRSS4;TSPAN14;HSPD1;SORL1;TASP1;GALNT2;PSEN1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3211386961161064,-0.9603755272082596,0.5240847784200385,0.7639691272475597,1.0,5/28,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.23617142821812678,-0.9599299689266863,0.5566218809980806,0.7645995960460293,1.0,24/137,11.10%,DOCK11;AFDN;ASAP3;LIMS1;ARAP1;GSK3B;SGSM2;ITGB1;CTSH;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;RAPGEF3;ZC3H15;S100A10;RSU1;WRN;NDEL1;USP6NL;TBC1D20;RHOA;RCN3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.32904576363266624,-0.9594188185744646,0.4896030245746692,0.7653674284161418,1.0,4/23,10.12%,SASH1;TAOK3;MAP3K5;TRAF2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2717525410811392,-0.9593857977667026,0.5325443786982249,0.7649689453559284,1.0,23/61,24.45%,CCNH;KHDRBS1;CDK7;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;CUL1;CDK6;DBF4;EIF4EBP1;CCNE2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.39916042615286956,0.9593205140550847,0.5170068027210885,0.8884587149783454,1.0,3/12,8.88%,FUT9;AKT1;SKAP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.401795166005705,0.959290366536386,0.5011441647597255,0.8874660900759972,1.0,3/11,12.26%,PTPRT;SOCS1;BCL3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.36506792465593774,-0.9592807948578194,0.5045703839122486,0.7647348966797223,1.0,6/16,20.92%,NPR3;HIF1A;APOE;TERF2;TERT;S100A1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.24566186615295454,-0.9592093281107207,0.539651837524178,0.76444108948741,1.0,25/108,17.28%,UACA;SMAD3;GSN;COL4A3;CFLAR;ROBO1;HMGB1;EIF2AK3;F3;REST;MAP3K5;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;DDX3X;ANP32B;DAPK1;DAP;HSPE1;BCL2L13
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.34650189291532785,-0.9587751913187105,0.5139664804469274,0.7650226340906988,1.0,3/20,5.41%,SULF1;SULF2;THBS1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.34333525996175207,-0.9586878564850918,0.499054820415879,0.764765293755696,1.0,5/21,9.09%,ADCY9;ADCY5;ADCY1;ADCY6;GUCY1A1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.30019917573127164,-0.958528381614194,0.55765595463138,0.7646888246663776,1.0,5/37,4.00%,PHLDB2;EPHA3;ROCK1;PRKAA2;GSK3B
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3919976866922178,0.9583795633400247,0.5387840670859538,0.8890375615444764,1.0,3/12,9.38%,GART;HPRT1;MTHFD1
prerank,carbohydrate homeostasis (GO:0033500),-0.269723738693405,-0.9580082012126071,0.5326530612244897,0.7654932072878761,1.0,9/67,6.07%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3845807192584437,0.957873272666568,0.5294117647058824,0.8894513641950851,1.0,4/14,16.17%,RPF2;RPL7;ZNHIT6;DDX18
prerank,protein acetylation (GO:0006473),-0.3220134100363711,-0.9576682916939517,0.5212355212355212,0.7658635093940868,1.0,8/30,16.27%,KAT2B;EP300;CREBBP;HAT1;ING5;NAA15;ESCO1;GTF2B
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3568701048021764,-0.9576676895578178,0.5092936802973977,0.7653920928319383,1.0,6/17,22.28%,TAOK3;LYN;MID1;EIF2AK2;TAOK1;KLHDC10
prerank,epiboly involved in wound healing (GO:0090505),-0.37010916331642457,-0.9576267194409693,0.5163776493256262,0.7650341943053417,1.0,8/16,23.13%,PDPN;FLNA;RHOA;CCN1;DDR1;RHOC;TOR1A;ARHGAP35
prerank,regulation of JUN kinase activity (GO:0043506),-0.30881741256087625,-0.9575321863669567,0.517578125,0.7647984556669799,1.0,11/33,26.75%,SASH1;TAOK3;MAP3K5;PTPN22;TRAF2;DUSP10;PDCD4;TRAF6;DVL3;DVL2;AIDA
prerank,negative regulation of response to stimulus (GO:0048585),0.26939517128804685,0.9574473003382852,0.5288065843621399,0.8895691922900786,1.0,12/60,11.29%,AQP11;MCTP1;SIRT1;HMGA2;THY1;SRMS;CLU;KLF4;CD34;GGT7;TLE5;UBASH3B
prerank,regulation of cell death (GO:0010941),-0.2522359517844359,-0.9573027406161595,0.5573122529644269,0.7649058191145891,1.0,31/94,22.55%,LRP1;CELF1;CCN2;BMP7;BMP4;PRKN;LRRK2;TBK1;VPS4B;SRSF6;CHMP4B;ACER3;IMPACT;CCN3;PRODH;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;RILPL1;SPEF1;BNIP3;FGF2;WNT16;CHP1
prerank,phosphate ion transport (GO:0006817),0.35769545655896035,0.9572681435313555,0.5,0.8890379910900257,1.0,3/16,7.95%,SLC37A4;SLC37A1;SLC25A14
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.40290582214284554,0.9572354451882377,0.5248380129589633,0.8880666504925014,1.0,2/11,3.31%,HCAR2;SIRT1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24314520741424905,0.9571692211193216,0.547808764940239,0.8871814769499804,1.0,25/117,19.10%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.29893971117340384,0.9571438462916391,0.49375,0.8861902111378498,1.0,6/39,5.95%,PAX8;TIE1;PAX2;KDR;FGF10;PAK1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.31365334236332454,0.9571224488331614,0.5173160173160173,0.8851702973554392,1.0,10/30,21.36%,HSPA13;HSPA8;CHCHD4;HSPA5;CCT2;PTGES3;ST13;GAK;BAG1;ENTPD5
prerank,monocyte differentiation (GO:0030224),0.4200067338046929,0.9570647028801534,0.4989517819706499,0.8842776607029189,1.0,3/10,5.22%,CSF1R;PPARG;MT1G
prerank,negative regulation of JNK cascade (GO:0046329),-0.31601994343804657,-0.9570026970906301,0.5268199233716475,0.765169982802484,1.0,9/31,16.89%,NCOR1;PRKN;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP10;PDCD4
prerank,atrial septum morphogenesis (GO:0060413),-0.42305427676852503,-0.9567296677495145,0.5363636363636364,0.7653933232178498,1.0,1/10,0.31%,NOTCH2
prerank,regulation of vasculature development (GO:1901342),0.31931206455036737,0.9566991037109428,0.5274261603375527,0.884247841626848,1.0,4/26,8.17%,HTATIP2;TSPAN12;ETS1;GPNMB
prerank,cellular glucose homeostasis (GO:0001678),-0.29461802644867624,-0.9566055430770618,0.5218216318785579,0.7652418329496915,1.0,13/41,17.80%,ZBTB20;PRKAA2;SLC39A14;LRRC8D;FOXK1;PPARGC1A;UNC13B;HIF1A;PCK2;ERN1;FOXK2;PRKACA;PRKAA1
prerank,ganglion development (GO:0061548),0.3978304589085449,0.9565427524652503,0.5204301075268817,0.8836552819496477,1.0,4/11,21.62%,UNC5C;TUBB3;CTNNB1;SEMA3A
prerank,positive regulation of protein modification process (GO:0031401),-0.22632102113094754,-0.9564575705056387,0.5692007797270955,0.7651596579958201,1.0,37/203,15.01%,TRABD2B;ROCK2;EGFR;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;UBE2N;FGF1;DAB2;FAM20A;BMP4;ABL1;LRRK2;AXIN1;RAB3GAP1;LYN;RAMP1;RAPGEF3;PPP1R7;IGF2;RB1CC1;ANKLE2;FAM161A;PRKCD;MAVS;FNIP1;CARD14;CCN1;WDFY2;TXN;VEGFA;CCND3;DDX3X;VEGFD
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.33517495907267264,-0.9563295610511238,0.5064935064935064,0.7644998186414157,1.0,10/21,33.11%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.33517495907267264,-0.9563295610511238,0.5064935064935064,0.7644998186414157,1.0,10/21,33.11%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,regulation of calcium ion transport (GO:0051924),0.2756211741763322,0.9563107285625315,0.5134575569358178,0.8832727119898968,1.0,9/54,10.86%,CAMK2A;CD33;CACNA2D1;EPB41;CACNB2;HOMER1;PLPP4;HOMER2;F2R
prerank,protein-containing complex subunit organization (GO:0043933),-0.243253548332828,-0.9560824105089648,0.5614754098360656,0.7646450746429023,1.0,35/109,22.65%,TEAD1;MDM4;DLG4;YAP1;DNM1L;SNX9;CREBBP;TUBGCP2;PPARGC1A;VAMP2;GEMIN5;MNAT1;WASL;TRAF2;CAPZA1;WIPF1;HES1;TEAD2;TPR;PARD3;RANBP9;WASF1;REPS2;PPIH;PICALM;GPAA1;TUBGCP4;PML;NUP98;FANCC;KIFAP3;KMT2A;PPID;DET1;LAMC1
prerank,potassium ion homeostasis (GO:0055075),-0.34205740926965816,-0.9560049870685887,0.5206286836935167,0.7643404521339068,1.0,7/23,20.31%,ATP1A2;SLC12A7;KCNJ2;SLC12A2;SLC12A8;ATP1B3;SLC12A9
prerank,regulation of protein kinase B signaling (GO:0051896),0.22748794650238663,0.9558838094837826,0.5337301587301587,0.8834646710023898,1.0,23/193,9.13%,IGF1R;KITLG;TEK;ERBB4;NRG2;NRG1;MAGI2;SIRT1;GAS6;FGF10;NTRK2;FLT3;HIP1;PHLPP1;CPNE1;FGF5;PIK3R5;TRIB3;PTPRJ;HSP90AB1;AKT1;THPO;MYORG
prerank,positive regulation of chemotaxis (GO:0050921),0.2896628429060974,0.955724566685071,0.5306553911205074,0.8828910087135593,1.0,8/43,10.48%,DSCAM;TMSB4X;PPM1F;KDR;STX3;HSPB1;PDGFB;AIF1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3554471113718605,0.9557022025407002,0.5170212765957447,0.8819197972966419,1.0,4/18,8.04%,TRIM13;RPS27A;UBC;UBB
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3888782231014244,-0.9551918303501848,0.5226824457593688,0.7658888862653441,1.0,5/13,19.18%,PLA2G4A;MOGAT3;ABHD12;ABHD6;MGLL
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41964347742116603,-0.9551708220324374,0.5294117647058824,0.765465908915406,1.0,3/10,13.00%,DNMT3A;IGF2;KDM1B
prerank,positive regulation of nuclear division (GO:0051785),-0.32818878717089467,-0.9549545411368412,0.528046421663443,0.7655201488662005,1.0,3/25,8.58%,IGF1;PDGFRB;IGF2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.35557911097581507,0.9549022839429417,0.5072164948453608,0.8832046484137311,1.0,4/17,14.35%,TERF1;UNG;TERF2IP;TINF2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.26345393032481534,-0.9545557122289771,0.5399610136452242,0.7659936479128857,1.0,19/73,18.41%,SMAD3;COL4A3;CFLAR;ROBO1;EIF2AK3;F3;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;ANP32B;DAP;HSPE1;BCL2L13;VCP
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3971578530814274,0.9543304291889249,0.5211864406779662,0.8838318690417518,1.0,2/12,1.57%,EPHB1;SPTBN4
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41921796394182986,-0.9541522963002227,0.5285451197053407,0.7660289224565192,1.0,4/10,22.48%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41921796394182986,-0.9541522963002227,0.5285451197053407,0.7660289224565192,1.0,4/10,22.48%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.314539605392656,-0.9539620490417834,0.5355086372360844,0.7660118303023533,1.0,13/29,43.90%,DDO;ACADSB;PRODH;SARDH;ALDH4A1;CBS;KMO;GOT2;BLMH;HGD;IL4I1;FAH;HAAO
prerank,regulation of multicellular organismal development (GO:2000026),-0.33124952215834225,-0.9538103738321513,0.50293542074364,0.7659297874402262,1.0,7/25,16.91%,PTN;TRIP12;MYSM1;DHX36;NIPBL;EHMT1;OAS2
prerank,microtubule anchoring (GO:0034453),-0.3934194177500766,-0.9536807313715019,0.5309090909090909,0.7657581074500144,1.0,2/12,1.98%,DAG1;PCM1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.25743877395602033,-0.9535182190025832,0.5485148514851486,0.7656792361669125,1.0,37/87,35.10%,FBXL7;KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;USP47;PSMF1;PKD2;RB1;PSMB2;FAM107A;DCUN1D3;CDC73;CUL1;CDK6;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9;RBX1;CDK2AP2;PINX1;PSME4;MYO16;PSMB8;PSMD10;CDKN2C;RBL2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3365765891462269,0.9531989488469962,0.5311203319502075,0.8860513080142721,1.0,4/22,10.79%,PDE4B;GPR35;CACNB2;CACNB4
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29585403952395084,-0.9531960081899618,0.5120481927710844,0.7660158097517556,1.0,8/41,12.86%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,acylglycerol metabolic process (GO:0006639),0.2994025034655794,0.9531760928009357,0.533195020746888,0.8850688907627102,1.0,5/37,7.01%,DGKI;ABHD2;DGAT2;DGKH;DGKB
prerank,B cell differentiation (GO:0030183),-0.2843271093732166,-0.9531693517397462,0.5415860735009671,0.7656120836016627,1.0,12/46,18.27%,HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN2;FNIP1;TCF3;ITGA4;KLF6;SYVN1;BLNK
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3163496732749609,-0.9530603737341421,0.515828677839851,0.765393709101071,1.0,10/27,26.15%,NFKB1;ABCA1;ITGAV;NR1H3;AGTR1;IL18;ITGB3;MAPK9;PPARA;LPL
prerank,regulation of response to oxidative stress (GO:1902882),0.39142032296182183,0.9529356509809307,0.502127659574468,0.8847021565369816,1.0,4/11,16.06%,MCTP1;HEBP2;GGT7;STOX1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3007743966295513,0.9529018838268366,0.5274261603375527,0.8837569498627525,1.0,9/35,13.89%,RIMS2;EPHA5;AKAP6;PDE2A;HTR2C;ADCYAP1;CAP2;PDE4D;CD36
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2421859156522428,0.9528829210501725,0.5666003976143141,0.8827779116314906,1.0,25/116,19.10%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,entry into host (GO:0044409),-0.3843278021982115,-0.9528678038393342,0.52046783625731,0.7653865322218752,1.0,2/13,6.03%,ITGAV;CDH1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3212166316041765,-0.9526655505017233,0.5329566854990584,0.7654491472249423,1.0,8/28,17.55%,PTN;ABL1;GSK3B;ADCY1;EPHA4;EIF2AK4;APOE;FAM107A
prerank,response to unfolded protein (GO:0006986),0.28315022160193815,0.9524716061463748,0.5147058823529411,0.8829589674726634,1.0,8/48,9.89%,HSPA13;PACRG;HSPA8;HSPA5;HSPA4L;HSP90AB1;HSPB1;DAB2IP
prerank,dorsal/ventral pattern formation (GO:0009953),-0.34761876566612865,-0.9524498901462691,0.5257352941176471,0.7654789951014852,1.0,3/20,1.77%,BMPR1A;GLI2;NBL1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.29209400296422716,0.9521635909843554,0.5185185185185185,0.8827614959814849,1.0,8/41,12.16%,PODXL;MAGI1;ANK3;THY1;SKAP1;TJP1;SMAD7;MEGF10
prerank,regulation of cholesterol transport (GO:0032374),-0.343978435561216,-0.9519476494822172,0.5204081632653061,0.7662115979129659,1.0,2/20,1.19%,LRP1;NFKB1
prerank,transferrin transport (GO:0033572),0.302307573507131,0.9513786720627997,0.4895833333333333,0.8839747281815811,1.0,13/33,22.73%,TFRC;ATP6V1F;ATP6V1A;ATP6AP1;ATP6V1C1;ATP6V0B;ATP6V0A1;ATP6V0E2;ATP6V1D;REP15;HFE;ATP6V0C;ATP6V1G1
prerank,cellular response to acid chemical (GO:0071229),0.3211142382975681,0.9513206951157576,0.5201698513800425,0.8831058160617143,1.0,9/27,20.80%,IPO5;GLRA1;GLRA2;KLF2;XBP1;LAMTOR2;CAPN2;SPAAR;RRAGD
prerank,vesicle transport along microtubule (GO:0047496),-0.33385668175222305,-0.950984594703765,0.5106382978723404,0.768159387516972,1.0,9/23,26.27%,TRAK1;KIF13A;NDEL1;KIF1C;DYNC1H1;FBXW11;KIFAP3;KIF3A;KIF5B
prerank,body fluid secretion (GO:0007589),0.37064271513324787,0.9505369356440302,0.5101123595505618,0.8843488982394645,1.0,2/15,7.12%,ERBB4;GUCA1B
prerank,transepithelial transport (GO:0070633),0.3629006068499791,0.9496927588622941,0.5117773019271948,0.8858038722998357,1.0,3/15,5.82%,ABCG2;SLC1A1;SLC1A2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3488291906466504,-0.9488676131441893,0.5419103313840156,0.7729147385077999,1.0,6/18,19.92%,NGLY1;DERA;OGA;ADAMTS9;MANBA;NAGA
prerank,neuron apoptotic process (GO:0051402),0.3439519844852399,0.9485092850229415,0.5282608695652173,0.8881117829462171,1.0,4/19,13.42%,TRPC5;TNFRSF21;SCN2A;CIT
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2272712869064133,-0.9481416853728832,0.5847107438016529,0.774236476343726,1.0,80/185,33.78%,APPL2;PKD1;INO80;PCM1;CDC14A;BTRC;ALMS1;ODF2;NINL;CEP63;CEP135;CENPJ;PCNT;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CSNK1E;ID2;PSMF1;ERCC3;CUL3;APPL1;MAPRE1;PSMB2;CDC26;CDC14B;YWHAE;AKAP9;CDC27;UBE2E1;DYNC1H1;CEP76;KLHL18;UBE2S;PRKACA;CEP57;CSNK1D;CDK2;NEK6;ANAPC11;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;PLK5;ACTR1A;PSMA3;TFAP4;PSMA4;CDC16;ANAPC1;HAUS3;PSME1;PSMD13;CEP41;FZR1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;HAUS5;UBA52;HAUS4;PLK4;NEK11;MAD2L1;CEP72;CENPE;PTPN6;SSNA1;CEP164;PSME4;BUB1B;DDB1;RIOK2;CKAP5;PSMB8
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.34985053931466725,-0.9478349286557354,0.5436363636363636,0.7745245365170319,1.0,10/20,29.43%,PRKAA2;BRD7;PPARGC1A;ARRB1;PRKAA1;NOS1;PAXIP1;RPS6KA4;RUVBL2;GLYR1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3145363047320892,0.9476791925118841,0.512087912087912,0.8894591790526881,1.0,3/29,4.46%,FLT1;TEK;FLT3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3348129078164227,0.9467565021909331,0.5365853658536586,0.8910339511348809,1.0,4/22,8.73%,PSMA1;ENC1;PSMA6;PSMB3
prerank,prostaglandin metabolic process (GO:0006693),-0.3251079557220221,-0.9466975871748993,0.551660516605166,0.776794077417226,1.0,6/26,12.45%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.39086005319618206,-0.9466380846842171,0.5340909090909091,0.7764668086086137,1.0,5/11,26.20%,DHX36;ZC3H3;CDC73;AHCYL1;NCBP2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.25918859711753395,-0.9460626205153664,0.5469924812030075,0.7773819600187287,1.0,28/73,29.72%,KAT2B;EP300;HDAC4;PPM1D;DNMT3A;SF3B1;IGF2;TAF1D;TBP;PHF2;MPHOSPH8;CGGBP1;KDM1B;PHF1;JARID2;EPC1;BAZ1B;POLR2H;EZH2;POLR2K;PPHLN1;POLR2E;CREBZF;TAF1C;POLR1G;TAF1A;SPHK2;POLR1C
prerank,positive regulation of JNK cascade (GO:0046330),0.26521609177610034,0.9459101108193573,0.5533199195171026,0.8924195996252366,1.0,16/70,14.55%,TIRAP;MAP4K2;TRAF1;PLCB1;TNFRSF19;WNT7B;ANKRD6;MAPK8IP1;TAOK2;DAB2IP;HIPK2;PJA2;DUSP15;MAP3K11;HRAS;MFHAS1
prerank,phagosome-lysosome fusion (GO:0090385),0.4096353086645636,0.9458439916171227,0.5373134328358209,0.8915871911664173,1.0,1/10,1.84%,SYT7
prerank,positive regulation of telomere capping (GO:1904355),-0.3579119166373044,-0.9452811114971298,0.5394990366088632,0.7788667872762968,1.0,4/17,15.73%,TNKS2;HNRNPD;NABP2;MAP2K7
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.39583233280608293,0.9450748206399318,0.5062761506276151,0.8926836830617786,1.0,2/12,4.90%,CSF1R;IL12A
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3958300192089482,-0.9450512113335348,0.5393474088291746,0.7789381655242923,1.0,5/12,26.50%,AR;SELENOS;HDAC2;AP2A1;TAF7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.3603259457030422,-0.9450054030790143,0.5275142314990512,0.7781019931460414,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),-0.3603259457030422,-0.9450054030790143,0.5275142314990512,0.7781019931460414,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,fatty acid transport (GO:0015908),0.3499172706145829,0.9445571454008989,0.5095137420718816,0.893099335270652,1.0,5/17,13.89%,PPARG;MFSD2A;FABP5;SLC27A4;CD36
prerank,cellular response to hydroxyurea (GO:0072711),-0.417858381308936,-0.944421236116782,0.5578747628083491,0.7790739406054088,1.0,2/10,7.42%,SPIDR;DDI2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.37096513210248383,-0.9443353344524078,0.5470383275261324,0.7788403215248653,1.0,8/14,33.29%,NMNAT2;ME1;NMNAT3;NMNAT1;CMPK2;AK1;PNP;AK7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.387707021411075,-0.9439339650760135,0.5415094339622641,0.7793470384117035,1.0,9/12,37.04%,UPP2;DHODH;TK2;UMPS;CDA;CAD;UCK1;DCK;TK1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4146453594936226,-0.9433159292488169,0.5610200364298725,0.7803826699573894,1.0,7/10,46.18%,RENBP;ST6GAL1;GNE;NANP;NPL;NAGK;GNPDA1
prerank,positive regulation of cell killing (GO:0031343),-0.38043715106897047,-0.9430530083954324,0.5418994413407822,0.7805053239794061,1.0,5/13,25.21%,FZD7;CYBA;WNT5A;SYK;DVL2
prerank,female gamete generation (GO:0007292),-0.3133024377166795,-0.9421505815127796,0.575098814229249,0.7822691076727852,1.0,3/29,4.94%,DIAPH2;PTN;KMT2D
prerank,regulation of endocytosis (GO:0030100),-0.27341842026414387,-0.9415388360872279,0.5747126436781609,0.7832881868827538,1.0,24/61,25.89%,LRP1;EPHA3;DAB2;ROCK1;ABL1;PACSIN2;GPC3;STON2;ARFGAP1;ABL2;APOE;ZFYVE16;RUBCN;PICALM;PRKD1;PTPN1;ABCA7;LRSAM1;STON1;SPHK1;HIP1R;SNX12;RAB5A;CLIP3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.33081122934096324,-0.9411626581108042,0.5432098765432098,0.7837038623661919,1.0,5/21,7.03%,SULF1;EXT1;SULF2;GLCE;HS2ST1
prerank,negative regulation of heart contraction (GO:0045822),-0.40229312058794575,-0.9410449620202306,0.5517857142857143,0.7835272635787829,1.0,1/11,0.03%,ATP1A2
prerank,interstrand cross-link repair (GO:0036297),-0.27419839662941065,-0.9409994365720021,0.5719844357976653,0.7831601887286147,1.0,25/53,32.51%,WDR48;RNF8;MCM9;RFWD3;FANCE;ERCC6L2;FANCM;FANCI;VCP;DCLRE1A;MSH6;POLN;FANCC;FAAP100;ATR;ERCC1;FANCB;UBA52;FANCD2;FANCG;FAAP20;NEIL3;RPA2;EXO5;RAD51
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.38679331106738646,-0.9404286609312178,0.5794392523364486,0.7841282864555829,1.0,7/12,33.07%,BDH2;CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3240823558494762,0.9402291654158648,0.5154004106776181,0.9043962000044976,1.0,8/26,15.33%,TIRAP;NINJ1;TLR2;PJA2;WDFY1;MFHAS1;RTN4;RSAD2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3807853485156241,0.9398250640212854,0.5372807017543859,0.9045185128671176,1.0,3/12,6.70%,PFDN5;CLU;PFDN6
prerank,chemical homeostasis (GO:0048878),-0.2670473654411653,-0.9397043253869399,0.5487077534791253,0.7854782902791986,1.0,12/61,12.69%,ZBTB20;RBP1;NR1D2;SLC4A10;ABHD5;TLCD2;WNK4;WNK1;NR1H3;PNPLA8;SLC4A3;FBXW7
prerank,positive regulation of immune system process (GO:0002684),0.3557968988813851,0.939430696863886,0.524731182795699,0.9046187680078347,1.0,2/16,5.82%,HCAR2;TGFB2
prerank,regulation of rRNA processing (GO:2000232),-0.3609220041361293,-0.9393554941699748,0.5316698656429942,0.7858305836263398,1.0,4/16,16.52%,KAT2B;WDR43;DIMT1;BUD23
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2944902274956964,-0.9393021985795887,0.5725338491295938,0.7855073483967023,1.0,21/40,35.64%,WRN;MCM9;RFWD3;FANCM;MSH3;BOD1L1;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;DONSON;TIPIN;ATRX;CDK9;TIMELESS;EME2;RAD51;POLE;CENPX;GEN1
prerank,Fc receptor signaling pathway (GO:0038093),-0.24464461531510795,-0.9391621382550817,0.5984990619136961,0.7853924857135981,1.0,36/110,29.10%,GAB2;NFKB1;BTRC;KIT;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,negative regulation of hydrolase activity (GO:0051346),0.2745152715363997,0.9388498343499325,0.588957055214724,0.9052371873474577,1.0,5/49,6.34%,CAMK2A;PLXNB3;MAP2;ZCCHC9;FICD
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.33113414468835317,-0.9386824245235315,0.5440613026819924,0.7860813478363295,1.0,6/22,12.96%,APPL2;LBP;LYN;PTPN22;NR1H3;APPL1
prerank,regulation of macrophage activation (GO:0043030),-0.3093272028240812,-0.9384923840509148,0.5716981132075472,0.786054799618134,1.0,11/30,22.24%,IL31RA;LBP;THBS1;NR1H3;TNIP2;TLR4;WNT5A;GPR137B;SHPK;KARS1;SPHK1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3831665446531657,-0.9384241757901775,0.5410447761194029,0.7857343431539247,1.0,4/13,14.35%,TGFBR2;NRP1;SEMA3E;VEGFA
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2843281473529055,0.9384007731583823,0.5769230769230769,0.9054432046451832,1.0,13/42,19.15%,SIRT1;ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,in utero embryonic development (GO:0001701),-0.31208791895842725,-0.9382262380262789,0.5610236220472441,0.7857415457691929,1.0,9/25,18.76%,TGFBR1;PKD1;FGFR2;IGF2;CHD7;HINFP;VEGFA;TGFB3;BMP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2553596962788197,0.9374940659199059,0.5807770961145194,0.9069860663499596,1.0,17/80,12.55%,SIRT1;PAX2;GAS6;PPM1F;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.29603116100120547,-0.937360031376884,0.567193675889328,0.7873941219842728,1.0,10/35,17.99%,SULF1;NR2F2;COL4A3;SPARC;THBS1;MEF2C;APOE;STAT1;ATOH8;ATP5IF1
prerank,regulation of dephosphorylation (GO:0035303),-0.3728084641424406,-0.9371300836075449,0.5700575815738963,0.7874715433011541,1.0,5/15,21.29%,SMG6;SMG7;MTMR3;INPP5K;CDK5RAP3
prerank,amyloid-beta metabolic process (GO:0050435),0.356461803479188,0.9368254370648409,0.5423728813559322,0.907829950867976,1.0,4/16,13.71%,MME;PSENEN;NAT8;PSEN1
prerank,T cell activation involved in immune response (GO:0002286),-0.395864713272764,-0.9367740974461481,0.5437616387337058,0.7878720049370039,1.0,11/12,58.53%,EIF2AK4;FCER1G;ICAM1;MDK;SLC11A1;LILRB1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4036749387554114,-0.9364502620354059,0.562862669245648,0.7881716931612571,1.0,4/11,15.59%,EP300;CLK2;SIK1;C1QTNF3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2613698197661805,0.9356204509859308,0.589247311827957,0.910203722809464,1.0,11/75,10.55%,EGFL7;TEK;PROX1;PLXNB3;SIRT1;PPP1R16B;KDR;APLNR;AKT1;PDGFB;SCG2
prerank,membrane fusion (GO:0061025),-0.3019162682444144,-0.9353389475739866,0.5496031746031746,0.7903876069484055,1.0,14/33,23.61%,OPA1;UBXN2B;HUWE1;DNM1L;MYOF;VTI1B;VAMP2;GCA;SNAP23;NAPA;CHP1;VAPA;NSF;USO1
prerank,tRNA modification (GO:0006400),-0.26585679569677106,-0.9352889904278558,0.597165991902834,0.7900609340782786,1.0,29/62,33.27%,TRMT9B;PUS10;NSUN6;ALKBH1;QTRT2;METTL2B;METTL2A;TYW5;METTL1;NSUN2;TYW1;THUMPD3;ELP5;FTSJ1;PUS3;CDKAL1;LCMT2;WDR6;DTWD1;GTPBP3;TRMT1;MTO1;DTWD2;TRMT44;TRMT61B;TYW3;PUS1;ALKBH8;TRMT12
prerank,amino acid transmembrane transport (GO:0003333),0.2827033997949413,0.9352694240381461,0.5714285714285714,0.9101237736528363,1.0,6/45,9.57%,SLC7A5;SLC6A6;SLC7A1;MFSD12;SLC7A8;SLC36A1
prerank,nuclear transport (GO:0051169),0.35320480477063054,0.935017455680521,0.563169164882227,0.9098225899364664,1.0,4/16,13.45%,NXT1;RBM15B;NUP205;ANP32A
prerank,modulation by symbiont of entry into host (GO:0052372),0.3584707105578592,0.9346126592736732,0.5384615384615384,0.9098924995085126,1.0,3/16,8.21%,HS3ST5;TRIM62;TRIM6
prerank,positive regulation of coagulation (GO:0050820),-0.4024363007500162,-0.9344933067617774,0.5398058252427185,0.7910799346429579,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.4024363007500162,-0.9344933067617774,0.5398058252427185,0.7910799346429579,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.32459433318358616,-0.9343429436891653,0.5580110497237569,0.790979670567831,1.0,6/22,14.08%,AKAP13;AEBP1;ABL1;PRUNE1;EFEMP2;APOE
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.39853223337955035,0.9341439699363643,0.5466666666666666,0.9101445472480106,1.0,2/10,3.78%,CXCL12;GAS6
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3026421439247947,-0.9336928518144667,0.587426326129666,0.792034142783112,1.0,16/32,27.98%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;CLSPN;DONSON;ABRAXAS1;FZR1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3420606820445108,0.9335391742268974,0.5615212527964206,0.9108041535340113,1.0,4/18,8.60%,SLC2A1;OCLN;TRIB3;RTN2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3721961162833798,-0.9334366297887013,0.5606060606060606,0.7922125289155022,1.0,6/14,21.05%,ADGRV1;VEGFA;WNT5A;MYADM;GPD1L;DGKD
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.37301497588684507,0.9332326210487369,0.5458333333333333,0.9106460262901761,1.0,4/14,14.50%,GAS6;GPS2;RFFL;TRAIP
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3764854530102552,-0.933047833779158,0.553875236294896,0.7927043248412919,1.0,4/14,34.35%,IL6ST;PARK7;OSMR;ADAM8
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3915488244339189,-0.9326900071546764,0.5436893203883495,0.7930802107937897,1.0,5/12,20.73%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119
prerank,purine-containing compound catabolic process (GO:0072523),0.3636982440123828,0.9321416186068615,0.5269709543568465,0.9126424182212342,1.0,2/13,9.52%,GPX1;NT5C
prerank,regulation of lymphocyte activation (GO:0051249),-0.3863651094340315,-0.931894260855332,0.5578747628083491,0.7945106603652038,1.0,1/12,3.42%,PAG1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.35055897490631954,-0.9315156932495103,0.541747572815534,0.7949691289917271,1.0,7/17,24.73%,BMP4;VEZF1;ATOH8;SFRP4;FGF2;TMEM100;NKX6-1
prerank,protein depolymerization (GO:0051261),-0.31503673585506237,-0.9314993680628056,0.5741444866920152,0.7945392688560725,1.0,4/27,5.95%,MICAL3;GSN;MICAL2;VPS4B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.34232478627369683,-0.9314342330040877,0.5717017208413002,0.794223559751389,1.0,7/20,18.34%,NFKB1;HM13;NCSTN;ADAM9;MBTPS2;MBTPS1;TRAF6
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2989248496529596,-0.9313719607007129,0.6031434184675835,0.7938919984910505,1.0,17/31,36.85%,UBE2N;BTRC;AXIN1;FBXW7;CDC14B;TOPORS;UBE2S;DCUN1D3;ARRDC4;MAGEC2;FZR1;DCUN1D5;UBE2L3;DCUN1D4;PIN1;GORASP1;SKP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.25682392704078044,-0.9312499631696867,0.5909943714821764,0.793712408693435,1.0,13/70,14.84%,SMAD3;ITGAV;GSK3B;BCL2;PDPK1;HIPK1;BAG3;NGF;TRAF2;IL6R;CASP2;APPL1;DDX3X
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.31662662813364584,-0.930288983601094,0.5538461538461539,0.795574982915862,1.0,8/27,20.63%,NFKB1;BTRC;MAP3K5;MAP3K20;MAP2K7;TNIP2;FBXW11;CUL1
prerank,NAD biosynthetic process (GO:0009435),-0.33625114275279755,-0.9300570877162863,0.5415896487985212,0.7956615013039977,1.0,6/20,14.92%,PTGIS;NMNAT2;PARP10;PARP9;NMNAT3;NMNAT1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.42007962468178806,-0.929989958469644,0.5587703435804702,0.7953376157700128,1.0,3/10,9.06%,FOXC1;NUMA1;MED1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.30630232798666507,-0.9296616523296504,0.5562130177514792,0.7956527648454473,1.0,9/29,29.38%,LDLRAD4;BMP5;IL17RD;VASN;SPRED2;PPP2CA;USF3;SDHAF2;MAD2L2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2954010621442305,-0.9292736269726196,0.5793650793650794,0.7960814205927171,1.0,8/36,10.96%,TRIM44;AXL;PRKN;UBE2K;PARP14;HIF1A;PARP9;MAVS
prerank,regulation of protein dephosphorylation (GO:0035304),0.2821848617357421,0.9291788671479557,0.5920502092050209,0.9199407085625346,1.0,12/37,22.83%,YWHAB;PPP1R16B;SMPD1;CALM1;CALM2;CALM3;MFHAS1;PPIA;CAMTA1;PPP2R5A;PPP1R16A;PPP6R1
prerank,organic substance transport (GO:0071702),0.2372130234906059,0.9290370706847412,0.6303030303030303,0.9193021877775824,1.0,11/121,6.79%,PLTP;LRP1B;ATP8A1;AQP9;RAMP2;ABCG2;MFSD2A;CHKA;SPNS2;MFSD12;SLC6A2
prerank,transcription by RNA polymerase III (GO:0006383),-0.309868797112064,-0.9286747209842734,0.5512367491166078,0.7969971313154968,1.0,16/27,39.92%,TBP;BRF1;SNAPC3;ICE1;GTF3C4;POLR2K;GTF3C1;SNAPC1;POLR3H;GTF3C6;SNAPC5;GTF3A;SNAPC4;POLR2L;SNAPC2;POLR3K
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2203303616336657,-0.9284783507894321,0.6552380952380953,0.7969821558799566,1.0,29/198,10.71%,PLCE1;EPHA7;PI4KA;PLPP3;ENPP1;LRRK2;NUDT4;GK5;TOP1;PLCD3;INPP5B;PAK2;NUDT5;INPP5A;STAT3;ISYNA1;NADK;DUSP16;PFKFB4;MTOR;GFPT1;INPPL1;PLA2G4A;PLCG1;PLCB3;PANK2;PLCD1;ENPP3;LIMD1
prerank,protein-DNA complex disassembly (GO:0032986),0.34692589671766455,0.9283474759769329,0.5418410041841004,0.9202206141749586,1.0,4/16,14.93%,RPL23;SMARCB1;SET;SMARCD1
prerank,pentose-phosphate shunt (GO:0006098),-0.39094183202948546,-0.9282160233769493,0.566003616636528,0.7971096450581666,1.0,6/11,26.14%,DERA;H6PD;PGLS;SHPK;RBKS;RPE
prerank,phosphate ion transmembrane transport (GO:0035435),0.37673045549444123,0.9280796171699761,0.56,0.9199609658194413,1.0,3/12,7.95%,SLC37A4;SLC37A1;SLC25A14
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.37405596579934475,0.9279215195726482,0.5524017467248908,0.9193495038233392,1.0,3/13,13.30%,CSTF2T;CSTF2;CPSF2
prerank,regulation of centrosome cycle (GO:0046605),-0.32689080940625614,-0.9276286617586061,0.5852272727272727,0.7980511907909477,1.0,5/21,10.04%,VPS4B;CHMP4B;MARK4;CHMP5;CHMP3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.23718679728953415,-0.9275982693920749,0.6324110671936759,0.7976466315014377,1.0,45/119,31.06%,PTPN13;PLEKHA2;PI4KA;SMG1;PIGN;SYNJ2;MTMR12;INPPL1;PIP4K2C;TTC7B;EFR3A;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;DPM1;SACM1L;PIK3R4;SOCS7;PIK3CD;INPP5K;ITPKC;PIGH;MPPE1;PIK3R1;FGF2;PIGC;PLEKHA4;PI4K2B;DPM3;PIGA;RAB5A;IP6K2;PLEKHA1;PIGZ;RUFY1;PIGP;PI4KB;PIGF;CISH;SOCS3;PIP5K1C
prerank,motile cilium assembly (GO:0044458),0.37734884890797615,0.9275405699980409,0.5859030837004405,0.9193856492328225,1.0,2/12,10.41%,DNAAF3;BBS5
prerank,extracellular matrix assembly (GO:0085029),0.32509731743884585,0.9272162993559958,0.5501066098081023,0.9192556770569312,1.0,5/23,8.90%,RAMP2;GPM6B;GAS6;NTNG1;NTNG2
prerank,blood vessel diameter maintenance (GO:0097746),-0.29215373017355284,-0.9271821794532097,0.579136690647482,0.7981874872201985,1.0,5/34,7.77%,ROCK2;ROCK1;EDNRA;ADCY6;ECE1
prerank,protein modification process (GO:0036211),-0.2516761128205902,-0.926851874959911,0.5846774193548387,0.798507888727958,1.0,25/76,21.32%,ARAF;ABL1;WWP2;PLOD2;PLAT;UBE2I;PPP4R2;ABL2;GGCX;YES1;PARP1;PARP4;LOX;PRKDC;MANBA;UBL5;FBXO22;UBE2S;UBA7;RPN1;RABGGTB;UBE2D3;B4GALT7;PIGH;AKT2
prerank,regulation of isotype switching (GO:0045191),0.3594171708694165,0.926726234541006,0.5571725571725572,0.9196155628908866,1.0,1/14,0.13%,TFRC
prerank,inner ear morphogenesis (GO:0042472),0.3234148084582233,0.9264365025738445,0.5508474576271186,0.9193872900401848,1.0,2/22,3.56%,PAX8;PAX2
prerank,translational elongation (GO:0006414),0.2395709634203335,0.9264003440944892,0.6298568507157464,0.9184454153753138,1.0,32/101,23.08%,MRPS25;MRPL14;MRPS12;EEF1B2;MRPL49;TUFM;MRPL13;MRPS18A;EEF1D;MRPS7;MRPS14;MRPL45;EEF1A2;MRPL36;MRPL23;EEF1A1;MRPL54;MRPS5;EEF2;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;RACK1;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.27484424627373016,-0.9261868608595304,0.5862745098039216,0.7997164754844821,1.0,9/47,17.41%,PID1;PDGFRB;SLC5A3;TGFBR2;THBS1;PRKCD;AGTR1;CYBA;TLR4
prerank,cAMP biosynthetic process (GO:0006171),-0.4076345977870351,-0.9259301098106553,0.5738007380073801,0.7998971562277929,1.0,4/10,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,axonal transport of mitochondrion (GO:0019896),-0.39481986945981806,-0.9257463485774224,0.5695488721804511,0.7998609865930167,1.0,3/11,10.52%,TRAK1;OPA1;HIF1A
prerank,positive regulation of dendrite development (GO:1900006),-0.40859253697796316,-0.9250875584553656,0.5714285714285714,0.8009563103355838,1.0,3/10,2.52%,PTN;BMP5;BMP7
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.234465085622498,-0.924769473712842,0.6647173489278753,0.8012553107993607,1.0,34/117,26.43%,IGF1;ALDH1A2;PCCA;ME2;HLCS;CYP26B1;ACADSB;ABAT;GNPAT;CPT1C;MCCC2;VDAC1;PANK2;ACSF2;ME1;SLC5A6;PNPLA8;ACOT11;GLO1;PDHA1;ECHDC3;CPT1A;AMACR;MECR;ACSL4;ALDH4A1;ACOT6;SCPEP1;GBA2;GGT5;PPARA;LPL;AASDH;ME3
prerank,engulfment of apoptotic cell (GO:0043652),0.3562954188618307,0.9246064451819173,0.5614406779661016,0.9223415125599799,1.0,4/15,16.20%,ADGRB1;XKR6;MEGF10;XKR4
prerank,protein targeting (GO:0006605),0.23679449266415076,0.9243755136237871,0.6424116424116424,0.9219396656405743,1.0,31/118,19.77%,NLGN1;GDAP1;AQP11;AKAP6;RASSF9;GABARAP;ZDHHC22;AP4B1;GOLGA7;PITRM1;CACNG3;ZDHHC15;TAOK2;HAP1;TIMM22;HACL1;SORL1;TSPO;SRPRA;ZDHHC4;SEC61G;ZDHHC14;HOMER3;VPS37A;RTP4;ARL6;TOMM70;TIMM10B;ZDHHC24;VPS37D;DNAJC19
prerank,second-messenger-mediated signaling (GO:0019932),0.2505846182527442,0.923974616541128,0.6069246435845214,0.9219911476822995,1.0,11/82,8.25%,CHRM3;KSR2;RYR2;MCTP1;NOS3;RCAN2;PPP2R1A;PPP1R9A;ACKR4;NDNF;RCAN3
prerank,regulation of myelination (GO:0031641),0.3165507225445608,0.9227069848301195,0.5766871165644172,0.9244783172917656,1.0,7/25,13.73%,JAM2;TENM4;TMEM98;NSUN5;TPPP;TNFRSF21;PTPRZ1
prerank,sterol biosynthetic process (GO:0016126),-0.29528024752079896,-0.922397111444096,0.5892857142857143,0.8064204939958975,1.0,11/33,23.75%,PRKAG2;INSIG2;ACAA2;HMGCR;SQLE;CYP51A1;SC5D;FDFT1;ARV1;LBR;MVK
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.22095663593025766,-0.9222628247552758,0.6625766871165644,0.8062509208468028,1.0,47/190,19.74%,UACA;ITPR1;CGNL1;DAG1;UBR2;BMP7;WWC2;PRKAA2;VGLL4;DEPTOR;WTIP;MARK3;THBS1;TMEM127;BCL2;LYN;MAPKBP1;UBR1;CCN3;LIMD1;TLE1;WWC1;FNIP1;RORA;RIOK3;PDE3A;PPM1A;STAT1;DUSP1;UBE2B;DDX3X;TRIM39;C1QTNF3;PRDM15;NOP53;NPRL3;PRKAA1;MYADM;PPP2R5C;RHOH;TANK;GPD1L;IFI35;INPP5K;ABCA7;AJUBA;TBC1D7
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2653368180744581,0.9219530632934272,0.6116700201207244,0.9255440781278705,1.0,11/57,12.55%,GRIN1;GRIN2A;SIRT1;GRIN2B;PPM1F;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24566048973630272,-0.9219333048059402,0.5992063492063492,0.8065497929181824,1.0,40/91,34.18%,BTRC;ANAPC5;ANAPC7;ANAPC4;ANAPC16;MN1;PSMF1;ERCC3;FBXW7;PSMB2;CDC26;TRIM39;CDC27;UBE2E1;UBE2S;ANAPC11;CUL1;PSMC1;PSMB6;PSMA3;TFAP4;PSMA4;DBF4;CDC16;ANAPC1;TCIM;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;NEK10;NEK11;MAD2L1;PSME4;BUB1B;DDB1;PSMB8;PSMD10
prerank,positive regulation of programmed cell death (GO:0043068),-0.21122603050507915,-0.9216877078961782,0.7021696252465484,0.8066672549572155,1.0,63/272,18.88%,AKAP13;PAWR;FOXO3;STK3;BMP4;TIAM2;ABL1;LRRK2;ARHGEF17;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;MARK4;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;ERCC3;SOS2;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;FGD4;RBM5;DDX3X;LATS1;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,cellular metal ion homeostasis (GO:0006875),-0.24100022046270198,-0.921683506482113,0.6479400749063671,0.8062117848195947,1.0,16/102,13.63%,ATP1A2;SLC24A3;STIM1;ANK2;ATP13A5;SLC41A1;SLC9A1;TPCN2;KCNJ2;SLC10A7;SLC12A2;DMPK;ATP2A2;ATP2B1;ATP13A3;LETM1
prerank,inositol phosphate catabolic process (GO:0071545),-0.38471363869792274,-0.9215666481055861,0.5656934306569343,0.8059933421478674,1.0,3/12,5.92%,INPP5B;SYNJ2;INPP5A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.25505673147316216,-0.9215554190652299,0.623046875,0.8055506124724222,1.0,10/71,7.80%,ADAMTS12;NGLY1;FBXL17;PRKN;HM13;CTSC;CTSH;VPS4B;DDI2;CHMP4B
prerank,protein localization to chromatin (GO:0071168),-0.345050130337351,-0.9214596055909384,0.5564516129032258,0.8053209974893264,1.0,10/18,37.27%,MCM9;NIPBL;RAD21;PIH1D1;PPHLN1;ESR1;RUVBL2;WAPL;MSH2;MRNIP
prerank,cell junction maintenance (GO:0034331),0.3598399923116627,0.9213671313229449,0.5476718403547672,0.9261099602233717,1.0,5/14,19.82%,CSF1R;F2R;DCTN1;CBLN2;CBLN1
prerank,regulation of cell development (GO:0060284),0.2869586286429664,0.9212088975567219,0.5762376237623762,0.9255191391451758,1.0,11/36,16.99%,HDAC9;RPS19;HEY1;AKT1;FOXO1;PER2;HES6;BHLHE40;DLL1;HES5;CTNNB1
prerank,negative regulation of blood pressure (GO:0045776),0.3663164401711983,0.9211945398379302,0.5446623093681917,0.9245244519334491,1.0,2/13,12.87%,NOS3;BMPR2
prerank,negative regulation of nuclear division (GO:0051784),-0.39400235610128753,-0.9211539451356557,0.5779092702169625,0.8055756225807813,1.0,3/11,9.76%,BMP7;BMP4;TOM1L2
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.19948387891670907,-0.9208544324017264,0.7909270216962525,0.8058285638435807,1.0,86/532,14.35%,COL1A2;GAB2;APPL2;LEPR;NFKB1;IL34;LIMS1;PELI2;ZEB1;UBE2N;BRWD1;FOXC1;GRB10;VIM;IL6ST;IL31RA;FOXO3;GHR;MAP3K3;EDA;JAK1;BTRC;KIT;YAP1;IRAK3;IRS1;LBP;IL15RA;ITGB1;IL13RA1;RAP1B;ANXA2;PAK2;STAT3;SHC1;BCL2;IL16;IFIT2;CAMK2D;ANXA1;IRAK2;TRIM8;TRAF3IP2;F3;MID1;INPPL1;CDC42;CAMK2G;CTR9;TNFRSF11B;SP100;IL17RA;PITPNA;FER;TRAF2;PRKCD;HIF1A;ABL2;SMAD4;GREM2;STX4;CNTFR;RORA;CAPZA1;TRIM5;UGCG;PSMF1;NUMBL;ARF1;RALA;IRF9;HSPA9;MMP2;TEC;TRIM25;IL6R;FN1;APPL1;IRF1;CARD14;LTBR;TYK2;SLC27A1;STAT1;PSMB2;VEGFA
prerank,regulation of endocytic recycling (GO:2001135),-0.3914811419711147,-0.9205633561776287,0.5750452079566004,0.806086066246764,1.0,5/11,28.67%,EHD2;ACTN2;EIPR1;ATP9A;EHD1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3525932789052146,0.9204960374399452,0.5833333333333334,0.925398822574499,1.0,6/17,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.28580454093863283,0.9203741310856921,0.5991820040899796,0.9247337550358948,1.0,9/39,13.02%,SPOCK1;ACER2;AJAP1;NOTCH1;MELTF;NEXMIF;SPRY4;FZD4;ACTN4
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2883739782697206,-0.9199793538828511,0.6003861003861004,0.8070100867591287,1.0,13/36,24.76%,AFDN;KIF13A;RAB10;VAMP5;VAMP2;GGA3;RILPL2;NECTIN3;VAMP4;RILPL1;GGA2;NSF;RAB7A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.33779397472116734,0.9198172785553846,0.5649484536082474,0.9252397057786504,1.0,5/17,16.89%,MIF;SIRT1;RNF34;RFFL;MDM2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3301240347762896,0.9195465704040474,0.58203125,0.9249412568368474,1.0,4/21,10.29%,SLC39A10;PRKCH;GPS2;LPXN
prerank,regulation of amyloid-beta formation (GO:1902003),-0.29651664697517544,-0.9189068573543883,0.5932835820895522,0.8091446636613782,1.0,9/34,19.20%,ROCK2;IGF1;ROCK1;EPHA4;GGA3;APOE;IFNGR1;PICALM;ABCA7
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3634041258601587,-0.9188444667462721,0.5778210116731517,0.8088133726006267,1.0,5/15,25.00%,VPS4B;SDC4;SNF8;RAB7A;SDC1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3139717418335014,0.9188327791477332,0.5656108597285068,0.9258461791656162,1.0,5/24,7.54%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3279400954854813,0.9188194660359918,0.5564853556485355,0.9248647016613513,1.0,3/22,2.63%,KANK3;TMSB4X;TMSB10
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2964887029499943,0.9186994316239738,0.5881104033970276,0.9241856238092999,1.0,6/34,11.13%,FLT1;TEK;FLT3;DAB2IP;PDGFB;PIK3R3
prerank,homeostasis of number of cells (GO:0048872),0.37751462365304767,0.9185971126229374,0.569937369519833,0.9234506729928625,1.0,4/12,10.86%,NOS3;NOTCH1;OCIAD1;F2R
prerank,cardiocyte differentiation (GO:0035051),-0.3952015028348477,-0.9182949919707062,0.5576592082616179,0.8096276462846272,1.0,5/10,21.34%,AKAP13;SIK1;EEF1AKMT4-ECE2;BMP2;GATA6
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3047117262167723,-0.9179934623738785,0.5930902111324377,0.8098752878371308,1.0,19/30,35.06%,RNF169;TRIP12;KLHL15;UBR5;SHLD2;HELB;SMCHD1;HSF1;TWIST1;UBQLN4;OGG1;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP;ERCC6
prerank,phagolysosome assembly (GO:0001845),0.3787073798302869,0.9178673747628825,0.6082251082251082,0.9244548407398792,1.0,2/12,10.67%,SYT7;CORO1A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29008950441179165,0.917735802558197,0.5769230769230769,0.9238148869836752,1.0,7/35,9.89%,SPRY3;RASAL3;STMN1;TGFB2;KCTD13;SPRY4;DAB2IP
prerank,mitotic DNA replication (GO:1902969),-0.3986358335936234,-0.9174208920367647,0.5834862385321101,0.8107916772372161,1.0,7/10,38.60%,MCM6;MCM4;MCMDC2;CDC45;POLA1;GINS1;MCM2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.27702237078121655,0.9172684959752646,0.6321138211382114,0.9240765353665192,1.0,8/42,13.90%,AARS2;VARS1;VARS2;GARS1;RARS1;FARSB;AIMP2;IARS1
prerank,estrogen metabolic process (GO:0008210),-0.361753042502623,-0.9170556545096388,0.5972762645914397,0.8111847984270096,1.0,3/15,10.63%,CYP1B1;SULT1A1;HSD17B11
prerank,peptide hormone secretion (GO:0030072),-0.3069030564629467,-0.9169727622202929,0.5988372093023255,0.8109326760999022,1.0,4/26,8.15%,CYB5R4;CDK16;ANXA1;CAMK2G
prerank,leukocyte tethering or rolling (GO:0050901),-0.34383572061849954,-0.9169432873850805,0.572992700729927,0.810527675403676,1.0,5/17,23.06%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,regulation of phosphorylation (GO:0042325),-0.23195129649252383,-0.9168535116501217,0.6714285714285714,0.8102748445019404,1.0,23/120,12.90%,PRKAG2;EGFR;BMP7;EP300;ROCK1;BMP4;THBS1;RANBP2;NRP1;LYN;NUP42;AR;PLXNB2;FER;ANKLE2;NUP214;HIF1A;FNIP1;TPR;KCTD20;FN1;OGT;FZD7
prerank,neurotrophin signaling pathway (GO:0038179),0.3263858212517058,0.9161742651050468,0.5741127348643006,0.9260036042568873,1.0,7/21,19.55%,MAGI2;NTRK2;HAP1;BCAR1;RAP1A;DDIT4;SORT1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3345979173692696,0.9161583708809626,0.6052631578947368,0.9250338179986415,1.0,4/17,13.73%,AJAP1;CD24;APOLD1;DLL1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3896407131519751,-0.9159527162503658,0.5878003696857671,0.8119360949912695,1.0,6/11,27.38%,GTF2H2;GRK3;ARRB1;ADM;SAG;ADRB2
prerank,regulation of membrane repolarization (GO:0060306),0.3674291004597326,0.915939854068977,0.5856236786469344,0.9246024256953925,1.0,2/13,3.72%,AKAP6;CACNA2D1
prerank,negative regulation of transferase activity (GO:0051348),-0.30218358622789376,-0.9156482483665528,0.6072874493927125,0.8122206648598203,1.0,8/28,20.46%,ABL1;GSK3B;EIF4A2;DTX3L;HNRNPU;INPP5K;PARK7;CDKN1C
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.2521729124495011,-0.9154742792703089,0.6304347826086957,0.812141451132905,1.0,26/70,25.76%,PARVA;ITGAV;LAMC3;RADIL;ARL13B;NRP1;ATRNL1;FER;RHOA;MEF2C;RB1;FN1;RILPL2;ITGA4;TBCD;SIPA1L3;ITGB3;RILPL1;PIK3R1;ANTXR1;LAMC1;LAMB2;ITGA8;DACT2;UNK;EPHB3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.31561748349332586,-0.9153540275222137,0.5879017013232514,0.81195431795967,1.0,14/25,42.81%,DNM1L;FAM162A;BMF;BNIP3;PDCD5;PLAUR;GPER1;PPIF;BCL2L11;PYCARD;BIK;TP53;HRK;PMAIP1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3816769541017583,-0.9152640179796142,0.5841035120147874,0.8116972680914132,1.0,6/11,30.04%,UQCRC1;UQCR10;UQCR11;CYC1;UQCRFS1;CYCS
prerank,positive regulation of embryonic development (GO:0040019),-0.3448897441415473,-0.9150755665044294,0.5896414342629482,0.8116624714207787,1.0,3/19,4.22%,WNT4;OSR1;NIBAN2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.32962065126746853,-0.9148442887799896,0.583984375,0.8117760591309028,1.0,7/21,23.66%,MCU;ANXA6;LETM1;MICU1;SLC8A3;FIS1;SLC8B1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.39487820754804653,0.9148141858943043,0.58004158004158,0.9267468646871899,1.0,3/10,13.04%,HECW1;HECW2;STK39
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3323808099774138,0.9145711350042001,0.5579399141630901,0.9264231118714383,1.0,4/18,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4074323956945647,-0.9143281601914802,0.5788497217068646,0.8120796740307634,1.0,3/10,18.67%,NFAT5;NFATC4;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.4074323956945647,-0.9143281601914802,0.5788497217068646,0.8120796740307634,1.0,3/10,18.67%,NFAT5;NFATC4;NFATC3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.39896225849190126,-0.9140367193126859,0.5905797101449275,0.8123018365052151,1.0,2/10,3.68%,TGFBR2;CD55
prerank,protein complex oligomerization (GO:0051259),0.24565245867252244,0.9137250651082499,0.6412371134020619,0.9276717468940332,1.0,21/85,19.16%,MPP2;ADCY8;KCNC2;AQP11;SNCA;GLRA3;KCNC3;NINJ1;HOMER1;KCNC1;RNF112;BCL10;HGSNAT;MAT2A;ZNHIT6;PNPT1;VSTM5;G3BP2;PDCD6IP;OXA1L;LRRC8A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.35429797540981867,-0.9134839346033826,0.5927272727272728,0.8131232970051273,1.0,10/16,33.93%,KLHL15;SHLD2;HELB;SMCHD1;UBQLN4;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2829874900997428,-0.9132797341697083,0.6147859922178989,0.8131028682011077,1.0,16/40,32.00%,UBE2N;SMG1;ABL1;PRKCD;BCLAF1;RFWD3;WDR76;NEK4;KMT5A;UBE2V2;NSMCE4A;FXR1;CDK9;POLH;PARG;RPA2
prerank,cell chemotaxis (GO:0060326),0.2602953160712126,0.9127878325342409,0.5978947368421053,0.9291274427735806,1.0,9/60,10.23%,LEF1;EPHB1;PLXNB3;CXCL12;DOCK4;PRKCQ;ACKR4;PDGFB;BIN2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.34118747877758415,-0.9125792121107773,0.5782442748091603,0.8143007269089853,1.0,2/17,4.65%,ANK2;SNTA1
prerank,cellular response to interleukin-2 (GO:0071352),-0.3897549469049217,-0.9125749913363744,0.601113172541744,0.8133739684784846,1.0,5/11,24.62%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3897549469049217,-0.9125749913363744,0.601113172541744,0.8133739684784846,1.0,5/11,24.62%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.3942089564989505,-0.9125040490295633,0.5936329588014981,0.8130596483547164,1.0,4/10,17.46%,RIPOR2;WASL;APOD;MIA3
prerank,positive regulation of hormone secretion (GO:0046887),0.34649839942973154,0.9124798969470537,0.5730994152046783,0.9289095087936835,1.0,3/17,9.75%,HCAR2;NMB;GRP
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.31155838257350565,0.9122877423083461,0.5991561181434599,0.9284346765641975,1.0,6/23,15.96%,CYP2E1;HPGD;ACOT7;FADS1;LTA4H;GSTM1
prerank,T-helper cell differentiation (GO:0042093),0.363249282118575,0.911942029183145,0.5828092243186582,0.9283833671879989,1.0,2/14,5.85%,LEF1;TMEM98
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2582654124355105,-0.911769379657718,0.6276595744680851,0.8142554750983182,1.0,30/57,32.28%,FOXN3;NBN;TAOK3;BRCC3;ATF2;BRSK1;RFWD3;RINT1;STK33;PRKDC;CDC14B;TRIM39;NOP53;MRE11;SDE2;CDK2;TAOK1;CDK5RAP3;WAC;CLSPN;DONSON;TIPIN;ABRAXAS1;FZR1;FANCD2;MDC1;NEK11;RPA2;EME2;RAD9A
prerank,Golgi to plasma membrane transport (GO:0006893),-0.27166592653040095,-0.9110891365103395,0.6193293885601578,0.8152909214080808,1.0,9/47,10.91%,KIF13A;CCDC93;ARL3;RAB10;OSBPL5;VAMP5;VAMP2;GGA3;EXOC2
prerank,amide biosynthetic process (GO:0043604),0.27519824946360316,0.9107996502332099,0.5841784989858012,0.9303755491242266,1.0,4/47,3.33%,SGMS1;PCSK1;FA2H;DEGS2
prerank,regulation of interleukin-6 production (GO:0032675),0.24007117300743955,0.9102564231583414,0.6268656716417911,0.9308378785677544,1.0,17/96,15.80%,TIRAP;MBP;IL17F;SYT11;GAS6;TLR2;FOXJ1;CD200R1;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1;MAPKAPK2;POU2F2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.25297546920253805,0.9098212194586838,0.6239316239316239,0.9310028018158315,1.0,11/68,13.68%,TIRAP;MBP;IL17F;TLR2;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.354948621611584,-0.9097194796595508,0.593065693430657,0.8180528754199721,1.0,5/15,15.01%,NTRK3;IL16;F3;VEGFA;VEGFD
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3114255279738013,0.9095952306475014,0.5812133072407045,0.9306349317317875,1.0,7/24,16.70%,DACH1;ACVRL1;TERF2IP;BMPR2;RPS3;CDKN1A;XRCC5
prerank,positive regulation of cell cycle (GO:0045787),-0.25743863906159403,-0.9095892549832618,0.6504854368932039,0.8179233835881092,1.0,16/62,16.74%,EGFR;PKD1;LRP6;ANKRD17;NUPR1;FGFR2;EIF4E;CCNYL1;HCFC1;PKD2;TTL;USP2;CCND3;CDC25B;CCDC57;CITED2
prerank,glycogen catabolic process (GO:0005980),-0.35870076315683874,-0.909177728597363,0.5913200723327305,0.8184269621944606,1.0,6/15,14.94%,PHKB;PYGB;PHKA1;AGL;RB1CC1;PYGM
prerank,positive regulation of isotype switching (GO:0045830),0.34961204103042565,0.9086890162076043,0.5835140997830802,0.9320356096648267,1.0,3/15,13.15%,TFRC;SHLD3;CD40
prerank,positive regulation of transport (GO:0051050),-0.24552988153795008,-0.9086175124413155,0.6447876447876448,0.8192738242235318,1.0,26/85,25.97%,LRP1;DAB2;CAMK1D;NUMA1;GSK3B;GPC3;IL15RA;ANXA2;ANXA1;MERTK;NR1H3;APOE;CYBA;RXRA;DYNC1H1;INPP5K;ABCA7;AKT2;KMT2A;ZNF205;CHP1;HIP1R;SIRPA;KCTD7;CLIP3;FCER1G
prerank,hexose biosynthetic process (GO:0019319),-0.275997248467139,-0.908546854789198,0.6151012891344383,0.8189750895306775,1.0,10/42,17.43%,RBP4;SLC39A14;AKR1B1;PPARGC1A;CHST15;MDH1;PGK1;PCK2;SLC25A11;CRTC2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.32446603730847345,-0.9084594998864062,0.5796545105566219,0.8186794156050515,1.0,11/22,30.58%,BMP7;ROCK1;BMP4;ANKLE2;INPP5K;INHBA;CDKN1C;PRKRIP1;TESK1;CDA;INHA
prerank,positive regulation by host of viral transcription (GO:0043923),0.35979880800982,0.9084499949063445,0.5739514348785872,0.9316682698444109,1.0,2/15,4.32%,LEF1;SMARCB1
prerank,negative regulation of phagocytosis (GO:0050765),0.3403900468254364,0.9083739159353379,0.5765199161425576,0.9308688197187438,1.0,4/17,9.10%,SYT11;TLR2;DYSF;CD300LF
prerank,positive regulation of response to stimulus (GO:0048584),0.2847452126060269,0.9083257245705315,0.628755364806867,0.9300022783479411,1.0,11/40,19.57%,SIRT1;HMGA2;YPEL3;TGFB2;HOMER1;B2M;RSAD2;IER5;CDKN2AIP;ILK;EEF1E1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3117530305842589,-0.907858512518885,0.6014492753623188,0.819651120275728,1.0,3/26,3.96%,ITPR1;ITPR2;IBTK
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.3783511211061237,-0.9076078294008851,0.5772811918063314,0.8197691265448126,1.0,6/12,24.64%,GLUD1;ACO2;ACO1;ASS1;SIRT4;IREB2
prerank,regulation of cellular component organization (GO:0051128),0.22758668915637134,0.9072652598753431,0.6849894291754757,0.9318584259536217,1.0,20/135,10.63%,NRG3;TFRC;SPOCK1;RIT2;RAB4B;OGFR;SEMA4D;PAK5;HIP1;HSPA8;PRKCQ;WFDC1;BBS10;MELTF;RAB4A;SGK3;TAOK2;DAB2IP;NET1;IL17RB
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.30693162133753826,0.9072634142377293,0.6033402922755741,0.9308604355803902,1.0,4/26,6.25%,USP44;LCMT1;UBE2C;HECW2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.24121904836612867,-0.9065560286268448,0.6918604651162791,0.8217175036550425,1.0,23/83,20.86%,CCNH;KHDRBS1;CDK16;CDK7;TFDP2;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;PCNA;CUL1;CDK6
prerank,cellular component disassembly (GO:0022411),0.2612942288132601,0.9062350556510242,0.6319018404907976,0.9326329125673832,1.0,5/53,8.11%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,extracellular matrix disassembly (GO:0022617),0.26094748538161694,0.906203531401632,0.6383838383838384,0.9317208272938586,1.0,5/53,8.11%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.38452236599353684,-0.9060562503052008,0.5906542056074766,0.8223865698729582,1.0,4/11,17.33%,ACTN2;LEPROTL1;LEPROT;PICALM
prerank,regulation of acute inflammatory response (GO:0002673),0.33568995854601485,0.9060227497518776,0.6,0.9312264506541559,1.0,1/18,1.05%,DNASE1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.3113453516531772,-0.9056646753435416,0.5942307692307692,0.8228202191641849,1.0,6/23,20.31%,SLC9A1;SLC12A7;ATP6V0A4;SLC12A2;SLC12A8;SLC12A9
prerank,protein import into peroxisome membrane (GO:0045046),-0.3211627642963851,-0.9055638752621004,0.5898989898989899,0.8225891178447938,1.0,7/22,20.63%,ABCD3;PXMP4;ABCD2;SLC25A17;FIS1;PXMP2;PEX26
prerank,cellular response to osmotic stress (GO:0071470),-0.3190438730512737,-0.9053361712686321,0.5894160583941606,0.8226468639646742,1.0,7/21,22.87%,MYLK;LRRC8D;PKD2;YBX3;DDX3X;CAB39;ZFAND1
prerank,positive regulation of organelle assembly (GO:1902117),-0.27184743626560925,-0.9052456915826699,0.6272189349112426,0.8223978426919037,1.0,16/44,26.39%,ASAP1;NUMA1;RAB3GAP1;STX18;PIP4K2C;MARK4;CNOT2;SDC4;DYNC1H1;CNOT1;LRSAM1;KCTD17;TAPT1;ARHGAP35;SDC1;BBS4
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3587058978607407,-0.9051190773723026,0.5944333996023857,0.8222208298304712,1.0,10/15,35.83%,TSEN2;ERN1;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.33201294798525793,-0.9050936559938547,0.575591985428051,0.8218120535934206,1.0,4/18,17.33%,ROCK2;EPHA4;IFNGR1;PICALM
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.25845868105820163,0.9050636468788302,0.6116910229645094,0.9327936243520246,1.0,20/60,18.94%,PRKCQ;KLF4;HSP90AB1;PDGFB;CCT2;DKC1;CCT4;ATM;PARM1;RFC4;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;RFC2;TCP1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3287077128284883,-0.9046307254527453,0.5899419729206963,0.8224371860869846,1.0,3/19,2.75%,DCN;CCBE1;ROBO1
prerank,regulation of phagocytosis (GO:0050764),0.2597252847662295,0.9044671444994071,0.6350515463917525,0.9334130429441436,1.0,6/53,7.68%,SYT7;SYT11;IL2RG;GAS6;TLR2;DYSF
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.36600280448482014,-0.9043016354995708,0.5904255319148937,0.8227225031861762,1.0,3/13,12.85%,ADHFE1;D2HGDH;DLST
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.29296723119658175,-0.9042610548799345,0.6043307086614174,0.8223485683500049,1.0,6/33,7.95%,TCF7L2;ANGPT1;CAST;NUPR1;YAP1;PDPK1
prerank,positive regulation of growth (GO:0045927),-0.2560095177310399,-0.9042173624980241,0.6428571428571429,0.8219797792968498,1.0,16/64,15.43%,EGFR;TGFBR1;INO80;RPTOR;BCL2;HDGFL2;CDC42;CXCL16;MMP14;USP47;N6AMT1;ADNP2;KLHL22;EXOSC9;DDX3X;CSNK2A1
prerank,negative regulation of nervous system development (GO:0051961),-0.3406926207184121,-0.9040573079709084,0.6022944550669216,0.8218885728348315,1.0,3/17,7.45%,APPL2;PCM1;REST
prerank,organophosphate ester transport (GO:0015748),0.3115644652728613,0.9037467240323139,0.6145374449339207,0.9342433991513693,1.0,8/24,18.19%,PLTP;PITPNM1;PRELID3A;PRELID2;SCARB1;SCP2;MTTP;PITPNB
prerank,positive regulation of heart contraction (GO:0045823),-0.3343703535463838,-0.9025384521962772,0.6041275797373359,0.8249045610986717,1.0,1/19,0.03%,ATP1A2
prerank,regulation of mitochondrial translation (GO:0070129),-0.3280729410691803,-0.9024842515282717,0.5973534971644613,0.8245504474499972,1.0,10/21,31.67%,RCC1L;NSUN3;ALKBH1;MTG2;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,nuclear membrane reassembly (GO:0031468),-0.25883169022785735,-0.9018949008881939,0.6385542168674698,0.8254772158942665,1.0,23/54,35.07%,LMNA;UBXN2B;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.24400070297768947,0.9015774193017622,0.6722689075630253,0.938986229244747,1.0,18/86,16.14%,CHEK1;ATF3;EPAS1;PSMA1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3;KLF2;HIGD1A;PSME3;ATF4;STOX1;PSMC3;PSMA2
prerank,cytosolic calcium ion transport (GO:0060401),0.30023168175118253,0.9015090761413579,0.618,0.9381858328089107,1.0,7/28,11.22%,RYR2;CACNA2D1;SLC8A1;ATP2B3;SLC25A23;ADRA1A;JPH3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3625128545701421,-0.9011350706413519,0.5980952380952381,0.8267016856716671,1.0,3/13,10.61%,RBPJ;TGFBR2;SMAD4
prerank,negative regulation of receptor internalization (GO:0002091),0.37331592479746323,0.9005274076748019,0.6063157894736843,0.939800204656701,1.0,1/12,1.67%,NECAB2
prerank,positive regulation of heart rate (GO:0010460),0.34059038346954423,0.9004685546265538,0.593607305936073,0.9389444516654701,1.0,6/17,16.31%,ADRB1;RYR2;ADRA1D;ADRA1A;PDE4D;EDN1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29598529890300174,-0.9002991564165315,0.6181474480151229,0.8281298803633561,1.0,8/29,20.26%,WWOX;THBS1;PAK2;TRAF2;LTBR;INHBA;PPP2R1B;PML
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2820492576532439,-0.9002730303118321,0.6377358490566037,0.8277317348235526,1.0,9/38,16.99%,BMP5;CFLAR;GSK3B;THBS1;SP100;TRAF2;STX4;DDX3X;SERPINE1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3271452196721386,-0.9001612451378846,0.5962264150943396,0.827537566820013,1.0,9/19,24.62%,ZMIZ1;AXL;ZBTB1;MMP14;PRKDC;RHOH;PPP2R3C;XRCC6;SYK
prerank,retinal metabolic process (GO:0042574),0.3724568374197874,0.9000990376972581,0.5949895615866388,0.9388906484335603,1.0,2/12,5.75%,BCO1;DHRS13
prerank,protein O-linked glycosylation (GO:0006493),0.23763163399717574,0.8999806009551093,0.670020120724346,0.938208416819313,1.0,16/96,13.34%,TMTC2;GALNT9;GALNT15;GALNT13;MGAT5B;EOGT;GALNT14;GALNT6;SLC35C1;PLOD3;GALNT3;ST8SIA6;GALNTL6;B3GNT2;GALNT2;POMGNT2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.34362256051898593,-0.8997011331333283,0.5824847250509165,0.8281116272402311,1.0,3/18,7.60%,FCHSD2;ERC1;TBC1D24
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31781545997985156,0.8996710729740599,0.6057494866529775,0.9380342815475449,1.0,6/22,16.15%,IPO5;CAMK2N1;MEN1;APC;CDKN1A;CDKN1B
prerank,positive regulation of endocytosis (GO:0045807),-0.2694255943175282,-0.8995378017973535,0.6435452793834296,0.8280456174118164,1.0,8/45,9.23%,LRP1;APPL2;AXL;DAB2;VTN;GPC3;CDC42;HNRNPK
prerank,regulation of transposition (GO:0010528),-0.36996087401496364,-0.899230294948432,0.6095617529880478,0.8282827855163533,1.0,2/13,16.92%,UBR2;MYBL1
prerank,organelle transport along microtubule (GO:0072384),-0.2969541691303066,-0.8992002419902956,0.6247544204322201,0.8278870117169982,1.0,9/31,18.60%,TRAK1;ARHGAP21;CDC42;NDEL1;RHOT1;COPG2;FBXW11;TMEM201;COPG1
prerank,atrioventricular valve development (GO:0003171),-0.35725264389526423,-0.8990955996012695,0.6134122287968442,0.8276799044951699,1.0,3/14,3.24%,BMPR1A;MDM4;TGFBR2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.32314478885254516,-0.899053219072739,0.6133828996282528,0.8273230713170142,1.0,10/20,31.29%,BCL2;CAMK2D;ATP2A2;FIS1;PML;KCTD17;WFS1;CCDC47;BAK1;HERPUD1
prerank,positive regulation of lipid transport (GO:0032370),-0.38721005414693055,-0.8983800779665813,0.6015325670498084,0.8284406232488897,1.0,3/12,20.21%,LRP1;APOE;SPP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3156922227479764,0.8977340019798844,0.6141078838174274,0.9410609513292442,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3156922227479764,0.8977340019798844,0.6141078838174274,0.9410609513292442,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,piRNA metabolic process (GO:0034587),0.3302660736716511,0.8976508716125993,0.5908141962421712,0.9402851368259885,1.0,3/19,19.07%,TDRD12;PIWIL2;TDRKH
prerank,negative regulation of cytokine production (GO:0001818),0.220948168703839,0.897566718781433,0.7245762711864406,0.9395167901448944,1.0,19/163,11.19%,CD33;LEF1;NAV3;HDAC9;TMSB4X;SYT11;GAS6;ISG15;IL12A;RPS6KA5;NPTN;KLF4;GPNMB;CD34;FOXJ1;CD200R1;HOMER2;PPP1R11;TNFRSF21
prerank,regulation of biomineral tissue development (GO:0070167),-0.3055389927643192,-0.897373990908793,0.6227897838899804,0.8301915260094301,1.0,4/26,8.44%,ROCK2;ROCK1;ENPP1;NBR1
prerank,regulation of organelle organization (GO:0033043),-0.24203143671785454,-0.8973368964002109,0.6843137254901961,0.8298031431069063,1.0,28/80,25.15%,DIAPH1;EP300;PRKN;DNM1L;PAK2;STX18;ZEB2;CLIC4;USP6NL;RHOT1;MAVS;STX5;ARMH3;SURF4;EHD3;AKAP9;PLXNB1;TAOK1;FIS1;SPEF1;MSN;PARL;F11R;LMAN1;RHOT2;PREB;SAR1B;NEXN
prerank,replication fork processing (GO:0031297),-0.28237127140507073,-0.8973049927301943,0.6459510357815442,0.8294111868872711,1.0,18/38,35.64%,WRN;RFWD3;FANCM;BRCA2;BOD1L1;MRE11;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;ATRX;CDK9;SAMHD1;EME2;RAD51;CENPX;GEN1
prerank,lysosome localization (GO:0032418),-0.2771731724460089,-0.8969733759075332,0.642578125,0.8297199654596785,1.0,18/37,41.58%,TFEB;KIT;NDEL1;SYTL4;PIK3CD;PLEKHM2;SPAG9;KIF5B;S100A13;KLC2;MYH9;RAB34;SNAPIN;MILR1;BORCS6;PIK3CG;HPS6;ARL8B
prerank,carbohydrate catabolic process (GO:0016052),0.2776035261435889,0.8968791761497591,0.6115702479338843,0.9403509700234363,1.0,12/38,21.41%,PGAM4;PGAM1;NEU2;ALDOC;GCK;PFKFB2;GAPDHS;NEU1;LDHA;ENO2;NEU4;GPI
prerank,positive regulation of protein transport (GO:0051222),0.247578844960759,0.8962357187078827,0.6617021276595745,0.941047975967085,1.0,6/67,5.82%,CD33;PRR5L;TENM1;APBB1;APBB3;TGFB2
prerank,response to tumor necrosis factor (GO:0034612),-0.23620757680036242,-0.8960790047963635,0.6607142857142857,0.8313401378054417,1.0,17/91,18.78%,PID1;ADAMTS12;ZFAND6;AFF3;GSDME;DHX9;NUB1;CXCL16;ADAM9;YBX3;GBP3;MAP2K7;GBP2;NPNT;TANK;INPP5K;SMPD4
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3806497339698973,-0.8959525603053077,0.6194029850746269,0.8311647027754349,1.0,3/12,12.11%,GSN;TRIM5;TRIM11
prerank,base-excision repair (GO:0006284),0.2664037316224645,0.8958604859612825,0.6523517382413088,0.9410339607031757,1.0,13/48,18.89%,HMGA2;LIG3;RPA3;UNG;APEX1;POLG;POLD1;PRMT6;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3546571273271636,-0.8957409152435316,0.6219739292364991,0.8311747414629455,1.0,3/14,10.27%,MEOX2;THBS1;RHOA
prerank,rRNA 3'-end processing (GO:0031125),-0.3880016747470868,-0.8955653317590233,0.6014760147601476,0.8310981765207625,1.0,4/10,15.97%,ERI3;ERI2;EXOSC9;EXOSC10
prerank,histone exchange (GO:0043486),-0.27933031951365966,-0.8951323556443205,0.6470588235294118,0.831589559797612,1.0,21/37,40.10%,RNF8;HJURP;SPTY2D1;CENPP;ANP32E;NASP;ITGB3BP;CENPT;ACTR6;DMAP1;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.35213080808286257,0.8949504273242253,0.5974025974025974,0.9424392437358684,1.0,1/14,0.13%,TFRC
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.381441999671707,-0.8945347727353675,0.6019417475728155,0.8325028950214111,1.0,2/12,1.57%,ADAMTS12;DCN
prerank,peptidyl-arginine modification (GO:0018195),0.3448140279246851,0.8943991481281554,0.5991091314031181,0.9428983194534805,1.0,3/15,12.85%,NDUFAF5;PRMT7;ART3
prerank,pre-replicative complex assembly (GO:0036388),0.2509190826645129,0.8940548165875126,0.6645435244161358,0.942807950370223,1.0,14/64,19.98%,PSMA1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;MCM3;PSME3;PSMC3;PSMA2;PSMB7;ORC6;MCM8
prerank,manganese ion transport (GO:0006828),0.35301134577668203,0.8940492162714351,0.603411513859275,0.9418359995222751,1.0,3/14,11.89%,TRPC5;SLC39A8;TRPC1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.24283277432502293,0.8937475900559975,0.6599597585513078,0.9416569499888827,1.0,13/75,11.24%,PRKAR2B;IPO5;SPRY3;SIRT1;SLC8A1;PTPRJ;AKT1;SPRY4;DAB2IP;UCHL1;MEN1;SMPD1;APC
prerank,protein localization to lysosome (GO:0061462),0.3014287281240238,0.893638846832736,0.6102783725910065,0.9409653295896149,1.0,13/28,23.56%,SCARB2;NCOA4;GLMP;SORL1;RTN4;M6PR;AP3M1;HGS;VPS4A;SNX16;LMBRD1;SH3BP4;GCC2
prerank,innate immune response (GO:0045087),0.21227882561747913,0.8932112995308055,0.7468879668049793,0.9410833128603663,1.0,33/217,16.08%,MASP2;PGLYRP1;MBL2;TRIM13;PPARG;SNCA;ISG15;CAPZA2;TRIM43;SRMS;TRIM62;TLR2;TRIM6;IFITM3;TRIM59;SLPI;CYBC1;CORO1A;SMPD1;MID2;BCL10;IRF7;PJA2;CD40;DEFA6;LCN2;TRIM35;POLR3A;MFHAS1;B2M;GCH1;OTULIN;RNASE3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.23380866230542274,-0.8927769333601142,0.708502024291498,0.8359494633782779,1.0,29/95,22.92%,PCM1;ALMS1;ODF2;NINL;CEP63;CEP135;CENPJ;CEP162;PCNT;MARK4;CSNK1E;RAB3IP;RAB11A;CC2D2A;C2CD3;MAPRE1;YWHAE;AKAP9;DYNC1H1;CEP76;TCTN1;PRKACA;CEP57;CSNK1D;CEP89;NPHP1;HAUS7;HAUS8;ACTR1A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3413593475291115,0.8927560987856047,0.6331877729257642,0.9412685313238947,1.0,3/16,7.29%,PPP1R16B;IL12A;APLNR
prerank,apoptotic process (GO:0006915),-0.21081822339109005,-0.8926401936550608,0.7888446215139442,0.8357873351943147,1.0,41/203,17.28%,NOTCH2;PAWR;RNF152;CFLAR;STK3;EP300;CYFIP2;TGFBR2;PLSCR1;ZBTB16;BCL2;IFIT2;MTOR;FAM162A;AIFM1;VDAC1;CASP12;TNFAIP1;EGLN3;MAGI3;PRKCD;DMPK;CDK11B;AKAP1;BCLAF1;NCKAP1;PARP1;FAP;ERCC3;OGT;CASP2;IRF1;RFK;DAPK1;DAP;IAPP;GLRX2;ARHGEF6;PDCD4;DAPK2;BCL2L13
prerank,positive regulation of T cell proliferation (GO:0042102),-0.25708175968449065,-0.8922502805319493,0.6336448598130842,0.8362026147872672,1.0,6/55,8.58%,IGF1;IGFBP2;IL6ST;HMGB1;ANXA1;IGF2
prerank,B cell homeostasis (GO:0001782),-0.38932993913889746,-0.8921093536709717,0.6162570888468809,0.8360816863208649,1.0,3/10,11.67%,DOCK11;LYN;MEF2C
prerank,microtubule polymerization (GO:0046785),-0.29821058907993814,-0.892010274636063,0.6075697211155379,0.8358388072517222,1.0,10/29,19.55%,CENPJ;TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;MAP7D3;TUBGCP4
prerank,gastrulation (GO:0007369),-0.34296198264860955,-0.8919934155364375,0.6231343283582089,0.8354098564435497,1.0,2/15,5.30%,GPC3;SMAD2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.31955217839281347,0.8915839136797832,0.6111111111111112,0.9434403529167144,1.0,5/21,12.85%,PDE2A;NUDT3;HPRT1;PDE4D;HINT1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.26751648908769543,0.8912974842543473,0.670061099796334,0.9431924017010553,1.0,12/48,13.89%,HDAC9;TMSB4X;SIRT1;KDR;NOS3;ETS1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;CIB1
prerank,cholesterol metabolic process (GO:0008203),-0.24643868383440734,-0.8909393112381034,0.6923076923076923,0.8372632948669658,1.0,23/68,31.09%,ABCA1;CYP27A1;SOAT1;INSIG2;OSBPL5;ACAA2;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;FDFT1;ARV1;LBR;MVK;GBA2;SCAP;CLN8;MT3;TSKU;ANGPTL3;CLN6
prerank,sulfur compound transport (GO:0072348),-0.3007856129131369,-0.8908804125394851,0.6294896030245747,0.8369439884212261,1.0,8/27,18.62%,SLC6A13;SLC13A4;SLC26A7;LRRC8D;SLC5A6;SLC27A1;SLC25A11;MGST1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.28228879953608815,-0.8906252635466926,0.6299212598425197,0.8370712469385791,1.0,10/36,20.74%,GULP1;GSN;THBS1;VAMP7;CDC42;RHOBTB2;DOCK1;RHOBTB1;RHOH;ARHGAP12
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2953119873770597,-0.8905334423378807,0.6697761194029851,0.8363492610253938,1.0,7/29,23.24%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2953119873770597,-0.8905334423378807,0.6697761194029851,0.8363492610253938,1.0,7/29,23.24%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.25357487665343326,-0.8904132108642946,0.6653919694072657,0.8361474917826184,1.0,8/55,13.50%,PID1;PDGFRB;PRKN;TGFBR2;THBS1;CYP1B1;AGTR1;SIRT5
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33309850748331765,-0.8903416623321749,0.60727969348659,0.8358442180490354,1.0,8/18,22.21%,MAP3K3;RHOJ;FOXC2;ANXA1;VEGFA;FGFBP1;FGF2;SRPX2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3892357952657496,-0.8900839201849324,0.6240157480314961,0.8359274990890638,1.0,5/10,21.02%,PIBF1;PTPN2;PARP14;NF2;PPP2CA
prerank,response to nitric oxide (GO:0071731),0.36122628517795896,0.8896129352037222,0.6030368763557483,0.9464061359299674,1.0,4/13,20.51%,KCNC2;FOXO1;EGLN1;CCL19
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28624892401447427,0.8894598869112779,0.6444444444444445,0.9458187906744905,1.0,5/33,7.97%,TFRC;OMA1;GPX1;CLU;AKT1
prerank,iron ion transmembrane transport (GO:0034755),0.38672522931343944,0.8891435290129204,0.6082004555808656,0.94562235392431,1.0,3/10,10.65%,SLC40A1;SLC25A37;SLC39A8
prerank,vesicle organization (GO:0016050),0.2636554707086725,0.8889173600737417,0.6387096774193548,0.9452145095266035,1.0,14/46,21.05%,CAV2;HOOK1;FNBP1L;CD34;AKTIP;SAR1A;CORO1A;CHMP2B;USP8;DNM1;SORT1;PI4K2A;DNAJC13;SNX11
prerank,O-glycan processing (GO:0016266),0.26042424768258776,0.8888362419588424,0.6611570247933884,0.9444317039067004,1.0,5/54,5.33%,GALNT9;GALNT15;GALNT13;GALNT14;GALNT6
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.26979961540473213,0.8887789788644933,0.681917211328976,0.9435991047473283,1.0,5/41,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.26093251079041946,0.887990962235194,0.687374749498998,0.9445895673600536,1.0,11/54,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;COPS9;ISG15;AKT1;RPL5;PER2;SMAD7;RPS3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2413517782078134,-0.8872933450259906,0.7054409005628518,0.8416787092763405,1.0,21/73,20.46%,EGFR;NTRK3;ARAF;RPTOR;TBK1;DOCK7;CREBL2;AXIN1;BRAF;RAPGEF3;NGF;FNIP1;TXN;VEGFA;LATS1;AKAP9;PRKD1;PARK7;MTCP1;EIF4G1;NOS1
prerank,quinone biosynthetic process (GO:1901663),0.3498861929515435,0.8872151277778632,0.5970464135021097,0.9456024145858949,1.0,2/14,5.43%,COQ2;COQ7
prerank,acute inflammatory response (GO:0002526),-0.3054026895634031,-0.887023198172161,0.634469696969697,0.8417923098798653,1.0,4/23,12.72%,LBP;PLSCR1;F3;IL6R
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.35335755740898067,-0.8869799254093119,0.6055776892430279,0.8414140881526315,1.0,5/15,14.16%,LDLR;NR1H3;SIK1;FBXW7;SLC27A1
prerank,response to ionizing radiation (GO:0010212),-0.24244837975618688,-0.88682364545781,0.7104166666666667,0.8413149339090444,1.0,23/70,26.91%,EYA1;INO80;SPIDR;ANXA1;BRCC3;RNF8;CLK2;BRSK1;RFWD3;XRCC4;NABP2;PRKAA1;TANK;DCUN1D3;COP1;BRAT1;USP28;PAXIP1;EYA3;MAPK14;TNKS1BP1;IKBIP;ABRAXAS1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.33605425091046065,0.8862717626477394,0.5836653386454184,0.9470028819375039,1.0,15/15,66.43%,KYAT1;KYNU;GSTZ1;TAT;QDPR;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;FAH;IL4I1;HGD;KMO
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.37180498878186075,-0.8860217445318375,0.6318785578747628,0.8426393162560877,1.0,4/13,19.76%,NFAT5;RHOA;TRAF6;IRAK1
prerank,regulation of cytokine production (GO:0001817),0.22275959661273992,0.8855636551847379,0.7382978723404255,0.9478770432370041,1.0,12/126,9.29%,CADM1;IL17F;HDAC9;MIF;BTNL9;SYT11;ISG15;MOG;RPS6KA5;NPTN;GPNMB;TRIL
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2749243764557643,-0.8849969489782256,0.6878612716763006,0.8444268025804129,1.0,7/40,14.16%,SLC7A11;SLC13A3;ABCC5;SLC38A11;SLC5A6;SLC38A6;SLC27A1
prerank,isotype switching (GO:0045190),-0.3869661053689162,-0.884719333312502,0.625,0.8445556762840541,1.0,6/10,37.26%,RNF8;MSH6;EXOSC3;BATF;LIG4;MSH2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3882755409170927,0.8844625776266267,0.6321353065539113,0.9496839210379688,1.0,2/10,7.00%,PPM1F;TERF1
prerank,maturation of LSU-rRNA (GO:0000470),0.29326511762634383,0.8838078946889052,0.6297872340425532,0.9503483167035394,1.0,8/26,16.17%,RPF2;RPL7;RPL10A;RPL7A;NHP2;NOP2;ZNHIT6;DDX18
prerank,secondary alcohol biosynthetic process (GO:1902653),0.28975486850439613,0.8834655046984657,0.649402390438247,0.9502351272418245,1.0,12/30,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.31447230759486994,0.8832015874446871,0.6175824175824176,0.9499424801415921,1.0,4/20,10.07%,AMPD1;GART;HPRT1;GMPR2
prerank,regulation of T cell proliferation (GO:0042129),0.24991697666522436,0.882730383637873,0.6886993603411514,0.9501727797015903,1.0,5/61,11.19%,TFRC;SLC7A1;GPNMB;AIF1;TNFRSF21
prerank,negative regulation of calcium ion transport (GO:0051926),0.33805594651759957,0.882484247376329,0.6328600405679513,0.9498121376383842,1.0,3/15,7.73%,CD33;SLC30A1;EPO
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.23224132904853012,0.8824606862668513,0.7347368421052631,0.9488978751942843,1.0,19/94,16.23%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;NOD1;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP
prerank,negative regulation of insulin secretion (GO:0046676),-0.33414854165060465,-0.8823488669600315,0.6408839779005525,0.8494084049076018,1.0,7/17,22.36%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,cardiac ventricle development (GO:0003231),0.31722929666159627,0.8821066845133456,0.6556701030927835,0.9487980350164333,1.0,3/20,5.70%,HEY1;PDE2A;NOTCH1
prerank,protein acylation (GO:0043543),-0.2771581504154404,-0.8820251067349818,0.6487523992322457,0.8496710393479486,1.0,14/38,28.19%,KAT2B;EP300;CREBBP;GLUL;ZDHHC13;ING5;GTF2B;ZDHHC1;ZDHHC16;HHAT;SPHK1;ZDHHC8;NAT10;NAA80
prerank,regulation of necroptotic process (GO:0060544),-0.30840570542289236,-0.8815263840567226,0.659217877094972,0.8502938445570227,1.0,4/23,12.86%,CFLAR;FLOT2;YBX3;OGT
prerank,axonemal dynein complex assembly (GO:0070286),0.29788240180977693,0.8813576955354862,0.6611226611226612,0.9497162699541754,1.0,4/28,10.03%,DNAAF3;LRRC49;CFAP100;DNAAF2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.26411540176831166,0.8811981149264808,0.6884531590413944,0.9491451915602723,1.0,5/43,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2296696426902723,-0.8808861551297427,0.7274436090225563,0.8512302918672568,1.0,35/109,29.10%,GAB2;NFKB1;BTRC;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,anterograde axonal transport (GO:0008089),0.2759089597779035,0.8805396457157509,0.665929203539823,0.9498538606786773,1.0,5/37,10.81%,DLG2;KIF1A;AP3B2;HSPB1;HAP1
prerank,histone H4 acetylation (GO:0043967),-0.26407347202771636,-0.8805202631749595,0.6698292220113852,0.8515669163122084,1.0,17/47,21.36%,EP300;TRRAP;ZZZ3;HAT1;ATF2;KANSL2;TADA3;HCFC1;OGT;KAT8;ING5;BRCA2;MSL2;EPC1;MSL3;KANSL3;KMT2A
prerank,response to lipopolysaccharide (GO:0032496),0.22169838597158278,0.8804206293648886,0.7599243856332704,0.9491842572444914,1.0,26/138,15.14%,PDE4B;TIRAP;GIT1;S100A9;S100A8;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;CCL2;DAB2IP;SLPI;GGT7;F2R;BCL10;GGT1;MAPK8;SCARB1;DEFA6;XBP1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22688005436889996,-0.8802558696775067,0.7348484848484849,0.8516639160567095,1.0,38/104,27.80%,LRP6;KSR1;ABL1;CCNT2;UVRAG;CCNH;RPTOR;CCNT1;CDK7;MAP2K1;CCNK;MNAT1;RHOA;TELO2;RB1;TRIB2;SLC27A1;CCND3;DDX3X;CNPPD1;SYAP1;SLC8A3;MTCP1;SNF8;CAB39;PPP2CA;PIH1D1;CDK5RAP3;EZH2;GTF2H1;BCCIP;CCNE2;CCNJ;IRGM;INCENP;ADRB2;TESK1;CAMK1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3311914064134532,0.8802419815637015,0.6483050847457628,0.9486571691233098,1.0,7/18,16.78%,TENM4;NOTCH1;TMEM98;OPALIN;TNFRSF21;PTPRZ1;HES5
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3609427110097268,0.880165658080997,0.6186252771618626,0.9478827871056787,1.0,3/12,3.94%,RYR2;CTNNA3;BIN1
prerank,regulation of T cell cytokine production (GO:0002724),-0.345612127853422,-0.880075424601749,0.6264367816091954,0.851572130762326,1.0,4/15,18.34%,CD55;TRAF2;TRPM4;TRAF6
prerank,sarcomere organization (GO:0045214),0.29902955298465556,0.8799430091474608,0.6258064516129033,0.9474749465767477,1.0,4/27,9.53%,MYH6;FHOD3;WDR1;TCAP
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.34639239768436575,0.8798192837062899,0.6449438202247191,0.9468216712535831,1.0,8/15,26.13%,NME2;ENTPD3;AK5;ENTPD1;ENTPD5;ENTPD7;AK4;ENTPD2
prerank,mammary gland development (GO:0030879),0.3147191834480955,0.8792080182690096,0.6539325842696629,0.9474445163803219,1.0,3/21,6.61%,ERBB4;NRG1;WNT7B
prerank,ubiquinone metabolic process (GO:0006743),0.33915305000317186,0.878335947608821,0.6329113924050633,0.9485664044588432,1.0,2/15,5.43%,COQ2;COQ7
prerank,ubiquinone biosynthetic process (GO:0006744),0.34226591504294035,0.8780977702441383,0.6276595744680851,0.9481674944563614,1.0,2/15,5.43%,COQ2;COQ7
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2862466593729235,-0.877754325362129,0.6356435643564357,0.8561483365635564,1.0,12/34,19.24%,PTPN13;TNS2;PTPN9;PTPRS;DUSP16;PTPN22;PTPN12;PTPN2;DUSP1;DUSP10;PTPN1;PTPN11
prerank,histone H4-K5 acetylation (GO:0043981),-0.3420442653462362,-0.8775538590898758,0.6213768115942029,0.855654056796452,1.0,6/15,23.96%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),-0.3420442653462362,-0.8775538590898758,0.6213768115942029,0.855654056796452,1.0,6/15,23.96%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3711799643766653,-0.8772830056934571,0.642578125,0.855761627996961,1.0,2/11,6.93%,RC3H1;LYN
prerank,negative regulation of anoikis (GO:2000811),-0.36086700110071324,-0.8771146033679805,0.6193181818181818,0.8556613186981273,1.0,4/14,15.35%,ITGB1;BCL2;TLE1;ITGA5
prerank,regulation of myotube differentiation (GO:0010830),-0.30405406819066605,-0.8769919161584135,0.6342857142857142,0.8554507646309679,1.0,13/24,28.16%,HDAC4;CCN3;MMP14;DMPK;SIK1;BHLHE41;MAML1;HDAC1;FBXO22;TMEM119;MAPK14;HDAC3;SMYD1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3740825242223275,0.8769709636393077,0.6225165562913907,0.9500404988354395,1.0,5/10,22.93%,MFSD2A;DNAJC19;ABCA3;MTMR9;MTMR2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2662446448945291,0.8766830687361685,0.6615720524017468,0.9497896673511764,1.0,8/42,19.26%,RPS19;ADGRB1;RPL30;DROSHA;DEFA6;RNASE3;OPTN;CHGA
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3221484791777421,0.8764683805473278,0.6147368421052631,0.9493875517189947,1.0,3/18,9.00%,FLT1;PPARG;CCL2
prerank,positive regulation of protein depolymerization (GO:1901881),0.36655895516879333,0.8762749503865651,0.6453608247422681,0.9489267033408392,1.0,2/11,8.71%,WDR1;STMN2
prerank,regulation of viral entry into host cell (GO:0046596),0.28740592850236496,0.8762432651826976,0.6487068965517241,0.9480337432784801,1.0,7/30,14.35%,HS3ST5;TRIM62;TRIM6;IFITM3;TMPRSS4;MID2;LY6E
prerank,glucan catabolic process (GO:0009251),0.3412977099960791,0.8761432511283465,0.6195899772209568,0.9473422434046865,1.0,2/15,1.96%,PHKG1;PGM2L1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3251041887887426,-0.8759515253677744,0.6329113924050633,0.857244661645909,1.0,7/18,22.36%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.281411877948856,0.8756088544738106,0.6887966804979253,0.9477127691180783,1.0,9/33,17.04%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23270116414773348,-0.8751346218602469,0.7247191011235955,0.858548047691676,1.0,40/88,37.06%,FBXL7;FBXL17;BTRC;FBXL4;FBXL12;PSMF1;FBXL18;AMN1;FBXW7;PSMB2;FBXO38;CUL2;FBXW11;FBXW5;CUL1;PSMC1;FBXW4;PSMB6;PSMA3;PSMA4;FBXL14;FBXO4;PSME1;PSMD13;PSMB10;PSMA5;FBXL3;PSMB9;RBX1;FBXL8;FBXO9;CCNF;PSME4;FBXL13;PSMB8;PSMD10;CUL5;FBXL6;SKP1;PSMD3
prerank,endocytic recycling (GO:0032456),-0.25802236826347413,-0.875114047015653,0.6824196597353497,0.8581341688420624,1.0,21/50,36.04%,CCDC93;ANKRD50;VPS26C;EHD2;VPS39;ANKRD27;ACAP2;EHD3;EIPR1;EHD4;SNF8;PTPN23;SNX12;RAB7A;ARL4C;EHD1;ARF6;DENND1B;STX6;MICALL1;CCDC22
prerank,regulation of cellular response to heat (GO:1900034),0.23925478125313057,0.8750576881776646,0.742393509127789,0.9480872951505412,1.0,27/77,22.09%,CAMK2A;SIRT1;NUP210;HSPA8;RPA3;HSP90AB1;CD34;NUP62;NUP205;ATM;MAPKAPK2;NUP54;FKBP4;PTGES3;CHORDC1;HSP90AA1;MLST8;IER5;MAPK3;NUP85;BAG2;CRYAB;BAG1;RAE1;AKT1S1;NUP107;DNAJC2
prerank,regulation of immune response (GO:0050776),0.21825958196180728,0.8739778544435199,0.76,0.9498047430709408,1.0,12/135,9.54%,CD33;LRP8;TIRAP;KLRC1;SPPL2B;SLA2;TGFB2;CD34;LAIR1;ICAM2;CD300LF;CD200R1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.37257431880129344,-0.8737229677863411,0.6642599277978339,0.8606996738654784,1.0,3/11,11.02%,DHX9;SAFB2;CDK11B
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.3295376733158396,-0.8736989407727904,0.6304761904761905,0.8602889803966309,1.0,2/17,4.65%,ANK2;SNTA1
prerank,glutathione metabolic process (GO:0006749),0.26739232025508336,0.8735853082336752,0.685370741482966,0.9497842198951093,1.0,6/38,11.62%,GSTA4;GPX1;GSTM5;GGT7;NAT8;GGT1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2894517853461558,-0.8734382440303686,0.6673114119922631,0.860411129723786,1.0,3/29,6.61%,TGFBR3;TPM1;FGFR2
prerank,membrane protein proteolysis (GO:0033619),-0.2732506822257228,-0.8734285399781938,0.6733466933867736,0.8599613605760785,1.0,12/37,20.19%,DAG1;NFKB1;HM13;CTSH;NCSTN;ADAM9;MBTPS2;ADAM19;MBTPS1;CLPP;TRAF6;SPPL3
prerank,mitochondrion transport along microtubule (GO:0047497),0.349808194662718,0.8724596616252605,0.6389496717724289,0.9515588104990255,1.0,2/13,8.04%,SYBU;UBB
prerank,glutathione derivative biosynthetic process (GO:1901687),0.31428533861985053,0.8722635707681828,0.6505263157894737,0.9501202176545935,1.0,5/20,19.26%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,glutathione derivative metabolic process (GO:1901685),0.31428533861985053,0.8722635707681828,0.6505263157894737,0.9501202176545935,1.0,5/20,19.26%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,positive regulation of transporter activity (GO:0032411),-0.36034434565122575,-0.8719495670819247,0.6556169429097606,0.8626594148722422,1.0,10/13,47.42%,NR1H3;RXRA;KMT2A;KCTD7;TRPC6;SGK1;SYNGR3;SGK2;PDZK1;WNK3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.23441309746760888,-0.8717752911058698,0.7358490566037735,0.8625786410127155,1.0,15/78,15.71%,NR2F2;EGFR;PKD1;CCNT2;CCNH;CCNT1;CDK7;CCNK;MNAT1;CCNYL1;PKD2;CDK5RAP1;CCND3;LATS1;CNPPD1
prerank,cochlea morphogenesis (GO:0090103),0.37946656223456815,0.8715128104320387,0.6265560165975104,0.9510198553349282,1.0,1/10,3.56%,PAX2
prerank,positive regulation of innate immune response (GO:0045089),-0.2881360421106348,-0.8711794646139838,0.6862745098039216,0.863390927003311,1.0,8/30,18.61%,LBP;PLSCR1;DHX9;UBE2K;MAVS;RIOK3;WNT5A;IFI35
prerank,negative regulation of platelet activation (GO:0010544),-0.33316701182129643,-0.8710379020890248,0.624765478424015,0.8631969032461698,1.0,4/16,14.08%,PDGFRA;CD9;PRKCD;APOE
prerank,regulation of actin filament-based movement (GO:1903115),-0.3923100502265906,-0.870367433439922,0.6544117647058824,0.864164963303423,1.0,2/10,2.84%,ANK2;PDPN
prerank,response to interferon-beta (GO:0035456),-0.3040963426751899,-0.8703370041414199,0.66,0.8637632495255887,1.0,9/22,28.22%,PLSCR1;UBE2K;IRF1;STAT1;IKBKE;SHFL;IRGM;HTRA2;CDC34
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2787665345751727,0.8697133432286123,0.6970387243735763,0.9545057378312137,1.0,5/32,8.50%,MFSD2A;PCYT1B;CHKA;CSNK2B;SLC44A5
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2679368773138842,0.8695691431958427,0.6679764243614931,0.9538993969715387,1.0,11/39,18.49%,MYO1E;KIF1A;FNBP1L;BICDL1;MYO6;HAP1;PPFIA2;ACTN4;SYT4;MYO5A;MYO19
prerank,cellular response to topologically incorrect protein (GO:0035967),0.282639312530644,0.8689532649265017,0.6700819672131147,0.954471295027491,1.0,5/31,9.89%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP
prerank,actin filament-based transport (GO:0099515),-0.30622916763777736,-0.868772976482132,0.673828125,0.8665645096011367,1.0,4/21,12.65%,SYNE2;MYO1B;WASL;MYO1F
prerank,protein processing (GO:0016485),-0.22749546289228578,-0.8686866480815775,0.7659137577002053,0.8662856358392402,1.0,30/102,22.48%,AEBP1;PCSK5;HM13;CTSH;F3;DDI2;ECE1;SEC11C;NCSTN;LONP2;MMP14;ADAM19;YME1L1;CPM;OGT;CASP2;CPXM2;STOML2;PTCH1;SPRTN;CPXM1;SEC11A;SDE2;EEF1AKMT4-ECE2;SPPL3;CLN5;FXN;CTSL;MYRF;PARL
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.25087909502401473,-0.8686579112209313,0.7348484848484849,0.8658873097717571,1.0,14/53,20.66%,PKD1;ARAF;PRKN;RAD23B;NUPR1;UFL1;PSMF1;FBXW7;RHBDF1;APOE;PSME3IP1;PRKACA;TMTC3;DESI1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3693856288876528,-0.8686499545918388,0.6410748560460653,0.8654331287359831,1.0,2/11,4.07%,PDPN;RREB1
prerank,regulation of protein transport (GO:0051223),-0.2921044849117598,-0.8686102647984286,0.6672932330827067,0.8650505678428211,1.0,5/27,8.46%,DNAJC1;STXBP5;WWP2;DISP1;NDEL1
prerank,basement membrane organization (GO:0071711),-0.34611384013695523,-0.8686090222179766,0.6534090909090909,0.8645856982429783,1.0,3/14,5.97%,NID1;FLRT2;NID2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.33255377163430977,0.8680996213179303,0.6577777777777778,0.9556049355774286,1.0,3/15,5.82%,STOX2;CELF4;TGFB2
prerank,glutamate metabolic process (GO:0006536),-0.31848259910827215,-0.8675572249818472,0.6766355140186916,0.8663672016851974,1.0,8/19,28.84%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;DGLUCY;GCLC;GOT1
prerank,autonomic nervous system development (GO:0048483),0.33206784349057694,0.867432894555026,0.6632016632016632,0.9562318785380644,1.0,1/17,0.21%,PHOX2A
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2786993535438016,0.8671949399371544,0.680672268907563,0.9558215591138723,1.0,10/32,18.25%,MAGI2;PPP1R16B;HSP90AB1;SMPD1;CALM1;DUSP26;CALM2;CALM3;PPIA;CAMTA1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23260924570264874,0.866927175760982,0.7495219885277247,0.9554573241376401,1.0,9/86,6.46%,NAV3;PROX1;TENM1;BIN1;GPX1;OCLN;PAK1;WDR1;CLU
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.2545278733218392,-0.8668937569867834,0.7240740740740741,0.8672952688066558,1.0,8/48,9.19%,ZMIZ1;KAT2B;EP300;ARID1B;SF3B1;TAF1D;TBP;PHF2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3317296703993168,-0.8666858464804712,0.6475247524752475,0.8672706278797269,1.0,6/17,18.22%,TPM1;MEF2C;EFEMP2;TGFB3;PDCD4;SOD2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.35082698862102685,-0.8654639652202242,0.662109375,0.8694018324327626,1.0,2/14,9.11%,IGF1;LDLR
prerank,regulation of intracellular pH (GO:0051453),-0.27625244820294165,-0.8652526725338882,0.6699604743083004,0.8693992842522058,1.0,5/34,6.17%,LRRK2;SLC4A10;SLC9A1;SLC9A8;SLC9A2
prerank,response to hexose (GO:0009746),-0.2963126321169039,-0.8651267830642174,0.6473880597014925,0.8692125033795759,1.0,9/25,26.15%,TCF7L2;THBS1;VAMP2;SELENOS;ZBED3;EIF2B4;PFKL;EIF2B5;LPL
prerank,regulation of glycogen metabolic process (GO:0070873),0.3512112824611529,0.8650878729494184,0.6263498920086393,0.9588109449203714,1.0,2/12,7.97%,KHK;AKT1
prerank,response to progesterone (GO:0032570),0.3174396057183401,0.864977189921361,0.657563025210084,0.9581110647872002,1.0,4/18,12.35%,ABHD2;TGFB2;UBE3A;WBP2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23763442808664276,0.8648176674188579,0.7483870967741936,0.9575285230228737,1.0,9/73,11.59%,TIRAP;IL17F;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2;BCL10
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.30832183227159893,-0.8647754879453026,0.6679245283018868,0.8694746752077583,1.0,6/23,10.13%,ABL1;PRKN;LRRK2;SLC9A1;ADCY6;GABPA
prerank,regulation of cellular component size (GO:0032535),-0.2844351042489611,-0.8647360658116894,0.6787762906309751,0.8691008006476241,1.0,5/30,7.90%,RPTOR;RARG;RAB22A;MTOR;VAV2
prerank,protein insertion into membrane (GO:0051205),-0.28701062375048236,-0.8642709690018381,0.7037773359840954,0.8696579511533896,1.0,11/32,29.09%,EGFR;TRAM2;VAMP2;STX5;COX18;EMD;GET4;VAPA;STX1A;APP;CCDC47
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2911533875585828,-0.8636023933067295,0.6884328358208955,0.8706310318170581,1.0,8/28,16.41%,EGFR;WWP2;NIBAN2;MMP14;NOTCH3;FBXW7;ARRB1;TSPAN15
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2959110975883804,-0.8631552362501952,0.6805555555555556,0.8711109509891782,1.0,6/25,9.41%,ANK2;COA8;SLC6A9;ACTN2;WNK4;WNK1
prerank,cAMP metabolic process (GO:0046058),-0.35400087120474166,-0.8624444322730708,0.6580406654343808,0.8721200881568089,1.0,4/13,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,tRNA processing (GO:0008033),-0.24581927809537876,-0.8621843431727358,0.7459349593495935,0.8722123538127482,1.0,23/61,26.37%,FARS2;TRMT9B;TSEN2;NSUN6;QTRT2;TSEN15;TYW5;METTL1;NSUN2;ELP5;KARS1;FTSJ1;PUS3;CDKAL1;LCMT2;CPSF4;TRNT1;DTWD1;RTRAF;TRMT1;CPSF1;ELAC2;DTWD2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.27256639091824586,0.8615901512787457,0.6924939467312349,0.9641346994150666,1.0,16/38,20.38%,CLU;KLF4;HSP90AB1;AKT1;CD34;KHSRP;GLA;KLF2;INSR;CD36;ATP2B4;EDN1;HSP90AA1;DDAH1;CD47;RAC1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.32873978714517815,0.8614564843032945,0.6552462526766595,0.9635162986639777,1.0,9/18,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA3;OXA1L;SCO1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2863860363159668,-0.8610284988792597,0.6815533980582524,0.874207590283008,1.0,8/27,21.55%,SMG6;PDGFRB;NIBAN2;NABP2;PARP4;TERF2;FGFR4;FGF2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.281039293550435,-0.8607546337018593,0.7037735849056603,0.8743127398760533,1.0,9/30,26.48%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3774747216147408,0.8606509060485792,0.6306695464362851,0.9644664802834547,1.0,3/10,13.42%,TIRAP;NINJ1;WDFY1
prerank,regulation of axon guidance (GO:1902667),-0.37650921949183924,-0.8603996171487379,0.6205607476635514,0.8745766761904211,1.0,3/10,14.35%,NRP1;ZSWIM8;VEGFA
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.37076738257293773,-0.8600253981119215,0.6493506493506493,0.8748505755497422,1.0,4/10,25.54%,COMT;SARDH;ALDH7A1;HNMT
prerank,positive regulation of DNA recombination (GO:0045911),-0.2848304777057508,-0.859943670200276,0.6611721611721612,0.8745551882453022,1.0,14/27,29.38%,KMT5B;FUS;WDR48;SHLD2;PARP1;KMT5C;MMS19;ARID2;PRDM9;PAXIP1;ACTR2;FANCB;TIMELESS;MAD2L2
prerank,stabilization of membrane potential (GO:0030322),0.32144831665283924,0.8597874459148445,0.6673596673596673,0.9655264143616726,1.0,4/16,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.3236453173052075,-0.8596019384095452,0.6486988847583643,0.8747821080107081,1.0,11/18,34.78%,RIPOR2;TNFAIP1;ABL2;CUL3;MYOC;ARHGAP35;KANK1;SCAI;MET;CCDC125;KCTD10
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.269503834961053,0.859565296042589,0.7118279569892473,0.9651121357064758,1.0,10/37,16.84%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3530455371812511,-0.8593728786627962,0.6518518518518519,0.8748099463608776,1.0,4/12,15.87%,GMPS;PPAT;ATIC;PAICS
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.28877646794727263,0.8592720468276545,0.6624472573839663,0.9648766072583588,1.0,3/25,5.60%,HSPA13;HSPA8;HSPA5
prerank,type I interferon signaling pathway (GO:0060337),-0.2707641447681045,-0.8591771815694416,0.732824427480916,0.8742798750339292,1.0,22/41,34.83%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,cellular response to type I interferon (GO:0071357),-0.2707641447681045,-0.8591771815694416,0.732824427480916,0.8742798750339292,1.0,22/41,34.83%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,peptidyl-glutamic acid modification (GO:0018200),0.29866841613448386,0.8588970228696894,0.6621621621621622,0.964751289600371,1.0,2/24,2.52%,TTLL7;AGBL4
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3116493216878923,-0.8588857574257214,0.6772983114446529,0.8744592206323748,1.0,3/21,9.10%,PAG1;PIBF1;PTPN22
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2629893684805469,-0.8588357929521099,0.7049504950495049,0.8740801370243441,1.0,11/45,20.76%,ASPA;MMUT;NOX4;GLUD1;MTHFR;GLUL;ASPG;OAT;ALDH18A1;THAP4;ASS1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3425950557613834,-0.8585761418851824,0.6626746506986028,0.8741165652315889,1.0,4/13,13.04%,SRSF10;PRPF6;PRPF3;USP4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.27431588060242884,-0.8585450997509861,0.7005649717514124,0.8737138514543392,1.0,8/33,14.08%,MEOX2;HMGB1;THBS1;JUP;RHOA;MEF2C;ANGPT2;APOE
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.3756016478983564,-0.858095243330388,0.6502732240437158,0.8741810245301798,1.0,2/10,11.42%,RC3H1;NFKBIZ
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3731943088005589,0.8579319376267219,0.6128318584070797,0.9660538659787767,1.0,2/10,7.89%,CD24;HSP90AB1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3234521204454166,-0.8571027789427953,0.6721611721611722,0.8757509715716748,1.0,6/18,25.93%,PAG1;PTPN22;WNK1;MIA3;ASS1;PPARA
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3791794962019617,-0.8571005018423276,0.6502732240437158,0.8752888560653855,1.0,6/10,51.98%,FCER1G;CD81;CD27;FCGR2B;TLR8;CARD9
prerank,positive regulation of lipid storage (GO:0010884),-0.3073839635501446,-0.8570667605309407,0.6666666666666666,0.8748870117629718,1.0,9/21,32.16%,NFKB1;OSBPL11;PLIN3;IKBKE;LPL;EHD1;FITM2;MSR1;C3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.35721333635766983,0.8568212636141371,0.6594360086767896,0.9677256877127641,1.0,1/12,1.66%,HUS1B
prerank,negative regulation of cation channel activity (GO:2001258),0.29294028409606554,0.8567662842370494,0.6688311688311688,0.9668990085660422,1.0,6/26,14.32%,GPR35;EPO;KCNAB1;CALM1;CALM2;CALM3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.30980950977399896,0.8566115621128225,0.6645435244161358,0.9663303072786505,1.0,8/19,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,regulation of anoikis (GO:2000209),-0.32686059004818463,-0.8562092340750266,0.6803921568627451,0.8761527978063012,1.0,5/19,15.35%,ITGB1;BCL2;TLE1;SIK1;ITGA5
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.34409727422783076,-0.8559082499586841,0.6443202979515829,0.8763252064319319,1.0,9/13,37.04%,MMS19;CIAO1;NFU1;YAE1;GLRX5;BOLA2;LTO1;CIAO2B;GLRX3
prerank,mitotic cytokinesis (GO:0000281),-0.25630739666168845,-0.8557971136301967,0.7186897880539499,0.876112662184598,1.0,7/47,7.80%,ROCK2;SON;ROCK1;ARL3;SNX9;KLHDC8B;CHMP4B
prerank,regulation of T cell differentiation (GO:0045580),0.27065744357981575,0.855482306076017,0.7077244258872651,0.9679415857146286,1.0,7/33,14.37%,IL7;CAMK4;PRDM1;FANCA;TCF7;XBP1;NFATC2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.30030472374474243,-0.8551178894973148,0.6872659176029963,0.8769664649045764,1.0,7/21,19.05%,DCN;BGN;CHST15;CHST11;CHPF2;CHSY1;CHST12
prerank,regulation of chromatin binding (GO:0035561),-0.37562950276354146,-0.8550470983209539,0.6538461538461539,0.8766599355425089,1.0,3/10,13.46%,BTAF1;PARP9;DTX3L
prerank,neuromuscular junction development (GO:0007528),-0.29535989155255,-0.8543751341666634,0.6962264150943396,0.877548674972042,1.0,4/24,9.25%,PDZRN3;LRRK2;UNC13B;UNC13C
prerank,telomere organization (GO:0032200),0.2564216304334601,0.8542791498110555,0.7204081632653061,0.9698370841095766,1.0,12/43,16.70%,HUS1B;RPA3;TERF1;H3-3A;TERF2IP;APEX1;POLD1;ATM;TINF2;POLD3;PTGES3;XRCC5
prerank,cellular response to mechanical stimulus (GO:0071260),-0.2591690597825569,-0.8540271864722805,0.7154150197628458,0.8777553665737148,1.0,13/46,22.72%,PIEZO2;NFKB1;SLC9A1;MAP2K4;CASP2;IRF1;LTBR;MAP3K14;TLR4;MAP3K1;CNN2;BNIP3;F11R
prerank,dopaminergic neuron differentiation (GO:0071542),0.30672005741010694,0.8539389207192235,0.6791666666666667,0.9696594276308554,1.0,1/19,0.21%,PHOX2A
prerank,maturation of SSU-rRNA (GO:0030490),0.2767318532061444,0.8537840933558777,0.7088607594936709,0.9690833517886949,1.0,4/34,6.76%,TSR3;RPS19;RPS8;RPS16
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.37673276698907204,0.8537366118576334,0.6417233560090703,0.9682494513864157,1.0,4/10,16.69%,DGKH;F2R;PRKD3;GAP43
prerank,t-circle formation (GO:0090656),-0.37129611694762166,-0.8530073153138823,0.6724137931034483,0.8783842489275923,1.0,4/10,23.38%,NBN;WRN;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.37129611694762166,-0.8530073153138823,0.6724137931034483,0.8783842489275923,1.0,4/10,23.38%,NBN;WRN;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.37129611694762166,-0.8530073153138823,0.6724137931034483,0.8783842489275923,1.0,4/10,23.38%,NBN;WRN;SMARCAL1;ERCC1
prerank,chromosome condensation (GO:0030261),-0.2714477819339318,-0.8528432164894365,0.6948818897637795,0.8782688804183993,1.0,11/36,21.81%,ACIN1;PHF8;SMC4;AKAP8L;AIFM1;RB1;MCPH1;CSNK2A1;KMT5A;H1-0;NCAPD3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.34753882986072376,0.8522908788479623,0.6652078774617067,0.9706363008628354,1.0,4/12,14.32%,CALM1;PDE4D;CALM2;CALM3
prerank,modulation by host of symbiont process (GO:0051851),0.2805708427157148,0.8521682971448982,0.6856581532416502,0.9699898445656835,1.0,3/31,4.32%,LEF1;HMGA2;SMARCB1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2942318499915897,0.8521347308549551,0.6904761904761905,0.9691277000397274,1.0,4/23,12.27%,METAP2;GUCA1B;CALM1;NMT1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2705330868828285,-0.851995784653384,0.6985446985446986,0.8795577375028227,1.0,7/31,14.70%,DIS3L2;DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,tRNA 5'-end processing (GO:0099116),0.3277794692806968,0.8516838798966866,0.6584867075664622,0.9692402311423106,1.0,3/15,12.31%,RPP40;RPP30;POP5
prerank,lysosome organization (GO:0007040),-0.2663121640653795,-0.8511320816293505,0.7220149253731343,0.8808205999900125,1.0,6/36,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3258899343153567,0.8510093729914274,0.6417233560090703,0.9698717403130954,1.0,2/16,1.96%,PHKG1;PGM2L1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3214467227569332,0.8509613240289146,0.6812227074235808,0.9690533413005099,1.0,6/17,22.82%,NLGN1;SYT10;CACNA1I;SYT4;SLC4A8;RAB3A
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.2802977449262738,-0.8503344582808732,0.7123809523809523,0.8819451480589997,1.0,16/29,30.31%,LIMA1;PRKN;PLEKHH2;ARFGEF1;PRKCD;SMAD4;MYADM;HIP1R;SLIT2;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3447040662662902,-0.8502902380191296,0.6666666666666666,0.8815682080097338,1.0,6/12,22.87%,RFWD3;PRKDC;SDE2;CDK2;WAC;PLK5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24015463748168808,0.849947183951502,0.7417355371900827,0.9704766987737038,1.0,10/62,9.76%,CXCL12;SIRT1;NME5;CLU;RTKN2;EPO;AKT1;TPT1;HSPB1;ARHGEF2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2828635136149905,-0.8496654603897489,0.7025440313111546,0.8823733639586819,1.0,14/28,32.54%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1;HSF1;ACTR2;PARP3;MAD2L2;NUDT16L1;PNKP;TFIP11
prerank,organelle fission (GO:0048285),0.29561541636441907,0.849662298212933,0.6817155756207675,0.9701625445265816,1.0,2/24,1.86%,DNM3;GDAP1
prerank,regulation of B cell differentiation (GO:0045577),-0.31796257324939153,-0.8490685180910524,0.6820809248554913,0.883083133769426,1.0,8/17,32.48%,MMP14;ID2;INHBA;PPP2R3C;SYK;ZFP36L2;INHA;CD27
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.21706218824088488,0.8487113675395643,0.8111587982832618,0.9713329838683489,1.0,22/114,18.95%,ST18;TMSB4X;PSMA1;TRAF1;TNFRSF9;TNFSF13B;PSMD12;PSMA6;PSMB3;TNFRSF12A;TNFRSF25;ACTN4;CD40;NFKBIA;PSME3;PSMC3;PSMA2;CDIP1;TNFRSF1A;ILK;PSMB7;RIPK1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.31557221011454395,0.8484677302053915,0.6632443531827515,0.9709617052552625,1.0,7/18,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2720269031268301,-0.8480341854549567,0.7316602316602316,0.8846639503956946,1.0,3/32,2.67%,FHIT;DDX5;EP300
prerank,myelin maintenance (GO:0043217),0.36347091843856133,0.8479025513921614,0.6730769230769231,0.9712627289318356,1.0,2/10,7.03%,CLU;EPB41L3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.36519064819783564,0.8476832743141672,0.6686991869918699,0.9708339220243435,1.0,3/10,15.24%,HSPA5;CCL2;ATF4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.23885609177772077,-0.8474664473880327,0.7713754646840149,0.885318879868401,1.0,28/70,35.74%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;MFSD6;CYBA;LNPEP;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3578588654529723,-0.8469748823600882,0.6741996233521658,0.8858630011137042,1.0,3/11,22.53%,SCARA3;TNIP2;TICAM1
prerank,response to organophosphorus (GO:0046683),0.3132817338706565,0.8467220137193715,0.6845637583892618,0.9720983262330412,1.0,3/16,13.32%,KCNJ11;P2RX7;VGF
prerank,telomere maintenance (GO:0000723),-0.24505799671224843,-0.8466463089571677,0.725050916496945,0.8860499545285252,1.0,17/50,21.94%,SMC6;NBN;NSMCE2;WRN;SP100;SMC5;PARP1;RAD51D;PRKDC;CTC1;MRE11;TERF2;TERT;PCNA;STN1;XRCC6;ATR
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3370238687232584,0.846408405421429,0.6600877192982456,0.9718781460056927,1.0,4/13,14.60%,NAXE;NUDT12;NAMPT;NAXD
prerank,positive regulation of ion transport (GO:0043270),0.25310371155769573,0.8463870326570375,0.7641129032258065,0.9710150491254013,1.0,7/48,11.50%,CAMK2A;CNKSR3;ANK3;SCN4B;CACNB2;F2R;P2RX7
prerank,myeloid cell differentiation (GO:0030099),0.25714049366361713,0.8462124100512596,0.7301587301587301,0.9704628970955951,1.0,9/47,14.55%,ALAS2;TIRAP;RPS19;TAL1;EPO;HIPK2;RPS14;SNRK;MFHAS1
prerank,B cell activation (GO:0042113),-0.23311614803348069,-0.844906668108476,0.8086785009861933,0.8889785942521546,1.0,14/68,18.27%,HDAC4;KIT;ITGB1;DCAF1;BCL2;CEBPG;PTPN2;MEF2C;TCF3;ITGA4;KLF6;CTPS1;PIK3CD;BLNK
prerank,RNA methylation (GO:0001510),-0.2405414771168567,-0.8448597605621889,0.7648221343873518,0.8886095926698364,1.0,25/60,33.27%,ZCCHC4;WTAP;NSUN6;NSUN3;TGS1;DIMT1;METTL2B;METTL2A;BUD23;METTL1;NSUN2;THUMPD3;FTSJ1;ZC3H13;LCMT2;WDR6;GTPBP3;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;MRM2;ALKBH8;TRMT12
prerank,regulation of neurogenesis (GO:0050767),-0.24116894226201618,-0.8446885289595465,0.7647058823529411,0.8884689151356582,1.0,12/55,18.03%,APPL2;PCM1;YAP1;DOCK7;REST;PRUNE1;NUMBL;HES1;BHLHE41;NUMB;HEYL;CX3CR1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.3574345469772123,-0.8446066620053997,0.6703296703296703,0.8881627008993624,1.0,10/12,61.39%,IL18;SLC11A1;CCR2;IL12RB1;IL23A;IL23R;IL12B;XCL1;IL1B;IL18R1
prerank,positive regulation of protein polymerization (GO:0032273),-0.2328894293424198,-0.8445086619223632,0.7826961770623743,0.8878887987488185,1.0,15/65,15.43%,FCHSD2;BAIAP2L1;NUMA1;SNX9;VASP;CDC42EP5;FER;NCKAP1;MAPRE1;TOGARAM1;CTTN;NCK1;CARMIL1;NCK2;AKAP9
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2873339904089697,-0.8443543790039492,0.6987951807228916,0.8877286592322731,1.0,8/28,16.31%,ARHGAP28;FCHSD2;PLEKHG2;BRK1;CTTN;LATS1;RASA1;ARHGAP18
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.280150663882777,-0.8443374236046632,0.70018281535649,0.8872923548701014,1.0,8/26,20.13%,ADCY5;CDK16;STXBP4;STX4;TRPM4;ADRA2A;ANO1;C2CD2L
prerank,ketone body metabolic process (GO:1902224),-0.37930871770262725,-0.844157837789154,0.685823754789272,0.8871909397915794,1.0,3/10,20.32%,ACSS3;BDH2;OXCT1
prerank,cellular response to virus (GO:0098586),-0.2771366352789389,-0.8440934381958091,0.7077244258872651,0.886831114346405,1.0,6/30,14.84%,GBF1;GSDME;HIF1A;RIOK3;ARF1;DDX3X
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.27527276291357106,0.8440744860858013,0.6801705756929638,0.9743756553886261,1.0,6/33,16.55%,SLA2;THY1;PTPRJ;BCL10;RPS3;RAB29
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3181408513671036,-0.8439479119814198,0.6920152091254753,0.8866593520185109,1.0,8/17,36.75%,DNM1L;BCL2;SOD2;FIS1;GGCT;BAK1;SFN;TIMM50
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3334760191489175,0.8436428229816048,0.6551724137931034,0.974380770968518,1.0,3/13,9.50%,TOX;CAMK4;FOXJ1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.25049839634360616,-0.8433537147378626,0.7363083164300203,0.8873550508188426,1.0,8/48,12.86%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.24458580639373273,-0.8430295974854061,0.7704590818363274,0.8870608635840209,1.0,22/51,35.07%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,mitotic nuclear membrane organization (GO:0101024),-0.24458580639373273,-0.8430295974854061,0.7704590818363274,0.8870608635840209,1.0,22/51,35.07%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,peptidyl-amino acid modification (GO:0018193),-0.364653940792385,-0.842796938376237,0.6776556776556777,0.8870360536997958,1.0,3/10,15.91%,TTLL4;FKBP10;FKBP7
prerank,cellular response to hypoxia (GO:0071456),-0.21363268802348456,-0.842781576185635,0.8448275862068966,0.8866006868619168,1.0,45/126,29.45%,MDM4;BMP7;EP300;PTGIS;ARNT;LMNA;CREBBP;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;LIMD1;RORA;PSMF1;ACAA2;NPEPPS;PGK1;PSMB2;VEGFA;CUL2;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;PSMC1;HIF3A;GATA6;TBL2;BNIP3;PSMB6;PSMA3;PSMA4;HYOU1;TWIST1;PSME1;PSMD13;PSMB10;MT3;EGLN2;PSMA5;PSMB9;RBX1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.24810627366602578,-0.8427804910745248,0.7348066298342542,0.8861395809828244,1.0,9/48,13.51%,ANK2;CEMIP;DIAPH1;JPH1;CAMK2D;PDPK1;PLCG1;SELENON;SRI
prerank,Rac protein signal transduction (GO:0016601),-0.316154257881823,-0.8424694932205363,0.7044534412955465,0.8863029145546109,1.0,5/18,18.44%,BRK1;NCKAP1;WASF1;FARP2;RHOH
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.2487540425166762,-0.8422227400368855,0.7360308285163777,0.8863339996787836,1.0,16/46,24.08%,PARVA;ITGAV;LAMC3;RADIL;NRP1;ATRNL1;FER;RHOA;FN1;ITGA4;ITGB3;PIK3R1;ANTXR1;LAMC1;LAMB2;ITGA8
prerank,protein polyglutamylation (GO:0018095),0.3527737449272701,0.8414886161279941,0.673202614379085,0.9781476678426653,1.0,1/11,2.40%,TTLL7
prerank,regulation of phosphatase activity (GO:0010921),-0.29280254881046897,-0.8413034451817355,0.6719022687609075,0.8876795400239513,1.0,11/24,34.25%,SH3RF2;PTPA;GPATCH2;BMP2;CDK5RAP3;CHP1;PPP1R2;PPP6R2;HTT;SH2D4A;URI1
prerank,telomere capping (GO:0016233),-0.32647189569787327,-0.8407974672811588,0.6815642458100558,0.8881859810346673,1.0,7/16,21.08%,NBN;PRKDC;CTC1;MRE11;DCLRE1A;TERF2;STN1
prerank,negative regulation of protein binding (GO:0032091),-0.22832294148986587,-0.8406462008287819,0.7739307535641547,0.8880200954276682,1.0,12/71,10.95%,DAB2;ROCK1;LRRK2;GSK3B;STYX;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;ATP2A2
prerank,regulation of nervous system development (GO:0051960),-0.25570809601114014,-0.8403181096654687,0.7485148514851485,0.8882037848813021,1.0,9/37,18.10%,PTN;YAP1;DOCK7;PRUNE1;HES1;BHLHE41;HEYL;CX3CR1;LGI4
prerank,cristae formation (GO:0042407),0.286073250038958,0.8399000935649367,0.7148760330578512,0.9806478787152259,1.0,8/27,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;UQCC3;CHCHD6;ATP5MG
prerank,regulation of tumor necrosis factor production (GO:0032680),0.21328472475105725,0.8397808201433287,0.837782340862423,0.9799585410068032,1.0,12/112,9.76%,CD33;TIRAP;MIF;SYT11;GAS6;CLU;TLR2;PTPRJ;CD34;HSPB1;POMC;ARHGEF2
prerank,regulation of cellular senescence (GO:2000772),-0.281703326201749,-0.8395536635532399,0.6851851851851852,0.8892193229285621,1.0,14/28,28.55%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;NEK4;NEK6;TERF2;TERT;CDK6;NUAK1;TWIST1;RSL1D1;VASH1;CGAS
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2340767058297424,0.8392691540135054,0.7839506172839507,0.9801375840718296,1.0,20/72,18.89%,COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;RFC2
prerank,negative regulation of protein secretion (GO:0050709),-0.26492740139975013,-0.8391363007967594,0.7392120075046904,0.8895512534979475,1.0,14/38,22.36%,PRKN;IRS1;REST;CCN3;NR1H3;SERGEF;RHBDF1;APOE;ADRA2A;HMGCR;CYP51A1;DPH3;SIRT4;KCNB1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.33381473496349695,-0.8391294204091186,0.6723484848484849,0.8891007028879518,1.0,4/15,11.01%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.22231622606507065,-0.8390720118672492,0.8224852071005917,0.8887405813552994,1.0,26/93,22.28%,SASH1;CCN2;HMGB1;AXIN1;SH3RF1;TAOK3;MID1;MAP3K5;RELL1;TRAF2;RASSF2;FZD7;LTBR;EIF2AK2;SH3RF2;TPD52L1;VEGFA;SH3RF3;TRAF3;TRAF6;BMP2;TAOK1;WNT16;TRAF5;SPHK1;KLHDC10
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3350993469320348,0.8387602619510162,0.7157894736842105,0.980300550183092,1.0,3/13,12.40%,ALG3;ALG1;ALG8
prerank,vesicle transport along actin filament (GO:0030050),0.3078093159452867,0.8385086067493016,0.7213114754098361,0.9799691089306625,1.0,6/19,18.49%,MYO1E;FNBP1L;MYO6;ACTN4;MYO5A;MYO19
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.35529111412633196,-0.8383966248299948,0.6815642458100558,0.8895788638375226,1.0,6/11,28.52%,MSH3;ZRANB3;SMARCAL1;DONSON;TIPIN;TIMELESS
prerank,granulocyte differentiation (GO:0030851),0.31414022631443217,0.8378972589367075,0.7012987012987013,0.9803854709620976,1.0,2/18,5.80%,LEF1;TAL1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3358327818058037,-0.8378652241252784,0.6915520628683693,0.8901541107881622,1.0,6/14,29.14%,THBS1;PLCG1;ITGA4;PDCD4;PRKCI;GPER1
prerank,lymphocyte migration (GO:0072676),0.26907596656387384,0.8376379865769598,0.7107942973523421,0.9800045148507979,1.0,7/32,20.51%,CCL2;RET;CCL25;CKLF;S1PR1;CCL13;CCL19
prerank,peptidyl-asparagine modification (GO:0018196),-0.2728086745796207,-0.8374167100338705,0.7418738049713193,0.8905503579357423,1.0,9/31,26.48%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.33082740294274704,0.8372391890440901,0.6807095343680709,0.9799310940038637,1.0,2/14,4.66%,CHKA;PISD
prerank,negative regulation of protein transport (GO:0051224),0.28432186691912453,0.8370925858122826,0.7157894736842105,0.9793163636549163,1.0,3/25,4.90%,RHBDF2;PPM1F;IL12A
prerank,ruffle organization (GO:0031529),-0.3184203529897097,-0.8369036013554191,0.6996336996336996,0.8910743549875749,1.0,9/16,31.44%,TPM1;LIMA1;ARFIP2;CARMIL1;INPP5K;AIF1L;PLEKHA1;ARF6;CORO1B
prerank,mitochondrial translational elongation (GO:0070125),0.21997184196507968,0.8369034566359532,0.8138613861386138,0.9788033837962102,1.0,26/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,negative regulation of GTPase activity (GO:0034260),-0.3012114630679601,-0.836823517311545,0.6785714285714286,0.8907729310481332,1.0,5/22,9.41%,LRRK2;BCAS3;ARFGEF1;GMIP;WNK1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.32686613569066636,-0.8367886521899106,0.7169459962756052,0.8903827563498512,1.0,8/15,34.31%,EIF2AK2;USP50;DDX3X;TLR4;NLRC3;NLRP2B;DHX33;MYD88
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2912776302561257,0.8366238888216512,0.6955602536997886,0.978466304618883,1.0,3/22,5.92%,PROX1;TOX;TAFA1
prerank,cognition (GO:0050890),0.2541836681347791,0.8366166807449444,0.7318087318087318,0.9775594562815182,1.0,7/42,13.20%,GRM5;PTCHD1;MFSD2A;NSUN5;TTC8;DGCR2;GPR155
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.34380543867862345,-0.8365428464724723,0.7032136105860114,0.890380579780447,1.0,4/13,10.96%,TRIM44;AXL;DHX9;MAVS
prerank,regulation of oxidoreductase activity (GO:0051341),-0.34984892396775785,-0.8361180734951397,0.7005444646098004,0.890762709906025,1.0,6/13,33.54%,ABL1;ABL2;SIRT4;SZT2;MT3;ATP7A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3144839048731021,0.8359217024455972,0.7002141327623126,0.978131368351809,1.0,3/16,18.04%,SLC2A5;BMPR2;DDAH1
prerank,endothelial cell development (GO:0001885),0.2788668094339854,0.8355742153312208,0.6957446808510638,0.9779962918775453,1.0,8/25,16.51%,ROBO4;PDE2A;PPP1R16B;PECAM1;MARVELD2;PDE4D;RAP1A;SOX18
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2945208398602186,-0.8354483691379665,0.712890625,0.8915822759941726,1.0,6/23,14.42%,GHR;KIT;CENPJ;CYP1B1;HES1;CRLF3
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3520232088851721,-0.8353694006389564,0.7023172905525846,0.8912517421551395,1.0,5/12,27.33%,ACSL1;ACOX1;ELOVL1;ACOT8;ELOVL5
prerank,regulation of cellular pH (GO:0030641),0.27323744793475985,0.8353377390751812,0.75,0.9776122977729015,1.0,5/29,11.41%,SLC4A1;CA2;ATP6AP1;ATP1A4;ATP5F1B
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.34942477386324133,0.83502497395763,0.6688311688311688,0.977380166830765,1.0,2/11,10.46%,NOVA2;ZNF445
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3456633799141592,0.8348789261554075,0.6659836065573771,0.9767606129718305,1.0,5/11,23.69%,TIMM22;NDUFA13;TOMM70;TIMM10B;ROMO1
prerank,exit from mitosis (GO:0010458),0.3437324301008686,0.8345498101590275,0.7002053388090349,0.9765141882779659,1.0,7/12,22.75%,UBE2C;CLASP2;CLASP1;CHMP2A;CHMP7;SIRT7;EPS8
prerank,response to organonitrogen compound (GO:0010243),0.25557575213731054,0.8344614465694055,0.7785087719298246,0.9757946546762292,1.0,6/38,11.20%,GLRA1;GLRA3;MEAK7;TRPM2;GLRA2;BRSK2
prerank,regulation of lymphocyte migration (GO:2000401),0.35691745417445825,0.8342984866405332,0.6760869565217391,0.9752336868426008,1.0,2/10,7.97%,JAM2;AKT1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.23998193760665254,-0.8342301013093718,0.7690763052208835,0.8929332456293567,1.0,13/55,18.54%,IGF1;PDGFRB;BMP7;BMP4;OBSL1;IGF2;CDK13;TOM1L2;DUSP1;RCC1;PRMT5;PHIP;NME6
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.33588808054762603,-0.8337630903590703,0.6857142857142857,0.8933823254058972,1.0,5/13,22.53%,AXL;ZBTB1;IL18;LAMP1;TICAM1
prerank,secretion (GO:0046903),0.3252189297761008,0.8337096272485547,0.6748329621380846,0.9755387598502647,1.0,2/14,7.12%,RIMS1;GUCA1B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2118936503749548,-0.8332208706575529,0.856858846918489,0.8939665186618557,1.0,32/113,24.62%,TRABD2B;ABCA1;MPP7;ASAP1;GTF2H2;GSK3B;SPIDR;RAP1B;BRK1;DDB2;UNC13B;FNIP1;PARP1;ERCC3;SLF1;USP50;VEGFA;DDX3X;ICE1;TLR4;VCP;PARK7;RHOC;AJUBA;EIF4G1;PIH1D1;BMF;ATR;ERCC1;GTF2H1;GNL3L;SYK
prerank,negative regulation of neuron death (GO:1901215),0.2200585532005004,0.8329263412854611,0.8161157024793388,0.9763390796010031,1.0,19/93,15.24%,MAG;FOXQ1;SNCA;NTRK2;VSTM2L;UNC5B;NDNF;AKT1;GPNMB;CD34;CCL2;CD200R1;RETREG1;SET;F2R;SORL1;PTPRZ1;PPT1;ATF4
prerank,positive regulation of peptidase activity (GO:0010952),-0.3014829338823578,-0.8328568585652386,0.7145631067961165,0.8942070302471382,1.0,7/20,28.00%,CTSH;NCSTN;RCN3;VCP;TANK;PSME1;GRN
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2424160657164689,-0.8326791353975068,0.7674418604651163,0.8940637604814416,1.0,13/52,21.12%,SAE1;HUWE1;TFDP2;BCL2;ABLIM3;LEPROT;NPEPPS;FBXW7;YWHAE;UBL5;UBE2D3;TOMM7;ARIH2
prerank,cholesterol biosynthetic process (GO:0006695),0.27151791801429703,0.8324031459886209,0.7345309381237525,0.9764923973822089,1.0,12/31,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,cholesterol homeostasis (GO:0042632),-0.23291335501235141,-0.8323747006521419,0.7684630738522954,0.8941969108548803,1.0,11/64,16.81%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,negative regulation of response to wounding (GO:1903035),0.30198185313274006,0.8320108296090111,0.6951983298538622,0.9764446778756957,1.0,3/19,8.96%,GIT1;AJAP1;RTN4R
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2530594765175944,-0.8320005471375945,0.7756653992395437,0.8944726016482561,1.0,15/45,17.34%,JAK1;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;STAT1;IFNGR1;OAS2;GBP2
prerank,cellular response to interferon-beta (GO:0035458),-0.32819019449153186,-0.8319416891868827,0.7054409005628518,0.894126574349826,1.0,6/14,28.22%,UBE2K;IRF1;STAT1;IRGM;HTRA2;CDC34
prerank,inorganic anion transport (GO:0015698),0.24296357400071714,0.8319264377721951,0.7963340122199593,0.9757094003845141,1.0,7/53,10.99%,SLC4A1;GLRA1;CLIC5;ANO5;SLC25A14;ANO4;CLCN1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2990220293178892,0.8318294635410329,0.6910229645093946,0.9750092565239771,1.0,5/21,16.57%,CNKSR3;PPM1F;SMAD7;PDE4D;DDIT4
prerank,regulation of histone acetylation (GO:0035065),0.2699205051542318,0.83173058957497,0.7368421052631579,0.9743170161471958,1.0,5/33,10.18%,CHEK1;SNCA;RPS6KA5;IWS1;SET
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3552099330476341,0.8316909639206781,0.6774193548387096,0.9734949255058946,1.0,1/11,0.45%,ST18
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2654883816165961,-0.8316494878203152,0.7430167597765364,0.8941759344185041,1.0,3/36,1.70%,GLI3;ZMIZ1;GLI2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.33145232416760384,-0.8315913179338078,0.6943396226415094,0.893811994234638,1.0,2/14,5.41%,IL34;THBS1
prerank,neuron projection fasciculation (GO:0106030),0.3517896186977278,0.8312473648461376,0.6632653061224489,0.9735680549555674,1.0,5/10,21.74%,NRCAM;CNTN4;RTN4;CDK5R1;AMIGO1
prerank,establishment of vesicle localization (GO:0051650),-0.3065457971284063,-0.8311332794588508,0.6854545454545454,0.8941941043500309,1.0,7/18,27.41%,TMEM230;SPG11;RAB11A;CCDC186;TOR1A;KIF5B;TESK1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3097719435269817,0.8311094857289065,0.7139917695473251,0.9729609815377799,1.0,2/17,4.81%,HDAC9;PCSK6
prerank,positive regulation of cytokine production (GO:0001819),-0.1888001383550265,-0.831099929274106,0.952286282306163,0.8937974045355723,1.0,49/292,17.53%,ROCK2;SULF1;FOXP1;NFKB1;CCBE1;IL6ST;EP300;ARNT;PLA2R1;TBK1;LBP;SULF2;PIBF1;HMGB1;CREBBP;STAT3;EIF2AK3;IL16;RUNX1;ANXA1;DHX9;F3;CEBPG;DHX36;IL17RA;PTPN22;CYP1B1;TRAF2;HIF1A;MAVS;RORA;IL6R;APPL1;IRF1;EIF2AK2;PRKDC;PRKCZ;IL17D;STOML2;CYBA;C1QTNF3;MRE11;ADRA2A;AFAP1L2;IL18;SERPINE1;PIK3CD;TLR4;WNT5A
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2944329250529215,-0.8310377146294244,0.7039106145251397,0.8934587429600741,1.0,5/21,22.17%,CYP26B1;ACOX1;LPIN2;LPIN3;ACOT8
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.23367169054485487,-0.8310105385109664,0.8082474226804124,0.8930560869408366,1.0,9/65,10.02%,EGFR;ERRFI1;ARAP1;RNF115;PTPN3;CDC42;PTPN12;FER;PTPN2
prerank,regulation of protein polymerization (GO:0032271),-0.26561534864314734,-0.8309013139778101,0.7400793650793651,0.8928069605004212,1.0,9/35,16.31%,ARHGAP28;FCHSD2;ABL1;PLEKHG2;PRUNE1;CTTN;LATS1;RASA1;ARHGAP18
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3505194032695308,-0.830748651803119,0.7094861660079052,0.8926254262149074,1.0,7/11,48.74%,P2RX4;PLCG2;TREM2;P2RX5;TRAT1;CCL4;NEUROD2
prerank,ear morphogenesis (GO:0042471),-0.299822749464663,-0.8307438635317129,0.7297794117647058,0.8921773161820103,1.0,6/20,17.00%,ZIC1;OSR1;FGFR2;NIPBL;CHD7;SIX1
prerank,regulation of myoblast fusion (GO:1901739),-0.36082087261122875,-0.8305394750041555,0.7056530214424951,0.8921161492126024,1.0,3/11,7.99%,CFLAR;RIPOR2;EHD2
prerank,protein palmitoylation (GO:0018345),0.2748436758160324,0.8301180508386465,0.7342047930283224,0.9742296938812427,1.0,8/30,19.52%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;PORCN;ZDHHC24
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2907140376004363,-0.8299741852123146,0.710172744721689,0.89271332084582,1.0,5/22,11.93%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3317997867711566,0.8296101521682233,0.6950207468879668,0.9744377003366123,1.0,3/14,9.89%,HSPA5;FICD;DAB2IP
prerank,regulation of receptor binding (GO:1900120),-0.3576707121386641,-0.8294661377120218,0.6944971537001897,0.8931895342651255,1.0,4/10,30.06%,ATP2A2;GREM2;ATP2A3;PTPRF
prerank,cardiolipin metabolic process (GO:0032048),0.3357391001494004,0.829349634618947,0.6989473684210527,0.9740896531771115,1.0,3/13,11.47%,HADHA;CRLS1;PTPMT1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.29372210555052786,-0.8292059634899576,0.7145454545454546,0.8932360176323351,1.0,7/23,30.98%,AXL;HMGB1;TLR4;INHBA;NR1H4;INHA;C1QBP
prerank,metallo-sulfur cluster assembly (GO:0031163),0.28881564501414114,0.8290992614320616,0.6947791164658634,0.9736978084603168,1.0,4/22,11.08%,NDOR1;IBA57;ISCU;ISCA2
prerank,regulation of amyloid fibril formation (GO:1905906),0.3173853342822081,0.8290607210458106,0.7186813186813187,0.9728721462313962,1.0,6/15,20.46%,PFDN5;CLU;PFDN6;PSEN1;PFDN1;CRYAB
prerank,negative regulation of viral genome replication (GO:0045071),0.25958380430406935,0.828844726672259,0.7407407407407407,0.9724239730505425,1.0,6/40,10.04%,PROX1;HMGA2;ISG15;TRIM6;IFITM3;SLPI
prerank,myeloid dendritic cell activation (GO:0001773),-0.34479698993368224,-0.8281955608887159,0.6983240223463687,0.8946354346330899,1.0,2/12,5.03%,TGFBR2;HMGB1
prerank,negative regulation of histone modification (GO:0031057),0.32367468321038056,0.8281806345767411,0.7121212121212122,0.9729400092279419,1.0,3/14,13.54%,SNCA;SET;PRMT6
prerank,cellular copper ion homeostasis (GO:0006878),0.3259844498639352,0.8277103453654766,0.6942675159235668,0.9730638539391971,1.0,1/14,0.93%,MT2A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.32307676307566485,0.8271469224737431,0.7089715536105032,0.9733114788837809,1.0,6/15,22.18%,NTRK2;HAP1;BCAR1;DDIT4;SORT1;BDNF
prerank,endodermal cell fate commitment (GO:0001711),-0.3664892626820956,-0.8270166547127924,0.7227722772277227,0.8963780518456225,1.0,3/10,19.85%,CTR9;RTF1;CDC73
prerank,histone H3 acetylation (GO:0043966),-0.2624607502845315,-0.8269628677460217,0.758220502901354,0.8960186367217258,1.0,13/40,25.46%,KAT2B;KAT6B;BRPF3;TADA3;KAT14;ING5;BRCA2;TAF5L;TAF6L;TAF12;YEATS2;JADE2;LDB1
prerank,cell-substrate junction assembly (GO:0007044),-0.26805452779231964,-0.8269033136363125,0.7623574144486692,0.8956675097882957,1.0,8/33,15.28%,SORBS1;BCR;PTPRK;ACTN2;LAMA3;FN1;CTTN;WHAMM
prerank,regulation of transport (GO:0051049),-0.2634238597638821,-0.8263671426394483,0.7230483271375465,0.8961876550584296,1.0,8/36,15.12%,LEPR;PRKN;LRRK2;NRP1;VAMP2;WWC1;RAB11A;MBTPS1
prerank,response to interferon-alpha (GO:0035455),0.31452574838631586,0.8261016884336859,0.6950959488272921,0.9746483377765438,1.0,7/16,21.37%,GAS6;IFNAR1;IFITM3;ADAR;KLHL20;BST2;RO60
prerank,sterol homeostasis (GO:0055092),-0.23121486590366905,-0.8259431411541481,0.7826961770623743,0.8965404807136781,1.0,11/65,16.81%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,regulation of fibroblast migration (GO:0010762),0.28903669852454544,0.8256705360775449,0.7321814254859611,0.9746327371250222,1.0,8/20,20.38%,PRR5L;RFFL;ARHGEF7;CORO1C;DDR2;GNA12;HYAL2;RAC1
prerank,regulation of T cell activation (GO:0050863),0.24760164426813241,0.8252287758989622,0.7740585774058577,0.9746576641570377,1.0,6/42,12.68%,THY1;PRKCQ;GPNMB;CCL2;CYRIB;HSPD1
prerank,response to ketone (GO:1901654),0.2855772424881613,0.8250519601302494,0.7181628392484343,0.9741168017051177,1.0,6/24,12.35%,ABHD2;TGFB2;SLIT3;UBE3A;ABCB4;WBP2
prerank,negative regulation of viral life cycle (GO:1903901),-0.330742110108458,-0.8249349474504316,0.7161654135338346,0.89801485553103,1.0,3/15,12.11%,GSN;TRIM5;TRIM11
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.33483188505966943,-0.8246323411516824,0.6806569343065694,0.8981219351285494,1.0,2/13,2.72%,ZMIZ1;ARID1B
prerank,establishment of melanosome localization (GO:0032401),-0.30579058786324437,-0.8245726839509394,0.70817843866171,0.8977730624313162,1.0,6/19,28.22%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3518689883274648,-0.8239686977473426,0.7020109689213894,0.8984189925531649,1.0,2/11,2.72%,ZMIZ1;ARID1B
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.31143789316361437,-0.8238976324764965,0.7182835820895522,0.8980952176577126,1.0,8/16,29.87%,PID1;PPARGC1A;PARP1;VCP;PPARA;SPHK2;ANTKMT;ENO1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.34113091734003115,-0.8228994603076781,0.7288135593220338,0.8994843436081454,1.0,3/12,12.62%,CBLB;F3;APOD
prerank,fatty acid metabolic process (GO:0006631),-0.20933450174642557,-0.8226475371886764,0.852,0.8994818313922589,1.0,31/115,26.23%,ACSL1;ACADSB;ABCD3;GNPAT;ACADM;CPT1C;ABCD2;PPARGC1A;CPT2;ACSF2;PON2;ACSL6;PNPLA8;ACOT11;ACOX1;ECHDC3;LPIN2;ACAD9;LPIN3;CPT1A;CBR4;MECR;ACSL4;ACOT8;ACOT6;PON3;GGT5;ACSBG1;PPARA;LPL;AASDH
prerank,proteoglycan biosynthetic process (GO:0030166),0.266499272871735,0.8226441886418336,0.7549800796812749,0.9781341039714533,1.0,4/31,5.63%,B3GAT1;CHST9;B3GAT2;CSGALNACT1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.25124977103630464,0.822576488642751,0.7731958762886598,0.9773956005933232,1.0,7/42,11.61%,SPOCK1;PPM1F;THY1;NOTCH1;NDNF;PDGFB;FZD4
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3326196816733509,-0.8224716128045025,0.7088846880907372,0.8993550407924975,1.0,4/13,12.11%,TRIM8;CHMP3;TRIM5;TRIM11
prerank,regulation of exit from mitosis (GO:0007096),-0.25447997625133917,-0.8222811626741794,0.7617107942973523,0.8992501927203868,1.0,14/38,25.38%,CDC14A;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CDC26;CDC14B;CDC27;UBE2E1;UBE2S;ANAPC11;CDC16;PHB2;ANAPC1
prerank,N-glycan processing (GO:0006491),0.3135235843810706,0.8219184783681168,0.7045951859956237,0.977773860496018,1.0,4/18,11.96%,ST8SIA4;ST8SIA1;ST8SIA6;ST8SIA3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.22979586345534517,-0.8213010280667354,0.8058455114822547,0.9005099434943847,1.0,20/63,28.73%,MDM4;EP300;TFDP2;RFWD3;CNOT8;CASP2;PRKDC;CNOT2;CNOT1;SDE2;CNOT10;CDK2;PML;PCNA;WAC;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.2746120248388709,0.8212660082704003,0.7341513292433538,0.9781766250915719,1.0,4/27,9.54%,SYT11;GAS6;FOXJ1;CD200R1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2884983968781245,0.8212495321107667,0.7303370786516854,0.977315678647801,1.0,7/21,21.90%,PGM2L1;TALDO1;GCK;TKT;RPIA;GPI;G6PC3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.29791122881946086,-0.8210426169145646,0.7359550561797753,0.9005305242932864,1.0,11/20,28.00%,TAF3;SP100;TAF8;TOPORS;MORC3;HNRNPU;PARK7;PML;SUN2;BBS4;CHCHD10
prerank,GPI anchor metabolic process (GO:0006505),-0.28059047151629213,-0.8205216738151416,0.7196078431372549,0.9009969839753337,1.0,11/26,32.31%,PIGN;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3349299309425593,0.8204865068948225,0.7037815126050421,0.9779552570753327,1.0,5/12,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;STARD3
prerank,vitamin D metabolic process (GO:0042359),-0.33231899648186564,-0.8202565468964718,0.7364341085271318,0.901038462308035,1.0,10/13,55.87%,PIAS4;CUBN;CYP2R1;LGMN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,positive regulation of protein maturation (GO:1903319),-0.3514182639443851,-0.8196975262534967,0.722753346080306,0.9016063376998427,1.0,1/11,2.47%,CCBE1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2551875072024325,0.8194642269353404,0.8029661016949152,0.9791414447059925,1.0,10/39,16.84%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.24014219162751063,-0.8194580278438849,0.7923809523809524,0.9015798064368656,1.0,21/55,34.18%,FBXL7;FHL1;USP47;PSMF1;PSMB2;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;PSME4;PSMB8;PSMD10
prerank,negative regulation of endocytosis (GO:0045806),-0.284669383466754,-0.819039855394388,0.7329650092081031,0.9018817672933976,1.0,8/24,22.46%,EPHA3;NR1H3;RUBCN;PICALM;PRKD1;ABCA7;LRSAM1;CD300A
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3094775182456925,-0.8187418176876291,0.7277777777777777,0.9019269391428334,1.0,6/16,21.02%,PIBF1;LEPROT;PTPN2;PARP14;NF2;PPP2CA
prerank,tryptophan catabolic process (GO:0006569),0.335969868173258,0.8179291117379758,0.6911764705882353,0.9813274967190257,1.0,11/11,66.43%,KYAT1;KYNU;AFMID;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3454127627717698,0.8173597641452008,0.7142857142857143,0.9815610902034236,1.0,3/10,14.24%,ACER2;NEXMIF;JAM3
prerank,regulation of double-strand break repair (GO:2000779),-0.25263743834840485,-0.8173544372741667,0.7954110898661568,0.9039812799264823,1.0,9/39,13.23%,RNF169;TRIP12;SPIDR;UBR5;PPP4C;PPP4R2;SETD2;SHLD2;SLF1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.33576272128451634,0.8172375908490451,0.6877729257641921,0.9808892791699461,1.0,3/11,11.90%,CXCL12;GAS6;IRF7
prerank,negative regulation of cell cycle process (GO:0010948),-0.2280745584012025,-0.8169895654785315,0.8176352705410822,0.9041911389273564,1.0,24/61,33.54%,BMP7;BMP4;RBBP8;CBX5;TFDP2;TOM1L2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1;NME6;TERF2;EZH2;PPP1R10;APAF1;E2F1;GPER1;FOXO4;WAPL;ZFYVE19;RAD51;E2F6;BRCA1
prerank,lipoxygenase pathway (GO:0019372),0.31690510143527817,0.8169287808453574,0.7429193899782135,0.9805885062260831,1.0,2/14,9.46%,GPX1;HPGD
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2870818790895477,0.8163601303751227,0.7282157676348547,0.9808464330156494,1.0,3/23,6.58%,PAX8;PAX2;LHX1
prerank,striated muscle contraction (GO:0006941),-0.23903492432109213,-0.8162807735873691,0.8140495867768595,0.9050521729108018,1.0,2/53,1.44%,ATP1A2;TPM1
prerank,positive regulation of inflammatory response (GO:0050729),0.2164677159029299,0.8151163267074655,0.8609271523178808,0.9824291089974051,1.0,8/86,7.50%,RPS19;S100A9;S100A8;PDE2A;SNCA;ETS1;NINJ1;TLR2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3296072007361597,0.8150609852048214,0.711340206185567,0.9816412396050004,1.0,3/13,13.73%,NOTCH1;EID2B;DLL1
prerank,tRNA aminoacylation (GO:0043039),0.256259717312626,0.8137009276762761,0.7956349206349206,0.983343633222356,1.0,8/37,14.30%,VARS1;GARS1;RARS1;FARSB;AIMP2;GATB;IARS1;GATC
prerank,positive regulation of integrin activation (GO:0033625),-0.3456322742144967,-0.8135490283252318,0.7244701348747592,0.9095320055965431,1.0,2/11,13.83%,RAP1B;P2RY12
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2763817655088927,0.8135306466194742,0.7494736842105263,0.9827806671741616,1.0,7/25,14.84%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A;RTN4
prerank,mitochondrion organization (GO:0007005),-0.1961729327891201,-0.8133648630152683,0.9349904397705545,0.9094058598404943,1.0,64/165,33.54%,PID1;TRAK1;OPA1;PRKN;LRRK2;MEF2A;DNM1L;CXADR;VPS13D;AFG1L;MIGA2;IFIT2;AIFM1;PPARGC1A;MTX3;GABPA;HCFC1;RHOT1;PARP1;NRF1;YME1L1;VPS13C;SIRT5;WASF1;STOML2;AIP;PARK7;MGME1;FIS1;TERT;TOMM7;PYROXD2;WDR81;FMC1;BNIP3;SIRT4;SSBP1;RHOT2;SIRT3;CLUH;PHB2;TIMM13;MFN2;SAMM50;TIMM44;LONP1;HIGD2A;MYH14;CHCHD10;MUL1;SUPV3L1;TOMM5;POLRMT;MIGA1;CYCS;FANCG;TWNK;HK2;TIMM9;PTCD2;AFG3L2;MTFR2;COX7A2L;ATP7A
prerank,chromatin assembly or disassembly (GO:0006333),-0.34233218544327315,-0.8131936807363976,0.7041742286751361,0.9092726211765927,1.0,1/11,1.47%,HDAC8
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.3256354906191518,-0.8130567256375472,0.7277882797731569,0.9090631434266196,1.0,5/13,30.87%,RHOT1;BMF;BNIP3;RHOT2;BCL2L11
prerank,ether lipid metabolic process (GO:0046485),-0.3242086749668264,-0.8124155792615091,0.6992337164750958,0.909748857297862,1.0,2/14,5.34%,AGMO;GNPAT
prerank,neural crest cell differentiation (GO:0014033),0.30569900280694967,0.8121842709561315,0.7057569296375267,0.9845031446916545,1.0,3/18,6.01%,NRG1;CDH2;CYP26C1
prerank,positive regulation of secretion by cell (GO:1903532),0.2249290629611131,0.8121563093375046,0.8409090909090909,0.9836572516840054,1.0,7/70,5.82%,CD33;CADPS;APBB1;SNCA;GRK2;APBB3;TGFB2
prerank,regulation of interferon-beta production (GO:0032648),-0.2436243792063657,-0.8114878884458051,0.8106060606060606,0.9109889828992102,1.0,17/46,27.36%,TBK1;PTPRS;DHX9;RNF216;MAVS;RIOK3;IRF1;DDX3X;TRAF3;OAS2;TLR4;PTPN11;NLRC3;POLR3D;SIRPA;DHX58;CACTIN
prerank,regulation of mRNA catabolic process (GO:0061013),0.20740493092278017,0.8114330895793601,0.8951612903225806,0.9841493952845976,1.0,17/121,10.80%,PRR5L;EXOSC5;YWHAB;PSMA1;HSPA8;RPS27A;UBC;AKT1;UBB;PSMD12;HSPB1;PSMA6;PSMB3;PABPC1;KHSRP;SET;APEX1
prerank,response to estrogen (GO:0043627),-0.27234435727302564,-0.8111663369328735,0.7724665391969407,0.911126022466108,1.0,6/31,16.74%,EP300;KMT2D;BCAS3;AR;TRIM25;CITED2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.32873964068309247,-0.811089930508904,0.7137254901960784,0.9107942028507975,1.0,6/13,22.45%,NUPR1;EIF2AK3;NR1H3;MBTPS2;LPCAT3;WFS1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2916517828956794,-0.8108999864411041,0.7392156862745098,0.9106906611041767,1.0,12/20,33.83%,PLOD2;PLSCR1;PTDSS1;SLC27A1;CHAC2;GSS;PTDSS2;GGCT;GCLC;HAGH;CNDP2;GAMT
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.32742420675051226,-0.8106692396907085,0.7326732673267327,0.9106597692214912,1.0,9/14,35.83%,TSEN2;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,"phototransduction, visible light (GO:0007603)",-0.31861087018049966,-0.8104831787021743,0.7123809523809523,0.910533028000672,1.0,8/14,47.71%,ABCA4;GNB1;SAG;PDE6A;CNGB1;PDE6G;GNA11;PDE6B
prerank,cellular lipid catabolic process (GO:0044242),-0.2748643209568088,-0.8100535494654637,0.7438330170777988,0.9108652108189212,1.0,12/27,36.45%,CYP1B1;ACOX1;LPIN2;ABHD12;LPIN3;ACOT8;MT3;ANGPTL3;SMPDL3B;NUDT19;FAAH;ACADL
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3318412907589516,-0.8098562901343322,0.7180451127819549,0.9107690248981742,1.0,6/14,23.76%,EHHADH;ACOX1;DECR2;AMACR;ACOT8;ACOX3
prerank,regulation of microtubule-based movement (GO:0060632),0.3372441116215925,0.8093380546758909,0.7186147186147186,0.9873247469996483,1.0,2/11,10.81%,MAP2;HAP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2643265874005223,0.8092310159807513,0.7677824267782427,0.9866735394099776,1.0,6/29,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.34547256696218526,0.8090170511834175,0.7184035476718403,0.9861750661585125,1.0,2/11,13.68%,SIRT1;XBP1
prerank,negative regulation of B cell activation (GO:0050869),-0.28631394801019905,-0.8079201602626513,0.7598425196850394,0.9137496584410552,1.0,11/21,39.22%,RC3H1;LYN;ID2;INHBA;CD300A;TNFAIP3;PARP3;INHA;FCGR2B;BANK1;SFRP1
prerank,positive regulation of vasoconstriction (GO:0045907),0.3234669713645748,0.8075243754407215,0.729957805907173,0.9881413603986323,1.0,3/13,10.86%,ADRA1D;ADRA1A;F2R
prerank,regulation of keratinocyte migration (GO:0051547),-0.33935094205548477,-0.8071905404547494,0.7335766423357665,0.914564153472173,1.0,3/12,10.53%,MAP4K4;MTOR;ADAM9
prerank,positive regulation of histone acetylation (GO:0035066),-0.28699889176511667,-0.8071670045326272,0.7690875232774674,0.9141452675671983,1.0,11/23,29.43%,BRD7;PPARGC1A;SMAD4;ARRB1;NOS1;PIH1D1;PAXIP1;RPS6KA4;RUVBL2;SPHK2;GLYR1
prerank,tryptophan metabolic process (GO:0006568),0.33553044569993723,0.8071651595044651,0.7257383966244726,0.987965548500755,1.0,11/11,66.47%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO;ATP7A
prerank,aerobic respiration (GO:0009060),0.2921439705117859,0.8071481968903584,0.7489361702127659,0.9871077340729315,1.0,3/20,7.95%,SDHC;ATP5F1D;SLC25A14
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3551343245984942,-0.8063886442193039,0.7184643510054844,0.9150095333364241,1.0,3/10,14.41%,DPP4;FAP;EMILIN1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.35035106764946955,-0.8062314676921823,0.7296786389413988,0.9148261225923542,1.0,1/11,0.80%,AFDN
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3151008149764968,0.8060008524819702,0.7440860215053764,0.9883283329354979,1.0,3/14,13.30%,CSTF2T;CSTF2;CPSF2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.31378879925643116,0.8058242277512763,0.7293868921775899,0.9877946510308081,1.0,2/15,3.31%,MIF;SIRT1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.31917981933259965,-0.8053561106685407,0.734375,0.9158813720006106,1.0,8/15,28.67%,RIPOR2;RAPGEF3;EHD2;ADAM9;MAPK14;CD53;CAMK1;EHD1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27987639264875475,-0.8053228003745104,0.7642436149312377,0.9154883170807296,1.0,9/22,27.78%,ERI3;ERI2;URB1;EXOSC9;EXOSC10;WDR12;EXOSC3;PES1;RRS1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3127027494448001,0.805007194691374,0.7333333333333333,0.9884038176191341,1.0,3/15,8.42%,TMSB4X;NOTCH1;HSPB1
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2089613779820093,-0.8048746246151484,0.8844621513944223,0.9158493277003878,1.0,37/105,29.40%,PTGIS;IRAK3;TRAFD1;PTPRS;MAPKBP1;EPHA4;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;CD109;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;SERPINE1;METRNL;CARD16;SHARPIN;FGF2;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3223486867361049,-0.8047672462239488,0.7341040462427746,0.9155508431646746,1.0,5/13,11.38%,MOV10;RC3H1;ZC3HAV1;UPF1;CNOT8
prerank,DNA replication checkpoint signaling (GO:0000076),0.3024426042588859,0.8046402513677665,0.7432712215320911,0.9882060348839796,1.0,1/16,1.66%,HUS1B
prerank,regulation of ATP metabolic process (GO:1903578),-0.23710252396496975,-0.8046077719931657,0.8067729083665338,0.9153896594501102,1.0,22/54,35.07%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT;ATP5IF1;FIS1;NUP98;NUP43;NUP160;ZBTB7A;NUP93;JMJD8;SPHK2;COX7A2L;ATP7A;NUP133;SEC13;NUP88
prerank,macrophage activation (GO:0042116),0.26032137136063843,0.8045677523005275,0.7945492662473794,0.9874643440558585,1.0,6/34,12.48%,CD93;SNCA;CLU;DYSF;AIF1;ITGAM
prerank,positive regulation of dephosphorylation (GO:0035306),0.2668948539536846,0.8041111315223353,0.7651991614255765,0.9874497133966195,1.0,9/27,20.82%,PPP1R16B;SMPD1;CALM1;CALM2;CALM3;PPIA;CAMTA1;PPP2R5A;MTMR9
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.27167088661697447,-0.8037282735791734,0.7753479125248509,0.9164455699116572,1.0,13/25,29.46%,YAP1;ARHGAP24;PRKCD;ODF2L;CAPZB;CDK10;TBC1D7;TCHP;SLIT2;KANK1;ARHGAP44;TESK1;PFN2
prerank,regulation of protein localization (GO:0032880),-0.2313380628877815,-0.8036399686939405,0.8262548262548263,0.9161508048917366,1.0,23/58,27.93%,AFDN;WDPCP;DLG1;UFL1;CSNK1E;PARP1;TRIM5;TPR;FBXW7;TRIM25;DZIP1L;PICALM;ITGB3;DVL3;PLEKHM2;BORA;RAB9A;TRIM68;KDM1A;RSL1D1;TESK1;CAMK1;TRIM46
prerank,glutathione biosynthetic process (GO:0006750),-0.3387231529117569,-0.8034249481834841,0.720226843100189,0.9160383348055001,1.0,6/11,33.07%,CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,protein import into mitochondrial matrix (GO:0030150),0.28960421863905983,0.8033500485518317,0.7505518763796909,0.9880598234051137,1.0,6/18,23.69%,TIMM21;DNAJC15;TOMM70;DNAJC19;TIMM17B;ROMO1
prerank,cellular response to UV (GO:0034644),-0.22081725170127453,-0.8033312358234688,0.8603773584905661,0.9157547665678325,1.0,24/76,25.44%,INO80;EP300;CREBBP;DHX36;PTPRK;IMPACT;DDB2;ZBTB1;PRKCD;USP47;PARP1;MMP2;EIF2AK4;SDE2;MFAP4;CARD16;PCNA;BMF;PPID;ATR;ERCC1;USP28;KDM1A;ACTR5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3386007941195871,-0.8033123115097015,0.7111111111111111,0.9153318472912645,1.0,3/11,14.50%,NBL1;CCN3;DUSP1
prerank,transition metal ion homeostasis (GO:0055076),-0.26921428198396646,-0.802708122926022,0.7533718689788054,0.9158589760881629,1.0,4/28,8.82%,CP;PRKN;SLC39A14;XIAP
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.20392843013297865,0.8026735750627506,0.9318181818181818,0.9883672872151201,1.0,25/124,18.41%,CAMK2A;LEF1;AP2M1;PSMA1;PLCB1;FZD6;GNG2;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;CALM1;FZD4;DVL1;PFN1;PSME3;PPP3CA;PSMC3;PSMA2;CTNNB1;AGO4;PRICKLE2;PSMB7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2602299912630071,0.8023707351905194,0.788135593220339,0.988041492132352,1.0,6/30,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,DNA replication (GO:0006260),-0.20617075378243988,-0.8023034226436754,0.9094488188976378,0.9161166831922231,1.0,42/105,34.62%,RBMS1;RBBP8;TOP1;BAZ1A;NBN;NT5M;WRN;UPF1;MCM9;REV1;ING5;MCM6;MRE11;HELB;CDK2;POLA2;RPAIN;ATR;CLSPN;DBF4;NAP1L1;DONSON;POLE2;RECQL5;KIN;ORC1;TIPIN;MCM4;TIMELESS;IGHMBP2;TOP1MT;POLD2;RPA2;RAD9A;PNKP;RMI2;CDC45;POLA1;BRCA1;PCLAF;RFC1;POLE
prerank,organophosphate catabolic process (GO:0046434),0.332011614902664,0.8021388841488053,0.7363083164300203,0.9875895663402322,1.0,1/11,4.79%,ENPP2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3495111681307046,-0.8021059624891591,0.702803738317757,0.9160092558023918,1.0,4/10,26.75%,PTPN22;DUSP10;PDCD4;AIDA
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.24945113280774267,0.8019365646783074,0.7775551102204409,0.9870964772793447,1.0,10/40,15.77%,BICD1;MAGI2;AHI1;HIP1;CLU;SGIP1;INSR;PPT1;B2M;TBC1D5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.34606663656871484,-0.8018668535685017,0.7295238095238096,0.9159570844379723,1.0,4/10,30.37%,ABCD2;NR1H3;ELOVL5;MLXIPL
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.293458575549546,0.8016636449695037,0.7371794871794872,0.9867111815576532,1.0,5/18,18.01%,SLA2;BCAR1;GPLD1;C3AR1;SH2B2
prerank,cytoplasmic translational initiation (GO:0002183),-0.30708680428640434,-0.8016595260760806,0.7351247600767754,0.9158344324364294,1.0,5/17,19.57%,EIF4A2;DENR;EIF3A;EIF4G1;RBM4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3252091857451476,0.801456044046882,0.7381443298969073,0.986226029213731,1.0,4/12,16.98%,MFSD2A;ACSL3;SOAT2;MTTP
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.33429872314972453,-0.8012356022161428,0.7541284403669725,0.9160981569608114,1.0,6/12,30.87%,ATF6;ERN1;PTPN1;PIK3R1;BAK1;BCL2L11
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2919089296404054,-0.8010415566692979,0.7557251908396947,0.9159678590536727,1.0,11/19,32.94%,TAF3;TAF8;TOPORS;MORC3;HNRNPU;PML;TAPT1;BBS4;CHCHD10;HK2;ARL2
prerank,microvillus organization (GO:0032528),-0.3222678610261661,-0.8004108069340529,0.7598566308243727,0.9165792511155818,1.0,4/13,16.99%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.3476995750393417,0.8003808049389436,0.75,0.9873182545298407,1.0,2/10,9.89%,NELL1;DAB2IP
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.35233252173347673,-0.8003632163531166,0.7295825771324864,0.916208089190974,1.0,3/10,10.53%,MAP4K4;MTOR;ADAM9
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23312982220484127,-0.8000807039789715,0.8330019880715706,0.9162068211973121,1.0,19/51,28.14%,SMG6;TNKS2;CCT6A;XRN1;CCT8;CTC1;CCT5;MAP2K7;EXOSC10;HNRNPU;TERF2;STN1;ATR;GNL3L;FBXO4;NEK7;NAT10;CCT3;PARN
prerank,regulation of protein localization to centrosome (GO:1904779),0.3530989571449724,0.7999167126248292,0.7268722466960352,0.9873268692654498,1.0,3/10,11.24%,BICD1;NUP62;APC
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.33605152406168,0.7994319236510661,0.7127659574468085,0.987368893129531,1.0,2/10,13.61%,SIRT1;DNMT1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.243551362656892,-0.7992296953240188,0.8290258449304175,0.9171587564227042,1.0,19/43,27.98%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;NABP2;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;NAE1;CLSPN;DONSON;ORC1;ABRAXAS1;FZR1
prerank,RNA modification (GO:0009451),0.23272744138635376,0.7987089190638995,0.8356435643564356,0.9878234081099357,1.0,6/54,8.12%,TSR3;AARS2;QTRT1;NSUN5;TFB1M;RBM15B
prerank,acute-phase response (GO:0006953),0.3307157848529494,0.7983453810966683,0.7515657620041754,0.9876167646701681,1.0,1/12,0.95%,MBL2
prerank,regulation of cellular response to stress (GO:0080135),-0.2049515637627989,-0.7983106560852661,0.8917835671342685,0.9182160684203752,1.0,17/115,11.11%,ROCK2;EP300;SMG1;ABL1;PRKN;NUPR1;GSK3B;RPTOR;RANBP2;CREBBP;CAMK2D;MTOR;NUP42;CAMK2G;BAG3;NUP214;MBTPS2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.19469695546985824,0.7983105021055431,0.9293139293139293,0.9868041883072343,1.0,32/163,18.41%,PDE4B;BTNL9;SLA2;VAV3;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;NFATC2;PAK3;CD38;PSMC3;PSMA2;BTK;SH2B2;NCKAP1L;FYN;PSMB7
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24028472244858656,0.7982325886161511,0.8263473053892215,0.9860659019126744,1.0,5/47,7.97%,GRM5;RPL10;NANOS3;KLF4;AKT1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3381313065010806,-0.7974008813026298,0.7208413001912046,0.9192693832992479,1.0,2/12,6.07%,NCOR1;STAT3
prerank,mitochondrial translational termination (GO:0070126),0.21038080615097193,0.7973965934226063,0.8951612903225806,0.9866870430037291,1.0,25/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,neuron fate commitment (GO:0048663),0.31769776785525217,0.7972496703190923,0.7665995975855131,0.9860762235553576,1.0,1/14,0.68%,MYT1L
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.23478730177576723,-0.7969998543483736,0.8407407407407408,0.9194471679116453,1.0,9/51,16.99%,PTN;IL34;HMGB1;THBS1;IL6R;VEGFA;VEGFD;CMKLR1;SERPINE1
prerank,positive regulation of rRNA processing (GO:2000234),-0.34831175659848945,-0.7962792850082928,0.7400379506641366,0.9201998148256564,1.0,3/10,16.52%,WDR43;DIMT1;BUD23
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3266415974163445,-0.7957889962480589,0.75,0.9205502751450856,1.0,5/12,23.93%,REST;JUN;HDAC1;INPP5K;TFAP4
prerank,indolalkylamine catabolic process (GO:0046218),0.3359487791099114,0.7947354186516016,0.7068607068607069,0.9896451213292623,1.0,10/10,66.43%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,regulation of viral life cycle (GO:1903900),-0.2799509226434724,-0.7946035301099634,0.7734806629834254,0.9220198706722175,1.0,5/21,14.32%,AXL;KPNA6;TRIM5;TRIM25;NECTIN2
prerank,cellular response to pH (GO:0071467),-0.29789676626048267,-0.7941592920355278,0.7508960573476703,0.9222789846776013,1.0,11/17,42.56%,SLC9A1;IMPACT;CHP1;MCOLN1;GPR68;PKD2L1;PKD1L3;HVCN1;KCNK4;RAB11FIP5;HYAL1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.31481588435399765,-0.7934822885258106,0.7490909090909091,0.9229392819398853,1.0,7/14,31.67%,RCC1L;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.33734698211130265,0.793356078819037,0.7023060796645703,0.991257863414209,1.0,2/10,7.97%,SNCA;AKT1
prerank,amyloid fibril formation (GO:1990000),0.23196015582579657,0.7932726297169138,0.8294573643410853,0.9905361794716576,1.0,12/51,14.59%,SNCA;PSENEN;RPS27A;UBC;UBB;H3-3A;NAT8;TSPAN14;SORL1;CD36;SERF1A;B2M
prerank,blood vessel endothelial cell migration (GO:0043534),-0.2790703583295178,-0.7929885719799342,0.7857142857142857,0.9232529907485142,1.0,9/22,25.21%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,regulation of neuron apoptotic process (GO:0043523),0.20693079485615773,0.7922196120080265,0.9081419624217119,0.9914730219253217,1.0,13/96,10.86%,MAG;GRID2;TRIM2;FOXQ1;NTRK2;TGFB2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,cGMP biosynthetic process (GO:0006182),-0.34826077996881744,-0.7921489805368133,0.7533206831119544,0.9241444340663052,1.0,2/10,17.36%,GUCY1A1;NPR2
prerank,translesion synthesis (GO:0019985),0.24003431281139176,0.7921440360306494,0.8414376321353065,0.9907268970304998,1.0,12/42,19.15%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26512352908876186,-0.7920226850685455,0.803921568627451,0.923891824825392,1.0,12/28,29.28%,CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;DONSON;E2F1;INTS7
prerank,inflammatory response (GO:0006954),-0.18945012288228197,-0.7919930498344643,0.9671179883945842,0.9234878989962267,1.0,34/195,19.18%,NFKB1;HDAC4;TPST1;KIT;TBK1;HSPG2;HMGB1;THBS1;STAT3;ADCY1;NOX4;ANXA1;TRAF3IP2;ABCF1;NFATC4;AGTR1;SCUBE1;PARP4;IL17D;CYBA;BDKRB2;LOXL3;CMKLR1;AFAP1L2;IL18;PTGDR;PIK3CD;TLR4;PXK;PTGFR;BLNK;NFATC3;BMP2;MGLL
prerank,global genome nucleotide-excision repair (GO:0070911),-0.26541714082804546,-0.7918111656221363,0.7933723196881092,0.9233121933857056,1.0,5/26,11.93%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2369346438031969,0.79157636186273,0.8208333333333333,0.9908619692769411,1.0,8/44,13.73%,RYR2;AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.29555767279922174,0.7913486763495795,0.7795275590551181,0.9904068226583025,1.0,5/19,14.35%,HNRNPC;TERF1;TEN1;PIF1;TINF2
prerank,protein methylation (GO:0006479),-0.24443817062379003,-0.7910369109350007,0.824,0.9241179309395455,1.0,14/40,22.30%,NSD3;NSD1;SETD3;PRMT2;N6AMT1;EHMT1;PCMT1;METTL21A;PRMT5;PRMT8;EEF2KMT;NTMT1;EZH2;CAMKMT
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2338148187647889,-0.7906233719863233,0.8435643564356435,0.9238901296680575,1.0,17/50,27.97%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2338148187647889,-0.7906233719863233,0.8435643564356435,0.9238901296680575,1.0,17/50,27.97%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,integrated stress response signaling (GO:0140467),0.316687054321377,0.7901011465770974,0.7536231884057971,0.9917318786504108,1.0,3/14,9.00%,OMA1;HSPA5;CCL2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2904490468708568,-0.7893191861723915,0.7647058823529411,0.9255646377857071,1.0,5/18,23.06%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,regulation of tissue remodeling (GO:0034103),-0.2977677218971464,-0.7891031423197808,0.7470588235294118,0.9254644898112473,1.0,4/18,16.81%,LEPR;RUNX1;SUCO;IL18
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3338355304456999,0.7888901467778803,0.7201834862385321,0.9929556615419046,1.0,11/11,66.64%,LPO;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;PKD1L3;PKD2L1
prerank,lysine metabolic process (GO:0006553),-0.3294823213106246,-0.7887056776718465,0.7649186256781193,0.9252012911016452,1.0,8/12,40.49%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,lysine catabolic process (GO:0006554),-0.3294823213106246,-0.7887056776718465,0.7649186256781193,0.9252012911016452,1.0,8/12,40.49%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3239109130898034,-0.788416187562265,0.7675276752767528,0.9251739923752134,1.0,4/13,13.95%,OS9;EDEM1;ERLEC1;UBAC2
prerank,cellular response to oxygen levels (GO:0071453),0.3410568782244977,0.7881129178252415,0.7316017316017316,0.9934082879493903,1.0,3/10,14.85%,ATP6V1A;ATP6AP1;TMEM199
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.27868056324137513,-0.7879847902555417,0.77882797731569,0.9253922465481692,1.0,5/21,11.32%,DAG1;HM13;NCSTN;ADAM9;ADAM19
prerank,renal absorption (GO:0070293),-0.3474646436911747,-0.7876039148035789,0.7411347517730497,0.9255547786527895,1.0,2/10,9.04%,GSN;WNK4
prerank,L-glutamate transmembrane transport (GO:0015813),0.34552330513793766,0.7873941768040705,0.7569892473118279,0.9937325243754422,1.0,2/10,5.82%,SLC1A1;SLC1A2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3122588441320888,-0.7866597863213196,0.7560975609756098,0.9266457347123135,1.0,6/14,25.93%,IRS1;ABCD2;LONP2;AKT2;TWIST1;PPARA
prerank,regulation of hormone secretion (GO:0046883),-0.3081191752402041,-0.786323849547522,0.7615384615384615,0.9267286918754027,1.0,3/15,8.49%,SNX6;ANXA1;VAMP2
prerank,lipid catabolic process (GO:0016042),0.2928288942006838,0.7863027679135239,0.7730192719486081,0.9946813105393866,1.0,3/18,14.53%,LIPE;HSD11B1;PPT1
prerank,copper ion transport (GO:0006825),0.32786508364792283,0.7862858939045365,0.7396963123644251,0.9938451333863536,1.0,3/11,15.26%,STEAP2;ATOX1;COX17
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32090314331820496,0.7861418924124582,0.7212389380530974,0.9932341560394772,1.0,1/12,1.19%,ADCY8
prerank,regulation of microglial cell activation (GO:1903978),0.3026885416565974,0.7850807414180534,0.7689075630252101,0.9941685983685077,1.0,1/15,2.79%,SYT11
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.27102839292852515,-0.7848237689508907,0.8076923076923077,0.9286365802047756,1.0,10/24,26.71%,TNKS2;XRN1;PARP1;CTC1;EXOSC10;HNRNPU;TERF2;STN1;GNL3L;NAT10
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2659858655704806,0.7848189031492238,0.8033126293995859,0.9937701470980956,1.0,3/27,6.39%,CHKA;PISD;PLAAT1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.34530555940080415,-0.7844574143204567,0.7485928705440901,0.9287639706581874,1.0,2/10,4.82%,RARB;RARG
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3194525735809708,-0.7840361192350791,0.7504835589941973,0.9289920740236662,1.0,3/13,18.02%,NIBAN2;EMILIN1;PTPN1
prerank,placenta development (GO:0001890),0.31952568237673246,0.783988746002729,0.7511210762331838,0.9942609523473013,1.0,2/12,12.29%,PPARG;E2F7
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33591825482240895,0.7833885992321308,0.7424892703862661,0.9943820152571269,1.0,5/10,24.41%,TERF2IP;APEX1;RTEL1;ACD;DCLRE1B
prerank,regulation of spindle organization (GO:0090224),-0.2951949057686469,-0.7833509159099806,0.7757201646090535,0.9295834909991276,1.0,10/18,39.20%,NUMA1;SENP6;MAP9;DYNC1H1;BORA;PARP3;TACC3;TPX2;FSD1;RNF4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2959770715767194,-0.7831897437066838,0.8022813688212928,0.929384142113932,1.0,10/17,32.81%,EMC2;EMC7;EMC9;GET4;EMC4;BAG6;EMC10;EMC3;GET3;EMC6
prerank,regulation of pH (GO:0006885),-0.33266898872227235,-0.783148964645055,0.7777777777777778,0.9289964123469496,1.0,2/11,7.13%,SLC9A1;ATP6V0A4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2548272118855611,-0.7830133503964368,0.7767175572519084,0.9287556584421842,1.0,7/31,14.78%,USP7;BRCC3;USP33;ABRAXAS2;USP50;OTUD4;USP13
prerank,zymogen activation (GO:0031638),-0.24021256991705697,-0.7829338954429315,0.8362235067437379,0.928424431913763,1.0,6/39,13.41%,CYFIP2;PLAT;CTSH;ASPH;MMP14;PGK1
prerank,translational termination (GO:0006415),0.20299958550885275,0.7825493184533061,0.9247524752475248,0.9948973307656287,1.0,26/95,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;ETF1;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.32512669492668966,-0.7821565219090028,0.7730627306273062,0.929171021543124,1.0,3/12,12.65%,HDAC8;RAD21;RB1
prerank,regulation of protein localization to cell surface (GO:2000008),0.25023808536413683,0.7821281394848649,0.8258196721311475,0.9947140454043101,1.0,4/33,7.89%,GPM6B;TMEM35A;STX3;HSP90AB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3039284979071266,-0.7821077779976735,0.769825918762089,0.9287934440091694,1.0,6/16,25.44%,ABHD5;LDLR;NR1H3;SLC27A1;DAGLB;PNPLA2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.24834631834642024,0.7814847775218892,0.8189300411522634,0.9949092149525443,1.0,2/36,1.66%,CHEK1;HUS1B
prerank,development of primary male sexual characteristics (GO:0046546),0.24874203987461982,0.7813096612720174,0.8326180257510729,0.9943491030455252,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,nucleotide-excision repair (GO:0006289),0.20480292235699737,0.7811948098303726,0.9190283400809717,0.9936996588448861,1.0,24/101,18.89%,HUS1B;SIRT1;COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;BRIP1;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;ATXN3;RFC2
prerank,negative regulation of DNA replication (GO:0008156),-0.3186678838723502,-0.7809167661942439,0.7726432532347505,0.930202762626881,1.0,9/13,44.85%,PDS5A;S100A11;CDAN1;ATR;WAPL;GMNC;TSPYL2;GMNN;CDC6
prerank,intermediate filament organization (GO:0045109),-0.300761911341247,-0.7805857620665022,0.7782026768642447,0.9302660979251152,1.0,6/17,36.22%,VIM;GFAP;DES;BFSP1;TCHH;KLHL24
prerank,epithelial cell development (GO:0002064),-0.280052125436499,-0.7800788617920076,0.7957198443579766,0.9305352871281903,1.0,15/20,51.43%,WNT5B;RILPL2;SIPA1L3;RILPL1;DACT2;BFSP1;EXPH5;ACTA2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;RAB25;ROS1
prerank,cranial nerve development (GO:0021545),0.32815829976951333,0.7796609141749016,0.7592997811816192,0.9952993772814787,1.0,2/11,13.09%,PAX2;TMEM126A
prerank,protein localization to mitochondrion (GO:0070585),0.3291972796322209,0.7796394768799,0.750561797752809,0.9944733367409286,1.0,3/11,11.37%,ISG15;AKT1;MTCH2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.29668327831428093,0.7792959737504486,0.7659574468085106,0.9941775951182052,1.0,1/15,0.80%,ATF3
prerank,synaptonemal complex organization (GO:0070193),-0.30186794181018706,-0.7792617110447809,0.7957198443579766,0.9308602124972316,1.0,8/15,46.99%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.30186794181018706,-0.7792617110447809,0.7957198443579766,0.9308602124972316,1.0,8/15,46.99%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,regulation of receptor internalization (GO:0002090),-0.2446180369086713,-0.7790480428023632,0.8390804597701149,0.9307331286411848,1.0,10/35,26.05%,ANGPT1;DLG4;MKLN1;ARF1;VEGFA;ARRB1;SFRP4;ANKRD13B;CD63;EGF
prerank,regulation of protein modification process (GO:0031399),-0.22634315201142755,-0.7789406004223732,0.8671726755218216,0.930438860457386,1.0,16/50,22.95%,KAT2B;LYN;IGF2;PLXNB2;FER;FNIP1;FN1;FKTN;NOP53;PHIP;SPRED2;PML;PPP2CA;ATG14;RABL3;CCAR2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23491590742233454,-0.7786740945467515,0.8515037593984962,0.930389062782937,1.0,22/48,34.01%,EP300;ABL1;BCL2;HIPK1;CASP2;PRKDC;TOPORS;IKBKE;MSH6;PML;USP28;BAG6;BCL2L2;HTRA2;E2F1;BAK1;HIC1;SNW1;BCL2L11;TNFRSF1B;BRCA1;PYCARD
prerank,iron-sulfur cluster assembly (GO:0016226),0.26779506874937503,0.7783130354867687,0.7864476386036962,0.9949067329200311,1.0,4/24,11.08%,NDOR1;IBA57;ISCU;ISCA2
prerank,nucleoside salvage (GO:0043174),0.32858533151130637,0.7775435076713408,0.7515400410677618,0.9952979617767922,1.0,2/10,7.42%,UCKL1;HPRT1
prerank,cellular response to interferon-gamma (GO:0071346),-0.20628965865183793,-0.7774040978857578,0.946257197696737,0.9318505630415285,1.0,21/88,17.53%,JAK1;SYNCRIP;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;GBP3;STAT1;DAPK1;IFNGR1;OAS2;GBP7;GBP2;TLR4;WNT5A
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3292430591568344,0.776893912604581,0.7315010570824524,0.9937860088105184,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3292430591568344,0.776893912604581,0.7315010570824524,0.9937860088105184,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.3292430591568344,0.776893912604581,0.7315010570824524,0.9937860088105184,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.23912994014457623,0.7765555519698853,0.83125,0.9934937204818418,1.0,5/38,9.89%,OTUD7A;SIRT1;CARD19;TRIM59;DAB2IP
prerank,negative regulation of kinase activity (GO:0033673),0.2235142525037406,0.7761161526015075,0.8760330578512396,0.9933755992071723,1.0,12/62,12.84%,CAMK2N1;PPM1F;SNCA;THY1;TRIB3;AKT1;YWHAG;HSPB1;CEP43;UBASH3B;DVL1;EPHA1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.28872332466165185,0.776078140081996,0.7861635220125787,0.9925925230926345,1.0,3/19,12.48%,TIRAP;TRIL;ITGAM
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2302084761139171,-0.7760163397158413,0.8627450980392157,0.9335089292955444,1.0,18/51,37.52%,HMGB1;STAT3;IL16;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;S100A13;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.33776637508490703,-0.7754869311952949,0.7796296296296297,0.9338367544243432,1.0,3/11,9.70%,STX18;VCPIP1;ATL2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.30281620073296545,-0.7754663025761128,0.7578125,0.932969272243878,1.0,4/15,17.08%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.30281620073296545,-0.7754663025761128,0.7578125,0.932969272243878,1.0,4/15,17.08%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26161889175970876,0.774803235229977,0.8043010752688172,0.9937427281819672,1.0,5/25,10.07%,AMPD1;GART;HPRT1;MTHFD1;GMPR2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2402986676194249,-0.7745690405716832,0.8326923076923077,0.9338392263969884,1.0,10/37,21.41%,NUPR1;GSDME;DNM1L;BCL2;BCLAF1;BECN1;NCK1;SFPQ;FIS1;BMF
prerank,ESCRT complex disassembly (GO:1904896),-0.33261567038440887,-0.7744570665154943,0.7679245283018868,0.9331015359702206,1.0,2/10,9.46%,VPS4B;CHMP5
prerank,ESCRT III complex disassembly (GO:1904903),-0.33261567038440887,-0.7744570665154943,0.7679245283018868,0.9331015359702206,1.0,2/10,9.46%,VPS4B;CHMP5
prerank,regulation of nuclear division (GO:0051783),-0.2813981012682958,-0.7743413573844004,0.7969348659003831,0.9328219479654741,1.0,7/20,26.56%,OBSL1;CDK13;RCC1;PRMT5;CUL7;BORA;CCDC8
prerank,neurogenesis (GO:0022008),-0.2322924495705315,-0.7739776180506422,0.8490566037735849,0.9329261445705659,1.0,5/43,7.02%,LPAR1;TRAK1;RYK;DAGLA;ANXA1
prerank,positive regulation of cell development (GO:0010720),-0.25212955447101476,-0.7736811629781248,0.8290766208251473,0.9329416028377898,1.0,11/31,30.12%,BMP4;NIBAN2;NUMBL;PDE3A;NUMB;CX3CR1;NKX6-1;SOX11;NAP1L1;GPER1;SNW1
prerank,ATP transport (GO:0015867),0.33837707234845865,0.7736474804164205,0.7900677200902935,0.9947258057791717,1.0,5/10,25.69%,SLC25A42;CD47;ABCC6;SLC25A5;SLC25A4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20671082776948727,0.7729569051884925,0.9254658385093167,0.9949344054839137,1.0,16/85,16.14%,MAGI2;AP2M1;PSMA1;FZD6;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;FZD4;DVL1;PFN1;PSME3;PSMC3;PSMA2
prerank,positive regulation of defense response (GO:0031349),0.2060606619541919,0.7727266352802409,0.9131403118040089,0.9944395419957524,1.0,8/89,7.50%,S100A9;S100A8;PDE2A;SNCA;NPAS2;ETS1;NINJ1;TLR2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2985440505576181,-0.7727022781416687,0.8070500927643784,0.9339430994043004,1.0,7/16,26.23%,TELO2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA
prerank,microvillus assembly (GO:0030033),-0.30435287838792996,-0.7725325764302418,0.7950530035335689,0.9337326466545295,1.0,4/14,16.99%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,regulation of DNA recombination (GO:0000018),-0.2527072716025312,-0.7719702337187371,0.8355640535372849,0.934106332174068,1.0,10/32,20.11%,SPIDR;PPP4C;PPP4R2;SETD2;SHLD2;MSH3;MRE11;ZRANB3;MSH6;H1-0
prerank,heterochromatin assembly (GO:0031507),-0.28599208522367714,-0.7718219575921123,0.799249530956848,0.9338569398519051,1.0,6/20,18.53%,EZH1;BAZ2A;MBD2;HDAC1;SMCHD1;RRP8
prerank,positive regulation of RNA splicing (GO:0033120),-0.2456957761949622,-0.7712134040045936,0.8216318785578748,0.9342870508392142,1.0,12/29,33.41%,U2AF2;DAZAP1;ERN1;NUP98;PIK3R1;RBM22;DYRK1A;SNW1;THRAP3;SF3B4;RBMX;HSPA1A
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.31835820899091993,0.7711271753322408,0.7638297872340426,0.995234889883781,1.0,4/12,15.14%,MELTF;SPRY4;ACTN4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.31835820899091993,0.7711271753322408,0.7638297872340426,0.995234889883781,1.0,4/12,15.14%,MELTF;SPRY4;ACTN4;CORO1C
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.24284888177843203,0.7706743969972819,0.8618556701030928,0.995071967878515,1.0,1/34,0.20%,SLC7A5
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2527104617694893,-0.770507334338065,0.8281853281853282,0.9348498958843272,1.0,9/33,19.24%,TBK1;DHX9;MAVS;RIOK3;IRF1;DDX3X;OAS2;TLR4;PTPN11
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.26175559303305684,0.7698704781041292,0.8252032520325203,0.9954604149249772,1.0,6/24,14.06%,RPS27A;UBC;UBB;RNF34;NOD1;TAB2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.33599688698241753,0.7697868855398912,0.7677824267782427,0.9947536265352721,1.0,4/11,12.95%,TERF1;CCT2;DKC1;CCT4
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.30839519235012774,0.7695637767190756,0.7627906976744186,0.994250093626069,1.0,1/13,2.83%,PTPRT
prerank,triglyceride metabolic process (GO:0006641),-0.22895668665464336,-0.7689709301741127,0.8658777120315582,0.9365950370054059,1.0,12/48,27.48%,AGMO;GK5;GPAT4;MOGAT3;APOE;LPIN2;LPIN3;GPAT3;LMF1;PNPLA2;LPL;SEL1L
prerank,reverse cholesterol transport (GO:0043691),-0.31383113872606294,-0.7687751363765591,0.7810760667903525,0.9364412533509605,1.0,2/13,14.08%,ABCA1;APOE
prerank,regulation of viral transcription (GO:0046782),-0.23900470040502741,-0.7683504659796736,0.8504854368932039,0.9366022410326499,1.0,15/39,28.24%,MDFIC;CCNT1;DHX9;UBP1;TRIM11;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3348468416640169,-0.7672727347492435,0.7655417406749556,0.9376973278820886,1.0,2/10,6.93%,KIT;LYN
prerank,regulation of histone deacetylation (GO:0031063),-0.31905502015916987,-0.7671001115873183,0.8086642599277978,0.9375146101848599,1.0,6/13,29.36%,CAMK2D;AKAP8L;NIPBL;SAP30BP;ZBTB7B;SPHK2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3090457465703969,0.7670704786433997,0.8004291845493562,0.9972507955959332,1.0,2/13,4.58%,TMSB4X;NOS3
prerank,protein-DNA complex assembly (GO:0065004),-0.1984974295280331,-0.7670161091950478,0.943089430894309,0.9371735511906164,1.0,43/116,34.75%,TCF4;GTF2H2;KAT6B;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;PSMF1;ERCC3;SPTY2D1;PSMB2;MCM6;ANP32B;DMC1;PSMC1;NAP1L4;PSMB6;PSMA3;GTF2H1;PSMA4;NAP1L1;ORC1;PSME1;ATRX;GTF2H4;PSMD13;MCM4;PSMB10;PSMA5;PSMB9;RBX1;UBA52;NAP1L2;RPA2;RAD51;PSME4;DDB1;CHAF1A;PSMB8;PSMD10;NAP1L3
prerank,protein localization to kinetochore (GO:0034501),-0.30324178191968265,-0.766957711297837,0.801094890510949,0.9368105113768274,1.0,8/14,44.99%,IK;CENPT;KNL1;TTK;RCC2;SPDL1;CDK1;MTBP
prerank,androgen metabolic process (GO:0008209),0.2864971899011755,0.7667346898431806,0.7887640449438202,0.9969284137922919,1.0,5/18,20.65%,SRD5A2;HSD17B7;HSD17B10;SRD5A1;HSD17B4
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.33182252863296285,-0.7662814358083613,0.7579737335834896,0.93731853877096,1.0,2/10,21.62%,RC3H1;SCRIB
prerank,microtubule-based transport (GO:0099111),0.31799347061778,0.7659588228439406,0.7652370203160271,0.9972717467695197,1.0,13/13,68.23%,DNAAF2;SPEF2;DYNC1I2;CCDC103;DYNC1I1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;HTT
prerank,sphingosine metabolic process (GO:0006670),-0.2827532999910324,-0.76592980886012,0.7821782178217822,0.9373660708658352,1.0,3/17,8.43%,PLPP3;ASAH2;ACER3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.24385913925920927,0.7657538030411497,0.8607594936708861,0.9967139552332367,1.0,6/33,11.40%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24744187867100614,-0.7654723935577167,0.8404452690166976,0.9375512086600288,1.0,8/33,16.16%,UBR2;RPTOR;MTOR;SESN1;UBR1;CASTOR2;KLHL22;CPEB1
prerank,gonad development (GO:0008406),-0.23514120472369004,-0.7653141443178262,0.8387096774193549,0.9373319767706743,1.0,5/41,10.06%,NR2F2;WNT4;KIT;AR;CSDE1
prerank,protein import into nucleus (GO:0006606),0.2155467006726267,0.7651165654167128,0.8747553816046967,0.9968497069230099,1.0,8/66,9.99%,IPO5;IPO4;MMP12;RPL23;NXT1;AKT1;NUP62;FAM53B
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1893783917828357,-0.7647023715906474,0.9622266401590457,0.9377332192501856,1.0,68/146,38.70%,FBXL7;PCM1;FHL1;ALMS1;ODF2;NINL;CEP63;CEP135;VPS4B;RAD51B;CENPJ;PCNT;CSNK1E;USP47;PSMF1;RAB11A;MAPRE1;PSMB2;YWHAE;CDC25B;AKAP9;DYNC1H1;CEP76;PRKACA;CEP57;CSNK1D;CDK2;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;ACTR1A;PSMA3;RAD51C;PSMA4;AVEN;HAUS3;PSME1;PSMD13;CEP41;PSMB10;PSMA5;PSMB9;RBX1;HAUS5;HAUS4;PINX1;PLK4;CEP72;SSNA1;CEP164;PSME4;CKAP5;PSMB8;PSMD10;TUBA1A;TPX2;CEP131;RCC2;SKP1;PSMD3;NEDD1;CENPF;PAFAH1B1;CDC25A;DTL;HMMR
prerank,non-motile cilium assembly (GO:1905515),-0.2549101648125406,-0.7645199019605025,0.844,0.9375511824747381,1.0,9/30,19.90%,PCM1;PIBF1;ARL13B;IFT88;C2CD3;TOGARAM1;CSNK1D;GORAB;CEP89
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27031969910817505,-0.7643921011115143,0.8152985074626866,0.9372792474548127,1.0,5/22,18.34%,CD55;ZBTB1;TRAF2;FBXO38;TRAF6
prerank,membrane repolarization during action potential (GO:0086011),0.30589828962767573,0.7637470059744285,0.7943548387096774,0.9980965740896135,1.0,3/13,13.24%,KCND3;ATP1A1;ATP1B1
prerank,male gonad development (GO:0008584),0.2416390483826547,0.7635006508024206,0.8476394849785408,0.9976190484891232,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.25121755269327817,-0.762779503234391,0.8432122370936902,0.9391386393792308,1.0,10/30,22.46%,PIBF1;PTPN2;PRKCD;PARP14;PRKCZ;SH3BP5L;NF2;MVP;PPP2CA;CD300A
prerank,skeletal muscle contraction (GO:0003009),0.278859439768873,0.7606942966251861,0.7644628099173554,1.0,1.0,19/19,72.15%,TCAP;STAC2;STAC;TNNI3;STAC3;MYH8;MYH3;MYH7;CHRNA1;TNNT1;JSRP1;TNNC2;TNNI2;RCSD1;CCDC78;TNNC1;TNNI1;TNNT3;MYH14
prerank,regulation of astrocyte differentiation (GO:0048710),0.31276886758070854,0.7606557704195563,0.8052208835341366,1.0,1.0,2/12,5.70%,BIN1;NOTCH1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.2674418801729176,0.7605610700746743,0.814968814968815,0.9994261705507288,1.0,2/22,5.87%,HCAR2;ALK
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.24389756528775697,-0.7603108846751566,0.8527724665391969,0.9421461438593643,1.0,15/33,35.61%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;NIT2;ALDH4A1;SIRT4;DGLUCY;GCLC;GOT1;CAD;PYCR2;GOT2;PYCR3
prerank,actin filament network formation (GO:0051639),0.3189994138140925,0.760259763818646,0.7703252032520326,0.9990680590295928,1.0,2/11,7.33%,FHOD3;SPIRE2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24430721162131333,0.7600757707757124,0.8433476394849786,0.9984596900390555,1.0,1/31,0.13%,TFRC
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.291863817477567,-0.7600122416532327,0.8014440433212996,0.9421143434280972,1.0,4/15,13.18%,NLGN2;STXBP1;SYN3;USP46
prerank,mesoderm development (GO:0007498),0.2769975951022969,0.7598499512008136,0.8086021505376344,0.9979631527706183,1.0,1/18,1.78%,TIE1
prerank,mitochondrial translation (GO:0032543),0.19596314233340673,0.7596032084192562,0.9302788844621513,0.9974852408043018,1.0,24/104,20.09%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;GATB;GATC;MRPL54;MRPS5;NDUFA7;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2767998731922765,-0.7591290309426477,0.8187022900763359,0.9428808659042074,1.0,12/20,38.25%,TXNIP;TXN;P2RX4;IL18;SUGT1;PSTPIP1;APP;C3;PYCARD;CASP1;NT5E;ANO6
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22544500063899947,0.7588585099070139,0.8679245283018868,0.9977482778274962,1.0,9/50,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;ISG15;AKT1;PER2;SMAD7;RPS3
prerank,copper ion homeostasis (GO:0055070),0.28268721155607,0.7584543378682539,0.7970401691331924,0.9974812287092667,1.0,1/17,0.93%,MT2A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2657514486283163,0.7580791656777938,0.8205645161290323,0.9971935887137869,1.0,4/23,8.04%,COPS6;RPS27A;UBC;UBB
prerank,regulation of lipase activity (GO:0060191),0.30640405083399636,0.7579539192442122,0.7967145790554415,0.9965451617580681,1.0,2/13,4.81%,SNCA;PCSK6
prerank,cellular response to fluid shear stress (GO:0071498),-0.3187957389733348,-0.7568112505590847,0.7911877394636015,0.9455956576647403,1.0,7/12,29.54%,MEF2C;PKD2;ASS1;MAPK7;MTSS1;HDAC3;NFE2L2
prerank,B cell proliferation (GO:0042100),-0.2925690746678986,-0.7565029835749311,0.8125,0.9455417966655002,1.0,3/17,16.87%,BCL2;MEF2C;CTPS1
prerank,nucleosome assembly (GO:0006334),-0.2447493043828715,-0.7561839876818041,0.8390804597701149,0.9455090094875088,1.0,7/31,16.43%,KAT6B;UBN1;HAT1;CABIN1;SPTY2D1;ANP32B;NASP
prerank,negative regulation of innate immune response (GO:0045824),-0.2404248445957803,-0.7559652640326818,0.8508604206500956,0.9453728943263618,1.0,13/34,29.58%,SERPING1;YTHDF3;IRAK3;TRAFD1;PTPN2;USP18;NLRC3;DHX58;CACTIN;GRN;MUL1;TNFAIP3;SAMHD1
prerank,positive regulation of TOR signaling (GO:0032008),-0.232438106345409,-0.7558122530271002,0.8757281553398059,0.945101243170819,1.0,21/40,41.44%,RPTOR;FNIP1;TELO2;WDR59;RICTOR;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA;HDAC3;RRAGC;SEC13;MIOS;LAMTOR4;LAMTOR5;SEH1L;WDR24;TREM2;HTR6
prerank,spermatid development (GO:0007286),0.24478985652003007,0.7557692825025518,0.8354166666666667,0.9988918619568817,1.0,5/32,15.12%,JAM2;NME5;IQCG;CIB1;ING2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.3205309251818914,-0.7554226279035274,0.7783882783882784,0.9451838876967518,1.0,1/12,5.93%,NBN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1904284018507768,-0.7550127663829167,0.9765166340508806,0.9452539775705867,1.0,64/125,40.47%,EML4;MAP4;RANBP2;PCNT;NDEL1;SETD2;DYNC1LI1;MAPRE1;NUDC;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;PMF1;EFHC1;NEK6;TAOK1;WDR62;NUP98;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;SUN2;INCENP;KIF11;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;TACC3;CKAP5;RAN;AHCTF1;NUP133;SEC13;TTK;B9D2;CENPI;DCTN6;RCC2;CENPH;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA;CENPQ;SGO1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2516287893301035,-0.7549252391955051,0.8623326959847036,0.9449141832848856,1.0,14/29,35.48%,YTHDF3;UBE2K;PTPN2;MAVS;WNT5A;PTPN1;PTPN11;USP18;CACTIN;MUL1;SAMHD1;PTPN6;ZBP1;TTLL12
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.29528256319376545,-0.7548774830234828,0.8052434456928839,0.9445214547006577,1.0,3/15,8.56%,RAB10;RAB3GAP1;EDEM1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.31220994205661184,-0.753918331872222,0.7981818181818182,0.945346625979154,1.0,6/12,30.12%,CYP26B1;DHRS3;CNOT1;EZH2;CALR;SNW1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.31691465535120544,-0.7539107384292144,0.7758620689655172,0.9449082168014071,1.0,6/12,27.02%,CCT6A;CCT8;CCT5;GNL3L;CCT3;GNL3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.24651218753831095,-0.7538948244301209,0.8480492813141683,0.9444815380868002,1.0,4/33,10.83%,IL34;ACIN1;RUNX1;ID2
prerank,ceramide catabolic process (GO:0046514),0.2921389922813796,0.7538640193811968,0.7757201646090535,1.0,1.0,6/14,20.72%,ACER2;NEU2;GLA;HEXB;NEU1;NEU4
prerank,bile acid biosynthetic process (GO:0006699),-0.2620307809838459,-0.7536256298855016,0.8130841121495327,0.9443792877253302,1.0,6/24,22.47%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3
prerank,sulfur amino acid metabolic process (GO:0000096),-0.25964097793948776,-0.7533741635326543,0.8557114228456913,0.944254525353475,1.0,12/24,39.17%,MMUT;NOX4;MTHFR;TXN2;CBS;GCLC;CDO1;MTR;CTH;ADO;MPST;AHCY
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2883939841254632,-0.753115304205539,0.7996146435452793,0.9441270562538102,1.0,7/16,30.47%,PIGN;PIGH;PIGC;PIGA;PIGZ;PIGP;PIGF
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2604869737058375,0.7530723588791626,0.8502202643171806,1.0,1.0,5/25,11.76%,RPL23;HSP90AB1;RPL5;HIPK2;RPS7
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.20835670988045124,0.7527191651585039,0.929637526652452,1.0,1.0,10/69,10.86%,MAG;FOXQ1;NTRK2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22569395983062138,-0.7523705846303329,0.8906882591093117,0.9446970940711777,1.0,10/49,18.92%,LBP;HMGB1;STAT3;F3;MAVS;IL17D;AFAP1L2;SERPINE1;TLR4;PARK7
prerank,UV protection (GO:0009650),0.3178103210632782,0.7523218276318353,0.7831050228310502,1.0,1.0,2/10,9.45%,GPX1;ERCC2
prerank,regulation of macrophage migration (GO:1905521),0.3283289539204556,0.7515788824100795,0.8079470198675497,1.0,1.0,2/10,9.54%,MTUS1;CD200R1
prerank,glucose metabolic process (GO:0006006),0.21234870613881487,0.7513727844567445,0.908315565031983,1.0,1.0,9/58,15.24%,OMA1;PGAM1;KCNJ11;SLC37A4;ALDOC;GDPGP1;PER2;ADPGK;ATF4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.20618405685076874,0.7509227106659052,0.917864476386037,0.9999212740501408,1.0,10/74,8.73%,EPAS1;PSMA1;NOTCH1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3
prerank,negative regulation of ATPase activity (GO:0032780),0.28523170601901376,0.7507293877297163,0.7694013303769401,0.9993686496250904,1.0,4/16,22.80%,SIRT1;VCPKMT;OXA1L;TNNI3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2860757280533824,0.7496947072497746,0.8197424892703863,0.9999999102289369,1.0,5/17,16.57%,CALM1;SMAD7;CALM2;CALM3;DDIT4
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.25828567243939304,-0.7495753221692529,0.8520599250936329,0.94790412057572,1.0,9/24,23.62%,JPH1;CAMK2D;SELENON;PKD2;SRI;PRKACA;NOS1;GSTM2;JPH2
prerank,membrane raft organization (GO:0031579),0.2879055131247356,0.7491784401099517,0.8189655172413793,0.9999043992336943,1.0,4/15,14.53%,FA2H;NAXE;RFTN1;PPT1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.30900671121368534,0.748133173565441,0.8008752735229759,1.0,1.0,2/12,8.88%,THY1;SKAP1
prerank,protein import (GO:0017038),0.20454930879394986,0.7481094301092429,0.9211538461538461,0.9997222975121463,1.0,9/84,9.99%,IPO5;IPO4;MMP12;GDAP1;NXT1;CLU;AKT1;NUP62;FAM53B
prerank,regulation of cell cycle process (GO:0010564),-0.1920456264967946,-0.7479789224096125,0.9670103092783505,0.9495363902417548,1.0,20/104,16.13%,KIF13A;BIRC6;KLHL13;NUMA1;UVRAG;OBSL1;CDC42;MARK4;CDK13;SETD2;RAB11A;BECN1;TTL;PIK3C3;MAP9;RCC1;CSNK2A1;PIK3R4;DYNC1H1;PRMT5
prerank,negative regulation of DNA recombination (GO:0045910),-0.2293889747228646,-0.7477416969353122,0.8865784499054821,0.9493750904911824,1.0,19/43,29.38%,KLHL15;SHLD2;MSH3;HELB;ZRANB3;SMCHD1;POLR2H;MSH6;TERF2;H1-0;POLR2K;POLR2E;UBQLN4;ATRX;FANCB;POLR2D;CGAS;PARP3;MAD2L2
prerank,regulation of T cell chemotaxis (GO:0010819),-0.31635355494360706,-0.7475847896455775,0.8013937282229965,0.9491209457842639,1.0,6/11,39.92%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CXCL10
prerank,tRNA wobble base modification (GO:0002097),-0.2974386144915661,-0.7475581530371029,0.8164435946462715,0.9487087384968181,1.0,10/14,44.32%,TRMT9B;ALKBH1;DPH3;GTPBP3;MTO1;ALKBH8;MOCS3;ADAT2;CTU2;CTU1
prerank,actin-myosin filament sliding (GO:0033275),0.23313716654155003,0.7472366460786949,0.889763779527559,0.9992702742469257,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,muscle filament sliding (GO:0030049),0.23313716654155003,0.7472366460786949,0.889763779527559,0.9992702742469257,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,regulation of smooth muscle contraction (GO:0006940),-0.26730113802503297,-0.7469334665617263,0.8232044198895028,0.9490660979920368,1.0,6/20,23.05%,PLCE1;SETD3;ATP2B1;CTTN;SPHK1;NMU
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2127130988062696,-0.7468960489899806,0.9256360078277887,0.9486644358661213,1.0,4/59,4.06%,ALDH1A2;CYP7B1;CYP27A1;ABCD3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.24049015143205626,-0.7467807040243496,0.8600746268656716,0.9483824143107115,1.0,7/33,22.71%,FBN1;MTOR;TLR4;TRAF6;GPR137B;TCTA;MAFB
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.30851171928676624,-0.746440620759919,0.797752808988764,0.9483846160715792,1.0,3/13,16.40%,ENPP1;ENPP3;ENTPD6
prerank,nucleus organization (GO:0006997),0.22075905566660958,0.7463165793374328,0.8904382470119522,0.9997215402105828,1.0,14/47,21.20%,SYNE1;RPS19;BIN1;SUN1;LEMD2;NUP205;REEP3;NUP54;CHMP2B;PITPNB;PDCD6IP;VPS4A;CHMP2A;CHMP7
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2843024574602334,-0.7458547494183712,0.8175182481751825,0.9486841285639014,1.0,7/16,24.36%,AMPD3;GMPS;PPAT;ATIC;PAICS;AMPD2;NUDT2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.21578199070781467,-0.745814196848456,0.900952380952381,0.948299131199509,1.0,13/49,21.41%,NUPR1;GSDME;DNM1L;UBQLN1;EIF2AK3;BCL2;BCLAF1;BECN1;DDX3X;DAPK2;FIS1;P4HB;BMF
prerank,prostanoid metabolic process (GO:0006692),-0.30394311143707736,-0.7452849509709223,0.8054545454545454,0.9485203538206615,1.0,6/13,34.19%,PTGS1;PTGES;ACOX1;CYP2S1;PTGR2;PTGR1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.27869436175037837,0.7448329819963516,0.8129032258064516,1.0,1.0,7/16,25.35%,SCD;PPT1;ACSS1;PPCS;ACAT1;DIP2A;HSD17B8
prerank,sister chromatid segregation (GO:0000819),-0.24287933727944855,-0.7442544243148683,0.8563106796116505,0.949380615933018,1.0,8/31,20.39%,INO80;SMC4;RB1;KLHL22;ZWINT;LATS1;TOP2B;SMC1A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.22865232852351128,-0.7438722639073613,0.8759842519685039,0.9494047825451021,1.0,5/39,7.81%,ANK2;FHL1;WWP2;PTPN3;CACNA1D
prerank,pore complex assembly (GO:0046931),-0.2728376600138532,-0.7436022956967512,0.8267419962335216,0.9492797779593668,1.0,3/19,12.59%,AFDN;TPR;GSDMD
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.2371385330673691,0.743276028686046,0.8762677484787018,1.0,1.0,7/35,14.59%,BICD1;HIP1;SNAP91;CLU;SGIP1;PPT1;B2M
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.2599204788257252,0.7431148315659373,0.8347826086956521,1.0,1.0,6/22,14.32%,GPNMB;TAOK2;PDGFB;CALM1;CALM2;CALM3
prerank,mitochondrial transport (GO:0006839),0.21755780624841514,0.7424822790628898,0.9023354564755839,1.0,1.0,19/53,25.69%,GDAP1;PITRM1;TIMM22;TMEM14C;TSPO;BCS1L;HSP90AA1;TOMM70;OXA1L;STARD3;TIMM10B;DNAJC19;ABCB10;TIMM17B;BCAP31;SLC25A5;MFF;TOMM22;SLC25A4
prerank,acylglycerol catabolic process (GO:0046464),0.24811749511568978,0.7423006635869047,0.8522483940042827,1.0,1.0,3/30,11.76%,ABHD2;LIPE;FABP5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.21398436884114053,-0.7418006043223141,0.9324055666003976,0.9510576033353763,1.0,22/54,38.03%,MDM4;EP300;TFDP2;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1;PLAGL1;RBL2;GADD45A;SFN;TRIAP1;TP53;PLK3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.29036052520655997,-0.7413094107581821,0.8302238805970149,0.9511705785907189,1.0,2/15,11.25%,MOXD1;SAT1
prerank,bile acid metabolic process (GO:0008206),-0.25144601378953735,-0.7411006332845217,0.8394833948339483,0.9509906097290555,1.0,7/27,24.69%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3;GBA2
prerank,cellular response to inorganic substance (GO:0071241),0.2647283479922422,0.7408736828391086,0.8577680525164114,1.0,1.0,3/21,11.79%,KCNC2;DDX11;FOXO1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24296820731390636,-0.7401211020821641,0.8970873786407767,0.9517812559343601,1.0,13/32,37.00%,CDK16;TFDP2;ID2;RB1;HINFP;PCNA;NPAT;ORC1;E2F1;CDC45;POLA1;CDK15;CDK18
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.30821464183285496,0.7400441322070255,0.8252631578947368,1.0,1.0,2/11,9.62%,SMARCB1;DDX11
prerank,regulation of phosphate metabolic process (GO:0019220),0.28238798232740003,0.7399235116629534,0.8354430379746836,1.0,1.0,5/16,19.82%,PGAM1;CD24;PSEN1;BARD1;SMG5
prerank,intracellular protein transmembrane transport (GO:0065002),0.22313839124368826,0.7397596047337839,0.9042553191489362,1.0,1.0,11/42,21.64%,CHCHD4;HSPA5;TIMM21;DNAJC15;RTN2;HSPD1;SEC61G;TOMM70;DNAJC19;SEC61A2;TIMM17B
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2272285047993014,-0.7396952884052845,0.8936567164179104,0.9518596103672994,1.0,11/39,22.45%,PI4KA;SMG1;PIP4K2C;TTC7B;EFR3A;PIK3C3;SOCS7;PIK3CD;ITPKC;PIK3R1;PI4K2B
prerank,lipid biosynthetic process (GO:0008610),-0.20006497007862173,-0.739398279030162,0.9529190207156308,0.9517483451288606,1.0,25/77,32.51%,ACSL1;PRKAA2;ABCD3;GNPAT;AGPAT4;PDSS2;GPAT4;ACSL6;HMGCR;PRKAA1;CYP51A1;CBR4;LPCAT1;DHRS11;FDFT1;MVK;LPL;CLN8;OXSM;DOLPP1;PDSS1;FITM2;STAR;MCAT;SREBF1
prerank,rRNA catabolic process (GO:0016075),0.2844412707632737,0.7393078986858662,0.8236559139784946,1.0,1.0,1/16,0.97%,EXOSC5
prerank,stress-activated MAPK cascade (GO:0051403),0.2123683158456621,0.7389687962735649,0.9402985074626866,1.0,1.0,17/61,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;TAOK2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;MAPK3;ADORA2B;NOD2
prerank,positive regulation of receptor internalization (GO:0002092),0.2618948955812568,0.7389176484080991,0.8325991189427313,0.9995490971431564,1.0,2/22,3.00%,MAGI2;AHI1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2896607307778237,0.7388290400475157,0.8373101952277657,0.9988480073494744,1.0,1/14,0.90%,TIRAP
prerank,positive regulation of phosphatase activity (GO:0010922),0.2607095893316011,0.7385070384449975,0.8438914027149321,0.9984582128881498,1.0,6/21,16.58%,MAGI2;HSP90AB1;CALM1;CALM2;CALM3;GPLD1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2093586289157628,-0.7379748911178524,0.9188191881918819,0.9530695729617944,1.0,25/67,35.74%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;CYBA;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2518003041436322,-0.7378927872553982,0.8633879781420765,0.9527243466432898,1.0,11/27,29.85%,RRM2B;CTPS2;AK6;DTYMK;CTPS1;NUDT13;NME1;RRM1;GSR;AK1;TXNRD1
prerank,T cell receptor signaling pathway (GO:0050852),0.18347890825111204,0.7377753133641498,0.9938144329896907,0.9985403085732575,1.0,23/138,16.14%,PDE4B;BTNL9;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;PAK3;PSMC3;PSMA2
prerank,mesoderm formation (GO:0001707),-0.2797328348971427,-0.7377450465740462,0.8330206378986866,0.952444211652868,1.0,5/17,24.74%,ITGB1;SMAD2;ITGB3;ITGA8;SNAI1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.23010696470489106,-0.7375698083992537,0.873046875,0.9522101017307858,1.0,8/36,16.87%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.27724650702571746,-0.7375113904162538,0.8326848249027238,0.9518367535336824,1.0,7/18,25.97%,LBP;SBNO2;ENPP3;IFI35;KARS1;SYK;FCER1G
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2663860776976358,0.7373619587153245,0.8385744234800838,0.9982211327108163,1.0,3/18,9.38%,SMS;ASNS;MTHFD1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.30911525910164606,0.7369095434791244,0.8195991091314031,0.9979855780752641,1.0,3/12,11.30%,SIRT1;TRIB3;ERLIN2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3129571315666948,0.7363175193401881,0.789247311827957,0.9979215867821057,1.0,2/11,11.56%,SEMA6A;KLF2
prerank,organelle fusion (GO:0048284),-0.2590316399363035,-0.7356698590019849,0.8493408662900188,0.9535551894196003,1.0,4/22,11.22%,OPA1;EEA1;MIGA2;STX4
prerank,regulation of viral release from host cell (GO:1902186),0.2641871970877455,0.7356125590263718,0.8638211382113821,0.9979993836929888,1.0,8/21,21.05%,TRIM13;TRIM62;MID2;TRIM35;CHMP2B;VPS4A;CHMP2A;TRIM21
prerank,regulation of T cell migration (GO:2000404),0.27006947153091243,0.7352166995980195,0.828693790149893,0.9976740271745854,1.0,5/18,19.30%,CXCL12;CD200R1;AIF1;DOCK8;LRCH1
prerank,axonal fasciculation (GO:0007413),-0.3079407559012638,-0.7350690662581443,0.8443579766536965,0.9538224653453913,1.0,5/12,25.76%,EPHA3;EPHA4;MEGF8;ARHGAP35;EPHB3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2379299087901442,0.7338967487699324,0.8819742489270386,0.9984795645716928,1.0,10/30,19.16%,GPX1;NOS3;ARHGEF2;RNF34;TNFSF10;RFFL;FAIM2;TMBIM1;RIPK1;FAIM
prerank,transcription preinitiation complex assembly (GO:0070897),-0.305396488245261,-0.733329982382989,0.8173598553345389,0.9553734860327483,1.0,4/12,26.50%,TBP;GTF2B;TAF12;TAF7
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.25111308856373843,0.7321242812103357,0.8530020703933747,0.9999268368738259,1.0,6/24,15.61%,ATF3;HSPA5;NOTCH1;KLF2;ATF4;CHD6
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24504429521172594,-0.7315512051513127,0.8747591522157996,0.9570149305059439,1.0,5/30,17.41%,PIBF1;HMGB1;STAT3;PRKCZ;TLR4
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.30386223373492827,0.7307541838286807,0.8265524625267666,1.0,1.0,2/11,6.51%,ANK3;PRKCQ
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.314287729001068,-0.730642981469557,0.8227611940298507,0.9576280507224145,1.0,3/11,11.51%,ENPP3;TPK1;CTPS2
prerank,magnesium ion transport (GO:0015693),0.3052200358545182,0.7304023584640663,0.8285714285714286,1.0,1.0,5/12,18.64%,NIPA1;NIPAL3;NIPAL4;MMGT1;MAGT1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.28131626137675153,0.7302602150445549,0.8089171974522293,0.9997820605457344,1.0,5/15,20.80%,ORMDL1;ORMDL2;SAMD8;TNFRSF1A;RACK1
prerank,heart looping (GO:0001947),0.2236811108398074,0.729722307508136,0.893970893970894,0.9996884763264781,1.0,7/40,13.73%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,mRNA stabilization (GO:0048255),-0.22435554827095566,-0.7287934605671378,0.8917835671342685,0.959261353347309,1.0,10/40,18.05%,SYNCRIP;EIF4ENIF1;FUS;DHX9;LARP1;YBX3;YBX1;TENT5A;HNRNPU;PAIP1
prerank,response to gamma radiation (GO:0010332),0.2532289607672847,0.7286440258302963,0.8624229979466119,1.0,1.0,9/24,20.96%,TMEM109;TRIM13;MEN1;HRAS;ATM;XRCC5;MDM2;CRYAB;TSPYL5
prerank,phospholipid dephosphorylation (GO:0046839),0.22980571606016734,0.7276552215710756,0.9026548672566371,1.0,1.0,6/37,10.19%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP4;MTMR6
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.21110591920864957,0.7275785529406946,0.9210526315789473,0.9998283637889849,1.0,14/56,16.71%,ANLN;ANK3;STMN1;TRIM36;SPIRE2;RAB35;NUSAP1;APC;SPTBN1;CIT;EFHC2;BIN3;MYH10;USP8
prerank,cellular response to chemokine (GO:1990869),-0.21729177510879732,-0.727429507295413,0.9280442804428044,0.9604021783817428,1.0,5/46,10.27%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.31666208454161016,-0.7272085769178268,0.8490566037735849,0.9601948006254599,1.0,6/10,37.56%,RFWD3;WDR76;CCAR2;RPA2;FEM1B;ETAA1
prerank,synaptic vesicle localization (GO:0097479),0.2908671486666475,0.7269024711634199,0.831858407079646,0.9998716802328715,1.0,1/13,1.68%,NLGN1
prerank,endoderm development (GO:0007492),0.29026763437177805,0.7267780521192552,0.8316008316008316,0.9992278650366753,1.0,3/13,15.20%,LHX1;SOX17;SOX7
prerank,purine-containing compound salvage (GO:0043101),0.2941737869391736,0.7251846897951244,0.8181818181818182,1.0,1.0,3/12,10.07%,AMPD1;HPRT1;GMPR2
prerank,mitotic chromosome condensation (GO:0007076),0.2525062349002951,0.7249689788130199,0.8692946058091287,0.9998289339740575,1.0,5/26,10.27%,CSNK2B;TENT4A;NUSAP1;SET;NCAPH2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.25141480655509035,-0.7249454722000676,0.8842504743833017,0.9622862448824547,1.0,5/25,12.60%,B3GALT1;EXT1;HS2ST1;NDST1;NDST2
prerank,regulation of chemokine production (GO:0032642),0.2230416863616306,0.7248167534747904,0.9031578947368422,0.9992012021303008,1.0,4/36,10.48%,CSF1R;IL7;TLR2;AIF1
prerank,folic acid metabolic process (GO:0046655),-0.27447062431540425,-0.7243670150624784,0.8665377176015474,0.9625151536158383,1.0,3/18,17.55%,MTHFR;MTHFD2L;ALDH1L1
prerank,regulation of adaptive immune response (GO:0002819),0.2691263016286801,0.7243642328190654,0.851528384279476,0.9989266721768146,1.0,3/18,11.90%,SIRT1;SKAP1;IRF7
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19991002367387226,-0.72350556333819,0.9654510556621881,0.9630224478207814,1.0,20/70,29.10%,FOXC1;ABL1;YAP1;RUNX1;PSMF1;TCF3;EIF2AK2;PSMB2;PRKDC;PSMC1;KMT2A;PSMB6;PSMA3;PSMA4;LDB1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,triglyceride homeostasis (GO:0070328),0.24389477688756364,0.7230682200375174,0.8734693877551021,0.9996466336116079,1.0,5/26,13.93%,SIRT1;DGAT2;SCARB1;XBP1;ANGPTL4
prerank,protein autoprocessing (GO:0016540),0.27901501822290986,0.723067531595347,0.8392156862745098,0.9988481938084037,1.0,1/17,2.11%,OMA1
prerank,regulation of cholesterol esterification (GO:0010872),-0.3199388319875456,-0.7230364000762776,0.8106617647058824,0.9630965901574458,1.0,2/10,14.08%,AGTR1;APOE
prerank,histone H3 deacetylation (GO:0070932),0.2791683829771746,0.7227761426055345,0.8458333333333333,0.9983854121195326,1.0,2/15,3.31%,HDAC9;SIRT1
prerank,defense response to virus (GO:0051607),-0.1909337703220689,-0.7224996920918628,0.972972972972973,0.9632593774476812,1.0,30/100,30.84%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;AKAP1;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;ZDHHC1;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;PHB2;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2149629716084919,-0.7223483175869017,0.9158316633266533,0.9629742168847192,1.0,19/49,30.23%,MDM4;ABL1;CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;PAXIP1;DONSON;MAPK14;ATRX;E2F1;INTS7;MAD2L2;BATF
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.25634795842787733,0.7214410856746472,0.8802521008403361,0.9990349984400431,1.0,3/21,9.52%,MBOAT1;PLA2G12A;OSBPL10
prerank,gluconeogenesis (GO:0006094),-0.222808720223051,-0.7213415043798336,0.8935779816513761,0.9636459871056373,1.0,13/39,29.87%,RBP4;SLC39A14;PPARGC1A;MDH1;PGK1;PCK2;SLC25A11;CRTC2;PGM1;ALDOA;ENO3;GOT1;ENO1
prerank,protein N-linked glycosylation (GO:0006487),0.20322769145596145,0.7213021043917149,0.936127744510978,0.9983996046193395,1.0,12/66,16.10%,GAL3ST1;MGAT5B;ALG3;PMM1;ALG1;MGAT4C;SLC39A8;TMEM258;ALG8;OSTC;OST4;MGAT1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.19908354785544718,0.7208302269247985,0.9620253164556962,0.9981107213038081,1.0,7/69,9.76%,TIRAP;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2
prerank,DNA-dependent DNA replication (GO:0006261),0.18083212568810592,0.7200961818952769,0.9873684210526316,0.9981311821444766,1.0,26/128,20.09%,GINS2;NOC3L;PSMA1;RPA3;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;RECQL;MCM3;POLG;POLD1;PSME3;RFC4;POLD3;PSMC3;PSMA2;RFC5;PSMB7;RFC2;ORC6;WDHD1;MCM8;CDK2AP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.23649847178601688,-0.7200474110528232,0.8895131086142322,0.9646216639868339,1.0,7/30,17.44%,ACSL1;ABCD3;ABCD2;ACSL6;ABCD4;HACD4;ACOX1
prerank,negative regulation of coagulation (GO:0050819),0.2819185244141739,0.7197264625015717,0.8446389496717724,0.9977665942833166,1.0,5/14,19.96%,HS3ST5;CD34;PROC;EDN1;PROCR
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3098928514696183,0.7193988872154714,0.8258928571428571,0.9973081282518974,1.0,2/10,10.98%,KLF4;TLE5
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2132179475192263,-0.7185397225477771,0.9232245681381958,0.9658133825534652,1.0,16/49,28.79%,NGLY1;PRKN;RAB12;OGA;HNRNPD;ADAMTS9;XRN2;MTREX;MANBA;SIDT2;MAGEC2;SIAH2;PABPC4;HTRA2;DNASE1L1;SUPV3L1
prerank,defense response to protozoan (GO:0042832),0.29963366722336915,0.7183273485219154,0.8347639484978541,0.9976804548023209,1.0,3/12,13.15%,BATF2;GBP4;CD40
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.31326720001082337,-0.7179909454839489,0.8431001890359168,0.9659457692781085,1.0,2/10,12.45%,PLA2G4A;PNPLA8
prerank,protein prenylation (GO:0018342),-0.30897089085103197,-0.7177888447825789,0.8138613861386138,0.9657114467667128,1.0,5/10,28.39%,RABGGTB;CHM;CHML;FNTA;RCE1
prerank,B cell receptor signaling pathway (GO:0050853),0.23612845175478386,0.7176229174150381,0.8921161825726142,0.9976737116108827,1.0,8/32,18.22%,VAV3;BCAR1;RFTN1;NFATC2;CD38;BTK;SH2B2;NCKAP1L
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2765478530552292,-0.7175189944716057,0.8552631578947368,0.965544766272881,1.0,9/15,40.12%,YTHDF3;PTPN2;USP18;CACTIN;MUL1;SAMHD1;TTLL12;NLRC5;YTHDF2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.26100689431191093,-0.7168973038461356,0.8705673758865248,0.9657489067841906,1.0,14/19,56.86%,APOE;SLC5A7;NQO1;CHRNA4;CHRNA7;CHRFAM7A;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,T cell homeostasis (GO:0043029),0.3036049205828643,0.716789724593854,0.8125,0.9977749411866977,1.0,2/10,18.22%,AKT1;NCKAP1L
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20924109787106432,0.7167031551397166,0.9262472885032538,0.997083460412074,1.0,12/50,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,DNA biosynthetic process (GO:0071897),0.2655098365576684,0.7160687756831601,0.8296460176991151,0.9969881064011594,1.0,7/16,25.04%,SIRT1;POLD1;POLD3;PPIA;CDKN2D;RFC3;TYMS
prerank,serine family amino acid metabolic process (GO:0009069),0.2743884426936742,0.7157612358233272,0.8616352201257862,0.9965405238353933,1.0,5/16,21.18%,SEPHS2;MTHFD1;SRR;SEPSECS;THNSL2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2555677367405671,0.7150448423542121,0.8902195608782435,0.9965315972626276,1.0,4/20,13.04%,HECW1;HECW2;EPO;STK39
prerank,leukocyte cell-cell adhesion (GO:0007159),0.2453757640894999,0.7149458196682795,0.8640350877192983,0.9958401728884283,1.0,3/24,7.13%,SEMA4D;FERMT3;PECAM1
prerank,cellular respiration (GO:0045333),0.22157935523639688,0.7148328512420082,0.9020833333333333,0.9951740621961604,1.0,11/41,20.63%,SDHC;ATP5F1D;SLC25A14;ETFB;ETFA;ETFDH;UQCRH;NR4A3;COX10;OXA1L;UQCRC2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.21236599491036404,0.7145413930137134,0.9230769230769231,0.9946765676081942,1.0,9/50,16.15%,ACTB;CCND1;CAMK2N1;HSP90AB1;CDK5R2;CCNB2;CDKN1A;STOX1;CDKN1B
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.22950439520736599,0.7144271625181242,0.9133192389006343,0.994014282515356,1.0,7/33,14.24%,ACER2;FERMT3;TGFB2;NEXMIF;RET;CIB1;JAM3
prerank,microtubule bundle formation (GO:0001578),0.21474545372401563,0.7143783488398048,0.9366336633663367,0.9932898363630508,1.0,7/42,15.28%,SPAG16;MTCL1;TPPP;FOXJ1;DCX;CAPN6;TPPP3
prerank,negative regulation of leukocyte activation (GO:0002695),0.2715449095350386,0.7138236272066154,0.825531914893617,0.9930897128451958,1.0,2/15,9.10%,LRFN5;CD300LF
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.22663349634607952,0.7129608748918623,0.9118279569892473,0.993216559271206,1.0,12/36,21.89%,ERBB4;NOTCH1;SOCS1;OCIAD1;F2R;BCL3;HES5;HGS;DOT1L;NLK;PIGU;IL10RB
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3071997991337644,0.7129145173948493,0.8227571115973742,0.9917079881374123,1.0,10/10,69.30%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3071997991337644,0.7129145173948493,0.8227571115973742,0.9917079881374123,1.0,10/10,69.30%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.23650278019463372,0.7125441151230776,0.9150743099787686,0.9913319748230507,1.0,4/26,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.22023388839276237,-0.7116614810769574,0.9182879377431906,0.9707554954970609,1.0,8/38,16.87%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.2781848586462438,-0.711646048585186,0.8627819548872181,0.9703201479608793,1.0,3/14,10.02%,IRS1;PPARGC1A;PTPN2
prerank,adipose tissue development (GO:0060612),-0.30030453977002486,-0.7114171217355292,0.8458646616541353,0.9700959306377858,1.0,3/11,11.76%,SH3PXD2B;PGRMC2;ARID5B
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.2985251082461733,-0.710696026402496,0.8279773156899811,0.9703852638909183,1.0,4/11,21.62%,LMNA;SMAD4;P2RX4;MLIP
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.30041683419664134,0.710087968244053,0.831081081081081,0.9931261991857365,1.0,5/11,19.79%,IPO4;H3-3A;HIRA;RBBP4;ASF1A
prerank,regulation of immunoglobulin production (GO:0002637),-0.24989073224190514,-0.7091486870679032,0.8876404494382022,0.9715329983819596,1.0,2/23,11.22%,RBP4;STX4
prerank,mitochondrial transcription (GO:0006390),-0.3134239980947231,-0.7080558522692292,0.8492647058823529,0.9721596426490581,1.0,1/10,2.62%,FOXO3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3079592353927586,-0.7068311260940046,0.8623188405797102,0.9729167582690983,1.0,3/10,13.95%,OS9;ERLEC1;UBAC2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24319001797833784,0.7066320000599879,0.9041666666666667,0.9959165493720976,1.0,1/25,0.20%,SLC7A5
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.225282773448094,-0.7064941248495319,0.9259962049335864,0.9728178964041486,1.0,11/35,28.14%,TNKS2;CCT6A;DHX36;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,pre-miRNA processing (GO:0031054),-0.28212349038043616,-0.7060150626231765,0.8625429553264605,0.9728594060904325,1.0,2/14,8.00%,DICER1;TUT4
prerank,phagosome maturation (GO:0090382),0.22217889771196864,0.7059854838070968,0.9235412474849095,0.9958072161752902,1.0,15/35,24.48%,ATP6V1F;ATP6V1A;CORO1A;ATP6V1C1;ATP6V0B;RAB31;ATP6V0A1;ATP6V0E2;ATP6V1D;RAB32;RAB14;ATP6V0C;ATP6V1G1;ATP6V1E1;MREG
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2914456320084518,0.7057550195100607,0.8442982456140351,0.9952347461261991,1.0,1/11,6.51%,PRKCQ
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.22496323098945203,-0.7052649375185432,0.926873857404022,0.9731659130803798,1.0,13/35,27.66%,PDGFRB;PPP1R12A;GSK3B;MTOR;BOD1L1;PTPA;CD300A;PPP1R2;NUAK1;CRY2;MASTL;BOD1;PPP1R15B
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.27881488860592396,-0.7049881227556997,0.8686131386861314,0.972543119000022,1.0,3/15,14.82%,DTNBP1;AP3B1;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.27881488860592396,-0.7049881227556997,0.8686131386861314,0.972543119000022,1.0,3/15,14.82%,DTNBP1;AP3B1;BLOC1S5
prerank,regulation of ruffle assembly (GO:1900027),0.24526818395556993,0.7047032546603527,0.889763779527559,0.9955269668651651,1.0,5/23,16.73%,NLGN1;FAM98A;HRAS;PFN1;EVL
prerank,canonical glycolysis (GO:0061621),-0.24506733212312254,-0.7046353981090472,0.8956043956043956,0.9720010538024706,1.0,11/24,32.18%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.24506733212312254,-0.7046353981090472,0.8956043956043956,0.9720010538024706,1.0,11/24,32.18%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,intestinal absorption (GO:0050892),0.28364276412677525,0.704094843006856,0.8684759916492694,0.9953862486310537,1.0,1/13,2.66%,SLC2A5
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2692906519340039,-0.7037842637209847,0.8676748582230623,0.9723549795985444,1.0,9/16,39.80%,NUPR1;VCP;PDE12;MLXIPL;PPIF;COX7A2L;ATP7A;SHMT2;UQCC2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.301808046077128,-0.7037123217080138,0.8307984790874525,0.9719743377970754,1.0,2/11,12.73%,NUPR1;YBX3
prerank,serine family amino acid catabolic process (GO:0009071),-0.30376652125454706,-0.7022009656617156,0.8789571694599627,0.9729966327596189,1.0,7/10,47.83%,AMT;CBS;SHMT2;DLD;GLDC;SHMT1;DAO
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3071186482282455,-0.7015434251310021,0.8391608391608392,0.9732044349937615,1.0,5/10,38.73%,WNK1;WNT5A;ADAM10;CCR2;ADAM17
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2646978737475756,-0.7014421392610473,0.875,0.9728436407900958,1.0,9/17,44.99%,IK;RB1;BOD1;KNL1;TTK;SPDL1;CENPA;CDK1;MTBP
prerank,vacuolar acidification (GO:0007035),-0.2563057682642573,-0.7011274256629312,0.8754578754578755,0.9726911688530375,1.0,11/21,40.41%,ATP6V0D1;ATP6V0A4;TCIRG1;CLN5;DMXL1;GRN;ATP6V0D2;CLN6;SLC11A1;TMEM9;ATP6V1H
prerank,phagosome acidification (GO:0090383),-0.23634158603590794,-0.7010435673360859,0.9087378640776699,0.9723314874134646,1.0,3/26,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,genitalia development (GO:0048806),-0.293063574839734,-0.7010281346723881,0.8687258687258688,0.9718999518133058,1.0,4/12,19.24%,PKD1;CHD7;WNT5A;PTPN11
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.25322368262938766,0.700695019831938,0.9044289044289044,0.9979558699308986,1.0,4/21,14.55%,YWHAB;PPP1R16B;PPP1R11;MFHAS1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2600410797511616,0.7005072593988875,0.8944099378881988,0.9973583618782452,1.0,1/18,0.29%,NELL1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.29033196514526316,-0.7004600445133771,0.8529411764705882,0.971982610249696,1.0,6/12,33.54%,YTHDC1;SMCHD1;HNRNPU;PCGF3;CDYL;BRCA1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2676815428473478,0.7003978221094251,0.8730512249443207,0.9966888500848986,1.0,2/17,10.48%,CXCL12;AIF1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2527385629071504,0.7003101697440545,0.899581589958159,0.9960081312875457,1.0,1/18,0.74%,ACTB
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2010198397495912,-0.7000746747115573,0.9490566037735849,0.9719051140700734,1.0,21/59,31.37%,ROCK2;ROCK1;ERC1;TBK1;IRAK2;TRAF2;MAP3K14;TLR4;TRAF6;TANK;SHARPIN;TICAM1;NKIRAS1;NLRC3;IRAK1BP1;TRADD;BIRC3;UBA52;TLR3;LY96;RNF31
prerank,protein deneddylation (GO:0000338),-0.30346896379101423,-0.7000000982588233,0.8585271317829457,0.9715404428620543,1.0,5/10,31.21%,COPS2;COPS8;TOR1A;GPS1;COPS5
prerank,AMP metabolic process (GO:0046033),0.2755166768134142,0.699409465834643,0.8423529411764706,0.996106240890385,1.0,1/13,2.25%,AMPD1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23937517370655959,-0.6993109152731309,0.8875968992248062,0.9717416006987676,1.0,5/24,21.00%,PLA2G4A;PNPLA8;SLC27A1;LPCAT1;CDS2
prerank,ncRNA metabolic process (GO:0034660),0.21812056612687733,0.6990786591684721,0.9200819672131147,0.9956593865579599,1.0,8/37,19.07%,TDRD12;KHSRP;DTD1;DROSHA;BCDIN3D;PIWIL2;MEPCE;TDRKH
prerank,respiratory electron transport chain (GO:0022904),0.280138918958055,0.6985942272990989,0.8461538461538461,0.9953268690405356,1.0,4/14,15.97%,ETFB;ETFA;ETFDH;GPD2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2860359084549784,-0.6982209092663677,0.8719851576994434,0.9723337670196841,1.0,2/13,6.82%,UPP2;NT5M
prerank,triglyceride catabolic process (GO:0019433),0.2546162542394171,0.6981923503329449,0.9019189765458422,0.9949533521824312,1.0,19/19,74.57%,FABP5;PNPLA3;FABP6;APOC3;PNPLA5;FABP2;PNPLA1;LIPI;PNLIPRP2;CPS1;LIPG;FABP3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL;PNPLA2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.19102508411520838,0.6980656041725051,0.9737373737373738,0.9943022357680688,1.0,12/72,15.38%,DNASE1;MEI4;RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;DDX1;RFC4;POLD3
prerank,UV-damage excision repair (GO:0070914),-0.29183464005018867,-0.697948480788394,0.860036832412523,0.972142819908045,1.0,2/12,8.90%,INO80;DDB2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.19254300198978327,0.6978912235721553,0.9721030042918455,0.9936911396100477,1.0,7/73,8.73%,KITLG;PSMA1;TAL1;LMO2;PSMD12;PSMA6;PSMB3
prerank,mitochondrial gene expression (GO:0140053),0.21406931722552264,0.6977217574720724,0.9136546184738956,0.993082206882336,1.0,14/42,22.12%,MRPS12;MRPS18A;MRPS7;MRPS14;MRPL23;FASTKD5;GATB;GATC;NDUFA7;MRPS28;MRPL2;PTCD3;TFB2M;MRPL16
prerank,lipid oxidation (GO:0034440),-0.29090803817281696,-0.6974361124588264,0.8389513108614233,0.9721711764476244,1.0,3/12,27.13%,PPARGC1A;ACOX1;ALOX12
prerank,regulation of lipid kinase activity (GO:0043550),-0.2941918204484053,-0.697232839438348,0.841796875,0.9719107370335502,1.0,4/11,21.14%,WDR91;RB1;PIK3R1;WDR81
prerank,cellular response to tumor necrosis factor (GO:0071356),0.16740471776461932,0.6968932327520131,1.0,0.9931224015907125,1.0,23/175,14.27%,ST18;TMSB4X;SIRT1;PSMA1;TRAF1;TNFRSF9;TNFSF13B;AKT1;PSMD12;PSMA6;PSMB3;CCL2;ARHGEF2;DAB2IP;TNFRSF12A;TNFRSF21;TNFRSF25;ACTN4;CD40;RPS3;NFKBIA;CIB1;PSME3
prerank,regulation of viral genome replication (GO:0045069),0.20019264065864917,0.6958194356489341,0.9435146443514645,0.9933644418904773,1.0,11/56,18.08%,PROX1;ISG15;TRIM6;IFITM3;PABPC1;SLPI;HACD3;RSAD2;TNIP1;PPIA;ADAR
prerank,nerve growth factor signaling pathway (GO:0038180),0.2940154323305777,0.6947964326472565,0.8538135593220338,0.9935574937615732,1.0,1/10,2.80%,MAGI2
prerank,negative regulation of phosphatase activity (GO:0010923),0.2352292705561419,0.6935773478768481,0.9044444444444445,0.993910553452261,1.0,4/25,11.18%,SEMA4D;ZCCHC9;TGFB2;PPP1R11
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.26761015452529024,0.692707354363444,0.8948453608247423,0.9939657616233164,1.0,1/15,1.66%,HUS1B
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.24089214429911882,0.6919881476753083,0.903420523138833,0.9938432438923962,1.0,2/23,9.41%,MBOAT1;PLA2G12A
prerank,regulation of superoxide anion generation (GO:0032928),-0.26789649367645074,-0.690824212617762,0.8880597014925373,0.9772670027761022,1.0,3/14,24.62%,PRKCD;AATF;SYK
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.2915489062707624,0.6906432312494026,0.8322981366459627,0.9942746309924196,1.0,2/11,12.48%,CAMK4;ITGAM
prerank,positive regulation of stem cell proliferation (GO:2000648),0.257628344789653,0.6904710677687522,0.8865096359743041,0.9936484122371776,1.0,3/17,15.42%,HMGA2;THPO;PDCD2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.1877309003453554,-0.6903046992975369,0.9779559118236473,0.9772940737033056,1.0,33/84,34.18%,ANAPC5;ANAPC7;ANAPC4;ANAPC16;PSMF1;CUL3;RB1;PSMB2;CDC26;CDC27;UBE2E1;UBE2S;CDK2;ANAPC11;PSMC1;ECRG4;PSMB6;PSMA3;PSMA4;CDC16;ANAPC1;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;UBA52;MAD2L1;PSME4;BUB1B;PSMB8;PSMD10
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.29923948978297976,-0.6893170115695991,0.8507751937984496,0.9777471538198206,1.0,5/10,32.90%,CD9;PRKCD;ALOX12;RDX;ADAMTS18
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2969033467417583,-0.6889808249211519,0.8505535055350554,0.9776173506945212,1.0,5/11,28.69%,EGLN3;P4HA2;P4HB;P4HA1;EGLN2
prerank,snRNA 3'-end processing (GO:0034472),0.2527484397463961,0.6886041725048345,0.8916666666666667,0.9945377898920835,1.0,5/19,20.60%,EXOSC5;INTS2;EXOSC4;TOE1;INTS5
prerank,regulation of inclusion body assembly (GO:0090083),0.28803209300838345,0.6881495232220683,0.8688172043010752,0.9941740449849663,1.0,3/11,16.45%,SACS;DNAJA4;DNAJB2
prerank,embryonic heart tube development (GO:0035050),-0.27811132957020773,-0.688071650628058,0.875717017208413,0.9779328816882221,1.0,5/14,19.51%,HES1;ACVR1;CITED2;TBX2;MEGF8
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.21994546265676088,-0.6879256887380795,0.9412915851272016,0.9776319531745626,1.0,11/36,27.38%,ITGB1;NRP1;HIF1A;FBXW7;HDAC1;ADRA2A;PARK7;HBEGF;HDAC2;EGF;ADRB2
prerank,cGMP metabolic process (GO:0046068),0.2820412443302707,0.6866845751037968,0.8482328482328483,0.9946950528231687,1.0,1/12,3.36%,PDE2A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.27225237809589037,0.6863220710439989,0.8703703703703703,0.9942611359061367,1.0,2/15,7.97%,PPARG;AKT1
prerank,response to hydrogen peroxide (GO:0042542),-0.2070769434666917,-0.6856244679787928,0.9375,0.9791431293620406,1.0,17/45,30.46%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD;ADAM9;APTX;GLRX2;PARK7;FXN;MAPK7;SIRPA;PLEKHA1;TNFAIP3;NFE2L2;PPIF
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.22317109226541293,0.6855708552494149,0.932,0.9941493002548198,1.0,9/30,18.37%,PREPL;ANK3;GOLGA7;SPTBN1;MACF1;RAB31;BBS1;BLZF1;OPTN
prerank,actin nucleation (GO:0045010),-0.24707566760850486,-0.6854216248936976,0.8908045977011494,0.9788755821194204,1.0,9/21,37.63%,IQGAP2;ARPC2;WHAMM;LMOD1;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,determination of heart left/right asymmetry (GO:0061371),0.2081882402745532,0.6853186454023462,0.9642105263157895,0.9936170405166759,1.0,7/43,13.73%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2541773950916044,0.6851205587324383,0.8757763975155279,0.9930338130624001,1.0,2/17,11.12%,PLA2G12A;CRLS1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2972830131023446,-0.6850192352020196,0.8642857142857143,0.978785172532691,1.0,1/10,2.74%,DICER1
prerank,coenzyme A metabolic process (GO:0015936),0.27317613939065755,0.6841173012995393,0.8744588744588745,0.9931421723914073,1.0,6/14,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2196617346805817,-0.6827884130674733,0.9442148760330579,0.9801880030826035,1.0,6/29,14.70%,DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2575864539473881,-0.6827581178894739,0.904296875,0.9797663813413342,1.0,4/18,14.97%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.26870906592062044,-0.6819972908283786,0.868421052631579,0.9799520508188219,1.0,9/15,33.39%,ANAPC7;TPR;CDC27;NEK6;CDC16;ANAPC1;CENPE;RIOK2;TACC3
prerank,glutamine family amino acid catabolic process (GO:0009065),0.2706677655275556,0.681767012577431,0.8657024793388429,0.9943890239588188,1.0,5/13,18.04%,NOS3;GAD1;GLS2;GLS;DDAH1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2738042714647485,-0.6801186068251898,0.8628158844765343,0.980979255703218,1.0,2/13,7.41%,ACSL1;BRAF
prerank,positive regulation of interleukin-2 production (GO:0032743),0.23710153853665394,0.679675819334824,0.9266247379454927,0.9953870719451335,1.0,4/25,13.23%,PDE4B;SPTBN1;PDE4D;RPS3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.29189808459953154,0.6787625364512061,0.8731501057082452,0.9945918509424782,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.29189808459953154,0.6787625364512061,0.8731501057082452,0.9945918509424782,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,membrane lipid catabolic process (GO:0046466),-0.30524969181935935,-0.6787523169359422,0.8752362948960303,0.9816465867951555,1.0,4/10,21.80%,CYP1B1;PDXDC1;NAGA;SMPD2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.22689919431652542,-0.6764484750571428,0.9403578528827038,0.9830536010262889,1.0,4/26,9.27%,CYB5B;ASAH2;ACER3;CYP1B1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.17915959679707458,-0.6764270142479395,0.9841897233201581,0.9826300135161622,1.0,27/88,29.10%,SMURF2;FZD2;VANGL1;CDC42;DACT1;RHOA;ROR2;PSMF1;FZD7;PSMB2;DAAM1;SMURF1;WNT5A;FZD1;SPEF1;PSMC1;DVL3;PSMB6;PSMA3;AP2A1;PSMA4;DVL2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,defense response to symbiont (GO:0140546),-0.18084634826164792,-0.6761303643355535,0.9922928709055877,0.9824219906700239,1.0,27/92,30.84%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24714929714967418,0.675735578672719,0.9041095890410958,0.9962593506121787,1.0,5/19,15.38%,AMPD1;HPRT1;GMPR2;POLD1;POLD3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.2909742374521713,-0.6756858123938511,0.8659217877094972,0.9823071068618753,1.0,3/10,21.32%,THBS1;INPP5K;AKT2
prerank,nitric oxide biosynthetic process (GO:0006809),0.2673415818273689,0.6754583586773022,0.8736616702355461,0.9957377079467359,1.0,3/13,15.09%,NOS3;AKT1;GCH1
prerank,nitric oxide metabolic process (GO:0046209),0.2628774176732623,0.6748638288959501,0.885593220338983,0.9954664121249372,1.0,3/14,15.09%,NOS3;AKT1;GCH1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2395854406050455,-0.674492799293284,0.9232209737827716,0.9828329651591424,1.0,4/22,12.33%,PHF8;EIF2AK3;MTOR;WDR43
prerank,detection of visible light (GO:0009584),-0.2570329419121787,-0.6736110258772006,0.8811320754716981,0.9830586907843523,1.0,1/16,5.82%,ABCA4
prerank,positive regulation of T cell migration (GO:2000406),0.2392630899348075,0.6727560536893742,0.9205298013245033,0.9963209579160223,1.0,4/20,17.21%,CXCL12;AIF1;STK39;DOCK8
prerank,alcohol catabolic process (GO:0046164),-0.2943315900676653,-0.6713929015519432,0.8731884057971014,0.9843457608603836,1.0,2/10,14.08%,CYP27A1;APOE
prerank,cilium-dependent cell motility (GO:0060285),-0.23714014911280856,-0.6713144848352394,0.9092702169625246,0.9839642741606269,1.0,7/22,28.26%,CFAP44;CCDC39;EFHC1;DNAH8;GAS8;RSPH9;DNAH2
prerank,steroid catabolic process (GO:0006706),-0.2911686311201579,-0.6705440020682537,0.8781818181818182,0.9841158532515965,1.0,2/10,20.21%,HSD17B11;SPP1
prerank,negative regulation of T cell activation (GO:0050868),-0.2153350286534862,-0.6700691123831555,0.9343936381709742,0.9840517162122205,1.0,6/35,22.91%,PAG1;RIPOR2;PTPN22;SDC4;DLG5;CD80
prerank,negative regulation of immune response (GO:0050777),-0.16365890737786914,-0.6695345951774011,1.0,0.9839946401999736,1.0,16/154,11.18%,COL3A1;ADCY9;ADCY5;IRAK3;TRAFD1;RC3H1;ADCY1;LYN;MAPKBP1;RAMP1;ADCY6;PCBP2;PLCG1;FER;ENPP3;YES1
prerank,mismatch repair (GO:0006298),-0.22513421201604883,-0.6692919067006106,0.9392156862745098,0.9837238461055632,1.0,8/27,23.38%,ABL1;MLH1;SETD2;MCM9;MSH3;MSH6;PCNA;ERCC1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.17840832688366826,-0.6692498332754453,0.9958762886597938,0.9833085149862125,1.0,21/83,22.92%,PCM1;ALMS1;ODF2;NINL;CEP63;CEP135;CENPJ;PCNT;CSNK1E;MAPRE1;YWHAE;AKAP9;DYNC1H1;CEP76;PRKACA;CEP57;CSNK1D;CDK2;HAUS7;HAUS8;ACTR1A
prerank,cellular response to lectin (GO:1990858),-0.17305045339278843,-0.6688552881324008,0.9961685823754789,0.9827166536349398,1.0,25/104,29.10%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.17305045339278843,-0.6688552881324008,0.9961685823754789,0.9827166536349398,1.0,25/104,29.10%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,nuclear body organization (GO:0030575),0.27881454032615827,0.6685637968658424,0.8806941431670282,0.9987218430766798,1.0,2/12,11.52%,ETS1;HIPK2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.2846163993785229,-0.6685579431574433,0.8717472118959108,0.9824995964850275,1.0,6/11,50.75%,AGTR1;ABCG1;LIPC;PLA2G5;PLA2G7;PLA2G3
prerank,calcium import into the mitochondrion (GO:0036444),-0.2909239578322278,-0.6684825935333429,0.8773946360153256,0.9821113514783613,1.0,2/10,14.64%,MCU;MICU1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.297233781515691,-0.6681310644197214,0.8980322003577818,0.9819114089911841,1.0,1/10,0.81%,STIM1
prerank,protein targeting to membrane (GO:0006612),0.17948311421203716,0.6673357401662295,0.9878296146044625,0.9988823891261133,1.0,18/83,19.70%,GDAP1;AQP11;ARL6IP1;ZDHHC22;SGTB;GOLGA7;ZDHHC15;TAOK2;SRPRA;ZDHHC4;ZDHHC14;VPS37A;RTP4;ARL6;PEX3;SGTA;ZDHHC24;VPS37D
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.23996270191003463,0.667041546780144,0.8997867803837953,0.9983285168029573,1.0,3/19,12.21%,DNAAF2;SPEF2;AQP4
prerank,N-terminal protein amino acid modification (GO:0031365),0.2610498096155923,0.666707937122872,0.8958333333333334,0.9978112541973355,1.0,1/14,3.27%,METAP2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.2819171852816267,0.6667051288822923,0.8839662447257384,0.9970588631171164,1.0,2/11,13.04%,BIN1;STK39
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2168450341612256,-0.6659118780426445,0.9349112426035503,0.983128714538593,1.0,6/33,10.43%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.17198631140500806,-0.6658052006982526,0.9942418426103646,0.9827648538728818,1.0,25/105,29.10%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,steroid metabolic process (GO:0008202),-0.18220145649983593,-0.6652369149733623,0.9797979797979798,0.9827354263095774,1.0,15/72,24.69%,CYP7B1;CYP26B1;CYP27A1;CYP1B1;SULT1A1;PIAS4;CUBN;CYP51A1;AMACR;DHRS11;FDX1;FDFT1;ARV1;CYP2R1;GBA2
prerank,regulation of neutrophil migration (GO:1902622),0.29582078410734647,0.6648785626673764,0.8602150537634409,0.9976279506998581,1.0,3/10,20.38%,JAM3;NCKAP1L;RAC1
prerank,negative regulation of hormone secretion (GO:0046888),-0.29444375793575056,-0.664527352475935,0.895870736086176,0.9827875040847196,1.0,1/10,8.60%,GJA1
prerank,intracellular pH reduction (GO:0051452),-0.21066967720639945,-0.6644010734206528,0.9465648854961832,0.982435002316175,1.0,11/33,29.77%,ATP6V1B2;ATP6V0D1;ATP6V0A4;TCIRG1;ATP6V1G2;GPR89B;GPR89A;DMXL1;RAB7A;RAB39A;ATP6V0D2
prerank,rRNA methylation (GO:0031167),-0.23379579454204258,-0.6638206964258917,0.9235074626865671,0.9824255781539974,1.0,5/22,16.52%,ZCCHC4;NSUN3;DIMT1;METTL15;BUD23
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.23571534952819745,-0.6628048732169504,0.911487758945386,0.9827105910402228,1.0,3/22,10.30%,RNF115;VPS4B;VPS37C
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2932081547098373,-0.6620704527408922,0.8809073724007561,0.9827920162816888,1.0,3/10,15.33%,CCT6A;CCT8;CCT5
prerank,positive regulation of cellular respiration (GO:1901857),-0.28039002829119053,-0.6617958695444038,0.9023508137432188,0.9825444387589461,1.0,3/11,18.92%,NUPR1;VCP;PARK7
prerank,melanosome localization (GO:0032400),-0.23737259995214727,-0.6600904578820308,0.9133709981167608,0.983313903206047,1.0,6/21,28.22%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,tRNA wobble uridine modification (GO:0002098),-0.2604781437717939,-0.6600507865248892,0.9040590405904059,0.9828963851274759,1.0,7/14,35.19%,TRMT9B;DPH3;GTPBP3;MTO1;TRMU;ALKBH8;MOCS3
prerank,regulation of cholesterol storage (GO:0010885),-0.25864536751756473,-0.6594763072253236,0.9153846153846154,0.9828632782933971,1.0,6/15,31.66%,ABCA1;NR1H3;PPARA;LPL;EHD1;MSR1
prerank,response to interferon-gamma (GO:0034341),-0.1833421120783954,-0.659293196571316,0.9882121807465619,0.9825413671643723,1.0,13/67,19.06%,SYNCRIP;SP100;NUB1;CXCL16;GBP3;STAT1;DAPK1;GBP7;GBP2;TLR4;SHFL;WNT5A;GBP6
prerank,neuron projection organization (GO:0106027),-0.2623139802991387,-0.658994757283833,0.8928571428571429,0.982302459515951,1.0,3/15,12.15%,GSK3B;ABCD2;ARF1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.1768858636036455,0.6567678105491742,0.9939148073022313,1.0,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.1768858636036455,0.6567678105491742,0.9939148073022313,1.0,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,oligodendrocyte differentiation (GO:0048709),0.2400284159972742,0.6562063188195689,0.9214876033057852,1.0,1.0,5/19,16.78%,NSUN5;EIF2B3;TPPP;PTPRZ1;HES5
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.20495195990834594,0.655780039705193,0.9652173913043478,1.0,1.0,8/37,18.57%,DNASE1;ENTPD3;SND1;RNASEH2A;DFFB;RNASE3;PNPT1;ENTPD1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.21498211015372415,-0.6556433209332516,0.953757225433526,0.984169142434836,1.0,10/32,28.14%,TNKS2;CCT6A;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,inner mitochondrial membrane organization (GO:0007007),0.19631425038942468,0.6547058797656556,0.97265625,1.0,1.0,13/47,19.38%,ATP5F1D;TIMM22;ATP5F1B;ATP5ME;NDUFA13;GHITM;ATP5MF;DMAC2L;UQCC3;TOMM70;CHCHD6;ATP5MG;TIMM10B
prerank,protein homotetramerization (GO:0051289),0.1933495644907772,0.6536469442554096,0.9688796680497925,1.0,1.0,8/49,15.56%,HCN1;RYR3;TRPM2;HPRT1;AQP4;GOLGA2;B2M;GLS
prerank,cellular response to gamma radiation (GO:0071480),-0.24450843758064175,-0.6535647758013634,0.9281553398058252,0.9851144337484423,1.0,7/17,25.22%,YAP1;WRN;MAP3K20;XRCC6;ATR;HSF1;KDM1A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.2823061931676342,-0.6532314590696882,0.9106796116504854,0.9849061409661048,1.0,3/11,14.16%,LDLR;NR1H3;SLC27A1
prerank,pancreas development (GO:0031016),0.27021479261725545,0.6522070351470733,0.9155251141552512,1.0,1.0,2/12,10.18%,PROX1;FOXF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28870072046542494,0.6520582017643849,0.8888888888888888,1.0,1.0,2/10,11.52%,ING4;HIPK2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.18935513206004378,0.6520485891667879,0.9714912280701754,0.9999808372478038,1.0,12/53,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2178433991778678,-0.6516622377661315,0.9510357815442562,0.9854986794567167,1.0,14/27,36.56%,DDX5;PLA2R1;KMT5A;SPRED2;ATR;SNAI1;TWIST1;KDM1A;DYRK1A;HIC1;PSMD10;CD44;MSX1;SPRED1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.260461678368193,-0.6513558249406437,0.9026717557251909,0.9852573885258831,1.0,6/14,30.76%,FOXO3;EARS2;FASTKD1;MRPL12;POLRMT;TWNK
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.18629294074120897,-0.6511879327959825,0.9701492537313433,0.9849284957768067,1.0,23/61,34.18%,PRKAG2;PANK2;PSMF1;SIRT5;PSMB2;FGFR4;PSMC1;PSMB6;PSMA3;PSMA4;PPARA;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;NR1H4;CAV1;PSME4;PDK4;NQO1;PSMB8;PSMD10
prerank,sphingoid metabolic process (GO:0046519),-0.2616284792603872,-0.6509155032007194,0.9187145557655955,0.9846733101510697,1.0,2/12,6.66%,PLPP3;ASAH2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.18171840296755631,-0.6507461862897082,0.9848771266540642,0.9843460338235456,1.0,23/72,29.19%,DICER1;BTRC;TRAF2;PSMF1;CARD14;COPS8;PSMB2;MAP3K14;FBXW11;TRAF6;IRAK1;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;NFKB2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;BIRC3
prerank,positive regulation of phagocytosis (GO:0050766),-0.19330069635649796,-0.6494874177860318,0.9769230769230769,0.9847381857385868,1.0,4/47,7.33%,APPL2;CAMK1D;IL15RA;MERTK
prerank,cellular response to interleukin-1 (GO:0071347),0.16182982951732627,0.6485939586628112,1.0,1.0,1.0,30/143,20.51%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;CCL2;DAB2IP;NOD1;CD40;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP;CCL25;MAPK3;PSMB7;NOD2;CD47;HYAL2;CCL13;CCL19
prerank,positive regulation of exocytosis (GO:0045921),-0.20381579160716257,-0.6481374428853461,0.9652509652509652,0.9851629279041185,1.0,11/35,25.61%,STXBP5;VPS4B;RAB2B;SDC4;SYTL4;SNF8;RAB3D;RAB9A;RAB7A;SDC1;RAB5A
prerank,mitochondrial fusion (GO:0008053),0.23460010561739317,0.6473494041608536,0.9217758985200846,1.0,1.0,4/18,15.78%,GDAP1;MIEF1;USP30;MFN1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.25765907946747135,0.6473447667684292,0.9113924050632911,1.0,1.0,4/14,21.73%,BCL10;RPS3;RAB29;CARD11
prerank,positive regulation of mRNA processing (GO:0050685),-0.22769279498074418,-0.647238369139554,0.9333333333333333,0.985295751269505,1.0,9/21,32.43%,DHX36;DAZAP1;CDC73;NUP98;NCBP2;SNW1;THRAP3;SF3B4;RBMX
prerank,lymphocyte proliferation (GO:0046651),-0.23870184029033703,-0.64656287751531,0.9349904397705545,0.9852915090841676,1.0,6/22,25.80%,BCL2;ELF4;MEF2C;CTPS1;MSN;LMBR1L
prerank,CENP-A containing chromatin organization (GO:0061641),-0.21529395031203952,-0.6463415738481151,0.9501915708812261,0.9845575407448971,1.0,16/29,40.10%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.21529395031203952,-0.6463415738481151,0.9501915708812261,0.9845575407448971,1.0,16/29,40.10%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,protein localization to condensed chromosome (GO:1903083),-0.27073121509815323,-0.6462167005779853,0.931098696461825,0.9841915753333513,1.0,1/12,5.15%,IK
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2507038116266155,-0.6461620126964335,0.9059500959692899,0.9837861949798462,1.0,5/15,26.15%,NFKB1;AGTR1;IL18;MAPK9;LPL
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.25564804518919226,-0.6459493389197634,0.9316888045540797,0.9834770366991448,1.0,7/14,31.25%,PPP2CB;DUSP1;NCK1;PPP2CA;PPP2R2C;PPP1R15B;PPP2R2A
prerank,polyamine metabolic process (GO:0006595),0.2639714812196227,0.6454947672233093,0.9356984478935698,1.0,1.0,5/13,21.31%,SMS;SMOX;SAT2;ODC1;HDAC6
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.23723320419170058,0.6453743409050239,0.9281314168377823,0.9990756272957871,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.23723320419170058,0.6453743409050239,0.9281314168377823,0.9990756272957871,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.23723320419170058,0.6453743409050239,0.9281314168377823,0.9990756272957871,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2683784292799297,0.6452477560055403,0.8978622327790974,0.9984117432855925,1.0,12/12,73.18%,RMDN1;MAD1L1;MIS12;CHAMP1;CDT1;CENPC;KIF2C;NUF2;NDC80;SEH1L;CENPE;BOD1
prerank,regulation of aerobic respiration (GO:1903715),0.2486478040561518,0.6437853323578918,0.9227166276346604,0.9985516805945771,1.0,1/15,3.24%,COX7A1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.25756780333462087,-0.6431202667544331,0.9110251450676983,0.9847949756292609,1.0,2/13,8.13%,CYFIP2;ASPH
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.218525937213655,-0.6429905446954236,0.9625468164794008,0.9844385492906859,1.0,7/26,20.89%,UBE2N;ALPK1;IRAK2;TRAF6;IRAK1;MAP2K6;AAMP
prerank,centromere complex assembly (GO:0034508),-0.20397842734743393,-0.6410971068325775,0.9718045112781954,0.9851090793415981,1.0,19/36,40.10%,HJURP;CENPP;NASP;ITGB3BP;CENPT;POGZ;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPF;CENPA;CENPQ
prerank,organophosphate biosynthetic process (GO:0090407),0.19851238077134334,0.6401935181813699,0.9621052631578947,1.0,1.0,13/37,22.40%,MBOAT1;GPAM;FADS1;GK;PIP5K1A;IPMK;TKT;IP6K1;PCYT2;PPIP5K1;IPPK;GPHN;PNPO
prerank,postreplication repair (GO:0006301),0.19097099852651395,0.6395980023358212,0.9832985386221295,0.9996255285995176,1.0,12/45,19.15%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,nucleosome disassembly (GO:0006337),0.2458804933458853,0.6394768059222758,0.9002123142250531,0.9982081912048412,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,chromatin disassembly (GO:0031498),0.2458804933458853,0.6394768059222758,0.9002123142250531,0.9982081912048412,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,vitamin transport (GO:0051180),0.21040849648030358,0.6392539323744593,0.9637096774193549,0.997609932947297,1.0,3/29,7.80%,ABCG2;SLC52A2;SLC52A3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2641976895339485,-0.6389871947456249,0.9064220183486239,0.9859249340284978,1.0,1/12,2.20%,B3GALT1
prerank,regulation of cell aging (GO:0090342),-0.2780357451639688,-0.6384864629122455,0.9124087591240876,0.985786204513321,1.0,6/11,27.14%,LMNA;NEK4;NEK6;NUAK1;RSL1D1;VASH1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2120250243458932,0.6382696521903762,0.948051948051948,0.9974224223912462,1.0,6/29,15.73%,ELOVL7;TECR;SCD;HACD1;PPT1;ACSL3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2655530417776703,0.6375914260791825,0.919661733615222,0.9970686803686404,1.0,5/12,20.61%,HSPA5;SGTB;SEC61G;SGTA;SEC61A2
prerank,positive regulation of myelination (GO:0031643),0.276154260533222,0.6374094875007772,0.9122807017543859,0.9964328980941184,1.0,2/11,9.18%,TENM4;TPPP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.19296768478797763,0.6373187649863341,0.9899598393574297,0.9957403032065536,1.0,5/48,8.56%,PPARG;GAS6;ISG15;SLIT3;GPS2
prerank,ether lipid biosynthetic process (GO:0008611),-0.27552306661870973,-0.6372802805970746,0.9177820267686424,0.9860759855848273,1.0,6/10,32.56%,GNPAT;PLA2G4A;PEX7;CHPT1;PLA2G4C;PEDS1
prerank,vasoconstriction (GO:0042310),0.26617010825112475,0.6371719461760482,0.8963963963963963,0.9950854592935279,1.0,3/11,17.97%,SLC8A1;EDN1;EDNRB
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.18430487587269268,-0.6369371507588445,0.9923664122137404,0.985834354240064,1.0,18/54,29.19%,CFLAR;TAX1BP1;PRKN;UBE2K;HIPK1;PTPN2;TRAF2;CCDC3;CARD16;SHARPIN;SPHK1;SYK;CLIP3;SPPL2A;TRADD;TNFAIP3;NLRP2B;BIRC3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2517772133547958,0.6366451123674759,0.9248434237995825,0.9946546876855868,1.0,2/15,10.32%,PPARG;MID1IP1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2286174451711664,0.6363582803139146,0.9334677419354839,0.9940941657147051,1.0,6/21,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,positive regulation of viral genome replication (GO:0045070),-0.2113569471280076,-0.6354222427404287,0.9749518304431599,0.9862652962595134,1.0,10/29,33.11%,LARP1;DDX3X;PPIH;TOP2B;PPID;PPARA;PDE12;ADARB1;NR5A2;DDB1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.25808194813060886,0.6348034439497933,0.9050772626931567,0.9942429280835107,1.0,1/12,6.51%,PRKCQ
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.17011214701990374,0.6340994265720595,0.9959514170040485,0.9938828979286545,1.0,12/79,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,DNA replication initiation (GO:0006270),-0.19665828990663364,-0.6332065972995079,0.9693486590038314,0.987059320142253,1.0,20/37,39.59%,MCM6;PRIM2;CDK2;POLE4;POLA2;DBF4;POLE2;ORC1;MCM4;CDC34;RPA2;CDC45;POLA1;POLE;MCM2;MCM7;PRIM1;POLE3;MCM5;MCM10
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.2167052150250216,-0.63120056495426,0.9480286738351255,0.9877092203063625,1.0,11/25,32.18%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,DNA strand elongation (GO:0022616),0.22624409199188802,0.6305418165681778,0.9466950959488273,0.9951217537693539,1.0,4/18,15.38%,GINS2;MCM3;RFC4;POLD3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.252699687529792,-0.6301808964713582,0.918625678119349,0.9878156789210517,1.0,1/13,2.20%,B3GALT1
prerank,regulation of protein metabolic process (GO:0051246),-0.190754617203613,-0.6301218428324864,0.974609375,0.9874131318621538,1.0,11/44,23.46%,ROCK2;LDLR;SPOPL;APOE;CENATAC;TRAF3;ABCA7;SNF8;WFS1;PARL;MAPK7
prerank,positive regulation of leukocyte migration (GO:0002687),-0.21546392464111605,-0.6297315527594352,0.9529190207156308,0.9871868213358759,1.0,4/27,17.46%,PTN;IL6R;VEGFA;MIA3
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2608646366609444,-0.6290116093341885,0.9340659340659341,0.9871370406872457,1.0,9/12,51.67%,NEK6;PRKCA;LPIN1;PLK1;CDK1;VRK1;NEK9;CCNB1;PRKCB
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.25032566743797496,-0.6278250176004632,0.926605504587156,0.9873266919190683,1.0,3/14,12.43%,PKD1;PKD2;SUFU
prerank,establishment of spindle localization (GO:0051293),-0.25181517680035537,-0.626348359130738,0.9464285714285714,0.9876697377179539,1.0,3/14,16.12%,MAP4;ZBED3;DYNC1H1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20568134349392736,0.6261650302339674,0.9530612244897959,0.9967870964947854,1.0,5/29,17.41%,LPCAT2;TMEM86B;PLA2G12A;DBI;PLA2G4E
prerank,endosome organization (GO:0007032),-0.1930894391610399,-0.6256339235170317,0.9786821705426356,0.9876266438865026,1.0,11/41,25.63%,EEA1;RAB22A;SNX10;USP50;TMCC1;PLEKHF1;ALS2;PI4K2B;WASHC4;ARFGEF2;PHETA1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.23379487967818655,-0.6255073486865447,0.947565543071161,0.9872614974745855,1.0,3/19,17.55%,MTHFR;MTHFD2L;ALDH1L1
prerank,protein import into peroxisome matrix (GO:0016558),-0.2615354222857066,-0.6254153233499209,0.9087221095334685,0.9868819665542065,1.0,8/12,44.81%,PEX6;PEX7;PEX26;PEX10;PEX16;PEX12;PEX1;PEX14
prerank,regulation of interleukin-1 beta production (GO:0032651),0.17312782522256798,0.6248200759583931,0.9922779922779923,0.9967553954084388,1.0,7/66,13.89%,CD33;GIT1;HSPB1;F2R;P2RX7;CPTP;CD36
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2534490577141641,0.623963674057826,0.9234135667396062,0.9964531072466111,1.0,2/12,11.96%,GINS2;MCM3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.22589297865505834,0.623183416848203,0.9537815126050421,0.9961072528344277,1.0,3/20,11.24%,IPO5;MEN1;APC
prerank,negative regulation of centrosome duplication (GO:0010826),-0.26403315045290215,-0.6228293730665576,0.9256505576208178,0.9878167721863056,1.0,1/11,2.52%,KAT2B
prerank,positive regulation of cilium assembly (GO:0045724),0.22643875237652486,0.6206074696753564,0.9596602972399151,0.9966779315756629,1.0,6/18,20.37%,CCP110;HAP1;CCDC88A;ENTR1;FUZ;CROCC
prerank,mRNA methylation (GO:0080009),-0.2399703841952181,-0.6203826219105503,0.9300184162062615,0.9886300660483714,1.0,5/15,30.75%,WTAP;NSUN2;ZC3H13;TRMT61B;TRMT10C
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.2472254027032703,-0.617301154651197,0.9562171628721541,0.989762072197425,1.0,8/14,49.49%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CCL5;CCL4;CCL7
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20737680409950848,0.6168643837871961,0.967391304347826,0.9978017252911329,1.0,11/28,24.18%,RPS27A;UBC;UBB;NOD1;TAB2;OTULIN;NOD2;CASP8;ITCH;UBE2V1;CYLD
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.1990148374811252,-0.616632592024467,0.9763313609467456,0.9896222301640909,1.0,14/31,42.81%,RC3H1;LYN;SDC4;DLG5;CD300A;CD80;SOX11;CEBPB;FCGR2B;CD274;LST1;CD86;LILRB1;IL4I1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.17265686837847435,-0.614112840529501,0.9867674858223062,0.9903765397912161,1.0,24/65,34.18%,FBXL7;FHL1;USP47;PSMF1;NABP2;PSMB2;CUL1;PSMC1;CDK5RAP3;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;ZFYVE19;PSME4;PSMB8;PSMD10
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.21847601801395253,-0.6080312932453694,0.9636015325670498,0.9927576963015231,1.0,4/21,14.97%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2466930693358647,-0.6078287078869056,0.9315589353612167,0.9924031000549488,1.0,2/14,7.97%,BCAS3;AR
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2217053761269353,-0.6076983631414751,0.941712204007286,0.9920304969552456,1.0,3/18,21.28%,ABL1;PRKDC;XRCC6
prerank,protein deacylation (GO:0035601),0.20799410060015946,0.6069215979475516,0.9563409563409564,1.0,1.0,9/23,22.16%,SIRT1;LYPLA1;SIN3A;PPT1;HDAC7;ABHD17C;NOTUM;HDAC6;SIRT7
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.2634728168414592,-0.6061874885531285,0.9403508771929825,0.9922488358590716,1.0,1/10,2.99%,PRKN
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.19174014550089646,0.6057821482530614,0.9790794979079498,1.0,1.0,3/31,7.25%,CHCHD4;TIMM21;DNAJC15
prerank,leukotriene biosynthetic process (GO:0019370),0.24368414544206202,0.6054056310184753,0.9508928571428571,1.0,1.0,4/14,19.26%,GGT7;GGT1;LTA4H;MGST3
prerank,sphingoid biosynthetic process (GO:0046520),-0.2512958276243282,-0.604259607787846,0.9327102803738317,0.992202512497731,1.0,5/11,30.38%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),-0.2512958276243282,-0.604259607787846,0.9327102803738317,0.992202512497731,1.0,5/11,30.38%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.24567888552302403,-0.602463819595163,0.9238683127572016,0.9925260235275462,1.0,3/12,17.45%,BTRC;CDC14B;UBE2S
prerank,ncRNA export from nucleus (GO:0097064),-0.18877333213550246,-0.5984797467643029,0.981404958677686,0.9937432865402475,1.0,16/36,37.28%,RANBP2;NUP42;PHAX;NUP214;TPR;NUP98;NUP43;NUP160;NCBP2;NUP93;RAN;NUP133;SEC13;NUP88;NPM1;SEH1L
prerank,cellular response to ionizing radiation (GO:0071479),0.1774466081609769,0.5982923896045916,0.996031746031746,1.0,1.0,10/47,16.89%,TMEM109;SIRT1;EEF1D;NET1;HRAS;KDM4D;ATM;CDKN1A;XRCC5;MDM2
prerank,regulation of catabolic process (GO:0009894),-0.22448644321433403,-0.5981750548451563,0.9651376146788991,0.993434235397528,1.0,4/18,20.12%,ITGB1;FAP;CENATAC;SNF8
prerank,positive regulation of immune response (GO:0050778),-0.169268133666711,-0.597919689779583,0.9961904761904762,0.9931040621115812,1.0,9/64,19.98%,IL6ST;PLSCR1;DHX9;STX4;RIOK3;EIF2AK4;CYBA;IFI35;KARS1
prerank,ncRNA catabolic process (GO:0034661),0.20046935721027972,0.5976648776694757,0.975051975051975,1.0,1.0,2/28,4.72%,EXOSC5;LIN28B
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2604970272202873,-0.5967019778096392,0.9392156862745098,0.9931585466524898,1.0,2/10,15.31%,ACTN2;CARMIL1
prerank,negative regulation of receptor binding (GO:1900121),-0.2621145805130255,-0.5961498798919834,0.9434697855750487,0.9929377346558703,1.0,3/10,30.06%,ATP2A2;ATP2A3;PTPRF
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.22140193171671546,0.5948154732068656,0.9678111587982833,1.0,1.0,4/18,15.73%,ELOVL7;TECR;HACD1;ACSL3
prerank,I-kappaB phosphorylation (GO:0007252),0.2630128487431569,0.594591798775614,0.952808988764045,1.0,1.0,2/10,9.89%,TLR2;DAB2IP
prerank,negative regulation of potassium ion transport (GO:0043267),0.23269119966941185,0.5935480495934651,0.9435146443514645,1.0,1.0,2/13,13.04%,BIN1;STK39
prerank,regulation of ERAD pathway (GO:1904292),-0.2537321975537529,-0.5935167332062028,0.9453551912568307,0.9935565710775667,1.0,6/11,31.29%,RNFT1;TMEM259;USP13;BAG6;USP19;HERPUD1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.21030831711355405,0.5931626279013498,0.9666666666666667,1.0,1.0,1/23,1.05%,DNASE1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.19261635323179782,0.5910039834080804,0.9821428571428571,1.0,1.0,8/31,23.25%,SRD5A2;SCP2;GCH1;NOXRED1;LIAS;SRD5A1;GPHN;LSS
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.24690070257285665,0.5902325375523569,0.9468085106382979,1.0,1.0,1/12,3.76%,PPARG
prerank,determination of left/right symmetry (GO:0007368),-0.18308884272454523,-0.5900924381023966,0.9900793650793651,0.9944102920200161,1.0,7/37,20.93%,SMO;PKD2;CCDC39;CITED2;MEGF8;GALNT11;ZIC3
prerank,tRNA metabolic process (GO:0006399),-0.222224873310647,-0.5894108762379131,0.9642857142857143,0.9942438885607204,1.0,1/17,1.83%,FARS2
prerank,amino sugar metabolic process (GO:0006040),0.2536424363320309,0.5886122700594965,0.933184855233853,1.0,1.0,1/10,5.63%,CSGALNACT1
prerank,icosanoid biosynthetic process (GO:0046456),0.25993398307375637,0.5885860496449936,0.9498861047835991,1.0,1.0,3/10,19.26%,FADS1;LTA4H;MGST3
prerank,regulation of interleukin-10 production (GO:0032653),-0.1811582827242536,-0.5883828935579708,0.9888475836431226,0.9941697402572058,1.0,6/44,17.41%,PIBF1;HMGB1;STAT3;TRIB2;PRKCZ;TLR4
prerank,dendritic cell chemotaxis (GO:0002407),-0.23585418041512246,-0.5883269205275281,0.9474671669793621,0.993764308489556,1.0,7/14,38.76%,HMGB1;TRPM4;GPR183;CCR5;CCR2;CXCR4;PIK3CG
prerank,lymphocyte chemotaxis (GO:0048247),-0.18885035724141339,-0.5869044038353598,0.9883495145631068,0.993899970630857,1.0,3/34,10.07%,CYP7B1;CXCL16;SLC12A2
prerank,RNA catabolic process (GO:0006401),-0.17674342300196158,-0.5865855103491623,0.9961013645224172,0.9935859595724442,1.0,15/46,34.05%,DIS3L2;HNRNPD;XRN2;ERN1;MTREX;CNOT10;SIDT2;PABPC4;LSM6;ZFP36L2;SUPV3L1;NUDT16;NUDT16L1;HSPA1A;RNASEH2C
prerank,regulation of sensory perception of pain (GO:0051930),-0.24994364122621834,-0.5856913477316525,0.9570093457943926,0.9934862519165457,1.0,4/11,21.84%,CCN3;MGLL;ZFHX2;TMEM100
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15935427035528643,-0.5851016904545053,0.9980430528375733,0.9932578532465517,1.0,20/72,28.73%,MDM4;EP300;NBN;TFDP2;SP100;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;TFAP4;CNOT4;PAXIP1;TNKS1BP1;CRADD;PCBP4;ATRX;E2F1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.2330487192365645,0.5849441066495,0.9581589958158996,1.0,1.0,13/13,76.71%,RPS15;NMD3;EIF6;NOP9;LSG1;LTV1;ABCE1;NPM1;NUP88;RAN;RRS1;XPO1;SDAD1
prerank,regulation of vacuole organization (GO:0044088),-0.21226862790765705,-0.5848036711714606,0.9637404580152672,0.9929248071559035,1.0,8/20,31.99%,ANXA2;IFT88;MTMR3;NPRL3;RAB5A;ENO3;ENO1;NPRL2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.25391931308303306,0.5841917684204702,0.9548387096774194,1.0,1.0,2/11,11.52%,ING4;HIPK2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.22054431485411607,0.5824583015671293,0.9544419134396356,1.0,1.0,2/15,12.04%,TGFB2;SMAD7
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.21849338990546685,-0.582146840925851,0.9718045112781954,0.9934091822217144,1.0,3/18,14.08%,NCSTN;ADAM19;APOE
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.21777576445910551,-0.5814496318130042,0.9746588693957114,0.993215859973766,1.0,8/17,46.56%,PLA2G4A;MBOAT7;PLA2G4C;LCLAT1;PLAAT3;PLA2G4F;PLA2G5;PLBD1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.23313991047644422,-0.578963957004342,0.9528985507246377,0.9935768361044436,1.0,8/14,41.87%,ECE1;AGTR1;EDN3;ACE2;CORIN;ENPEP;ACE;RASL10B
prerank,regulation of cellular respiration (GO:0043457),-0.21735929652916308,-0.5781061572964303,0.9755639097744361,0.9934203967036733,1.0,10/17,44.42%,CBFA2T3;NOP53;VCP;NOA1;IDE;PRDM16;SHMT2;TRAP1;IFNLR1;NOS2
prerank,cilium movement (GO:0003341),-0.17284269747776007,-0.576655478514037,0.9920792079207921,0.9934407016250767,1.0,31/48,48.31%,ODAD1;CFAP251;CCDC39;SPEF1;DNAAF5;DNAH11;GAS8;RSPH9;CFAP61;DNAI4;DNHD1;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;ADCY10;CFAP54;SPAG17;ODAD3;SPA17;ODAD4;TEKT2;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.2320016354084799,-0.5764521790033529,0.9695817490494296,0.9930799695385462,1.0,6/14,37.93%,NUDT5;ENTPD6;NUDT1;NUDT16;NUDT18;ADPRM
prerank,phasic smooth muscle contraction (GO:0014821),0.24957629778419427,0.5757899895573027,0.9485981308411215,1.0,1.0,10/10,75.06%,EDN1;EDNRB;PTGER3;EDN2;DRD2;HTR1D;TIFAB;HTR2B;GDNF;EDN3
prerank,nuclear envelope organization (GO:0006998),-0.20692783252188407,-0.5746081480136735,0.971042471042471,0.9932364976865758,1.0,6/20,26.38%,DMPK;EMD;TOR1A;NEMP1;SUN2;NUP93
prerank,cellular response to superoxide (GO:0071451),-0.2477988406371066,-0.5713134271525016,0.9596928982725528,0.9938247864878599,1.0,6/10,33.54%,SOD3;SOD2;PRDX2;CCS;MT3;ATP7A
prerank,purine ribonucleotide transport (GO:0015868),-0.22491116719840254,-0.56857306234408,0.9756554307116105,0.9942248887462869,1.0,7/16,34.57%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,meiosis I (GO:0007127),0.19592116653891833,0.5681495569417347,0.9854771784232366,1.0,1.0,22/23,69.14%,ZCWPW1;ING2;FOXJ3;PTTG1;FOXJ2;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;MEIKIN;MOV10L1;BRDT;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZSCAN21;HSF2BP;BCL2L11
prerank,histone H2A acetylation (GO:0043968),0.21859645653836962,0.5673477841090445,0.957983193277311,1.0,1.0,2/16,6.80%,RUVBL1;YEATS4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.1869453342101305,0.5670456328730443,0.9854166666666667,1.0,1.0,11/28,25.74%,GABARAP;DAB2IP;DELE1;TNFRSF1A;SORT1;DDX47;CASP8;TNFRSF10B;BAX;CASP8AP2;BID
prerank,diol biosynthetic process (GO:0034312),-0.21745914833098118,-0.566203736809238,0.9576923076923077,0.9944577204888126,1.0,2/15,8.43%,ASAH2;ACER3
prerank,lipoprotein catabolic process (GO:0042159),-0.24189180363673032,-0.5658199206938778,0.9582608695652174,0.9941257399862936,1.0,4/11,24.54%,ABHD17B;APOE;ABHD10;LYPLA2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2501412340719352,0.5647142351386364,0.9602510460251046,1.0,1.0,10/10,75.00%,ATP5F1D;ATP5MG;ATP5MC3;ATP5PD;ATP5PO;VPS9D1;ATP5F1C;ATP5F1A;ATP5MC2;ATP5MC1
prerank,pseudouridine synthesis (GO:0001522),-0.2331150131311501,-0.5642819418017477,0.9714795008912656,0.9941301881149032,1.0,7/13,41.10%,PUS10;PUS3;GAR1;PUS1;PUS7L;PUSL1;RPUSD2
prerank,chromatin remodeling at centromere (GO:0031055),-0.18423865559656818,-0.5616531550867202,0.9905838041431262,0.9944515321450992,1.0,16/31,40.10%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,protein localization to vacuole (GO:0072665),0.22601707684580602,0.5610893085272387,0.962882096069869,1.0,1.0,13/13,77.42%,GLMP;RTN4;LMBRD1;SH3BP4;MFSD1;SH3GLB1;ATP13A2;RNF128;LAMTOR5;LAMTOR4;CD81;KPTN;SZT2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.2343011134329921,0.5604644851742879,0.9605263157894737,1.0,1.0,3/11,14.32%,CALM1;CALM2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.2343011134329921,0.5604644851742879,0.9605263157894737,1.0,1.0,3/11,14.32%,CALM1;CALM2;CALM3
prerank,glycine metabolic process (GO:0006544),0.22976960261158877,0.5595925696313047,0.9504310344827587,1.0,1.0,12/12,77.04%,RIDA;GCSH;SDSL;SDS;BAAT;GLYAT;SHMT1;GLDC;DLD;GCAT;SHMT2;AMT
prerank,extracellular transport (GO:0006858),-0.22806531045672157,-0.5587118023844553,0.9714795008912656,0.9948530790214026,1.0,1/13,3.63%,WWP2
prerank,negative regulation of chemokine production (GO:0032682),-0.22226097657279192,-0.5573067704344601,0.97678916827853,0.9947989357626402,1.0,4/14,28.25%,APOD;C1QTNF3;SIRPA;MUL1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.18355844516259473,0.5551773502020646,0.9892933618843683,1.0,1.0,10/31,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2485884492711713,0.5550366205250764,0.9599109131403119,1.0,1.0,3/10,22.88%,ASRGL1;KYAT1;KYNU
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.23589906963585194,-0.5532875951573238,0.9629629629629629,0.9953937972104127,1.0,1/12,3.12%,LRRK2
prerank,determination of bilateral symmetry (GO:0009855),0.1928099349403697,0.5531586668296152,0.9735234215885947,1.0,1.0,7/25,23.19%,NOTCH1;FOXJ1;DLL1;ARL6;DNAH5;NPHP3;TBX1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.22388430681209642,-0.5528926257953471,0.9717514124293786,0.995052482767612,1.0,1/13,6.09%,ADGRV1
prerank,negative regulation of cyclase activity (GO:0031280),-0.21843464411827465,-0.5508278453067851,0.9774859287054409,0.9951033857172276,1.0,1/14,6.09%,ADGRV1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.22058744323608548,-0.5497850512012008,0.9887850467289719,0.9949169272573479,1.0,7/14,45.32%,PRKCZ;IL18;CD81;DENND1B;CD86;RARA;NLRP3
prerank,mRNA modification (GO:0016556),-0.19374260652774392,-0.549224478946815,0.9833024118738405,0.99460867714444,1.0,11/22,43.89%,WTAP;NSUN2;PUS3;ZC3H13;TRMT61B;TRMT10C;PUS1;CBLL1;RPUSD2;TRMT61A;VIRMA
prerank,macrophage migration (GO:1905517),0.21749868681687615,0.5488169336832561,0.9755600814663951,1.0,1.0,3/13,18.29%,CCL2;EDNRB;CKLF
prerank,melanosome transport (GO:0032402),-0.20819118838982079,-0.5466937229014138,0.9757009345794393,0.9943189275439102,1.0,5/18,28.22%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,pigment granule transport (GO:0051904),-0.20819118838982079,-0.5466937229014138,0.9757009345794393,0.9943189275439102,1.0,5/18,28.22%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,sympathetic nervous system development (GO:0048485),-0.20970290218797683,-0.5460228991266657,0.9662288930581614,0.9940478197383107,1.0,5/15,35.30%,NRP1;SOX11;NRP2;GDNF;SEMA3F
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.16883079747855717,0.5446767627769394,0.9919678714859438,1.0,1.0,9/38,20.15%,IPO4;RUVBL1;H3-3A;HIRA;CENPL;SMARCA5;RBBP4;ASF1A;CENPO
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.20058082060589186,-0.5438937736618501,0.974155069582505,0.9940995371200976,1.0,4/19,19.87%,CYBA;ACOX1;PARK7;PRDX2
prerank,adenine nucleotide transport (GO:0051503),-0.21054615922031983,-0.5431210787470019,0.9753787878787878,0.9938539163178952,1.0,7/17,34.57%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,outer dynein arm assembly (GO:0036158),-0.21070244798555937,-0.5427529875850727,0.982824427480916,0.9935058586219552,1.0,10/15,47.12%,DNAL1;ODAD1;DNAH8;DNAAF5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,nuclear membrane disassembly (GO:0051081),-0.21543173300270027,-0.5393488949849877,0.9833333333333333,0.9938316945880061,1.0,3/14,22.02%,AKAP8L;NEK6;PRKCA
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2159669097531723,-0.5388687389093645,0.9789473684210527,0.993517790074514,1.0,2/14,10.36%,ENPP1;ENPP3
prerank,regulation of integrin activation (GO:0033623),-0.20491690450332206,-0.5369236042617962,0.9866920152091255,0.9934988880298442,1.0,4/15,27.69%,RAP1B;FARP2;FBLIM1;FERMT2
prerank,snRNA metabolic process (GO:0016073),-0.20144886016921393,-0.53081113205771,0.9831460674157303,0.9942685231251476,1.0,3/17,18.52%,INTS4;MTREX;INTS6
prerank,chromatin assembly (GO:0031497),0.16524281101565197,0.5268032146442692,0.99800796812749,1.0,1.0,9/38,21.35%,SIRT1;HMGA2;H3-3A;NAA60;SMARCA5;RBBP4;CTCF;ASF1A;NOC2L
prerank,receptor recycling (GO:0001881),-0.23259337983755385,-0.5232206943155892,0.9632495164410058,0.9952275019348331,1.0,3/10,25.63%,EHD3;ARFGEF2;PHETA1
prerank,eye photoreceptor cell development (GO:0042462),0.20218894012059946,0.5216600050644583,0.9783549783549783,1.0,1.0,2/15,13.34%,THY1;RORB
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15648611718120914,-0.5133444511539638,1.0,0.9964057842648978,1.0,15/45,37.52%,STAT3;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.19457623608483388,0.5117268379228815,0.9780876494023905,1.0,1.0,5/16,21.57%,CELF4;CIRBP;PRDX6;RBMXL1;RBM3
prerank,inner dynein arm assembly (GO:0036159),0.20736180604153467,0.5054198799943075,0.9876543209876543,1.0,1.0,1/11,8.92%,CFAP100
prerank,protein neddylation (GO:0045116),-0.20314172124278138,-0.5034382342938657,0.9777777777777777,0.9973497214015361,1.0,5/13,33.47%,DCUN1D3;NAE1;DCUN1D5;RBX1;DCUN1D4
prerank,negative regulation of lyase activity (GO:0051350),-0.19315703348185442,-0.5020020606604979,0.985239852398524,0.9971128620440182,1.0,1/16,6.09%,ADGRV1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.21187552853853248,0.5005177178763435,0.9826086956521739,1.0,1.0,4/11,19.57%,IPMK;IP6K1;PPIP5K1;IPPK
prerank,positive regulation of bone resorption (GO:0045780),-0.21655481063520018,-0.4995531081133069,0.9796296296296296,0.9970173139585521,1.0,3/11,24.62%,SPP1;PRKCA;SYK
prerank,dendritic cell migration (GO:0036336),-0.19275710373255878,-0.49940818187964503,0.9924242424242424,0.9966106219411114,1.0,2/16,12.94%,HMGB1;TRPM4
prerank,negative regulation of cell division (GO:0051782),0.20807670930450023,0.4993083575411687,0.9878542510121457,1.0,1.0,5/11,25.92%,E2F7;ORC6;VPS4A;SUSD2;CHMP4C
prerank,negative regulation of bone remodeling (GO:0046851),0.20638642920824934,0.4987746541775701,0.9754464285714286,1.0,1.0,2/11,11.50%,UBASH3B;P2RX7
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.16801063833429414,0.49846146353763215,0.9918367346938776,1.0,1.0,3/29,14.94%,MEI4;ZCWPW1;SYCP2
prerank,tRNA transport (GO:0051031),-0.157209964859305,-0.4976320165500514,0.996039603960396,0.9964285301118222,1.0,5/35,13.27%,RANBP2;NUP42;NUP214;TPR;YBX1
prerank,snRNA processing (GO:0016180),0.18470909584865292,0.49672603804934623,0.9853249475890985,1.0,1.0,5/16,20.60%,INTS2;INTS11;INTS10;TOE1;INTS5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.21244110275507083,0.49667350753232387,0.986870897155361,1.0,1.0,2/10,13.89%,AKT1;CD36
prerank,pinocytosis (GO:0006907),-0.21600038349686934,-0.4929536962901707,0.9849906191369606,0.9966157627494218,1.0,8/10,47.49%,CARMIL1;PYCARD;RAB34;MAPKAPK3;DOCK2;AHSG;SNX33;SNX5
prerank,L-serine metabolic process (GO:0006563),0.21226760440276943,0.4897620933272937,0.9799554565701559,1.0,1.0,3/10,20.31%,PHGDH;SERINC3;SRR
prerank,cellular response to radiation (GO:0071478),0.15066928872618537,0.48838477101962885,1.0,1.0,1.0,5/40,14.52%,SIRT1;EEF1D;NET1;KDM4D;CDKN1A
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.15985882400048812,0.4869236959600394,1.0,1.0,1.0,9/32,22.06%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,tRNA export from nucleus (GO:0006409),0.15985882400048812,0.4869236959600394,1.0,1.0,1.0,9/32,22.06%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,heterocycle biosynthetic process (GO:0018130),-0.19303918623667687,-0.4858167116825374,0.9862475442043221,0.9969952518843099,1.0,8/14,43.91%,MOCS1;NFS1;PYCR2;MOCS3;PYCR3;MOCS2;PYCR1;ALOX5
prerank,regulation of B cell activation (GO:0050864),0.16546903899708473,0.4835359112936973,0.9955555555555555,1.0,1.0,24/25,71.73%,FOXJ1;SH3KBP1;NOD2;ZFP36L1;LAPTM5;AHR;SAMSN1;TLR9;IGLL1;TNFSF4;MZB1;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;BANK1;FCGR2B;ZFP36L2;TNFAIP3
prerank,negative regulation of interleukin-10 production (GO:0032693),0.18257267169921243,0.48097225196670257,0.9913419913419913,0.9997344185579654,1.0,2/16,13.73%,TNFRSF21;DLL1
prerank,toxin transport (GO:1901998),-0.21273855886334536,-0.4791653827569123,0.9831460674157303,0.9972096316915601,1.0,4/10,32.84%,ANTXR2;ANTXR1;SLC22A2;ADAM10
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.18907918552870945,-0.47724014031444156,0.9981167608286252,0.9969582415147478,1.0,2/13,24.62%,PRKCD;SYK
prerank,ncRNA 3'-end processing (GO:0043628),0.18522006655365092,0.4750465346108565,0.9958246346555324,0.9996056336171026,1.0,14/14,81.49%,INTS2;ERI1;TOE1;INTS5;INTS8;INTS12;PTCD1;SSB;INTS6L;INTS7;ELAC2;TRNT1;INTS14;INTS6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.18339925911973376,0.4695408470952235,0.9918032786885246,0.999388779773435,1.0,14/14,81.68%,ATP6AP1;POU4F2;IFNG;TYROBP;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TRAF6
prerank,negative regulation of T cell proliferation (GO:0042130),-0.15535339961026062,-0.465576473089548,0.994392523364486,0.9975144864107232,1.0,5/28,22.91%,RC3H1;SDC4;SCRIB;DLG5;CD80
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.18066919565901454,-0.45528273835112854,0.9906890130353817,0.9978328214512142,1.0,7/14,38.73%,NCSTN;ADAM19;ABCA7;DYRK1A;ADAM10;ABCG1;ADAM17
prerank,nuclear pore organization (GO:0006999),0.17772903423028494,0.45079003541594864,0.9958419958419958,1.0,1.0,3/14,15.35%,NUP205;RTN4;NUP54
prerank,male meiosis I (GO:0007141),0.16923076923076935,0.4449685010973813,0.9978213507625272,0.9997022806268148,1.0,16/16,83.09%,ING2;FOXJ3;FOXJ2;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;BRDT;SLC25A31;DDX4;TDRD9;SYCP3;ZSCAN21;HSF2BP;MYBL1
prerank,leukotriene metabolic process (GO:0006691),0.1612063524201424,0.444882127131105,1.0,0.9990009082958025,1.0,4/19,19.26%,GGT1;MAPKAPK2;LTA4H;MGST3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.15319366869652754,0.43534314522231543,0.9979757085020243,0.9988502615529253,1.0,7/23,23.69%,TIMM22;NDUFA13;HSP90AA1;TOMM70;TIMM10B;BAX;ROMO1
prerank,nuclear pore complex assembly (GO:0051292),-0.1834134529574371,-0.41820705137129843,0.998109640831758,0.9992550482843005,1.0,4/10,34.38%,TPR;NUP98;NUP93;AHCTF1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.1507317902365331,-0.4180158086210486,0.9981617647058824,0.9988377627824457,1.0,3/22,16.02%,RUNX1;IRF1;DUSP10
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.1577925363970485,0.4051839228792597,1.0,0.9992235700748879,1.0,1/16,6.66%,HFM1
